WO2014194117A2 - Novel metalloproteases - Google Patents
Novel metalloproteases Download PDFInfo
- Publication number
- WO2014194117A2 WO2014194117A2 PCT/US2014/040063 US2014040063W WO2014194117A2 WO 2014194117 A2 WO2014194117 A2 WO 2014194117A2 US 2014040063 W US2014040063 W US 2014040063W WO 2014194117 A2 WO2014194117 A2 WO 2014194117A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- atom
- polypeptide
- amino acid
- composition
- metalloprotease
- Prior art date
Links
- 108010006035 Metalloproteases Proteins 0.000 title claims abstract description 261
- 102000005741 Metalloproteases Human genes 0.000 title claims abstract description 261
- 239000000203 mixture Substances 0.000 claims abstract description 338
- 238000000034 method Methods 0.000 claims abstract description 133
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 46
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 46
- 239000002157 polynucleotide Substances 0.000 claims abstract description 46
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 372
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 364
- 229920001184 polypeptide Polymers 0.000 claims description 359
- 238000004140 cleaning Methods 0.000 claims description 204
- 235000001014 amino acid Nutrition 0.000 claims description 107
- 102000004190 Enzymes Human genes 0.000 claims description 100
- 108090000790 Enzymes Proteins 0.000 claims description 100
- 229940088598 enzyme Drugs 0.000 claims description 98
- 239000003599 detergent Substances 0.000 claims description 97
- 108091005804 Peptidases Proteins 0.000 claims description 93
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 91
- 102000035195 Peptidases Human genes 0.000 claims description 88
- 229940024606 amino acid Drugs 0.000 claims description 88
- 239000004365 Protease Substances 0.000 claims description 79
- -1 bar Substances 0.000 claims description 78
- 102000005701 Calcium-Binding Proteins Human genes 0.000 claims description 69
- 108010045403 Calcium-Binding Proteins Proteins 0.000 claims description 69
- 150000001413 amino acids Chemical class 0.000 claims description 57
- 108090001060 Lipase Proteins 0.000 claims description 39
- 102000004882 Lipase Human genes 0.000 claims description 39
- 125000000539 amino acid group Chemical group 0.000 claims description 39
- 239000004367 Lipase Substances 0.000 claims description 38
- 235000019421 lipase Nutrition 0.000 claims description 38
- 239000004094 surface-active agent Substances 0.000 claims description 36
- 239000004744 fabric Substances 0.000 claims description 35
- 238000012217 deletion Methods 0.000 claims description 33
- 230000037430 deletion Effects 0.000 claims description 33
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 31
- 239000007844 bleaching agent Substances 0.000 claims description 31
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 29
- 230000000694 effects Effects 0.000 claims description 29
- 235000004400 serine Nutrition 0.000 claims description 29
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 28
- 238000012986 modification Methods 0.000 claims description 28
- 230000004048 modification Effects 0.000 claims description 28
- 229910001424 calcium ion Inorganic materials 0.000 claims description 27
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 24
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 24
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 22
- 238000004851 dishwashing Methods 0.000 claims description 22
- 229910019142 PO4 Inorganic materials 0.000 claims description 20
- 235000003704 aspartic acid Nutrition 0.000 claims description 20
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 20
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 19
- 239000004473 Threonine Substances 0.000 claims description 19
- 235000008521 threonine Nutrition 0.000 claims description 19
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 18
- 241001465754 Metazoa Species 0.000 claims description 18
- 239000013604 expression vector Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 17
- 108010084185 Cellulases Proteins 0.000 claims description 16
- 102000005575 Cellulases Human genes 0.000 claims description 16
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 16
- 102000004316 Oxidoreductases Human genes 0.000 claims description 16
- 108090000854 Oxidoreductases Proteins 0.000 claims description 16
- 239000010452 phosphate Substances 0.000 claims description 16
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 239000002736 nonionic surfactant Substances 0.000 claims description 15
- 241000193389 Bacillus thermoproteolyticus Species 0.000 claims description 14
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 14
- 230000001580 bacterial effect Effects 0.000 claims description 14
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 14
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 14
- 239000000654 additive Substances 0.000 claims description 13
- 102000003992 Peroxidases Human genes 0.000 claims description 12
- 235000009582 asparagine Nutrition 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 12
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 11
- 230000000996 additive effect Effects 0.000 claims description 11
- 108090000637 alpha-Amylases Proteins 0.000 claims description 11
- 235000013922 glutamic acid Nutrition 0.000 claims description 11
- 239000004220 glutamic acid Substances 0.000 claims description 11
- 239000004471 Glycine Substances 0.000 claims description 10
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 10
- 108010059820 Polygalacturonase Proteins 0.000 claims description 10
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 10
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 10
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 10
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 9
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 9
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 9
- 229960001230 asparagine Drugs 0.000 claims description 9
- 108010005400 cutinase Proteins 0.000 claims description 9
- 229930182817 methionine Natural products 0.000 claims description 9
- 239000004474 valine Substances 0.000 claims description 9
- 239000004475 Arginine Chemical group 0.000 claims description 8
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 8
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 8
- 108700020962 Peroxidase Proteins 0.000 claims description 8
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 8
- 235000004279 alanine Nutrition 0.000 claims description 8
- 229960000310 isoleucine Drugs 0.000 claims description 8
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 7
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical group NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 7
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical group OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Chemical group OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 7
- 235000009697 arginine Nutrition 0.000 claims description 7
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims description 7
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 239000004753 textile Substances 0.000 claims description 7
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 claims description 6
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 6
- 102000005840 alpha-Galactosidase Human genes 0.000 claims description 6
- 108010030291 alpha-Galactosidase Proteins 0.000 claims description 6
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 6
- 239000003381 stabilizer Substances 0.000 claims description 6
- 108010011619 6-Phytase Proteins 0.000 claims description 5
- 108010013043 Acetylesterase Proteins 0.000 claims description 5
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 claims description 5
- 108700038091 Beta-glucanases Proteins 0.000 claims description 5
- 108010053835 Catalase Proteins 0.000 claims description 5
- 102000016938 Catalase Human genes 0.000 claims description 5
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 claims description 5
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 claims description 5
- 101001096557 Dickeya dadantii (strain 3937) Rhamnogalacturonate lyase Proteins 0.000 claims description 5
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 claims description 5
- 101710111935 Endo-beta-1,4-glucanase Proteins 0.000 claims description 5
- 108090000371 Esterases Proteins 0.000 claims description 5
- 102100022624 Glucoamylase Human genes 0.000 claims description 5
- 108050008938 Glucoamylases Proteins 0.000 claims description 5
- 108050009363 Hyaluronidases Proteins 0.000 claims description 5
- 102000001974 Hyaluronidases Human genes 0.000 claims description 5
- 108010029541 Laccase Proteins 0.000 claims description 5
- 102000003820 Lipoxygenases Human genes 0.000 claims description 5
- 108090000128 Lipoxygenases Proteins 0.000 claims description 5
- 239000004472 Lysine Substances 0.000 claims description 5
- 102100036617 Monoacylglycerol lipase ABHD2 Human genes 0.000 claims description 5
- 108010064785 Phospholipases Proteins 0.000 claims description 5
- 102000015439 Phospholipases Human genes 0.000 claims description 5
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 5
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 5
- 108091007187 Reductases Proteins 0.000 claims description 5
- 108060008539 Transglutaminase Proteins 0.000 claims description 5
- 102000003425 Tyrosinase Human genes 0.000 claims description 5
- 108060008724 Tyrosinase Proteins 0.000 claims description 5
- 108010027199 Xylosidases Proteins 0.000 claims description 5
- 102000004139 alpha-Amylases Human genes 0.000 claims description 5
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 claims description 5
- 108010009043 arylesterase Proteins 0.000 claims description 5
- 102000028848 arylesterase Human genes 0.000 claims description 5
- 108010019077 beta-Amylase Proteins 0.000 claims description 5
- 238000004113 cell culture Methods 0.000 claims description 5
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 5
- 210000003746 feather Anatomy 0.000 claims description 5
- 108010002430 hemicellulase Proteins 0.000 claims description 5
- 239000002563 ionic surfactant Substances 0.000 claims description 5
- 108010059345 keratinase Proteins 0.000 claims description 5
- 108010062085 ligninase Proteins 0.000 claims description 5
- 235000018977 lysine Nutrition 0.000 claims description 5
- 108010087558 pectate lyase Proteins 0.000 claims description 5
- 108010072638 pectinacetylesterase Proteins 0.000 claims description 5
- 102000004251 pectinacetylesterase Human genes 0.000 claims description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Chemical group OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims description 5
- 108010038851 tannase Proteins 0.000 claims description 5
- 102000003601 transglutaminase Human genes 0.000 claims description 5
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims description 5
- 229920001221 xylan Polymers 0.000 claims description 5
- 150000004823 xylans Chemical class 0.000 claims description 5
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 claims description 5
- 102000057234 Acyl transferases Human genes 0.000 claims description 4
- 108700016155 Acyl transferases Proteins 0.000 claims description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 4
- 108700014220 acyltransferase activity proteins Proteins 0.000 claims description 4
- 239000010985 leather Substances 0.000 claims description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- 241000589516 Pseudomonas Species 0.000 claims description 3
- 238000001804 debridement Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 241000228212 Aspergillus Species 0.000 claims description 2
- 241000186216 Corynebacterium Species 0.000 claims description 2
- 241000588722 Escherichia Species 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 241000235648 Pichia Species 0.000 claims description 2
- 241000235070 Saccharomyces Species 0.000 claims description 2
- 241000187747 Streptomyces Species 0.000 claims description 2
- 241000223259 Trichoderma Species 0.000 claims description 2
- 239000003945 anionic surfactant Substances 0.000 claims description 2
- 239000003093 cationic surfactant Substances 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 239000002888 zwitterionic surfactant Substances 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 claims 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 claims 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 description 120
- 108090000623 proteins and genes Proteins 0.000 description 108
- 210000004027 cell Anatomy 0.000 description 98
- 102000039446 nucleic acids Human genes 0.000 description 87
- 108020004707 nucleic acids Proteins 0.000 description 87
- 102000004169 proteins and genes Human genes 0.000 description 82
- 235000018102 proteins Nutrition 0.000 description 80
- 235000019419 proteases Nutrition 0.000 description 49
- 108090001109 Thermolysin Proteins 0.000 description 48
- 150000003839 salts Chemical class 0.000 description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 47
- 239000000463 material Substances 0.000 description 41
- 108091028043 Nucleic acid sequence Proteins 0.000 description 39
- 238000006467 substitution reaction Methods 0.000 description 37
- 108020004414 DNA Proteins 0.000 description 34
- 102000053602 DNA Human genes 0.000 description 33
- 239000002253 acid Substances 0.000 description 31
- 239000003795 chemical substances by application Substances 0.000 description 30
- 239000013598 vector Substances 0.000 description 30
- 230000014509 gene expression Effects 0.000 description 25
- 229910052751 metal Inorganic materials 0.000 description 25
- 239000002184 metal Substances 0.000 description 25
- 229920000642 polymer Polymers 0.000 description 23
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 22
- 239000011575 calcium Substances 0.000 description 22
- 239000000758 substrate Substances 0.000 description 22
- 229910052791 calcium Inorganic materials 0.000 description 21
- 230000035772 mutation Effects 0.000 description 21
- 235000013339 cereals Nutrition 0.000 description 20
- 239000013612 plasmid Substances 0.000 description 20
- 238000003556 assay Methods 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 235000014469 Bacillus subtilis Nutrition 0.000 description 17
- 235000021317 phosphate Nutrition 0.000 description 17
- 230000008569 process Effects 0.000 description 17
- 238000005406 washing Methods 0.000 description 17
- 239000000975 dye Substances 0.000 description 16
- 238000003780 insertion Methods 0.000 description 16
- 230000037431 insertion Effects 0.000 description 16
- 230000002797 proteolythic effect Effects 0.000 description 16
- 108010065511 Amylases Proteins 0.000 description 15
- 230000002255 enzymatic effect Effects 0.000 description 15
- 102000013142 Amylases Human genes 0.000 description 14
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 14
- 235000019418 amylase Nutrition 0.000 description 14
- 239000003054 catalyst Substances 0.000 description 14
- 239000002738 chelating agent Substances 0.000 description 14
- 239000002773 nucleotide Substances 0.000 description 14
- 125000003729 nucleotide group Chemical group 0.000 description 14
- 241000894007 species Species 0.000 description 14
- 150000007513 acids Chemical class 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 238000000746 purification Methods 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 238000004061 bleaching Methods 0.000 description 11
- 239000002243 precursor Substances 0.000 description 11
- 238000012546 transfer Methods 0.000 description 11
- 108010076504 Protein Sorting Signals Proteins 0.000 description 10
- 230000003197 catalytic effect Effects 0.000 description 10
- 239000000945 filler Substances 0.000 description 10
- 238000009396 hybridization Methods 0.000 description 10
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 9
- 108020004705 Codon Proteins 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- 239000012190 activator Substances 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 9
- 229920002678 cellulose Polymers 0.000 description 9
- 239000001913 cellulose Substances 0.000 description 9
- 235000010980 cellulose Nutrition 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 230000007935 neutral effect Effects 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- CIEZZGWIJBXOTE-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]propanoic acid Chemical group OC(=O)C(C)N(CC(O)=O)CC(O)=O CIEZZGWIJBXOTE-UHFFFAOYSA-N 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 8
- 239000002270 dispersing agent Substances 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 235000019832 sodium triphosphate Nutrition 0.000 description 8
- 239000002689 soil Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- PQHYOGIRXOKOEJ-UHFFFAOYSA-N 2-(1,2-dicarboxyethylamino)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)NC(C(O)=O)CC(O)=O PQHYOGIRXOKOEJ-UHFFFAOYSA-N 0.000 description 7
- 239000004382 Amylase Substances 0.000 description 7
- 108020004635 Complementary DNA Proteins 0.000 description 7
- 229920001131 Pulp (paper) Polymers 0.000 description 7
- 229910052783 alkali metal Inorganic materials 0.000 description 7
- 229940025131 amylases Drugs 0.000 description 7
- 238000010804 cDNA synthesis Methods 0.000 description 7
- 125000002091 cationic group Chemical group 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 235000019833 protease Nutrition 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 150000004760 silicates Chemical class 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 235000015424 sodium Nutrition 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 108010059892 Cellulase Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 6
- 108020004511 Recombinant DNA Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 229910052802 copper Inorganic materials 0.000 description 6
- 239000010949 copper Substances 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 229910001425 magnesium ion Inorganic materials 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 238000002703 mutagenesis Methods 0.000 description 6
- 231100000350 mutagenesis Toxicity 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 239000004115 Sodium Silicate Substances 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 108010056079 Subtilisins Proteins 0.000 description 5
- 102000005158 Subtilisins Human genes 0.000 description 5
- 229910021536 Zeolite Inorganic materials 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 150000001768 cations Chemical class 0.000 description 5
- 229940106157 cellulase Drugs 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000008021 deposition Effects 0.000 description 5
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 5
- 229960001484 edetic acid Drugs 0.000 description 5
- 239000002979 fabric softener Substances 0.000 description 5
- 230000002538 fungal effect Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 229920001519 homopolymer Polymers 0.000 description 5
- 239000003752 hydrotrope Substances 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 229910052748 manganese Inorganic materials 0.000 description 5
- 239000011572 manganese Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 108010009355 microbial metalloproteinases Proteins 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 150000004965 peroxy acids Chemical class 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229910052723 transition metal Inorganic materials 0.000 description 5
- 238000009941 weaving Methods 0.000 description 5
- 239000010457 zeolite Substances 0.000 description 5
- VCVKIIDXVWEWSZ-YFKPBYRVSA-N (2s)-2-[bis(carboxymethyl)amino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)N(CC(O)=O)CC(O)=O VCVKIIDXVWEWSZ-YFKPBYRVSA-N 0.000 description 4
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 4
- 241000194108 Bacillus licheniformis Species 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 241000579835 Merops Species 0.000 description 4
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 4
- 239000006057 Non-nutritive feed additive Substances 0.000 description 4
- 241000282849 Ruminantia Species 0.000 description 4
- 108090000787 Subtilisin Proteins 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 235000019730 animal feed additive Nutrition 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 238000005260 corrosion Methods 0.000 description 4
- 238000009990 desizing Methods 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 239000000976 ink Substances 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 239000005022 packaging material Substances 0.000 description 4
- 229960003330 pentetic acid Drugs 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 238000002864 sequence alignment Methods 0.000 description 4
- 229910052911 sodium silicate Inorganic materials 0.000 description 4
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 150000003624 transition metals Chemical class 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 241001328122 Bacillus clausii Species 0.000 description 3
- 241000193422 Bacillus lentus Species 0.000 description 3
- 241000194103 Bacillus pumilus Species 0.000 description 3
- 241000193388 Bacillus thuringiensis Species 0.000 description 3
- 108091005658 Basic proteases Proteins 0.000 description 3
- 241000193764 Brevibacillus brevis Species 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000194105 Paenibacillus polymyxa Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical class [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 150000001340 alkali metals Chemical group 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 150000001508 asparagines Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001669 calcium Chemical class 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000004927 clay Chemical class 0.000 description 3
- 229910017052 cobalt Inorganic materials 0.000 description 3
- 239000010941 cobalt Substances 0.000 description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 230000007797 corrosion Effects 0.000 description 3
- 230000009260 cross reactivity Effects 0.000 description 3
- 101150089588 degU gene Proteins 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 239000007897 gelcap Substances 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000011256 inorganic filler Substances 0.000 description 3
- 229910003475 inorganic filler Inorganic materials 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 125000005342 perphosphate group Chemical group 0.000 description 3
- 229920000768 polyamine Polymers 0.000 description 3
- 229920005646 polycarboxylate Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 230000003362 replicative effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000019795 sodium metasilicate Nutrition 0.000 description 3
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- VXWBQOJISHAKKM-UHFFFAOYSA-N (4-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)C=C1 VXWBQOJISHAKKM-UHFFFAOYSA-N 0.000 description 2
- CIOXZGOUEYHNBF-UHFFFAOYSA-N (carboxymethoxy)succinic acid Chemical compound OC(=O)COC(C(O)=O)CC(O)=O CIOXZGOUEYHNBF-UHFFFAOYSA-N 0.000 description 2
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 2
- GTXVUMKMNLRHKO-UHFFFAOYSA-N 2-[carboxymethyl(2-sulfoethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CCS(O)(=O)=O GTXVUMKMNLRHKO-UHFFFAOYSA-N 0.000 description 2
- KWYJDIUEHHCHCZ-UHFFFAOYSA-N 3-[2-[bis(2-carboxyethyl)amino]ethyl-(2-carboxyethyl)amino]propanoic acid Chemical compound OC(=O)CCN(CCC(O)=O)CCN(CCC(O)=O)CCC(O)=O KWYJDIUEHHCHCZ-UHFFFAOYSA-N 0.000 description 2
- LKDMKWNDBAVNQZ-WJNSRDFLSA-N 4-[[(2s)-1-[[(2s)-1-[(2s)-2-[[(2s)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-WJNSRDFLSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 241000193752 Bacillus circulans Species 0.000 description 2
- 241000193749 Bacillus coagulans Species 0.000 description 2
- 241000194107 Bacillus megaterium Species 0.000 description 2
- 241001645709 Bacillus proteolyticus Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical class [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 241000282994 Cervidae Species 0.000 description 2
- 241000242346 Constrictibacter antarcticus Species 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- 108010062466 Enzyme Precursors Proteins 0.000 description 2
- 102000010911 Enzyme Precursors Human genes 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 241000270322 Lepidosauria Species 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- JYXGIOKAKDAARW-UHFFFAOYSA-N N-(2-hydroxyethyl)iminodiacetic acid Chemical compound OCCN(CC(O)=O)CC(O)=O JYXGIOKAKDAARW-UHFFFAOYSA-N 0.000 description 2
- 241000700124 Octodon degus Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical class [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241001337870 Paenibacillus ehimensis Species 0.000 description 2
- 241001497751 Paenibacillus hunanensis Species 0.000 description 2
- 241000592795 Paenibacillus sp. Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241001659629 Virgibacillus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 2
- 125000005600 alkyl phosphonate group Chemical group 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000012753 anti-shrinkage agent Substances 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 108010041102 azocasein Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 150000001860 citric acid derivatives Chemical class 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940090960 diethylenetriamine pentamethylene phosphonic acid Drugs 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000010011 enzymatic desizing Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229960004585 etidronic acid Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000002825 functional assay Methods 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000002070 germicidal effect Effects 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008233 hard water Substances 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- PMYUVOOOQDGQNW-UHFFFAOYSA-N hexasodium;trioxido(trioxidosilyloxy)silane Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-] PMYUVOOOQDGQNW-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- BQKYBHBRPYDELH-UHFFFAOYSA-N manganese;triazonane Chemical compound [Mn].C1CCCNNNCC1 BQKYBHBRPYDELH-UHFFFAOYSA-N 0.000 description 2
- YDSWCNNOKPMOTP-UHFFFAOYSA-N mellitic acid Chemical compound OC(=O)C1=C(C(O)=O)C(C(O)=O)=C(C(O)=O)C(C(O)=O)=C1C(O)=O YDSWCNNOKPMOTP-UHFFFAOYSA-N 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 108010020132 microbial serine proteinases Proteins 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 150000004712 monophosphates Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 101150077915 oppA gene Proteins 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000004967 organic peroxy acids Chemical class 0.000 description 2
- 229920000620 organic polymer Polymers 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 125000001151 peptidyl group Chemical group 0.000 description 2
- 229910052615 phyllosilicate Inorganic materials 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000019353 potassium silicate Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 108020004418 ribosomal RNA Proteins 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 102220162858 rs369457258 Human genes 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 235000019351 sodium silicates Nutrition 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 108010082371 succinyl-alanyl-alanyl-prolyl-phenylalanine-4-nitroanilide Proteins 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 238000002424 x-ray crystallography Methods 0.000 description 2
- LLSHAMSYHZEJBZ-BYPYZUCNSA-N (2s)-2-(2-sulfoethylamino)butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCS(O)(=O)=O LLSHAMSYHZEJBZ-BYPYZUCNSA-N 0.000 description 1
- UWRLZJRHSWQCQV-YFKPBYRVSA-N (2s)-2-(2-sulfoethylamino)pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NCCS(O)(=O)=O UWRLZJRHSWQCQV-YFKPBYRVSA-N 0.000 description 1
- HWXFTWCFFAXRMQ-JTQLQIEISA-N (2s)-2-[bis(carboxymethyl)amino]-3-phenylpropanoic acid Chemical compound OC(=O)CN(CC(O)=O)[C@H](C(O)=O)CC1=CC=CC=C1 HWXFTWCFFAXRMQ-JTQLQIEISA-N 0.000 description 1
- DCCWEYXHEXDZQW-BYPYZUCNSA-N (2s)-2-[bis(carboxymethyl)amino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)N(CC(O)=O)CC(O)=O DCCWEYXHEXDZQW-BYPYZUCNSA-N 0.000 description 1
- BEJKOYIMCGMNRB-GRHHLOCNSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BEJKOYIMCGMNRB-GRHHLOCNSA-N 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- SNUSZUYTMHKCPM-UHFFFAOYSA-N 1-hydroxypyridin-2-one Chemical compound ON1C=CC=CC1=O SNUSZUYTMHKCPM-UHFFFAOYSA-N 0.000 description 1
- YMEZKRMAPQIBQH-UHFFFAOYSA-N 1-oxidopyridin-1-ium-3-ol Chemical compound OC1=CC=C[N+]([O-])=C1 YMEZKRMAPQIBQH-UHFFFAOYSA-N 0.000 description 1
- VJSWLXWONORKLD-UHFFFAOYSA-N 2,4,6-trihydroxybenzene-1,3,5-trisulfonic acid Chemical compound OC1=C(S(O)(=O)=O)C(O)=C(S(O)(=O)=O)C(O)=C1S(O)(=O)=O VJSWLXWONORKLD-UHFFFAOYSA-N 0.000 description 1
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
- CFPOJWPDQWJEMO-UHFFFAOYSA-N 2-(1,2-dicarboxyethoxy)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)OC(C(O)=O)CC(O)=O CFPOJWPDQWJEMO-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- XWSGEVNYFYKXCP-UHFFFAOYSA-N 2-[carboxymethyl(methyl)amino]acetic acid Chemical compound OC(=O)CN(C)CC(O)=O XWSGEVNYFYKXCP-UHFFFAOYSA-N 0.000 description 1
- GZFRVDZZXXKIGR-UHFFFAOYSA-N 2-decanoyloxybenzoic acid Chemical compound CCCCCCCCCC(=O)OC1=CC=CC=C1C(O)=O GZFRVDZZXXKIGR-UHFFFAOYSA-N 0.000 description 1
- PSZAEHPBBUYICS-UHFFFAOYSA-N 2-methylidenepropanedioic acid Chemical compound OC(=O)C(=C)C(O)=O PSZAEHPBBUYICS-UHFFFAOYSA-N 0.000 description 1
- VSCBATMPTLKTOV-UHFFFAOYSA-N 2-tert-butylimino-n,n-diethyl-1,3-dimethyl-1,3,2$l^{5}-diazaphosphinan-2-amine Chemical compound CCN(CC)P1(=NC(C)(C)C)N(C)CCCN1C VSCBATMPTLKTOV-UHFFFAOYSA-N 0.000 description 1
- WYGJTQGGQYPSQV-UHFFFAOYSA-N 3,4-diacetylhex-3-ene-2,5-dione Chemical group CC(=O)C(C(C)=O)=C(C(C)=O)C(C)=O WYGJTQGGQYPSQV-UHFFFAOYSA-N 0.000 description 1
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical class C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- LLLVZDVNHNWSDS-UHFFFAOYSA-N 4-methylidene-3,5-dioxabicyclo[5.2.2]undeca-1(9),7,10-triene-2,6-dione Chemical compound C1(C2=CC=C(C(=O)OC(=C)O1)C=C2)=O LLLVZDVNHNWSDS-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000282979 Alces alces Species 0.000 description 1
- 241001147780 Alicyclobacillus Species 0.000 description 1
- 241001147782 Amphibacillus Species 0.000 description 1
- 241000555286 Aneurinibacillus Species 0.000 description 1
- 235000002198 Annona diversifolia Nutrition 0.000 description 1
- 241001626813 Anoxybacillus Species 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241000282815 Antilocapra americana Species 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000726096 Aratinga Species 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000006382 Bacillus halodurans Species 0.000 description 1
- 241000283726 Bison Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 101000851056 Bos taurus Elastin Proteins 0.000 description 1
- 241000283700 Boselaphus Species 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000555281 Brevibacillus Species 0.000 description 1
- 241000030939 Bubalus bubalis Species 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 241000700114 Chinchillidae Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- XXAXVMUWHZHZMJ-UHFFFAOYSA-N Chymopapain Chemical compound OC1=CC(S(O)(=O)=O)=CC(S(O)(=O)=O)=C1O XXAXVMUWHZHZMJ-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000252210 Cyprinidae Species 0.000 description 1
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 description 1
- 102100025698 Cytosolic carboxypeptidase 4 Human genes 0.000 description 1
- 102000016559 DNA Primase Human genes 0.000 description 1
- 108010092681 DNA Primase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 108091060211 Expressed sequence tag Proteins 0.000 description 1
- 101710107427 Extracellular metalloprotease Proteins 0.000 description 1
- 101710200557 Extracellular small neutral protease Proteins 0.000 description 1
- 108091092566 Extrachromosomal DNA Proteins 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000321606 Filobacillus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 241000699694 Gerbillinae Species 0.000 description 1
- 241000282818 Giraffidae Species 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 241001261512 Gracilibacillus Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000193004 Halobacillus Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101001054807 Homo sapiens Importin subunit alpha-6 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241001480714 Humicola insolens Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102100027007 Importin subunit alpha-6 Human genes 0.000 description 1
- 102100027612 Kallikrein-11 Human genes 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- 101710098556 Lipase A Proteins 0.000 description 1
- 101710098554 Lipase B Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000023320 Luma <angiosperm> Species 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 101710099648 Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 description 1
- 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 1
- 235000019735 Meat-and-bone meal Nutrition 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 108010049190 N,N-dimethylcasein Proteins 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- VEQPNABPJHWNSG-UHFFFAOYSA-N Nickel(2+) Chemical compound [Ni+2] VEQPNABPJHWNSG-UHFFFAOYSA-N 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091005461 Nucleic proteins Chemical group 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 241000179039 Paenibacillus Species 0.000 description 1
- 241001506910 Paenibacillus barcinonensis Species 0.000 description 1
- 241000194109 Paenibacillus lautus Species 0.000 description 1
- 241000611735 Paenibacillus peoriae Species 0.000 description 1
- 241000058353 Paenibacillus terrae Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000271379 Penicillium camembertii Species 0.000 description 1
- 235000002245 Penicillium camembertii Nutrition 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 239000004353 Polyethylene glycol 8000 Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004111 Potassium silicate Substances 0.000 description 1
- 102220643724 Prolactin-inducible protein_A90Y_mutation Human genes 0.000 description 1
- 101710118538 Protease Proteins 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000168225 Pseudomonas alcaligenes Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000589755 Pseudomonas mendocina Species 0.000 description 1
- 241000589614 Pseudomonas stutzeri Species 0.000 description 1
- 241000287530 Psittaciformes Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000303962 Rhizopus delemar Species 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 244000016016 Rubus hypargyrus var. niveus Species 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 241000287231 Serinus Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 101100309436 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) ftf gene Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 241001291204 Thermobacillus Species 0.000 description 1
- 241000223258 Thermomyces lanuginosus Species 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108091061763 Triple-stranded DNA Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 101710152431 Trypsin-like protease Proteins 0.000 description 1
- 241000321595 Ureibacillus Species 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 241001416177 Vicugna pacos Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 235000019752 Wheat Middilings Nutrition 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910052910 alkali metal silicate Inorganic materials 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229920002214 alkoxylated polymer Polymers 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- REDXJYDRNCIFBQ-UHFFFAOYSA-N aluminium(3+) Chemical compound [Al+3] REDXJYDRNCIFBQ-UHFFFAOYSA-N 0.000 description 1
- HPTYUNKZVDYXLP-UHFFFAOYSA-N aluminum;trihydroxy(trihydroxysilyloxy)silane;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O[Si](O)(O)O HPTYUNKZVDYXLP-UHFFFAOYSA-N 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000010868 animal carcass Substances 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 101150009206 aprE gene Proteins 0.000 description 1
- 230000002358 autolytic effect Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 229940044172 calcium formate Drugs 0.000 description 1
- 235000019255 calcium formate Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 1
- ZUKDFIXDKRLHRB-UHFFFAOYSA-K cobalt(3+);triacetate Chemical compound [Co+3].CC([O-])=O.CC([O-])=O.CC([O-])=O ZUKDFIXDKRLHRB-UHFFFAOYSA-K 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000011549 crystallization solution Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 150000005676 cyclic carbonates Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 101150085919 degQ gene Proteins 0.000 description 1
- 101150023726 degR gene Proteins 0.000 description 1
- 101150083941 degS gene Proteins 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- NHWGPUVJQFTOQX-UHFFFAOYSA-N ethyl-[2-[2-[ethyl(dimethyl)azaniumyl]ethyl-methylamino]ethyl]-dimethylazanium Chemical compound CC[N+](C)(C)CCN(C)CC[N+](C)(C)CC NHWGPUVJQFTOQX-UHFFFAOYSA-N 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007730 finishing process Methods 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000008394 flocculating agent Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical class OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229910052621 halloysite Inorganic materials 0.000 description 1
- 238000012835 hanging drop method Methods 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000012615 high-resolution technique Methods 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 229910052900 illite Inorganic materials 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002743 insertional mutagenesis Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002697 manganese compounds Chemical class 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000008402 moderately hard water Substances 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical compound [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 description 1
- 101150112117 nprE gene Proteins 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- MHHDXUNFNAZUGB-UHFFFAOYSA-N oxidovanadium(2+) Chemical compound [V+2]=O MHHDXUNFNAZUGB-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- SIENSFABYFDZCL-UHFFFAOYSA-N phenyl decanoate Chemical compound CCCCCCCCCC(=O)OC1=CC=CC=C1 SIENSFABYFDZCL-UHFFFAOYSA-N 0.000 description 1
- ZPORCTAUIXXZAI-UHFFFAOYSA-N phenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC1=CC=CC=C1 ZPORCTAUIXXZAI-UHFFFAOYSA-N 0.000 description 1
- SOOXQKVMQBCEGW-UHFFFAOYSA-N phenyl hexanoate Chemical compound CCCCCC(=O)OC1=CC=CC=C1 SOOXQKVMQBCEGW-UHFFFAOYSA-N 0.000 description 1
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical class OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920003214 poly(methacrylonitrile) Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 235000019446 polyethylene glycol 8000 Nutrition 0.000 description 1
- 229940085678 polyethylene glycol 8000 Drugs 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical compound [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 description 1
- 229910052913 potassium silicate Inorganic materials 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000004076 pulp bleaching Methods 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 101150025220 sacB gene Proteins 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 229910052706 scandium Inorganic materials 0.000 description 1
- SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- NCGJACBPALRHNG-UHFFFAOYSA-M sodium;2,4,6-trinitrobenzenesulfonate Chemical compound [Na+].[O-][N+](=O)C1=CC([N+]([O-])=O)=C(S([O-])(=O)=O)C([N+]([O-])=O)=C1 NCGJACBPALRHNG-UHFFFAOYSA-M 0.000 description 1
- 239000008234 soft water Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 101150105742 spoIIE gene Proteins 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000000454 talc Chemical class 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000005494 tarnishing Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- LKHDXIBHVSGUHN-UHFFFAOYSA-N thiadiazole 1,1-dioxide Chemical class O=S1(=O)C=CN=N1 LKHDXIBHVSGUHN-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 108010087967 type I signal peptidase Proteins 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 150000003732 xanthenes Chemical class 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24027—Thermolysin (3.4.24.27)
Definitions
- compositions containing the proteases are suitable for use in cleaning, food and feed as well as in a variety of other industrial applications.
- M4 Metalloproteases
- MEROPS Rotarys et al., (2012) Nucleic Acids Res 40:D343-D350. They are generally active at elevated temperatures and this stability is attributed to calcium binding.
- proteases have long been known in the art of industrial enzymes, there remains a need for novel proteases that are suitable for particular conditions and uses, such as environments that have calcium chelators that destabilize metalloproteases.
- the present disclosure provides, inter alia, metalloproteases comprising modifications in calcium binding regions, novel metallopro tease polypeptides with signature amino acids in the calcium binding regions, nucleic acids encoding the same, and compositions and methods related to the production and use thereof.
- the invention is a metalloprotease polypeptide comprising one or more calcium binding regions.
- the polypeptide comprises a modification in at least one amino acid residue in one of the calcium binding regions, Cal-2, Ca3 and Ca4, (including residues 55-66, 136, 138, 177-190, and 193-200) of the polypeptide, wherein the amino acid positions of the polypeptide are numbered by correspondence with the amino acid sequence of Bacillus thermoproteolyticus metalloprotease set forth in SEQ ID NO: 13.
- the polypeptide has a calcium binding region Cal-2 that binds fewer than two calcium ions.
- the polypeptide has a calcium binding region 3 that binds fewer than one calcium ion. In some embodiments, the polypeptide has a calcium binding region 4 that binds fewer than one calcium ion. In some embodiments, the polypeptide is a variant of a parent polypeptide. In some embodiments, the parent polypeptide is an M4 metalloprotease. In some embodiments, the polypeptide has at least 60% sequence identity to any one of SEQ ID NOs: 1-15.
- the invention is a composition comprising at least one variant as listed above. In some embodiments, the invention is a method of cleaning using a cleaning composition as listed above.
- Figure 1 provides a schematic showing the arrangement of the two independent molecules of PehProl in the asymmetric unit of the crystal unit cell.
- Figure 2 provides a stereo showing a schematic of the Thermolysin main chain folding (black) and the schematic of PehProl (light gray).
- Figure 3 provides a close up view of the 3 residue deletion.
- Figure 4 provides a close up view of the 5 residue deletion.
- Figure 5 provides a comparison of calcium binding site 1 in PehProl and the Cal-2 calcium binding site in Thermolysin.
- Figure 6 provides a schematic comparing Thermolysin (black lines) with PehProl (light gray sticks) in the vicinity of the second calcium binding site (Ca4) in PehProl.
- Figure 7 provides a comparison of the structures of Thermolysin (black lines) and PehProl (light gray sticks) in the region of calcium binding Ca3 present in Thermolysin.
- Figure 8 provides a schematic comparing the main chain folding of PehProl (dark gray) and
- Figure 9 provides a comparison of the first common calcium binding site between PehProl (light gray) and Ppopro2 (dark gray).
- Figure 10 provides a comparison of the structure of PehProl (light gray) and PpoPro2 (dark gray) at the second common calcium site.
- Figure 11 provides a comparison of the third calcium binding site seen in PpoPro2 (dark gray) as compared to PehProl (light gray).
- Figure 12a-f provides a structure-based alignment of the various metalloproteases Pehl.A (Paenibacillus ehimensis, protein 1), PbaProl (Paenibacillus barcinonensis, protein 1)), PhuProl (Paenibacillus hunanensis, protein 1), PpoPro2 (Paenibacillus polymyxa, protein 2), PpoProl(Paenibacillus polymyxa, protein 1), Thermolysin (Bacillus thermoproteolyticus, protein 1), PhuPro2 (Paenibacillus hunanensis, protein 2), PspPro2 (Paenibacillus sp., protein 2), PspPro3 (Paenibacillus sp., protein 3), PpeProl (Paenibacillus peoriae, protein 1), PteProl (Paenibacillus terrae,
- Figure 14 provides a comparison of NprE variant with Thermolysin at the Ca3 site.
- Figure 15 provides several proteases contain the double delete and lack of the DxD motif shown in a rectangle.
- Figure 16 provides a stereodiagram comparing the overall main chain folding pattern of
- Thermolysin black with the NprE variant structure (gray).
- Figure 17 provides a comparison of the structures of the NprE variant and Thermolysin at the Ca4 binding site of Thermolysin.
- the deletion of three residues in NprE relative to Thermolysin results in the elimination of a calcium binding site.
- the present invention provides novel variant metalloproteases having modifications at calcium binding regions.
- the MEROPS database https://merops.sanger.ac.uk
- a peptidase is classified into a family based on sharing significant similarities in amino acid sequence with the type example or another member of the family.
- Release 9.4 of the MEROPS database there are a total of 63 metalloprotease families, nine of which include but are not limited to BEMP members. These proteases are distributed among 9 families of metalloproteases because of differences in primary sequences and structural characteristics.
- BEMPs Bacterial extracellular metalloproteases (BEMPs) are a large group of metal-containing proteases secreted by heterotropic bacteria [Wu and Chen (2011) Appl. Biol. Biotechnol. 92:253].
- BEMPs are distributed among the metalloprotease families M4, M5, M9, M10, M12, M13, M23, M30, and M34.
- the M4 is a large family of metalloproteases, mostly BEMPs.
- Thermolysin is the prototype of the M4 family.
- Thermolysin-like proteases are broad-specificity proteases which contain a catalytic zinc ion in their active sites.
- the thermostable Bacillus neutral metalloproteases bind 4 Ca 2+ ions. Two Ca 2+ ions are bound in one double calcium binding site (Cal-2) and 2 Ca 2+ ions are bound in single binding sites Ca3 and Ca4 [Stark et al (1992) Eur. J. Biochem. 207:207, Veltman et al (1998) Biochem. 37:5312].
- Several studies have shown that these proteases are dependent on calcium binding for their stability [Veltman et al (1997) FEBS 405:241].
- the single sites Ca3 and Ca4 are absent in the thermolysin-like proteases considered thermolabile [Eijsink et al (2011) Prot. Sci. 20: 1346].
- thermolysin-like proteinases can perform well in a number of industrial applications such as a detergent additive for laundry and dish cleaning, potentially as feed additives, fermentation aides, as well as a number of pharmaceutical application such as cell culture and tissue dissociation.
- Earlier studies have demonstrated the importance of calcium binding in a number of mutational studies.
- Eijsink et al 2011, [Eijsink, Matthews and Vriend (2011) Prot Sci 20: 1346-1355]
- mutation of Asp57 or Asp 59 in the Ca3 site were shown to dramatically reduce stability in thermolysin.
- the authors postulate that calcium binding site may have evolved evolutionarily as a means or regulating function but destabilizing structure and hence function in the low calcium environment of the cytosol until secreted into a higher calcium environment outside the cell membrane.
- Metalloproteases for example, M4 clan metalloproteases, have calcium binding regions. Without being bound by theory, these calcium binding regions are thought to contribute to the thermostability of these molecules. In some applications, it is beneficial to reduce the dependence of the metalloproteases on calcium binding.
- detergent compositions contain metal chelators, such as surfactants, which compete for calcium ions and affects the amount of free calcium available to bind the enzyme [Stoner et al. (2005) Biotechnol Prog. 21(6): 1716-23]. In detergent environments, metalloproteases can be subject to destabilization and autolysis due to this lack of free calcium. Thus, there is a need in the art to discover improved metalloproteases which are stable in environments that compete for free calcium, such as detergent compositions, while allowing for maintained proteolytic activity of the
- thermolysin-like proteases having fewer calcium binding sites
- PehProl as shown in Example 2, and PpoPro2, Paenibacillus polymyxa protease in Ruf et al 2013 [Ruf et al (2013) Acta Cryst. D69:24-31).
- the elimination of calcium binding is attributed to a combination of specific amino acid substitutions and deletion that are found to be common to these and related structures resulting in fewer calcium binding coordination sites. Based on these finding, a means for further reducing the number of calcium bound to only one or none is proposed for thermolysin and other thermolysin-like proteinases.
- the invention is variant metalloproteases having modified calcium binding regions. In some embodiments, these modified calcium binding regions result in reduced calcium binding of the metalloprotease enzyme. In other embodiments, the invention is novel metalloproteases having newly discovered calcium binding regions. In some
- the invention includes compositions comprising at least one of the novel metalloprotease enzymes set forth herein. Some such compositions comprise detergent compositions.
- the metalloprotease enzymes of the present invention can be combined with other enzymes useful in detergent compositions.
- the invention also provides methods of cleaning using metalloprotease enzymes of the present invention.
- protease As used herein, the terms “protease” and “proteinase” refer to an enzyme that has the ability to break down proteins and peptides.
- a protease has the ability to conduct “proteolysis,” by hydrolysis of peptide bonds that link amino acids together in a peptide or polypeptide chain forming the protein. This activity of a protease as a protein-digesting enzyme is referred to as "proteolytic activity.”
- proteolytic activity Many well known procedures exist for measuring proteolytic activity (See e.g., Kalisz, "Microbial Proteinases," In: Fiechter (ed.), Advances in Biochemical
- proteolytic activity may be ascertained by comparative assays which analyze the respective protease' s ability to hydrolyze a suitable substrate.
- substrates useful in the analysis of protease or proteolytic activity include, but are not limited to, di-methyl casein (Sigma C-9801), bovine collagen (Sigma C- 9879), bovine elastin (Sigma E- 1625), and bovine keratin (ICN Biomedical 902111).
- pNA peptidyl assay See e.g., Del Mar et ah, Anal. Biochem. 99:316-320 [1979]) also finds use in determining the active enzyme concentration. This assay measures the rate at which p- nitroaniline is released as the enzyme hydrolyzes a soluble synthetic substrate, such as succinyl- alanine-alanine-proline-phenylalanine-p-nitroanilide (suc-AAPF-pNA).
- a soluble synthetic substrate such as succinyl- alanine-alanine-proline-phenylalanine-p-nitroanilide (suc-AAPF-pNA).
- variable polypeptide refers to a polypeptide comprising an amino acid sequence that differs in at least one amino acid residue from the amino acid sequence of a parent or reference polypeptide (including but not limited to wild-type polypeptides).
- the genus Bacillus includes all species within the genus "Bacillus " as known to those of skill in the art, including but not limited to B. subtilis, B. licheniformis, B. lentus, B. brevis, B. stearothermophilus, B. alkalophilus, B. amyloliquefaciens, B. clausii, B. halodurans, B. megaterium, B. coagulans, B. circulans, B. lautus, and B. thuringiensis . It is recognized that the genus Bacillus continues to undergo taxonomical reorganization. Thus, it is intended that the genus include species that have been reclassified, including but not limited to such organisms as B. stearothermophilus, which is now named "Geobacillus
- Anoxybacillus Brevibacillus, Filobacillus, Gracilibacillus, Halobacillus, Paenibacillus, Salibacillus, Thermobacillus, Ureibacillus, and Virgibacillus .
- calcium binding site refers to a region within a metalloprotease which can bind a calcium ion in the presence of free calcium.
- Calcium can act to assist in maintaining the structural integrity of metallopro teases under many conditions.
- the amount of free calcium can be related to the water hardness during wash conditions, and can range from soft water, having less than 1.0 Calcium grains per gallon, to slightly hard water, having from about 1.0 to 3.5 Calcium grains per gallon, to moderately hard water, having from about 3.5 to 7.0 Calcium grains per gallon, to hard water, having from about 7.0 to 10.5 or more Calcium grains per gallon.
- the characteristics of the calcium binding site are modified compared to a parent or reference metalloprotease so as to modify the performance of the metalloprotease.
- Modification of the calcium binding site may include reducing or increasing the affinity of the site to bind calcium ion.
- Modifying the performance of the metalloprotease is intended to include modification of the stability (e.g., oxidative or thermal) or the activity (e.g., the rate or efficiency with which the metalloprotease hydrolyzes a protein substrate) of the enzyme in its various applications.
- calcium ligand means an amino acid residue or residues within a metalloprotease enzyme which forms a ligand with calcium ion bound within a calcium binding site.
- polynucleotide and “nucleic acid,” which are used interchangeably herein, refer to a polymer of any length of nucleotide monomers covalently bonded in a chain.
- DNA deoxyribonucleic acid
- RNA RNA
- ribonucleic acid a polymer of ribonucleotides
- Polynucleotides or nucleic acids include, but are not limited to, a single-, double- or triple- stranded DNA, genomic DNA, cDNA, RNA, DNA-RNA hybrid, or a polymer comprising purine and pyrimidine bases, or other natural, chemically, biochemically modified, non-natural or derivatized nucleotide bases.
- polynucleotides genes, gene fragments, chromosomal fragments, expressed sequence tag(s) (EST(s)), exons, introns, messenger RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), ribozymes, complementary DNA (cDNA), recombinant polynucleotides, branched polynucleotides, plasmids, vectors, isolated DNA of any sequence, isolated RNA of any sequence, nucleic acid probes, and primers.
- EST(s) expressed sequence tag(s)
- mRNA messenger RNA
- tRNA transfer RNA
- rRNA ribosomal RNA
- cDNA complementary DNA
- modification refers to changes made to a reference amino acid or nucleic acid sequence. It is intended that the term encompass substitutions, insertions and deletions.
- vector refers to a nucleic acid construct used to introduce or transfer nucleic acid(s) into a target cell or tissue.
- a vector is typically used to introduce foreign DNA into a cell or tissue.
- Vectors include plasmids, cloning vectors, bacteriophages, viruses (e.g., viral vector), cosmids, expression vectors, shuttle vectors, and the like.
- a vector typically includes an origin of replication, a multicloning site, and a selectable marker. The process of inserting a vector into a target cell is typically referred to as transformation.
- the present invention includes, in some embodiments, a vector that comprises a DNA sequence encoding a metalloprotease polypeptide (e.g., precursor or mature metalloprotease polypeptide) that is operably linked to a suitable prosequence (e.g., secretory, signal peptide sequence, etc.) capable of effecting the expression of the DNA sequence in a suitable host, and the folding and translocation of the recombinant polypeptide chain.
- a metalloprotease polypeptide e.g., precursor or mature metalloprotease polypeptide
- a suitable prosequence e.g., secretory, signal peptide sequence, etc.
- expression cassette refers to a nucleic acid construct or vector generated recombinantly or synthetically for the expression of a nucleic acid of interest in a target cell.
- An expression vector or expression cassette typically comprises a promoter nucleotide sequence that drives expression of the foreign nucleic acid.
- the expression vector or cassette also typically includes any other specified nucleic acid elements that permit transcription of a particular nucleic acid in a target cell.
- a recombinant expression cassette can be incorporated into a plasmid, chromosome, mitochondrial DNA, plastid DNA, virus, or nucleic acid fragment. Many prokaryotic and eukaryotic expression vectors are commercially available.
- the ends of the sequence are closed such that the DNA construct forms a closed circle.
- the nucleic acid sequence of interest which is incorporated into the DNA construct, using techniques well known in the art, may be a wild-type, mutant, or modified nucleic acid.
- the DNA construct comprises one or more nucleic acid sequences homologous to the host cell chromosome.
- the DNA construct comprises one or more non-homologous nucleotide sequences.
- DNA construct is used interchangeably herein with "expression cassette.”
- plasmid refers to an extrachromosomal DNA molecule which is capable of replicating independently from the chromosomal DNA.
- a plasmid is double stranded (ds) and may be circular and is typically used as a cloning vector.
- the term "introduced” refers to any method suitable for transferring the nucleic acid sequence into the cell. Such methods for introduction include but are not limited to protoplast fusion, transfection, transformation, electroporation, conjugation, and transduction (See e.g., Ferrari et ah ,
- Transformation refers to the genetic alteration of a cell which results from the uptake, optional genomic incorporation, and expression of genetic material (e.g., DNA).
- a nucleic acid is "operably linked" with another nucleic acid sequence when it is placed into a functional relationship with another nucleic acid sequence.
- a promoter or enhancer is operably linked to a nucleotide coding sequence if the promoter affects the transcription of the coding sequence.
- a ribosome binding site may be operably linked to a coding sequence if it is positioned so as to facilitate translation of the coding sequence.
- "operably linked" DNA sequences are contiguous. However, enhancers do not have to be contiguous. Linking is accomplished by ligation at convenient restriction sites. If such sites do not exist, synthetic oligonucleotide adaptors or linkers may be used in accordance with conventional practice.
- the term “gene” refers to a polynucleotide (e.g., a DNA segment), that encodes a polypeptide and includes regions preceding and following the coding regions as well as intervening sequences (introns) between individual coding segments (exons).
- “recombinant” when used with reference to a cell typically indicates that the cell has been modified by the introduction of a foreign nucleic acid sequence or that the cell is derived from a cell so modified.
- a recombinant cell may comprise a gene not found in identical form within the native (non-recombinant) form of the cell, or a recombinant cell may comprise a native gene (found in the native form of the cell) but which has been modified and re-introduced into the cell.
- a recombinant cell may comprise a nucleic acid endogenous to the cell that has been modified without removing the nucleic acid from the cell; such modifications include those obtained by gene replacement, site-specific mutation, and related techniques known to those of ordinary skill in the art.
- Recombinant DNA technology includes techniques for the production of recombinant DNA in vitro, and transfer of the recombinant DNA into cells where it may be expressed or propagated, thereby producing a recombinant polypeptide. "Recombination,” “recombining,” and “recombined” of
- polynucleotides or nucleic acids refer generally to the assembly or combining of two or more nucleic acid or polynucleotide strands or fragments to generate a new polynucleotide or nucleic acid.
- the recombinant polynucleotide or nucleic acid is sometimes referred to as a chimera.
- a nucleic acid or polypeptide is "recombinant" when it is artificial or engineered.
- a nucleic acid or polynucleotide is said to "encode" a polypeptide if, in its native state or when manipulated by methods known to those of skill in the art, it can be transcribed and/or translated to produce the polypeptide or a fragment thereof.
- the anti-sense strand of such a nucleic acid is also said to encode the sequence.
- “Host strain” or “host cell” refers to a suitable host for an expression vector comprising a DNA sequence of interest.
- a “protein” or “polypeptide” comprises a polymeric sequence of amino acid residues.
- the terms “protein” and “polypeptide” are used interchangeably herein.
- the single and 3-letter code for amino acids as defined in conformity with the IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN) is used through out this disclosure.
- the single letter X refers to any of the twenty amino acids. It is also understood that a polypeptide may be coded for by more than one nucleotide sequence due to the degeneracy of the genetic code. Mutations can be named by the one letter code for the parent amino acid, followed by a position number and then the one letter code for the variant amino acid.
- mutating glycine (G) at position 87 to serine (S) is represented as “G087S” or “G87S”.
- Mutations can also be named by using the three letter code for an amino acid followed by its position in the polypeptide chain as counted from the N-terminus; for example, AlalO for alanine at position 10. Multiple mutations are indicated by inserting a "+,” “/,” or “;” between the mutations.
- Mutations at positions 87 and 90 are represented as either “G087S-A090Y” or “G87S-A90Y” or “G87S + A90Y” or "G087S + A090Y”.
- one or more inserted amino acids can be listed after a position.
- G087GS describes a serine inserted after the glycine at position 87; as a second example, “G087GSA” describes a serine and alanine inserted after the glycine at position 87. Insertions can be done in combination with substitutions; thus, “G087RS” describes a substitution at position 87 from glycine to arginine, followed by an inserted serine residue. For deletions, either a " ⁇ " or “del” is used following the position number. Thus, for example, "G087del” describes deletion of the glycine at position 87.
- a position followed by amino acids listed in parentheses indicates a list of substitutions at that position by any of the listed amino acids. For example, 6(L,I) means position 6 can be substituted with a leucine or isoleucine.
- prosequence or “propetide sequence” refers to an amino acid sequence between the signal peptide sequence and mature protease sequence that is necessary for the proper folding and secretion of the protease; they are sometimes referred to as intramolecular chaperones. Cleavage of the prosequence or propeptide sequence results in a mature active protease.
- Bacterial metalloproteases are often expressed as pro-enzymes.
- signal sequence or “signal peptide” refers to a sequence of amino acid residues that may participate in the secretion or direct transport of the mature or precursor form of a protein.
- the signal sequence is typically located N-terminal to the precursor or mature protein sequence.
- the signal sequence may be endogenous or exogenous.
- a signal sequence is normally absent from the mature protein.
- a signal sequence is typically cleaved from the protein by a signal peptidase after the protein is transported.
- mature form of a protein, polypeptide, or peptide refers to the functional form of the protein, polypeptide, or peptide without the signal peptide sequence and propeptide sequence.
- precursor form of a protein or peptide refers to a mature form of the protein having a prosequence operably linked to the amino or carbonyl terminus of the protein.
- the precursor may also have a "signal" sequence operably linked to the amino terminus of the prosequence.
- the precursor may also have additional polypeptides that are involved in post- translational activity (e.g., polypeptides cleaved therefrom to leave the mature form of a protein or peptide).
- wild-type in reference to an amino acid sequence or nucleic acid sequence indicates that the amino acid sequence or nucleic acid sequence is native or naturally occurring sequence.
- naturally-occurring refers to anything (e.g., proteins, amino acids, or nucleic acid sequences) that are found in nature.
- non-naturally occurring refers to anything that is not found in nature (e.g., recombinant nucleic acids and protein sequences produced in the laboratory), as modification of the wild-type sequence.
- corresponding to or “corresponds to” or “corresponds” refers to an amino acid residue at the enumerated position in a protein or peptide, or an amino acid residue that is analogous, homologous, or equivalent to an enumerated residue in a protein or peptide.
- corresponding region generally refers to an analogous position in a related proteins or a reference protein.
- derived from and “obtained from” refer to not only a protein produced or producible by a strain of the organism in question, but also a protein encoded by a DNA sequence isolated from such strain and produced in a host organism containing such DNA sequence. Additionally, the term refers to a protein which is encoded by a DNA sequence of synthetic and/or cDNA origin and which has the identifying characteristics of the protein in question.
- proteases derived from Bacillus refers to those enzymes having proteolytic activity which are naturally produced by Bacillus, as well as to metalloproteases like those produced by Bacillus sources but which through the use of genetic engineering techniques are produced by non-Bacillus organisms transformed with a nucleic acid encoding the serine proteases.
- nucleic acids or polypeptide sequences refers to the residues in the two sequences that are the same when aligned for maximum
- homologous genes refers to a pair of genes from different, but usually related species, which correspond to each other and which are identical or very similar to each other.
- the term encompasses genes that are separated by speciation (i.e., the development of new species) (e.g., orthologous genes), as well as genes that have been separated by genetic duplication (e.g., paralogous genes).
- homologous proteins refers to proteins from different, but usually related species, which are very similar to each other.
- % identity or percent identity refers to sequence identity, at the gene or protein level. The output for these calculations are highly dependent on the algorithm used and the parameters selected such as length of compared sequences. Percent identity may be determined using standard techniques known in the art (See e.g., Smith and Waterman, Adv. Appl. Math. 2:482 [1981]; Needleman and Wunsch, J. Mol. Biol. 48:443 [1970]; Pearson and Lipman, Proc. Natl. Acad. Sci. USA 85:2444 [1988]; software programs such as GAP,
- PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pair-wise alignments. It can also plot a tree showing the clustering relationships used to create the alignment. PILEUP uses a simplification of the progressive alignment method of Feng and Doolittle ⁇ See, Feng and Doolittle, J. Mol. Evol. 35:351-360 [1987]).
- Useful PILEUP parameters include a default gap weight of 3.00, a default gap length weight of 0.10, and weighted end gaps.
- Other useful algorithm is the BLAST algorithms described by Altschul et al, ⁇ See, Altschul et al., J. Mol. Biol. 215:403-410 [1990]; and Karlin and Altschul, Proc. Natl. Acad. Sci. USA 90:5873-5787 [1993]). The BLAST program uses several search parameters, most of which are set to the default values.
- NCBI BLAST algorithm finds the most relevant sequences in terms of biological similarity but is not recommended for query sequences of less than 20 residues (Altschul, SF et al. (1997) Nucleic Acids Res. 25:3389-3402 and Schaffer, AA et al. (2001) Nucleic Acids Res. 29:2994-3005).
- Example default BLAST parameters for a nucleic acid sequence searches are:
- a percent ( ) amino acid sequence identity value is determined by the number of matching identical residues divided by the total number of residues of the "reference” sequence including any gaps created by the program for optimal/maximum alignment. If a sequence is 90% identical to SEQ ID NO: A, SEQ ID NO: A is is the “reference” sequence. BLAST algorithms refer the "reference” sequence as "query” sequence.
- CLUSTAL W algorithm is another example of a sequence alignment algorithm. See Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680. Default parameters for the
- Gap extension penalty 0.05
- deletions occurring at either terminus are included.
- a variant with five amino acid deletion at either terminus (or within the polypeptide) of a polypeptide of 500 amino acids would have a percent sequence identity of 99% (495/500 identical residues x 100) relative to the "reference" polypeptide.
- Such a variant would be encompassed by a variant having "at least 99% sequence identity" to the polypeptide.
- a polypeptide of interest may be said to be "substantially identical" to a reference polypeptide if the polypeptide of interest comprises an amino acid sequence having at least about 60%, least about 65%, least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or at least about 99.5% sequence identity to the amino acid sequence of the reference polypeptide.
- the percent identity between two such polypeptides can be determined manually by inspection of the two optimally aligned polypeptide sequences or by using software programs or algorithms ⁇ e.g., BLAST, ALIGN, CLUSTAL) using standard parameters.
- One indication that two polypeptides are substantially identical is that the first polypeptide is immunologically cross-reactive with the second polypeptide.
- polypeptides that differ by conservative amino acid substitutions are immunologically cross-reactive.
- a polypeptide is substantially identical to a second polypeptide, for example, where the two peptides differ only by a conservative amino acid substitution or one or more conservative amino acid substitutions.
- a nucleic acid of interest may be said to be "substantially identical" to a reference nucleic acid if the nucleic acid of interest comprises a nucleotide sequence having least about 60%, least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or at least about 99.5% sequence identity to the nucleotide sequence of the reference nucleic acid.
- the percent identity between two such nucleic acids can be determined manually by inspection of the two optimally aligned nucleic acid sequences or by using software programs or algorithms (e.g., BLAST, ALIGN, CLUSTAL) using standard parameters.
- One indication that two nucleic acid sequences are substantially identical is that the two nucleic acid molecules hybridize to each other under stringent conditions (e.g., within a range of medium to high stringency).
- a nucleic acid or polynucleotide is “isolated” when it is at least partially or completely separated from other components, including but not limited to for example, other proteins, nucleic acids, cells, etc.
- a polypeptide, protein or peptide is “isolated” when it is at least partially or completely separated from other components, including but not limited to for example, other proteins, nucleic acids, cells, etc.
- an isolated species is more abundant than are other species in a composition.
- an isolated species may comprise at least about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, or about 100% (on a molar basis) of all macromolecular species present.
- the species of interest is purified to essential homogeneity (i.e., contaminant species cannot be detected in the composition by conventional detection methods).
- Purity and homogeneity can be determined using a number of techniques well known in the art, such as agarose or polyacrylamide gel electrophoresis of a nucleic acid or a protein sample, respectively, followed by visualization upon staining.
- a high-resolution technique such as high performance liquid chromatography (HPLC) or a similar means can be utilized for purification of the material.
- HPLC high performance liquid chromatography
- Hybridization refers to the process by which one strand of nucleic acid forms a duplex with, i.e. , base pairs with, a complementary strand.
- a nucleic acid sequence is considered to be “selectively hybridizable" to a reference nucleic acid sequence if the two sequences specifically hybridize to one another under moderate to high stringency hybridization and wash conditions.
- Hybridization conditions are based on the melting temperature (Tm) of the nucleic acid binding complex or probe.
- maximum stringency typically occurs at about Tm-5°C (5° below the Tm of the probe); “high stringency” at about 5- 10°C below the Tm; “intermediate stringency” at about 10-20°C below the Tm of the probe; and “low stringency” at about 20-25°C below the Tm.
- maximum stringency conditions can be used to identify sequences having strict identity or near-strict identity with the hybridization probe; while intermediate or low stringency hybridization can be used to identify or detect polynucleotide sequence homologs.
- Hybridized, duplex nucleic acids are characterized by a melting temperature (T m ), where one half of the hybridized nucleic acids are unpaired with the complementary strand. Mismatched nucleic acids within the duplex lower the T m .
- Very stringent hybridization conditions involve 68°C and 0. IX SSC.
- a nucleic acid encoding a variant metalloprotease can have a T m reduced by 1°C - 3°C or more compared to a duplex formed between the nucleic acid of SEQ ID NO: 4 and its identical complement.
- high stringency conditions includes hybridization at about 42°C in 50% formamide, 5X SSC, 5X Denhardt' s solution, 0.5% SDS and 100 denatured carrier DNA followed by washing two times in 2X SSC and 0.5% SDS at room temperature and two additional times in 0.1X SSC and 0.5% SDS at 42°C.
- moderate stringent conditions include an overnight incubation at 37°C in a solution comprising 20% formamide, 5 x SSC (150mM NaCl, 15 mM trisodium citrate), 50 mM sodium phosphate (pH 7.6), 5 x
- Denhardt' s solution 10% dextran sulfate and 20 mg/ml denatured sheared salmon sperm DNA, followed by washing the filters in lx SSC at about 37 - 50°C.
- Those of skill in the art know how to adjust the temperature, ionic strength, etc. to accommodate factors such as probe length and the like.
- nucleic acids or polypeptides generally denotes a nucleic acid or polypeptide that is essentially free from other components as determined by analytical techniques well known in the art (e.g. , a purified polypeptide or polynucleotide forms a discrete band in an electrophoretic gel, chromatographic eluate, and/or a media subjected to density gradient centrifugation).
- a nucleic acid or polypeptide that gives rise to essentially one band in an electrophoretic gel is "purified.”
- a purified nucleic acid or polypeptide is at least about 50% pure, usually at least about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91 %, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, about 99.5%, about 99.6%, about 99.7%, about 99.8% or more pure (e.g., percent by weight on a molar basis).
- the invention provides methods of enriching compositions for one or more molecules of the invention, such as one or more polypeptides or polynucleotides of the invention.
- a composition is enriched for a molecule when there is a substantial increase in the concentration of the molecule after application of a purification or enrichment technique.
- a substantially pure polypeptide or polynucleotide of the invention (e.g., substantially pure metalloprotease polypeptide or polynucleotide encoding a metalloprotease polypeptide of the invention, respectively) will typically comprise at least about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98, about 99%, about 99.5% or more by weight (on a molar basis) of all macromolecular species in a particular composition.
- enriched refers to a compound, polypeptide, cell, nucleic acid, amino acid, or other specified material or component that is present in a composition at a relative or absolute concentration that is higher than a starting composition.
- the invention provides methods of enriching compositions for one or more molecules of the invention, such as one or more polypeptides of the invention (e.g., one or more metalloprotease polypeptides of the invention) or one or more nucleic acids of the invention (e.g. , one or more nucleic acids encoding one or more metalloprotease polypeptides of the invention).
- a composition is enriched for a molecule when there is a substantial increase in the concentration of the molecule after application of a purification or enrichment technique.
- a substantially pure polypeptide or polynucleotide will typically comprise at least about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98, about 99%, about 99.5% or more by weight (on a molar basis) of all macromolecular species in a particular composition.
- the term "functional assay” refers to an assay that provides an indication of a protein's activity.
- the term refers to assay systems in which a protein is analyzed for its ability to function in its usual capacity.
- a functional assay involves determining the effectiveness of the protease to hydrolyze a proteinaceous substrate.
- modified nucleic acid sequence and “modified gene” are used interchangeably herein to refer to a nucleic acid sequence that includes a deletion, insertion or interruption of naturally occurring (i.e., wild-type) nucleic acid sequence.
- the expression product of the modified nucleic acid sequence is a truncated protein (e.g., if the modification is a deletion or interruption of the sequence). In some embodiments, the truncated protein retains biological activity. In alternative embodiments, the expression product of the modified nucleic acid sequence is an elongated protein (e.g., modifications comprising an insertion into the nucleic acid sequence). In some embodiments, a nucleotide insertion in the nucleic acid sequence leads to a truncated protein (e.g., when the insertion results in the formation of a stop codon). Thus, an insertion may result in either a truncated protein or an elongated protein as an expression product.
- a “mutant" nucleic acid sequence typically refers to a nucleic acid sequence that has an alteration in at least one codon occurring in a host cell' s wild-type sequence such that the expression product of the mutant nucleic acid sequence is a protein with an altered amino acid sequence relative to the wild-type protein.
- the expression product may have an altered functional capacity (e.g., enhanced enzymatic activity).
- alteration in substrate specificity refers to changes in the substrate specificity of an enzyme.
- a change in substrate specificity is defined as a change in k cat and/or K m for a particular substrate, resulting from mutations of the enzyme or alteration of reaction conditions.
- the substrate specificity of an enzyme is determined by comparing the catalytic efficiencies it exhibits with different substrates. These determinations find particular use in assessing the efficiency of mutant enzymes, as it is generally desired to produce variant enzymes that exhibit greater ratios of k cat /K m for substrates of interest. However, it is not intended that the present invention be limited to any particular substrate composition or substrate specificity.
- surface property is used in reference to electrostatic charge, as well as properties such as the hydrophobicity and hydrophilicity exhibited by the surface of a protein.
- net charge is defined as the sum of all charges present in a molecule.
- Net charge changes are made to a parent protein molecule to provide a variant that has a net charge that differs from that of the parent molecule (i.e., the variant has a net charge that is not the same as that of the parent molecule). For example, substitution of a neutral amino acid with a negatively charged amino acid or a positively charged amino acid with a neutral amino acid results in net charge of -1 with respect to the parent molecule. Substitution of a positively charged amino acid with a negatively charged amino acid results in a net charge of -2 with respect to the parent.
- Substitution of a neutral amino acid with a positively charged amino acid or a negatively charged amino acid with a neutral amino acid results in net charge of +1 with respect to the parent.
- Substitution of a negatively charged amino acid with a positively charged amino acid results in a net charge of +2 with respect to the parent.
- the net charge of a parent protein can also be altered by deletion and/or insertion of charged amino acids. A net change change applies to changes in charge of a variant versus a parent when measured at the same pH conditions.
- thermoally stable and “thermostable” and “thermostability” refer to proteases that retain a specified amount of enzymatic activity after exposure to identified temperatures over a given period of time under conditions prevailing during the proteolytic, hydrolyzing, cleaning or other process of the invention, while being exposed to altered temperatures.
- altered temperatures encompass increased or decreased temperatures.
- the proteases retain at least about 50%, about 60%, about 70%, about 75%, about 80%, about 85%, about 90%, about 92%, about 95%, about 96%, about 97%, about 98%, or about 99% proteolytic activity after exposure to altered temperatures over a given time period, for example, at least about 60 minutes, about 120 minutes, about 180 minutes, about 240 minutes, about 300 minutes, etc.
- enhanced stability in the context of an oxidation, chelator, thermal, chemical, autolytic and/or pH stable protease refers to a higher retained proteolytic activity over time as compared to other proteases (e.g., thermolysin proteases) and/or wild-type enzymes.
- diminished stability in the context of an oxidation, chelator, thermal and/or pH stable protease refers to a lower retained proteolytic activity over time as compared to other proteases (e.g., thermolysin proteases) and/or wild-type enzymes.
- cleaning activity refers to a cleaning performance achieved by a
- cleaning performance of a metalloprotease polypeptide or reference protease may be determined by using various assays for cleaning one or more various enzyme sensitive stains on an item or surface (e.g., a stain resulting from food, grass, blood, ink, milk, oil, and/or egg protein).
- Cleaning performance of a variant or reference protease can be determined by subjecting the stain on the item or surface to standard wash condition(s) and assessing the degree to which the stain is removed by using various chromatographic, spectrophotometric, or other quantitative methodologies.
- Exemplary cleaning assays and methods are known in the art and include, but are not limited to those described in WO 99/34011 and U.S. Pat. 6,605,458, both of which are herein incorporated by reference, as well as those cleaning assays and methods included in the Examples provided below.
- cleaning effective amount of a metalloprotease polypeptide or reference protease refers to the amount of protease that achieves a desired level of enzymatic activity in a specific cleaning composition. Such effective amounts are readily ascertained by one of ordinary skill in the art and are based on many factors, such as the particular protease used, the cleaning application, the specific composition of the cleaning composition, and whether a liquid or dry (e.g., granular, tablet, bar) composition is required, etc.
- enhanced performance in the context of cleaning activity refers to an increased or greater cleaning activity by an enzyme with respect to a parent or reference protein as measured on certain enzyme sensitive stains such as egg, milk, grass, ink, oil, and/or blood, as determined by usual evaluation after a standard wash cycle and/or multiple wash cycles.
- diminished performance in the context of cleaning activity refers to a decreased or lesser cleaning activity by an enzyme on certain enzyme sensitive stains such as egg, milk, grass or blood, as determined by usual evaluation after a standard wash cycle and/or multiple wash cycles.
- Cleaning compositions and cleaning formulations include any composition that is suited for cleaning, bleaching, disinfecting, and/or sterilizing any object, item, and/or surface.
- Such compositions and formulations include, but are not limited to for example, liquid and/or solid compositions, including cleaning or detergent compositions (e.g., liquid, tablet, gel, bar, granule, unit dose and/or solid laundry cleaning or detergent compositions and fine fabric detergent compositions; hard surface cleaning compositions and formulations, such as for glass, wood, ceramic and metal counter tops and windows; carpet cleaners; oven cleaners; fabric fresheners; fabric softeners; and textile, laundry booster cleaning or detergent compositions, laundry additive cleaning compositions, and laundry pre-spotter cleaning compositions; dishwashing compositions, including hand or manual dishwash compositions (e.g., "hand” or “manual” dishwashing detergents) and automatic dishwashing compositions (e.g., "automatic dishwashing detergents").
- cleaning or detergent compositions e.g., liquid, tablet, gel
- bleaching refers to the treatment of a material (e.g., fabric, laundry, pulp, etc.) or surface for a sufficient length of time and/or under appropriate pH and/or temperature conditions to effect a brightening (i.e., whitening) and/or cleaning of the material.
- a material e.g., fabric, laundry, pulp, etc.
- chemicals suitable for bleaching include, but are not limited to, for example, C10 2 , H 2 0 2 , peracids, N0 2 , etc.
- wash performance of a protease refers to the contribution of a metalloprotease polypeptide to washing that provides additional cleaning performance to the detergent as compared to the detergent without the addition of the metalloprotease polypeptide to the composition. Wash performance is compared under relevant washing conditions. In some test systems, other relevant factors, such as detergent composition, sud concentration, water hardness, washing mechanics, time, pH, and/or temperature, can be controlled in such a way that condition(s) typical for household application in a certain market segment (e.g., hand or manual dishwashing, automatic dishwashing, dishware cleaning, tableware cleaning, fabric cleaning, etc.) are imitated.
- condition(s) typical for household application in a certain market segment e.g., hand or manual dishwashing, automatic dishwashing, dishware cleaning, tableware cleaning, fabric cleaning, etc.
- relevant washing conditions is used herein to indicate the conditions, particularly washing temperature, time, washing mechanics, sud concentration, type of detergent and water hardness, actually used in households in a hand dishwashing, automatic dishwashing, or laundry detergent market segment.
- improved wash performance is used to indicate that a better end result is obtained in stain removal under relevant washing conditions, or that less metalloprotease polypeptide, on weight basis, is needed to obtain the same end result relative to the
- the term "disinfecting” refers to the removal of contaminants from the surfaces, as well as the inhibition or killing of microbes on the surfaces of items. It is not intended that the present invention be limited to any particular surface, item, or contaminant(s) or microbes to be removed.
- inorganic filler salts are conventional ingredients of detergent compositions in powder form.
- the filler salts are present in substantial amounts, typically about 17 to about 35% by weight of the total composition.
- the filler salt is present in amounts not exceeding about 15% of the total composition.
- the filler salt is present in amounts that do not exceed about 10%, or more preferably, about 5%, by weight of the composition.
- the inorganic filler salts are selected from the alkali and alkaline-earth-metal salts of sulfates and chlorides.
- the filler salt is sodium sulfate.
- the term “about” refers to a range of +/- 0.5 of the numerical value, unless the term is otherwise specifically defined in context.
- the phrase a "pH value of about 6" refers to pH values of from 5.5 to 6.5, unless the pH value is specifically defined otherwise.
- Oligonucleotide synthesis and purification steps are typically performed according to specifications. Techniques and procedures are generally performed according to conventional methods well known in the art and various general references that are provided throughout this document. Procedures therein are believed to be well known to those of ordinary skill in the art and are provided for the convenience of the reader.
- the present invention provides novel variant metalloprotease enzyme polypeptides having a modification in a calcium binding region.
- the variant is a variant of a parent or reference sequence.
- the parent or reference sequence can be, for example, any M4 metalloprotease, or a Bacillus derived metalloprotease, such as Bacillus thermoproteolyticus, Bacillus cereus, or Bacillus subtilis (for example, the sequences of SEQ ID NOs: 13-15), or a PaenibaciUus derived metalloprotease, such as the sequences of SEQ ID NOs: 1-12.
- a residue (amino acid) of a metalloprotease is equivalent to a residue of Thermolysin metalloprotease if it is either homologous (i.e., corresponding in position in either primary or tertiary structure) or analogous to a specific residue or portion of that residue in Thermolysin metalloprotease from Bacillus thermoproteolyticus (i.e., having the same or similar functional capacity to react or interact chemically).
- the amino acid sequence of a metalloprotease is directly compared to the Thermolysin primary sequence and particularly to a set of residues known to be invariant in diverse M4
- PaenibaciUus organisms such as PehProl. These two particular sequences (Thermolysin (1_KEI) and PehProl) are aligned in FIG. 6.1 to produce the maximum homology of conserved residues. As can be seen, there are a number of insertions and deletions in the PehProl sequence as compared to Thermolysin.
- the position of an amino acid residue in a given amino acid sequence is typically numbered herein using the numbering of the position of the corresponding amino acid residue of the Bacillus thermoproteolyticus metalloprotease Thermolysin amino acid sequence shown in SEQ ID NO: 13.
- the Bacillus thermoproteolyticus metalloprotease Thermolysin amino acid sequence of SEQ ID NO: 13 thus serves as a reference parent sequence.
- a given amino acid sequence such as a metalloprotease enzyme amino acid sequence and variants thereof described herein, can be aligned with the Thermolysin sequence (SEQ ID NO: 13) using an alignment algorithm as described herein on the primary and/or tertiary structures, and an amino acid residue in the given amino acid sequence that aligns (preferably optimally aligns) with an amino acid residue in the Thermolysin sequence can be conveniently numbered by reference to the corresponding amino acid residue in the metalloprotease Thermolysin sequence.
- the equivalent amino acid of Asp57 in Thermolysin, in PehPro is the particular Serine shown at that aligned position.
- the equivalent amino acid at position 57 in PpoProl is again Aspartic acid.
- these particular residues in PehProl, and thermolysin may be substituted by a different amino acid to produce a mutant metalloprotease, since they are equivalent in primary structure to Asp 57 in thermolysin.
- Equivalent amino acids of course are not limited to those for Asp57 but extend to any residue which is equivalent to a residue in Thermolysin, and this is intended as an example of equivalent residues.
- Equivalent residues homologous at the level of tertiary structure for a metalloprotease whose tertiary structure has been determined by x-ray crystallography are defined as those for which the atomic coordinates of 2 or more of the main chain atoms of a particular amino acid residue of the M4 metalloproteinase and Thermolysin (N on N. CA on CA, C on C, and 0 on 0) are within 0.13 nm and preferably 0.1 nm after superposition.
- Superposition can be
- Thermolysin are defined as those amino acids of the metalloproteases which may adopt a conformation such that they either alter, modify or contribute to protein structure, substrate binding or catalysis in a manner defined and attributed to a specific residue of thermolysin as described herein.
- residues of the metalloproteinase for which a tertiary structure has been obtained by x-ray crystallography
- residues of the metalloproteinase which occupy an analogous position to the extent that although the main chain atoms of the given residue may not satisfy the criteria of equivalence on the basis of occupying a homologous position, the atomic coordinates of at least two of the side chain atoms of the residue lie with 0.13 nm of the corresponding side chain atoms of Thermolysin.
- the three dimensional structures would be aligned as outlined above.
- the structure of the M4 class metallopro tease thermolysin has been found to have four calcium-binding regions.
- metalloproteases can be used to determine modifications that can be made to M4 class metalloproteases in order to remove calcium binding.
- thermolysin there is a double cation binding site, herein referred to as Cal-2, which has a calcium binding region including residues 136, 138 and 177-190 using the numbering of thermolysin from Bacillus thermoproteolyticus found in SEQ ID NO: 13.
- Ca3 a calcium binding site including residues 55-66
- Ca4 a fourth binding site referred to as Ca4 which has a calcium binding region including residues 193-200.
- the invention is a variant of a parent metallopro tease, such as a M4 class metalloprotease or a variant of any one of SEQ ID NOs: 1- 15, which exhibits protease activity and which has a decreased Ca 2+ dependency as compared to the parent metalloprotease.
- the decreased Ca 2+ dependency has the functional result that the variant exhibits proteolytic activity in the presence of a lower concentration of calcium ion in the extraneous medium than is necessary for the parent enzyme and, for example, therefore is less sensitive than the parent to calcium ion-depleting conditions such as those obtained in media containing calcium-complexing agents (such as certain detergent builders).
- the variant retains at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100% or even has greater activity compared to the parent metalloprotease. This can be measured in a proteolytic assay, such as those described in Example 1.
- a stabilization strategy based around decreased calcium binding can improve enzyme stability in environments with decreased availability of free calcium ions.
- One of the major industrial uses of subtilisins is in environments containing high concentrations of metal chelators. Additionally, because these calcium binding regions are found in various M4 metalloproteases, it is expected that equivalent mutations for other M4 metalloproteases will likewise eliminate calcium binding and provide for enzymatically active variants. These calcium binding regions can also be found in various metalloproteases that are not categorized as M4 metalloproteases, but share the same properties as an M4 metalloprotease, including the calcium binding regions.
- the invention is a metalloprotease polypeptide comprising a calcium binding region.
- the above polypeptide comprises a modification in at least one amino acid residue in one of the calcium binding regions, Cal-2, Ca3 and Ca4, (including residues 55-66, 136, 138, 177-190, and 193-200) of the polypeptide, wherein the amino acid positions of the polypeptide are numbered by correspondence with the amino acid sequence of Bacillus thermoproteolyticus metalloprotease set forth in SEQ ID NO: 13.
- the variant comprises a modification in at least one amino acid residue in a calcium binding region Cal-2 of residues 177-190 of a parent M4 metalloprotease.
- the polypeptide at position 184 is a lysine, threonine, alanine, glutamic acid or aspartic acid.
- the polypeptide at position 185 is a residue other than aspartic acid.
- the polypeptide at position 185 is a non-negatively charged residue; in other embodiments, the polypeptide at position 185 is a neutrally charged residue; and in yet other embodiments, the polypeptide at position 185 is an asparagine or serine. In any of the above embodiments and in new
- the polypeptide at position 187 is a non-negatively charged residue. In some embodiments, the polypeptide at position 187 is a neutrally charged residue; and in other embodiments, the polypeptide at position 187 is a leucine or methionine; and in yet other embodiments, the polypeptide at position 187 is aspartic acid. In any of the above embodiments and in new embodiments, the polypeptide at position 188 is a leucine, valine, or methionine. In any of the above embodiments and in new embodiments, the polypeptide at position 190 is a residue other than glutamic acid. In some embodiments, the polypeptide at position 190 is aspartic acid.
- the polypeptide comprises seven amino acid residues between the glycine residue at position 173 and tryptophan at position 186. In any of the above embodiments and in new embodiments, the polypeptide comprises seven amino acid residues between the glycine residue at position 173 and tryptophan at position 186. In any of the above embodiments and in new embodiments, the polypeptide comprises seven amino acid residues between the glycine residue at position 173 and tryptophan at position 186. In any of the above
- the polypeptide comprises a deletion of five amino acid residues between the glycine residue at position 173 and tryptophan at position 186.
- the polypeptide comprises a seven amino acid loop sequence between positions 177 to 185 which is replaced by a two amino acid sequence.
- a polypeptide of the instant invention has improved stability by replacement of the loop structure with a shorter amino acid sequence that can span the region between positions 177 to 185, and in particular, a two amino acid sequence is preferred to span the region between positions 177 to 185.
- the two amino acid sequence contains at least one positively charged amino acid, and in some embodiments, the positively charged amino acid is lysine.
- the polypeptide comprises a deletion at amino acid residue positions 179-183.
- the polypeptide at position 177 is a neutrally charged residue or aspartic acid; and in some embodiments, the neutrally charged residue is glutamine.
- the polypeptide at position 178 is a glycine, serine, arginine, alanine, asparagines, and threonine.
- the polypeptide at position 136 is aspartic acid or serine.
- the invention is a metalloprotease polypeptide having a modification in at least one amino acid residue in a calcium binding region Ca3 of residues 55-66, wherein the amino acid positions of the variant are numbered by correspondence with the amino acid sequence of Bacillus proteolyticus metalloprotease set forth in SEQ ID NO: 13.
- the polypeptide at position 55 is a leucine, serine, valine, and methionine.
- the polypeptide at position 56 is a serine, arginine and threonine.
- the polypeptide at position 57 is a serine. In any of the above embodiments and in new embodiments,
- the polypeptide at position 58 is a serine and threonine.
- the polypeptide at position 59 is a serine, threonine, and asparagine.
- the polypeptide has a serine at position 57, serine at position 58 and serine or asparagines at position 59.
- the polypeptide at position 60 is a serine.
- the polypeptide at position 61 is an isoleucine, valine, and threonine.
- the polypeptide at position 62 is a tryptophan and phenylalanine.
- the polypeptide at position 63 is a asparagine, glutamic acid, and threonine. In sequence alignment of the Ca3 region, there are conserved residues phenylalanine/tryptophan at position 62 and aspartic acid at position 67 (see Figure 12).
- the polypeptide comprises four amino acid residues between the phenylalanine/tryptophan residue at position 62 and aspartic acid at position 67.
- the polypeptide comprises a deletion of three amino acid residues between the phenylalanine/tryptophan residue at position 62 and aspartic acid at position 67.
- residues 62 and 67 inclusive of amino acids 62 and 67 in the loop.
- the polypeptide comprises a four amino acid loop sequence between positions 62 to 67 which is replaced by a one amino acid sequence.
- a polypeptide of the instant invention has improved stability by replacement of the loop structure with a shorter amino acid sequence that can span the region between positions 62 to 67, and in particular, a one amino acid sequence is preferred to span the region between positions 62 to 67.
- the one amino acid sequence is an asparagines, threonine, or glutamic acid.
- the polypeptide comprises a deletion at amino acid residue positions 64-66.
- the invention is a metalloprotease polypeptide having a modification in at least one amino acid residue in a calcium binding region Ca4 of residues 193-200, wherein the amino acid positions of the variant are numbered by correspondence with the amino acid sequence of Bacillus proteolyticus metalloprotease set forth in SEQ ID NO: 13.
- the polypeptide at position 193 is a threonine.
- the polypeptide at position 194 is a isoleucine.
- the polypeptide at position 195 is a serine.
- the polypeptide comprises a deletion at amino acid residue positions 196-198.
- the polypeptide at position 199 is a glutamine.
- the polypeptide at position 200 is a proline.
- the calcium binding region Cal-2 has been modified to bind fewer than two calcium ions. In some embodiments of the invention, the calcium binding region Ca3 has been modified to bind fewer than one calcium ion. In some embodiments of the invention, the calcium binding region Ca4 has been modified to bind fewer than one calcium ion.
- the invention is a variant metalloprotease of a parent
- the variant comprises a modification in a calcium binding region of the parent polypeptide. In some embodiments, the variant comprises a modification to any of the amino acids listed above. In some embodiments, the parent polypeptide is an M4 metalloprotease. In some embodiments, the metalloprotease polypeptide of the present invention has at least 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, 99, or 100% sequence identity to the parent polypeptide.
- the metalloprotease polypeptide of the present invention has at least 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, 99, or 100% sequence identity to any of the sequences found in SEQ ID NOs: 1-15. In some embodiments, the metalloprotease polypeptide of the present invention has at least 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, 99, or 100% sequence identity to SEQ ID NO: 13.
- the invention is a variant metalloprotease having immunological cross-reactivity with any of the variant metalloproteases described above.
- Immunological cross- reactivity can be assayed using an antibody raised against or reactive with at least one epitope of any of the variant metalloproteases listed above.
- the antibody which can either be monoclonal or polyclonal, can be produced by methods known in the art. Immunological cross -reactivity can be measured using assays known in the art, such as Western blotting, radial
- immunodiffusion assay or enzyme-linked immunosorbant assay (ELISA).
- ELISA enzyme-linked immunosorbant assay
- the present invention provides novel metalloprotease enzyme polypeptides, which may be collectively referred to as "enzymes of the invention” or "polypeptides of the invention.”
- Polypeptides of the invention include isolated, recombinant, substantially pure, or non-naturally occurring polypeptides.
- the invention includes variants, as described above, of M4 class metalloproteases.
- polypeptides of the invention are useful in cleaning applications and can be incorporated into cleaning compositions that are useful in methods of cleaning an item or a surface in need of cleaning.
- the enzyme of the present invention has 50, 60, 65, 70, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a M4 class metalloprotease. In some embodiments, the enzyme of the present invention has 50, 60, 65, 70, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to SEQ ID NO: 13.
- the enzyme of the present invention has 50, 60, 65, 70, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a metalloprotease enzyme from any of SEQ ID NO: 1-15.
- the invention includes an isolated, recombinant, substantially pure, or non-naturally occurring enzyme having protease activity, which polypeptide comprises a polypeptide sequence having at least about 60%, 65%, 70%, 75%, 80%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to a parent enzyme as provided herein.
- the polypeptide of the present invention is a polypeptide having a specified degree of amino acid sequence homology to the exemplified polypeptides, e.g. , at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99% sequence homology to the amino acid sequence of any of SEQ ID NO: 1-15.
- Homology can be determined by amino acid sequence alignment, e.g. , using a program such as BLAST, ALIGN, or CLUSTAL, as described herein.
- polypeptide enzyme of the present invention having protease activity, said enzyme comprising an amino acid sequence which differs from the amino acid sequence of any of SEQ ID NO: 1-15 by no more than 50, no more than 40, no more than 30, no more than 35, no more than 25, no more than 20, no more than 19, no more than 18, no more than 17, no more than 16, no more than 15, no more than 14, no more than 13, no more than 12, no more than 11, no more than 10, no more than 9, no more than 8, no more than 7, no more than 6, no more than 5, no more than 4, no more than 3, no more than 2, or no more than 1 amino acid residue(s), when aligned using any of the previously described alignment methods.
- the variant enzyme polypeptides of the invention have enzymatic activities (e.g., protease activities) and thus are useful in cleaning applications, including but not limited to, methods for cleaning dishware items, tableware items, fabrics, and items having hard surfaces (e.g., the hard surface of a table, table top, wall, furniture item, floor, ceiling, etc.).
- exemplary cleaning compositions comprising one or more variant metalloprotease enzyme polypeptides of the invention are described infra.
- the enzymatic activity (e.g., protease enzyme activity) of an enzyme polypeptide of the invention can be determined readily using procedures well known to those of ordinary skill in the art. The Examples presented infra describe methods for evaluating the enzymatic activity and cleaning performance.
- polypeptide enzymes of the invention in removing stains (e.g., a protein stain such as blood/milk/ink or egg yolk), cleaning hard surfaces, or cleaning laundry, dishware or tableware item(s), or cleaning contact lenses can be readily determined using procedures well known in the art and/or by using procedures set forth in the Examples.
- the metalloprotease polypeptides of the present invention can have protease activity over a broad range of pH conditions.
- the metalloprotease polypeptides have protease activity on azo-casein as a substrate, as demonstrated in Example 3.
- the metalloprotease polypeptides have protease activity at a pH of from about 3.0 to about 12.0.
- the metalloprotease polypeptides have protease activity at a pH of from about 4.0 to about 11.0.
- the metalloprotease polypeptides of the present invention have protease activity at a temperature range of from about 10°C to about 100°C. In some embodiments, the metalloprotease polypeptides of the present invention have protease activity at a temperature range of from about 10°C to about 100°C. In some embodiments, the metalloprotease polypeptides of the present invention have protease activity at a temperature range of from about 10°C to about 100°C. In some
- the metalloprotease polypeptides of the present invention have protease activity at a temperature range of from about 20°C to about 90°C.
- the metalloprotease polypeptides of the present invention demonstrate cleaning performance in a cleaning composition.
- Cleaning compositions often include ingredients harmful to the stability and performance of enzymes, making cleaning compositions a harsh environment for enzymes, e.g. metallopro teases, to retain function. Thus, it is not trivial for an enzyme to be put in a cleaning composition and expect enzymatic function (e.g. metalloprotease activity, such as demonstrated by cleaning performance).
- the metalloprotease polypeptides of the present invention demonstrate cleaning performance in automatic dishwashing (ADW) detergent compositions.
- the cleaning performance in automatic dishwashing (ADW) detergent compositions includes cleaning of egg yolk stains.
- the metalloprotease polypeptides of the present invention demonstrate cleaning performance in laundry detergent compositions.
- the cleaning performance in laundry detergent compositions includes cleaning of blood/milk/ink stains.
- the metalloprotease polypeptides of the present invention demonstrate cleaning performance with or without a bleach component.
- a polypeptide of the invention can be subject to various changes, such as one or more amino acid insertions, deletions, and/or substitutions, either conservative or non-conservative, including where such changes do not substantially alter the enzymatic activity of the
- a nucleic acid of the invention can also be subject to various changes, such as one or more substitutions of one or more nucleotides in one or more codons such that a particular codon encodes the same or a different amino acid, resulting in either a silent variation (e.g., when the encoded amino acid is not altered by the nucleotide mutation) or non-silent variation, one or more deletions of one or more nucleic acids (or codons) in the sequence, one or more additions or insertions of one or more nucleic acids (or codons) in the sequence, and/or cleavage of or one or more truncations of one or more nucleic acids (or codons) in the sequence.
- nucleic acid sequence of the invention can also be modified to include one or more codons that provide for optimum expression in an expression system (e.g., bacterial expression system), while, if desired, said one or more codons still encode the same amino acid(s).
- an expression system e.g., bacterial expression system
- the present invention provides a genus of enzyme polypeptides having the desired enzymatic activity (e.g., protease enzyme activity or cleaning performance activity) which comprise sequences having the amino acid substitutions described herein and also which comprise one or more additional amino acid substitutions, such as conservative and non-conservative substitutions, wherein the polypeptide exhibits, maintains, or approximately maintains the desired enzymatic activity (e.g., proteolytic activity, as reflected in the cleaning activity or performance of the polypeptide enzyme of SEQ ID NO: 13).
- Amino acid e.g., protease enzyme activity or cleaning performance activity
- substitutions in accordance with the invention may include, but are not limited to, one or more non-conservative substitutions and/or one or more conservative amino acid substitutions.
- a conservative amino acid residue substitution typically involves exchanging a member within one functional class of amino acid residues for a residue that belongs to the same functional class (conservative amino acid residues are considered functionally homologous or conserved in calculating percent functional homology).
- a conservative amino acid substitution typically involves the substitution of an amino acid in an amino acid sequence with a functionally similar amino acid. For example, alanine, glycine, serine, and threonine are functionally similar and thus may serve as conservative amino acid substitutions for one another. Aspartic acid and glutamic acid may serve as conservative substitutions for one another.
- amino acids can be grouped by similar function or chemical structure or composition (e.g., acidic, basic, aliphatic, aromatic, sulfur-containing).
- an aliphatic grouping may comprise: Glycine (G), Alanine (A), Valine (V), Leucine (L), Isoleucine (I).
- Conservatively substituted variations of a polypeptide sequence of the invention include substitutions of a small percentage, sometimes less than 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, or 6% of the amino acids of the polypeptide sequence, or less than 5%, 4%, 3%, 2%, or 1 %, or less than 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 amino acid substitution of the amino acids of the polypeptide sequence, with a conservatively selected amino acid of the same conservative substitution group.
- polypeptides of the invention may have cleaning abilities that may be compared to known proteases, including known metalloproteases.
- nucleic acids of the invention or “polynucleotides of the invention”, which encode polypeptides of the invention.
- Nucleic acids of the invention including all described below, are useful in recombinant production (e.g., expression) of polypeptides of the invention, typically through expression of a plasmid expression vector comprising a sequence encoding the polypeptide of interest or fragment thereof.
- polypeptides include metalloprotease polypeptides having enzymatic activity (e.g., proteolytic activity) which are useful in cleaning applications and cleaning compositions for cleaning an item or a surface (e.g., surface of an item) in need of cleaning.
- enzymatic activity e.g., proteolytic activity
- the invention provides an isolated, recombinant, substantially pure, or non-naturally occurring nucleic acid comprising a nucleotide sequence encoding any polypeptide (including any fusion protein, etc.) of the invention described above in the section entitled "Polypeptides of the Invention" and elsewhere herein.
- the invention also provides an isolated, recombinant, substantially pure, or non-naturally-occurring nucleic acid comprising a nucleotide sequence encoding a combination of two or more of any polypeptides of the invention described above and elsewhere herein.
- the present invention provides nucleic acids encoding a metalloprotease polypeptide of the present invention, wherein the metalloprotease polypeptide is a mature form having proteolytic activity, wherein the amino acid positions of the thermolysin variant are numbered by correspondence with the amino acid sequence of Bacillus thermoproteolyticus
- metalloprotease polypeptide set forth as SEQ ID NO: 13.
- Nucleic acids of the invention can be generated by using any suitable synthesis, manipulation, and/or isolation techniques, or combinations thereof. For example, a
- polynucleotide of the invention may be produced using standard nucleic acid synthesis techniques, such as solid-phase synthesis techniques that are well-known to those skilled in the art. In such techniques, fragments of up to 50 or more nucleotide bases are typically
- nucleic acids of the invention can be synthesized, then joined (e.g., by enzymatic or chemical ligation methods) to form essentially any desired continuous nucleic acid sequence.
- the synthesis of the nucleic acids of the invention can be also facilitated by any suitable method known in the art, including but not limited to chemical synthesis using the classical phosphoramidite method (See e.g., Beaucage et al. Tetrahedron Letters 22: 1859-69 [1981]); or the method described by Matthes et al. (See, Matthes et al., EMBO J. 3:801-805 [1984], as is typically practiced in automated synthetic methods. Nucleic acids of the invention also can be produced by using an automatic DNA synthesizer.
- Customized nucleic acids can be ordered from a variety of commercial sources (e.g., The Midland Certified Reagent Company, the Great American Gene Company, Operon Technologies Inc., and DNA2.0). Other techniques for synthesizing nucleic acids and related principles are known in the art (See e.g., Itakura et al., Ann. Rev. Biochem. 53:323 [1984]; and Itakura et al., Science 198: 1056 [1984]).
- nucleic acids useful in modification of nucleic acids are well known in the art. For example, techniques such as restriction endonuclease digestion, ligation, reverse transcription and cDNA production, and polymerase chain reaction (e.g., PCR) are known and readily employed by those of skill in the art. Nucleotides of the invention may also be obtained by screening cDNA libraries using one or more oligonucleotide probes that can hybridize to or PCR-amplify polynucleotides which encode a metalloprotease polypeptide polypeptide(s) of the invention.
- oligonucleotide probes that can hybridize to or PCR-amplify polynucleotides which encode a metalloprotease polypeptide polypeptide(s) of the invention.
- nucleic acids of the invention can be obtained by altering a naturally occurring polynucleotide backbone (e.g., that encodes an enzyme or parent protease) by, for example, a known mutagenesis procedure (e.g., site-directed
- modified polynucleotides of the invention that encode metalloprotease polypeptides of the invention, including, but not limited to, for example, site- saturation mutagenesis, scanning mutagenesis, insertional mutagenesis, deletion mutagenesis, random mutagenesis, site-directed mutagenesis, and directed-evolution, as well as various other recombinatorial approaches.
- Methods for making modified polynucleotides and proteins include DNA shuffling methodologies, methods based on non-homologous recombination of genes, such as ITCHY (See, Ostermeier et al., 7:2139-44 [1999]), SCRACHY (See, Lutz et al.
- the present invention provides vectors comprising at least one metalloprotease polynucleotide of the invention described herein (e.g., a polynucleotide encoding a
- expression vectors or expression cassettes comprising at least one nucleic acid or polynucleotide of the invention, isolated, substantially pure, or recombinant DNA constructs comprising at least one nucleic acid or polynucleotide of the invention, isolated or recombinant cells comprising at least one polynucleotide of the invention, and compositions comprising one or more such vectors, nucleic acids, expression vectors, expression cassettes, DNA constructs, cells, cell cultures, or any combination or mixtures thereof.
- the invention provides recombinant cells comprising at least one vector (e.g., expression vector or DNA construct) of the invention which comprises at least one nucleic acid or polynucleotide of the invention. Some such recombinant cells are transformed or transfected with such at least one vector. Such cells are typically referred to as host cells. Some such cells comprise bacterial cells, including, but are not limited to Bacillus sp. cells, such as B. subtilis cells. The invention also provides recombinant cells (e.g., recombinant host cells) comprising at least one metalloprotease polypeptide of the invention.
- vector e.g., expression vector or DNA construct
- Some such recombinant cells are transformed or transfected with such at least one vector.
- Such cells are typically referred to as host cells. Some such cells comprise bacterial cells, including, but are not limited to Bacillus sp. cells, such as B. subtilis cells.
- the invention also provides recombinant cells (e.g.
- the invention provides a vector comprising a nucleic acid or polynucleotide of the invention.
- the vector is an expression vector or expression cassette in which a polynucleotide sequence of the invention which encodes a metalloprotease polypeptide of the invention is operably linked to one or additional nucleic acid segments required for efficient gene expression (e.g., a promoter operably linked to the polynucleotide of the invention which encodes a metalloprotease polypeptide of the invention).
- a vector may include a transcription terminator and/or a selection gene, such as an antibiotic resistance gene, that enables continuous cultural maintenance of plasmid-infected host cells by growth in antimicrobial-containing media.
- An expression vector may be derived from plasmid or viral DNA, or in alternative embodiments, contains elements of both.
- Exemplary vectors include, but are not limited to pC194, pJHIOl, pE194, pHP13 (See, Harwood and Cutting [eds.], Chapter 3, Molecular Biological Methods for Bacillus, John Wiley & Sons [1990]; suitable replicating plasmids for B. subtilis include those listed on p.
- At least one expression vector comprising at least one copy of a polynucleotide encoding the metalloprotease polypeptide, and in some instances comprising multiple copies, is transformed into the cell under conditions suitable for expression of the metalloprotease.
- metalloprotease polypeptide (as well as other sequences included in the vector) is integrated into the genome of the host cell, while in other embodiments, a plasmid vector comprising a polynucleotide sequence encoding the metalloprotease polypeptide remains as autonomous extra-chromosomal element within the cell.
- the invention provides both extrachromosomal nucleic acid elements as well as incoming nucleotide sequences that are integrated into the host cell genome.
- the vectors described herein are useful for production of the metalloprotease polypeptides of the invention.
- a polynucleotide construct encoding the metalloprotease polypeptide is present on an integrating vector that enables the integration and optionally the amplification of the polynucleotide encoding the metalloprotease polypeptide into the host chromosome. Examples of sites for integration are well known to those skilled in the art.
- transcription of a polynucleotide encoding a metalloprotease polypeptide of the invention is effectuated by a promoter that is the wild-type promoter for the selected precursor protease. In some other embodiments, the promoter is heterologous to the precursor protease, but is functional in the host cell.
- suitable promoters for use in bacterial host cells include, but are not limited to, for example, the amyE, amyQ, amyL, pstS, sacB, pSPAC, pAprE, pVeg, pHpall promoters, the promoter of the B. stearothermophilus maltogenic amylase gene, the B. amyloliquefaciens (BAN) amylase gene, the B. subtilis alkaline protease gene, the B. clausii alkaline protease gene the B. pumilis xylosidase gene, the B. thuringiensis crylllA, and the B. licheniformis alpha- amylase gene.
- Additional promoters include, but are not limited to the A4 promoter, as well as phage Lambda PR or PL promoters, and the E. coli lac, trp or tac promoters.
- Metalloprotease polypeptides of the present invention can be produced in host cells of any suitable microorganism, including bacteria and fungi. In some embodiments,
- metalloprotease polypeptides of the present invention can be produced in Gram-positive bacteria.
- the host cells are Bacillus spp., Streptomyces spp., Escherichia spp., Aspergillus spp., Trichoderma spp., Pseudomonas spp., Corynebacterium spp.,
- the metalloprotease polypeptides are produced by Bacillus sp. host cells.
- Bacillus sp. host cells that find use in the production of the metalloprotease polypeptides of the invention include, but are not limited to B. licheniformis, B. lentus, B. subtilis, B. amyloliquefaciens, B. lentus, B. brevis, B.
- B. subtilis host cells are used for production of metalloprotease polypeptides.
- U.S. Patents 5,264,366 and 4,760,025 describe various Bacillus host strains that can be used for producing metalloprotease polypeptide of the invention, although other suitable strains can be used.
- the host strain is a recombinant strain, wherein a polynucleotide encoding a polypeptide of interest has been introduced into the host.
- the host strain is a B. subtilis host strain and particularly a recombinant Bacillus subtilis host strain. Numerous B.
- subtilis strains are known, including, but not limited to for example, 1A6 (ATCC 39085), 168 (1A01), SB19, W23, Ts85, B637, PB1753 through PB1758, PB3360, JH642, 1A243 (ATCC 39,087), ATCC 21332, ATCC 6051, Mil 13, DE100 (ATCC 39,094), GX4931, PBT 110, and PEP 211strain (See e.g., Hoch et al., Genetics 73:215-228 [1973]; See also, U.S. Patent Nos. 4,450,235 and 4,302,544, and EP 0134048, each of which is incorporated by reference in its entirety). The use of B.
- subtilis as an expression host cells is well known in the art (See e.g., Palva et al., Gene 19:81-87 [1982]; Fahnestock and Fischer, J. Bacterid. , 165:796-804 [1986]; and Wang et al., Gene 69:39-47 [1988]).
- the Bacillus host cell is a Bacillus sp. that includes a mutation or deletion in at least one of the following genes, degU, degS, degR and degQ. In some
- the mutation is in a degU gene, and in some embodiments the mutation is degU(Hy)32 (See e.g., Msadek et al., J. Bacteriol. 172:824-834 [1990]; and Olmos et al., Mol. Gen. Genet. 253:562-567 [1997]).
- the Bacillus host comprises a mutation or deletion in scoC4 (See e.g., Caldwell et al., J. Bacteriol. 183:7329-7340 [2001]); spoIIE (See e.g., Arigoni et al., Mol. Microbiol.
- any mutation in the opp operon that causes the same phenotype as a mutation in the oppA gene will find use in some embodiments of the altered Bacillus strain of the invention. In some embodiments, these mutations occur alone, while in other embodiments, combinations of mutations are present.
- an altered Bacillus host cell strain that can be used to produce a metalloprotease polypeptide of the invention is a Bacillus host strain that already includes a mutation in one or more of the above-mentioned genes.
- Bacillus sp. host cells that comprise mutation(s) and/or deletions of endogenous protease genes find use.
- the Bacillus host cell comprises a deletion of the aprE and the nprE genes.
- the Bacillus sp. host cell comprises a deletion of 5 protease genes, while in other embodiments, the Bacillus sp. host cell comprises a deletion of 9 protease genes (See e.g., U.S. Pat. Appln. Pub. No. 2005/0202535, incorporated herein by reference).
- Host cells are transformed with at least one nucleic acid encoding at least one metalloprotease polypeptide of the invention using any suitable method known in the art.
- nucleic acid e.g., DNA
- E. coli cells utilizing plasmid DNA constructs or vectors and transforming such plasmid DNA constructs or vectors into such cells are well known.
- the plasmids are subsequently isolated from E. coli cells and transformed into Bacillus cells.
- host cells are directly transformed with a DNA construct or vector comprising a nucleic acid encoding a
- metalloprotease polypeptide of the invention i.e., an intermediate cell is not used to amplify, or otherwise process, the DNA construct or vector prior to introduction into the host cell.
- DNA constructs or vector of the invention are co-transformed with a plasmid, without being inserted into the plasmid.
- a selective marker is deleted from the altered Bacillus strain by methods known in the art (See, Stahl et al., J. Bacteriol.
- the transformed cells of the present invention are cultured in conventional nutrient media.
- suitable specific culture conditions such as temperature, pH and the like are known to those skilled in the art and are well described in the scientific literature.
- the invention provides a culture (e.g., cell culture) comprising at least one metalloprotease polypeptide or at least one nucleic acid of the invention.
- host cells transformed with at least one polynucleotide sequence encoding at least one metalloprotease polypeptide of the invention are cultured in a suitable nutrient medium under conditions permitting the expression of the present protease, after which the resulting protease is recovered from the culture.
- the protease produced by the cells is recovered from the culture medium by conventional procedures, including, but not limited to for example, separating the host cells from the medium by centrifugation or filtration, precipitating the proteinaceous components of the supernatant or filtrate by means of a salt (e.g., ammonium sulfate), chromatographic purification (e.g., ion exchange, gel filtration, affinity, etc.).
- a salt e.g., ammonium sulfate
- chromatographic purification e.g., ion exchange, gel filtration, affinity, etc.
- a metalloprotease polypeptide produced by a recombinant host cell is secreted into the culture medium.
- a nucleic acid sequence that encodes a purification facilitating domain may be used to facilitate purification of proteins.
- a vector or DNA construct comprising a polynucleotide sequence encoding a metalloprotease polypeptide may further comprise a nucleic acid sequence encoding a purification facilitating domain to facilitate purification of the metalloprotease polypeptide (See e.g., Kroll et al., DNA Cell Biol. 12:441-53 [1993]).
- Such purification facilitating domains include, but are not limited to, for example, metal chelating peptides such as histidine-tryptophan modules that allow purification on immobilized metals (See, Porath, Protein Expr. Purif. 3:263-281 [1992]), protein A domains that allow purification on immobilized immunoglobulin, and the domain utilized in the FLAGS extension/affinity purification system.
- metal chelating peptides such as histidine-tryptophan modules that allow purification on immobilized metals (See, Porath, Protein Expr. Purif. 3:263-281 [1992]
- protein A domains that allow purification on immobilized immunoglobulin
- the domain utilized in the FLAGS extension/affinity purification system The inclusion of a cleavable linker sequence such as Factor XA or enterokinase (e.g., sequences available from Invitrogen, San Diego, CA) between the purification domain and the heterologous protein
- Assays for detecting and measuring the enzymatic activity of an enzyme such as a metalloprotease polypeptide of the invention, are well known.
- Various assays for detecting and measuring activity of proteases are also known to those of ordinary skill in the art.
- assays are available for measuring protease activity that are based on the release of acid- soluble peptides from casein or
- hemoglobin measured as absorbance at 280 nm or colorimetrically using the Folin method.
- Other exemplary assays involve the solubilization of chromogenic substrates (See e.g., Ward, "Proteinases,” in Fogarty (ed.)., Microbial Enzymes and Biotechnology, Applied Science, London, [1983], pp. 251-317).
- exemplary assays include, but are not limited to hydrolysis of protein substrates such as casein (azo-casein, dimethyl-casein and other forms), and peptidyl substrates such as succinyl-Ala-Ala-Pro-Phe-para nitroanilide assay (suc-AAPF-pNA) and the 2,4,6-trinitrobenzene sulfonate sodium salt (TNBS).
- protein substrates such as casein (azo-casein, dimethyl-casein and other forms
- peptidyl substrates such as succinyl-Ala-Ala-Pro-Phe-para nitroanilide assay (suc-AAPF-pNA) and the 2,4,6-trinitrobenzene sulfonate sodium salt (TNBS).
- suc-AAPF-pNA succinyl-Ala-Ala-Pro-Phe-para nitroanilide assay
- TNBS 2,4,6-trinitrobenzene sulfonate sodium salt
- a variety of methods can be used to determine the level of production of a mature protease (e.g., mature metalloprotease polypeptides of the present invention) in a host cell. Such methods include, but are not limited to, for example, methods that utilize either polyclonal or monoclonal antibodies specific for the protease. Exemplary methods include, but are not limited to enzyme-linked immunosorbent assays (ELISA), radioimmunoassays (RIA), fluorescent immunoassays (FIA), and fluorescent activated cell sorting (FACS). These and other assays are well known in the art (See e.g., Maddox et al., J. Exp. Med. 158: 1211 [1983]).
- ELISA enzyme-linked immunosorbent assays
- RIA radioimmunoassays
- FACS fluorescent activated cell sorting
- the invention provides methods for making or producing a mature metalloprotease polypeptide of the invention.
- a mature metalloprotease polypeptide does not include a signal peptide or a propeptide sequence.
- Some methods comprise making or producing a metalloprotease polypeptide of the invention in a recombinant bacterial host cell, such as for example, a Bacillus sp. cell (e.g., a B. subtilis cell).
- the invention provides a method of producing a metalloprotease polypeptide of the invention, the method comprising cultivating a recombinant host cell comprising a recombinant expression vector comprising a nucleic acid encoding a metalloprotease polypeptide of the invention under conditions conducive to the production of the metalloprotease polypeptide. Some such methods further comprise recovering the metalloprotease polypeptide from the culture.
- the invention provides methods of producing a metalloprotease polypeptide of the invention, the methods comprising: (a) introducing a recombinant expression vector comprising a nucleic acid encoding a metalloprotease polypeptide of the invention into a population of cells (e.g., bacterial cells, such as B. subtilis cells); and (b) culturing the cells in a culture medium under conditions conducive to produce the metalloprotease polypeptide encoded by the expression vector. Some such methods further comprise: (c) isolating the metalloprotease polypeptide from the cells or from the culture medium.
- a recombinant expression vector comprising a nucleic acid encoding a metalloprotease polypeptide of the invention into a population of cells (e.g., bacterial cells, such as B. subtilis cells); and (b) culturing the cells in a culture medium under conditions conducive to produce the metalloprotease polypeptide encoded by the expression vector.
- Some such methods further comprise: (
- compositions having the metalloprotease polypeptide of the present invention having the metalloprotease polypeptide of the present invention
- compositions of the invention include cleaning compositions, such as detergent compositions.
- the enzymes levels are expressed by pure enzyme by weight of the total composition and unless otherwise specified, the detergent ingredients are expressed by weight of the total compositions.
- the cleaning compositions of the present invention further comprise adjunct materials including, but not limited to, surfactants, builders, bleaches, bleach activators, bleach catalysts, other enzymes, enzyme stabilizing systems, chelants, optical brighteners, soil release polymers, dye transfer agents, dispersants, suds suppressors, dyes, perfumes, colorants, filler salts, hydrotropes, photoactivators, fluorescers, fabric conditioners, hydrolyzable surfactants, preservatives, anti-oxidants, anti- shrinkage agents, anti-wrinkle agents, germicides, fungicides, color speckles, silvercare, anti-tarnish and/or anti- corrosion agents, alkalinity sources, solubilizing agents, carriers, processing aids, pigments, and pH control agents (See e.g., U.S. Pat. Nos. 6,610,642, 6,605,458, 5,705,464, 5,710,115,
- the cleaning compositions of the present invention are advantageously employed for example, in laundry applications, hard surface cleaning, dishwashing applications, including automatic dishwashing and hand dishwashing, as well as cosmetic applications such as dentures, teeth, hair and skin.
- the enzymes of the present invention are ideally suited for laundry applications.
- the enzymes of the present invention find use in granular and liquid compositions.
- the metalloprotease polypeptides of the present invention also find use in cleaning additive products.
- low temperature solution cleaning applications find use.
- the present invention provides cleaning additive products including at least one enzyme of the present invention is ideally suited for inclusion in a wash process when additional bleaching effectiveness is desired. Such instances include, but are not limited to low temperature solution cleaning applications.
- the additive product is in its simplest form, one or more proteases.
- the additive is packaged in dosage form for addition to a cleaning process.
- the additive is packaged in dosage form for addition to a cleaning process where a source of peroxygen is employed and increased bleaching effectiveness is desired.
- any suitable single dosage unit form finds use with the present invention, including but not limited to pills, tablets, gelcaps, or other single dosage units such as pre-measured powders or liquids.
- filler(s) or carrier material(s) are included to increase the volume of such compositions.
- suitable filler or carrier materials include, but are not limited to, various salts of sulfate, carbonate and silicate as well as talc, clay and the like.
- Suitable filler or carrier materials for liquid compositions include, but are not limited to water or low molecular weight primary and secondary alcohols including polyols and diols. Examples of such alcohols include, but are not limited to, methanol, ethanol, propanol and isopropanol.
- the compositions contain from about 5% to about 90% of such materials. Acidic fillers find use to reduce pH.
- the cleaning additive includes adjunct ingredients, as more fully described below.
- the present cleaning compositions and cleaning additives require an effective amount of at least one of the metalloprotease polypeptides provided herein, alone or in combination with other proteases and/or additional enzymes.
- the required level of enzyme is achieved by the addition of one or more metalloprotease polypeptides of the present invention.
- the present cleaning compositions comprise at least about 0.0001 weight percent, from about 0.0001 to about 10, from about 0.001 to about 1, or from about 0.01 to about 0.1 weight percent of at least one of the metalloprotease polypeptides of the present invention.
- the cleaning compositions herein are typically formulated such that, during use in aqueous cleaning operations, the wash water will have a pH of from about 4.0 to about 11.5 or even from about 5.0 to about 11.5, or even from about 5.0 to about 8.0, or even from about 7.5 to about 10.5.
- Liquid product formulations are typically formulated to have a pH from about 3.0 to about 9.0 or even from about 3 to about 5.
- Granular laundry products are typically formulated to have a pH from about 9 to about 11. Techniques for controlling pH at recommended usage levels include the use of buffers, alkalis, acids, etc., and are well known to those skilled in the art.
- Suitable "low pH cleaning compositions” typically have a pH of from about 3 to about 5, and are typically free of surfactants that hydrolyze in such a pH environment.
- Such surfactants include sodium alkyl sulfate surfactants that comprise at least one ethylene oxide moiety or even from about 1 to about 16 moles of ethylene oxide.
- Such cleaning compositions typically comprise a sufficient amount of a pH modifier, such as sodium hydroxide, monoethanolamine or hydrochloric acid, to provide such cleaning composition with a pH of from about 3 to about 5.
- Such compositions typically comprise at least one acid stable enzyme.
- the compositions are liquids, while in other embodiments, they are solids.
- the pH of such liquid compositions is typically measured as a neat pH.
- the pH of such solid compositions is measured as a 10% solids solution of said composition wherein the solvent is distilled water. In these embodiments, all pH measurements are taken at 20°C, unless otherwise indicated.
- the metalloprotease polypeptide(s) when the metalloprotease polypeptide(s) is/are employed in a granular composition or liquid, it is desirable for the metalloprotease polypeptide to be in the form of an encapsulated particle to protect the metalloprotease polypeptide from other components of the granular composition during storage.
- encapsulation is also a means of controlling the availability of the metalloprotease polypeptide during the cleaning process.
- encapsulation enhances the performance of the metalloprotease polypeptide(s) and/or additional enzymes.
- the metalloprotease polypeptides of the present invention are encapsulated with any suitable encapsulating material known in the art.
- the encapsulating material typically encapsulates at least part of the metalloprotease polypeptide(s) of the present invention.
- the encapsulating material is water-soluble and/or water-dispersible.
- the encapsulating material has a glass transition temperature (Tg) of 0°C or higher. Glass transition temperature is described in more detail in WO 97/11151.
- the encapsulating material is typically selected from consisting of carbohydrates, natural or synthetic gums, chitin, chitosan, cellulose and cellulose derivatives, silicates, phosphates, borates, polyvinyl alcohol, polyethylene glycol, paraffin waxes, and combinations thereof.
- the encapsulating material When the encapsulating material is a carbohydrate, it is typically selected from monosaccharides, oligosaccharides, polysaccharides, and combinations thereof. In some typical embodiments, the encapsulating material is a starch (See e.g., EP 0 922 499; US 4,977,252; US 5,354,559, and US 5,935,826).
- the encapsulating material is a microsphere made from plastic such as thermoplastics, acrylonitrile, methacrylonitrile, polyacrylonitrile, polymethacrylonitrile and mixtures thereof; commercially available microspheres that find use include, but are not limited to those supplied by EXPANCEL® (Stockviksverken, Sweden), and PM 6545, PM 6550, PM 7220, PM 7228,
- EXTENDOSPHERES® EXTENDOSPHERES®, LUXSIL®, Q-CEL®, and SPHERICEL® (PQ Corp., Valley Forge, PA).
- the metalloprotease polypeptides of the present invention find particular use in the cleaning industry, including, but not limited to laundry and dish detergents. These applications place enzymes under various environmental stresses.
- the metalloprotease polypeptides of the present invention provide advantages over many currently used enzymes, due to their stability under various conditions.
- wash conditions including varying detergent formulations, wash water volumes, wash water temperatures, and lengths of wash time, to which proteases involved in washing are exposed.
- detergent formulations used in different geographical areas have different concentrations of their relevant components present in the wash water.
- European detergents typically have about 4500-5000 ppm of detergent components in the wash water
- Japanese detergents typically have
- detergents typically have about 975 ppm of detergent components present in the wash water.
- a low detergent concentration system includes detergents where less than about 800 ppm of the detergent components are present in the wash water.
- Japanese detergents are typically considered low detergent concentration system as they have approximately 667 ppm of detergent components present in the wash water.
- a medium detergent concentration includes detergents where between about 800 ppm and about 2000ppm of the detergent components are present in the wash water.
- North American detergents are generally considered to be medium detergent concentration systems as they have approximately 975 ppm of detergent components present in the wash water. Brazil typically has approximately 1500 ppm of detergent components present in the wash water.
- a high detergent concentration system includes detergents where greater than about 2000 ppm of the detergent components are present in the wash water.
- European detergents are generally considered to be high detergent concentration systems as they have approximately 4500-5000 ppm of detergent components in the wash water.
- Latin American detergents are generally high suds phosphate builder detergents and the range of detergents used in Latin America can fall in both the medium and high detergent concentrations as they range from 1500 ppm to 6000 ppm of detergent components in the wash water. As mentioned above, Brazil typically has approximately 1500 ppm of detergent components present in the wash water.
- other high suds phosphate builder detergent geographies not limited to other Latin American countries, may have high detergent
- concentration systems up to about 6000 ppm of detergent components present in the wash water.
- concentrations of detergent compositions in typical wash solutions throughout the world varies from less than about 800 ppm of detergent to about 6000 ppm in high suds phosphate builder geographies.
- concentrations of the typical wash solutions are determined empirically. For example, in the U.S., a typical washing machine holds a volume of about 64.4 L of wash solution. Accordingly, in order to obtain a concentration of about 975 ppm of detergent within the wash solution about 62.79 g of detergent composition must be added to the 64.4 L of wash solution. This amount is the typical amount measured into the wash water by the consumer using the measuring cup provided with the detergent.
- different geographies use different wash temperatures.
- the temperature of the wash water in Japan is typically less than that used in Europe.
- the temperature of the wash water in North America and Japan is typically between about 10 and about 40°C (e.g., about 20°C), whereas the temperature of wash water in Europe is typically between about 30 and about 60°C (e.g., about 40°C).
- cold water is typically used for laundry, as well as dish washing applications.
- the "cold water washing” of the present invention utilizes “cold water detergent” suitable for washing at temperatures from about 10°C to about 40°C, or from about 20°C to about 30°C, or from about 15°C to about 25°C, as well as all other combinations within the range of about 15°C to about 35°C, and all ranges within 10°C to 40°C.
- Water hardness is usually described in terms of the grains per gallon mixed Ca 2+ /Mg 2+ .
- Hardness is a measure of the amount of calcium (Ca 2+ ) and magnesium (Mg 2+ ) in the water. Most water in the United States is hard, but the degree of hardness varies. Moderately hard (60- 120 ppm) to hard (121-181 ppm) water has 60 to 181 parts per million (parts per million converted to grains per U.S. gallon is ppm # divided by 17.1 equals grains per gallon) of hardness minerals. Water Grains per gallon Parts per million
- European water hardness is typically greater than about 10.5 (for example about 10.5 to about 20.0) grains per gallon mixed Ca 2+ /Mg 2+ (e.g., about 15 grains per gallon mixed
- North American water hardness is typically greater than Japanese water hardness, but less than European water hardness.
- North American water hardness can be between about 3 to about 10 grains, about 3 to about 8 grains or about 6 grains.
- Japanese water hardness is typically lower than North American water hardness, usually less than about 4, for example about 3 grains per gallon mixed Ca 2+ /Mg 2+ .
- the present invention provides metallopro tease polypeptides that show surprising wash performance in at least one set of wash conditions (e.g., water temperature, water hardness, and/or detergent concentration).
- the metalloprotease polypeptides of the present invention are comparable in wash performance to other metalloprotease polypeptide proteases.
- the metalloprotease polypeptides provided herein exhibit enhanced oxidative stability, enhanced thermal stability, enhanced cleaning capabilities under various conditions, and/or enhanced chelator stability.
- the metalloprotease polypeptides of the present invention find use in cleaning compositions that do not include detergents, again either alone or in combination with builders and stabilizers.
- the cleaning compositions comprise at least one metalloprotease polypeptide of the present invention at a level from about 0.00001 % to about 10% by weight of the composition and the balance (e.g., about 99.999% to about 90.0%) comprising cleaning adjunct materials by weight of composition.
- the cleaning compositions of the present invention comprises at least one metalloprotease polypeptide at a level of about 0.0001 % to about 10%, about 0.001% to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% by weight of the composition and the balance of the cleaning composition (e.g., about 99.9999% to about 90.0%, about 99.999 % to about 98%, about 99.995% to about 99.5% by weight) comprising cleaning adjunct materials.
- the cleaning compositions of the present invention comprise one or more additional detergent enzymes, which provide cleaning performance and/or fabric care and/or dishwashing benefits.
- Suitable enzymes include, but are not limited to, acyl transferases, alpha- amylases, beta- amylases, alpha-galactosidases, arabinosidases, aryl esterases, beta-galactosidases, carrageenases, catalases, cellobiohydrolases, cellulases, chondroitinases, cutinases, endo-beta-1, 4-glucanases, endo-beta-mannanases, esterases, exo-mannanases, galactanases, glucoamylases, hemicellulases, hyaluronidases, keratinases, laccases, lactases, ligninases, lipases, lipoxygenases, mannanases, oxidases, pectate lyases, pectin acetyl esterases, pectinases, pentosan
- a combination of enzymes is used (i.e., a "cocktail") comprising conventional applicable enzymes like protease, lipase, cutinase and/or cellulase in conjunction with amylase is used.
- any other suitable protease finds use in the compositions of the present invention.
- Suitable proteases include those of animal, vegetable or microbial origin. In some embodiments, microbial proteases are used. In some embodiments, chemically or genetically modified mutants are included.
- the protease is a serine protease, preferably an alkaline microbial protease or a trypsin-like protease.
- alkaline proteases examples include subtilisins, especially those derived from Bacillus (e.g., subtilisin, lentus, amyloliquefaciens, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168). Additional examples include those mutant proteases described in U.S. Pat. Nos. RE 34,606, 5,955,340, 5,700,676, 6,312,936, and 6,482,628, all of which are incorporated herein by reference. Additional protease examples include, but are not limited to trypsin (e.g., of porcine or bovine origin), and the Fusarium protease described in WO 89/06270. In some embodiments, commercially available protease enzymes that find use in the present invention include, but are not limited to MAXATASE®, MAXACALTM,
- metalloproteases find use in the present invention, including but not limited to the neutral metallopro tease described in WO 07/044993.
- any suitable lipase finds use in the present invention.
- Suitable lipases include, but are not limited to those of bacterial or fungal origin. Chemically or genetically modified mutants are encompassed by the present invention.
- useful lipases include Humicola lanuginosa lipase (See e.g., EP 258 068, and EP 305 216), Rhizomucor miehei lipase (See e.g., EP 238 023), Candida lipase, such as C. antarctica lipase (e.g., the C. antarctica lipase A or B; See e.g., EP 214 761), Pseudomonas lipases such as P. alcaligenes lipase and P.
- pseudoalcaligenes lipase See e.g., EP 218 272
- P. cepacia lipase See e.g., EP 331 376
- P. stutzeri lipase See e.g., GB 1,372,034
- P. fluorescens lipase Bacillus lipase (e.g., B. subtilis lipase [Dartois et al., Biochem. Biophys. Acta 1131:253-260 [1993]); B. stearothermophilus lipase [See e.g., JP 64/744992]; and B. pumilus lipase [See e.g., WO 91/16422]).
- cloned lipases find use in some embodiments of the present invention, including but not limited to Penicillium camembertii lipase (See, Yamaguchi et al., Gene 103:61-67 [1991]), Geotricum candidum lipase (See, Schimada et al., J. Biochem., 106:383-388 [1989]), and various Rhizopus lipases such as R. delemar lipase (See, Hass et al., Gene 109: 117-113 [1991]), a R. niveus lipase (Kugimiya et al., Biosci. Biotech. Biochem.
- lipase polypeptide enzymes such as cutinases also find use in some embodiments of the present invention, including but not limited to the cutinase derived from Pseudomonas mendocina (See, WO 88/09367), and the cutinase derived from Fusarium solani pisi (See, WO 90/09446).
- lipases such as Ml
- LIPASETM LIPASETM, LUMA FASTTM, and LIPOMAXTM (Genencor); LIPEX®, LIPOLASE® and LIPOLASE® ULTRA (Novozymes); and LIPASE PTM "Amano” (Amano Pharmaceutical Co. Ltd., Japan).
- Various lipases are described in WO2010065455, WO2010107560,
- the cleaning compositions of the present invention further comprise lipases at a level from about 0.00001 % to about 10% of additional lipase by weight of the composition and the balance of cleaning adjunct materials by weight of composition.
- the cleaning compositions of the present invention also comprise lipases at a level of about 0.0001 % to about 10%, about 0.001% to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% lipase by weight of the composition.
- any suitable amylase finds use in the present invention.
- any amylase e.g., alpha and/or beta
- suitable amylases include, but are not limited to those of bacterial or fungal origin. Chemically or genetically modified mutants are included in some embodiments.
- Amylases that find use in the present invention include, but are not limited to a- amylases obtained from B. licheniformis (See e.g., GB 1,296,839).
- Additional suitable amylases include those found in W09510603, W09526397, W09623874, W09623873, W09741213, W09919467, WO0060060, WO0029560, W09923211, W09946399, WO0060058,
- WO2006066594 WO2006066596, WO2006012899, WO2008092919, WO2008000825, WO2005018336, WO2005066338, WO2009140504, WO2005019443, WO2010091221, WO2010088447, WO0134784, WO2006012902, WO2006031554, WO2006136161,
- WO2008088493 WO2009149419, WO2009061381, WO2009100102, WO2010104675, WO2010117511, and WO2010115021.
- Commercially available amylases that find use in the present invention include, but are not limited to DURAMYL®, TERM AM YL®,
- the cleaning compositions of the present invention further comprise amylases at a level from about 0.00001 % to about 10% of additional amylase by weight of the composition and the balance of cleaning adjunct materials by weight of composition.
- the cleaning compositions of the present invention also comprise amylases at a level of about 0.0001 % to about 10%, about 0.001 to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% amylase by weight of the composition.
- any suitable cellulase finds used in the cleaning compositions of the present invention.
- Suitable cellulases include, but are not limited to those of bacterial or fungal origin. Chemically or genetically modified mutants are included in some embodiments.
- Suitable cellulases include, but are not limited to Humicola insolens cellulases (See e.g., U.S. Pat. No. 4,435,307).
- Especially suitable cellulases are the cellulases having color care benefits (See e.g., EP 0 495 257).
- cellulases that find use in the present include, but are not limited to CELLUZYME®, CAREZYME® (Novozymes), and KAC-500(B)TM (Kao Corporation).
- cellulases are incorporated as portions or fragments of mature wild- type or variant cellulases, wherein a portion of the N- terminus is deleted (See e.g., U.S. Pat. No. 5,874,276).
- Additional suitable cellulases include those found in WO2005054475, WO2005056787, U.S. Pat. No. 7,449,318, and U.S. Pat. No. 7,833,773.
- the cleaning compositions of the present invention further comprise cellulases at a level from about 0.00001 % to about 10% of additional cellulase by weight of the composition and the balance of cleaning adjunct materials by weight of composition. In some other embodiments of the present invention, the cleaning compositions of the present invention also comprise cellulases at a level of about 0.0001 % to about 10%, about 0.001% to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% cellulase by weight of the composition.
- mannanase suitable for use in detergent compositions also finds use in the present invention.
- Suitable mannanases include, but are not limited to those of bacterial or fungal origin. Chemically or genetically modified mutants are included in some embodiments.
- Various mannanases are known which find use in the present invention (See e.g., U.S. Pat. No.
- the cleaning compositions of the present invention further comprise mannanases at a level from about 0.00001 % to about 10% of additional mannanase by weight of the composition and the balance of cleaning adjunct materials by weight of composition.
- the cleaning compositions of the present invention also comprise mannanases at a level of about 0.0001 % to about 10%, about 0.001% to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% mannanase by weight of the composition.
- peroxidases are used in combination with hydrogen peroxide or a source thereof (e.g., a percarbonate, perborate or persulfate) in the compositions of the present invention.
- oxidases are used in combination with oxygen.
- Both types of enzymes are used for "solution bleaching" (i.e., to prevent transfer of a textile dye from a dyed fabric to another fabric when the fabrics are washed together in a wash liquor), preferably together with an enhancing agent (See e.g., WO 94/12621 and WO 95/01426).
- Suitable peroxidases/oxidases include, but are not limited to those of plant, bacterial or fungal origin. Chemically or genetically modified mutants are included in some embodiments.
- the cleaning compositions of the present invention further comprise peroxidase and/or oxidase enzymes at a level from about 0.00001 % to about 10% of additional peroxidase and/or oxidase by weight of the composition and the balance of cleaning adjunct materials by weight of composition.
- the cleaning compositions of the present invention also comprise, peroxidase and/or oxidase enzymes at a level of about 0.0001 % to about 10%, about 0.001% to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% peroxidase and/or oxidase enzymes by weight of the composition.
- additional enzymes find use, including but not limited to perhydrolases (See e.g., WO 05/056782).
- mixtures of the above mentioned enzymes are encompassed herein, in particular one or more additional protease, amylase, lipase, mannanase, and/or at least one cellulase. Indeed, it is contemplated that various mixtures of these enzymes will find use in the present invention.
- the varying levels of the metalloprotease polypeptide (s) and one or more additional enzymes may both independently range to about 10%, the balance of the cleaning composition being cleaning adjunct materials. The specific selection of cleaning adjunct materials are readily made by considering the surface, item, or fabric to be cleaned, and the desired form of the composition for the cleaning conditions during use (e.g., through the wash detergent use).
- cleaning adjunct materials include, but are not limited to, surfactants, builders, bleaches, bleach activators, bleach catalysts, other enzymes, enzyme stabilizing systems, chelants, optical brighteners, soil release polymers, dye transfer agents, dye transfer inhibiting agents, catalytic materials, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersing agents, clay soil removal agents, structure elasticizing agents, dispersants, suds suppressors, dyes, perfumes, colorants, filler salts, hydrotropes, photoactivators, fluorescers, fabric conditioners, fabric softeners, carriers, hydrotropes, processing aids, solvents, pigments, hydrolyzable surfactants, preservatives, anti- oxidants, anti- shrinkage agents, anti-wrinkle agents, germicides, fungicides, color speckles, silvercare, anti- tarnish and/or anti-corrosion agents, alkalinity sources, solubilizing agents, carriers, processing aids, pigments, pigments
- an effective amount of one or more metalloprotease polypeptide (s) provided herein is included in compositions useful for cleaning a variety of surfaces in need of proteinaceous stain removal.
- cleaning compositions include cleaning compositions for such applications as cleaning hard surfaces, fabrics, and dishes.
- the present invention provides fabric cleaning compositions, while in other embodiments, the present invention provides non-fabric cleaning compositions.
- the present invention also provides cleaning compositions suitable for personal care, including oral care (including dentrifices, toothpastes, mouthwashes, etc., as well as denture cleaning compositions), skin, and hair cleaning compositions. It is intended that the present invention encompass detergent compositions in any form (i.e., liquid, granular, bar, semi-solid, gels, emulsions, tablets, capsules, etc.).
- compositions of the present invention preferably contain at least one surfactant and at least one builder compound, as well as one or more cleaning adjunct materials preferably selected from organic polymeric compounds, bleaching agents, additional enzymes, suds suppressors, dispersants, lime-soap dispersants, soil suspension and anti-redeposition agents and corrosion inhibitors.
- cleaning adjunct materials preferably selected from organic polymeric compounds, bleaching agents, additional enzymes, suds suppressors, dispersants, lime-soap dispersants, soil suspension and anti-redeposition agents and corrosion inhibitors.
- laundry compositions also contain softening agents (i.e., as additional cleaning adjunct materials).
- compositions of the present invention also find use in detergent additive products in solid or liquid form. Such additive products are intended to supplement and/or boost the performance of conventional detergent compositions and can be added at any stage of the cleaning process.
- density of the laundry detergent compositions herein ranges from about 400 to about 1200 g/liter, while in other embodiments, it ranges from about 500 to about 950 g/liter of composition measured at 20°C.
- compositions of the invention preferably contain at least one surfactant and preferably at least one additional cleaning adjunct material selected from organic polymeric compounds, suds enhancing agents, group II metal ions, solvents, hydrotropes and additional enzymes.
- various cleaning compositions such as those provided in U.S, Pat. No. 6,605,458, find use with the metalloprotease polypeptides of the present invention.
- the compositions comprising at least one metalloprotease polypeptide of the present invention is a compact granular fabric cleaning composition, while in other embodiments, the composition is a granular fabric cleaning composition useful in the laundering of colored fabrics, in further embodiments, the composition is a granular fabric cleaning composition which provides softening through the wash capacity, in additional embodiments, the composition is a heavy duty liquid fabric cleaning composition.
- the compositions comprising at least one metalloprotease polypeptide of the present invention are fabric cleaning compositions such as those described in U.S. Pat. Nos.
- metalloprotease polypeptides of the present invention find use in granular laundry detergent compositions of particular utility under European or Japanese washing conditions (See e.g., U.S. Pat. No. 6,610,642).
- the present invention provides hard surface cleaning compositions comprising at least one metalloprotease polypeptide provided herein.
- the compositions comprising at least one metalloprotease polypeptide of the present invention is a hard surface cleaning composition such as those described in U.S. Pat. Nos. 6,610,642, 6,376,450, and 6,376,450.
- the present invention provides dishwashing compositions comprising at least one metalloprotease polypeptide provided herein.
- compositions comprising at least one metalloprotease polypeptide of the present invention is a hard surface cleaning composition such as those in U.S. Pat. Nos.
- the present invention provides dishwashing compositions comprising at least one metalloprotease polypeptide provided herein.
- the compositions comprising at least one metalloprotease polypeptide of the present invention comprise oral care compositions such as those in U.S. Pat. No. 6,376,450, and 6,376,450.
- the cleaning compositions of the present invention are formulated into any suitable form and prepared by any process chosen by the formulator, non-limiting examples of which are described in U.S. Pat. Nos. 5,879,584, 5,691,297, 5,574,005, 5,569,645, 5,565,422, 5,516,448, 5,489,392, and 5,486,303, all of which are incorporated herein by reference.
- the pH of such composition is adjusted via the addition of a material such as monoethanolamine or an acidic material such as HC1.
- the cleaning compositions of the present invention can be formulated to have an alkaline pH under wash conditions, such as a pH of from about 8.0 to about 12.0, or from about 8.5 to about 11.0, or from about 9.0 to about 11.0.
- an alkaline pH under wash conditions such as a pH of from about 8.0 to about 12.0, or from about 8.5 to about 11.0, or from about 9.0 to about 11.0.
- the cleaning compositions of the present invention can be formulated to have a neutral pH under wash conditions, such as a pH of from about 5.0 to about 8.0, or from about 5.5 to about 8.0, or from about 6.0 to about 8.0, or from about 6.0 to about 7.5.
- the neutral pH conditions can be measured when the cleaning composition is dissolved 1: 100 (wt:wt) in de-ionised water at 20°C, measured using a conventional pH meter.
- adjuncts illustrated hereinafter are suitable for use in the instant cleaning compositions.
- these adjuncts are incorporated for example, to assist or enhance cleaning performance, for treatment of the substrate to be cleaned, or to modify the aesthetics of the cleaning composition as is the case with perfumes, colorants, dyes or the like. It is understood that such adjuncts are in addition to the metalloprotease polypeptides of the present invention. The precise nature of these additional components, and levels of incorporation thereof, will depend on the physical form of the composition and the nature of the cleaning operation for which it is to be used.
- Suitable adjunct materials include, but are not limited to, surfactants, builders, chelating agents, dye transfer inhibiting agents, deposition aids, dispersants, additional enzymes, and enzyme stabilizers, catalytic materials, bleach activators, bleach boosters, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersing agents, clay soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, perfumes, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids and/or pigments.
- suitable examples of such other adjuncts and levels of use are found in U.S. Patent Nos. 5,576,282, 6,306,812, and 6,326,348, incorporated by reference.
- the cleaning compositions according to the present invention comprise an acidifying particle or an amino carboxylic builder.
- an amino carboxylic builder include aminocarboxylic acids, salts and derivatives thereof.
- the amino carboxylic builder is an aminopolycarboxylic builder, such as glycine- ⁇ , ⁇ -diacetic acid or derivative of general formula MOOC-CHR-N (CH 2 COOM) 2 where R is Ci_ 12 alkyl and M is alkali metal.
- the amino carboxylic builder can be methyl glycine diacetic acid (MGDA), GLDA (glutamic-N,N-diacetic acid), iminodisuccinic acid (IDS), carboxymethyl inulin and salts and derivatives thereof, aspartic acid-N-monoacetic acid (ASMA), aspartic acid-N,N-diacetic acid (ASDA), aspartic acid-N-monopropionic acid (ASMP), iminodisuccinic acid (IDA), N-(2-sulfomethyl) aspartic acid (SMAS), N-(2- sulfoethyl)aspartic acid (SEAS), N-(2-sulfomethyl)glutamic acid (SMGL), N-(2-sulfoethyl) glutamic acid (SEGL), IDS (iminodiacetic acid) and salts and derivatives thereof such as N- methyliminodiacetic acid (MID A) , alpha-a
- the acidifying particle has a weight geometric mean particle size of from about 400 ⁇ to about 1200 ⁇ and a bulk density of at least 550 g/L. In some embodiments, the acidifying particle comprises at least about 5% of the builder.
- the acidifying particle can comprise any acid, including organic acids and mineral acids.
- Organic acids can have one or two carboxyls and in some instances up to 15 carbons, especially up to 10 carbons, such as formic, acetic, propionic, capric, oxalic, succinic, adipic, maleic, fumaric, sebacic, malic, lactic, glycolic, tartaric and glyoxylic acids.
- the acid is citric acid.
- Mineral acids include hydrochloric and sulphuric acid.
- the acidifying particle of the invention is a highly active particle comprising a high level of amino carboxylic builder. Sulphuric acid has been found to further contribute to the stability of the final particle.
- the cleaning compositions according to the present invention comprise at least one surfactant and/or a surfactant system wherein the surfactant is selected from nonionic surfactants, anionic surfactants, cationic surfactants, ampholytic surfactants, zwitterionic surfactants, semi-polar nonionic surfactants and mixtures thereof.
- the surfactant is selected from nonionic surfactants, anionic surfactants, cationic surfactants, ampholytic surfactants, zwitterionic surfactants, semi-polar nonionic surfactants and mixtures thereof.
- the composition typically does not contain alkyl ethoxylated sulfate, as it is believed that such surfactant may be hydrolyzed by such compositions the acidic contents.
- the surfactant is present at a level of from about 0.1% to about 60%, while in alternative embodiments the level is from about 1% to about 50%, while in still further embodiments the level is from about 5% to about 40%, by weight of the cleaning composition.
- the cleaning compositions of the present invention comprise one or more detergent builders or builder systems. In some embodiments incorporating at least one builder, the cleaning compositions comprise at least about 1%, from about 3% to about 60% or even from about 5% to about 40% builder by weight of the cleaning composition.
- Builders include, but are not limited to, the alkali metal, ammonium and alkanolammonium salts of polyphosphates, alkali metal silicates, alkaline earth and alkali metal carbonates,
- aluminosilicates polycarboxylate compounds, ether hydroxypolycarboxylates, copolymers of maleic anhydride with ethylene or vinyl methyl ether, 1, 3, 5-trihydroxy benzene-2, 4, 6- trisulphonic acid, and carboxymethyloxysuccinic acid, the various alkali metal, ammonium and substituted ammonium salts of polyacetic acids such as ethylenediamine tetraacetic acid and nitrilotriacetic acid, as well as polycarboxylates such as mellitic acid, succinic acid, citric acid, oxydisuccinic acid, polymaleic acid, benzene 1,3,5-tricarboxylic acid,
- the builders form water-soluble hardness ion complexes (e.g., sequestering builders), such as citrates and polyphosphates (e.g., sodium tripolyphosphate and sodium tripolyphospate hexahydrate, potassium tripolyphosphate, and mixed sodium and potassium tripolyphosphate, etc.). It is contemplated that any suitable builder will find use in the present invention, including those known in the art (See e.g., EP 2 100 949).
- water-soluble hardness ion complexes e.g., sequestering builders
- citrates and polyphosphates e.g., sodium tripolyphosphate and sodium tripolyphospate hexahydrate, potassium tripolyphosphate, and mixed sodium and potassium tripolyphosphate, etc.
- polyphosphates e.g., sodium tripolyphosphate and sodium tripolyphospate hexahydrate, potassium tripolyphosphate, and mixed sodium and potassium tripolyphosphate,
- builders for use herein include phosphate builders and non- phosphate builders.
- the builder is a phosphate builder.
- the builder is a non-phosphate builder. If present, builders are used in a level of from 0.1% to 80%, or from 5 to 60%, or from 10 to 50% by weight of the composition.
- the product comprises a mixture of phosphate and non-phosphate builders.
- Suitable phosphate builders include mono-phosphates, di-phosphates, tri-polyphosphates or oligomeric-poylphosphates, including the alkali metal salts of these compounds, including the sodium salts.
- a builder can be sodium tripolyphosphate (STPP).
- composition can comprise carbonate and/or citrate, preferably citrate that helps to achieve a neutral pH composition of the invention.
- suitable non-phosphate builders include homopolymers and copolymers of polycarboxylic acids and their partially or completely neutralized salts, monomeric polycarboxylic acids and hydroxycarboxylic acids and their salts.
- salts of the above mentioned compounds include the ammonium and/or alkali metal salts, i.e. the lithium, sodium, and potassium salts, including sodium salts.
- Suitable polycarboxylic acids include acyclic, alicyclic, hetero-cyclic and aromatic carboxylic acids, wherein in some embodiments, they can contain at least two carboxyl groups which are in each case separated from one another by, in some instances, no more than two carbon atoms.
- the cleaning compositions of the present invention contain at least one chelating agent.
- Suitable chelating agents include, but are not limited to copper, iron and/or manganese chelating agents and mixtures thereof.
- the cleaning compositions of the present invention comprise from about 0.1% to about 15% or even from about 3.0% to about 10% chelating agent by weight of the subject cleaning composition.
- the cleaning compositions provided herein contain at least one deposition aid.
- Suitable deposition aids include, but are not limited to, polyethylene glycol, polypropylene glycol, polycarboxylate, soil release polymers such as polytelephthalic acid, clays such as kaolinite, montmorillonite, atapulgite, illite, bentonite, halloysite, and mixtures thereof.
- anti-redeposition agents find use in some embodiments of the present invention.
- non-ionic surfactants find use.
- non-ionic surfactants find use for surface modification purposes, in particular for sheeting, to avoid filming and spotting and to improve shine.
- these non-ionic surfactants also find use in preventing the re-deposition of soils.
- the anti-redeposition agent is a non-ionic surfactant as known in the art (See e.g., EP 2 100 949).
- the non-ionic surfactant can be ethoxylated nonionic surfactants, epoxy-capped poly(oxyalkylated) alcohols and amine oxides surfactants.
- the cleaning compositions of the present invention include one or more dye transfer inhibiting agents.
- Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof.
- the cleaning compositions of the present invention comprise from about 0.0001% to about 10%, from about 0.01% to about 5%, or even from about 0.1% to about 3% by weight of the cleaning composition.
- silicates are included within the compositions of the present invention.
- sodium silicates find use.
- silicates are present at a level of from about 1% to about 20%. In some embodiments, silicates are present at a level of from about 5% to about 15% by weight of the composition.
- the cleaning compositions of the present invention also contain dispersants.
- Suitable water-soluble organic materials include, but are not limited to the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms.
- the enzymes used in the cleaning compositions are stabilized by any suitable technique.
- the enzymes employed herein are stabilized by the presence of water-soluble sources of calcium and/or magnesium ions in the finished compositions that provide such ions to the enzymes.
- the enzyme stabilizers include oligosaccharides, polysaccharides, and inorganic divalent metal salts, including alkaline earth metals, such as calcium salts, such as calcium formate. It is
- the enzymes employed herein are stabilized by the presence of water-soluble sources of zinc (II), calcium (II) and/or magnesium (II) ions in the finished compositions that provide such ions to the enzymes, as well as other metal ions (e.g., barium (II), scandium (II), iron (II), manganese (II), aluminum (III), Tin (II), cobalt (II), copper (II), nickel (II), and oxovanadium (IV). Chlorides and sulfates also find use in some
- polysaccharides e.g., dextrins
- reversible protease inhibitors also find use, such as boron-containing compounds (e.g., borate, 4-formyl phenyl boronic acid) and/or a tripeptide aldehyde find use to further improve stability, as desired.
- boron-containing compounds e.g., borate, 4-formyl phenyl boronic acid
- a tripeptide aldehyde find use to further improve stability, as desired.
- bleaches, bleach activators and/or bleach catalysts are present in the compositions of the present invention.
- the cleaning compositions of the present invention comprise inorganic and/or organic bleaching compound(s).
- Inorganic bleaches include, but are not limited to perhydrate salts (e.g., perborate, percarbonate, perphosphate, persulfate, and persilicate salts).
- inorganic perhydrate salts are alkali metal salts.
- inorganic perhydrate salts are included as the crystalline solid, without additional protection, although in some other embodiments, the salt is coated. Any suitable salt known in the art finds use in the present invention (See e.g., EP 2 100 949).
- bleach activators are used in the compositions of the present invention.
- Bleach activators are typically organic peracid precursors that enhance the bleaching action in the course of cleaning at temperatures of 60°C and below.
- Bleach activators suitable for use herein include compounds which, under perhydrolysis conditions, give aliphatic peroxoycarboxylic acids having preferably from about 1 to about 10 carbon atoms, in particular from about 2 to about 4 carbon atoms, and/or optionally substituted perbenzoic acid. Additional bleach activators are known in the art and find use in the present invention (See e.g., EP 2 100 949).
- the cleaning compositions of the present invention further comprise at least one bleach catalyst.
- the manganese triazacyclononane and related complexes find use, as well as cobalt, copper, manganese, and iron complexes.
- Additional bleach catalysts find use in the present invention (See e.g., US 4,246,612, 5,227,084, 4,810410, WO 99/06521, and EP 2 100 949).
- the cleaning compositions of the present invention contain one or more catalytic metal complexes.
- a metal-containing bleach catalyst finds use.
- the metal bleach catalyst comprises a catalyst system comprising a transition metal cation of defined bleach catalytic activity, (e.g., copper, iron, titanium, ruthenium, tungsten, molybdenum, or manganese cations), an auxiliary metal cation having little or no bleach catalytic activity (e.g., zinc or aluminum cations), and a sequestrate having defined stability constants for the catalytic and auxiliary metal cations, particularly
- the cleaning compositions of the present invention are catalyzed by means of a manganese compound.
- a manganese compound Such compounds and levels of use are well known in the art (See e.g., US Patent No. 5,576,282).
- cobalt bleach catalysts find use in the cleaning compositions of the present invention.
- Various cobalt bleach catalysts are known in the art (See e.g., US Patent Nos. 5,597,936 and 5,595,967) and are readily prepared by known procedures.
- the cleaning compositions of the present invention include a transition metal complex of a macropolycyclic rigid ligand (MRL).
- MRL macropolycyclic rigid ligand
- the compositions and cleaning processes provided by the present invention are adjusted to provide on the order of at least one part per hundred million of the active MRL species in the aqueous washing medium, and in some embodiments, provide from about 0.005 ppm to about 25 ppm, more preferably from about 0.05 ppm to about 10 ppm, and most preferably from about 0.1 ppm to about 5 ppm, of the MRL in the wash liquor.
- transition-metals in the instant transition-metal bleach catalyst include, but are not limited to manganese, iron and chromium.
- MRLs also include, but are not limited to special ultra-rigid ligands that are cross-bridged (e.g., 5,12-diethyl-l,5,8, 12- tetraazabicyclo[6.6.2]hexadecane).
- Suitable transition metal MRLs are readily prepared by known procedures (See e.g., WO 2000/32601, and US Patent No. 6,225,464).
- the cleaning compositions of the present invention comprise metal care agents.
- Metal care agents find use in preventing and/or reducing the tarnishing, corrosion, and/or oxidation of metals, including aluminum, stainless steel, and non-ferrous metals (e.g., silver and copper). Suitable metal care agents include those described in EP 2 100 949, WO 9426860 and WO 94/26859).
- the metal care agent is a zinc salt.
- the cleaning compositions of the present invention comprise from about 0.1% to about 5% by weight of one or more metal care agent.
- the cleaning composition is a high density liquid (HDL) composition having a variant metalloprotease polypeptide protease.
- the HDL liquid laundry detergent can comprise a detersive surfactant (10%-40%) comprising anionic detersive surfactant (selected from a group of linear or branched or random chain, substituted or unsubstituted alkyl sulphates, alkyl sulphonates, alkyl alkoxylated sulphate, alkyl phosphates, alkyl phosphonates, alkyl carboxylates, and/or mixtures thereof); and optionally non-ionic surfactant (selected from a group of linear or branched or random chain, substituted or unsubstituted alkyl alkoxylated alcohol, for example a C 8 -C 18 alkyl ethoxylated alcohol and/or C6-C 12 alkyl phenol alkoxylates), optionally wherein the weight ratio of anionic detersive surfactant (with
- the composition can comprise optionally, a surfactancy boosting polymer consisting of amphiphilic alkoxylated grease cleaning polymers (selected from a group of alkoxylated polymers having branched hydrophilic and hydrophobic properties, such as alkoxylated polyalkylenimines in the range of 0.05wt%- 10wt%) and/or random graft polymers (typically comprising of hydrophilic backbone comprising monomers selected from the group consisting of: unsaturated C -C carboxylic acids, ethers, alcohols, aldehydes, ketones, esters, sugar units, alkoxy units, maleic anhydride, saturated polyalcohols such as glycerol, and mixtures thereof; and hydrophobic side chain(s) selected from the group consisting of: C4-C25 alkyl group, polypropylene, polybutylene, vinyl ester of a saturated C-C 6 mono-carboxylic acid, C -C alkyl ester of acrylic or methacryl
- the composition can comprise additional polymers such as soil release polymers (include anionically end-capped polyesters, for example SRPl, polymers comprising at least one monomer unit selected from saccharide, dicarboxylic acid, polyol and combinations thereof, in random or block configuration, ethylene terephthalate-based polymers and co-polymers thereof in random or block configuration, for example Repel-o-tex SF, SF-2 and SRP6, Texcare SRA100, SRA300, SRN100, SRN170, SRN240, SRN300 and SRN325, Marloquest SL), anti- redeposition polymers (0.1 wt to 10wt , include carboxylate polymers, such as polymers comprising at least one monomer selected from acrylic acid, maleic acid (or maleic anhydride), fumaric acid, itaconic acid, aconitic acid, mesaconic acid, citraconic acid, methylenemalonic acid, and any mixture thereof, vinylpyrrolidone homopolymer, and
- the composition can further comprise saturated or unsaturated fatty acid, preferably saturated or unsaturated C 12 -C24 fatty acid (0 wt to 10 wt ); deposition aids (examples for which include polysaccharides, preferably cellulosic polymers, poly diallyl dimethyl ammonium halides (DADMAC), and co-polymers of DAD MAC with vinyl pyrrolidone, acrylamides, imidazoles, imidazolinium halides, and mixtures thereof, in random or block configuration, cationic guar gum, cationic cellulose such as cationic hydoxyethyl cellulose, cationic starch, cationic polyacylamides, and mixtures thereof.
- deposition aids include polysaccharides, preferably cellulosic polymers, poly diallyl dimethyl ammonium halides (DADMAC), and co-polymers of DAD MAC with vinyl pyrrolidone, acrylamides, imidazo
- composition can further comprise dye transfer inhibiting agents examples of which include manganese phthalocyanine, peroxidases, polyvinylpyrrolidone polymers, polyamine N- oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole,
- polyvinyloxazolidones and polyvinylimidazoles and/or mixtures thereof chelating agents examples of which include ethylene-diamine-tetraacetic acid (EDTA); diethylene triamine penta methylene phosphonic acid (DTPMP); hydroxy-ethane diphosphonic acid (HEDP);
- EDTA ethylene-diamine-tetraacetic acid
- DTPMP diethylene triamine penta methylene phosphonic acid
- HEDP hydroxy-ethane diphosphonic acid
- ethylenediamine ⁇ , ⁇ '-disuccinic acid EDDS
- MGDA methyl glycine diacetic acid
- DTPA diethylene triamine penta acetic acid
- HPNO propylene diamine tetracetic acid
- MGDA methyl glycine diacetic acid
- glutamic acid ⁇ , ⁇ -diacetic acid N,N-dicarboxymethyl glutamic acid tetrasodium salt (GLDA); nitrilotriacetic acid (NTA); 4,5-dihydroxy-m-benzenedisulfonic acid; citric acid and any salts thereof; N- hydroxyethylethylenediaminetri-acetic acid (HEDTA), triethylenetetraaminehexaacetic acid (TTHA), N-hydroxyethyliminodiacetic acid (HEIDA), dihydroxyethylglycine (DHEG), ethylenediaminetetrapropionic acid (
- the composition can further comprise enzymes (0.01 wt active enzyme to 0.03wt active enzyme) selected from a group of acyl transferases, alpha-amylases, beta-amylases, alpha-galactosidases, arabinosidases, aryl esterases, beta-galactosidases, carrageenases, catalases, cellobiohydrolases, cellulases, chondroitinases, cutinases, endo-beta-1, 4-glucanases, endo-beta-mannanases, esterases, exo-mannanases, galactanases, glucoamylases, hemicellulases, hyaluronidases, keratinases, laccases, lactases, ligninases, lipases, lipoxygenases, mannanases, oxidases, pectate lyases, pectin acet
- the composition may comprise an enzyme stabilizer (examples of which include polyols such as propylene glycol or glycerol, sugar or sugar alcohol, lactic acid, reversible protease inhibitor, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid).
- an enzyme stabilizer examples of which include polyols such as propylene glycol or glycerol, sugar or sugar alcohol, lactic acid, reversible protease inhibitor, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid).
- composition can further comprise silicone or fatty- acid based suds suppressors; heuing dyes, calcium and magnesium cations, visual signaling ingredients, anti-foam (0.001 wt to about 4.0wt ), and/or structurant/thickener (0.01 wt to 5wt , selected from the group consisting of diglycerides and triglycerides, ethylene glycol distearate, microcrystalline cellulose, cellulose based materials, microfiber cellulose, biopolymers, xanthan gum, gellan gum, and mixtures thereof).
- silicone or fatty- acid based suds suppressors heuing dyes, calcium and magnesium cations, visual signaling ingredients, anti-foam (0.001 wt to about 4.0wt ), and/or structurant/thickener (0.01 wt to 5wt , selected from the group consisting of diglycerides and triglycerides, ethylene glycol distearate, microcrystalline cellulose, cellulose based
- Suitable detersive surfactants also include cationic detersive surfactants (selected from a group of alkyl pyridinium compounds, alkyl quarternary ammonium compounds, alkyl quarternary phosphonium compounds, alkyl ternary sulphonium compounds, and/or mixtures thereof); zwitterionic and/or amphoteric detersive surfactants (selected from a group of alkanolamine sulpho-betaines); ampholytic surfactants; semi-polar non-ionic surfactants and mixtures thereof.
- the composition can be any liquid form, for example a liquid or gel form, or any combination thereof.
- the composition may be in any unit dose form, for example a pouch.
- the cleaning composition is a high density powder (HDD) composition having a variant metalloprotease polypeptide protease.
- the HDD powder laundry detergent can comprise a detersive surfactant including anionic detersive surfactants (selected from a group of linear or branched or random chain, substituted or unsubstituted alkyl sulphates, alkyl sulphonates, alkyl alkoxylated sulphate, alkyl phosphates, alkyl phosphonates, alkyl carboxylates and/or mixtures thereof), non-ionic detersive surfactant (selected from a group of linear or branched or random chain, substituted or unsubstituted Cg-Cig alkyl ethoxylates, and/or C6-C 12 alkyl phenol alkoxylates), cationic detersive surfactants (selected from a group of alkyl pyridinium compounds, alkyl quaternary ammonium compounds
- ampholytic surfactants include ampholytic surfactants; semi-polar non-ionic surfactants and mixtures thereof; builders
- phosphate free builders for example zeolite builders examples of which include zeolite A, zeolite X, zeolite P and zeolite MAP in the range of 0wt to less than 10wt ] ; phosphate builders [examples of which include sodium tri-polyphosphate in the range of 0wt to less than 10wt ] ; citric acid, citrate salts and nitrilotriacetic acid or salt thereof in the range of less than 15 wt ); silicate salt (sodium or potassium silicate or sodium meta-silicate in the range of 0wt to less than 10wt , or layered silicate (SKS-6)); carbonate salt (sodium carbonate and/or sodium bicarbonate in the range of 0 wt to less than 10 wt ); and bleaching agents
- zeolite builders examples of which include zeolite A, zeolite X, zeolite P and zeolite MAP in the range of
- hydrophobic or hydrophilic bleach activators examples of which include dodecanoyl oxybenzene sulfonate, decanoyl oxybenzene sulfonate, decanoyl oxybenzoic acid or salts thereof, 3,5,5-trimethy hexanoyl oxybenzene sulfonate, tetraacetyl ethylene diamine-TAED, and nonanoyloxybenzene sulfonate- NOBS, nitrile quats, and mixtures thereof; hydrogen peroxide; sources of hydrogen peroxide (inorganic perhydrate salts examples of which include mono or tetra hydrate sodium salt of perborate, percarbonate, persulfate, perphosphate, or persilicate); preformed hydrophililicate
- ethylenediaminetetraacetic acid ethylenediaminetetra(methylenephos-iphonic acid) and water- soluble salts thereof ).
- composition can further comprise enzymes selected from a group of acyl
- composition can further comprise additional detergent ingredients including perfume microcapsules, starch encapsulated perfume accord, hueing agents, additional polymers including fabric integrity and cationic polymers, dye lock ingredients, fabric-softening agents, brighteners (for example C.I. Fluorescent brighteners), flocculating agents, chelating agents, alkoxylated polyamines, fabric deposition aids, and/or cyclodextrin.
- additional detergent ingredients including perfume microcapsules, starch encapsulated perfume accord, hueing agents, additional polymers including fabric integrity and cationic polymers, dye lock ingredients, fabric-softening agents, brighteners (for example C.I. Fluorescent brighteners), flocculating agents, chelating agents, alkoxylated polyamines, fabric deposition aids, and/or cyclodextrin.
- the cleaning composition is an automatic dishwashing (ADW) detergent composition having a metalloprotease of the present invention.
- ADW detergent composition can comprise two or more non-ionic surfactants selected from a group of ethoxylated non-ionic surfactants, alcohol alkoxylated surfactants, epoxy-capped
- poly(oxyalkylated) alcohols or amine oxide surfactants present in amounts from 0 to 10% by weight; builders in the range of 5-60% comprising either phosphate (mono-phosphates, diphosphates, tri-polyphosphates or oligomeric-poylphosphates, preferred sodium
- tripolyphosphate-STPP or phosphate-free builders [amino acid based compounds, examples of which include MGDA (methyl-glycine-diacetic acid), and salts and derivatives thereof, GLDA (glutamic-N,Ndiacetic acid) and salts and derivatives thereof, IDS (iminodisuccinic acid) and salts and derivatives thereof, carboxy methyl inulin and salts and derivatives thereof and mixtures thereof, nitrilotriacetic acid (NTA), diethylene triamine penta acetic acid (DTPA), B- alaninediacetic acid (B-ADA) and their salts], homopolymers and copolymers of poly- carboxylic acids and their partially or completely neutralized salts, monomeric polycarboxylic acids and hydroxycarboxylic acids and their salts in the range of 0.5% to 50% by weight;
- NDA diethylene triamine penta acetic acid
- B-ADA B- alaninediacetic acid
- sulfonated/carboxylated polymers provide dimensional stability to the product in the range of about 0.1 % to about 50% by weight; drying aids in the range of about 0.1 % to about 10% by weight (selected from polyesters, especially anionic polyesters optionally together with further monomers with 3 to 6 functionalities which are conducive to polycondensation, specifically acid, alcohol or ester functionalities, polycarbonate-, polyurethane- and/or polyurea- polyorganosiloxane compounds or precursor compounds thereof of the reactive cyclic carbonate and urea type); silicates in the range from about 1 % to about 20% by weight (sodium or potassium silicates for example sodium disilicate, sodium meta-silicate and crystalline phyllosilicates); bleach-inorganic (for example perhydrate salts such as perborate, percarbonate, perphosphate, persulfate and persilicate salts) and organic (for example organic peroxyacids including diacyl and tetraacyl
- bleach activators- organic peracid precursors in the range from about 0.1 % to about 10% by weight; bleach catalysts (selected from manganese triazacyclononane and related complexes, Co, Cu, Mn and Fe bispyridylamine and related complexes, and pentamine acetate cobalt(III) and related
- metal care agents in the range from about 0.1% to 5% by weight (selected from benzatriazoles, metal salts and complexes, and/or silicates); enzymes in the range from about 0.01 to 5.0mg of active enzyme per gram of automatic dishwashing detergent composition (acyl transferases, alpha- amylases, beta- amylases, alpha-galactosidases, arabinosidases, aryl esterases, beta-galactosidases, carrageenases, catalases, cellobiohydrolases, cellulases, chondroitinases, cutinases, endo-beta-1, 4-glucanases, endo-beta-mannanases, esterases, exo-mannanases, galactanases, glucoamylases, hemicellulases, hyaluronidases, keratinases, laccases, lactases,
- the metalloproteases are normally incorporated into the detergent composition at a level of from 0.000001 % to 5% of enzyme protein by weight of the composition, or from 0.00001 % to 2 %, or from 0.0001% to 1%, or from 0.001 % to 0.75% of enzyme protein by weight of the composition.
- Metalloprotease polypeptides of the present invention for use in Animal Feed
- the metalloprotease polypeptides of the present invention can be used as a compontent of an animal feed composition, animal feed additive and/or pet food comprising a metalloprotease and variants thereof.
- the present invention further relates to a method for preparing such an animal feed composition, animal feed additive composition and/or pet food comprising mixing the metalloprotease polypeptide with one or more animal feed ingredients and/or animal feed additive ingredients and/or pet food
- the present invention relates to the use of the metalloprotease polypeptide in the preparation of an animal feed composition and/or animal feed additive composition and/or pet food.
- animal includes all non-ruminant and ruminant animals.
- the animal is a non-ruminant animal, such as a horse and a mono-gastric animal.
- mono-gastric animals include, but are not limited to, pigs and swine, such as piglets, growing pigs, sows; poultry such as turkeys, ducks, chicken, broiler chicks, layers; fish such as salmon, trout, tilapia, catfish and carps; and crustaceans such as shrimps and prawns.
- the animal is a ruminant animal including, but not limited to, cattle, young calves, goats, sheep, giraffes, bison, moose, elk, yaks, water buffalo, deer, camels, alpacas, llamas, antelope, pronghorn and nilgai.
- pet food is understood to mean a food for a household animal such as, but not limited to, dogs, cats, gerbils, hamsters, chinchillas, fancy rats, guinea pigs; avian pets, such as canaries, parakeets, and parrots; reptile pets, such as turtles, lizards and snakes; and aquatic pets, such as tropical fish and frogs.
- animal feed composition can comprise one or more feed materials selected from the group comprising a) cereals, such as small grains (e.g. , wheat, barley, rye, oats and combinations thereof) and/or large grains such as maize or sorghum; b) by products from cereals, such as corn gluten meal, Distillers Dried Grain Solubles (DDGS) (particularly corn based Distillers Dried Grain Solubles
- cDDGS wheat bran, wheat middlings, wheat shorts, rice bran, rice hulls, oat hulls, palm kernel, and citrus pulp
- protein obtained from sources such as soya, sunflower, peanut, lupin, peas, fava beans, cotton, canola, fish meal, dried plasma protein, meat and bone meal, potato protein, whey, copra, sesame
- oils and fats obtained from vegetable and animal sources
- minerals and vitamins obtained from sources such as soya, sunflower, peanut, lupin, peas, fava beans, cotton, canola, fish meal, dried plasma protein, meat and bone meal, potato protein, whey, copra, sesame
- Metalloprotease polypeptides of the present invention for use in Textile Desizing
- compositions and methods of treating fabrics e.g. , to desize a textile
- a metalloprotease polypeptide of the present invention are well known in the art (see, e.g. , U.S. Patent No. 6,077,316).
- the feel and appearance of a fabric can be improved by a method comprising contacting the fabric with a metalloprotease in a solution.
- the fabric can be treated with the solution under pressure.
- a metalloprotease of the present invention can be applied during or after the weaving of a textile, or during the desizing stage, or one or more additional fabric processing steps.
- the threads are exposed to considerable mechanical strain.
- warp yarns Prior to weaving on mechanical looms, warp yarns are often coated with sizing starch or starch derivatives to increase their tensile strength and to prevent breaking.
- a metalloprotease of the present invention can be applied during or after the weaving to remove these sizing starch or starch derivatives. After weaving, the metalloprotease can be used to remove the size coating before further processing the fabric to ensure a homogeneous and wash-proof result.
- a metalloprotease of the present invention can be used alone or with other desizing chemical reagents and/or desizing enzymes to desize fabrics, including cotton-containing fabrics, as detergent additives, e.g. , in aqueous compositions.
- An amylase also can be used in compositions and methods for producing a stonewashed look on indigo-dyed denim fabric and garments.
- the fabric can be cut and sewn into clothes or garments, which are afterwards finished.
- different enzymatic finishing methods have been developed.
- the finishing of denim garment normally is initiated with an enzymatic desizing step, during which garments are subjected to the action of proteolytic enzymes to provide softness to the fabric and make the cotton more accessible to the subsequent enzymatic finishing steps.
- the metalloprotease can be used in methods of finishing denim garments (e.g., a "bio-stoning process"), enzymatic desizing and providing softness to fabrics, and/or finishing process.
- Metalloprotease polypeptides of the present invention for use in Paper Pulp Bleaching
- the metalloprotease polypeptides described herein find further use in the enzyme aided bleaching of paper pulps such as chemical pulps, semi-chemical pulps, kraft pulps, mechanical pulps or pulps prepared by the sulfite method.
- paper pulps are incubated with a metalloprotease polypeptide of the present invention under conditions suitable for bleaching the paper pulp.
- the pulps are chlorine free pulps bleached with oxygen, ozone, peroxide or peroxyacids.
- the metalloprotease polypeptides are used in enzyme aided bleaching of pulps produced by modified or continuous pulping methods that exhibit low lignin contents.
- the metalloprotease polypeptides are applied alone or preferably in combination with xylanase and/or endoglucanase and/or alpha-galactosidase and/or cellobiohydrolase enzymes.
- Metalloprotease polypeptides of the present invention for use in Protein degradation
- the metalloprotease polypeptides described herein find further use in the enzyme aided removal of proteins from animals and their subsequent degradation or disposal, such as feathers, skin, hair, hide, and the like.
- immersion of the animal carcass in a solution comprising a metalloprotease polypeptide of the present invention can act to protect the skin from damage in comparison to the traditional immersion in scalding water or the defeathering process.
- feathers can be sprayed with an isolated
- metalloprotase polypeptide of the present invention under conditions suitable for digesting or initiating degradation of the plumage.
- a metalloprotease of the present invention can be used, as above, in combination with an oxidizing agent.
- removal of the oil or fat associated with raw feathers is assisted by using a metalloprotease polypeptide of the present invention.
- the metalloprotease polypeptides are used in compositions for cleaning the feathers as well as to sanitize and partially dehydrate the fibers.
- the metalloprotease polypeptides are applied in a wash solution in combination with 95% ethanol or other polar organic solvent with or without a surfactant at about 0.5% (v/v).
- the disclosed metalloprotease polypeptides find use in recovering protein from plumage.
- the recovered protein can be subsequently used in animal or fish feed.
- Metalloprotease polypeptides of the present invention for use in Tissue Debridement
- metalloprotease polypeptides described herein find further use in the enzyme aided debridement of tissue. This involves the removal of dead or damaged tissue, for example, removal from wounds to aid in healing. Metalloprotease polypeptides of the present invention for use in tissue culture
- metalloprotease polypeptides described herein find further use in tissue culture.
- metalloproteases of the present invention can be used to suspend or resuspend cells adherent to a cell culture wall, such as during the process of harvesting cells.
- Metalloproteases of the present invention can be used to cleave protein bonds between cultured cells and the dish, allowing cells to become suspended in solution.
- Metalloprotease polypeptides of the present invention for use in leather processing
- the metalloprotease polypeptides described herein find further use in leather processing by removing hair from animal hides, soaking, degreasing, or bating, which is a process involving degradation of non-structural proteins during leather making.
- the model was fitted in the resulting electron density using the program COOT (Emsley, P et al Acta Cryst. D66 486-501 (2010)). After fitting and refitting adjustments, the coordinates were refined using the REFMAC program with standard defaults in the CCP4 software suite. The statistics of the current model are presented in Table 1.2.
- PehProl consists of a dimer of two equivalent molecules. Electron density was available for residues 1-304 of each monomer. Each model was fitted to contiguous density. The overall dimer arrangement is presented in Figure 1.
- the residues forming the active site regions include the catalytic residues; Hisl35, Glul36, Hisl39 and Glul59
- ATOM 18 CA THR A 4 -19. .612 -59. .576 -18. .593 1. .00 20. .58 A c
- ATOM 66 C ASP A 11 -16. .647 -54. .501 -25. .529 1. .00 14. .72 A c ATOM 67 o ASP A 11 -16..756 -53..984 -24..433 1..00 14..88 A o
- ATOM 76 CA LYS A 13 -15. .333 -57. .703 -21. .603 1. .00 18. .19 A c
- ATOM 102 CA THR A 16 -14. .843 -60. .461 -11. .492 1. .00 12. .27 A c
- ATOM 109 CA THR A 17 -17. .952 -59. .582 -9. .540 1. .00 12. .14 A c
- ATOM 138 CA GLY A 21 -28. .389 -61. .717 -2. .286 1. .00 25. .86 A c
- ATOM 140 o GLY A 21 -28. .612 -63. .233 -4. .137 1. .00 26. .33 A o
- ATOM 180 CD 2 LEU A 26 -18. .478 -54. .406 -12. .088 1. .00 14. .65 A c
- ATOM 201 CA THR A 29 -12. .519 -59. .651 -3. .769 1. .00 14. .71 A c
- ATOM 208 CA THR A 30 -9. .723 -61. .573 -5. .413 1. .00 13. .87 A c
- ATOM 215 CA ARG A 31 -7. .297 -58. .698 -5. .580 1. .00 15. .08 A c
- ATOM 218 CD ARG A 31 -8. .195 -58. .329 -9. .061 1. .00 16. .47 A c
- ATOM 226 CA GLY A 32 -6. .087 -56. .875 -2. .471 1. .00 14. .18 A C
- ATOM 239 CA GLY A 34 -10. .766 -55. .551 -3. .369 1. .00 13. .93 A c
- ATOM 243 CA ILE A 35 -11. .706 -53. .495 -6. .353 1. .00 12. .48 A c
- ATOM 258 CA THR A 37 -16. .821 -49. .656 -8. .699 1. .00 11. .95 A c
- ATOM 282 N ALA A 40 -21. .697 -42. .011 -9. .422 1. .00 15. .34 A N
- ATOM 283 CA ALA A 40 -22. .070 -40. .810 -8. .672 1. .00 15. .65 A c
- ATOM 286 o ALA A 40 -23. .871 -39. .252 -8. .542 1. .00 16. .26 A o
- ATOM 303 CD ARG A 43 -27. .117 -36. .068 -7. .163 1. .00 42. .30 A c ATOM 304 NE ARG A 43 -28..483 -35..870 -7..661 1..00 51..16 A N
- ATOM 331 CA PRO A 47 -18. .098 -42. .713 -3. .302 1. .00 16. .33 A c
- ATOM 334 CD PRO A 47 -18. .710 -42. .968 -0. .980 1. .00 15. .87 A c
- ATOM 338 CA GLY A 48 -21. .680 -42. .866 -4. .577 1. .00 15. .71 A c
- ATOM 342 CA THR A 49 -23. .844 -45. .889 -5. .184 1. .00 15. .14 A c
- ATOM 372 CA SER A 53 -26. .900 -56. .061 -11. .829 1. .00 18. .54 A c
- ATOM 390 CA ASN A 56 -24. .472 -60. .215 -13. .852 1. .00 15. .95 A c
- ATOM 398 CA ILE A 57 -24. .682 -58. .525 -17. .259 1. .00 18. .93 A c
- ATOM 406 CA TRP A 58 -23. .663 -54. .869 -17. .151 1. .00 19. .08 A c
- ATOM 420 CA ASN A 59 -25. .040 -52. .065 -19. .306 1. .00 24. .38 A c
- ATOM 426 o ASN A 59 -24. .810 -49. .744 -19. .806 1. .00 27. .95 A o
- ATOM 433 C ASP A 60 -21. .437 -49. .304 -18. .376 1. .00 18. .14 A c
- ATOM 434 o ASP A 60 -20. .592 -49. .914 -17. .694 1. .00 17. .59 A o
- ATOM 436 CA GLY A 61 -19. .822 -48. .709 -20. .138 1. .00 15. .68 A c
- ATOM 440 CA ALA A 62 -17. .870 -46. .232 -18. .027 1. .00 13. .21 A c
- ATOM 443 o ALA A 62 -16. .441 -47. .297 -16. .457 1. .00 12. .77 A o
- ATOM 445 CA ALA A 63 -18. .434 -48. .493 -15. .027 1. .00 12. .59 A c
- ATOM 448 o ALA A 63 -16. .674 -50. .096 -14. .771 1. .00 11. .48 A o
- ATOM 456 N ASP A 65 -15. .499 -50. .244 -17. .972 1. .00 11. .62 A N
- ATOM 463 o ASP A 65 -12. .287 -50. .237 -16. .795 1. .00 12. .17 A o
- ATOM 468 o ALA A 66 -11. .835 -50. .016 -13. .538 1. .00 11. .80 A o
- ATOM 470 CA HIS A 67 -13. .758 -51. .933 -13. .275 1. .00 12. .20 A c
- ATOM 482 C ALA A 68 -10. .449 -53. .368 -15. .986 1. .00 10. .67 A c
- ATOM 483 o ALA A 68 -9. .451 -54. .078 -15. .807 1. .00 10. .44 A o
- ATOM 485 CA TYR A 69 -9. .083 -51. .445 -16. .372 1. .00 9. .92 A c
- ATOM 504 CA ALA A 71 -8. .127 -54. .785 -12. .428 1. .00 9. .42 A c
- ATOM 507 o ALA A 71 -5. .878 -55. .594 -12. .835 1. .00 9. .53 A o
- ATOM 516 o LYS A 72 -3. .320 -54. .296 -14. .566 1. .00 10. .53 A o
- ATOM 536 N ASP A 75 -3. .062 -55. .670 -11. .683 1. .00 12. .59 A N
- ATOM 540 ODl ASP A 75 -4. .408 -58. .613 -11. .704 1. .00 11. .68 A o ATOM 541 OD2 ASP A 75 -4..889 -58..488 -13..848 1..00 12..29 A o
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
Abstract
Aspects of the present compositions and methods relate to novel metalloproteases polynucleotides encoding the novel metalloprotease, compositions and methods for use thereof.
Description
NOVEL METALLOPROTEASES
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims benefit of priority from International patent applications Serial No. PCT/CN2013/076419; Serial No. PCT/CN2013/076387; Serial No.
PCT/CN2013/076401; Serial No. PCT/CN2013/076406; Serial No. PCT/CN2013/076414; PCT/CN2013/076384; Serial No. PCT/CN2013/076398; PCT/CN2013/076415; Serial No. PCT/CN2013/076386; Serial No. PCT/CN2013/076390; PCT/CN2013/076383; Serial No. PCT/CN2013/076369, all filed on 29 May 2013, and also claims benefit of priority from U.S. Provisional Application Serial No. 61/874,813 filed on 06 September 2013, the contents of all of which are incorporated herein by reference in their entirety.
FIELD OF THE INVENTION
The present disclosure relates to proteases. Compositions containing the proteases are suitable for use in cleaning, food and feed as well as in a variety of other industrial applications.
Background
Metalloproteases (MPs) are among the hydrolases that mediate nucleophilic attack on peptide bonds using a water molecule coordinated in the active site. Thermolysin-like proteases are found in the M4 family as defined by MEROPS (Rawlings et al., (2012) Nucleic Acids Res 40:D343-D350). They are generally active at elevated temperatures and this stability is attributed to calcium binding. Although proteases have long been known in the art of industrial enzymes, there remains a need for novel proteases that are suitable for particular conditions and uses, such as environments that have calcium chelators that destabilize metalloproteases.
Summary
The present disclosure provides, inter alia, metalloproteases comprising modifications in calcium binding regions, novel metallopro tease polypeptides with signature amino acids in the calcium binding regions, nucleic acids encoding the same, and compositions and methods related to the production and use thereof.
In some embodiments, the invention is a metalloprotease polypeptide comprising one or more calcium binding regions. In some embodiments, the polypeptide comprises a modification in at least one amino acid residue in one of the calcium binding regions, Cal-2, Ca3 and Ca4,
(including residues 55-66, 136, 138, 177-190, and 193-200) of the polypeptide, wherein the amino acid positions of the polypeptide are numbered by correspondence with the amino acid sequence of Bacillus thermoproteolyticus metalloprotease set forth in SEQ ID NO: 13. In some embodiments, the polypeptide has a calcium binding region Cal-2 that binds fewer than two calcium ions. In some embodiments, the polypeptide has a calcium binding region 3 that binds fewer than one calcium ion. In some embodiments, the polypeptide has a calcium binding region 4 that binds fewer than one calcium ion. In some embodiments, the polypeptide is a variant of a parent polypeptide. In some embodiments, the parent polypeptide is an M4 metalloprotease. In some embodiments, the polypeptide has at least 60% sequence identity to any one of SEQ ID NOs: 1-15.
In some embodiments, the invention is a composition comprising at least one variant as listed above. In some embodiments, the invention is a method of cleaning using a cleaning composition as listed above.
Brief Description of the Drawings
Figure 1 provides a schematic showing the arrangement of the two independent molecules of PehProl in the asymmetric unit of the crystal unit cell.
Figure 2 provides a stereo showing a schematic of the Thermolysin main chain folding (black) and the schematic of PehProl (light gray).
Figure 3 provides a close up view of the 3 residue deletion.
Figure 4 provides a close up view of the 5 residue deletion.
Figure 5 provides a comparison of calcium binding site 1 in PehProl and the Cal-2 calcium binding site in Thermolysin.
Figure 6 provides a schematic comparing Thermolysin (black lines) with PehProl (light gray sticks) in the vicinity of the second calcium binding site (Ca4) in PehProl.
Figure 7 provides a comparison of the structures of Thermolysin (black lines) and PehProl (light gray sticks) in the region of calcium binding Ca3 present in Thermolysin.
Figure 8 provides a schematic comparing the main chain folding of PehProl (dark gray) and
PpoPro2 (light gray).
Figure 9 provides a comparison of the first common calcium binding site between PehProl (light gray) and Ppopro2 (dark gray).
Figure 10 provides a comparison of the structure of PehProl (light gray) and PpoPro2 (dark gray) at the second common calcium site.
Figure 11 provides a comparison of the third calcium binding site seen in PpoPro2 (dark gray) as compared to PehProl (light gray).
Figure 12a-f provides a structure-based alignment of the various metalloproteases Pehl.A (Paenibacillus ehimensis, protein 1), PbaProl (Paenibacillus barcinonensis, protein 1)), PhuProl (Paenibacillus hunanensis, protein 1), PpoPro2 (Paenibacillus polymyxa, protein 2), PpoProl(Paenibacillus polymyxa, protein 1), Thermolysin (Bacillus thermoproteolyticus, protein 1), PhuPro2 (Paenibacillus hunanensis, protein 2), PspPro2 (Paenibacillus sp., protein 2), PspPro3 (Paenibacillus sp., protein 3), PpeProl (Paenibacillus peoriae, protein 1), PteProl (Paenibacillus terrae, protein 1), BbrProl (Brevibacillus brevis, protein 1), 1KEI.A (Bacillus thermoproteolyticus, thermolysin), 1NPC.A (Bacillus cereus), Npre_var (Bacillus subtilis). Figure 13 provides a comparison of the calcium binding sites of NprE (gray sticks) with the double calcium site (Cal,2) of Thermolysin (black lines).
Figure 14 provides a comparison of NprE variant with Thermolysin at the Ca3 site.
Figure 15 provides several proteases contain the double delete and lack of the DxD motif shown in a rectangle.
Figure 16 provides a stereodiagram comparing the overall main chain folding pattern of
Thermolysin (black) with the NprE variant structure (gray).
Figure 17 provides a comparison of the structures of the NprE variant and Thermolysin at the Ca4 binding site of Thermolysin. The deletion of three residues in NprE relative to Thermolysin results in the elimination of a calcium binding site.
Detailed Description
The present invention provides novel variant metalloproteases having modifications at calcium binding regions. The MEROPS database (https://merops.sanger.ac.uk) groups peptidases into families based on sequence homology [Rawlings et al. (2010) Nucleic Acid Res. 38:D227]. A peptidase is classified into a family based on sharing significant similarities in amino acid sequence with the type example or another member of the family. In the current release (Release 9.4) of the MEROPS database, there are a total of 63 metalloprotease families, nine of which include but are not limited to BEMP members. These proteases are distributed among 9 families of metalloproteases because of differences in primary sequences and structural characteristics. So far, all BEMPs are endoproteases that harbor 1 catalytic Zinc ion in their active center. They are synthetized as inactive zymogens with a propeptide and their main function is nutrition of the microorganism. Bacterial extracellular metalloproteases (BEMPs) are a large group of metal-containing proteases secreted by heterotropic bacteria [Wu and Chen (2011) Appl. Biol.
Biotechnol. 92:253]. BEMPs are distributed among the metalloprotease families M4, M5, M9, M10, M12, M13, M23, M30, and M34. The M4 is a large family of metalloproteases, mostly BEMPs. Thermolysin is the prototype of the M4 family.
Thermolysin-like proteases are broad-specificity proteases which contain a catalytic zinc ion in their active sites. The thermostable Bacillus neutral metalloproteases bind 4 Ca2+ ions. Two Ca2+ ions are bound in one double calcium binding site (Cal-2) and 2 Ca2+ ions are bound in single binding sites Ca3 and Ca4 [Stark et al (1992) Eur. J. Biochem. 207:207, Veltman et al (1998) Biochem. 37:5312]. Several studies have shown that these proteases are dependent on calcium binding for their stability [Veltman et al (1997) FEBS 405:241]. The single sites Ca3 and Ca4 are absent in the thermolysin-like proteases considered thermolabile [Eijsink et al (2011) Prot. Sci. 20: 1346].
It has also become known that thermolysin-like proteinases can perform well in a number of industrial applications such as a detergent additive for laundry and dish cleaning, potentially as feed additives, fermentation aides, as well as a number of pharmaceutical application such as cell culture and tissue dissociation. Earlier studies have demonstrated the importance of calcium binding in a number of mutational studies. In Eijsink et al 2011, [Eijsink, Matthews and Vriend (2011) Prot Sci 20: 1346-1355], mutation of Asp57 or Asp 59 in the Ca3 site were shown to dramatically reduce stability in thermolysin. In the same paper the authors postulate that calcium binding site may have evolved evolutionarily as a means or regulating function but destabilizing structure and hence function in the low calcium environment of the cytosol until secreted into a higher calcium environment outside the cell membrane.
Metalloproteases, for example, M4 clan metalloproteases, have calcium binding regions. Without being bound by theory, these calcium binding regions are thought to contribute to the thermostability of these molecules. In some applications, it is beneficial to reduce the dependence of the metalloproteases on calcium binding. For example, detergent compositions contain metal chelators, such as surfactants, which compete for calcium ions and affects the amount of free calcium available to bind the enzyme [Stoner et al. (2005) Biotechnol Prog. 21(6): 1716-23]. In detergent environments, metalloproteases can be subject to destabilization and autolysis due to this lack of free calcium. Thus, there is a need in the art to discover improved metalloproteases which are stable in environments that compete for free calcium, such as detergent compositions, while allowing for maintained proteolytic activity of the
metalloproteases in these environments. As such, it would be beneficial to find variant metalloproteases with modified calcium binding regions.
The invention described here arises in part from the observation of two novel crystal structures of thermolysin-like proteases having fewer calcium binding sites (PehProl as shown in Example 2, and PpoPro2, Paenibacillus polymyxa protease in Ruf et al 2013 [Ruf et al (2013) Acta Cryst. D69:24-31). The elimination of calcium binding is attributed to a combination of specific amino acid substitutions and deletion that are found to be common to these and related structures resulting in fewer calcium binding coordination sites. Based on these finding, a means for further reducing the number of calcium bound to only one or none is proposed for thermolysin and other thermolysin-like proteinases.
In some embodiments, the invention is variant metalloproteases having modified calcium binding regions. In some embodiments, these modified calcium binding regions result in reduced calcium binding of the metalloprotease enzyme. In other embodiments, the invention is novel metalloproteases having newly discovered calcium binding regions. In some
embodiments, the invention includes compositions comprising at least one of the novel metalloprotease enzymes set forth herein. Some such compositions comprise detergent compositions. The metalloprotease enzymes of the present invention can be combined with other enzymes useful in detergent compositions. The invention also provides methods of cleaning using metalloprotease enzymes of the present invention.
Definitions and Abbreviations
Unless otherwise indicated, the practice of the present invention involves conventional techniques commonly used in molecular biology, protein engineering, microbiology, and recombinant DNA technology, which are within the skill of the art. Such techniques are known to those of skill in the art and are described in numerous texts and reference works well known to those of skill in the art. All patents, patent applications, articles and publications mentioned herein, both supra and infra, are hereby expressly incorporated herein by reference.
Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Many technical dictionaries are known to those of skill in the art. Although any methods and materials similar or equivalent to those described herein find use in the practice of the present invention, some suitable methods and materials are described herein. Accordingly, the terms defined immediately below are more fully described by reference to the Specification as a whole. Also, as used herein, the singular "a", "an" and "the" includes the plural reference unless the context clearly indicates otherwise. Unless otherwise indicated, nucleic acids are written left to right in 5' to 3' orientation; amino acid sequences are written left to right in amino
to carboxy orientation, respectively. It is to be understood that this invention is not limited to the particular methodology, protocols, and reagents described, as these may vary, depending upon the context they are used by those of skill in the art.
Furthermore, the headings provided herein are not limitations of the various aspects or embodiments of the invention.
It is intended that every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if such lower numerical limitations were expressly written herein. Every minimum numerical limitation given throughout this specification will include every higher numerical limitation, as if such higher numerical limitations were expressly written herein. Every numerical range given throughout this specification will include every narrower numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.
As used herein, the terms "protease" and "proteinase" refer to an enzyme that has the ability to break down proteins and peptides. A protease has the ability to conduct "proteolysis," by hydrolysis of peptide bonds that link amino acids together in a peptide or polypeptide chain forming the protein. This activity of a protease as a protein-digesting enzyme is referred to as "proteolytic activity." Many well known procedures exist for measuring proteolytic activity (See e.g., Kalisz, "Microbial Proteinases," In: Fiechter (ed.), Advances in Biochemical
Engineering/Biotechnology, (1988)). For example, proteolytic activity may be ascertained by comparative assays which analyze the respective protease' s ability to hydrolyze a suitable substrate. Exemplary substrates useful in the analysis of protease or proteolytic activity, include, but are not limited to, di-methyl casein (Sigma C-9801), bovine collagen (Sigma C- 9879), bovine elastin (Sigma E- 1625), and bovine keratin (ICN Biomedical 902111).
Colorimetric assays utilizing these substrates are well known in the art (See e.g., WO 99/34011 and U.S. Pat. No. 6,376,450, both of which are incorporated herein by reference). The pNA peptidyl assay (See e.g., Del Mar et ah, Anal. Biochem. 99:316-320 [1979]) also finds use in determining the active enzyme concentration. This assay measures the rate at which p- nitroaniline is released as the enzyme hydrolyzes a soluble synthetic substrate, such as succinyl- alanine-alanine-proline-phenylalanine-p-nitroanilide (suc-AAPF-pNA). The rate of production of yellow color from the hydrolysis reaction is measured at 410 nm on a spectrophotometer and is proportional to the active enzyme concentration. In addition, absorbance measurements at 280 nanometers (nm) can be used to determine the total protein concentration in a sample of purified protein. The activity on substrate/protein concentration gives the enzyme specific activity.
As used herein, the term "variant polypeptide" refers to a polypeptide comprising an amino acid sequence that differs in at least one amino acid residue from the amino acid sequence of a parent or reference polypeptide (including but not limited to wild-type polypeptides).
As used herein, "the genus Bacillus" includes all species within the genus "Bacillus " as known to those of skill in the art, including but not limited to B. subtilis, B. licheniformis, B. lentus, B. brevis, B. stearothermophilus, B. alkalophilus, B. amyloliquefaciens, B. clausii, B. halodurans, B. megaterium, B. coagulans, B. circulans, B. lautus, and B. thuringiensis . It is recognized that the genus Bacillus continues to undergo taxonomical reorganization. Thus, it is intended that the genus include species that have been reclassified, including but not limited to such organisms as B. stearothermophilus, which is now named "Geobacillus
stearothermophilus ." The production of resistant endospores under stressful environmental conditions is considered the defining feature of the genus Bacillus, although this characteristic also applies to the recently named Alicyclobacillus, Amphibacillus, Aneurinibacillus,
Anoxybacillus, Brevibacillus, Filobacillus, Gracilibacillus, Halobacillus, Paenibacillus, Salibacillus, Thermobacillus, Ureibacillus, and Virgibacillus .
As used herein, "calcium binding site" refers to a region within a metalloprotease which can bind a calcium ion in the presence of free calcium. Calcium can act to assist in maintaining the structural integrity of metallopro teases under many conditions. In some embodiments, the amount of free calcium can be related to the water hardness during wash conditions, and can range from soft water, having less than 1.0 Calcium grains per gallon, to slightly hard water, having from about 1.0 to 3.5 Calcium grains per gallon, to moderately hard water, having from about 3.5 to 7.0 Calcium grains per gallon, to hard water, having from about 7.0 to 10.5 or more Calcium grains per gallon. In some embodiments of the present invention, the characteristics of the calcium binding site are modified compared to a parent or reference metalloprotease so as to modify the performance of the metalloprotease. Modification of the calcium binding site may include reducing or increasing the affinity of the site to bind calcium ion. Modifying the performance of the metalloprotease is intended to include modification of the stability (e.g., oxidative or thermal) or the activity (e.g., the rate or efficiency with which the metalloprotease hydrolyzes a protein substrate) of the enzyme in its various applications.
As used herein, "calcium ligand" means an amino acid residue or residues within a metalloprotease enzyme which forms a ligand with calcium ion bound within a calcium binding site.
The terms "polynucleotide" and "nucleic acid," which are used interchangeably herein, refer to a polymer of any length of nucleotide monomers covalently bonded in a chain. DNA
(deoxyribonucleic acid), a polynucleotide comprising deoxyribonucleotides, and RNA
(ribonucleic acid), a polymer of ribonucleotides, are examples of polynucleotides or nucleic acids having distinct biological function. Polynucleotides or nucleic acids include, but are not limited to, a single-, double- or triple- stranded DNA, genomic DNA, cDNA, RNA, DNA-RNA hybrid, or a polymer comprising purine and pyrimidine bases, or other natural, chemically, biochemically modified, non-natural or derivatized nucleotide bases. The following are non- limiting examples of polynucleotides: genes, gene fragments, chromosomal fragments, expressed sequence tag(s) (EST(s)), exons, introns, messenger RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), ribozymes, complementary DNA (cDNA), recombinant polynucleotides, branched polynucleotides, plasmids, vectors, isolated DNA of any sequence, isolated RNA of any sequence, nucleic acid probes, and primers.
As used herein, the term "modification" refers to changes made to a reference amino acid or nucleic acid sequence. It is intended that the term encompass substitutions, insertions and deletions.
As used herein, the term "vector" refers to a nucleic acid construct used to introduce or transfer nucleic acid(s) into a target cell or tissue. A vector is typically used to introduce foreign DNA into a cell or tissue. Vectors include plasmids, cloning vectors, bacteriophages, viruses (e.g., viral vector), cosmids, expression vectors, shuttle vectors, and the like. A vector typically includes an origin of replication, a multicloning site, and a selectable marker. The process of inserting a vector into a target cell is typically referred to as transformation. The present invention includes, in some embodiments, a vector that comprises a DNA sequence encoding a metalloprotease polypeptide (e.g., precursor or mature metalloprotease polypeptide) that is operably linked to a suitable prosequence (e.g., secretory, signal peptide sequence, etc.) capable of effecting the expression of the DNA sequence in a suitable host, and the folding and translocation of the recombinant polypeptide chain.
As used herein, the term "expression cassette," "expression plasmid" or "expression vector" refers to a nucleic acid construct or vector generated recombinantly or synthetically for the expression of a nucleic acid of interest in a target cell. An expression vector or expression cassette typically comprises a promoter nucleotide sequence that drives expression of the foreign nucleic acid. The expression vector or cassette also typically includes any other specified nucleic acid elements that permit transcription of a particular nucleic acid in a target cell. A recombinant expression cassette can be incorporated into a plasmid, chromosome, mitochondrial DNA, plastid DNA, virus, or nucleic acid fragment. Many prokaryotic and eukaryotic expression vectors are commercially available.
In some embodiments, the ends of the sequence are closed such that the DNA construct forms a closed circle. The nucleic acid sequence of interest, which is incorporated into the DNA construct, using techniques well known in the art, may be a wild-type, mutant, or modified nucleic acid. In some embodiments, the DNA construct comprises one or more nucleic acid sequences homologous to the host cell chromosome. In other embodiments, the DNA construct comprises one or more non-homologous nucleotide sequences. Once the DNA construct is assembled in vitro, it may be used, for example, to: 1) insert heterologous sequences into a desired target sequence of a host cell; and/or 2) mutagenize a region of the host cell
chromosome (i.e., replace an endogenous sequence with a heterologous sequence); 3) delete target genes; and/or 4) introduce a replicating plasmid into the host. "DNA construct" is used interchangeably herein with "expression cassette."
As used herein, a "plasmid" refers to an extrachromosomal DNA molecule which is capable of replicating independently from the chromosomal DNA. A plasmid is double stranded (ds) and may be circular and is typically used as a cloning vector.
As used herein in the context of introducing a nucleic acid sequence into a cell, the term "introduced" refers to any method suitable for transferring the nucleic acid sequence into the cell. Such methods for introduction include but are not limited to protoplast fusion, transfection, transformation, electroporation, conjugation, and transduction (See e.g., Ferrari et ah ,
"Genetics," in Hardwood et al. (eds.), Bacillus, Plenum Publishing Corp., pp. 57-72 [1989]).
Transformation refers to the genetic alteration of a cell which results from the uptake, optional genomic incorporation, and expression of genetic material (e.g., DNA).
As used herein, a nucleic acid is "operably linked" with another nucleic acid sequence when it is placed into a functional relationship with another nucleic acid sequence. For example, a promoter or enhancer is operably linked to a nucleotide coding sequence if the promoter affects the transcription of the coding sequence. A ribosome binding site may be operably linked to a coding sequence if it is positioned so as to facilitate translation of the coding sequence. Typically, "operably linked" DNA sequences are contiguous. However, enhancers do not have to be contiguous. Linking is accomplished by ligation at convenient restriction sites. If such sites do not exist, synthetic oligonucleotide adaptors or linkers may be used in accordance with conventional practice.
As used herein the term "gene" refers to a polynucleotide (e.g., a DNA segment), that encodes a polypeptide and includes regions preceding and following the coding regions as well as intervening sequences (introns) between individual coding segments (exons).
As used herein, "recombinant" when used with reference to a cell typically indicates that the cell has been modified by the introduction of a foreign nucleic acid sequence or that the cell is derived from a cell so modified. For example, a recombinant cell may comprise a gene not found in identical form within the native (non-recombinant) form of the cell, or a recombinant cell may comprise a native gene (found in the native form of the cell) but which has been modified and re-introduced into the cell. A recombinant cell may comprise a nucleic acid endogenous to the cell that has been modified without removing the nucleic acid from the cell; such modifications include those obtained by gene replacement, site-specific mutation, and related techniques known to those of ordinary skill in the art. Recombinant DNA technology includes techniques for the production of recombinant DNA in vitro, and transfer of the recombinant DNA into cells where it may be expressed or propagated, thereby producing a recombinant polypeptide. "Recombination," "recombining," and "recombined" of
polynucleotides or nucleic acids refer generally to the assembly or combining of two or more nucleic acid or polynucleotide strands or fragments to generate a new polynucleotide or nucleic acid. The recombinant polynucleotide or nucleic acid is sometimes referred to as a chimera. A nucleic acid or polypeptide is "recombinant" when it is artificial or engineered.
A nucleic acid or polynucleotide is said to "encode" a polypeptide if, in its native state or when manipulated by methods known to those of skill in the art, it can be transcribed and/or translated to produce the polypeptide or a fragment thereof. The anti-sense strand of such a nucleic acid is also said to encode the sequence.
"Host strain" or "host cell" refers to a suitable host for an expression vector comprising a DNA sequence of interest.
A "protein" or "polypeptide" comprises a polymeric sequence of amino acid residues. The terms "protein" and "polypeptide" are used interchangeably herein. The single and 3-letter code for amino acids as defined in conformity with the IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN) is used through out this disclosure. The single letter X refers to any of the twenty amino acids. It is also understood that a polypeptide may be coded for by more than one nucleotide sequence due to the degeneracy of the genetic code. Mutations can be named by the one letter code for the parent amino acid, followed by a position number and then the one letter code for the variant amino acid. For example, mutating glycine (G) at position 87 to serine (S) is represented as "G087S" or "G87S". Mutations can also be named by using the three letter code for an amino acid followed by its position in the polypeptide chain as counted from the N-terminus; for example, AlalO for alanine at position 10. Multiple mutations are indicated by inserting a "+," "/," or ";" between the mutations. Mutations at positions 87
and 90 are represented as either "G087S-A090Y" or "G87S-A90Y" or "G87S + A90Y" or "G087S + A090Y". For insertions, one or more inserted amino acids can be listed after a position. For example, "G087GS" describes a serine inserted after the glycine at position 87; as a second example, "G087GSA" describes a serine and alanine inserted after the glycine at position 87. Insertions can be done in combination with substitutions; thus, "G087RS" describes a substitution at position 87 from glycine to arginine, followed by an inserted serine residue. For deletions, either a "Δ" or "del" is used following the position number. Thus, for example, "G087del" describes deletion of the glycine at position 87. When describing modifications, a position followed by amino acids listed in parentheses indicates a list of substitutions at that position by any of the listed amino acids. For example, 6(L,I) means position 6 can be substituted with a leucine or isoleucine.
A "prosequence" or "propetide sequence" refers to an amino acid sequence between the signal peptide sequence and mature protease sequence that is necessary for the proper folding and secretion of the protease; they are sometimes referred to as intramolecular chaperones. Cleavage of the prosequence or propeptide sequence results in a mature active protease.
Bacterial metalloproteases are often expressed as pro-enzymes.
The term "signal sequence" or "signal peptide" refers to a sequence of amino acid residues that may participate in the secretion or direct transport of the mature or precursor form of a protein. The signal sequence is typically located N-terminal to the precursor or mature protein sequence. The signal sequence may be endogenous or exogenous. A signal sequence is normally absent from the mature protein. A signal sequence is typically cleaved from the protein by a signal peptidase after the protein is transported.
The term "mature" form of a protein, polypeptide, or peptide refers to the functional form of the protein, polypeptide, or peptide without the signal peptide sequence and propeptide sequence.
The term "precursor" form of a protein or peptide refers to a mature form of the protein having a prosequence operably linked to the amino or carbonyl terminus of the protein. The precursor may also have a "signal" sequence operably linked to the amino terminus of the prosequence. The precursor may also have additional polypeptides that are involved in post- translational activity (e.g., polypeptides cleaved therefrom to leave the mature form of a protein or peptide).
The term "wild-type" in reference to an amino acid sequence or nucleic acid sequence indicates that the amino acid sequence or nucleic acid sequence is native or naturally occurring
sequence. As used herein, the term "naturally-occurring" refers to anything (e.g., proteins, amino acids, or nucleic acid sequences) that are found in nature.
As used herein, the term "non-naturally occurring" refers to anything that is not found in nature (e.g., recombinant nucleic acids and protein sequences produced in the laboratory), as modification of the wild-type sequence.
As used herein with regard to amino acid residue positions, "corresponding to" or "corresponds to" or "corresponds" refers to an amino acid residue at the enumerated position in a protein or peptide, or an amino acid residue that is analogous, homologous, or equivalent to an enumerated residue in a protein or peptide. As used herein, "corresponding region" generally refers to an analogous position in a related proteins or a reference protein.
The terms "derived from" and "obtained from" refer to not only a protein produced or producible by a strain of the organism in question, but also a protein encoded by a DNA sequence isolated from such strain and produced in a host organism containing such DNA sequence. Additionally, the term refers to a protein which is encoded by a DNA sequence of synthetic and/or cDNA origin and which has the identifying characteristics of the protein in question. To exemplify, "proteases derived from Bacillus" refers to those enzymes having proteolytic activity which are naturally produced by Bacillus, as well as to metalloproteases like those produced by Bacillus sources but which through the use of genetic engineering techniques are produced by non-Bacillus organisms transformed with a nucleic acid encoding the serine proteases.
The term "identical" in the context of two nucleic acids or polypeptide sequences refers to the residues in the two sequences that are the same when aligned for maximum
correspondence, as measured using one of the following sequence comparison or analysis algorithms.
As used herein, "homologous genes" refers to a pair of genes from different, but usually related species, which correspond to each other and which are identical or very similar to each other. The term encompasses genes that are separated by speciation (i.e., the development of new species) (e.g., orthologous genes), as well as genes that have been separated by genetic duplication (e.g., paralogous genes). As used herein, "homologous proteins" refers to proteins from different, but usually related species, which are very similar to each other.
As used herein, "% identity or percent identity" refers to sequence identity, at the gene or protein level. The output for these calculations are highly dependent on the algorithm used and the parameters selected such as length of compared sequences. Percent identity may be determined using standard techniques known in the art (See e.g., Smith and Waterman, Adv.
Appl. Math. 2:482 [1981]; Needleman and Wunsch, J. Mol. Biol. 48:443 [1970]; Pearson and Lipman, Proc. Natl. Acad. Sci. USA 85:2444 [1988]; software programs such as GAP,
BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package (Genetics Computer Group, Madison, WI); and Devereux et al, Nucl. Acid Res. 12:387-395 [1984]). One example of a useful algorithm is PILEUP. PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pair-wise alignments. It can also plot a tree showing the clustering relationships used to create the alignment. PILEUP uses a simplification of the progressive alignment method of Feng and Doolittle {See, Feng and Doolittle, J. Mol. Evol. 35:351-360 [1987]). The method is similar to that described by Higgins and Sharp {See, Higgins and Sharp, CABIOS 5: 151-153 [1989]). Useful PILEUP parameters include a default gap weight of 3.00, a default gap length weight of 0.10, and weighted end gaps. Other useful algorithm is the BLAST algorithms described by Altschul et al, {See, Altschul et al., J. Mol. Biol. 215:403-410 [1990]; and Karlin and Altschul, Proc. Natl. Acad. Sci. USA 90:5873-5787 [1993]). The BLAST program uses several search parameters, most of which are set to the default values.
The NCBI BLAST algorithm finds the most relevant sequences in terms of biological similarity but is not recommended for query sequences of less than 20 residues (Altschul, SF et al. (1997) Nucleic Acids Res. 25:3389-3402 and Schaffer, AA et al. (2001) Nucleic Acids Res. 29:2994-3005). Example default BLAST parameters for a nucleic acid sequence searches are:
• Neighboring words threshold : 11
• E-value cutoff : 10
• Scoring Matrix : NUC.3.1 (match = 1, mismatch = -3)
• Gap Opening : 5
• Gap Extension : 2 and the following parameters for amino acid sequence searches:
• Word size : 3
• E-value cutoff : 10
• Scoring Matrix : BLOSUM62
• Gap Opening : 11
• Gap extension : 1
A percent ( ) amino acid sequence identity value is determined by the number of matching identical residues divided by the total number of residues of the "reference" sequence including any gaps created by the program for optimal/maximum alignment. If a sequence is
90% identical to SEQ ID NO: A, SEQ ID NO: A is is the "reference" sequence. BLAST algorithms refer the "reference" sequence as "query" sequence.
The CLUSTAL W algorithm is another example of a sequence alignment algorithm. See Thompson et al. (1994) Nucleic Acids Res. 22:4673-4680. Default parameters for the
CLUSTAL W algorithm are:
Gap opening penalty: 10.0
Gap extension penalty: 0.05
Protein weight matrix: BLOSUM series
DNA weight matrix: IUB
Delay divergent sequences %: 40
Gap separation distance: 8
DNA transitions weight: 0.50
List hydrophilic residues: GPSNDQEKR
Use negative matrix: OFF
Toggle Residue specific penalties: ON
Toggle hydrophilic penalties: ON
Toggle end gap separation penalty OFF.
In CLUSTAL algorithms, deletions occurring at either terminus are included. For example, a variant with five amino acid deletion at either terminus (or within the polypeptide) of a polypeptide of 500 amino acids would have a percent sequence identity of 99% (495/500 identical residues x 100) relative to the "reference" polypeptide. Such a variant would be encompassed by a variant having "at least 99% sequence identity" to the polypeptide.
A polypeptide of interest may be said to be "substantially identical" to a reference polypeptide if the polypeptide of interest comprises an amino acid sequence having at least about 60%, least about 65%, least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or at least about 99.5% sequence identity to the amino acid sequence of the reference polypeptide. The percent identity between two such polypeptides can be determined manually by inspection of the two optimally aligned polypeptide sequences or by using software programs or algorithms {e.g., BLAST, ALIGN, CLUSTAL) using standard parameters. One indication that two polypeptides are substantially identical is that the first polypeptide is immunologically cross-reactive with the second polypeptide. Typically, polypeptides that differ by conservative amino acid substitutions are immunologically cross-reactive. Thus, a
polypeptide is substantially identical to a second polypeptide, for example, where the two peptides differ only by a conservative amino acid substitution or one or more conservative amino acid substitutions.
A nucleic acid of interest may be said to be "substantially identical" to a reference nucleic acid if the nucleic acid of interest comprises a nucleotide sequence having least about 60%, least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or at least about 99.5% sequence identity to the nucleotide sequence of the reference nucleic acid. The percent identity between two such nucleic acids can be determined manually by inspection of the two optimally aligned nucleic acid sequences or by using software programs or algorithms (e.g., BLAST, ALIGN, CLUSTAL) using standard parameters. One indication that two nucleic acid sequences are substantially identical is that the two nucleic acid molecules hybridize to each other under stringent conditions (e.g., within a range of medium to high stringency).
A nucleic acid or polynucleotide is "isolated" when it is at least partially or completely separated from other components, including but not limited to for example, other proteins, nucleic acids, cells, etc. Similarly, a polypeptide, protein or peptide is "isolated" when it is at least partially or completely separated from other components, including but not limited to for example, other proteins, nucleic acids, cells, etc. On a molar basis, an isolated species is more abundant than are other species in a composition. For example, an isolated species may comprise at least about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, or about 100% (on a molar basis) of all macromolecular species present.
Preferably, the species of interest is purified to essential homogeneity (i.e., contaminant species cannot be detected in the composition by conventional detection methods). Purity and homogeneity can be determined using a number of techniques well known in the art, such as agarose or polyacrylamide gel electrophoresis of a nucleic acid or a protein sample, respectively, followed by visualization upon staining. If desired, a high-resolution technique, such as high performance liquid chromatography (HPLC) or a similar means can be utilized for purification of the material.
"Hybridization" refers to the process by which one strand of nucleic acid forms a duplex with, i.e. , base pairs with, a complementary strand. A nucleic acid sequence is considered to be "selectively hybridizable" to a reference nucleic acid sequence if the two sequences specifically
hybridize to one another under moderate to high stringency hybridization and wash conditions. Hybridization conditions are based on the melting temperature (Tm) of the nucleic acid binding complex or probe. For example, "maximum stringency" typically occurs at about Tm-5°C (5° below the Tm of the probe); "high stringency" at about 5- 10°C below the Tm; "intermediate stringency" at about 10-20°C below the Tm of the probe; and "low stringency" at about 20-25°C below the Tm. Functionally, maximum stringency conditions can be used to identify sequences having strict identity or near-strict identity with the hybridization probe; while intermediate or low stringency hybridization can be used to identify or detect polynucleotide sequence homologs.
Moderate and high stringency hybridization conditions are well known in the art.
Stringent hybridization conditions are exemplified by hybridization under the following conditions: 65°C and 0.1X SSC (where IX SSC = 0.15 M NaCl, 0.015 M Na3 citrate, pH 7.0). Hybridized, duplex nucleic acids are characterized by a melting temperature (Tm), where one half of the hybridized nucleic acids are unpaired with the complementary strand. Mismatched nucleic acids within the duplex lower the Tm. Very stringent hybridization conditions involve 68°C and 0. IX SSC. A nucleic acid encoding a variant metalloprotease can have a Tm reduced by 1°C - 3°C or more compared to a duplex formed between the nucleic acid of SEQ ID NO: 4 and its identical complement.
Another example of high stringency conditions includes hybridization at about 42°C in 50% formamide, 5X SSC, 5X Denhardt' s solution, 0.5% SDS and 100
denatured carrier DNA followed by washing two times in 2X SSC and 0.5% SDS at room temperature and two additional times in 0.1X SSC and 0.5% SDS at 42°C. An example of moderate stringent conditions include an overnight incubation at 37°C in a solution comprising 20% formamide, 5 x SSC (150mM NaCl, 15 mM trisodium citrate), 50 mM sodium phosphate (pH 7.6), 5 x
Denhardt' s solution, 10% dextran sulfate and 20 mg/ml denatured sheared salmon sperm DNA, followed by washing the filters in lx SSC at about 37 - 50°C. Those of skill in the art know how to adjust the temperature, ionic strength, etc. to accommodate factors such as probe length and the like.
The term "purified" as applied to nucleic acids or polypeptides generally denotes a nucleic acid or polypeptide that is essentially free from other components as determined by analytical techniques well known in the art (e.g. , a purified polypeptide or polynucleotide forms a discrete band in an electrophoretic gel, chromatographic eluate, and/or a media subjected to density gradient centrifugation). For example, a nucleic acid or polypeptide that gives rise to essentially one band in an electrophoretic gel is "purified." A purified nucleic acid or
polypeptide is at least about 50% pure, usually at least about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91 %, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, about 99.5%, about 99.6%, about 99.7%, about 99.8% or more pure (e.g., percent by weight on a molar basis). In a related sense, the invention provides methods of enriching compositions for one or more molecules of the invention, such as one or more polypeptides or polynucleotides of the invention. A composition is enriched for a molecule when there is a substantial increase in the concentration of the molecule after application of a purification or enrichment technique. A substantially pure polypeptide or polynucleotide of the invention (e.g., substantially pure metalloprotease polypeptide or polynucleotide encoding a metalloprotease polypeptide of the invention, respectively) will typically comprise at least about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98, about 99%, about 99.5% or more by weight (on a molar basis) of all macromolecular species in a particular composition.
The term "enriched" refers to a compound, polypeptide, cell, nucleic acid, amino acid, or other specified material or component that is present in a composition at a relative or absolute concentration that is higher than a starting composition.
In a related sense, the invention provides methods of enriching compositions for one or more molecules of the invention, such as one or more polypeptides of the invention (e.g., one or more metalloprotease polypeptides of the invention) or one or more nucleic acids of the invention (e.g. , one or more nucleic acids encoding one or more metalloprotease polypeptides of the invention). A composition is enriched for a molecule when there is a substantial increase in the concentration of the molecule after application of a purification or enrichment technique. A substantially pure polypeptide or polynucleotide will typically comprise at least about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98, about 99%, about 99.5% or more by weight (on a molar basis) of all macromolecular species in a particular composition.
As used herein, the term "functional assay" refers to an assay that provides an indication of a protein's activity. In some embodiments, the term refers to assay systems in which a protein is analyzed for its ability to function in its usual capacity. For example, in the case of a protease, a functional assay involves determining the effectiveness of the protease to hydrolyze a proteinaceous substrate.
The terms "modified nucleic acid sequence" and "modified gene" are used interchangeably herein to refer to a nucleic acid sequence that includes a deletion, insertion or interruption of naturally occurring (i.e., wild-type) nucleic acid sequence. In some
embodiments, the expression product of the modified nucleic acid sequence is a truncated protein (e.g., if the modification is a deletion or interruption of the sequence). In some embodiments, the truncated protein retains biological activity. In alternative embodiments, the expression product of the modified nucleic acid sequence is an elongated protein (e.g., modifications comprising an insertion into the nucleic acid sequence). In some embodiments, a nucleotide insertion in the nucleic acid sequence leads to a truncated protein (e.g., when the insertion results in the formation of a stop codon). Thus, an insertion may result in either a truncated protein or an elongated protein as an expression product.
A "mutant" nucleic acid sequence typically refers to a nucleic acid sequence that has an alteration in at least one codon occurring in a host cell' s wild-type sequence such that the expression product of the mutant nucleic acid sequence is a protein with an altered amino acid sequence relative to the wild-type protein. The expression product may have an altered functional capacity (e.g., enhanced enzymatic activity).
As used herein, the phrase "alteration in substrate specificity" refers to changes in the substrate specificity of an enzyme. In some embodiments, a change in substrate specificity is defined as a change in kcat and/or Km for a particular substrate, resulting from mutations of the enzyme or alteration of reaction conditions. The substrate specificity of an enzyme is determined by comparing the catalytic efficiencies it exhibits with different substrates. These determinations find particular use in assessing the efficiency of mutant enzymes, as it is generally desired to produce variant enzymes that exhibit greater ratios of kcat/Km for substrates of interest. However, it is not intended that the present invention be limited to any particular substrate composition or substrate specificity.
As used herein, "surface property" is used in reference to electrostatic charge, as well as properties such as the hydrophobicity and hydrophilicity exhibited by the surface of a protein.
As used herein, the term "net charge" is defined as the sum of all charges present in a molecule. "Net charge changes" are made to a parent protein molecule to provide a variant that has a net charge that differs from that of the parent molecule (i.e., the variant has a net charge that is not the same as that of the parent molecule). For example, substitution of a neutral amino acid with a negatively charged amino acid or a positively charged amino acid with a neutral amino acid results in net charge of -1 with respect to the parent molecule. Substitution of a positively charged amino acid with a negatively charged amino acid results in a net charge of -2
with respect to the parent. Substitution of a neutral amino acid with a positively charged amino acid or a negatively charged amino acid with a neutral amino acid results in net charge of +1 with respect to the parent. Substitution of a negatively charged amino acid with a positively charged amino acid results in a net charge of +2 with respect to the parent. The net charge of a parent protein can also be altered by deletion and/or insertion of charged amino acids. A net change change applies to changes in charge of a variant versus a parent when measured at the same pH conditions.
The terms "thermally stable" and "thermostable" and "thermostability" refer to proteases that retain a specified amount of enzymatic activity after exposure to identified temperatures over a given period of time under conditions prevailing during the proteolytic, hydrolyzing, cleaning or other process of the invention, while being exposed to altered temperatures.
"Altered temperatures" encompass increased or decreased temperatures. In some embodiments, the proteases retain at least about 50%, about 60%, about 70%, about 75%, about 80%, about 85%, about 90%, about 92%, about 95%, about 96%, about 97%, about 98%, or about 99% proteolytic activity after exposure to altered temperatures over a given time period, for example, at least about 60 minutes, about 120 minutes, about 180 minutes, about 240 minutes, about 300 minutes, etc.
The term "enhanced stability" in the context of an oxidation, chelator, thermal, chemical, autolytic and/or pH stable protease refers to a higher retained proteolytic activity over time as compared to other proteases (e.g., thermolysin proteases) and/or wild-type enzymes.
The term "diminished stability" in the context of an oxidation, chelator, thermal and/or pH stable protease refers to a lower retained proteolytic activity over time as compared to other proteases (e.g., thermolysin proteases) and/or wild-type enzymes.
The term "cleaning activity" refers to a cleaning performance achieved by a
metalloprotease polypeptide or reference protease under conditions prevailing during the proteolytic, hydrolyzing, cleaning, or other process of the invention. In some embodiments, cleaning performance of a metalloprotease polypeptide or reference protease may be determined by using various assays for cleaning one or more various enzyme sensitive stains on an item or surface (e.g., a stain resulting from food, grass, blood, ink, milk, oil, and/or egg protein).
Cleaning performance of a variant or reference protease can be determined by subjecting the stain on the item or surface to standard wash condition(s) and assessing the degree to which the stain is removed by using various chromatographic, spectrophotometric, or other quantitative methodologies. Exemplary cleaning assays and methods are known in the art and include, but are not limited to those described in WO 99/34011 and U.S. Pat. 6,605,458, both of which are
herein incorporated by reference, as well as those cleaning assays and methods included in the Examples provided below.
The term "cleaning effective amount" of a metalloprotease polypeptide or reference protease refers to the amount of protease that achieves a desired level of enzymatic activity in a specific cleaning composition. Such effective amounts are readily ascertained by one of ordinary skill in the art and are based on many factors, such as the particular protease used, the cleaning application, the specific composition of the cleaning composition, and whether a liquid or dry (e.g., granular, tablet, bar) composition is required, etc.
The term "enhanced performance" in the context of cleaning activity refers to an increased or greater cleaning activity by an enzyme with respect to a parent or reference protein as measured on certain enzyme sensitive stains such as egg, milk, grass, ink, oil, and/or blood, as determined by usual evaluation after a standard wash cycle and/or multiple wash cycles.
The term "diminished performance" in the context of cleaning activity refers to a decreased or lesser cleaning activity by an enzyme on certain enzyme sensitive stains such as egg, milk, grass or blood, as determined by usual evaluation after a standard wash cycle and/or multiple wash cycles.
Cleaning compositions and cleaning formulations include any composition that is suited for cleaning, bleaching, disinfecting, and/or sterilizing any object, item, and/or surface. Such compositions and formulations include, but are not limited to for example, liquid and/or solid compositions, including cleaning or detergent compositions (e.g., liquid, tablet, gel, bar, granule, unit dose and/or solid laundry cleaning or detergent compositions and fine fabric detergent compositions; hard surface cleaning compositions and formulations, such as for glass, wood, ceramic and metal counter tops and windows; carpet cleaners; oven cleaners; fabric fresheners; fabric softeners; and textile, laundry booster cleaning or detergent compositions, laundry additive cleaning compositions, and laundry pre-spotter cleaning compositions; dishwashing compositions, including hand or manual dishwash compositions (e.g., "hand" or "manual" dishwashing detergents) and automatic dishwashing compositions (e.g., "automatic dishwashing detergents").
As used herein, the term "bleaching" refers to the treatment of a material (e.g., fabric, laundry, pulp, etc.) or surface for a sufficient length of time and/or under appropriate pH and/or temperature conditions to effect a brightening (i.e., whitening) and/or cleaning of the material. Examples of chemicals suitable for bleaching include, but are not limited to, for example, C102, H202, peracids, N02, etc.
As used herein, "wash performance" of a protease (e.g., a metalloprotease polypeptide of the invention) refers to the contribution of a metalloprotease polypeptide to washing that provides additional cleaning performance to the detergent as compared to the detergent without the addition of the metalloprotease polypeptide to the composition. Wash performance is compared under relevant washing conditions. In some test systems, other relevant factors, such as detergent composition, sud concentration, water hardness, washing mechanics, time, pH, and/or temperature, can be controlled in such a way that condition(s) typical for household application in a certain market segment (e.g., hand or manual dishwashing, automatic dishwashing, dishware cleaning, tableware cleaning, fabric cleaning, etc.) are imitated.
The term "relevant washing conditions" is used herein to indicate the conditions, particularly washing temperature, time, washing mechanics, sud concentration, type of detergent and water hardness, actually used in households in a hand dishwashing, automatic dishwashing, or laundry detergent market segment.
The term "improved wash performance" is used to indicate that a better end result is obtained in stain removal under relevant washing conditions, or that less metalloprotease polypeptide, on weight basis, is needed to obtain the same end result relative to the
corresponding wild-type or starting parent protease.
As used herein, the term "disinfecting" refers to the removal of contaminants from the surfaces, as well as the inhibition or killing of microbes on the surfaces of items. It is not intended that the present invention be limited to any particular surface, item, or contaminant(s) or microbes to be removed.
The "compact" form of the cleaning compositions herein is best reflected by density and, in terms of composition, by the amount of inorganic filler salt. Inorganic filler salts are conventional ingredients of detergent compositions in powder form. In conventional detergent compositions, the filler salts are present in substantial amounts, typically about 17 to about 35% by weight of the total composition. In contrast, in compact compositions, the filler salt is present in amounts not exceeding about 15% of the total composition. In some embodiments, the filler salt is present in amounts that do not exceed about 10%, or more preferably, about 5%, by weight of the composition. In some embodiments, the inorganic filler salts are selected from the alkali and alkaline-earth-metal salts of sulfates and chlorides. In some embodiments, the filler salt is sodium sulfate.
As used herein in connection with a numerical value, the term "about" refers to a range of +/- 0.5 of the numerical value, unless the term is otherwise specifically defined in context.
For instance, the phrase a "pH value of about 6" refers to pH values of from 5.5 to 6.5, unless the pH value is specifically defined otherwise.
Oligonucleotide synthesis and purification steps are typically performed according to specifications. Techniques and procedures are generally performed according to conventional methods well known in the art and various general references that are provided throughout this document. Procedures therein are believed to be well known to those of ordinary skill in the art and are provided for the convenience of the reader.
Variant Metalloprotease Polypeptides of the present invention
In some embodiments, the present invention provides novel variant metalloprotease enzyme polypeptides having a modification in a calcium binding region. In some embodiments, the variant is a variant of a parent or reference sequence. The parent or reference sequence can be, for example, any M4 metalloprotease, or a Bacillus derived metalloprotease, such as Bacillus thermoproteolyticus, Bacillus cereus, or Bacillus subtilis (for example, the sequences of SEQ ID NOs: 13-15), or a PaenibaciUus derived metalloprotease, such as the sequences of SEQ ID NOs: 1-12.
A residue (amino acid) of a metalloprotease is equivalent to a residue of Thermolysin metalloprotease if it is either homologous (i.e., corresponding in position in either primary or tertiary structure) or analogous to a specific residue or portion of that residue in Thermolysin metalloprotease from Bacillus thermoproteolyticus (i.e., having the same or similar functional capacity to react or interact chemically). In order to establish homology to primary structure, the amino acid sequence of a metalloprotease is directly compared to the Thermolysin primary sequence and particularly to a set of residues known to be invariant in diverse M4
metalloproteinases as shown in FIG. 6.1).
After aligning the conserved residues, allowing for necessary insertions and deletions in order to maintain alignment (i.e. avoiding the elimination of conserved residues through arbitrary deletions and insertions) the residues equivalent to particular amino acids in the primary sequence of thermolysin are defined. Suitable methods to produce such modifications include those disclosed herein and an example is shown in Example 6. These conserved residues thus may be used to define the corresponding equivalent amino acid residues of Thermolysin and in other M4 metalloproteinases such as the metalloproteinases from
PaenibaciUus organisms such as PehProl. These two particular sequences (Thermolysin (1_KEI) and PehProl) are aligned in FIG. 6.1 to produce the maximum homology of conserved residues.
As can be seen, there are a number of insertions and deletions in the PehProl sequence as compared to Thermolysin.
The position of an amino acid residue in a given amino acid sequence is typically numbered herein using the numbering of the position of the corresponding amino acid residue of the Bacillus thermoproteolyticus metalloprotease Thermolysin amino acid sequence shown in SEQ ID NO: 13. The Bacillus thermoproteolyticus metalloprotease Thermolysin amino acid sequence of SEQ ID NO: 13 thus serves as a reference parent sequence. A given amino acid sequence, such as a metalloprotease enzyme amino acid sequence and variants thereof described herein, can be aligned with the Thermolysin sequence (SEQ ID NO: 13) using an alignment algorithm as described herein on the primary and/or tertiary structures, and an amino acid residue in the given amino acid sequence that aligns (preferably optimally aligns) with an amino acid residue in the Thermolysin sequence can be conveniently numbered by reference to the corresponding amino acid residue in the metalloprotease Thermolysin sequence.
The equivalent amino acid of Asp57 in Thermolysin, in PehPro is the particular Serine shown at that aligned position. In FIG. 6.1, the equivalent amino acid at position 57 in PpoProl is again Aspartic acid. Thus, these particular residues in PehProl, and thermolysin may be substituted by a different amino acid to produce a mutant metalloprotease, since they are equivalent in primary structure to Asp 57 in thermolysin. Equivalent amino acids of course are not limited to those for Asp57 but extend to any residue which is equivalent to a residue in Thermolysin, and this is intended as an example of equivalent residues.
Equivalent residues homologous at the level of tertiary structure for a metalloprotease whose tertiary structure has been determined by x-ray crystallography, are defined as those for which the atomic coordinates of 2 or more of the main chain atoms of a particular amino acid residue of the M4 metalloproteinase and Thermolysin (N on N. CA on CA, C on C, and 0 on 0) are within 0.13 nm and preferably 0.1 nm after superposition. Superposition can be
accomplished by superimposing the common secondary structure. This can be accomplished using any one of several known algorithms in the art, such as The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrodinger, LLC or Coot [Emsley et al. (2010) Acta Crystallogr D Biol Crystallogr. 66(Pt4): 486]. Superposition is achieved after the best model has been oriented and positioned to give the maximum overlap of atomic coordinates of non-hydrogen protein atoms of the metalloprotease in question to the Thermolysin metalloprotease from Bacillus thermoproteolyticus. The best model is the crystallographic model determined at the highest resolution, and if more than one, the one giving the lowest R factor.
Equivalent residues which are functionally analogous to a specific residue of
Thermolysin are defined as those amino acids of the metalloproteases which may adopt a conformation such that they either alter, modify or contribute to protein structure, substrate binding or catalysis in a manner defined and attributed to a specific residue of thermolysin as described herein. Further, they are those residues of the metalloproteinase (for which a tertiary structure has been obtained by x-ray crystallography), which occupy an analogous position to the extent that although the main chain atoms of the given residue may not satisfy the criteria of equivalence on the basis of occupying a homologous position, the atomic coordinates of at least two of the side chain atoms of the residue lie with 0.13 nm of the corresponding side chain atoms of Thermolysin. The three dimensional structures would be aligned as outlined above.
Calcium binding region
The structure of the M4 class metallopro tease thermolysin has been found to have four calcium-binding regions. The structural information from Thermolysin and other
metalloproteases can be used to determine modifications that can be made to M4 class metalloproteases in order to remove calcium binding.
Based largely on analysis of the three-dimensional structure of thermolysin, it has been discovered that M4 class metalloproteases can have as many as four calcium binding sites. In thermolysin, there is a double cation binding site, herein referred to as Cal-2, which has a calcium binding region including residues 136, 138 and 177-190 using the numbering of thermolysin from Bacillus thermoproteolyticus found in SEQ ID NO: 13. There is also a calcium binding site, herein referred to as Ca3, which has a calcium binding region including residues 55-66, and a fourth binding site referred to as Ca4, which has a calcium binding region including residues 193-200.
In some embodiments, it is desirable to be able to decrease the Ca2+ dependency of a metalloprotease. As such, in some embodiments, the invention is a variant of a parent metallopro tease, such as a M4 class metalloprotease or a variant of any one of SEQ ID NOs: 1- 15, which exhibits protease activity and which has a decreased Ca2+ dependency as compared to the parent metalloprotease. The decreased Ca2+ dependency has the functional result that the variant exhibits proteolytic activity in the presence of a lower concentration of calcium ion in the extraneous medium than is necessary for the parent enzyme and, for example, therefore is less sensitive than the parent to calcium ion-depleting conditions such as those obtained in media containing calcium-complexing agents (such as certain detergent builders). In some
embodiments, the variant retains at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100% or even has greater activity compared to the parent metalloprotease. This can be measured in a proteolytic assay, such as those described in Example 1.
Calcium Binding
A stabilization strategy based around decreased calcium binding can improve enzyme stability in environments with decreased availability of free calcium ions. One of the major industrial uses of subtilisins is in environments containing high concentrations of metal chelators. Additionally, because these calcium binding regions are found in various M4 metalloproteases, it is expected that equivalent mutations for other M4 metalloproteases will likewise eliminate calcium binding and provide for enzymatically active variants. These calcium binding regions can also be found in various metalloproteases that are not categorized as M4 metalloproteases, but share the same properties as an M4 metalloprotease, including the calcium binding regions.
In some embodiments, the invention is a metalloprotease polypeptide comprising a calcium binding region. In some embodiments, the above polypeptide comprises a modification in at least one amino acid residue in one of the calcium binding regions, Cal-2, Ca3 and Ca4, (including residues 55-66, 136, 138, 177-190, and 193-200) of the polypeptide, wherein the amino acid positions of the polypeptide are numbered by correspondence with the amino acid sequence of Bacillus thermoproteolyticus metalloprotease set forth in SEQ ID NO: 13.
In any of the above embodiments and in new embodiments, the variant comprises a modification in at least one amino acid residue in a calcium binding region Cal-2 of residues 177-190 of a parent M4 metalloprotease. In any of the above embodiments and in new embodiments, the polypeptide at position 184 is a lysine, threonine, alanine, glutamic acid or aspartic acid. In any of the above embodiments and in new embodiments, the polypeptide at position 185 is a residue other than aspartic acid. In some embodiments, the polypeptide at position 185 is a non-negatively charged residue; in other embodiments, the polypeptide at position 185 is a neutrally charged residue; and in yet other embodiments, the polypeptide at position 185 is an asparagine or serine. In any of the above embodiments and in new
embodiments, the polypeptide at position 187 is a non-negatively charged residue. In some embodiments, the polypeptide at position 187 is a neutrally charged residue; and in other embodiments, the polypeptide at position 187 is a leucine or methionine; and in yet other embodiments, the polypeptide at position 187 is aspartic acid. In any of the above embodiments and in new embodiments, the polypeptide at position 188 is a leucine, valine, or methionine. In any of the above embodiments and in new embodiments, the polypeptide at position 190 is a
residue other than glutamic acid. In some embodiments, the polypeptide at position 190 is aspartic acid. In sequence alignment of Cal-2 regions, there are conserved residues glycine at position 173 and tryptophan at position 186 (see Figure 12). In any of the above embodiments and in new embodiments, the polypeptide comprises seven amino acid residues between the glycine residue at position 173 and tryptophan at position 186. In any of the above
embodiments and in new embodiments, the polypeptide comprises a deletion of five amino acid residues between the glycine residue at position 173 and tryptophan at position 186. In structural alignment of Cal-2 regions, there is a known loop structure between residues 176 and 186 (inclusive of amino acids 177 and 185 in the loop). In any of the above embodiments and in new embodiments, the polypeptide comprises a seven amino acid loop sequence between positions 177 to 185 which is replaced by a two amino acid sequence. Without being bound by theory, a polypeptide of the instant invention has improved stability by replacement of the loop structure with a shorter amino acid sequence that can span the region between positions 177 to 185, and in particular, a two amino acid sequence is preferred to span the region between positions 177 to 185. In any of the above embodiments, the two amino acid sequence contains at least one positively charged amino acid, and in some embodiments, the positively charged amino acid is lysine. In any of the above embodiments and in new embodiments, the polypeptide comprises a deletion at amino acid residue positions 179-183. In any of the above embodiments and in new embodiments, the polypeptide at position 177 is a neutrally charged residue or aspartic acid; and in some embodiments, the neutrally charged residue is glutamine. In any of the above embodiments and in new embodiments, the polypeptide at position 178 is a glycine, serine, arginine, alanine, asparagines, and threonine. In any of the above embodiments and in new embodiments, the polypeptide at position 136 is aspartic acid or serine.
In any of the above embodiments and in new embodiments, the invention is a metalloprotease polypeptide having a modification in at least one amino acid residue in a calcium binding region Ca3 of residues 55-66, wherein the amino acid positions of the variant are numbered by correspondence with the amino acid sequence of Bacillus proteolyticus metalloprotease set forth in SEQ ID NO: 13. In any of the above embodiments and in new embodiments, the polypeptide at position 55 is a leucine, serine, valine, and methionine. In any of the above embodiments and in new embodiments, the polypeptide at position 56 is a serine, arginine and threonine. In any of the above embodiments and in new embodiments, the polypeptide at position 57 is a serine. In any of the above embodiments and in new
embodiments, the polypeptide at position 58 is a serine and threonine. In any of the above embodiments and in new embodiments, the polypeptide at position 59 is a serine, threonine, and
asparagine. In any of the above embodiments and in new embodiments, the polypeptide has a serine at position 57, serine at position 58 and serine or asparagines at position 59. In any of the above embodiments and in new embodiments, the polypeptide at position 60 is a serine. In any of the above embodiments and in new embodiments, the polypeptide at position 61 is an isoleucine, valine, and threonine. In any of the above embodiments and in new embodiments, the polypeptide at position 62 is a tryptophan and phenylalanine. In any of the above embodiments and in new embodiments, the polypeptide at position 63 is a asparagine, glutamic acid, and threonine. In sequence alignment of the Ca3 region, there are conserved residues phenylalanine/tryptophan at position 62 and aspartic acid at position 67 (see Figure 12). In any of the above embodiments and in new embodiments, the polypeptide comprises four amino acid residues between the phenylalanine/tryptophan residue at position 62 and aspartic acid at position 67. In any of the above embodiments and in new embodiments, the polypeptide comprises a deletion of three amino acid residues between the phenylalanine/tryptophan residue at position 62 and aspartic acid at position 67. In structural alignment of the Ca3 region, there is a known loop structure between residues 62 and 67 (inclusive of amino acids 62 and 67 in the loop). In any of the above embodiments and in new embodiments, the polypeptide comprises a four amino acid loop sequence between positions 62 to 67 which is replaced by a one amino acid sequence. Without being bound by theory, a polypeptide of the instant invention has improved stability by replacement of the loop structure with a shorter amino acid sequence that can span the region between positions 62 to 67, and in particular, a one amino acid sequence is preferred to span the region between positions 62 to 67. In any of the above embodiments, the one amino acid sequence is an asparagines, threonine, or glutamic acid. In any of the above embodiments and in new embodiments, the polypeptide comprises a deletion at amino acid residue positions 64-66.
In any of the above embodiments and in new embodiments, the invention is a metalloprotease polypeptide having a modification in at least one amino acid residue in a calcium binding region Ca4 of residues 193-200, wherein the amino acid positions of the variant are numbered by correspondence with the amino acid sequence of Bacillus proteolyticus metalloprotease set forth in SEQ ID NO: 13. In any of the above embodiments and in new embodiments, the polypeptide at position 193 is a threonine. In any of the above embodiments and in new embodiments, the polypeptide at position 194 is a isoleucine. In any of the above embodiments and in new embodiments, the polypeptide at position 195 is a serine. In any of the above embodiments and in new embodiments, the polypeptide comprises a deletion at amino acid residue positions 196-198. In any of the above embodiments and in new embodiments, the
polypeptide at position 199 is a glutamine. In any of the above embodiments and in new embodiments, the polypeptide at position 200 is a proline.
In some embodiments of the invention, the calcium binding region Cal-2 has been modified to bind fewer than two calcium ions. In some embodiments of the invention, the calcium binding region Ca3 has been modified to bind fewer than one calcium ion. In some embodiments of the invention, the calcium binding region Ca4 has been modified to bind fewer than one calcium ion.
In some embodiments, the invention is a variant metalloprotease of a parent
metalloprotease polypeptide. In some embodiments, the variant comprises a modification in a calcium binding region of the parent polypeptide. In some embodiments, the variant comprises a modification to any of the amino acids listed above. In some embodiments, the parent polypeptide is an M4 metalloprotease. In some embodiments, the metalloprotease polypeptide of the present invention has at least 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, 99, or 100% sequence identity to the parent polypeptide. In some embodiments, the metalloprotease polypeptide of the present invention has at least 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, 99, or 100% sequence identity to any of the sequences found in SEQ ID NOs: 1-15. In some embodiments, the metalloprotease polypeptide of the present invention has at least 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, 99, or 100% sequence identity to SEQ ID NO: 13.
In some embodiments, the invention is a variant metalloprotease having immunological cross-reactivity with any of the variant metalloproteases described above. Immunological cross- reactivity can be assayed using an antibody raised against or reactive with at least one epitope of any of the variant metalloproteases listed above. The antibody, which can either be monoclonal or polyclonal, can be produced by methods known in the art. Immunological cross -reactivity can be measured using assays known in the art, such as Western blotting, radial
immunodiffusion assay, or enzyme-linked immunosorbant assay (ELISA).
Metalloprotease Polypeptides of the present invention
The present invention provides novel metalloprotease enzyme polypeptides, which may be collectively referred to as "enzymes of the invention" or "polypeptides of the invention." Polypeptides of the invention include isolated, recombinant, substantially pure, or non-naturally occurring polypeptides. In some embodiments, the invention includes variants, as described above, of M4 class metalloproteases. In some embodiments, polypeptides of the invention are useful in cleaning applications and can be incorporated into cleaning compositions that are useful in methods of cleaning an item or a surface in need of cleaning.
In some embodiments, the enzyme of the present invention has 50, 60, 65, 70, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a M4 class metalloprotease. In some embodiments, the enzyme of the present invention has 50, 60, 65, 70, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to SEQ ID NO: 13. In various embodiments, the enzyme of the present invention has 50, 60, 65, 70, 75, 80, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100% identity to a metalloprotease enzyme from any of SEQ ID NO: 1-15.
In some embodiments, the invention includes an isolated, recombinant, substantially pure, or non-naturally occurring enzyme having protease activity, which polypeptide comprises a polypeptide sequence having at least about 60%, 65%, 70%, 75%, 80%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to a parent enzyme as provided herein.
In some embodiments, the polypeptide of the present invention, is a polypeptide having a specified degree of amino acid sequence homology to the exemplified polypeptides, e.g. , at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or even at least 99% sequence homology to the amino acid sequence of any of SEQ ID NO: 1-15. Homology can be determined by amino acid sequence alignment, e.g. , using a program such as BLAST, ALIGN, or CLUSTAL, as described herein.
Also provided is a polypeptide enzyme of the present invention, having protease activity, said enzyme comprising an amino acid sequence which differs from the amino acid sequence of any of SEQ ID NO: 1-15 by no more than 50, no more than 40, no more than 30, no more than 35, no more than 25, no more than 20, no more than 19, no more than 18, no more than 17, no more than 16, no more than 15, no more than 14, no more than 13, no more than 12, no more than 11, no more than 10, no more than 9, no more than 8, no more than 7, no more than 6, no more than 5, no more than 4, no more than 3, no more than 2, or no more than 1 amino acid residue(s), when aligned using any of the previously described alignment methods.
As noted above, the variant enzyme polypeptides of the invention have enzymatic activities (e.g., protease activities) and thus are useful in cleaning applications, including but not limited to, methods for cleaning dishware items, tableware items, fabrics, and items having hard surfaces (e.g., the hard surface of a table, table top, wall, furniture item, floor, ceiling, etc.). Exemplary cleaning compositions comprising one or more variant metalloprotease enzyme polypeptides of the invention are described infra. The enzymatic activity (e.g., protease enzyme activity) of an enzyme polypeptide of the invention can be determined readily using procedures well known to those of ordinary skill in the art. The Examples presented infra describe methods
for evaluating the enzymatic activity and cleaning performance. The performance of polypeptide enzymes of the invention in removing stains (e.g., a protein stain such as blood/milk/ink or egg yolk), cleaning hard surfaces, or cleaning laundry, dishware or tableware item(s), or cleaning contact lenses can be readily determined using procedures well known in the art and/or by using procedures set forth in the Examples.
The metalloprotease polypeptides of the present invention can have protease activity over a broad range of pH conditions. In some embodiments, the metalloprotease polypeptides have protease activity on azo-casein as a substrate, as demonstrated in Example 3. In some embodiments, the metalloprotease polypeptides have protease activity at a pH of from about 3.0 to about 12.0. In some embodiments, the metalloprotease polypeptides have protease activity at a pH of from about 4.0 to about 11.0.
In some embodiments, the metalloprotease polypeptides of the present invention have protease activity at a temperature range of from about 10°C to about 100°C. In some
embodiments, the metalloprotease polypeptides of the present invention have protease activity at a temperature range of from about 20°C to about 90°C.
In some embodiments, the metalloprotease polypeptides of the present invention demonstrate cleaning performance in a cleaning composition. Cleaning compositions often include ingredients harmful to the stability and performance of enzymes, making cleaning compositions a harsh environment for enzymes, e.g. metallopro teases, to retain function. Thus, it is not trivial for an enzyme to be put in a cleaning composition and expect enzymatic function (e.g. metalloprotease activity, such as demonstrated by cleaning performance). In some embodiments, the metalloprotease polypeptides of the present invention demonstrate cleaning performance in automatic dishwashing (ADW) detergent compositions. In some embodiments, the cleaning performance in automatic dishwashing (ADW) detergent compositions includes cleaning of egg yolk stains. In some embodiments, the metalloprotease polypeptides of the present invention demonstrate cleaning performance in laundry detergent compositions. In some embodiments, the cleaning performance in laundry detergent compositions includes cleaning of blood/milk/ink stains. In each of the cleaning compositions, the metalloprotease polypeptides of the present invention demonstrate cleaning performance with or without a bleach component.
A polypeptide of the invention can be subject to various changes, such as one or more amino acid insertions, deletions, and/or substitutions, either conservative or non-conservative, including where such changes do not substantially alter the enzymatic activity of the
polypeptide. Similarly, a nucleic acid of the invention can also be subject to various changes,
such as one or more substitutions of one or more nucleotides in one or more codons such that a particular codon encodes the same or a different amino acid, resulting in either a silent variation (e.g., when the encoded amino acid is not altered by the nucleotide mutation) or non-silent variation, one or more deletions of one or more nucleic acids (or codons) in the sequence, one or more additions or insertions of one or more nucleic acids (or codons) in the sequence, and/or cleavage of or one or more truncations of one or more nucleic acids (or codons) in the sequence. Many such changes in the nucleic acid sequence may not substantially alter the enzymatic activity of the resulting encoded polypeptide enzyme compared to the polypeptide enzyme encoded by the original nucleic acid sequence. A nucleic acid sequence of the invention can also be modified to include one or more codons that provide for optimum expression in an expression system (e.g., bacterial expression system), while, if desired, said one or more codons still encode the same amino acid(s).
In some embodiments, the present invention provides a genus of enzyme polypeptides having the desired enzymatic activity (e.g., protease enzyme activity or cleaning performance activity) which comprise sequences having the amino acid substitutions described herein and also which comprise one or more additional amino acid substitutions, such as conservative and non-conservative substitutions, wherein the polypeptide exhibits, maintains, or approximately maintains the desired enzymatic activity (e.g., proteolytic activity, as reflected in the cleaning activity or performance of the polypeptide enzyme of SEQ ID NO: 13). Amino acid
substitutions in accordance with the invention may include, but are not limited to, one or more non-conservative substitutions and/or one or more conservative amino acid substitutions. A conservative amino acid residue substitution typically involves exchanging a member within one functional class of amino acid residues for a residue that belongs to the same functional class (conservative amino acid residues are considered functionally homologous or conserved in calculating percent functional homology). A conservative amino acid substitution typically involves the substitution of an amino acid in an amino acid sequence with a functionally similar amino acid. For example, alanine, glycine, serine, and threonine are functionally similar and thus may serve as conservative amino acid substitutions for one another. Aspartic acid and glutamic acid may serve as conservative substitutions for one another. Asparagine and glutamine may serve as conservative substitutions for one another. Arginine, lysine, and histidine may serve as conservative substitutions for one another. Isoleucine, leucine, methionine, and valine may serve as conservative substitutions for one another. Phenylalanine, tyrosine, and tryptophan may serve as conservative substitutions for one another.
Other conservative amino acid substitution groups can be envisioned. For example, amino acids can be grouped by similar function or chemical structure or composition (e.g., acidic, basic, aliphatic, aromatic, sulfur-containing). For instance, an aliphatic grouping may comprise: Glycine (G), Alanine (A), Valine (V), Leucine (L), Isoleucine (I). Other groups containing amino acids that are considered conservative substitutions for one another include: aromatic: Phenylalanine (F), Tyrosine (Y), Tryptophan (W); sulfur-containing: Methionine (M), Cysteine (C); Basic: Arginine (R), Lysine (K), Histidine (H); Acidic: Aspartic acid (D), Glutamic acid (E); non-polar uncharged residues, Cysteine (C), Methionine (M), and Proline (P); hydrophilic uncharged residues: Serine (S), Threonine (T), Asparagine (N), and Glutamine (Q). Additional groupings of amino acids are well-known to those of skill in the art and described in various standard textbooks. Listing of a polypeptide sequence herein, in conjunction with the above substitution groups, provides an express listing of all conservatively substituted polypeptide sequences.
More conservative substitutions exist within the amino acid residue classes described above, which also or alternatively can be suitable. Conservation groups for substitutions that are more conservative include: valine-leucine-isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine-valine, and asparagine-glutamine.
Conservatively substituted variations of a polypeptide sequence of the invention (e.g., variant metalloproteases of the invention) include substitutions of a small percentage, sometimes less than 25%, 20%, 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, or 6% of the amino acids of the polypeptide sequence, or less than 5%, 4%, 3%, 2%, or 1 %, or less than 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 amino acid substitution of the amino acids of the polypeptide sequence, with a conservatively selected amino acid of the same conservative substitution group.
As described elsewhere herein in greater detail and in the Examples provided herein, polypeptides of the invention may have cleaning abilities that may be compared to known proteases, including known metalloproteases.
Nucleic Acids of the Invention
The invention provides isolated, non-naturally occurring, or recombinant nucleic acids which may be collectively referred to as "nucleic acids of the invention" or "polynucleotides of the invention", which encode polypeptides of the invention. Nucleic acids of the invention, including all described below, are useful in recombinant production (e.g., expression) of polypeptides of the invention, typically through expression of a plasmid expression vector comprising a sequence encoding the polypeptide of interest or fragment thereof. As discussed
above, polypeptides include metalloprotease polypeptides having enzymatic activity (e.g., proteolytic activity) which are useful in cleaning applications and cleaning compositions for cleaning an item or a surface (e.g., surface of an item) in need of cleaning.
In some embodiments, the invention provides an isolated, recombinant, substantially pure, or non-naturally occurring nucleic acid comprising a nucleotide sequence encoding any polypeptide (including any fusion protein, etc.) of the invention described above in the section entitled "Polypeptides of the Invention" and elsewhere herein. The invention also provides an isolated, recombinant, substantially pure, or non-naturally-occurring nucleic acid comprising a nucleotide sequence encoding a combination of two or more of any polypeptides of the invention described above and elsewhere herein.
The present invention provides nucleic acids encoding a metalloprotease polypeptide of the present invention, wherein the metalloprotease polypeptide is a mature form having proteolytic activity, wherein the amino acid positions of the thermolysin variant are numbered by correspondence with the amino acid sequence of Bacillus thermoproteolyticus
metalloprotease polypeptide set forth as SEQ ID NO: 13.
Nucleic acids of the invention can be generated by using any suitable synthesis, manipulation, and/or isolation techniques, or combinations thereof. For example, a
polynucleotide of the invention may be produced using standard nucleic acid synthesis techniques, such as solid-phase synthesis techniques that are well-known to those skilled in the art. In such techniques, fragments of up to 50 or more nucleotide bases are typically
synthesized, then joined (e.g., by enzymatic or chemical ligation methods) to form essentially any desired continuous nucleic acid sequence. The synthesis of the nucleic acids of the invention can be also facilitated by any suitable method known in the art, including but not limited to chemical synthesis using the classical phosphoramidite method (See e.g., Beaucage et al. Tetrahedron Letters 22: 1859-69 [1981]); or the method described by Matthes et al. (See, Matthes et al., EMBO J. 3:801-805 [1984], as is typically practiced in automated synthetic methods. Nucleic acids of the invention also can be produced by using an automatic DNA synthesizer. Customized nucleic acids can be ordered from a variety of commercial sources (e.g., The Midland Certified Reagent Company, the Great American Gene Company, Operon Technologies Inc., and DNA2.0). Other techniques for synthesizing nucleic acids and related principles are known in the art (See e.g., Itakura et al., Ann. Rev. Biochem. 53:323 [1984]; and Itakura et al., Science 198: 1056 [1984]).
As indicated above, recombinant DNA techniques useful in modification of nucleic acids are well known in the art. For example, techniques such as restriction endonuclease digestion,
ligation, reverse transcription and cDNA production, and polymerase chain reaction (e.g., PCR) are known and readily employed by those of skill in the art. Nucleotides of the invention may also be obtained by screening cDNA libraries using one or more oligonucleotide probes that can hybridize to or PCR-amplify polynucleotides which encode a metalloprotease polypeptide polypeptide(s) of the invention. Procedures for screening and isolating cDNA clones and PCR amplification procedures are well known to those of skill in the art and described in standard references known to those skilled in the art. Some nucleic acids of the invention can be obtained by altering a naturally occurring polynucleotide backbone (e.g., that encodes an enzyme or parent protease) by, for example, a known mutagenesis procedure (e.g., site-directed
mutagenesis, site saturation mutagenesis, and in vitro recombination).
Methods for Making Modified Metalloprotease polypeptides of the Invention
A variety of methods are known in the art that are suitable for generating modified polynucleotides of the invention that encode metalloprotease polypeptides of the invention, including, but not limited to, for example, site- saturation mutagenesis, scanning mutagenesis, insertional mutagenesis, deletion mutagenesis, random mutagenesis, site-directed mutagenesis, and directed-evolution, as well as various other recombinatorial approaches. Methods for making modified polynucleotides and proteins (e.g., metalloprotease polypeptides) include DNA shuffling methodologies, methods based on non-homologous recombination of genes, such as ITCHY (See, Ostermeier et al., 7:2139-44 [1999]), SCRACHY (See, Lutz et al. 98: 11248-53 [2001]), SHIPREC (See, Sieber et al., 19:456-60 [2001]), and NRR (See, Bittker et al., 20: 1024- 9 [2001]; Bittker et al., 101:7011-6 [2004]), and methods that rely on the use of oligonucleotides to insert random and targeted mutations, deletions and/or insertions (See, Ness et al., 20: 1251-5 [2002]; Coco et al., 20: 1246-50 [2002]; Zha et al., 4:34-9 [2003]; Glaser et al., 149:3903-13 [1992]).
Vectors, Cells, and Methods for Producing Metalloprotease polypeptides of the Invention
The present invention provides vectors comprising at least one metalloprotease polynucleotide of the invention described herein (e.g., a polynucleotide encoding a
metalloprotease polypeptide of the invention described herein), expression vectors or expression cassettes comprising at least one nucleic acid or polynucleotide of the invention, isolated, substantially pure, or recombinant DNA constructs comprising at least one nucleic acid or polynucleotide of the invention, isolated or recombinant cells comprising at least one polynucleotide of the invention, and compositions comprising one or more such vectors, nucleic
acids, expression vectors, expression cassettes, DNA constructs, cells, cell cultures, or any combination or mixtures thereof.
In some embodiments, the invention provides recombinant cells comprising at least one vector (e.g., expression vector or DNA construct) of the invention which comprises at least one nucleic acid or polynucleotide of the invention. Some such recombinant cells are transformed or transfected with such at least one vector. Such cells are typically referred to as host cells. Some such cells comprise bacterial cells, including, but are not limited to Bacillus sp. cells, such as B. subtilis cells. The invention also provides recombinant cells (e.g., recombinant host cells) comprising at least one metalloprotease polypeptide of the invention.
In some embodiments, the invention provides a vector comprising a nucleic acid or polynucleotide of the invention. In some embodiments, the vector is an expression vector or expression cassette in which a polynucleotide sequence of the invention which encodes a metalloprotease polypeptide of the invention is operably linked to one or additional nucleic acid segments required for efficient gene expression (e.g., a promoter operably linked to the polynucleotide of the invention which encodes a metalloprotease polypeptide of the invention). A vector may include a transcription terminator and/or a selection gene, such as an antibiotic resistance gene, that enables continuous cultural maintenance of plasmid-infected host cells by growth in antimicrobial-containing media.
An expression vector may be derived from plasmid or viral DNA, or in alternative embodiments, contains elements of both. Exemplary vectors include, but are not limited to pC194, pJHIOl, pE194, pHP13 (See, Harwood and Cutting [eds.], Chapter 3, Molecular Biological Methods for Bacillus, John Wiley & Sons [1990]; suitable replicating plasmids for B. subtilis include those listed on p. 92) See also, Perego, Integrational Vectors for Genetic Manipulations in Bacillus subtilis, in Sonenshein et al., [eds.] Bacillus subtilis and Other Gram- Positive Bacteria: Biochemistry, Physiology and Molecular Genetics, American Society for Microbiology, Washington, D.C. [1993], pp. 615-624), and p2JM103BBI.
For expression and production of a protein of interest (e.g., metalloprotease polypeptide) in a cell, at least one expression vector comprising at least one copy of a polynucleotide encoding the metalloprotease polypeptide, and in some instances comprising multiple copies, is transformed into the cell under conditions suitable for expression of the metalloprotease. In some embodiments of the present invention, a polynucleotide sequence encoding the
metalloprotease polypeptide (as well as other sequences included in the vector) is integrated into the genome of the host cell, while in other embodiments, a plasmid vector comprising a polynucleotide sequence encoding the metalloprotease polypeptide remains as autonomous
extra-chromosomal element within the cell. The invention provides both extrachromosomal nucleic acid elements as well as incoming nucleotide sequences that are integrated into the host cell genome. The vectors described herein are useful for production of the metalloprotease polypeptides of the invention. In some embodiments, a polynucleotide construct encoding the metalloprotease polypeptide is present on an integrating vector that enables the integration and optionally the amplification of the polynucleotide encoding the metalloprotease polypeptide into the host chromosome. Examples of sites for integration are well known to those skilled in the art. In some embodiments, transcription of a polynucleotide encoding a metalloprotease polypeptide of the invention is effectuated by a promoter that is the wild-type promoter for the selected precursor protease. In some other embodiments, the promoter is heterologous to the precursor protease, but is functional in the host cell. Specifically, examples of suitable promoters for use in bacterial host cells include, but are not limited to, for example, the amyE, amyQ, amyL, pstS, sacB, pSPAC, pAprE, pVeg, pHpall promoters, the promoter of the B. stearothermophilus maltogenic amylase gene, the B. amyloliquefaciens (BAN) amylase gene, the B. subtilis alkaline protease gene, the B. clausii alkaline protease gene the B. pumilis xylosidase gene, the B. thuringiensis crylllA, and the B. licheniformis alpha- amylase gene. Additional promoters include, but are not limited to the A4 promoter, as well as phage Lambda PR or PL promoters, and the E. coli lac, trp or tac promoters.
Metalloprotease polypeptides of the present invention can be produced in host cells of any suitable microorganism, including bacteria and fungi. In some embodiments,
metalloprotease polypeptides of the present invention can be produced in Gram-positive bacteria. In some embodiments, the host cells are Bacillus spp., Streptomyces spp., Escherichia spp., Aspergillus spp., Trichoderma spp., Pseudomonas spp., Corynebacterium spp.,
Saccharomyces spp., or Pichia spp. In some embodiments, the metalloprotease polypeptides are produced by Bacillus sp. host cells. Examples of Bacillus sp. host cells that find use in the production of the metalloprotease polypeptides of the invention include, but are not limited to B. licheniformis, B. lentus, B. subtilis, B. amyloliquefaciens, B. lentus, B. brevis, B.
stearothermophilus, B. alkalophilus, B. coagulans, B. circulans, B. pumilis, B. thuringiensis, B. clausii, and B. megaterium, as well as other organisms within the genus Bacillus. In some embodiments, B. subtilis host cells are used for production of metalloprotease polypeptides. U.S. Patents 5,264,366 and 4,760,025 (RE 34,606) describe various Bacillus host strains that can be used for producing metalloprotease polypeptide of the invention, although other suitable strains can be used.
Several bacterial strains that can be used to produce metalloprotease polypeptides of the invention include non-recombinant (i.e., wild-type) Bacillus sp. strains, as well as variants of naturally-occurring strains and/or recombinant strains. In some embodiments, the host strain is a recombinant strain, wherein a polynucleotide encoding a polypeptide of interest has been introduced into the host. In some embodiments, the host strain is a B. subtilis host strain and particularly a recombinant Bacillus subtilis host strain. Numerous B. subtilis strains are known, including, but not limited to for example, 1A6 (ATCC 39085), 168 (1A01), SB19, W23, Ts85, B637, PB1753 through PB1758, PB3360, JH642, 1A243 (ATCC 39,087), ATCC 21332, ATCC 6051, Mil 13, DE100 (ATCC 39,094), GX4931, PBT 110, and PEP 211strain (See e.g., Hoch et al., Genetics 73:215-228 [1973]; See also, U.S. Patent Nos. 4,450,235 and 4,302,544, and EP 0134048, each of which is incorporated by reference in its entirety). The use of B. subtilis as an expression host cells is well known in the art (See e.g., Palva et al., Gene 19:81-87 [1982]; Fahnestock and Fischer, J. Bacterid. , 165:796-804 [1986]; and Wang et al., Gene 69:39-47 [1988]).
In some embodiments, the Bacillus host cell is a Bacillus sp. that includes a mutation or deletion in at least one of the following genes, degU, degS, degR and degQ. In some
embodiments, the mutation is in a degU gene, and in some embodiments the mutation is degU(Hy)32 (See e.g., Msadek et al., J. Bacteriol. 172:824-834 [1990]; and Olmos et al., Mol. Gen. Genet. 253:562-567 [1997]). In some embodiments, the Bacillus host comprises a mutation or deletion in scoC4 (See e.g., Caldwell et al., J. Bacteriol. 183:7329-7340 [2001]); spoIIE (See e.g., Arigoni et al., Mol. Microbiol. 31: 1407-1415 [1999]); and/or oppA or other genes of the opp operon (See e.g., Perego et al., Mol. Microbiol. 5: 173-185 [1991]). Indeed, it is contemplated that any mutation in the opp operon that causes the same phenotype as a mutation in the oppA gene will find use in some embodiments of the altered Bacillus strain of the invention. In some embodiments, these mutations occur alone, while in other embodiments, combinations of mutations are present. In some embodiments, an altered Bacillus host cell strain that can be used to produce a metalloprotease polypeptide of the invention is a Bacillus host strain that already includes a mutation in one or more of the above-mentioned genes. In addition, Bacillus sp. host cells that comprise mutation(s) and/or deletions of endogenous protease genes find use. In some embodiments, the Bacillus host cell comprises a deletion of the aprE and the nprE genes. In other embodiments, the Bacillus sp. host cell comprises a deletion of 5 protease genes, while in other embodiments, the Bacillus sp. host cell comprises a deletion of 9 protease genes (See e.g., U.S. Pat. Appln. Pub. No. 2005/0202535, incorporated herein by reference).
Host cells are transformed with at least one nucleic acid encoding at least one metalloprotease polypeptide of the invention using any suitable method known in the art.
Methods for introducing a nucleic acid (e.g., DNA) into Bacillus cells or E. coli cells utilizing plasmid DNA constructs or vectors and transforming such plasmid DNA constructs or vectors into such cells are well known. In some embodiments, the plasmids are subsequently isolated from E. coli cells and transformed into Bacillus cells. However, it is not essential to use intervening microorganisms such as E. coli, and in some embodiments, a DNA construct or vector is directly introduced into a Bacillus host.
Those of skill in the art are well aware of suitable methods for introducing nucleic acid sequences of the invention into Bacillus cells (See e.g., Ferrari et al., "Genetics," in Harwood et al. [eds.], Bacillus, Plenum Publishing Corp. [1989], pp. 57-72; Saunders et al., J. Bacteriol. 157:718-726 [1984]; Hoch et al., J. Bacteriol. 93: 1925 -1937 [1967]; Mann et al., Current Microbiol. 13: 131-135 [1986]; Holubova, Folia Microbiol. 30:97 [1985]; Chang et al., Mol. Gen. Genet. 168: 11-115 [1979]; Vorobjeva et al., FEMS Microbiol. Lett. 7:261-263 [1980]; Smith et al., Appl. Env. Microbiol. 51:634 [1986]; Fisher et al., Arch. Microbiol. 139:213-217 [1981]; and McDonald, J. Gen. Microbiol. 130:203 [1984]). Indeed, such methods as transformation, including protoplast transformation and transfection, transduction, and protoplast fusion are well known and suited for use in the present invention. Methods known in the art to transform Bacillus cells include such methods as plasmid marker rescue
transformation, which involves the uptake of a donor plasmid by competent cells carrying a partially homologous resident plasmid (See, Contente et al., Plasmid 2:555-571 [1979]; Haima et al., Mol. Gen. Genet. 223: 185-191 [1990]; Weinrauch et al., J. Bacteriol. 154: 1077-1087 [1983]; and Weinrauch et al., J. Bacteriol. 169: 1205-1211 [1987]). In this method, the incoming donor plasmid recombines with the homologous region of the resident "helper" plasmid in a process that mimics chromosomal transformation.
In addition to commonly used methods, in some embodiments, host cells are directly transformed with a DNA construct or vector comprising a nucleic acid encoding a
metalloprotease polypeptide of the invention (i.e., an intermediate cell is not used to amplify, or otherwise process, the DNA construct or vector prior to introduction into the host cell).
Introduction of the DNA construct or vector of the invention into the host cell includes those physical and chemical methods known in the art to introduce a nucleic acid sequence (e.g., DNA sequence) into a host cell without insertion into the host genome. Such methods include, but are not limited to calcium chloride precipitation, electroporation, naked DNA, liposomes and the like. In additional embodiments, DNA constructs or vector are co-transformed with a plasmid,
without being inserted into the plasmid. In further embodiments, a selective marker is deleted from the altered Bacillus strain by methods known in the art (See, Stahl et al., J. Bacteriol.
158:411-418 [1984]; and Palmeros et al, Gene 247:255 -264 [2000]).
In some embodiments, the transformed cells of the present invention are cultured in conventional nutrient media. The suitable specific culture conditions, such as temperature, pH and the like are known to those skilled in the art and are well described in the scientific literature. In some embodiments, the invention provides a culture (e.g., cell culture) comprising at least one metalloprotease polypeptide or at least one nucleic acid of the invention.
In some embodiments, host cells transformed with at least one polynucleotide sequence encoding at least one metalloprotease polypeptide of the invention are cultured in a suitable nutrient medium under conditions permitting the expression of the present protease, after which the resulting protease is recovered from the culture. In some embodiments, the protease produced by the cells is recovered from the culture medium by conventional procedures, including, but not limited to for example, separating the host cells from the medium by centrifugation or filtration, precipitating the proteinaceous components of the supernatant or filtrate by means of a salt (e.g., ammonium sulfate), chromatographic purification (e.g., ion exchange, gel filtration, affinity, etc.).
In some embodiments, a metalloprotease polypeptide produced by a recombinant host cell is secreted into the culture medium. A nucleic acid sequence that encodes a purification facilitating domain may be used to facilitate purification of proteins. A vector or DNA construct comprising a polynucleotide sequence encoding a metalloprotease polypeptide may further comprise a nucleic acid sequence encoding a purification facilitating domain to facilitate purification of the metalloprotease polypeptide (See e.g., Kroll et al., DNA Cell Biol. 12:441-53 [1993]). Such purification facilitating domains include, but are not limited to, for example, metal chelating peptides such as histidine-tryptophan modules that allow purification on immobilized metals (See, Porath, Protein Expr. Purif. 3:263-281 [1992]), protein A domains that allow purification on immobilized immunoglobulin, and the domain utilized in the FLAGS extension/affinity purification system. The inclusion of a cleavable linker sequence such as Factor XA or enterokinase (e.g., sequences available from Invitrogen, San Diego, CA) between the purification domain and the heterologous protein also find use to facilitate purification.
Assays for detecting and measuring the enzymatic activity of an enzyme, such as a metalloprotease polypeptide of the invention, are well known. Various assays for detecting and measuring activity of proteases (e.g., metalloprotease polypeptides of the invention), are also known to those of ordinary skill in the art. In particular, assays are available for measuring
protease activity that are based on the release of acid- soluble peptides from casein or
hemoglobin, measured as absorbance at 280 nm or colorimetrically using the Folin method. Other exemplary assays involve the solubilization of chromogenic substrates (See e.g., Ward, "Proteinases," in Fogarty (ed.)., Microbial Enzymes and Biotechnology, Applied Science, London, [1983], pp. 251-317). Other exemplary assays include, but are not limited to hydrolysis of protein substrates such as casein (azo-casein, dimethyl-casein and other forms), and peptidyl substrates such as succinyl-Ala-Ala-Pro-Phe-para nitroanilide assay (suc-AAPF-pNA) and the 2,4,6-trinitrobenzene sulfonate sodium salt (TNBS). Numerous additional references known to those in the art provide suitable methods (See e.g., Wells et al., Nucleic Acids Res. 11:7911- 7925 [1983]; Christianson et al., Anal. Biochem. 223: 119 -129 [1994]; and Hsia et al., Anal Biochem. 242:221-227 [1999]).
A variety of methods can be used to determine the level of production of a mature protease (e.g., mature metalloprotease polypeptides of the present invention) in a host cell. Such methods include, but are not limited to, for example, methods that utilize either polyclonal or monoclonal antibodies specific for the protease. Exemplary methods include, but are not limited to enzyme-linked immunosorbent assays (ELISA), radioimmunoassays (RIA), fluorescent immunoassays (FIA), and fluorescent activated cell sorting (FACS). These and other assays are well known in the art (See e.g., Maddox et al., J. Exp. Med. 158: 1211 [1983]).
In some other embodiments, the invention provides methods for making or producing a mature metalloprotease polypeptide of the invention. A mature metalloprotease polypeptide does not include a signal peptide or a propeptide sequence. Some methods comprise making or producing a metalloprotease polypeptide of the invention in a recombinant bacterial host cell, such as for example, a Bacillus sp. cell (e.g., a B. subtilis cell). In some embodiments, the invention provides a method of producing a metalloprotease polypeptide of the invention, the method comprising cultivating a recombinant host cell comprising a recombinant expression vector comprising a nucleic acid encoding a metalloprotease polypeptide of the invention under conditions conducive to the production of the metalloprotease polypeptide. Some such methods further comprise recovering the metalloprotease polypeptide from the culture.
In some embodiments the invention provides methods of producing a metalloprotease polypeptide of the invention, the methods comprising: (a) introducing a recombinant expression vector comprising a nucleic acid encoding a metalloprotease polypeptide of the invention into a population of cells (e.g., bacterial cells, such as B. subtilis cells); and (b) culturing the cells in a culture medium under conditions conducive to produce the metalloprotease polypeptide encoded
by the expression vector. Some such methods further comprise: (c) isolating the metalloprotease polypeptide from the cells or from the culture medium.
Compositions having the metalloprotease polypeptide of the present invention
Unless otherwise noted, all component or composition levels provided herein are made in reference to the active level of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources. Enzyme components weights are based on total active protein. All
percentages and ratios are calculated by weight unless otherwise indicated. All percentages and ratios are calculated based on the total composition unless otherwise indicated. Compositions of the invention include cleaning compositions, such as detergent compositions. In the exemplified detergent compositions, the enzymes levels are expressed by pure enzyme by weight of the total composition and unless otherwise specified, the detergent ingredients are expressed by weight of the total compositions.
As indicated herein, in some embodiments, the cleaning compositions of the present invention further comprise adjunct materials including, but not limited to, surfactants, builders, bleaches, bleach activators, bleach catalysts, other enzymes, enzyme stabilizing systems, chelants, optical brighteners, soil release polymers, dye transfer agents, dispersants, suds suppressors, dyes, perfumes, colorants, filler salts, hydrotropes, photoactivators, fluorescers, fabric conditioners, hydrolyzable surfactants, preservatives, anti-oxidants, anti- shrinkage agents, anti-wrinkle agents, germicides, fungicides, color speckles, silvercare, anti-tarnish and/or anti- corrosion agents, alkalinity sources, solubilizing agents, carriers, processing aids, pigments, and pH control agents (See e.g., U.S. Pat. Nos. 6,610,642, 6,605,458, 5,705,464, 5,710,115,
5,698,504, 5,695,679, 5,686,014 and 5,646,101, all of which are incorporated herein by reference). Embodiments of specific cleaning composition materials are exemplified in detail below. In embodiments in which the cleaning adjunct materials are not compatible with the metalloprotease polypeptides of the present invention in the cleaning compositions, then suitable methods of keeping the cleaning adjunct materials and the protease(s) separated (i.e., not in contact with each other) until combination of the two components is appropriate are used. Such separation methods include any suitable method known in the art (e.g., gelcaps, encapsulation, tablets, physical separation, etc.).
The cleaning compositions of the present invention are advantageously employed for example, in laundry applications, hard surface cleaning, dishwashing applications, including automatic dishwashing and hand dishwashing, as well as cosmetic applications such as dentures,
teeth, hair and skin. In addition, due to the unique advantages of increased effectiveness in lower temperature solutions, the enzymes of the present invention are ideally suited for laundry applications. Furthermore, the enzymes of the present invention find use in granular and liquid compositions.
The metalloprotease polypeptides of the present invention also find use in cleaning additive products. In some embodiments, low temperature solution cleaning applications find use. In some embodiments, the present invention provides cleaning additive products including at least one enzyme of the present invention is ideally suited for inclusion in a wash process when additional bleaching effectiveness is desired. Such instances include, but are not limited to low temperature solution cleaning applications. In some embodiments, the additive product is in its simplest form, one or more proteases. In some embodiments, the additive is packaged in dosage form for addition to a cleaning process. In some embodiments, the additive is packaged in dosage form for addition to a cleaning process where a source of peroxygen is employed and increased bleaching effectiveness is desired. Any suitable single dosage unit form finds use with the present invention, including but not limited to pills, tablets, gelcaps, or other single dosage units such as pre-measured powders or liquids. In some embodiments, filler(s) or carrier material(s) are included to increase the volume of such compositions. Suitable filler or carrier materials include, but are not limited to, various salts of sulfate, carbonate and silicate as well as talc, clay and the like. Suitable filler or carrier materials for liquid compositions include, but are not limited to water or low molecular weight primary and secondary alcohols including polyols and diols. Examples of such alcohols include, but are not limited to, methanol, ethanol, propanol and isopropanol. In some embodiments, the compositions contain from about 5% to about 90% of such materials. Acidic fillers find use to reduce pH. Alternatively, in some embodiments, the cleaning additive includes adjunct ingredients, as more fully described below.
The present cleaning compositions and cleaning additives require an effective amount of at least one of the metalloprotease polypeptides provided herein, alone or in combination with other proteases and/or additional enzymes. The required level of enzyme is achieved by the addition of one or more metalloprotease polypeptides of the present invention. Typically the present cleaning compositions comprise at least about 0.0001 weight percent, from about 0.0001 to about 10, from about 0.001 to about 1, or from about 0.01 to about 0.1 weight percent of at least one of the metalloprotease polypeptides of the present invention.
The cleaning compositions herein are typically formulated such that, during use in aqueous cleaning operations, the wash water will have a pH of from about 4.0 to about 11.5 or even from about 5.0 to about 11.5, or even from about 5.0 to about 8.0, or even from about 7.5
to about 10.5. Liquid product formulations are typically formulated to have a pH from about 3.0 to about 9.0 or even from about 3 to about 5. Granular laundry products are typically formulated to have a pH from about 9 to about 11. Techniques for controlling pH at recommended usage levels include the use of buffers, alkalis, acids, etc., and are well known to those skilled in the art.
Suitable "low pH cleaning compositions" typically have a pH of from about 3 to about 5, and are typically free of surfactants that hydrolyze in such a pH environment. Such surfactants include sodium alkyl sulfate surfactants that comprise at least one ethylene oxide moiety or even from about 1 to about 16 moles of ethylene oxide. Such cleaning compositions typically comprise a sufficient amount of a pH modifier, such as sodium hydroxide, monoethanolamine or hydrochloric acid, to provide such cleaning composition with a pH of from about 3 to about 5. Such compositions typically comprise at least one acid stable enzyme. In some embodiments, the compositions are liquids, while in other embodiments, they are solids. The pH of such liquid compositions is typically measured as a neat pH. The pH of such solid compositions is measured as a 10% solids solution of said composition wherein the solvent is distilled water. In these embodiments, all pH measurements are taken at 20°C, unless otherwise indicated.
In some embodiments, when the metalloprotease polypeptide(s) is/are employed in a granular composition or liquid, it is desirable for the metalloprotease polypeptide to be in the form of an encapsulated particle to protect the metalloprotease polypeptide from other components of the granular composition during storage. In addition, encapsulation is also a means of controlling the availability of the metalloprotease polypeptide during the cleaning process. In some embodiments, encapsulation enhances the performance of the metalloprotease polypeptide(s) and/or additional enzymes. In this regard, the metalloprotease polypeptides of the present invention are encapsulated with any suitable encapsulating material known in the art. In some embodiments, the encapsulating material typically encapsulates at least part of the metalloprotease polypeptide(s) of the present invention. Typically, the encapsulating material is water-soluble and/or water-dispersible. In some embodiments, the encapsulating material has a glass transition temperature (Tg) of 0°C or higher. Glass transition temperature is described in more detail in WO 97/11151. The encapsulating material is typically selected from consisting of carbohydrates, natural or synthetic gums, chitin, chitosan, cellulose and cellulose derivatives, silicates, phosphates, borates, polyvinyl alcohol, polyethylene glycol, paraffin waxes, and combinations thereof. When the encapsulating material is a carbohydrate, it is typically selected from monosaccharides, oligosaccharides, polysaccharides, and combinations thereof. In some typical embodiments, the encapsulating material is a starch (See e.g., EP 0 922 499; US
4,977,252; US 5,354,559, and US 5,935,826). In some embodiments, the encapsulating material is a microsphere made from plastic such as thermoplastics, acrylonitrile, methacrylonitrile, polyacrylonitrile, polymethacrylonitrile and mixtures thereof; commercially available microspheres that find use include, but are not limited to those supplied by EXPANCEL® (Stockviksverken, Sweden), and PM 6545, PM 6550, PM 7220, PM 7228,
EXTENDOSPHERES®, LUXSIL®, Q-CEL®, and SPHERICEL® (PQ Corp., Valley Forge, PA).
As described herein, the metalloprotease polypeptides of the present invention find particular use in the cleaning industry, including, but not limited to laundry and dish detergents. These applications place enzymes under various environmental stresses. The metalloprotease polypeptides of the present invention provide advantages over many currently used enzymes, due to their stability under various conditions.
Indeed, there are a variety of wash conditions including varying detergent formulations, wash water volumes, wash water temperatures, and lengths of wash time, to which proteases involved in washing are exposed. In addition, detergent formulations used in different geographical areas have different concentrations of their relevant components present in the wash water. For example, European detergents typically have about 4500-5000 ppm of detergent components in the wash water, while Japanese detergents typically have
approximately 667 ppm of detergent components in the wash water. In North America, particularly the United States, detergents typically have about 975 ppm of detergent components present in the wash water.
A low detergent concentration system includes detergents where less than about 800 ppm of the detergent components are present in the wash water. Japanese detergents are typically considered low detergent concentration system as they have approximately 667 ppm of detergent components present in the wash water.
A medium detergent concentration includes detergents where between about 800 ppm and about 2000ppm of the detergent components are present in the wash water. North American detergents are generally considered to be medium detergent concentration systems as they have approximately 975 ppm of detergent components present in the wash water. Brazil typically has approximately 1500 ppm of detergent components present in the wash water.
A high detergent concentration system includes detergents where greater than about 2000 ppm of the detergent components are present in the wash water. European detergents are generally considered to be high detergent concentration systems as they have approximately 4500-5000 ppm of detergent components in the wash water.
Latin American detergents are generally high suds phosphate builder detergents and the range of detergents used in Latin America can fall in both the medium and high detergent concentrations as they range from 1500 ppm to 6000 ppm of detergent components in the wash water. As mentioned above, Brazil typically has approximately 1500 ppm of detergent components present in the wash water. However, other high suds phosphate builder detergent geographies, not limited to other Latin American countries, may have high detergent
concentration systems up to about 6000 ppm of detergent components present in the wash water.
In light of the foregoing, it is evident that concentrations of detergent compositions in typical wash solutions throughout the world varies from less than about 800 ppm of detergent to about 6000 ppm in high suds phosphate builder geographies.
The concentrations of the typical wash solutions are determined empirically. For example, in the U.S., a typical washing machine holds a volume of about 64.4 L of wash solution. Accordingly, in order to obtain a concentration of about 975 ppm of detergent within the wash solution about 62.79 g of detergent composition must be added to the 64.4 L of wash solution. This amount is the typical amount measured into the wash water by the consumer using the measuring cup provided with the detergent.
As a further example, different geographies use different wash temperatures. The temperature of the wash water in Japan is typically less than that used in Europe. For example, the temperature of the wash water in North America and Japan is typically between about 10 and about 40°C (e.g., about 20°C), whereas the temperature of wash water in Europe is typically between about 30 and about 60°C (e.g., about 40°C). However, in the interest of saving energy, many consumers are switching to using cold water washing. In addition, in some further regions, cold water is typically used for laundry, as well as dish washing applications. In some embodiments, the "cold water washing" of the present invention utilizes "cold water detergent" suitable for washing at temperatures from about 10°C to about 40°C, or from about 20°C to about 30°C, or from about 15°C to about 25°C, as well as all other combinations within the range of about 15°C to about 35°C, and all ranges within 10°C to 40°C.
As a further example, different geographies typically have different water hardness. Water hardness is usually described in terms of the grains per gallon mixed Ca2+/Mg2+.
Hardness is a measure of the amount of calcium (Ca2+) and magnesium (Mg2+) in the water. Most water in the United States is hard, but the degree of hardness varies. Moderately hard (60- 120 ppm) to hard (121-181 ppm) water has 60 to 181 parts per million (parts per million converted to grains per U.S. gallon is ppm # divided by 17.1 equals grains per gallon) of hardness minerals.
Water Grains per gallon Parts per million
Soft less than 1.0 less than 17
Slightly hard 1.0 to 3.5 17 to 60
Moderately hard 3.5 to 7.0 60 to 120
Hard 7.0 to 10.5 120 to 180
Very hard greater than 10.5 greater than 180
European water hardness is typically greater than about 10.5 (for example about 10.5 to about 20.0) grains per gallon mixed Ca2+/Mg2+ (e.g., about 15 grains per gallon mixed
Ca2+/Mg2+ ). North American water hardness is typically greater than Japanese water hardness, but less than European water hardness. For example, North American water hardness can be between about 3 to about 10 grains, about 3 to about 8 grains or about 6 grains. Japanese water hardness is typically lower than North American water hardness, usually less than about 4, for example about 3 grains per gallon mixed Ca2+/Mg2+.
Accordingly, in some embodiments, the present invention provides metallopro tease polypeptides that show surprising wash performance in at least one set of wash conditions (e.g., water temperature, water hardness, and/or detergent concentration). In some embodiments, the metalloprotease polypeptides of the present invention are comparable in wash performance to other metalloprotease polypeptide proteases. In some embodiments of the present invention, the metalloprotease polypeptides provided herein exhibit enhanced oxidative stability, enhanced thermal stability, enhanced cleaning capabilities under various conditions, and/or enhanced chelator stability. In addition, the metalloprotease polypeptides of the present invention find use in cleaning compositions that do not include detergents, again either alone or in combination with builders and stabilizers.
In some embodiments of the present invention, the cleaning compositions comprise at least one metalloprotease polypeptide of the present invention at a level from about 0.00001 % to about 10% by weight of the composition and the balance (e.g., about 99.999% to about 90.0%) comprising cleaning adjunct materials by weight of composition. In some other embodiments of the present invention, the cleaning compositions of the present invention comprises at least one metalloprotease polypeptide at a level of about 0.0001 % to about 10%, about 0.001% to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% by weight of the composition and the balance of the cleaning composition (e.g., about 99.9999% to about 90.0%, about 99.999 % to about 98%, about 99.995% to about 99.5% by weight) comprising cleaning adjunct materials.
In some embodiments, the cleaning compositions of the present invention comprise one or more additional detergent enzymes, which provide cleaning performance and/or fabric care and/or dishwashing benefits. Examples of suitable enzymes include, but are not limited to, acyl transferases, alpha- amylases, beta- amylases, alpha-galactosidases, arabinosidases, aryl esterases, beta-galactosidases, carrageenases, catalases, cellobiohydrolases, cellulases, chondroitinases, cutinases, endo-beta-1, 4-glucanases, endo-beta-mannanases, esterases, exo-mannanases, galactanases, glucoamylases, hemicellulases, hyaluronidases, keratinases, laccases, lactases, ligninases, lipases, lipoxygenases, mannanases, oxidases, pectate lyases, pectin acetyl esterases, pectinases, pentosanases, peroxidases, phenoloxidases, phosphatases, phospholipases, phytases, polygalacturonases, proteases, pullulanases, reductases, rhamnogalacturonases, beta-glucanases, tannases, transglutaminases, xylan acetyl-esterases, xylanases, xyloglucanases, and xylosidases, or any combinations or mixtures thereof. In some embodiments, a combination of enzymes is used (i.e., a "cocktail") comprising conventional applicable enzymes like protease, lipase, cutinase and/or cellulase in conjunction with amylase is used.
In addition to the metalloprotease polypeptides provided herein, any other suitable protease finds use in the compositions of the present invention. Suitable proteases include those of animal, vegetable or microbial origin. In some embodiments, microbial proteases are used. In some embodiments, chemically or genetically modified mutants are included. In some embodiments, the protease is a serine protease, preferably an alkaline microbial protease or a trypsin-like protease. Examples of alkaline proteases include subtilisins, especially those derived from Bacillus (e.g., subtilisin, lentus, amyloliquefaciens, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168). Additional examples include those mutant proteases described in U.S. Pat. Nos. RE 34,606, 5,955,340, 5,700,676, 6,312,936, and 6,482,628, all of which are incorporated herein by reference. Additional protease examples include, but are not limited to trypsin (e.g., of porcine or bovine origin), and the Fusarium protease described in WO 89/06270. In some embodiments, commercially available protease enzymes that find use in the present invention include, but are not limited to MAXATASE®, MAXACAL™,
MAXAPEM™, OPTICLEAN®, OPTIMASE®, PROPERASE®, PURAFECT®,
PURAFECT® OXP, PURAMAX™, EXCELLASE™, and PURAFAST™ (Genencor);
ALCALASE®, SAVINASE®, PRIMASE®, DURAZYM™, POLARZYME®, OVOZYME®, KANNASE®, LIQUANASE®, NEUTRASE®, RELASE® and ESPERASE® (Novozymes); BLAP™ and BLAP™ variants (Henkel Kommanditgesellschaft auf Aktien, Duesseldorf, Germany), and KAP (B. alkalophilus subtilisin; Kao Corp., Tokyo, Japan). Various proteases are described in W095/23221, WO 92/21760, WO 09/149200, WO 09/149144, WO 09/149145,
WO 11/072099, WO 10/056640, WO 10/056653, WO 11/140364, WO 12/151534, U.S. Pat. Publ. No. 2008/0090747, and U.S. Pat. Nos. 5,801,039, 5,340,735, 5,500,364, 5,855,625, US RE 34,606, 5,955,340, 5,700,676, 6,312,936, and 6,482,628, and various other patents. In some further embodiments, metalloproteases find use in the present invention, including but not limited to the neutral metallopro tease described in WO 07/044993.
In addition, any suitable lipase finds use in the present invention. Suitable lipases include, but are not limited to those of bacterial or fungal origin. Chemically or genetically modified mutants are encompassed by the present invention. Examples of useful lipases include Humicola lanuginosa lipase (See e.g., EP 258 068, and EP 305 216), Rhizomucor miehei lipase (See e.g., EP 238 023), Candida lipase, such as C. antarctica lipase (e.g., the C. antarctica lipase A or B; See e.g., EP 214 761), Pseudomonas lipases such as P. alcaligenes lipase and P.
pseudoalcaligenes lipase (See e.g., EP 218 272), P. cepacia lipase (See e.g., EP 331 376), P. stutzeri lipase (See e.g., GB 1,372,034), P. fluorescens lipase, Bacillus lipase (e.g., B. subtilis lipase [Dartois et al., Biochem. Biophys. Acta 1131:253-260 [1993]); B. stearothermophilus lipase [See e.g., JP 64/744992]; and B. pumilus lipase [See e.g., WO 91/16422]).
Furthermore, a number of cloned lipases find use in some embodiments of the present invention, including but not limited to Penicillium camembertii lipase (See, Yamaguchi et al., Gene 103:61-67 [1991]), Geotricum candidum lipase (See, Schimada et al., J. Biochem., 106:383-388 [1989]), and various Rhizopus lipases such as R. delemar lipase (See, Hass et al., Gene 109: 117-113 [1991]), a R. niveus lipase (Kugimiya et al., Biosci. Biotech. Biochem.
56:716-719 [1992]) and R. oryzae lipase.
Other types of lipase polypeptide enzymes such as cutinases also find use in some embodiments of the present invention, including but not limited to the cutinase derived from Pseudomonas mendocina (See, WO 88/09367), and the cutinase derived from Fusarium solani pisi (See, WO 90/09446).
Additional suitable lipases include commercially available lipases such as Ml
LIPASE™, LUMA FAST™, and LIPOMAX™ (Genencor); LIPEX®, LIPOLASE® and LIPOLASE® ULTRA (Novozymes); and LIPASE P™ "Amano" (Amano Pharmaceutical Co. Ltd., Japan). Various lipases are described in WO2010065455, WO2010107560,
WO2011084412, WO2011084417, WO2011084599, WO2011078949, WO2011150157, WO2012137147, WO2013033318, WO2013096653, and US Patent Application No. 61/713436.
In some embodiments of the present invention, the cleaning compositions of the present invention further comprise lipases at a level from about 0.00001 % to about 10% of additional lipase by weight of the composition and the balance of cleaning adjunct materials by weight of
composition. In some other embodiments of the present invention, the cleaning compositions of the present invention also comprise lipases at a level of about 0.0001 % to about 10%, about 0.001% to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% lipase by weight of the composition.
In some embodiments of the present invention, any suitable amylase finds use in the present invention. In some embodiments, any amylase (e.g., alpha and/or beta) suitable for use in alkaline solutions also find use. Suitable amylases include, but are not limited to those of bacterial or fungal origin. Chemically or genetically modified mutants are included in some embodiments. Amylases that find use in the present invention, include, but are not limited to a- amylases obtained from B. licheniformis (See e.g., GB 1,296,839). Additional suitable amylases include those found in W09510603, W09526397, W09623874, W09623873, W09741213, W09919467, WO0060060, WO0029560, W09923211, W09946399, WO0060058,
WO0060059, W09942567, WO0114532, WO02092797, WO0166712, WO0188107,
WO0196537, WO0210355, WO9402597, WO0231124, W09943793, W09943794,
WO2004113551, WO2005001064, WO2005003311, WO0164852, WO2006063594,
WO2006066594, WO2006066596, WO2006012899, WO2008092919, WO2008000825, WO2005018336, WO2005066338, WO2009140504, WO2005019443, WO2010091221, WO2010088447, WO0134784, WO2006012902, WO2006031554, WO2006136161,
WO2008101894, WO2010059413, WO2011098531, WO2011080352, WO2011080353, WO2011080354, WO2011082425, WO2011082429, WO2011076123, WO2011087836, WO2011076897, W094183314, W09535382, WO9909183, WO9826078, WO9902702, W09743424, W09929876, WO9100353, WO9605295, WO9630481, WO9710342,
WO2008088493, WO2009149419, WO2009061381, WO2009100102, WO2010104675, WO2010117511, and WO2010115021. Commercially available amylases that find use in the present invention include, but are not limited to DURAMYL®, TERM AM YL®,
FUNG AM YL®, STAINZYME®, STAINZYME PLUS®, STAINZYME ULTRA®, and BAN™ (Novozymes), as well as POWERASE™, RAPID ASE® and MAXAMYL® P
(Genencor).
In some embodiments of the present invention, the cleaning compositions of the present invention further comprise amylases at a level from about 0.00001 % to about 10% of additional amylase by weight of the composition and the balance of cleaning adjunct materials by weight of composition. In some other embodiments of the present invention, the cleaning compositions of the present invention also comprise amylases at a level of about 0.0001 % to about 10%,
about 0.001 to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% amylase by weight of the composition.
In some further embodiments, any suitable cellulase finds used in the cleaning compositions of the present invention. Suitable cellulases include, but are not limited to those of bacterial or fungal origin. Chemically or genetically modified mutants are included in some embodiments. Suitable cellulases include, but are not limited to Humicola insolens cellulases (See e.g., U.S. Pat. No. 4,435,307). Especially suitable cellulases are the cellulases having color care benefits (See e.g., EP 0 495 257). Commercially available cellulases that find use in the present include, but are not limited to CELLUZYME®, CAREZYME® (Novozymes), and KAC-500(B)™ (Kao Corporation). In some embodiments, cellulases are incorporated as portions or fragments of mature wild- type or variant cellulases, wherein a portion of the N- terminus is deleted (See e.g., U.S. Pat. No. 5,874,276). Additional suitable cellulases include those found in WO2005054475, WO2005056787, U.S. Pat. No. 7,449,318, and U.S. Pat. No. 7,833,773. In some embodiments, the cleaning compositions of the present invention further comprise cellulases at a level from about 0.00001 % to about 10% of additional cellulase by weight of the composition and the balance of cleaning adjunct materials by weight of composition. In some other embodiments of the present invention, the cleaning compositions of the present invention also comprise cellulases at a level of about 0.0001 % to about 10%, about 0.001% to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% cellulase by weight of the composition.
Any mannanase suitable for use in detergent compositions also finds use in the present invention. Suitable mannanases include, but are not limited to those of bacterial or fungal origin. Chemically or genetically modified mutants are included in some embodiments. Various mannanases are known which find use in the present invention (See e.g., U.S. Pat. No.
6,566,114, U.S. Pat. No.6,602,842, and US Patent No. 6,440,991, all of which are incorporated herein by reference). Commercially available mannanases that find use in the present invention include, but are not limited to MANNASTAR®, PURABRITE™, and MANNAWAY®. In some embodiments, the cleaning compositions of the present invention further comprise mannanases at a level from about 0.00001 % to about 10% of additional mannanase by weight of the composition and the balance of cleaning adjunct materials by weight of composition. In some embodiments of the present invention, the cleaning compositions of the present invention also comprise mannanases at a level of about 0.0001 % to about 10%, about 0.001% to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% mannanase by weight of the composition.
In some embodiments, peroxidases are used in combination with hydrogen peroxide or a source thereof (e.g., a percarbonate, perborate or persulfate) in the compositions of the present invention. In some alternative embodiments, oxidases are used in combination with oxygen. Both types of enzymes are used for "solution bleaching" (i.e., to prevent transfer of a textile dye from a dyed fabric to another fabric when the fabrics are washed together in a wash liquor), preferably together with an enhancing agent (See e.g., WO 94/12621 and WO 95/01426).
Suitable peroxidases/oxidases include, but are not limited to those of plant, bacterial or fungal origin. Chemically or genetically modified mutants are included in some embodiments. In some embodiments, the cleaning compositions of the present invention further comprise peroxidase and/or oxidase enzymes at a level from about 0.00001 % to about 10% of additional peroxidase and/or oxidase by weight of the composition and the balance of cleaning adjunct materials by weight of composition. In some other embodiments of the present invention, the cleaning compositions of the present invention also comprise, peroxidase and/or oxidase enzymes at a level of about 0.0001 % to about 10%, about 0.001% to about 5%, about 0.001% to about 2%, about 0.005% to about 0.5% peroxidase and/or oxidase enzymes by weight of the composition.
In some embodiments, additional enzymes find use, including but not limited to perhydrolases (See e.g., WO 05/056782). In addition, in some embodiments, mixtures of the above mentioned enzymes are encompassed herein, in particular one or more additional protease, amylase, lipase, mannanase, and/or at least one cellulase. Indeed, it is contemplated that various mixtures of these enzymes will find use in the present invention. It is also contemplated that the varying levels of the metalloprotease polypeptide (s) and one or more additional enzymes may both independently range to about 10%, the balance of the cleaning composition being cleaning adjunct materials. The specific selection of cleaning adjunct materials are readily made by considering the surface, item, or fabric to be cleaned, and the desired form of the composition for the cleaning conditions during use (e.g., through the wash detergent use).
Examples of suitable cleaning adjunct materials include, but are not limited to, surfactants, builders, bleaches, bleach activators, bleach catalysts, other enzymes, enzyme stabilizing systems, chelants, optical brighteners, soil release polymers, dye transfer agents, dye transfer inhibiting agents, catalytic materials, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersing agents, clay soil removal agents, structure elasticizing agents, dispersants, suds suppressors, dyes, perfumes, colorants, filler salts, hydrotropes, photoactivators, fluorescers, fabric conditioners, fabric softeners, carriers, hydrotropes, processing aids, solvents, pigments, hydrolyzable surfactants, preservatives, anti- oxidants, anti-
shrinkage agents, anti-wrinkle agents, germicides, fungicides, color speckles, silvercare, anti- tarnish and/or anti-corrosion agents, alkalinity sources, solubilizing agents, carriers, processing aids, pigments, and pH control agents (See e.g., U.S. Pat. Nos. 6,610,642, 6,605,458, 5,705,464, 5,710,115, 5,698,504, 5,695,679, 5,686,014 and 5,646,101, all of which are incorporated herein by reference). Embodiments of specific cleaning composition materials are exemplified in detail below. In embodiments in which the cleaning adjunct materials are not compatible with the metalloprotease polypeptides of the present invention in the cleaning compositions, then suitable methods of keeping the cleaning adjunct materials and the protease(s) separated (i.e., not in contact with each other) until combination of the two components is appropriate are used. Such separation methods include any suitable method known in the art (e.g., gelcaps, encapsulation, tablets, physical separation, etc.).
In some embodiments, an effective amount of one or more metalloprotease polypeptide (s) provided herein is included in compositions useful for cleaning a variety of surfaces in need of proteinaceous stain removal. Such cleaning compositions include cleaning compositions for such applications as cleaning hard surfaces, fabrics, and dishes. Indeed, in some embodiments, the present invention provides fabric cleaning compositions, while in other embodiments, the present invention provides non-fabric cleaning compositions. Notably, the present invention also provides cleaning compositions suitable for personal care, including oral care (including dentrifices, toothpastes, mouthwashes, etc., as well as denture cleaning compositions), skin, and hair cleaning compositions. It is intended that the present invention encompass detergent compositions in any form (i.e., liquid, granular, bar, semi-solid, gels, emulsions, tablets, capsules, etc.).
By way of example, several cleaning compositions wherein the metalloprotease polypeptides of the present invention find use are described in greater detail below. In some embodiments in which the cleaning compositions of the present invention are formulated as compositions suitable for use in laundry machine washing method(s), the compositions of the present invention preferably contain at least one surfactant and at least one builder compound, as well as one or more cleaning adjunct materials preferably selected from organic polymeric compounds, bleaching agents, additional enzymes, suds suppressors, dispersants, lime-soap dispersants, soil suspension and anti-redeposition agents and corrosion inhibitors. In some embodiments, laundry compositions also contain softening agents (i.e., as additional cleaning adjunct materials). The compositions of the present invention also find use in detergent additive products in solid or liquid form. Such additive products are intended to supplement and/or boost the performance of conventional detergent compositions and can be added at any stage of the
cleaning process. In some embodiments, the density of the laundry detergent compositions herein ranges from about 400 to about 1200 g/liter, while in other embodiments, it ranges from about 500 to about 950 g/liter of composition measured at 20°C.
In embodiments formulated as compositions for use in manual dishwashing methods, the compositions of the invention preferably contain at least one surfactant and preferably at least one additional cleaning adjunct material selected from organic polymeric compounds, suds enhancing agents, group II metal ions, solvents, hydrotropes and additional enzymes.
In some embodiments, various cleaning compositions such as those provided in U.S, Pat. No. 6,605,458, find use with the metalloprotease polypeptides of the present invention. Thus, in some embodiments, the compositions comprising at least one metalloprotease polypeptide of the present invention is a compact granular fabric cleaning composition, while in other embodiments, the composition is a granular fabric cleaning composition useful in the laundering of colored fabrics, in further embodiments, the composition is a granular fabric cleaning composition which provides softening through the wash capacity, in additional embodiments, the composition is a heavy duty liquid fabric cleaning composition. In some embodiments, the compositions comprising at least one metalloprotease polypeptide of the present invention are fabric cleaning compositions such as those described in U.S. Pat. Nos. 6,610,642 and 6,376,450. In addition, the metalloprotease polypeptides of the present invention find use in granular laundry detergent compositions of particular utility under European or Japanese washing conditions (See e.g., U.S. Pat. No. 6,610,642).
In some alternative embodiments, the present invention provides hard surface cleaning compositions comprising at least one metalloprotease polypeptide provided herein. Thus, in some embodiments, the compositions comprising at least one metalloprotease polypeptide of the present invention is a hard surface cleaning composition such as those described in U.S. Pat. Nos. 6,610,642, 6,376,450, and 6,376,450.
In yet further embodiments, the present invention provides dishwashing compositions comprising at least one metalloprotease polypeptide provided herein. Thus, in some
embodiments, the compositions comprising at least one metalloprotease polypeptide of the present invention is a hard surface cleaning composition such as those in U.S. Pat. Nos.
6,610,642 and 6,376,450. In some still further embodiments, the present invention provides dishwashing compositions comprising at least one metalloprotease polypeptide provided herein. In some further embodiments, the compositions comprising at least one metalloprotease polypeptide of the present invention comprise oral care compositions such as those in U.S. Pat. No. 6,376,450, and 6,376,450. The formulations and descriptions of the compounds and
cleaning adjunct materials contained in the aforementioned US Pat. Nos. 6,376,450, 6,605,458, 6,605,458, and 6,610,642, find use with the metalloprotease polypeptides provided herein.
The cleaning compositions of the present invention are formulated into any suitable form and prepared by any process chosen by the formulator, non-limiting examples of which are described in U.S. Pat. Nos. 5,879,584, 5,691,297, 5,574,005, 5,569,645, 5,565,422, 5,516,448, 5,489,392, and 5,486,303, all of which are incorporated herein by reference. When a low pH cleaning composition is desired, the pH of such composition is adjusted via the addition of a material such as monoethanolamine or an acidic material such as HC1.
In some embodiments, the cleaning compositions of the present invention can be formulated to have an alkaline pH under wash conditions, such as a pH of from about 8.0 to about 12.0, or from about 8.5 to about 11.0, or from about 9.0 to about 11.0. In some
embodiments, the cleaning compositions of the present invention can be formulated to have a neutral pH under wash conditions, such as a pH of from about 5.0 to about 8.0, or from about 5.5 to about 8.0, or from about 6.0 to about 8.0, or from about 6.0 to about 7.5. In some embodiments, the neutral pH conditions can be measured when the cleaning composition is dissolved 1: 100 (wt:wt) in de-ionised water at 20°C, measured using a conventional pH meter.
While not essential for the purposes of the present invention, the non-limiting list of adjuncts illustrated hereinafter are suitable for use in the instant cleaning compositions. In some embodiments, these adjuncts are incorporated for example, to assist or enhance cleaning performance, for treatment of the substrate to be cleaned, or to modify the aesthetics of the cleaning composition as is the case with perfumes, colorants, dyes or the like. It is understood that such adjuncts are in addition to the metalloprotease polypeptides of the present invention. The precise nature of these additional components, and levels of incorporation thereof, will depend on the physical form of the composition and the nature of the cleaning operation for which it is to be used. Suitable adjunct materials include, but are not limited to, surfactants, builders, chelating agents, dye transfer inhibiting agents, deposition aids, dispersants, additional enzymes, and enzyme stabilizers, catalytic materials, bleach activators, bleach boosters, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersing agents, clay soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, perfumes, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids and/or pigments. In addition to the disclosure below, suitable examples of such other adjuncts and levels of use are found in U.S. Patent Nos. 5,576,282, 6,306,812, and 6,326,348, incorporated by reference. The aforementioned adjunct ingredients may constitute the balance of the cleaning compositions of the present invention.
In some embodiments, the cleaning compositions according to the present invention comprise an acidifying particle or an amino carboxylic builder. Examples of an amino carboxylic builder include aminocarboxylic acids, salts and derivatives thereof. In some embodiment, the amino carboxylic builder is an aminopolycarboxylic builder, such as glycine- Ν,Ν-diacetic acid or derivative of general formula MOOC-CHR-N (CH2COOM)2 where R is Ci_ 12 alkyl and M is alkali metal. In some embodiments, the amino carboxylic builder can be methyl glycine diacetic acid (MGDA), GLDA (glutamic-N,N-diacetic acid), iminodisuccinic acid (IDS), carboxymethyl inulin and salts and derivatives thereof, aspartic acid-N-monoacetic acid (ASMA), aspartic acid-N,N-diacetic acid (ASDA), aspartic acid-N-monopropionic acid (ASMP), iminodisuccinic acid (IDA), N-(2-sulfomethyl) aspartic acid (SMAS), N-(2- sulfoethyl)aspartic acid (SEAS), N-(2-sulfomethyl)glutamic acid (SMGL), N-(2-sulfoethyl) glutamic acid (SEGL), IDS (iminodiacetic acid) and salts and derivatives thereof such as N- methyliminodiacetic acid (MID A) , alpha-alanine-N,N-diacetic acid (alpha-ALDA) , serine- Ν,Ν-diacetic acid (SEDA), isoserine-N,Ndiacetic acid (ISDA) , phenylalanine-N,N-diacetic acid (PHDA), anthranilic acid-N,N-diacetic acid (AND A), sulfanilic acid-N,N-diacetic acid (SLDA), taurine-N,N-diacetic acid (TUDA) and sulfomethyl-N,N-diacetic acid (SMDA) and alkali metal salts and derivative thereof. In some embodiments, the acidifying particle has a weight geometric mean particle size of from about 400 μ to about 1200 μ and a bulk density of at least 550 g/L. In some embodiments, the acidifying particle comprises at least about 5% of the builder.
In some embodiments, the acidifying particle can comprise any acid, including organic acids and mineral acids. Organic acids can have one or two carboxyls and in some instances up to 15 carbons, especially up to 10 carbons, such as formic, acetic, propionic, capric, oxalic, succinic, adipic, maleic, fumaric, sebacic, malic, lactic, glycolic, tartaric and glyoxylic acids. In some embodiments, the acid is citric acid. Mineral acids include hydrochloric and sulphuric acid. In some instances, the acidifying particle of the invention is a highly active particle comprising a high level of amino carboxylic builder. Sulphuric acid has been found to further contribute to the stability of the final particle.
In some embodiments, the cleaning compositions according to the present invention comprise at least one surfactant and/or a surfactant system wherein the surfactant is selected from nonionic surfactants, anionic surfactants, cationic surfactants, ampholytic surfactants, zwitterionic surfactants, semi-polar nonionic surfactants and mixtures thereof. In some low pH cleaning composition embodiments (e.g., compositions having a neat pH of from about 3 to about 5), the composition typically does not contain alkyl ethoxylated sulfate, as it is believed
that such surfactant may be hydrolyzed by such compositions the acidic contents. In some embodiments, the surfactant is present at a level of from about 0.1% to about 60%, while in alternative embodiments the level is from about 1% to about 50%, while in still further embodiments the level is from about 5% to about 40%, by weight of the cleaning composition.
In some embodiments, the cleaning compositions of the present invention comprise one or more detergent builders or builder systems. In some embodiments incorporating at least one builder, the cleaning compositions comprise at least about 1%, from about 3% to about 60% or even from about 5% to about 40% builder by weight of the cleaning composition. Builders include, but are not limited to, the alkali metal, ammonium and alkanolammonium salts of polyphosphates, alkali metal silicates, alkaline earth and alkali metal carbonates,
aluminosilicates, polycarboxylate compounds, ether hydroxypolycarboxylates, copolymers of maleic anhydride with ethylene or vinyl methyl ether, 1, 3, 5-trihydroxy benzene-2, 4, 6- trisulphonic acid, and carboxymethyloxysuccinic acid, the various alkali metal, ammonium and substituted ammonium salts of polyacetic acids such as ethylenediamine tetraacetic acid and nitrilotriacetic acid, as well as polycarboxylates such as mellitic acid, succinic acid, citric acid, oxydisuccinic acid, polymaleic acid, benzene 1,3,5-tricarboxylic acid,
carboxymethyloxysuccinic acid, and soluble salts thereof. Indeed, it is contemplated that any suitable builder will find use in various embodiments of the present invention.
In some embodiments, the builders form water-soluble hardness ion complexes (e.g., sequestering builders), such as citrates and polyphosphates (e.g., sodium tripolyphosphate and sodium tripolyphospate hexahydrate, potassium tripolyphosphate, and mixed sodium and potassium tripolyphosphate, etc.). It is contemplated that any suitable builder will find use in the present invention, including those known in the art (See e.g., EP 2 100 949).
In some embodiments, builders for use herein include phosphate builders and non- phosphate builders. In some embodiments, the builder is a phosphate builder. In some embodiments, the builder is a non-phosphate builder. If present, builders are used in a level of from 0.1% to 80%, or from 5 to 60%, or from 10 to 50% by weight of the composition. In some embodiments the product comprises a mixture of phosphate and non-phosphate builders.
Suitable phosphate builders include mono-phosphates, di-phosphates, tri-polyphosphates or oligomeric-poylphosphates, including the alkali metal salts of these compounds, including the sodium salts. In some embodiments, a builder can be sodium tripolyphosphate (STPP).
Additionally, the composition can comprise carbonate and/or citrate, preferably citrate that helps to achieve a neutral pH composition of the invention. Other suitable non-phosphate builders include homopolymers and copolymers of polycarboxylic acids and their partially or completely
neutralized salts, monomeric polycarboxylic acids and hydroxycarboxylic acids and their salts. In some embodiments, salts of the above mentioned compounds include the ammonium and/or alkali metal salts, i.e. the lithium, sodium, and potassium salts, including sodium salts. Suitable polycarboxylic acids include acyclic, alicyclic, hetero-cyclic and aromatic carboxylic acids, wherein in some embodiments, they can contain at least two carboxyl groups which are in each case separated from one another by, in some instances, no more than two carbon atoms.
In some embodiments, the cleaning compositions of the present invention contain at least one chelating agent. Suitable chelating agents include, but are not limited to copper, iron and/or manganese chelating agents and mixtures thereof. In embodiments in which at least one chelating agent is used, the cleaning compositions of the present invention comprise from about 0.1% to about 15% or even from about 3.0% to about 10% chelating agent by weight of the subject cleaning composition.
In some still further embodiments, the cleaning compositions provided herein contain at least one deposition aid. Suitable deposition aids include, but are not limited to, polyethylene glycol, polypropylene glycol, polycarboxylate, soil release polymers such as polytelephthalic acid, clays such as kaolinite, montmorillonite, atapulgite, illite, bentonite, halloysite, and mixtures thereof.
As indicated herein, in some embodiments, anti-redeposition agents find use in some embodiments of the present invention. In some embodiments, non-ionic surfactants find use. For example, in automatic dishwashing embodiments, non-ionic surfactants find use for surface modification purposes, in particular for sheeting, to avoid filming and spotting and to improve shine. These non-ionic surfactants also find use in preventing the re-deposition of soils. In some embodiments, the anti-redeposition agent is a non-ionic surfactant as known in the art (See e.g., EP 2 100 949). In some embodiments, the non-ionic surfactant can be ethoxylated nonionic surfactants, epoxy-capped poly(oxyalkylated) alcohols and amine oxides surfactants.
In some embodiments, the cleaning compositions of the present invention include one or more dye transfer inhibiting agents. Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof. In embodiments in which at least one dye transfer inhibiting agent is used, the cleaning compositions of the present invention comprise from about 0.0001% to about 10%, from about 0.01% to about 5%, or even from about 0.1% to about 3% by weight of the cleaning composition.
In some embodiments, silicates are included within the compositions of the present invention. In some such embodiments, sodium silicates (e.g., sodium disilicate, sodium metasilicate, and crystalline phyllosilicates) find use. In some embodiments, silicates are present at a level of from about 1% to about 20%. In some embodiments, silicates are present at a level of from about 5% to about 15% by weight of the composition.
In some still additional embodiments, the cleaning compositions of the present invention also contain dispersants. Suitable water-soluble organic materials include, but are not limited to the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms.
In some further embodiments, the enzymes used in the cleaning compositions are stabilized by any suitable technique. In some embodiments, the enzymes employed herein are stabilized by the presence of water-soluble sources of calcium and/or magnesium ions in the finished compositions that provide such ions to the enzymes. In some embodiments, the enzyme stabilizers include oligosaccharides, polysaccharides, and inorganic divalent metal salts, including alkaline earth metals, such as calcium salts, such as calcium formate. It is
contemplated that various techniques for enzyme stabilization will find use in the present invention. For example, in some embodiments, the enzymes employed herein are stabilized by the presence of water-soluble sources of zinc (II), calcium (II) and/or magnesium (II) ions in the finished compositions that provide such ions to the enzymes, as well as other metal ions (e.g., barium (II), scandium (II), iron (II), manganese (II), aluminum (III), Tin (II), cobalt (II), copper (II), nickel (II), and oxovanadium (IV). Chlorides and sulfates also find use in some
embodiments of the present invention. Examples of suitable oligosaccharides and
polysaccharides (e.g., dextrins) are known in the art (See e.g., WO 07/145964). In some embodiments, reversible protease inhibitors also find use, such as boron-containing compounds (e.g., borate, 4-formyl phenyl boronic acid) and/or a tripeptide aldehyde find use to further improve stability, as desired.
In some embodiments, bleaches, bleach activators and/or bleach catalysts are present in the compositions of the present invention. In some embodiments, the cleaning compositions of the present invention comprise inorganic and/or organic bleaching compound(s). Inorganic bleaches include, but are not limited to perhydrate salts (e.g., perborate, percarbonate, perphosphate, persulfate, and persilicate salts). In some embodiments, inorganic perhydrate salts are alkali metal salts. In some embodiments, inorganic perhydrate salts are included as the crystalline solid, without additional protection, although in some other embodiments, the salt is
coated. Any suitable salt known in the art finds use in the present invention (See e.g., EP 2 100 949).
In some embodiments, bleach activators are used in the compositions of the present invention. Bleach activators are typically organic peracid precursors that enhance the bleaching action in the course of cleaning at temperatures of 60°C and below. Bleach activators suitable for use herein include compounds which, under perhydrolysis conditions, give aliphatic peroxoycarboxylic acids having preferably from about 1 to about 10 carbon atoms, in particular from about 2 to about 4 carbon atoms, and/or optionally substituted perbenzoic acid. Additional bleach activators are known in the art and find use in the present invention (See e.g., EP 2 100 949).
In addition, in some embodiments and as further described herein, the cleaning compositions of the present invention further comprise at least one bleach catalyst. In some embodiments, the manganese triazacyclononane and related complexes find use, as well as cobalt, copper, manganese, and iron complexes. Additional bleach catalysts find use in the present invention (See e.g., US 4,246,612, 5,227,084, 4,810410, WO 99/06521, and EP 2 100 949).
In some embodiments, the cleaning compositions of the present invention contain one or more catalytic metal complexes. In some embodiments, a metal-containing bleach catalyst finds use. In some embodiments, the metal bleach catalyst comprises a catalyst system comprising a transition metal cation of defined bleach catalytic activity, (e.g., copper, iron, titanium, ruthenium, tungsten, molybdenum, or manganese cations), an auxiliary metal cation having little or no bleach catalytic activity (e.g., zinc or aluminum cations), and a sequestrate having defined stability constants for the catalytic and auxiliary metal cations, particularly
ethylenediaminetetraacetic acid, ethylenediaminetetra (methylenephosphonic acid) and water- soluble salts thereof are used (See e.g., US Patent No. 4,430,243). In some embodiments, the cleaning compositions of the present invention are catalyzed by means of a manganese compound. Such compounds and levels of use are well known in the art (See e.g., US Patent No. 5,576,282). In additional embodiments, cobalt bleach catalysts find use in the cleaning compositions of the present invention. Various cobalt bleach catalysts are known in the art (See e.g., US Patent Nos. 5,597,936 and 5,595,967) and are readily prepared by known procedures.
In some additional embodiments, the cleaning compositions of the present invention include a transition metal complex of a macropolycyclic rigid ligand (MRL). As a practical matter, and not by way of limitation, in some embodiments, the compositions and cleaning processes provided by the present invention are adjusted to provide on the order of at least one
part per hundred million of the active MRL species in the aqueous washing medium, and in some embodiments, provide from about 0.005 ppm to about 25 ppm, more preferably from about 0.05 ppm to about 10 ppm, and most preferably from about 0.1 ppm to about 5 ppm, of the MRL in the wash liquor.
In some embodiments, transition-metals in the instant transition-metal bleach catalyst include, but are not limited to manganese, iron and chromium. MRLs also include, but are not limited to special ultra-rigid ligands that are cross-bridged (e.g., 5,12-diethyl-l,5,8, 12- tetraazabicyclo[6.6.2]hexadecane). Suitable transition metal MRLs are readily prepared by known procedures (See e.g., WO 2000/32601, and US Patent No. 6,225,464).
In some embodiments, the cleaning compositions of the present invention comprise metal care agents. Metal care agents find use in preventing and/or reducing the tarnishing, corrosion, and/or oxidation of metals, including aluminum, stainless steel, and non-ferrous metals (e.g., silver and copper). Suitable metal care agents include those described in EP 2 100 949, WO 9426860 and WO 94/26859). In some embodiments, the metal care agent is a zinc salt. In some further embodiments, the cleaning compositions of the present invention comprise from about 0.1% to about 5% by weight of one or more metal care agent.
In some embodiments, the cleaning composition is a high density liquid (HDL) composition having a variant metalloprotease polypeptide protease. The HDL liquid laundry detergent can comprise a detersive surfactant (10%-40%) comprising anionic detersive surfactant (selected from a group of linear or branched or random chain, substituted or unsubstituted alkyl sulphates, alkyl sulphonates, alkyl alkoxylated sulphate, alkyl phosphates, alkyl phosphonates, alkyl carboxylates, and/or mixtures thereof); and optionally non-ionic surfactant (selected from a group of linear or branched or random chain, substituted or unsubstituted alkyl alkoxylated alcohol, for example a C8-C18 alkyl ethoxylated alcohol and/or C6-C12 alkyl phenol alkoxylates), optionally wherein the weight ratio of anionic detersive surfactant (with a hydrophilic index (HIc) of from 6.0 to 9) to non-ionic detersive surfactant is greater than 1 : 1.
The composition can comprise optionally, a surfactancy boosting polymer consisting of amphiphilic alkoxylated grease cleaning polymers (selected from a group of alkoxylated polymers having branched hydrophilic and hydrophobic properties, such as alkoxylated polyalkylenimines in the range of 0.05wt%- 10wt%) and/or random graft polymers (typically comprising of hydrophilic backbone comprising monomers selected from the group consisting of: unsaturated C -C carboxylic acids, ethers, alcohols, aldehydes, ketones, esters, sugar units, alkoxy units, maleic anhydride, saturated polyalcohols such as glycerol, and mixtures thereof;
and hydrophobic side chain(s) selected from the group consisting of: C4-C25 alkyl group, polypropylene, polybutylene, vinyl ester of a saturated C-C6 mono-carboxylic acid, C -C alkyl ester of acrylic or methacrylic acid, and mixtures thereof.
The composition can comprise additional polymers such as soil release polymers (include anionically end-capped polyesters, for example SRPl, polymers comprising at least one monomer unit selected from saccharide, dicarboxylic acid, polyol and combinations thereof, in random or block configuration, ethylene terephthalate-based polymers and co-polymers thereof in random or block configuration, for example Repel-o-tex SF, SF-2 and SRP6, Texcare SRA100, SRA300, SRN100, SRN170, SRN240, SRN300 and SRN325, Marloquest SL), anti- redeposition polymers (0.1 wt to 10wt , include carboxylate polymers, such as polymers comprising at least one monomer selected from acrylic acid, maleic acid (or maleic anhydride), fumaric acid, itaconic acid, aconitic acid, mesaconic acid, citraconic acid, methylenemalonic acid, and any mixture thereof, vinylpyrrolidone homopolymer, and/or polyethylene glycol, molecular weight in the range of from 500 to 100,000 Da); cellulosic polymer (including those selected from alkyl cellulose, alkyl alkoxyalkyl cellulose, carboxyalkyl cellulose, alkyl carboxyalkyl cellulose examples of which include carboxymethyl cellulose, methyl cellulose, methyl hydroxyethyl cellulose, methyl carboxymethyl cellulose, and mixures thereof) and polymeric carboxylate (such as maleate/acrylate random copolymer or polyacrylate
homopolymer).
The composition can further comprise saturated or unsaturated fatty acid, preferably saturated or unsaturated C12-C24 fatty acid (0 wt to 10 wt ); deposition aids (examples for which include polysaccharides, preferably cellulosic polymers, poly diallyl dimethyl ammonium halides (DADMAC), and co-polymers of DAD MAC with vinyl pyrrolidone, acrylamides, imidazoles, imidazolinium halides, and mixtures thereof, in random or block configuration, cationic guar gum, cationic cellulose such as cationic hydoxyethyl cellulose, cationic starch, cationic polyacylamides, and mixtures thereof.
The composition can further comprise dye transfer inhibiting agents examples of which include manganese phthalocyanine, peroxidases, polyvinylpyrrolidone polymers, polyamine N- oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole,
polyvinyloxazolidones and polyvinylimidazoles and/or mixtures thereof; chelating agents examples of which include ethylene-diamine-tetraacetic acid (EDTA); diethylene triamine penta methylene phosphonic acid (DTPMP); hydroxy-ethane diphosphonic acid (HEDP);
ethylenediamine Ν,Ν'-disuccinic acid (EDDS); methyl glycine diacetic acid (MGDA);
diethylene triamine penta acetic acid (DTPA); propylene diamine tetracetic acid (PDT A); 2- hydroxypyridine-N-oxide (HPNO); or methyl glycine diacetic acid (MGDA); glutamic acid Ν,Ν-diacetic acid (N,N-dicarboxymethyl glutamic acid tetrasodium salt (GLDA); nitrilotriacetic acid (NTA); 4,5-dihydroxy-m-benzenedisulfonic acid; citric acid and any salts thereof; N- hydroxyethylethylenediaminetri-acetic acid (HEDTA), triethylenetetraaminehexaacetic acid (TTHA), N-hydroxyethyliminodiacetic acid (HEIDA), dihydroxyethylglycine (DHEG), ethylenediaminetetrapropionic acid (EDTP) and derivatives thereof.
The composition can further comprise enzymes (0.01 wt active enzyme to 0.03wt active enzyme) selected from a group of acyl transferases, alpha-amylases, beta-amylases, alpha-galactosidases, arabinosidases, aryl esterases, beta-galactosidases, carrageenases, catalases, cellobiohydrolases, cellulases, chondroitinases, cutinases, endo-beta-1, 4-glucanases, endo-beta-mannanases, esterases, exo-mannanases, galactanases, glucoamylases, hemicellulases, hyaluronidases, keratinases, laccases, lactases, ligninases, lipases, lipoxygenases, mannanases, oxidases, pectate lyases, pectin acetyl esterases, pectinases, pentosanases, peroxidases, phenoloxidases, phosphatases, phospholipases, phytases, polygalacturonases, proteases, pullulanases, reductases, rhamnogalacturonases, beta-glucanases, tannases, transglutaminases, xylan acetyl-esterases, xylanases, xyloglucanases, and xylosidases, and any mixture thereof. The composition may comprise an enzyme stabilizer (examples of which include polyols such as propylene glycol or glycerol, sugar or sugar alcohol, lactic acid, reversible protease inhibitor, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid).
The composition can further comprise silicone or fatty- acid based suds suppressors; heuing dyes, calcium and magnesium cations, visual signaling ingredients, anti-foam (0.001 wt to about 4.0wt ), and/or structurant/thickener (0.01 wt to 5wt , selected from the group consisting of diglycerides and triglycerides, ethylene glycol distearate, microcrystalline cellulose, cellulose based materials, microfiber cellulose, biopolymers, xanthan gum, gellan gum, and mixtures thereof).
Suitable detersive surfactants also include cationic detersive surfactants (selected from a group of alkyl pyridinium compounds, alkyl quarternary ammonium compounds, alkyl quarternary phosphonium compounds, alkyl ternary sulphonium compounds, and/or mixtures thereof); zwitterionic and/or amphoteric detersive surfactants (selected from a group of alkanolamine sulpho-betaines); ampholytic surfactants; semi-polar non-ionic surfactants and mixtures thereof.
The composition can be any liquid form, for example a liquid or gel form, or any combination thereof. The composition may be in any unit dose form, for example a pouch.
In some embodiments, the cleaning composition is a high density powder (HDD) composition having a variant metalloprotease polypeptide protease. The HDD powder laundry detergent can comprise a detersive surfactant including anionic detersive surfactants (selected from a group of linear or branched or random chain, substituted or unsubstituted alkyl sulphates, alkyl sulphonates, alkyl alkoxylated sulphate, alkyl phosphates, alkyl phosphonates, alkyl carboxylates and/or mixtures thereof), non-ionic detersive surfactant (selected from a group of linear or branched or random chain, substituted or unsubstituted Cg-Cig alkyl ethoxylates, and/or C6-C12 alkyl phenol alkoxylates), cationic detersive surfactants (selected from a group of alkyl pyridinium compounds, alkyl quaternary ammonium compounds, alkyl quaternary phosphonium compounds, alkyl ternary sulphonium compounds, and mixtures thereof), zwitterionic and/or amphoteric detersive surfactants (selected from a group of alkanolamine sulpho-betaines);
ampholytic surfactants; semi-polar non-ionic surfactants and mixtures thereof; builders
(phosphate free builders [for example zeolite builders examples of which include zeolite A, zeolite X, zeolite P and zeolite MAP in the range of 0wt to less than 10wt ] ; phosphate builders [examples of which include sodium tri-polyphosphate in the range of 0wt to less than 10wt ] ; citric acid, citrate salts and nitrilotriacetic acid or salt thereof in the range of less than 15 wt ); silicate salt (sodium or potassium silicate or sodium meta-silicate in the range of 0wt to less than 10wt , or layered silicate (SKS-6)); carbonate salt (sodium carbonate and/or sodium bicarbonate in the range of 0 wt to less than 10 wt ); and bleaching agents
(photobleaches, examples of which include sulfonated zinc phthalocyanines, sulfonated aluminum phthalocyanines, xanthenes dyes, and mixtures thereof; hydrophobic or hydrophilic bleach activators (examples of which include dodecanoyl oxybenzene sulfonate, decanoyl oxybenzene sulfonate, decanoyl oxybenzoic acid or salts thereof, 3,5,5-trimethy hexanoyl oxybenzene sulfonate, tetraacetyl ethylene diamine-TAED, and nonanoyloxybenzene sulfonate- NOBS, nitrile quats, and mixtures thereof; hydrogen peroxide; sources of hydrogen peroxide (inorganic perhydrate salts examples of which include mono or tetra hydrate sodium salt of perborate, percarbonate, persulfate, perphosphate, or persilicate); preformed hydrophilic and/or hydrophobic peracids (selected from a group consisting of percarboxylic acids and salts, percarbonic acids and salts, perimidic acids and salts, peroxymono sulfuric acids and salts) & mixtures thereof and/or bleach catalyst (such as imine bleach boosters examples of which include iminium cations and polyions; iminium zwitterions; modified amines; modified amine oxides; N-sulphonyl imines; N-phosphonyl imines; N-acyl imines; thiadiazole dioxides;
perfluoroimines; cyclic sugar ketones and mixtures thereof; metal-containing bleach catalyst for example copper, iron, titanium, ruthenium, tungsten, molybdenum, or manganese cations along with an auxiliary metal cations such as zinc or aluminum and a sequestrate such as
ethylenediaminetetraacetic acid, ethylenediaminetetra(methylenephos-iphonic acid) and water- soluble salts thereof ).
The composition can further comprise enzymes selected from a group of acyl
transferases, alpha- amylases, beta- amylases, alpha-galactosidases, arabinosidases, aryl esterases, beta-galactosidases, carrageenases, catalases, cellobiohydrolases, cellulases, chondroitinases, cutinases, endo-beta-1, 4-glucanases, endo-beta-mannanases, esterases, exo-mannanases, galactanases, glucoamylases, glucose oxidases, hemicellulases, hyaluronidases, keratinases, laccases, lactases, ligninases, lipases, lipoxygenases, mannanases, oxidases, pectate lyases, pectin acetyl esterases, pectinases, pentosanases, perhydrolases, peroxidases, phenoloxidases, phosphatases, phospholipases, phytases, polygalacturonases, proteases, pullulanases, reductases, rhamnogalacturonases, beta-glucanases, tannases, transglutaminases, xylan acetyl-esterases, xylanases, xyloglucanases, and xylosidases and any mixture thereof.
The composition can further comprise additional detergent ingredients including perfume microcapsules, starch encapsulated perfume accord, hueing agents, additional polymers including fabric integrity and cationic polymers, dye lock ingredients, fabric-softening agents, brighteners (for example C.I. Fluorescent brighteners), flocculating agents, chelating agents, alkoxylated polyamines, fabric deposition aids, and/or cyclodextrin.
In some embodiments, the cleaning composition is an automatic dishwashing (ADW) detergent composition having a metalloprotease of the present invention. The ADW detergent composition can comprise two or more non-ionic surfactants selected from a group of ethoxylated non-ionic surfactants, alcohol alkoxylated surfactants, epoxy-capped
poly(oxyalkylated) alcohols, or amine oxide surfactants present in amounts from 0 to 10% by weight; builders in the range of 5-60% comprising either phosphate (mono-phosphates, diphosphates, tri-polyphosphates or oligomeric-poylphosphates, preferred sodium
tripolyphosphate-STPP or phosphate-free builders [amino acid based compounds, examples of which include MGDA (methyl-glycine-diacetic acid), and salts and derivatives thereof, GLDA (glutamic-N,Ndiacetic acid) and salts and derivatives thereof, IDS (iminodisuccinic acid) and salts and derivatives thereof, carboxy methyl inulin and salts and derivatives thereof and mixtures thereof, nitrilotriacetic acid (NTA), diethylene triamine penta acetic acid (DTPA), B- alaninediacetic acid (B-ADA) and their salts], homopolymers and copolymers of poly- carboxylic acids and their partially or completely neutralized salts, monomeric polycarboxylic
acids and hydroxycarboxylic acids and their salts in the range of 0.5% to 50% by weight;
sulfonated/carboxylated polymers (provide dimensional stability to the product) in the range of about 0.1 % to about 50% by weight; drying aids in the range of about 0.1 % to about 10% by weight (selected from polyesters, especially anionic polyesters optionally together with further monomers with 3 to 6 functionalities which are conducive to polycondensation, specifically acid, alcohol or ester functionalities, polycarbonate-, polyurethane- and/or polyurea- polyorganosiloxane compounds or precursor compounds thereof of the reactive cyclic carbonate and urea type); silicates in the range from about 1 % to about 20% by weight (sodium or potassium silicates for example sodium disilicate, sodium meta-silicate and crystalline phyllosilicates); bleach-inorganic (for example perhydrate salts such as perborate, percarbonate, perphosphate, persulfate and persilicate salts) and organic (for example organic peroxyacids including diacyl and tetraacylperoxides, especially diperoxydodecanedioc acid,
diperoxytetradecanedioc acid, and diperoxyhexadecanedioc acid); bleach activators- organic peracid precursors in the range from about 0.1 % to about 10% by weight; bleach catalysts (selected from manganese triazacyclononane and related complexes, Co, Cu, Mn and Fe bispyridylamine and related complexes, and pentamine acetate cobalt(III) and related
complexes); metal care agents in the range from about 0.1% to 5% by weight (selected from benzatriazoles, metal salts and complexes, and/or silicates); enzymes in the range from about 0.01 to 5.0mg of active enzyme per gram of automatic dishwashing detergent composition (acyl transferases, alpha- amylases, beta- amylases, alpha-galactosidases, arabinosidases, aryl esterases, beta-galactosidases, carrageenases, catalases, cellobiohydrolases, cellulases, chondroitinases, cutinases, endo-beta-1, 4-glucanases, endo-beta-mannanases, esterases, exo-mannanases, galactanases, glucoamylases, hemicellulases, hyaluronidases, keratinases, laccases, lactases, ligninases, lipases, lipoxygenases, mannanases, oxidases, pectate lyases, pectin acetyl esterases, pectinases, pentosanases, peroxidases, phenoloxidases, phosphatases, phospholipases, phytases, polygalacturonases, proteases, pullulanases, reductases, rhamnogalacturonases, beta-glucanases, tannases, transglutaminases, xylan acetyl-esterases, xylanases, xyloglucanases, and xylosidases, and any mixture thereof); and enzyme stabilizer components (selected from oligosaccharides, polysaccharides and inorganic divalent metal salts).
Representative detergent formulations that beneficially include a metalloprotease polypeptide of the present invention include the detergent formulations found in
WO2013063460, pages 78-152, and in particular the tables of pages 94 to 152 are hereby incorporated by reference. The metalloproteases are normally incorporated into the detergent composition at a level of from 0.000001 % to 5% of enzyme protein by weight of the
composition, or from 0.00001 % to 2 %, or from 0.0001% to 1%, or from 0.001 % to 0.75% of enzyme protein by weight of the composition.
Metalloprotease polypeptides of the present invention for use in Animal Feed
In a further aspect of the invention, the metalloprotease polypeptides of the present invention can be used as a compontent of an animal feed composition, animal feed additive and/or pet food comprising a metalloprotease and variants thereof. The present invention further relates to a method for preparing such an animal feed composition, animal feed additive composition and/or pet food comprising mixing the metalloprotease polypeptide with one or more animal feed ingredients and/or animal feed additive ingredients and/or pet food
ingredients. Furthermore, the present invention relates to the use of the metalloprotease polypeptide in the preparation of an animal feed composition and/or animal feed additive composition and/or pet food.
The term "animal" includes all non-ruminant and ruminant animals. In a particular embodiment, the animal is a non-ruminant animal, such as a horse and a mono-gastric animal. Examples of mono-gastric animals include, but are not limited to, pigs and swine, such as piglets, growing pigs, sows; poultry such as turkeys, ducks, chicken, broiler chicks, layers; fish such as salmon, trout, tilapia, catfish and carps; and crustaceans such as shrimps and prawns. In a further embodiment the animal is a ruminant animal including, but not limited to, cattle, young calves, goats, sheep, giraffes, bison, moose, elk, yaks, water buffalo, deer, camels, alpacas, llamas, antelope, pronghorn and nilgai.
In the present context, it is intended that the term "pet food" is understood to mean a food for a household animal such as, but not limited to, dogs, cats, gerbils, hamsters, chinchillas, fancy rats, guinea pigs; avian pets, such as canaries, parakeets, and parrots; reptile pets, such as turtles, lizards and snakes; and aquatic pets, such as tropical fish and frogs.
The terms "animal feed composition," "feedstuff and "fodder" are used interchangeably and can comprise one or more feed materials selected from the group comprising a) cereals, such as small grains (e.g. , wheat, barley, rye, oats and combinations thereof) and/or large grains such as maize or sorghum; b) by products from cereals, such as corn gluten meal, Distillers Dried Grain Solubles (DDGS) (particularly corn based Distillers Dried Grain Solubles
(cDDGS), wheat bran, wheat middlings, wheat shorts, rice bran, rice hulls, oat hulls, palm kernel, and citrus pulp; c) protein obtained from sources such as soya, sunflower, peanut, lupin, peas, fava beans, cotton, canola, fish meal, dried plasma protein, meat and bone meal, potato
protein, whey, copra, sesame; d) oils and fats obtained from vegetable and animal sources; e) minerals and vitamins.
Metalloprotease polypeptides of the present invention for use in Textile Desizing
Also contemplated are compositions and methods of treating fabrics (e.g. , to desize a textile) using a metalloprotease polypeptide of the present invention. Fabric-treating methods are well known in the art (see, e.g. , U.S. Patent No. 6,077,316). For example, the feel and appearance of a fabric can be improved by a method comprising contacting the fabric with a metalloprotease in a solution. The fabric can be treated with the solution under pressure.
A metalloprotease of the present invention can be applied during or after the weaving of a textile, or during the desizing stage, or one or more additional fabric processing steps. During the weaving of textiles, the threads are exposed to considerable mechanical strain. Prior to weaving on mechanical looms, warp yarns are often coated with sizing starch or starch derivatives to increase their tensile strength and to prevent breaking. A metalloprotease of the present invention can be applied during or after the weaving to remove these sizing starch or starch derivatives. After weaving, the metalloprotease can be used to remove the size coating before further processing the fabric to ensure a homogeneous and wash-proof result.
A metalloprotease of the present invention can be used alone or with other desizing chemical reagents and/or desizing enzymes to desize fabrics, including cotton-containing fabrics, as detergent additives, e.g. , in aqueous compositions. An amylase also can be used in compositions and methods for producing a stonewashed look on indigo-dyed denim fabric and garments. For the manufacture of clothes, the fabric can be cut and sewn into clothes or garments, which are afterwards finished. In particular, for the manufacture of denim jeans, different enzymatic finishing methods have been developed. The finishing of denim garment normally is initiated with an enzymatic desizing step, during which garments are subjected to the action of proteolytic enzymes to provide softness to the fabric and make the cotton more accessible to the subsequent enzymatic finishing steps. The metalloprotease can be used in methods of finishing denim garments (e.g., a "bio-stoning process"), enzymatic desizing and providing softness to fabrics, and/or finishing process.
Metalloprotease polypeptides of the present invention for use in Paper Pulp Bleaching
The metalloprotease polypeptides described herein find further use in the enzyme aided bleaching of paper pulps such as chemical pulps, semi-chemical pulps, kraft pulps, mechanical pulps or pulps prepared by the sulfite method. In general terms, paper pulps are
incubated with a metalloprotease polypeptide of the present invention under conditions suitable for bleaching the paper pulp.
In some embodiments, the pulps are chlorine free pulps bleached with oxygen, ozone, peroxide or peroxyacids. In some embodiments, the metalloprotease polypeptides are used in enzyme aided bleaching of pulps produced by modified or continuous pulping methods that exhibit low lignin contents. In some other embodiments, the metalloprotease polypeptides are applied alone or preferably in combination with xylanase and/or endoglucanase and/or alpha-galactosidase and/or cellobiohydrolase enzymes.
Metalloprotease polypeptides of the present invention for use in Protein degradation
The metalloprotease polypeptides described herein find further use in the enzyme aided removal of proteins from animals and their subsequent degradation or disposal, such as feathers, skin, hair, hide, and the like. In some instances, immersion of the animal carcass in a solution comprising a metalloprotease polypeptide of the present invention can act to protect the skin from damage in comparison to the traditional immersion in scalding water or the defeathering process. In one embodiment, feathers can be sprayed with an isolated
metalloprotase polypeptide of the present invention under conditions suitable for digesting or initiating degradation of the plumage. In some embodiments, a metalloprotease of the present invention can be used, as above, in combination with an oxidizing agent.
In some embodiments, removal of the oil or fat associated with raw feathers is assisted by using a metalloprotease polypeptide of the present invention. In some embodiments, the metalloprotease polypeptides are used in compositions for cleaning the feathers as well as to sanitize and partially dehydrate the fibers. In some other embodiments, the metalloprotease polypeptides are applied in a wash solution in combination with 95% ethanol or other polar organic solvent with or without a surfactant at about 0.5% (v/v).
In yet other embodiments, the disclosed metalloprotease polypeptides find use in recovering protein from plumage. In some embodiments, the recovered protein can be subsequently used in animal or fish feed.
Metalloprotease polypeptides of the present invention for use in Tissue Debridement
The metalloprotease polypeptides described herein find further use in the enzyme aided debridement of tissue. This involves the removal of dead or damaged tissue, for example, removal from wounds to aid in healing.
Metalloprotease polypeptides of the present invention for use in tissue culture
The metalloprotease polypeptides described herein find further use in tissue culture. In particular, metalloproteases of the present invention can be used to suspend or resuspend cells adherent to a cell culture wall, such as during the process of harvesting cells. Metalloproteases of the present invention can be used to cleave protein bonds between cultured cells and the dish, allowing cells to become suspended in solution.
Metalloprotease polypeptides of the present invention for use in leather processing
The metalloprotease polypeptides described herein find further use in leather processing by removing hair from animal hides, soaking, degreasing, or bating, which is a process involving degradation of non-structural proteins during leather making.
EXPERIMENTAL
The claimed invention is described in further detail in the following examples which are not in any way intended to limit the scope of the invention as claimed.
EXAMPLE 1
Crystallization and structure determination of PehProl metalloprotease
The metalloprotease PehProl, encoded by a Paenibacillus ehimensis strain was crystallized using the hanging drop method from a solution of protein stock at a concentration of 27.9 mg/mL in 20mM Tris pH 8.5 + 0.10M Sodium chloride + ImM Calcium chloride. Aliquots of 2 \L of the protein stock and 2 \L of the crystallization solution were mixed on a plastic coverslip and inverted and sealed on a chamber containing 15-25% Polyethylene Glycol 8000 + 50mM Potassium phosphate monobasic + 0.10M HEPES pH 7.5 in a Linbro 6 X 4 culture plate.
Crystals grew in the space group C 2 2 2\ with unit cell dimensions; a=58.814 A, b=194.346 A, and c=138.355 A. Data were collected on native crystal to 2.79 A resolution and the structure of PehProl was determined by molecular replacement using a related protein (pdb ID 1ESP) as the phasing model. The statistics of data collected are presented in Table 1.1.
Table 1.1: Statistics of PehProl Data collection
Wavelength 1.54 A
Space group C222
Molecules in asymmetric unit 2
Unit cell dimensions a=58.81 A, b=194.35 A and
c=138.36 A
Resolution 32.6 - 2.79 A
Unique reflections 19103
Multiplicity 17 (11*)
Completeness 99.33% (92%*)
Rmerge 0.08 (0.30*)
Ι/σι 17 (8*)
Value in parenthesis is that of the outermost shell of data
The model was fitted in the resulting electron density using the program COOT (Emsley, P et al Acta Cryst. D66 486-501 (2010)). After fitting and refitting adjustments, the coordinates were refined using the REFMAC program with standard defaults in the CCP4 software suite. The statistics of the current model are presented in Table 1.2.
EXAMPLE 2
PehProl crystal structure details
The structure of PehProl consists of a dimer of two equivalent molecules. Electron density was available for residues 1-304 of each monomer. Each model was fitted to contiguous density. The overall dimer arrangement is presented in Figure 1. The residues forming the active site regions include the catalytic residues; Hisl35, Glul36, Hisl39 and Glul59
(numbering based on PehProl mature sequence) forming the characteristic zinc metal binding site, along with other residues forming the substrate binding pocket are conserved between the
PehProl and Thermolysin structures (Matthews, B.W., Weaver, L.H., Kester, W.R., The Conformation of Thermolysin, (1974) J.Biol.Chem.249: 8030; Dahlquist, F.W., Long, J.W., Bigbee, W.L., Role of Calcium in the Thermal Stability of Thermolysin, (1976) Biochemistry 15: 1103).
The coordinates for this molecule are listed below.
ATOM 1 N ALA A 1 -17. .159 -64. .455 -9. .260 1. .00 39. .68 A N
ATOM 2 CA ALA A 1 -18. .338 -64. .728 -10. .130 1. .00 33. .72 A C
ATOM 3 CB ALA A 1 -19. .640 -64. .092 -9. .687 1. .00 32. .16 A C
ATOM 4 c ALA A 1 -17. .839 -63. .991 -11. .323 1. .00 30. .98 A c
ATOM 5 o ALA A 1 -17. .083 -63. .038 -11. .132 1. .00 31. .11 A o
ATOM 6 N THR A 2 -18. .230 -64. .375 -12. .537 1. .00 27. .24 A N
ATOM 7 CA THR A 2 -17. .655 -63. .718 -13. .709 1. .00 23. .73 A c
ATOM 8 CB THR A 2 -16. .933 -64. .722 -14. .609 1. .00 23. .24 A c
ATOM 9 OGl THR A 2 -16. .035 -65. .475 -13. .800 1. .00 23. .09 A o
ATOM 10 CG2 THR A 2 -16. .117 -64. .026 -15. .659 1. .00 22. .84 A c
ATOM 11 c THR A 2 -18. .690 -62. .894 -14. .454 1. .00 22. .06 A c
ATOM 12 o THR A 2 -19. .503 -63. .421 -15. .169 1. .00 22. .29 A o
ATOM 13 N GLY A 3 -18. .652 -61. .581 -14. .259 1. .00 21. .36 A N
ATOM 14 CA GLY A 3 -19. .512 -60. .660 -14. .981 1. .00 20. .30 A c
ATOM 15 c GLY A 3 -18. .962 -60. .326 -16. .364 1. .00 20. .22 A c
ATOM 16 o GLY A 3 -17. .744 -60. .439 -16. .667 1. .00 18. .32 A o
ATOM 17 N THR A 4 -19. .885 -59. .870 -17. .199 1. .00 20. .55 A N
ATOM 18 CA THR A 4 -19. .612 -59. .576 -18. .593 1. .00 20. .58 A c
ATOM 19 CB THR A 4 -19. .948 -60. .825 -19. .426 1. .00 20. .39 A c
ATOM 20 OGl THR A 4 -19. .095 -60. .904 -20. .570 1. .00 21. .45 A o
ATOM 21 CG2 THR A 4 -21. .404 -60. .866 -19. .797 1. .00 20. .52 A c
ATOM 22 c THR A 4 -20. .371 -58. .290 -18. .979 1. .00 20. .82 A c
ATOM 23 o THR A 4 -21. .362 -57. .946 -18. .344 1. .00 20. .84 A o
ATOM 24 N GLY A 5 -19. .870 -57. .532 -19. .955 1. .00 22. .14 A N
ATOM 25 CA GLY A 5 -20. .474 -56. .214 -20. .307 1. .00 21. .26 A c
ATOM 26 c GLY A 5 -19. .683 -55. .446 -21. .353 1. .00 21. .65 A c
ATOM 27 o GLY A 5 -18. .525 -55. .770 -21. .629 1. .00 21. .95 A o
ATOM 28 N LYS A 6 -20. .293 -54. .433 -21. .958 1. .00 23. .22 A N
ATOM 29 CA LYS A 6 -19. .599 -53. .661 -22. .999 1. .00 23. .98 A c
ATOM 30 CB LYS A 6 -20. .501 -53. .316 -24. .191 1. .00 26. .75 A c
ATOM 31 CG LYS A 6 -21. .062 -54. .545 -24. .928 1. .00 31. .43 A c
ATOM 32 CD LYS A 6 -21. .426 -54. .362 -26. .429 1. .00 34. .80 A c
ATOM 33 CE LYS A 6 -22. .314 -53. .151 -26. .767 1. .00 37. .30 A c
ATOM 34 NZ LYS A 6 -23. .750 -53. .306 -26. .350 1. .00 38. .51 A N
ATOM 35 c LYS A 6 -19. .019 -52. .412 -22. .379 1. .00 21. .52 A c
ATOM 36 o LYS A 6 -19. .655 -51. .799 -21. .527 1. .00 21. .20 A o
ATOM 37 N GLY A 7 -17. .806 -52. .049 -22. .801 1. .00 19. .41 A N
ATOM 38 CA GLY A 7 -17. .124 -50. .843 -22. .311 1. .00 17. .91 A c
ATOM 39 c GLY A 7 -17. .709 -49. .607 -22. .918 1. .00 17. .02 A c
ATOM 40 o GLY A 7 -18. .733 -49. .657 -23. .599 1. .00 17. .62 A o
ATOM 41 N VAL A 8 -17. .062 -48. .481 -22. .697 1. .00 16. .27 A N
ATOM 42 CA VAL A 8 -17. .536 -47. .207 -23. .273 1. .00 15. .98 A c
ATOM 43 CB VAL A 8 -16. .608 -46. .061 -22. .849 1. .00 16. .24 A c
ATOM 44 CGl VAL A 8 -16. .843 -44. .785 -23. .665 1. .00 15. .97 A c
ATOM 45 CG2 VAL A 8 -16. .770 -45. .827 -21. .354 1. .00 16. .69 A c
ATOM 46 C VAL A 8 -17. .580 -47. .271 -24. .800 1. .00 15. .88 A c
ATOM 47 o VAL A 8 -18. .502 -46. .760 -25. .430 1. .00 14. .79 A o
ATOM 48 N LEU A 9 -16. .564 -47. .928 -25. .366 1. .00 15. .93 A N
ATOM 49 CA LEU A 9 -16. .361 -48. .015 -26. .814 1. .00 15. .86 A c
ATOM 50 CB LEU A 9 -14. .852 -48. .093 -27. .086 1. .00 15. .92 A c
ATOM 51 CG LEU A 9 -14. .126 -46. .852 -27. .579 1. .00 15. .70 A c
ATOM 52 CDl LEU A 9 -14. .696 -45. .602 -26. .965 1. .00 15. .39 A c
ATOM 53 CD 2 LEU A 9 -12. .636 -46. .998 -27. .283 1. .00 15. .95 A c
ATOM 54 C LEU A 9 -17. .023 -49. .217 -27. .493 1. .00 15. .36 A c
ATOM 55 o LEU A 9 -16. .577 -49. .596 -28. .592 1. .00 15. .14 A o
ATOM 56 N GLY A 10 -18. .010 -49. .842 -26. .831 1. .00 14. .23 A N
ATOM 57 CA GLY A 10 -18. .771 -50. .970 -27. .404 1. .00 13. .71 A c
ATOM 58 C GLY A 10 -18. .144 -52. .351 -27. .326 1. .00 13. .72 A c
ATOM 59 o GLY A 10 -18. .738 -53. .341 -27. .753 1. .00 13. .58 A o
ATOM 60 N ASP A 11 -16. .945 -52. .433 -26. .768 1. .00 13. .97 A N
ATOM 61 CA ASP A 11 -16. .223 -53. .677 -26. .721 1. .00 14. .03 A c
ATOM 62 CB ASP A 11 -14. .715 -53. .447 -26. .716 1. .00 14. .10 A c
ATOM 63 CG ASP A 11 -14. .243 -52. .431 -25. .655 1. .00 14. .65 A c
ATOM 64 ODl ASP A 11 -14. .971 -51. .470 -25. .307 1. .00 14. .45 A o
ATOM 65 OD2 ASP A 11 -13. .091 -52. .593 -25. .195 1. .00 15. .19 A o
ATOM 66 C ASP A 11 -16. .647 -54. .501 -25. .529 1. .00 14. .72 A c
ATOM 67 o ASP A 11 -16..756 -53..984 -24..433 1..00 14..88 A o
ATOM 68 N THR A 12 -16. .844 -55. .802 -25. .763 1. .00 15. .81 A N
ATOM 69 CA THR A 12 -17. .317 -56. .754 -24. .758 1. .00 15. .88 A C
ATOM 70 CB THR A 12 -17. .962 -57. .966 -25. .452 1. .00 15. .68 A C
ATOM 71 OGl THR A 12 -19. .275 -57. .606 -25. .914 1. .00 15. .63 A o
ATOM 72 CG2 THR A 12 -18. .054 -59. .155 -24. .518 1. .00 15. .69 A c
ATOM 73 C THR A 12 -16. .171 -57. .235 -23. .884 1. .00 16. .48 A c
ATOM 74 o THR A 12 -15. .136 -57. .569 -24. .392 1. .00 16. .69 A o
ATOM 75 N LYS A 13 -16. .380 -57. .296 -22. .572 1. .00 17. .65 A N
ATOM 76 CA LYS A 13 -15. .333 -57. .703 -21. .603 1. .00 18. .19 A c
ATOM 77 CB LYS A 13 -14. .788 -56. .474 -20. .861 1. .00 19. .32 A c
ATOM 78 CG LYS A 13 -13. .717 -55. .737 -21. .568 1. .00 20. .03 A c
ATOM 79 CD LYS A 13 -13. .757 -54. .265 -21. .245 1. .00 20. .24 A c
ATOM 80 CE LYS A 13 -12. .730 -53. .620 -22. .168 1. .00 21. .08 A c
ATOM 81 NZ LYS A 13 -13. .089 -52. .212 -22. .399 1. .00 21. .72 A N
ATOM 82 C LYS A 13 -15. .855 -58. .583 -20. .482 1. .00 17. .16 A c
ATOM 83 o LYS A 13 -17. .047 -58. .515 -20. .130 1. .00 15. .92 A o
ATOM 84 N SER A 14 -14. .904 -59. .286 -19. .864 1. .00 16. .11 A N
ATOM 85 CA SER A 14 -15. .114 -60. .029 -18. .621 1. .00 16. .16 A c
ATOM 86 CB SER A 14 -14. .659 -61. .492 -18. .751 1. .00 15. .77 A c
ATOM 87 OG SER A 14 -15. .523 -62. .202 -19. .587 1. .00 15. .69 A o
ATOM 88 C SER A 14 -14. .324 -59. .439 -17. .460 1. .00 15. .77 A c
ATOM 89 o SER A 14 -13. .254 -58. .842 -17. .641 1. .00 16. .38 A o
ATOM 90 N PHE A 15 -14. .833 -59. .712 -16. .263 1. .00 14. .76 A N
ATOM 91 CA PHE A 15 -14. .281 -59. .224 -15. .009 1. .00 13. .44 A c
ATOM 92 CB PHE A 15 -14. .562 -57. .741 -14. .855 1. .00 12. .78 A c
ATOM 93 CG PHE A 15 -15. .901 -57. .329 -15. .375 1. .00 12. .44 A c
ATOM 94 CDl PHE A 15 -17. .004 -57. .402 -14. .588 1. .00 12. .46 A c
ATOM 95 CEl PHE A 15 -18. .248 -57. .033 -15. .066 1. .00 12. .45 A c
ATOM 96 CZ PHE A 15 -18. .398 -56. .582 -16. .350 1. .00 12. .34 A c
ATOM 97 CE2 PHE A 15 -17. .288 -56. .491 -17. .148 1. .00 12. .82 A c
ATOM 98 CD 2 PHE A 15 -16. .046 -56. .868 -16. .655 1. .00 12. .74 A c
ATOM 99 C PHE A 15 -14. .946 -59. .973 -13. .852 1. .00 13. .24 A c
ATOM 100 o PHE A 15 -15. .970 -60. .647 -14. .005 1. .00 12. .99 A o
ATOM 101 N THR A 16 -14. .373 -59. .798 -12. .679 1. .00 12. .90 A N
ATOM 102 CA THR A 16 -14. .843 -60. .461 -11. .492 1. .00 12. .27 A c
ATOM 103 CB THR A 16 -13. .661 -60. .746 -10. .602 1. .00 11. .79 A c
ATOM 104 OGl THR A 16 -12. .628 -61. .323 -11. .424 1. .00 11. .21 A o
ATOM 105 CG2 THR A 16 -14. .056 -61. .662 -9. .465 1. .00 11. .43 A c
ATOM 106 C THR A 16 -15. .862 -59. .593 -10. .771 1. .00 12. .41 A c
ATOM 107 o THR A 16 -15. .728 -58. .359 -10. .686 1. .00 12. .07 A o
ATOM 108 N THR A 17 -16. .914 -60. .252 -10. .303 1. .00 12. .28 A N
ATOM 109 CA THR A 17 -17. .952 -59. .582 -9. .540 1. .00 12. .14 A c
ATOM 110 CB THR A 17 -19. .202 -59. .303 -10. .396 1. .00 11. .78 A c
ATOM 111 OGl THR A 17 -19. .721 -60. .532 -10. .919 1. .00 11. .36 A o
ATOM 112 CG2 THR A 17 -18. .838 -58. .371 -11. .537 1. .00 11. .82 A c
ATOM 113 C THR A 17 -18. .321 -60. .453 -8. .367 1. .00 12. .21 A c
ATOM 114 o THR A 17 -17. .882 -61. .580 -8. .242 1. .00 10. .79 A o
ATOM 115 N THR A 18 -19. .156 -59. .908 -7. .515 1. .00 13. .29 A N
ATOM 116 CA THR A 18 -19. .482 -60. .584 -6. .301 1. .00 14. .74 A c
ATOM 117 CB THR A 18 -18. .921 -59. .785 -5. .103 1. .00 14. .74 A c
ATOM 118 OGl THR A 18 -17. .470 -59. .893 -5. .058 1. .00 14. .74 A o
ATOM 119 CG2 THR A 18 -19. .524 -60. .310 -3. .835 1. .00 15. .11 A c
ATOM 120 C THR A 18 -21. .010 -60. .819 -6. .232 1. .00 15. .79 A c
ATOM 121 o THR A 18 -21. .779 -59. .898 -6. .354 1. .00 14. .67 A o
ATOM 122 N GLN A 19 -21. .424 -62. .076 -6. .075 1. .00 17. .88 A N
ATOM 123 CA GLN A 19 -22. .843 -62. .418 -5. .943 1. .00 19. .54 A c
ATOM 124 CB GLN A 19 -23. .100 -63. .901 -6. .252 1. .00 21. .61 A c
ATOM 125 CG GLN A 19 -24. .527 -64. .361 -5. .945 1. .00 22. .69 A c
ATOM 126 CD GLN A 19 -24. .762 -65. .830 -6. .230 1. .00 22. .70 A c
ATOM 127 OEl GLN A 19 -23. .902 -66. .679 -6. .031 1. .00 22. .41 A o
ATOM 128 NE2 GLN A 19 -25. .944 -66. .128 -6. .686 1. .00 23. .42 A N
ATOM 129 C GLN A 19 -23. .281 -62. .147 -4. .541 1. .00 19. .39 A c
ATOM 130 o GLN A 19 -22. .680 -62. .642 -3. .603 1. .00 19. .37 A o
ATOM 131 N SER A 20 -24. .364 -61. .405 -4. .416 1. .00 20. .36 A N
ATOM 132 CA SER A 20 -24. .805 -60. .864 -3. .142 1. .00 21. .93 A c
ATOM 133 CB SER A 20 -24. .242 -59. .446 -2. .917 1. .00 20. .94 A c
ATOM 134 OG SER A 20 -24. .848 -58. .804 -1. .798 1. .00 20. .47 A o
ATOM 135 C SER A 20 -26. .316 -60. .793 -3. .153 1. .00 24. .09 A c
ATOM 136 o SER A 20 -26. .900 -59. .913 -3. .817 1. .00 24. .70 A o
ATOM 137 N GLY A 21 -26. .941 -61. .719 -2. .431 1. .00 25. .06 A N
ATOM 138 CA GLY A 21 -28. .389 -61. .717 -2. .286 1. .00 25. .86 A c
ATOM 139 C GLY A 21 -29. .009 -62. .180 -3. .585 1. .00 26. .74 A c
ATOM 140 o GLY A 21 -28. .612 -63. .233 -4. .137 1. .00 26. .33 A o
ATOM 141 N SER A 22 -29. .973 -61. .376 -4. .055 1. .00 26. .86 A N
ATOM 142 CA SER A 22 -30. .620 -61. .522 -5. .374 1. .00 26. .16 A c
ATOM 143 CB SER A 22 -31. .916 -60. .704 -5. .410 1. .00 25. .69 A c
ATOM 144 OG SER A 22 -32. .699 -60. .973 -4. .264 1. .00 25. .00 A o
ATOM 145 C SER A 22 -29. .765 -61. .040 -6. .537 1. .00 25. .41 A c
ATOM 146 o SER A 22 -30..092 -61..342 -7..678 1..00 28..42 A o
ATOM 147 N THR A 23 -28. .692 -60. .295 -6. .259 1. .00 24. .03 A N
ATOM 148 CA THR A 23 -27. .894 -59. .630 -7. .305 1. .00 23. .15 A C
ATOM 149 CB THR A 23 -27. .851 -58. .107 -7. .116 1. .00 22. .84 A C
ATOM 150 OGl THR A 23 -28. .241 -57. .818 -5. .783 1. .00 23. .29 A o
ATOM 151 CG2 THR A 23 -28. .727 -57. .393 -8. .116 1. .00 23. .29 A c
ATOM 152 C THR A 23 -26. .442 -59. .995 -7. .328 1. .00 21. .31 A c
ATOM 153 o THR A 23 -26. .004 -60. .983 -6. .747 1. .00 20. .69 A o
ATOM 154 N TYR A 24 -25. .721 -59. .153 -8. .058 1. .00 20. .03 A N
ATOM 155 CA TYR A 24 -24. .288 -59. .137 -8. .090 1. .00 19. .44 A c
ATOM 156 CB TYR A 24 -23. .808 -59. .724 -9. .415 1. .00 20. .32 A c
ATOM 157 CG TYR A 24 -24. .253 -61. .153 -9. .647 1. .00 20. .98 A c
ATOM 158 CDl TYR A 24 -25. .577 -61. .463 -10. .012 1. .00 22. .25 A c
ATOM 159 CEl TYR A 24 -25. .973 -62. .786 -10. .223 1. .00 22. .82 A c
ATOM 160 CZ TYR A 24 -25. .027 -63. .803 -10. .075 1. .00 22. .98 A c
ATOM 161 OH TYR A 24 -25. .333 -65. .114 -10. .258 1. .00 22. .47 A o
ATOM 162 CE2 TYR A 24 -23. .725 -63. .508 -9. .714 1. .00 22. .86 A c
ATOM 163 CD 2 TYR A 24 -23. .353 -62. .193 -9. .502 1. .00 21. .74 A c
ATOM 164 C TYR A 24 -23. .790 -57. .707 -7. .944 1. .00 18. .03 A c
ATOM 165 o TYR A 24 -24. .420 -56. .776 -8. .398 1. .00 18. .83 A o
ATOM 166 N GLN A 25 -22. .646 -57. .554 -7. .304 1. .00 16. .91 A N
ATOM 167 CA GLN A 25 -22. .035 -56. .282 -7. .074 1. .00 16. .05 A c
ATOM 168 CB GLN A 25 -21. .610 -56. .204 -5. .617 1. .00 17. .12 A c
ATOM 169 CG GLN A 25 -22. .750 -56. .234 -4. .604 1. .00 18. .02 A c
ATOM 170 CD GLN A 25 -22. .238 -56. .131 -3. .157 1. .00 18. .84 A c
ATOM 171 OEl GLN A 25 -21. .652 -57. .073 -2. .611 1. .00 18. .68 A o
ATOM 172 NE2 GLN A 25 -22. .436 -54. .961 -2. .547 1. .00 19. .37 A N
ATOM 173 C GLN A 25 -20. .804 -56. .174 -7. .940 1. .00 14. .92 A c
ATOM 174 o GLN A 25 -20. .054 -57. .139 -8. .082 1. .00 13. .71 A o
ATOM 175 N LEU A 26 -20. .586 -54. .991 -8. .507 1. .00 14. .84 A N
ATOM 176 CA LEU A 26 -19. .323 -54. .675 -9. .200 1. .00 14. .71 A c
ATOM 177 CB LEU A 26 -19. .445 -53. .347 -9. .978 1. .00 14. .61 A c
ATOM 178 CG LEU A 26 -19. .423 -53. .351 -11. .519 1. .00 14. .51 A c
ATOM 179 CDl LEU A 26 -19. .059 -51. .976 -12. .079 1. .00 14. .06 A c
ATOM 180 CD 2 LEU A 26 -18. .478 -54. .406 -12. .088 1. .00 14. .65 A c
ATOM 181 C LEU A 26 -18. .128 -54. .605 -8. .242 1. .00 14. .74 A c
ATOM 182 o LEU A 26 -17. .595 -53. .535 -8. .002 1. .00 15. .14 A o
ATOM 183 N LYS A 27 -17. .714 -55. .748 -7. .703 1. .00 15. .19 A N
ATOM 184 CA LYS A 27 -16. .706 -55. .808 -6. .643 1. .00 15. .66 A c
ATOM 185 CB LYS A 27 -17. .364 -55. .826 -5. .267 1. .00 17. .97 A c
ATOM 186 CG LYS A 27 -16. .461 -55. .674 -4. .013 1. .00 20. .16 A c
ATOM 187 CD LYS A 27 -17. .235 -56. .135 -2. .756 1. .00 22. .07 A c
ATOM 188 CE LYS A 27 -16. .523 -55. .982 -1. .402 1. .00 23. .86 A c
ATOM 189 NZ LYS A 27 -16. .851 -54. .674 -0. .719 1. .00 24. .48 A N
ATOM 190 C LYS A 27 -15. .913 -57. .057 -6. .827 1. .00 14. .55 A c
ATOM 191 o LYS A 27 -16. .489 -58. .120 -6. .996 1. .00 14. .47 A o
ATOM 192 N ASP A 28 -14. .587 -56. .917 -6. .825 1. .00 13. .97 A N
ATOM 193 CA ASP A 28 -13. .659 -58. .031 -7. .050 1. .00 13. .42 A c
ATOM 194 CB ASP A 28 -12. .763 -57. .725 -8. .266 1. .00 13. .08 A c
ATOM 195 CG ASP A 28 -11. .674 -58. .771 -8. .521 1. .00 13. .48 A c
ATOM 196 ODl ASP A 28 -11. .473 -59. .690 -7. .689 1. .00 14. .37 A o
ATOM 197 OD2 ASP A 28 -11. .005 -58. .691 -9. .587 1. .00 12. .98 A o
ATOM 198 C ASP A 28 -12. .893 -58. .207 -5. .739 1. .00 13. .01 A c
ATOM 199 o ASP A 28 -12. .178 -57. .368 -5. .343 1. .00 12. .32 A o
ATOM 200 N THR A 29 -13. .117 -59. .315 -5. .068 1. .00 13. .89 A N
ATOM 201 CA THR A 29 -12. .519 -59. .651 -3. .769 1. .00 14. .71 A c
ATOM 202 CB THR A 29 -13. .399 -60. .741 -3. .052 1. .00 15. .35 A c
ATOM 203 OGl THR A 29 -14. .777 -60. .336 -3. .027 1. .00 15. .18 A o
ATOM 204 CG2 THR A 29 -12. .900 -61. .030 -1. .614 1. .00 16. .17 A c
ATOM 205 C THR A 29 -11. .158 -60. .301 -3. .937 1. .00 14. .50 A c
ATOM 206 o THR A 29 -10. .416 -60. .477 -2. .966 1. .00 14. .03 A o
ATOM 207 N THR A 30 -10. .858 -60. .707 -5. .166 1. .00 14. .01 A N
ATOM 208 CA THR A 30 -9. .723 -61. .573 -5. .413 1. .00 13. .87 A c
ATOM 209 CB THR A 30 -9. .932 -62. .391 -6. .680 1. .00 13. .93 A c
ATOM 210 OGl THR A 30 -9. .673 -61. .570 -7. .827 1. .00 14. .25 A o
ATOM 211 CG2 THR A 30 -11. .361 -62. .916 -6. .702 1. .00 13. .81 A c
ATOM 212 C THR A 30 -8. .429 -60. .802 -5. .518 1. .00 13. .58 A c
ATOM 213 o THR A 30 -7. .359 -61. .401 -5. .502 1. .00 12. .36 A o
ATOM 214 N ARG A 31 -8. .521 -59. .476 -5. .615 1. .00 14. .16 A N
ATOM 215 CA ARG A 31 -7. .297 -58. .698 -5. .580 1. .00 15. .08 A c
ATOM 216 CB ARG A 31 -6. .770 -58. .358 -6. .990 1. .00 15. .55 A c
ATOM 217 CG ARG A 31 -7. .598 -57. .511 -7. .921 1. .00 16. .02 A c
ATOM 218 CD ARG A 31 -8. .195 -58. .329 -9. .061 1. .00 16. .47 A c
ATOM 219 NE ARG A 31 -7. .390 -58. .608 -10. .270 1. .00 15. .99 A N
ATOM 220 CZ ARG A 31 -7. .738 -59. .539 -11. .181 1. .00 15. .52 A c
ATOM 221 NHl ARG A 31 -8. .823 -60. .305 -11. .035 1. .00 15. .13 A N
ATOM 222 NH2 ARG A 31 -6. .991 -59. .741 -12. .238 1. .00 15. .37 A N
ATOM 223 C ARG A 31 -7. .235 -57. .525 -4. .589 1. .00 14. .78 A C
ATOM 224 o ARG A 31 -8. .080 -56. .638 -4. .583 1. .00 14. .51 A o
ATOM 225 N GLY A 32 -6..182 -57..584 -3..753 1..00 14..67 A N
ATOM 226 CA GLY A 32 -6. .087 -56. .875 -2. .471 1. .00 14. .18 A C
ATOM 227 C GLY A 32 -7. .325 -56. .959 -1. .608 1. .00 13. .91 A C
ATOM 228 o GLY A 32 -8. .032 -57. .952 -1. .604 1. .00 13. .27 A o
ATOM 229 N GLN A 33 -7. .608 -55. .897 -0. .875 1. .00 14. .47 A N
ATOM 230 CA GLN A 33 -8. .876 -55. .840 -0. .160 1. .00 15. .13 A c
ATOM 231 CB GLN A 33 -8. .834 -54. .815 0. .957 1. .00 16. .42 A c
ATOM 232 CG GLN A 33 -7. .964 -55. .204 2. .146 1. .00 17. .07 A c
ATOM 233 CD GLN A 33 -7. .000 -54. .094 2. .468 1. .00 18. .22 A c
ATOM 234 OEl GLN A 33 -5. .796 -54. .344 2. .529 1. .00 18. .93 A o
ATOM 235 NE2 GLN A 33 -7. .516 -52. .821 2. .619 1. .00 18. .12 A N
ATOM 236 C GLN A 33 -10. .024 -55. .539 -1. .099 1. .00 14. .63 A c
ATOM 237 o GLN A 33 -11. .164 -55. .372 -0. .671 1. .00 14. .46 A o
ATOM 238 N GLY A 34 -9. .727 -55. .477 -2. .386 1. .00 14. .20 A N
ATOM 239 CA GLY A 34 -10. .766 -55. .551 -3. .369 1. .00 13. .93 A c
ATOM 240 C GLY A 34 -10. .802 -54. .379 -4. .303 1. .00 13. .69 A c
ATOM 241 o GLY A 34 -10. .151 -53. .360 -4. .073 1. .00 14. .83 A o
ATOM 242 N ILE A 35 -11. .563 -54. .533 -5. .371 1. .00 12. .80 A N
ATOM 243 CA ILE A 35 -11. .706 -53. .495 -6. .353 1. .00 12. .48 A c
ATOM 244 CB ILE A 35 -11. .136 -53. .951 -7. .695 1. .00 12. .26 A c
ATOM 245 CGl ILE A 35 -9. .639 -54. .116 -7. .554 1. .00 12. .72 A c
ATOM 246 CDl ILE A 35 -8. .906 -54. .294 -8. .876 1. .00 13. .19 A c
ATOM 247 CG2 ILE A 35 -11. .468 -52. .976 -8. .798 1. .00 12. .20 A c
ATOM 248 C ILE A 35 -13. .193 -53. .286 -6. .417 1. .00 12. .31 A c
ATOM 249 o ILE A 35 -13. .938 -54. .242 -6. .575 1. .00 12. .03 A o
ATOM 250 N VAL A 36 -13. .625 -52. .043 -6. .257 1. .00 12. .28 A N
ATOM 251 CA VAL A 36 -15. .051 -51. .755 -6. .160 1. .00 12. .25 A c
ATOM 252 CB VAL A 36 -15. .459 -51. .351 -4. .737 1. .00 12. .50 A c
ATOM 253 CGl VAL A 36 -16. .968 -51. .376 -4. .631 1. .00 12. .79 A c
ATOM 254 CG2 VAL A 36 -14. .829 -52. .271 -3. .691 1. .00 12. .49 A c
ATOM 255 C VAL A 36 -15. .378 -50. .600 -7. .042 1. .00 11. .79 A c
ATOM 256 o VAL A 36 -14. .656 -49. .627 -7. .068 1. .00 11. .66 A o
ATOM 257 N THR A 37 -16. .480 -50. .693 -7. .752 1. .00 11. .73 A N
ATOM 258 CA THR A 37 -16. .821 -49. .656 -8. .699 1. .00 11. .95 A c
ATOM 259 CB THR A 37 -16. .651 -50. .214 -10. .125 1. .00 12. .12 A c
ATOM 260 OGl THR A 37 -15. .306 -50. .678 -10. .323 1. .00 11. .60 A o
ATOM 261 CG2 THR A 37 -16. .978 -49. .158 -11. .163 1. .00 12. .41 A c
ATOM 262 C THR A 37 -18. .242 -49. .064 -8. .450 1. .00 12. .02 A c
ATOM 263 o THR A 37 -19. .220 -49. .806 -8. .348 1. .00 11. .27 A o
ATOM 264 N TYR A 38 -18. .310 -47. .727 -8. .348 1. .00 12. .30 A N
ATOM 265 CA TYR A 38 -19. .531 -46. .984 -8. .027 1. .00 12. .80 A c
ATOM 266 CB TYR A 38 -19. .301 -46. .102 -6. .793 1. .00 13. .01 A c
ATOM 267 CG TYR A 38 -18. .714 -46. .788 -5. .592 1. .00 13. .05 A c
ATOM 268 CDl TYR A 38 -17. .349 -47. .059 -5. .500 1. .00 12. .97 A c
ATOM 269 CEl TYR A 38 -16. .826 -47. .706 -4. .387 1. .00 12. .85 A c
ATOM 270 CZ TYR A 38 -17. .664 -48. .041 -3. .345 1. .00 12. .79 A c
ATOM 271 OH TYR A 38 -17. .222 -48. .655 -2. .229 1. .00 13. .25 A o
ATOM 272 CE2 TYR A 38 -18. .991 -47. .767 -3. .402 1. .00 13. .05 A c
ATOM 273 CD 2 TYR A 38 -19. .519 -47. .145 -4. .523 1. .00 13. .15 A c
ATOM 274 C TYR A 38 -19. .921 -46. .001 -9. .123 1. .00 13. .22 A c
ATOM 275 o TYR A 38 -19. .061 -45. .563 -9. .886 1. .00 13. .13 A o
ATOM 276 N SER A 39 -21. .196 -45. .588 -9. .132 1. .00 13. .71 A N
ATOM 277 CA SER A 39 -21. .668 -44. .417 -9. .919 1. .00 14. .12 A c
ATOM 278 CB SER A 39 -22. .854 -44. .784 -10. .823 1. .00 13. .74 A c
ATOM 279 OG SER A 39 -23. .634 -43. .628 -11. .165 1. .00 13. .56 A o
ATOM 280 C SER A 39 -22. .052 -43. .226 -9. .009 1. .00 14. .90 A c
ATOM 281 o SER A 39 -22. .651 -43. .409 -7. .942 1. .00 15. .79 A o
ATOM 282 N ALA A 40 -21. .697 -42. .011 -9. .422 1. .00 15. .34 A N
ATOM 283 CA ALA A 40 -22. .070 -40. .810 -8. .672 1. .00 15. .65 A c
ATOM 284 CB ALA A 40 -21. .026 -39. .738 -8. .857 1. .00 15. .26 A c
ATOM 285 C ALA A 40 -23. .444 -40. .255 -9. .080 1. .00 16. .51 A c
ATOM 286 o ALA A 40 -23. .871 -39. .252 -8. .542 1. .00 16. .26 A o
ATOM 287 N GLY A 41 -24. .125 -40. .884 -10. .037 1. .00 17. .11 A N
ATOM 288 CA GLY A 41 -25. .400 -40. .386 -10. .509 1. .00 17. .44 A c
ATOM 289 C GLY A 41 -25. .335 -38. .944 -10. .945 1. .00 18. .31 A c
ATOM 290 o GLY A 41 -26. .259 -38. .156 -10. .687 1. .00 18. .80 A o
ATOM 291 N ASN A 42 -24. .230 -38. .586 -11. .583 1. .00 18. .86 A N
ATOM 292 CA ASN A 42 -24. .007 -37. .213 -12. .060 1. .00 19. .31 A c
ATOM 293 CB ASN A 42 -24. .917 -36. .897 -13. .253 1. .00 18. .59 A c
ATOM 294 CG ASN A 42 -24. .664 -37. .831 -14. .428 1. .00 18. .02 A c
ATOM 295 ODl ASN A 42 -25. .567 -38. .474 -14. .893 1. .00 18. .09 A o
ATOM 296 ND2 ASN A 42 -23. .419 -37. .928 -14. .879 1. .00 17. .76 A N
ATOM 297 C ASN A 42 -24. .075 -36. .119 -11. .010 1. .00 20. .65 A c
ATOM 298 o ASN A 42 -24. .293 -34. .976 -11. .332 1. .00 20. .22 A o
ATOM 299 N ARG A 43 -23. .827 -36. .470 -9. .761 1. .00 23. .59 A N
ATOM 300 CA ARG A 43 -23. .646 -35. .496 -8. .707 1. .00 26. .15 A c
ATOM 301 CB ARG A 43 -24. .688 -35. .719 -7. .618 1. .00 30. .73 A c
ATOM 302 CG ARG A 43 -26. .103 -35. .379 -8. .056 1. .00 35. .36 A c
ATOM 303 CD ARG A 43 -27. .117 -36. .068 -7. .163 1. .00 42. .30 A c
ATOM 304 NE ARG A 43 -28..483 -35..870 -7..661 1..00 51..16 A N
ATOM 305 CZ ARG A 43 -29. .263 -36. .813 -8. .216 1. .00 54. .64 A C
ATOM 306 NHl ARG A 43 -28. .842 -38. .082 -8. .366 1. .00 55. .48 A N
ATOM 307 NH2 ARG A 43 -30. .493 -36. .474 -8. .620 1. .00 51. .20 A N
ATOM 308 C ARG A 43 -22. .227 -35. .710 -8. .203 1. .00 25. .25 A C
ATOM 309 o ARG A 43 -21. .465 -36. .443 -8. .850 1. .00 25. .16 A o
ATOM 310 N SER A 44 -21. .856 -35. .091 -7. .080 1. .00 23. .65 A N
ATOM 311 CA SER A 44 -20. .469 -35. .117 -6. .638 1. .00 23. .20 A C
ATOM 312 CB SER A 44 -19. .913 -33. .725 -6. .728 1. .00 23. .30 A C
ATOM 313 OG SER A 44 -20. .575 -32. .930 -5. .806 1. .00 24. .80 A o
ATOM 314 C SER A 44 -20. .254 -35. .685 -5. .235 1. .00 22. .60 A c
ATOM 315 o SER A 44 -19. .168 -35. .591 -4. .637 1. .00 23. .35 A o
ATOM 316 N SER A 45 -21. .291 -36. .310 -4. .728 1. .00 21. .47 A N
ATOM 317 CA SER A 45 -21. .198 -37. .091 -3. .516 1. .00 20. .72 A c
ATOM 318 CB SER A 45 -22. .604 -37. .567 -3. .142 1. .00 20. .80 A c
ATOM 319 OG SER A 45 -22. .968 -37. .078 -1. .894 1. .00 21. .92 A o
ATOM 320 C SER A 45 -20. .325 -38. .324 -3. .784 1. .00 19. .65 A c
ATOM 321 o SER A 45 -20. .563 -39. .037 -4. .775 1. .00 19. .28 A o
ATOM 322 N LEU A 46 -19. .357 -38. .602 -2. .901 1. .00 17. .76 A N
ATOM 323 CA LEU A 46 -18. .494 -39. .787 -3. .055 1. .00 16. .26 A c
ATOM 324 CB LEU A 46 -17. .059 -39. .358 -3. .308 1. .00 15. .57 A c
ATOM 325 CG LEU A 46 -16. .799 -38. .486 -4. .528 1. .00 15. .28 A c
ATOM 326 CDl LEU A 46 -15. .336 -38. .131 -4. .537 1. .00 15. .11 A c
ATOM 327 CD 2 LEU A 46 -17. .173 -39. .184 -5. .834 1. .00 15. .38 A c
ATOM 328 C LEU A 46 -18. .528 -40. .707 -1. .854 1. .00 15. .97 A c
ATOM 329 o LEU A 46 -18. .512 -40. .255 -0. .740 1. .00 15. .97 A o
ATOM 330 N PRO A 47 -18. .450 -42. .021 -2. .068 1. .00 16. .23 A N
ATOM 331 CA PRO A 47 -18. .098 -42. .713 -3. .302 1. .00 16. .33 A c
ATOM 332 CB PRO A 47 -17. .593 -44. .069 -2. .806 1. .00 16. .02 A c
ATOM 333 CG PRO A 47 -17. .843 -44. .110 -1. .340 1. .00 15. .83 A c
ATOM 334 CD PRO A 47 -18. .710 -42. .968 -0. .980 1. .00 15. .87 A c
ATOM 335 C PRO A 47 -19. .271 -42. .898 -4. .262 1. .00 16. .88 A c
ATOM 336 o PRO A 47 -19. .062 -43. .188 -5. .448 1. .00 16. .98 A o
ATOM 337 N GLY A 48 -20. .496 -42. .741 -3. .752 1. .00 16. .89 A N
ATOM 338 CA GLY A 48 -21. .680 -42. .866 -4. .577 1. .00 15. .71 A c
ATOM 339 C GLY A 48 -22. .281 -44. .214 -4. .323 1. .00 14. .63 A c
ATOM 340 o GLY A 48 -21. .984 -44. .833 -3. .317 1. .00 13. .70 A o
ATOM 341 N THR A 49 -23. .111 -44. .644 -5. .262 1. .00 14. .42 A N
ATOM 342 CA THR A 49 -23. .844 -45. .889 -5. .184 1. .00 15. .14 A c
ATOM 343 CB THR A 49 -25. .186 -45. .825 -5. .997 1. .00 15. .13 A c
ATOM 344 OGl THR A 49 -25. .981 -44. .687 -5. .619 1. .00 14. .36 A o
ATOM 345 CG2 THR A 49 -25. .983 -47. .129 -5. .846 1. .00 14. .54 A c
ATOM 346 C THR A 49 -23. .005 -46. .995 -5. .821 1. .00 15. .82 A c
ATOM 347 o THR A 49 -22. .654 -46. .911 -7. .008 1. .00 15. .76 A o
ATOM 348 N LEU A 50 -22. .696 -48. .036 -5. .055 1. .00 16. .29 A N
ATOM 349 CA LEU A 50 -21. .971 -49. .177 -5. .612 1. .00 16. .67 A c
ATOM 350 CB LEU A 50 -21. .402 -50. .030 -4. .494 1. .00 16. .62 A c
ATOM 351 CG LEU A 50 -21. .206 -51. .532 -4. .619 1. .00 17. .18 A c
ATOM 352 CDl LEU A 50 -20. .505 -51. .964 -5. .905 1. .00 17. .48 A c
ATOM 353 CD 2 LEU A 50 -20. .430 -51. .992 -3. .379 1. .00 17. .09 A c
ATOM 354 C LEU A 50 -22. .908 -49. .955 -6. .527 1. .00 16. .87 A c
ATOM 355 o LEU A 50 -24. .039 -50. .225 -6. .155 1. .00 18. .03 A o
ATOM 356 N LEU A 51 -22. .438 -50. .289 -7. .724 1. .00 16. .66 A N
ATOM 357 CA LEU A 51 -23. .304 -50. .807 -8. .767 1. .00 16. .90 A c
ATOM 358 CB LEU A 51 -22. .702 -50. .580 -10. .165 1. .00 17. .78 A c
ATOM 359 CG LEU A 51 -22. .995 -49. .231 -10. .854 1. .00 18. .55 A c
ATOM 360 CDl LEU A 51 -21. .780 -48. .321 -10. .737 1. .00 18. .87 A c
ATOM 361 CD 2 LEU A 51 -23. .352 -49. .435 -12. .335 1. .00 19. .37 A c
ATOM 362 C LEU A 51 -23. .664 -52. .270 -8. .629 1. .00 16. .37 A c
ATOM 363 o LEU A 51 -22. .888 -53. .090 -8. .130 1. .00 16. .35 A o
ATOM 364 N THR A 52 -24. .843 -52. .591 -9. .151 1. .00 16. .12 A N
ATOM 365 CA THR A 52 -25. .398 -53. .941 -9. .097 1. .00 15. .93 A c
ATOM 366 CB THR A 52 -26. .453 -54. .014 -7. .998 1. .00 15. .10 A c
ATOM 367 OGl THR A 52 -27. .129 -52. .773 -7. .961 1. .00 14. .51 A o
ATOM 368 CG2 THR A 52 -25. .826 -54. .189 -6. .670 1. .00 15. .28 A c
ATOM 369 C THR A 52 -26. .087 -54. .312 -10. .398 1. .00 16. .34 A c
ATOM 370 o THR A 52 -26. .640 -53. .474 -11. .070 1. .00 16. .38 A o
ATOM 371 N SER A 53 -26. .044 -55. .575 -10. .764 1. .00 17. .42 A N
ATOM 372 CA SER A 53 -26. .900 -56. .061 -11. .829 1. .00 18. .54 A c
ATOM 373 CB SER A 53 -26. .179 -56. .074 -13. .170 1. .00 19. .26 A c
ATOM 374 OG SER A 53 -26. .656 -57. .168 -13. .945 1. .00 19. .86 A o
ATOM 375 C SER A 53 -27. .334 -57. .468 -11. .510 1. .00 18. .55 A c
ATOM 376 o SER A 53 -26. .473 -58. .367 -11. .355 1. .00 17. .72 A o
ATOM 377 N SER A 54 -28. .651 -57. .665 -11. .445 1. .00 18. .20 A N
ATOM 378 CA SER A 54 -29. .183 -58. .969 -11. .039 1. .00 19. .04 A c
ATOM 379 CB SER A 54 -30. .671 -58. .894 -10. .731 1. .00 19. .67 A c
ATOM 380 OG SER A 54 -31. .362 -58. .586 -11. .907 1. .00 21. .03 A o
ATOM 381 C SER A 54 -28. .905 -60. .070 -12. .047 1. .00 17. .88 A c
ATOM 382 o SER A 54 -28. .803 -61. .243 -11. .644 1. .00 18. .22 A o
ATOM 383 N SER A 55 -28..737 -59..695 -13..324 1..00 16..80 A N
ATOM 384 CA SER A 55 -28. .274 -60. .644 -14. .363 1. .00 16. .20 A C
ATOM 385 CB SER A 55 -28. .701 -60. .186 -15. .757 1. .00 15. .87 A C
ATOM 386 OG SER A 55 -28. .447 -58. .827 -15. .969 1. .00 15. .88 A o
ATOM 387 C SER A 55 -26. .775 -60. .983 -14. .384 1. .00 15. .91 A c
ATOM 388 o SER A 55 -26. .388 -61. .948 -15. .025 1. .00 15. .99 A o
ATOM 389 N ASN A 56 -25. .947 -60. .220 -13. .671 1. .00 16. .14 A N
ATOM 390 CA ASN A 56 -24. .472 -60. .215 -13. .852 1. .00 15. .95 A c
ATOM 391 CB ASN A 56 -23. .805 -61. .536 -13. .382 1. .00 15. .78 A c
ATOM 392 CG ASN A 56 -22. .360 -61. .358 -12. .860 1. .00 15. .19 A c
ATOM 393 ODl ASN A 56 -21. .554 -62. .306 -12. .853 1. .00 14. .47 A o
ATOM 394 ND2 ASN A 56 -22. .041 -60. .169 -12. .400 1. .00 14. .98 A N
ATOM 395 C ASN A 56 -24. .092 -59. .885 -15. .296 1. .00 16. .66 A c
ATOM 396 o ASN A 56 -23. .018 -60. .280 -15. .756 1. .00 16. .28 A o
ATOM 397 N ILE A 57 -24. .984 -59. .161 -15. .989 1. .00 17. .56 A N
ATOM 398 CA ILE A 57 -24. .682 -58. .525 -17. .259 1. .00 18. .93 A c
ATOM 399 CB ILE A 57 -25. .650 -58. .958 -18. .366 1. .00 20. .60 A c
ATOM 400 CGl ILE A 57 -25. .606 -60. .475 -18. .578 1. .00 21. .60 A c
ATOM 401 CDl ILE A 57 -26. .715 -60. .933 -19. .510 1. .00 21. .99 A c
ATOM 402 CG2 ILE A 57 -25. .300 -58. .247 -19. .673 1. .00 20. .37 A c
ATOM 403 C ILE A 57 -24. .827 -57. .017 -17. .089 1. .00 18. .81 A c
ATOM 404 o ILE A 57 -25. .830 -56. .572 -16. .550 1. .00 18. .38 A o
ATOM 405 N TRP A 58 -23. .869 -56. .241 -17. .603 1. .00 18. .79 A N
ATOM 406 CA TRP A 58 -23. .663 -54. .869 -17. .151 1. .00 19. .08 A c
ATOM 407 CB TRP A 58 -22. .285 -54. .753 -16. .467 1. .00 18. .65 A c
ATOM 408 CG TRP A 58 -22. .126 -55. .653 -15. .263 1. .00 17. .04 A c
ATOM 409 CDl TRP A 58 -21. .699 -56. .943 -15. .248 1. .00 16. .33 A c
ATOM 410 NEl TRP A 58 -21. .716 -57. .436 -13. .972 1. .00 15. .66 A N
ATOM 411 CE2 TRP A 58 -22. .166 -56. .454 -13. .135 1. .00 15. .87 A c
ATOM 412 CD 2 TRP A 58 -22. .431 -55. .318 -13. .921 1. .00 15. .82 A c
ATOM 413 CE3 TRP A 58 -22. .930 -54. .178 -13. .310 1. .00 15. .17 A c
ATOM 414 CZ3 TRP A 58 -23. .119 -54. .190 -11. .949 1. .00 15. .35 A c
ATOM 415 CH2 TRP A 58 -22. .833 -55. .320 -11. .181 1. .00 15. .47 A c
ATOM 416 CZ2 TRP A 58 -22. .357 -56. .465 -11. .757 1. .00 15. .91 A c
ATOM 417 C TRP A 58 -23. .743 -53. .866 -18. .273 1. .00 21. .25 A c
ATOM 418 o TRP A 58 -22. .885 -53. .847 -19. .163 1. .00 21. .87 A o
ATOM 419 N ASN A 59 -24. .748 -52. .994 -18. .211 1. .00 23. .98 A N
ATOM 420 CA ASN A 59 -25. .040 -52. .065 -19. .306 1. .00 24. .38 A c
ATOM 421 CB ASN A 59 -26. .548 -51. .940 -19. .490 1. .00 26. .43 A c
ATOM 422 CG ASN A 59 -27. .209 -51. .187 -18. .334 1. .00 29. .93 A c
ATOM 423 ODl ASN A 59 -26. .529 -50. .504 -17. .551 1. .00 31. .64 A o
ATOM 424 ND2 ASN A 59 -28. .536 -51. .308 -18. .213 1. .00 32. .05 A N
ATOM 425 C ASN A 59 -24. .455 -50. .672 -19. .083 1. .00 23. .75 A c
ATOM 426 o ASN A 59 -24. .810 -49. .744 -19. .806 1. .00 27. .95 A o
ATOM 427 N ASP A 60 -23. .589 -50. .499 -18. .093 1. .00 20. .98 A N
ATOM 428 CA ASP A 60 -22. .892 -49. .230 -17. .924 1. .00 19. .55 A c
ATOM 429 CB ASP A 60 -22. .924 -48. .781 -16. .477 1. .00 19. .97 A c
ATOM 430 CG ASP A 60 -22. .413 -47. .377 -16. .304 1. .00 21. .08 A c
ATOM 431 ODl ASP A 60 -21. .574 -46. .928 -17. .121 1. .00 22. .86 A o
ATOM 432 OD2 ASP A 60 -22. .856 -46. .703 -15. .354 1. .00 22. .23 A o
ATOM 433 C ASP A 60 -21. .437 -49. .304 -18. .376 1. .00 18. .14 A c
ATOM 434 o ASP A 60 -20. .592 -49. .914 -17. .694 1. .00 17. .59 A o
ATOM 435 N GLY A 61 -21. .133 -48. .599 -19. .466 1. .00 16. .48 A N
ATOM 436 CA GLY A 61 -19. .822 -48. .709 -20. .138 1. .00 15. .68 A c
ATOM 437 C GLY A 61 -18. .639 -48. .102 -19. .392 1. .00 14. .75 A c
ATOM 438 o GLY A 61 -17. .577 -48. .719 -19. .298 1. .00 14. .18 A o
ATOM 439 N ALA A 62 -18. .826 -46. .885 -18. .896 1. .00 13. .68 A N
ATOM 440 CA ALA A 62 -17. .870 -46. .232 -18. .027 1. .00 13. .21 A c
ATOM 441 CB ALA A 62 -18. .383 -44. .874 -17. .598 1. .00 13. .34 A c
ATOM 442 C ALA A 62 -17. .597 -47. .074 -16. .805 1. .00 12. .94 A c
ATOM 443 o ALA A 62 -16. .441 -47. .297 -16. .457 1. .00 12. .77 A o
ATOM 444 N ALA A 63 -18. .646 -47. .569 -16. .161 1. .00 12. .70 A N
ATOM 445 CA ALA A 63 -18. .434 -48. .493 -15. .027 1. .00 12. .59 A c
ATOM 446 CB ALA A 63 -19. .759 -48. .903 -14. .401 1. .00 12. .74 A c
ATOM 447 C ALA A 63 -17. .626 -49. .732 -15. .433 1. .00 11. .84 A c
ATOM 448 o ALA A 63 -16. .674 -50. .096 -14. .771 1. .00 11. .48 A o
ATOM 449 N VAL A 64 -18. .007 -50. .362 -16. .530 1. .00 11. .59 A N
ATOM 450 CA VAL A 64 -17. .296 -51. .555 -17. .001 1. .00 11. .64 A c
ATOM 451 CB VAL A 64 -17. .946 -52. .163 -18. .282 1. .00 11. .76 A c
ATOM 452 CGl VAL A 64 -16. .973 -53. .097 -18. .988 1. .00 11. .89 A c
ATOM 453 CG2 VAL A 64 -19. .239 -52. .927 -17. .954 1. .00 11. .63 A c
ATOM 454 C VAL A 64 -15. .811 -51. .314 -17. .274 1. .00 11. .25 A c
ATOM 455 o VAL A 64 -14. .967 -52. .092 -16. .889 1. .00 10. .71 A o
ATOM 456 N ASP A 65 -15. .499 -50. .244 -17. .972 1. .00 11. .62 A N
ATOM 457 CA ASP A 65 -14. .103 -49. .937 -18. .299 1. .00 11. .62 A c
ATOM 458 CB ASP A 65 -13. .988 -48. .750 -19. .282 1. .00 11. .58 A c
ATOM 459 CG ASP A 65 -14. .272 -49. .144 -20. .735 1. .00 11. .39 A c
ATOM 460 ODl ASP A 65 -14. .119 -50. .315 -21. .053 1. .00 11. .29 A o
ATOM 461 OD2 ASP A 65 -14. .647 -48. .294 -21. .563 1. .00 11. .28 A o
ATOM 462 C ASP A 65 -13..343 -49..657 -17..011 1..00 11..68 A C
ATOM 463 o ASP A 65 -12. .287 -50. .237 -16. .795 1. .00 12. .17 A o
ATOM 464 N ALA A 66 -13. .881 -48. .805 -16. .142 1. .00 11. .22 A N
ATOM 465 CA ALA A 66 -13. .206 -48. .530 -14. .877 1. .00 11. .26 A C
ATOM 466 CB ALA A 66 -14. .002 -47. .545 -14. .038 1. .00 11. .11 A C
ATOM 467 C ALA A 66 -12. .942 -49. .816 -14. .076 1. .00 11. .77 A c
ATOM 468 o ALA A 66 -11. .835 -50. .016 -13. .538 1. .00 11. .80 A o
ATOM 469 N HIS A 67 -13. .944 -50. .690 -13. .995 1. .00 11. .93 A N
ATOM 470 CA HIS A 67 -13. .758 -51. .933 -13. .275 1. .00 12. .20 A c
ATOM 471 CB HIS A 67 -15. .047 -52. .745 -13. .195 1. .00 12. .39 A c
ATOM 472 CG HIS A 67 -15. .079 -53. .722 -12. .053 1. .00 12. .80 A c
ATOM 473 NDl HIS A 67 -15. .102 -53. .327 -10. .736 1. .00 13. .19 A N
ATOM 474 CEl HIS A 67 -15. .143 -54. .396 -9. .955 1. .00 13. .25 A c
ATOM 475 NE2 HIS A 67 -15. .176 -55. .469 -10. .719 1. .00 12. .96 A N
ATOM 476 CD 2 HIS A 67 -15. .137 -55. .075 -12. .033 1. .00 13. .09 A C
ATOM 477 C HIS A 67 -12. .649 -52. .740 -13. .934 1. .00 12. .01 A c
ATOM 478 o HIS A 67 -11. .651 -53. .041 -13. .316 1. .00 12. .49 A o
ATOM 479 N ALA A 68 -12. .809 -53. .051 -15. .205 1. .00 11. .74 A N
ATOM 480 CA ALA A 68 -11. .876 -53. .929 -15. .905 1. .00 11. .42 A c
ATOM 481 CB ALA A 68 -12. .395 -54. .188 -17. .313 1. .00 11. .62 A c
ATOM 482 C ALA A 68 -10. .449 -53. .368 -15. .986 1. .00 10. .67 A c
ATOM 483 o ALA A 68 -9. .451 -54. .078 -15. .807 1. .00 10. .44 A o
ATOM 484 N TYR A 69 -10. .368 -52. .089 -16. .267 1. .00 10. .14 A N
ATOM 485 CA TYR A 69 -9. .083 -51. .445 -16. .372 1. .00 9. .92 A c
ATOM 486 CB TYR A 69 -9. .211 -50. .127 -17. .137 1. .00 9. .77 A c
ATOM 487 CG TYR A 69 -9. .568 -50. .343 -18. .608 1. .00 9. .70 A c
ATOM 488 CDl TYR A 69 -9. .263 -51. .544 -19. .258 1. .00 9. .60 A c
ATOM 489 CEl TYR A 69 -9. .588 -51. .750 -20. .584 1. .00 9. .57 A c
ATOM 490 CZ TYR A 69 -10. .204 -50. .755 -21. .307 1. .00 9. .49 A c
ATOM 491 OH TYR A 69 -10. .500 -50. .982 -22. .645 1. .00 8. .99 A o
ATOM 492 CE2 TYR A 69 -10. .509 -49. .549 -20. .685 1. .00 9. .61 A c
ATOM 493 CD 2 TYR A 69 -10. .201 -49. .356 -19. .341 1. .00 9. .63 A c
ATOM 494 C TYR A 69 -8. .366 -51. .278 -15. .053 1. .00 9. .69 A c
ATOM 495 o TYR A 69 -7. .129 -51. .268 -15. .022 1. .00 9. .58 A o
ATOM 496 N THR A 70 -9. .129 -51. .193 -13. .965 1. .00 9. .51 A N
ATOM 497 CA THR A 70 -8. .532 -51. .019 -12. .645 1. .00 9. .27 A c
ATOM 498 CB THR A 70 -9. .549 -50. .438 -11. .620 1. .00 9. .02 A c
ATOM 499 OGl THR A 70 -9. .925 -49. .095 -11. .972 1. .00 8. .65 A o
ATOM 500 CG2 THR A 70 -8. .960 -50. .394 -10. .262 1. .00 8. .99 A c
ATOM 501 C THR A 70 -7. .970 -52. .395 -12. .257 1. .00 9. .35 A c
ATOM 502 o THR A 70 -6. .910 -52. .516 -11. .659 1. .00 9. .65 A o
ATOM 503 N ALA A 71 -8. .655 -53. .452 -12. .651 1. .00 9. .39 A N
ATOM 504 CA ALA A 71 -8. .127 -54. .785 -12. .428 1. .00 9. .42 A c
ATOM 505 CB ALA A 71 -9. .190 -55. .834 -12. .721 1. .00 9. .15 A c
ATOM 506 C ALA A 71 -6. .854 -54. .985 -13. .284 1. .00 9. .65 A c
ATOM 507 o ALA A 71 -5. .878 -55. .594 -12. .835 1. .00 9. .53 A o
ATOM 508 N LYS A 72 -6. .842 -54. .432 -14. .491 1. .00 10. .10 A N
ATOM 509 CA LYS A 72 -5. .638 -54. .469 -15. .315 1. .00 10. .84 A c
ATOM 510 CB LYS A 72 -5. .945 -53. .814 -16. .635 1. .00 11. .60 A c
ATOM 511 CG LYS A 72 -5. .034 -54. .225 -17. .764 1. .00 12. .60 A c
ATOM 512 CD LYS A 72 -5. .285 -53. .298 -18. .948 1. .00 13. .78 A c
ATOM 513 CE LYS A 72 -4. .237 -53. .477 -20. .052 1. .00 14. .79 A c
ATOM 514 NZ LYS A 72 -4. .525 -54. .698 -20. .852 1. .00 15. .32 A N
ATOM 515 C LYS A 72 -4. .428 -53. .773 -14. .648 1. .00 10. .95 A c
ATOM 516 o LYS A 72 -3. .320 -54. .296 -14. .566 1. .00 10. .53 A o
ATOM 517 N VAL A 73 -4. .666 -52. .580 -14. .143 1. .00 11. .11 A N
ATOM 518 CA VAL A 73 -3. .613 -51. .873 -13. .539 1. .00 11. .29 A c
ATOM 519 CB VAL A 73 -4. .052 -50. .456 -13. .206 1. .00 11. .29 A c
ATOM 520 CGl VAL A 73 -2. .976 -49. .773 -12. .375 1. .00 11. .51 A c
ATOM 521 CG2 VAL A 73 -4. .297 -49. .674 -14. .477 1. .00 11. .25 A c
ATOM 522 C VAL A 73 -3. .179 -52. .631 -12. .286 1. .00 11. .79 A c
ATOM 523 o VAL A 73 -1. .973 -52. .775 -12. .023 1. .00 12. .54 A o
ATOM 524 N TYR A 74 -4. .146 -53. .094 -11. .488 1. .00 11. .69 A N
ATOM 525 CA TYR A 74 -3. .803 -53. .789 -10. .253 1. .00 11. .38 A c
ATOM 526 CB TYR A 74 -5. .052 -54. .356 -9. .512 1. .00 10. .72 A c
ATOM 527 CG TYR A 74 -4. .642 -55. .235 -8. .341 1. .00 9. .87 A c
ATOM 528 CDl TYR A 74 -4. .236 -56. .541 -8. .538 1. .00 9. .52 A c
ATOM 529 CEl TYR A 74 -3. .798 -57. .334 -7. .492 1. .00 9. .27 A c
ATOM 530 CZ TYR A 74 -3. .767 -56. .822 -6. .235 1. .00 9. .43 A c
ATOM 531 OH TYR A 74 -3. .319 -57. .598 -5. .195 1. .00 9. .43 A o
ATOM 532 CE2 TYR A 74 -4. .152 -55. .514 -6. .010 1. .00 9. .49 A c
ATOM 533 CD 2 TYR A 74 -4. .577 -54. .729 -7. .062 1. .00 9. .59 A c
ATOM 534 C TYR A 74 -2. .797 -54. .923 -10. .602 1. .00 12. .02 A c
ATOM 535 o TYR A 74 -1. .816 -55. .093 -9. .905 1. .00 11. .97 A o
ATOM 536 N ASP A 75 -3. .062 -55. .670 -11. .683 1. .00 12. .59 A N
ATOM 537 CA ASP A 75 -2. .225 -56. .802 -12. .099 1. .00 13. .15 A c
ATOM 538 CB ASP A 75 -2. .863 -57. .577 -13. .258 1. .00 12. .65 A c
ATOM 539 CG ASP A 75 -4. .140 -58. .272 -12. .887 1. .00 12. .28 A c
ATOM 540 ODl ASP A 75 -4. .408 -58. .613 -11. .704 1. .00 11. .68 A o
ATOM 541 OD2 ASP A 75 -4..889 -58..488 -13..848 1..00 12..29 A o
ATOM 542 C ASP A 75 -0. .884 -56. .370 -12. .652 1. .00 13. .93 A C
ATOM 543 o ASP A 75 0. .029 -57. .189 -12. .744 1. .00 14. .31 A o
ATOM 544 N TYR A 76 -0. .790 -55. .129 -13. .108 1. .00 14. .12 A N
ATOM 545 CA TYR A 76 0. .435 -54. .684 -13. .703 1. .00 15. .01 A c
ATOM 546 CB TYR A 76 0. .232 -53. .411 -14. .549 1. .00 14. .93 A c
ATOM 547 CG TYR A 76 1. .483 -52. .846 -15. .181 1. .00 14. .82 A c
ATOM 548 CDl TYR A 76 2. .257 -51. .907 -14. .523 1. .00 15. .03 A c
ATOM 549 CEl TYR A 76 3. .409 -51. .387 -15. .107 1. .00 15. .40 A c
ATOM 550 CZ TYR A 76 3. .787 -51. .815 -16. .375 1. .00 15. .55 A c
ATOM 551 OH TYR A 76 4. .929 -51. .315 -16. .990 1. .00 15. .74 A o
ATOM 552 CE2 TYR A 76 3. .022 -52. .753 -17. .036 1. .00 15. .06 A c
ATOM 553 CD 2 TYR A 76 1. .880 -53. .248 -16. .444 1. .00 15. .02 A c
ATOM 554 C TYR A 76 1. .381 -54. .465 -12. .538 1. .00 15. .85 A c
ATOM 555 o TYR A 76 2. .541 -54. .932 -12. .545 1. .00 16. .76 A o
ATOM 556 N TYR A 77 0. .898 -53. .779 -11. .522 1. .00 16. .19 A N
ATOM 557 CA TYR A 77 1. .796 -53. .445 -10. .429 1. .00 17. .84 A c
ATOM 558 CB TYR A 77 1. .163 -52. .449 -9. .451 1. .00 16. .53 A c
ATOM 559 CG TYR A 77 1. .341 -50. .967 -9. .805 1. .00 15. .02 A c
ATOM 560 CDl TYR A 77 2. .441 -50. .267 -9. .364 1. .00 14. .53 A c
ATOM 561 CEl TYR A 77 2. .587 -48. .923 -9. .613 1. .00 14. .07 A c
ATOM 562 CZ TYR A 77 1. .622 -48. .263 -10. .311 1. .00 13. .99 A c
ATOM 563 OH TYR A 77 1. .805 -46. .916 -10. .568 1. .00 14. .22 A o
ATOM 564 CE2 TYR A 77 0. .492 -48. .927 -10. .740 1. .00 13. .72 A c
ATOM 565 CD 2 TYR A 77 0. .360 -50. .266 -10. .487 1. .00 14. .12 A c
ATOM 566 C TYR A 77 2. .211 -54. .723 -9. .712 1. .00 19. .97 A c
ATOM 567 o TYR A 77 3. .325 -54. .819 -9. .174 1. .00 21. .51 A o
ATOM 568 N LYS A 78 1. .315 -55. .704 -9. .730 1. .00 22. .11 A N
ATOM 569 CA LYS A 78 1. .556 -56. .962 -9. .075 1. .00 23. .87 A c
ATOM 570 CB LYS A 78 0. .239 -57. .743 -8. .908 1. .00 25. .91 A c
ATOM 571 CG LYS A 78 0. .347 -59. .104 -8. .221 1. .00 28. .58 A c
ATOM 572 CD LYS A 78 1. .136 -59. .006 -6. .918 1. .00 33. .48 A c
ATOM 573 CE LYS A 78 0. .619 -59. .934 -5. .815 1. .00 37. .52 A c
ATOM 574 NZ LYS A 78 -0. .673 -59. .444 -5. .218 1. .00 39. .88 A N
ATOM 575 C LYS A 78 2. .622 -57. .747 -9. .855 1. .00 22. .86 A c
ATOM 576 o LYS A 78 3. .600 -58. .188 -9. .247 1. .00 22. .16 A o
ATOM 577 N ASN A 79 2. .471 -57. .888 -11. .173 1. .00 21. .47 A N
ATOM 578 CA ASN A 79 3. .422 -58. .714 -11. .919 1. .00 22. .64 A c
ATOM 579 CB ASN A 79 2. .899 -59. .148 -13. .278 1. .00 23. .04 A c
ATOM 580 CG ASN A 79 1. .578 -59. .888 -13. .188 1. .00 24. .12 A c
ATOM 581 ODl ASN A 79 0. .759 -59. .783 -14. .094 1. .00 24. .68 A o
ATOM 582 ND2 ASN A 79 1. .348 -60. .617 -12. .087 1. .00 24. .13 A N
ATOM 583 C ASN A 79 4. .769 -58. .059 -12. .103 1. .00 23. .13 A c
ATOM 584 o ASN A 79 5. .794 -58. .714 -11. .909 1. .00 23. .42 A o
ATOM 585 N LYS A 80 4. .776 -56. .780 -12. .460 1. .00 23. .09 A N
ATOM 586 CA LYS A 80 6. .024 -56. .117 -12. .778 1. .00 24. .20 A c
ATOM 587 CB LYS A 80 5. .783 -54. .871 -13. .631 1. .00 27. .00 A c
ATOM 588 CG LYS A 80 5. .314 -55. .181 -15. .037 1. .00 30. .36 A c
ATOM 589 CD LYS A 80 6. .423 -55. .858 -15. .854 1. .00 33. .94 A c
ATOM 590 CE LYS A 80 5. .916 -57. .048 -16. .688 1. .00 36. .49 A c
ATOM 591 NZ LYS A 80 5. .336 -56. .639 -17. .999 1. .00 37. .18 A N
ATOM 592 C LYS A 80 6. .841 -55. .741 -11. .554 1. .00 22. .72 A c
ATOM 593 o LYS A 80 8. .080 -55. .784 -11. .599 1. .00 24. .14 A o
ATOM 594 N PHE A 81 6. .173 -55. .352 -10. .472 1. .00 20. .24 A N
ATOM 595 CA PHE A 81 6. .876 -54. .813 -9. .318 1. .00 18. .15 A c
ATOM 596 CB PHE A 81 6. .447 -53. .380 -9. .064 1. .00 18. .87 A c
ATOM 597 CG PHE A 81 6. .461 -52. .505 -10. .289 1. .00 18. .61 A c
ATOM 598 CDl PHE A 81 7. .599 -52. .404 -11. .065 1. .00 18. .00 A c
ATOM 599 CEl PHE A 81 7. .632 -51. .587 -12. .184 1. .00 18. .22 A c
ATOM 600 CZ PHE A 81 6. .510 -50. .862 -12. .542 1. .00 18. .35 A c
ATOM 601 CE2 PHE A 81 5. .354 -50. .955 -11. .759 1. .00 18. .91 A c
ATOM 602 CD 2 PHE A 81 5. .335 -51. .770 -10. .643 1. .00 18. .40 A c
ATOM 603 C PHE A 81 6. .655 -55. .584 -8. .054 1. .00 16. .49 A c
ATOM 604 o PHE A 81 7. .232 -55. .247 -7. .031 1. .00 15. .88 A o
ATOM 605 N GLY A 82 5. .840 -56. .626 -8. .098 1. .00 15. .73 A N
ATOM 606 CA GLY A 82 5. .448 -57. .296 -6. .856 1. .00 15. .78 A c
ATOM 607 C GLY A 82 4. .790 -56. .346 -5. .834 1. .00 15. .32 A c
ATOM 608 o GLY A 82 4. .948 -56. .516 -4. .643 1. .00 15. .40 A o
ATOM 609 N ARG A 83 4. .057 -55. .343 -6. .311 1. .00 14. .39 A N
ATOM 610 CA ARG A 83 3. .366 -54. .424 -5. .447 1. .00 13. .68 A c
ATOM 611 CB ARG A 83 3. .555 -52. .995 -5. .912 1. .00 13. .45 A c
ATOM 612 CG ARG A 83 3. .011 -52. .011 -4. .904 1. .00 13. .06 A c
ATOM 613 CD ARG A 83 2. .913 -50. .629 -5. .479 1. .00 13. .28 A c
ATOM 614 NE ARG A 83 2. .721 -49. .736 -4. .358 1. .00 13. .46 A N
ATOM 615 CZ ARG A 83 3. .697 -49. .171 -3. .662 1. .00 13. .30 A c
ATOM 616 NHl ARG A 83 4. .971 -49. .321 -3. .998 1. .00 13. .23 A N
ATOM 617 NH2 ARG A 83 3. .375 -48. .419 -2. .631 1. .00 13. .54 A N
ATOM 618 C ARG A 83 1. .871 -54. .704 -5. .384 1. .00 13. .51 A C
ATOM 619 o ARG A 83 1. .183 -54. .725 -6. .390 1. .00 13. .70 A o
ATOM 620 N ASN A 84 1..390 -54..879 -4..167 1..00 13..56 A N
ATOM 621 CA ASN A 84 0. .009 -55. .148 -3. .893 1. .00 13. .51 A C
ATOM 622 CB ASN A 84 -0. .088 -56. .018 -2. .658 1. .00 13. .59 A C
ATOM 623 CG ASN A 84 -1. .491 -56. .487 -2. .384 1. .00 14. .02 A c
ATOM 624 ODl ASN A 84 -1. .725 -57. .145 -1. .381 1. .00 15. .08 A o
ATOM 625 ND2 ASN A 84 -2. .428 -56. .165 -3. .261 1. .00 13. .79 A N
ATOM 626 C ASN A 84 -0. .760 -53. .864 -3. .630 1. .00 13. .38 A c
ATOM 627 o ASN A 84 -0. .857 -53. .447 -2. .476 1. .00 13. .02 A o
ATOM 628 N SER A 85 -1. .301 -53. .271 -4. .707 1. .00 12. .63 A N
ATOM 629 CA SER A 85 -2. .121 -52. .055 -4. .669 1. .00 11. .89 A c
ATOM 630 CB SER A 85 -3. .343 -52. .185 -3. .746 1. .00 11. .20 A c
ATOM 631 OG SER A 85 -4. .254 -51. .134 -3. .980 1. .00 10. .14 A o
ATOM 632 C SER A 85 -1. .291 -50. .867 -4. .273 1. .00 12. .38 A c
ATOM 633 o SER A 85 -0. .066 -50. .944 -4. .210 1. .00 12. .63 A o
ATOM 634 N ILE A 86 -1. .990 -49. .773 -3. .990 1. .00 12. .96 A N
ATOM 635 CA ILE A 86 -1. .396 -48. .453 -3. .822 1. .00 13. .20 A c
ATOM 636 CB ILE A 86 -2. .512 -47. .385 -3. .647 1. .00 13. .89 A c
ATOM 637 CGl ILE A 86 -3. .144 -47. .100 -5. .011 1. .00 13. .93 A c
ATOM 638 CDl ILE A 86 -4. .318 -46. .147 -4. .967 1. .00 14. .24 A c
ATOM 639 CG2 ILE A 86 -1. .996 -46. .082 -3. .034 1. .00 14. .48 A c
ATOM 640 C ILE A 86 -0. .431 -48. .423 -2. .663 1. .00 13. .17 A c
ATOM 641 o ILE A 86 0. .620 -47. .786 -2. .759 1. .00 13. .10 A o
ATOM 642 N ASP A 87 -0. .767 -49. .114 -1. .569 1. .00 12. .99 A N
ATOM 643 CA ASP A 87 0. .130 -49. .095 -0. .380 1. .00 12. .59 A c
ATOM 644 CB ASP A 87 -0. .644 -48. .780 0. .920 1. .00 12. .29 A c
ATOM 645 CG ASP A 87 -1. .666 -49. .810 1. .265 1. .00 11. .98 A c
ATOM 646 ODl ASP A 87 -1. .658 -50. .921 0. .683 1. .00 12. .11 A o
ATOM 647 OD2 ASP A 87 -2. .496 -49. .479 2. .115 1. .00 11. .43 A o
ATOM 648 C ASP A 87 1. .028 -50. .320 -0. .225 1. .00 12. .13 A c
ATOM 649 o ASP A 87 1. .692 -50. .494 0. .782 1. .00 11. .57 A o
ATOM 650 N GLY A 88 1. .067 -51. .168 -1. .236 1. .00 12. .40 A N
ATOM 651 CA GLY A 88 1. .807 -52. .407 -1. .092 1. .00 12. .89 A c
ATOM 652 C GLY A 88 1. .201 -53. .421 -0. .146 1. .00 13. .24 A c
ATOM 653 o GLY A 88 1. .699 -54. .542 -0. .132 1. .00 14. .52 A o
ATOM 654 N ASN A 89 0. .115 -53. .051 0. .567 1. .00 12. .96 A N
ATOM 655 CA ASN A 89 -0. .658 -53. .912 1. .473 1. .00 12. .96 A c
ATOM 656 CB ASN A 89 -0. .669 -53. .249 2. .844 1. .00 13. .56 A c
ATOM 657 CG ASN A 89 0. .641 -53. .362 3. .537 1. .00 13. .79 A c
ATOM 658 ODl ASN A 89 1. .205 -54. .457 3. .631 1. .00 14. .84 A o
ATOM 659 ND2 ASN A 89 1. .149 -52. .242 4. .029 1. .00 13. .75 A N
ATOM 660 C ASN A 89 -2. .147 -54. .210 1. .165 1. .00 12. .88 A c
ATOM 661 o ASN A 89 -2. .907 -54. .462 2. .095 1. .00 12. .88 A o
ATOM 662 N GLY A 90 -2. .574 -54. .175 -0. .097 1. .00 12. .86 A N
ATOM 663 CA GLY A 90 -3. .958 -54. .471 -0. .469 1. .00 12. .39 A c
ATOM 664 C GLY A 90 -4. .961 -53. .302 -0. .474 1. .00 12. .26 A c
ATOM 665 o GLY A 90 -6. .137 -53. .514 -0. .791 1. .00 12. .36 A o
ATOM 666 N PHE A 91 -4. .527 -52. .091 -0. .118 1. .00 11. .47 A N
ATOM 667 CA PHE A 91 -5. .390 -50. .906 -0. .131 1. .00 11. .28 A c
ATOM 668 CB PHE A 91 -4. .545 -49. .680 -0. .502 1. .00 11. .72 A c
ATOM 669 CG PHE A 91 -5. .262 -48. .333 -0. .429 1. .00 11. .82 A c
ATOM 670 CDl PHE A 91 -6. .027 -47. .869 -1. .503 1. .00 11. .80 A c
ATOM 671 CEl PHE A 91 -6. .634 -46. .609 -1. .454 1. .00 11. .78 A c
ATOM 672 CZ PHE A 91 -6. .457 -45. .791 -0. .341 1. .00 11. .56 A c
ATOM 673 CE2 PHE A 91 -5. .647 -46. .217 0. .706 1. .00 11. .63 A c
ATOM 674 CD 2 PHE A 91 -5. .053 -47. .470 0. .663 1. .00 11. .62 A c
ATOM 675 C PHE A 91 -6. .509 -51. .027 -1. .132 1. .00 10. .82 A c
ATOM 676 o PHE A 91 -6. .262 -50. .984 -2. .306 1. .00 11. .40 A o
ATOM 677 N GLN A 92 -7. .739 -51. .128 -0. .659 1. .00 10. .46 A N
ATOM 678 CA GLN A 92 -8. .903 -51. .300 -1. .520 1. .00 10. .16 A c
ATOM 679 CB GLN A 92 -10. .190 -51. .348 -0. .665 1. .00 9. .81 A c
ATOM 680 CG GLN A 92 -11. .435 -51. .789 -1. .424 1. .00 9. .40 A c
ATOM 681 CD GLN A 92 -12. .658 -51. .830 -0. .560 1. .00 9. .00 A c
ATOM 682 OEl GLN A 92 -13. .251 -50. .800 -0. .244 1. .00 8. .91 A o
ATOM 683 NE2 GLN A 92 -13. .056 -53. .023 -0. .179 1. .00 8. .85 A N
ATOM 684 C GLN A 92 -9. .020 -50. .172 -2. .547 1. .00 10. .41 A c
ATOM 685 o GLN A 92 -8. .852 -49. .014 -2. .220 1. .00 10. .73 A o
ATOM 686 N LEU A 93 -9. .372 -50. .531 -3. .774 1. .00 10. .45 A N
ATOM 687 CA LEU A 93 -9. .461 -49. .608 -4. .873 1. .00 10. .53 A c
ATOM 688 CB LEU A 93 -8. .795 -50. .248 -6. .088 1. .00 10. .43 A c
ATOM 689 CG LEU A 93 -7. .325 -50. .530 -5. .783 1. .00 10. .45 A c
ATOM 690 CDl LEU A 93 -6. .629 -51. .095 -6. .991 1. .00 10. .58 A c
ATOM 691 CD 2 LEU A 93 -6. .606 -49. .286 -5. .321 1. .00 10. .42 A c
ATOM 692 C LEU A 93 -10. .894 -49. .254 -5. .222 1. .00 10. .87 A c
ATOM 693 o LEU A 93 -11. .686 -50. .097 -5. .637 1. .00 10. .94 A o
ATOM 694 N LYS A 94 -11. .228 -47. .996 -5. .085 1. .00 11. .36 A N
ATOM 695 CA LYS A 94 -12. .557 -47. .606 -5. .384 1. .00 12. .41 A c
ATOM 696 CB LYS A 94 -13. .181 -46. .937 -4. .197 1. .00 13. .22 A c
ATOM 697 CG LYS A 94 -13. .478 -47. .903 -3. .087 1. .00 13. .81 A c
ATOM 698 CD LYS A 94 -14. .287 -47. .225 -1. .995 1. .00 14. .67 A c
ATOM 699 CE LYS A 94 -13 ..694 -47..606 -0..647 1..00 15..89 A C
ATOM 700 NZ LYS A 94 -14. .804 -47. . 787 0. .313 1. .00 16. . 73 A N
ATOM 701 C LYS A 94 -12 . . 553 -46. .638 -6. .490 1. .00 12. .80 A C
ATOM 702 o LYS A 94 -11. .826 -45. .662 -6. .437 1. .00 14. .03 A o
ATOM 703 N SER A 95 -13 . .419 -46. .878 -7. .462 1. .00 12. . 71 A N
ATOM 704 CA SER A 95 -13 . . 544 -46. .022 -8. .613 1. .00 12. . 55 A C
ATOM 705 CB SER A 95 -13 . .161 -46. .813 -9. .861 1. .00 12. . 73 A C
ATOM 706 OG SER A 95 -11. .804 -47. .234 -9. .800 1. .00 12. . 59 A o
ATOM 707 C SER A 95 -14. .974 -45. . 525 -8. .688 1. .00 12. . 34 A c
ATOM 708 o SER A 95 -15 . .918 -46. .275 -8. .456 1. .00 12. . 56 A o
ATOM 709 N THR A 96 -15 . .138 -44. .241 -8. .962 1. .00 12. . 35 A N
ATOM 710 CA THR A 96 -16. .466 -43. .667 -9. .154 1. .00 12. .18 A c
ATOM 711 CB THR A 96 -16. .765 -42. . 598 -8. .118 1. .00 12. .24 A c
ATOM 712 OGl THR A 96 -16. . 552 -43. .158 -6. .828 1. .00 12. .21 A o
ATOM 713 CG2 THR A 96 -18. .231 -42. .087 -8. .247 1. .00 12. .24 A c
ATOM 714 C THR A 96 -16. . 560 -42. .995 -10. .490 1. .00 12. .02 A c
ATOM 715 o THR A 96 -15 . .804 -42. .073 -10. .768 1. .00 11. .98 A o
ATOM 716 N VAL A 97 -17. . 512 -43. .453 -11. .286 1. .00 12. .10 A N
ATOM 717 CA VAL A 97 -17. .796 -42. .903 -12 . .610 1. .00 12. .29 A c
ATOM 718 CB VAL A 97 -18. .031 -44. .046 -13 . .614 1. .00 11. .84 A c
ATOM 719 CGl VAL A 97 -16. .842 -44. .997 -13 . .607 1. .00 11. .85 A c
ATOM 720 CG2 VAL A 97 -19. .294 -44. .816 -13 . .291 1. .00 11. .48 A c
ATOM 721 C VAL A 97 -19. .043 -41. .989 -12 . . 574 1. .00 12. . 50 A c
ATOM 722 o VAL A 97 -19. .760 -41. .922 -11. . 573 1. .00 12. .20 A o
ATOM 723 N HIS A 98 -19. .307 -41. . 321 -13 . .693 1. .00 12. . 79 A N
ATOM 724 CA HIS A 98 -20. .400 -40. . 338 -13 . .803 1. .00 12. . 70 A c
ATOM 725 CB HIS A 98 -21. .764 -40. .997 -13 . .788 1. .00 12. . 30 A c
ATOM 726 CG HIS A 98 -21. .870 -42. .180 -14. .687 1. .00 11. .98 A c
ATOM 727 NDl HIS A 98 -21. .648 -42. .103 -16. .040 1. .00 11. . 73 A N
ATOM 728 CEl HIS A 98 -21. .815 -43. .295 -16. . 574 1. .00 11. .81 A c
ATOM 729 NE2 HIS A 98 -22 . .147 -44. .138 -15 . .617 1. .00 11. . 79 A N
ATOM 730 CD 2 HIS A 98 -22 . .206 -43. .463 -14. .429 1. .00 11. . 79 A C
ATOM 731 C HIS A 98 -20. .334 -39. . 328 -12 . .685 1. .00 13. .21 A c
ATOM 732 o HIS A 98 -21. .348 -38. .988 -12 . .091 1. .00 13. .62 A o
ATOM 733 N TYR A 99 -19. .117 -38. .883 -12 . .389 1. .00 13. .68 A N
ATOM 734 CA TYR A 99 -18. .894 -37. .826 -11. .446 1. .00 13. .61 A c
ATOM 735 CB TYR A 99 -17. .410 -37. .665 -11. .086 1. .00 13. .46 A c
ATOM 736 CG TYR A 99 -17. .177 -36. . 565 -10. .042 1. .00 13. .94 A c
ATOM 737 CDl TYR A 99 -17. .426 -36. .805 -8. .691 1. .00 14. .10 A c
ATOM 738 CEl TYR A 99 -17. .213 -35. .826 -7. .731 1. .00 13. .91 A c
ATOM 739 CZ TYR A 99 -16. .774 -34. . 579 -8. .108 1. .00 13. .62 A c
ATOM 740 OH TYR A 99 -16. .605 -33. .644 -7. .112 1. .00 12. .97 A o
ATOM 741 CE2 TYR A 99 -16. . 553 -34. .292 -9. .445 1. .00 13. .47 A c
ATOM 742 CD 2 TYR A 99 -16. .756 -35. .278 -10. .400 1. .00 13. . 78 A c
ATOM 743 C TYR A 99 -19. .384 -36. . 564 -12 . .086 1. .00 13. .49 A c
ATOM 744 o TYR A 99 -18. .870 -36. .163 -13 . .106 1. .00 12. .90 A o
ATOM 745 N SER A 100 -20. .399 -35. .974 -11. .471 1. .00 14. .43 A N
ATOM 746 CA SER A 100 -20. .823 -34. .601 -11. .733 1. .00 15. .24 A c
ATOM 747 CB SER A 100 -19. .639 -33. .661 -11. . 530 1. .00 15. . 55 A c
ATOM 748 OG SER A 100 -20. .037 -32. . 309 -11. .482 1. .00 15. . 70 A o
ATOM 749 C SER A 100 -21. .440 -34. .469 -13 . .114 1. .00 16. .08 A c
ATOM 750 o SER A 100 -21. .916 -35. .443 -13 . .679 1. .00 16. .02 A o
ATOM 751 N SER A 101 -21. .448 -33. .271 -13 . .668 1. .00 18. .00 A N
ATOM 752 CA SER A 101 -22 . .109 -33. .064 -14. .954 1. .00 20. .04 A c
ATOM 753 CB SER A 101 -23 . .285 -32. .117 -14. .785 1. .00 20. . 79 A c
ATOM 754 OG SER A 101 -24. .125 -32. .255 -15 . .909 1. .00 22. .68 A o
ATOM 755 C SER A 101 -21. .172 -32. . 575 -16. .074 1. .00 20. .29 A c
ATOM 756 o SER A 101 -20. .448 -31. . 590 -15 . .909 1. .00 18. .68 A o
ATOM 757 N ARG A 102 -21. .210 -33. .275 -17. .212 1. .00 21. . 31 A N
ATOM 758 CA ARG A 102 -20. .354 -32. .962 -18. .351 1. .00 22. .92 A c
ATOM 759 CB ARG A 102 -20. .973 -31. .842 -19. .222 1. .00 25. . 54 A c
ATOM 760 CG ARG A 102 -22 . .375 -32. .170 -19. .771 1. .00 29. . 36 A c
ATOM 761 CD ARG A 102 -22 . . 597 -31. .658 -21. .202 1. .00 32. . 59 A c
ATOM 762 NE ARG A 102 -22 . .425 -30. .196 -21. .266 1. .00 35. . 58 A N
ATOM 763 CZ ARG A 102 -21. .863 -29. . 501 -22 . .268 1. .00 38. .08 A c
ATOM 764 NHl ARG A 102 -21. .371 -30. .080 -23 . .375 1. .00 37. .26 A N
ATOM 765 NH2 ARG A 102 -21. .785 -28. .183 -22 . .160 1. .00 40. .05 A N
ATOM 766 C ARG A 102 -18. .972 -32. . 558 -17. .854 1. .00 21. .22 A C
ATOM 767 o ARG A 102 -18. .499 -31. .478 -18. .155 1. .00 22. .96 A o
ATOM 768 N TYR A 103 -18. .337 -33. .431 -17. .088 1. .00 19. .27 A N
ATOM 769 CA TYR A 103 -17. .131 -33. .068 -16. .304 1. .00 18. .16 A C
ATOM 770 CB TYR A 103 -17. .246 -33. .653 -14. .876 1. .00 17. .43 A c
ATOM 771 CG TYR A 103 -16. .076 -33. . 397 -14. .001 1. .00 17. .19 A c
ATOM 772 CDl TYR A 103 -15 . .957 -32. .216 -13 . .283 1. .00 18. .00 A c
ATOM 773 CEl TYR A 103 -14. .860 -31. .991 -12 . .450 1. .00 18. .06 A c
ATOM 774 CZ TYR A 103 -13 . .875 -32. .964 -12 . .348 1. .00 17. . 35 A c
ATOM 775 OH TYR A 103 -12 . .774 -32. . 784 -11. . 574 1. .00 17. .41 A o
ATOM 776 CE2 TYR A 103 -13 . .985 -34. .135 -13 . .042 1. .00 17. .27 A c
ATOM 777 CD 2 TYR A 103 -15 . .078 -34. . 345 -13 . .864 1. .00 17. . 58 A c
ATOM 778 C TYR A 103 -15..854 -33..534 -17..030 1..00 16..89 A C
ATOM 779 o TYR A 103 -15. .682 -34. .721 -17. .328 1. .00 16. .93 A o
ATOM 780 N ASN A 104 -14. .967 -32. .600 -17. .341 1. .00 15. .51 A N
ATOM 781 CA ASN A 104 -13. .893 -32. .910 -18. .257 1. .00 14. .63 A C
ATOM 782 CB ASN A 104 -13. .665 -31. .743 -19. .205 1. .00 14. .81 A C
ATOM 783 CG ASN A 104 -14. .612 -31. .750 -20. .400 1. .00 15. .08 A c
ATOM 784 ODl ASN A 104 -15. .024 -32. .796 -20. .896 1. .00 15. .19 A o
ATOM 785 ND2 ASN A 104 -14. .920 -30. .571 -20. .894 1. .00 14. .99 A N
ATOM 786 C ASN A 104 -12. .614 -33. .257 -17. .504 1. .00 13. .94 A c
ATOM 787 o ASN A 104 -11. .578 -32. .636 -17. .730 1. .00 13. .92 A o
ATOM 788 N ASN A 105 -12. .697 -34. .257 -16. .616 1. .00 12. .63 A N
ATOM 789 CA ASN A 105 -11. .555 -34. .707 -15. .844 1. .00 11. .74 A c
ATOM 790 CB ASN A 105 -11. .145 -33. .649 -14. .826 1. .00 11. .60 A c
ATOM 791 CG ASN A 105 -9. .690 -33. .277 -14. .949 1. .00 11. .53 A c
ATOM 792 ODl ASN A 105 -8. .832 -34. .125 -15. .116 1. .00 11. .68 A o
ATOM 793 ND2 ASN A 105 -9. .410 -32. .009 -14. .887 1. .00 11. .47 A N
ATOM 794 C ASN A 105 -11. .738 -36. .035 -15. .116 1. .00 11. .37 A c
ATOM 795 o ASN A 105 -12. .840 -36. .575 -15. .031 1. .00 11. .26 A o
ATOM 796 N ALA A 106 -10. .614 -36. .562 -14. .637 1. .00 11. .03 A N
ATOM 797 CA ALA A 106 -10. .579 -37. .638 -13. .650 1. .00 10. .62 A c
ATOM 798 CB ALA A 106 -10. .233 -38. .958 -14. .290 1. .00 10. .51 A c
ATOM 799 C ALA A 106 -9. .512 -37. .269 -12. .681 1. .00 10. .35 A c
ATOM 800 o ALA A 106 -8. .663 -36. .428 -12. .992 1. .00 10. .10 A o
ATOM 801 N PHE A 107 -9. .522 -37. .920 -11. .525 1. .00 10. .44 A N
ATOM 802 CA PHE A 107 -8. .637 -37. .527 -10. .431 1. .00 10. .55 A c
ATOM 803 CB PHE A 107 -8. .983 -36. .124 -9. .903 1. .00 10. .32 A c
ATOM 804 CG PHE A 107 -10. .352 -36. .015 -9. .323 1. .00 10. .51 A c
ATOM 805 CD 2 PHE A 107 -11. .421 -35. .620 -10. .104 1. .00 10. .75 A c
ATOM 806 CE2 PHE A 107 -12. .694 -35. .504 -9. .561 1. .00 10. .83 A c
ATOM 807 CZ PHE A 107 -12. .905 -35. .812 -8. .233 1. .00 10. .89 A c
ATOM 808 CEl PHE A 107 -11. .841 -36. .197 -7. .445 1. .00 10. .78 A c
ATOM 809 CDl PHE A 107 -10. .575 -36. .280 -7. .994 1. .00 10. .79 A c
ATOM 810 C PHE A 107 -8. .568 -38. .494 -9. .258 1. .00 10. .67 A c
ATOM 811 o PHE A 107 -9. .372 -39. .418 -9. .136 1. .00 10. .36 A o
ATOM 812 N TRP A 108 -7. .575 -38. .222 -8. .404 1. .00 11. .14 A N
ATOM 813 CA TRP A 108 -7. .276 -38. .991 -7. .221 1. .00 11. .55 A c
ATOM 814 CB TRP A 108 -5. .895 -39. .634 -7. .328 1. .00 11. .58 A c
ATOM 815 CG TRP A 108 -5. .269 -39. .991 -6. .019 1. .00 11. .70 A c
ATOM 816 CDl TRP A 108 -4. .276 -39. .320 -5. .372 1. .00 11. .59 A c
ATOM 817 NEl TRP A 108 -3. .967 -39. .954 -4. .192 1. .00 11. .77 A N
ATOM 818 CE2 TRP A 108 -4. .765 -41. .058 -4. .059 1. .00 11. .81 A c
ATOM 819 CD 2 TRP A 108 -5. .600 -41. .113 -5. .189 1. .00 12. .15 A c
ATOM 820 CE3 TRP A 108 -6. .526 -42. .169 -5. .295 1. .00 12. .29 A c
ATOM 821 CZ3 TRP A 108 -6. .583 -43. .109 -4. .277 1. .00 11. .79 A c
ATOM 822 CH2 TRP A 108 -5. .736 -43. .017 -3. .178 1. .00 11. .69 A c
ATOM 823 CZ2 TRP A 108 -4. .827 -42. .005 -3. .049 1. .00 11. .78 A c
ATOM 824 C TRP A 108 -7. .301 -38. .046 -6. .058 1. .00 11. .89 A c
ATOM 825 o TRP A 108 -6. .541 -37. .070 -6. .011 1. .00 12. .66 A o
ATOM 826 N ASN A 109 -8. .146 -38. .361 -5. .086 1. .00 12. .02 A N
ATOM 827 CA ASN A 109 -8. .413 -37. .441 -3. .998 1. .00 11. .55 A c
ATOM 828 CB ASN A 109 -9. .910 -37. .250 -3. .866 1. .00 10. .98 A c
ATOM 829 CG ASN A 109 -10. .615 -38. .456 -3. .291 1. .00 10. .78 A c
ATOM 830 ODl ASN A 109 -10. .027 -39. .428 -2. .857 1. .00 9. .78 A o
ATOM 831 ND2 ASN A 109 -11. .918 -38. .378 -3. .297 1. .00 11. .23 A N
ATOM 832 C ASN A 109 -7. .821 -37. .800 -2. .637 1. .00 11. .83 A c
ATOM 833 o ASN A 109 -8. .205 -37. .180 -1. .653 1. .00 12. .98 A o
ATOM 834 N GLY A 110 -6. .911 -38. .767 -2. .566 1. .00 11. .58 A N
ATOM 835 CA GLY A 110 -6. .353 -39. .211 -1. .286 1. .00 11. .33 A c
ATOM 836 C GLY A 110 -6. .978 -40. .526 -0. .825 1. .00 11. .37 A c
ATOM 837 o GLY A 110 -6. .430 -41. .220 0. .014 1. .00 12. .11 A o
ATOM 838 N VAL A 111 -8. .105 -40. .898 -1. .404 1. .00 11. .10 A N
ATOM 839 CA VAL A 111 -8. .926 -42. .006 -0. .912 1. .00 10. .97 A c
ATOM 840 CB VAL A 111 -10. .193 -41. .411 -0. .186 1. .00 11. .34 A c
ATOM 841 CGl VAL A 111 -11. .387 -42. .362 -0. .056 1. .00 11. .21 A c
ATOM 842 CG2 VAL A 111 -9. .789 -40. .889 1. .181 1. .00 11. .73 A c
ATOM 843 C VAL A 111 -9. .306 -42. .918 -2. .065 1. .00 10. .59 A c
ATOM 844 o VAL A 111 -9. .366 -44. .119 -1. .902 1. .00 10. .53 A o
ATOM 845 N GLN A 112 -9. .574 -42. .345 -3. .227 1. .00 10. .74 A N
ATOM 846 CA GLN A 112 -10. .166 -43. .079 -4. .322 1. .00 10. .93 A c
ATOM 847 CB GLN A 112 -11. .652 -43. .280 -4. .029 1. .00 10. .80 A c
ATOM 848 CG GLN A 112 -12. .502 -42. .023 -4. .050 1. .00 10. .59 A c
ATOM 849 CD GLN A 112 -13. .930 -42. .371 -4. .436 1. .00 10. .69 A c
ATOM 850 OEl GLN A 112 -14. .867 -42. .252 -3. .631 1. .00 10. .62 A o
ATOM 851 NE2 GLN A 112 -14. .092 -42. .878 -5. .659 1. .00 10. .64 A N
ATOM 852 C GLN A 112 -10. .020 -42. .410 -5. .681 1. .00 11. .08 A c
ATOM 853 o GLN A 112 -9. .555 -41. .283 -5. .792 1. .00 10. .83 A o
ATOM 854 N MET A 113 -10. .449 -43. .117 -6. .713 1. .00 11. .57 A N
ATOM 855 CA MET A 113 -10. .386 -42. .607 -8. .068 1. .00 12. .22 A c
ATOM 856 CB MET A 113 -9. .770 -43. .655 -9. .012 1. .00 12. .75 A c
ATOM 857 CG MET A 113 -8..248 -43..793 -8..921 1..00 12..88 A C
ATOM 858 SD MET A 113 -7. .704 -44. .724 -7. .465 1. .00 13. .61 A s
ATOM 859 CE MET A 113 -8. .484 -46. .336 -7. .684 1. .00 12. .88 A c
ATOM 860 c MET A 113 -11. .779 -42. .229 -8. .566 1. .00 12. .30 A c
ATOM 861 o MET A 113 -12. .777 -42. .930 -8. .298 1. .00 11. .89 A o
ATOM 862 N VAL A 114 -11. .813 -41. .138 -9. .338 1. .00 12. .45 A N
ATOM 863 CA VAL A 114 -13. .060 -40. .524 -9. .829 1. .00 12. .39 A c
ATOM 864 CB VAL A 114 -13. .312 -39. .200 -9. .108 1. .00 12. .60 A c
ATOM 865 CGl VAL A 114 -14. .735 -38. .756 -9. .269 1. .00 12. .58 A c
ATOM 866 CG2 VAL A 114 -13. .006 -39. .354 -7. .641 1. .00 13. .14 A c
ATOM 867 C VAL A 114 -12. .892 -40. .165 -11. .291 1. .00 11. .82 A c
ATOM 868 o VAL A 114 -11. .824 -39. .682 -11. .672 1. .00 11. .70 A o
ATOM 869 N TYR A 115 -13. .943 -40. .368 -12. .085 1. .00 11. .01 A N
ATOM 870 CA TYR A 115 -13. .868 -40. .205 -13. .517 1. .00 10. .70 A c
ATOM 871 CB TYR A 115 -13. .724 -41. .578 -14. .192 1. .00 10. .58 A c
ATOM 872 CG TYR A 115 -12. .538 -42. .408 -13. .680 1. .00 10. .64 A c
ATOM 873 CDl TYR A 115 -11. .258 -42. .218 -14. .179 1. .00 10. .65 A c
ATOM 874 CEl TYR A 115 -10. .189 -42. .936 -13. .703 1. .00 10. .73 A c
ATOM 875 CZ TYR A 115 -10. .376 -43. .877 -12. .724 1. .00 11. .06 A c
ATOM 876 OH TYR A 115 -9. .298 -44. .623 -12. .258 1. .00 11. .31 A o
ATOM 877 CE2 TYR A 115 -11. .637 -44. .098 -12. .219 1. .00 10. .82 A c
ATOM 878 CD 2 TYR A 115 -12. .698 -43. .351 -12. .682 1. .00 10. .64 A c
ATOM 879 C TYR A 115 -15. .103 -39. .493 -14. .016 1. .00 10. .93 A c
ATOM 880 o TYR A 115 -16. .210 -40. .015 -13. .945 1. .00 11. .10 A o
ATOM 881 N GLY A 116 -14. .917 -38. .278 -14. .505 1. .00 11. .20 A N
ATOM 882 CA GLY A 116 -15. .952 -37. .601 -15. .247 1. .00 11. .38 A c
ATOM 883 C GLY A 116 -16. .368 -38. .324 -16. .522 1. .00 11. .63 A c
ATOM 884 o GLY A 116 -15. .747 -39. .265 -16. .955 1. .00 10. .90 A o
ATOM 885 N ASP A 117 -17. .456 -37. .839 -17. .105 1. .00 12. .56 A N
ATOM 886 CA ASP A 117 -18. .020 -38. .340 -18. .365 1. .00 12. .79 A c
ATOM 887 CB ASP A 117 -19. .545 -38. .204 -18. .392 1. .00 12. .28 A c
ATOM 888 CG ASP A 117 -20. .245 -39. .348 -17. .701 1. .00 12. .14 A c
ATOM 889 ODl ASP A 117 -19. .932 -40. .511 -17. .976 1. .00 11. .76 A o
ATOM 890 OD2 ASP A 117 -21. .149 -39. .081 -16. .895 1. .00 12. .59 A o
ATOM 891 C ASP A 117 -17. .509 -37. .570 -19. .541 1. .00 13. .10 A c
ATOM 892 o ASP A 117 -17. .586 -38. .054 -20. .648 1. .00 13. .73 A o
ATOM 893 N GLY A 118 -17. .039 -36. .356 -19. .301 1. .00 13. .57 A N
ATOM 894 CA GLY A 118 -16. .573 -35. .481 -20. .364 1. .00 13. .80 A c
ATOM 895 C GLY A 118 -17. .762 -34. .764 -20. .948 1. .00 14. .14 A c
ATOM 896 o GLY A 118 -18. .900 -35. .121 -20. .631 1. .00 14. .07 A o
ATOM 897 N ASP A 119 -17. .507 -33. .780 -21. .812 1. .00 14. .55 A N
ATOM 898 CA ASP A 119 -18. .589 -32. .932 -22. .323 1. .00 15. .19 A c
ATOM 899 CB ASP A 119 -18. .176 -31. .444 -22. .475 1. .00 14. .84 A c
ATOM 900 CG ASP A 119 -17. .010 -31. .211 -23. .418 1. .00 14. .26 A c
ATOM 901 ODl ASP A 119 -16. .861 -31. .947 -24. .414 1. .00 14. .21 A o
ATOM 902 OD2 ASP A 119 -16. .275 -30. .231 -23. .168 1. .00 13. .01 A o
ATOM 903 C ASP A 119 -19. .192 -33. .458 -23. .599 1. .00 16. .45 A c
ATOM 904 o ASP A 119 -20. .148 -32. .880 -24. .119 1. .00 16. .55 A o
ATOM 905 N GLY A 120 -18. .645 -34. .573 -24. .091 1. .00 18. .15 A N
ATOM 906 CA GLY A 120 -19. .134 -35. .212 -25. .316 1. .00 18. .51 A c
ATOM 907 C GLY A 120 -18. .466 -34. .701 -26. .573 1. .00 19. .67 A c
ATOM 908 o GLY A 120 -18. .547 -35. .358 -27. .603 1. .00 21. .88 A o
ATOM 909 N VAL A 121 -17. .798 -33. .549 -26. .504 1. .00 19. .75 A N
ATOM 910 CA VAL A 121 -17. .223 -32. .918 -27. .683 1. .00 20. .14 A c
ATOM 911 CB VAL A 121 -17. .736 -31. .456 -27. .839 1. .00 20. .88 A c
ATOM 912 CGl VAL A 121 -16. .946 -30. .680 -28. .902 1. .00 21. .41 A c
ATOM 913 CG2 VAL A 121 -19. .228 -31. .416 -28. .157 1. .00 20. .58 A c
ATOM 914 C VAL A 121 -15. .679 -32. .991 -27. .596 1. .00 20. .30 A c
ATOM 915 o VAL A 121 -15. .035 -33. .586 -28. .457 1. .00 19. .79 A o
ATOM 916 N THR A 122 -15. .090 -32. .404 -26. .555 1. .00 20. .14 A N
ATOM 917 CA THR A 122 -13. .635 -32. .494 -26. .351 1. .00 19. .96 A c
ATOM 918 CB THR A 122 -13. .061 -31. .238 -25. .637 1. .00 21. .45 A c
ATOM 919 OGl THR A 122 -13. .999 -30. .796 -24. .662 1. .00 24. .36 A o
ATOM 920 CG2 THR A 122 -12. .845 -30. .074 -26. .636 1. .00 21. .78 A c
ATOM 921 C THR A 122 -13. .191 -33. .764 -25. .610 1. .00 17. .15 A c
ATOM 922 o THR A 122 -12. .032 -34. .113 -25. .706 1. .00 15. .97 A o
ATOM 923 N PHE A 123 -14. .103 -34. .428 -24. .892 1. .00 15. .54 A N
ATOM 924 CA PHE A 123 -13. .837 -35. .724 -24. .212 1. .00 14. .59 A c
ATOM 925 CB PHE A 123 -13. .458 -35. .540 -22. .736 1. .00 14. .75 A c
ATOM 926 CG PHE A 123 -12. .146 -34. .912 -22. .502 1. .00 14. .63 A c
ATOM 927 CDl PHE A 123 -11. .007 -35. .663 -22. .517 1. .00 15. .07 A c
ATOM 928 CEl PHE A 123 -9. .772 -35. .088 -22. .268 1. .00 15. .58 A c
ATOM 929 CZ PHE A 123 -9. .678 -33. .744 -21. .996 1. .00 15. .40 A c
ATOM 930 CE2 PHE A 123 -10. .830 -32. .989 -21. .968 1. .00 15. .55 A c
ATOM 931 CD 2 PHE A 123 -12. .056 -33. .583 -22. .207 1. .00 15. .01 A c
ATOM 932 C PHE A 123 -15. .054 -36. .631 -24. .117 1. .00 13. .43 A c
ATOM 933 o PHE A 123 -16. .159 -36. .177 -24. .004 1. .00 13. .18 A o
ATOM 934 N ILE A 124 -14. .808 -37. .916 -24. .031 1. .00 13. .11 A N
ATOM 935 CA ILE A 124 -15. .829 -38. .898 -23. .717 1. .00 12. .99 A c
ATOM 936 CB ILE A 124 -15..856 -40..029 -24..779 1..00 13..41 A C
ATOM 937 CGl ILE A 124 -14. .577 -40. .925 -24. .768 1. .00 13. .15 A C
ATOM 938 CDl ILE A 124 -14. .749 -42. .242 -25. .530 1. .00 12. .52 A c
ATOM 939 CG2 ILE A 124 -16. .078 -39. .429 -26. .161 1. .00 13. .31 A c
ATOM 940 C ILE A 124 -15. .517 -39. .451 -22. .339 1. .00 12. .74 A c
ATOM 941 o ILE A 124 -14. .551 -39. .000 -21. .705 1. .00 13. .23 A o
ATOM 942 N PRO A 125 -16. .331 -40. .396 -21. .844 1. .00 12. .24 A N
ATOM 943 CA PRO A 125 -16. .094 -40. .854 -20. .471 1. .00 12. .10 A c
ATOM 944 CB PRO A 125 -17. .132 -41. .978 -20. .285 1. .00 12. .45 A c
ATOM 945 CG PRO A 125 -18. .265 -41. .554 -21. .152 1. .00 12. .47 A c
ATOM 946 CD PRO A 125 -17. .607 -40. .918 -22. .360 1. .00 12. .48 A c
ATOM 947 C PRO A 125 -14. .674 -41. .348 -20. .232 1. .00 11. .45 A c
ATOM 948 o PRO A 125 -14. .164 -42. .208 -20. .969 1. .00 10. .89 A o
ATOM 949 N PHE A 126 -14. .071 -40. .769 -19. .199 1. .00 10. .85 A N
ATOM 950 CA PHE A 126 -12. .645 -40. .875 -18. .936 1. .00 10. .71 A c
ATOM 951 CB PHE A 126 -12. .247 -39. .967 -17. .783 1. .00 10. .54 A c
ATOM 952 CG PHE A 126 -12. .017 -38. .547 -18. .201 1. .00 10. .47 A c
ATOM 953 CDl PHE A 126 -13. .050 -37. .780 -18. .712 1. .00 10. .57 A c
ATOM 954 CEl PHE A 126 -12. .828 -36. .463 -19. .123 1. .00 10. .33 A c
ATOM 955 CZ PHE A 126 -11. .574 -35. .925 -19. .018 1. .00 10. .16 A c
ATOM 956 CE2 PHE A 126 -10. .544 -36. .690 -18. .518 1. .00 10. .11 A c
ATOM 957 CD 2 PHE A 126 -10. .760 -37. .981 -18. .116 1. .00 10. .22 A c
ATOM 958 C PHE A 126 -12. .090 -42. .276 -18. .691 1. .00 10. .71 A c
ATOM 959 o PHE A 126 -10. .893 -42. .501 -18. .969 1. .00 10. .90 A o
ATOM 960 N SER A 127 -12. .930 -43. .220 -18. .246 1. .00 10. .31 A N
ATOM 961 CA SER A 127 -12. .456 -44. .588 -18. .018 1. .00 10. .08 A c
ATOM 962 CB SER A 127 -13. .430 -45. .374 -17. .180 1. .00 10. .12 A c
ATOM 963 OG SER A 127 -14. .738 -45. .075 -17. .550 1. .00 10. .16 A o
ATOM 964 C SER A 127 -12. .147 -45. .358 -19. .281 1. .00 9. .98 A c
ATOM 965 o SER A 127 -11. .453 -46. .356 -19. .242 1. .00 10. .28 A o
ATOM 966 N ALA A 128 -12. .598 -44. .864 -20. .412 1. .00 10. .04 A N
ATOM 967 CA ALA A 128 -12. .371 -45. .532 -21. .693 1. .00 10. .10 A c
ATOM 968 CB ALA A 128 -13. .180 -44. .831 -22. .782 1. .00 10. .16 A c
ATOM 969 C ALA A 128 -10. .899 -45. .715 -22. .144 1. .00 10. .16 A c
ATOM 970 o ALA A 128 -10. .633 -46. .559 -23. .017 1. .00 10. .10 A o
ATOM 971 N ASP A 129 -9. .957 -44. .956 -21. .580 1. .00 10. .09 A N
ATOM 972 CA ASP A 129 -8. .545 -45. .186 -21. .882 1. .00 10. .27 A c
ATOM 973 CB ASP A 129 -7. .842 -43. .893 -22. .314 1. .00 10. .08 A c
ATOM 974 CG ASP A 129 -6. .541 -44. .156 -23. .060 1. .00 10. .15 A c
ATOM 975 ODl ASP A 129 -5. .845 -45. .112 -22. .681 1. .00 10. .22 A o
ATOM 976 OD2 ASP A 129 -6. .191 -43. .422 -24. .030 1. .00 10. .06 A o
ATOM 977 C ASP A 129 -7. .836 -45. .809 -20. .686 1. .00 10. .67 A c
ATOM 978 o ASP A 129 -7. .789 -45. .228 -19. .607 1. .00 11. .36 A o
ATOM 979 N PRO A 130 -7. .247 -46. .992 -20. .866 1. .00 11. .05 A N
ATOM 980 CA PRO A 130 -6. .480 -47. .543 -19. .758 1. .00 11. .13 A c
ATOM 981 CB PRO A 130 -5. .810 -48. .755 -20. .375 1. .00 11. .09 A c
ATOM 982 CG PRO A 130 -6. .739 -49. .200 -21. .455 1. .00 11. .13 A c
ATOM 983 CD PRO A 130 -7. .447 -47. .969 -21. .952 1. .00 11. .07 A c
ATOM 984 C PRO A 130 -5. .425 -46. .594 -19. .201 1. .00 11. .90 A c
ATOM 985 o PRO A 130 -5. .090 -46. .672 -18. .021 1. .00 11. .81 A o
ATOM 986 N ASP A 131 -4. .871 -45. .691 -20. .012 1. .00 12. .81 A N
ATOM 987 CA ASP A 131 -3. .767 -44. .936 -19. .473 1. .00 13. .21 A c
ATOM 988 CB ASP A 131 -2. .861 -44. .298 -20. .538 1. .00 12. .98 A c
ATOM 989 CG ASP A 131 -3. .566 -43. .310 -21. .446 1. .00 13. .07 A c
ATOM 990 ODl ASP A 131 -4. .133 -42. .275 -21. .008 1. .00 13. .36 A o
ATOM 991 OD2 ASP A 131 -3. .468 -43. .524 -22. .667 1. .00 13. .50 A o
ATOM 992 C ASP A 131 -4. .291 -43. .959 -18. .422 1. .00 14. .31 A c
ATOM 993 o ASP A 131 -3. .505 -43. .461 -17. .584 1. .00 14. .98 A o
ATOM 994 N VAL A 132 -5. .607 -43. .685 -18. .438 1. .00 14. .33 A N
ATOM 995 CA VAL A 132 -6. .153 -42. .702 -17. .498 1. .00 14. .09 A c
ATOM 996 CB VAL A 132 -7. .528 -42. .180 -17. .937 1. .00 14. .79 A c
ATOM 997 CGl VAL A 132 -8. .084 -41. .168 -16. .922 1. .00 14. .72 A c
ATOM 998 CG2 VAL A 132 -7. .420 -41. .532 -19. .314 1. .00 15. .01 A c
ATOM 999 C VAL A 132 -6. .253 -43. .352 -16. .140 1. .00 13. .25 A c
ATOM 1000 o VAL A 132 -5. .903 -42. .755 -15. .150 1. .00 12. .79 A o
ATOM 1001 N ILE A 133 -6. .691 -44. .603 -16. .121 1. .00 12. .74 A N
ATOM 1002 CA ILE A 133 -6. .835 -45. .351 -14. .883 1. .00 12. .12 A c
ATOM 1003 CB ILE A 133 -7. .565 -46. .703 -15. .122 1. .00 12. .05 A c
ATOM 1004 CGl ILE A 133 -9. .069 -46. .437 -15. .301 1. .00 12. .13 A c
ATOM 1005 CDl ILE A 133 -9. .507 -46. .212 -16. .734 1. .00 12. .16 A c
ATOM 1006 CG2 ILE A 133 -7. .403 -47. .665 -13. .948 1. .00 12. .02 A c
ATOM 1007 C ILE A 133 -5. .476 -45. .527 -14. .246 1. .00 11. .61 A c
ATOM 1008 o ILE A 133 -5. .292 -45. .217 -13. .067 1. .00 11. .61 A o
ATOM 1009 N GLY A 134 -4. .515 -45. .989 -15. .029 1. .00 11. .10 A N
ATOM 1010 CA GLY A 134 -3. .132 -46. .092 -14. .555 1. .00 10. .85 A c
ATOM 1011 C GLY A 134 -2. .611 -44. .784 -13. .982 1. .00 10. .75 A c
ATOM 1012 o GLY A 134 -1. .919 -44. .773 -12. .946 1. .00 11. .06 A o
ATOM 1013 N HIS A 135 -2. .962 -43. .675 -14. .631 1. .00 10. .39 A N
ATOM 1014 CA HIS A 135 -2. .510 -42. .340 -14. .219 1. .00 10. .07 A c
ATOM 1015 CB HIS A 135 -2..987 -41..329 -15..262 1..00 9..93 A C
ATOM 1016 CG HIS A 135 -2. .513 -39. .933 -15. .049 1. .00 9. .63 A C
ATOM 1017 NDl HIS A 135 -1. .472 -39. .389 -15. .765 1. .00 9. .67 A N
ATOM 1018 CEl HIS A 135 -1. .291 -38. .133 -15. .392 1. .00 9. .59 A C
ATOM 1019 NE2 HIS A 135 -2. .181 -37. .845 -14. .459 1. .00 9. .71 A N
ATOM 1020 CD 2 HIS A 135 -2. .964 -38. .953 -14. .237 1. .00 9. .62 A C
ATOM 1021 C HIS A 135 -3. .024 -41. .996 -12. .813 1. .00 10. .10 A C
ATOM 1022 o HIS A 135 -2. .251 -41. .630 -11. .902 1. .00 10. .09 A o
ATOM 1023 N GLU A 136 -4. .326 -42. .136 -12. .624 1. .00 10. .10 A N
ATOM 1024 CA GLU A 136 -4. .951 -41. .752 -11. .347 1. .00 10. .17 A c
ATOM 1025 CB GLU A 136 -6. .475 -41. .654 -11. .514 1. .00 10. .47 A c
ATOM 1026 CG GLU A 136 -6. .894 -40. .641 -12. .554 1. .00 10. .55 A c
ATOM 1027 CD GLU A 136 -6. .148 -39. .345 -12. .359 1. .00 11. .18 A c
ATOM 1028 OEl GLU A 136 -5. .972 -38. .931 -11. .195 1. .00 11. .67 A o
ATOM 1029 OE2 GLU A 136 -5. .723 -38. .736 -13. .351 1. .00 11. .52 A o
ATOM 1030 C GLU A 136 -4. .592 -42. .714 -10. .224 1. .00 9. .84 A c
ATOM 1031 o GLU A 136 -4. .247 -42. .287 -9. .155 1. .00 9. .75 A o
ATOM 1032 N LEU A 137 -4. .638 -44. .006 -10. .482 1. .00 9. .71 A N
ATOM 1033 CA LEU A 137 -4. .113 -44. .998 -9. .549 1. .00 10. .13 A c
ATOM 1034 CB LEU A 137 -4. .199 -46. .328 -10. .278 1. .00 10. .76 A c
ATOM 1035 CG LEU A 137 -4. .003 -47. .670 -9. .581 1. .00 11. .56 A c
ATOM 1036 CDl LEU A 137 -2. .714 -47. .741 -8. .743 1. .00 11. .82 A c
ATOM 1037 CD 2 LEU A 137 -5. .230 -48. .010 -8. .760 1. .00 11. .81 A c
ATOM 1038 C LEU A 137 -2. .644 -44. .669 -9. .113 1. .00 9. .92 A c
ATOM 1039 o LEU A 137 -2. .286 -44. .625 -7. .953 1. .00 9. .14 A o
ATOM 1040 N THR A 138 -1. .796 -44. .397 -10. .086 1. .00 10. .20 A N
ATOM 1041 CA THR A 138 -0. .425 -44. .011 -9. .817 1. .00 10. .26 A c
ATOM 1042 CB THR A 138 0. .361 -43. .954 -11. .146 1. .00 10. .02 A c
ATOM 1043 OGl THR A 138 0. .355 -45. .258 -11. .754 1. .00 9. .32 A o
ATOM 1044 CG2 THR A 138 1. .785 -43. .463 -10. .929 1. .00 9. .83 A c
ATOM 1045 C THR A 138 -0. .303 -42. .695 -8. .973 1. .00 10. .57 A c
ATOM 1046 o THR A 138 0. .662 -42. .538 -8. .183 1. .00 10. .60 A o
ATOM 1047 N HIS A 139 -1. .263 -41. .771 -9. .095 1. .00 10. .54 A N
ATOM 1048 CA HIS A 139 -1. .272 -40. .620 -8. .177 1. .00 10. .42 A c
ATOM 1049 CB HIS A 139 -2. .468 -39. .695 -8. .370 1. .00 10. .27 A c
ATOM 1050 CG HIS A 139 -2. .317 -38. .717 -9. .486 1. .00 10. .44 A c
ATOM 1051 NDl HIS A 139 -1. .094 -38. .259 -9. .918 1. .00 10. .59 A N
ATOM 1052 CEl HIS A 139 -1. .265 -37. .406 -10. .914 1. .00 10. .87 A c
ATOM 1053 NE2 HIS A 139 -2. .563 -37. .285 -11. .142 1. .00 11. .18 A N
ATOM 1054 CD 2 HIS A 139 -3. .241 -38. .089 -10. .249 1. .00 10. .94 A C
ATOM 1055 C HIS A 139 -1. .245 -41. .129 -6. .747 1. .00 10. .73 A c
ATOM 1056 o HIS A 139 -0. .491 -40. .621 -5. .920 1. .00 10. .94 A o
ATOM 1057 N GLY A 140 -2. .052 -42. .151 -6. .466 1. .00 11. .04 A N
ATOM 1058 CA GLY A 140 -2. .056 -42. .807 -5. .160 1. .00 10. .90 A c
ATOM 1059 C GLY A 140 -0. .692 -43. .407 -4. .803 1. .00 10. .98 A c
ATOM 1060 o GLY A 140 -0. .171 -43. .198 -3. .693 1. .00 11. .37 A o
ATOM 1061 N VAL A 141 -0. .086 -44. .150 -5. .726 1. .00 10. .36 A N
ATOM 1062 CA VAL A 141 1. .177 -44. .811 -5. .416 1. .00 9. .75 A c
ATOM 1063 CB VAL A 141 1. .682 -45. .578 -6. .619 1. .00 9. .53 A c
ATOM 1064 CGl VAL A 141 3. .058 -46. .151 -6. .348 1. .00 9. .58 A c
ATOM 1065 CG2 VAL A 141 0. .705 -46. .676 -6. .968 1. .00 9. .43 A c
ATOM 1066 C VAL A 141 2. .215 -43. .784 -5. .013 1. .00 9. .84 A c
ATOM 1067 o VAL A 141 2. .931 -43. .938 -4. .031 1. .00 9. .44 A o
ATOM 1068 N THR A 142 2. .255 -42. .703 -5. .779 1. .00 10. .29 A N
ATOM 1069 CA THR A 142 3. .151 -41. .590 -5. .513 1. .00 10. .26 A c
ATOM 1070 CB THR A 142 3. .000 -40. .503 -6. .577 1. .00 10. .08 A c
ATOM 1071 OGl THR A 142 3. .358 -41. .026 -7. .880 1. .00 9. .80 A o
ATOM 1072 CG2 THR A 142 3. .871 -39. .305 -6. .210 1. .00 10. .03 A c
ATOM 1073 C THR A 142 2. .904 -40. .965 -4. .158 1. .00 10. .52 A c
ATOM 1074 o THR A 142 3. .843 -40. .718 -3. .399 1. .00 10. .56 A o
ATOM 1075 N GLU A 143 1. .650 -40. .695 -3. .841 1. .00 10. .94 A N
ATOM 1076 CA GLU A 143 1. .352 -40. .031 -2. .570 1. .00 11. .25 A c
ATOM 1077 CB GLU A 143 -0. .118 -39. .677 -2. .462 1. .00 11. .65 A c
ATOM 1078 CG GLU A 143 -0. .691 -39. .862 -1. .082 1. .00 12. .22 A c
ATOM 1079 CD GLU A 143 -1. .934 -39. .052 -0. .832 1. .00 12. .99 A c
ATOM 1080 OEl GLU A 143 -2. .020 -38. .543 0. .317 1. .00 12. .86 A o
ATOM 1081 OE2 GLU A 143 -2. .804 -38. .922 -1. .764 1. .00 13. .79 A o
ATOM 1082 C GLU A 143 1. .782 -40. .903 -1. .415 1. .00 11. .45 A c
ATOM 1083 o GLU A 143 2. .210 -40. .390 -0. .398 1. .00 11. .64 A o
ATOM 1084 N HIS A 144 1. .680 -42. .218 -1. .589 1. .00 11. .88 A N
ATOM 1085 CA HIS A 144 2. .095 -43. .209 -0. .589 1. .00 12. .29 A c
ATOM 1086 CB HIS A 144 1. .247 -44. .484 -0. .746 1. .00 13. .27 A c
ATOM 1087 CG HIS A 144 -0. .045 -44. .440 -0. .009 1. .00 14. .23 A c
ATOM 1088 NDl HIS A 144 -1. .080 -43. .600 -0. .368 1. .00 15. .20 A N
ATOM 1089 CEl HIS A 144 -2. .097 -43. .770 0. .457 1. .00 15. .20 A c
ATOM 1090 NE2 HIS A 144 -1. .749 -44. .684 1. .343 1. .00 15. .38 A N
ATOM 1091 CD 2 HIS A 144 -0. .467 -45. .116 1. .079 1. .00 14. .62 A C
ATOM 1092 C HIS A 144 3. .586 -43. .619 -0. .631 1. .00 11. .95 A c
ATOM 1093 o HIS A 144 4. .007 -44. .456 0. .135 1. .00 11. .54 A o
ATOM 1094 N THR A 145 4..383 -43..055 -1..532 1..00 11..84 A N
ATOM 1095 CA THR A 145 5. .798 -43. .407 -1. .620 1. .00 11. .38 A C
ATOM 1096 CB THR A 145 6. .062 -44. .234 -2. .900 1. .00 11. .59 A C
ATOM 1097 OGl THR A 145 5. .547 -43. .557 -4. .068 1. .00 11. .59 A o
ATOM 1098 CG2 THR A 145 5. .398 -45. .593 -2. .785 1. .00 11. .38 A c
ATOM 1099 C THR A 145 6. .655 -42. .135 -1. .532 1. .00 11. .05 A c
ATOM 1100 o THR A 145 6. .939 -41. .644 -0. .443 1. .00 11. .35 A o
ATOM 1101 N ALA A 146 7. .038 -41. .572 -2. .667 1. .00 10. .67 A N
ATOM 1102 CA ALA A 146 7. .849 -40. .366 -2. .692 1. .00 10. .41 A c
ATOM 1103 CB ALA A 146 8. .226 -40. .046 -4. .120 1. .00 10. .53 A c
ATOM 1104 C ALA A 146 7. .137 -39. .167 -2. .080 1. .00 10. .31 A c
ATOM 1105 o ALA A 146 7. .769 -38. .361 -1. .394 1. .00 9. .96 A o
ATOM 1106 N GLY A 147 5. .827 -39. .051 -2. .349 1. .00 10. .33 A N
ATOM 1107 CA GLY A 147 5. .001 -37. .925 -1. .877 1. .00 10. .08 A c
ATOM 1108 C GLY A 147 5. .238 -36. .619 -2. .623 1. .00 10. .00 A c
ATOM 1109 o GLY A 147 4. .962 -35. .549 -2. .107 1. .00 9. .60 A o
ATOM 1110 N LEU A 148 5. .745 -36. .706 -3. .848 1. .00 10. .31 A N
ATOM 1111 CA LEU A 148 5. .933 -35. .528 -4. .707 1. .00 10. .49 A c
ATOM 1112 CB LEU A 148 6. .018 -35. .939 -6. .165 1. .00 10. .25 A c
ATOM 1113 CG LEU A 148 7. .210 -36. .812 -6. .508 1. .00 10. .29 A c
ATOM 1114 CDl LEU A 148 6. .994 -37. .473 -7. .848 1. .00 10. .47 A c
ATOM 1115 CD 2 LEU A 148 8. .476 -36. .004 -6. .551 1. .00 10. .32 A c
ATOM 1116 C LEU A 148 4. .772 -34. .565 -4. .557 1. .00 10. .94 A c
ATOM 1117 o LEU A 148 3. .636 -34. .881 -4. .915 1. .00 10. .71 A o
ATOM 1118 N GLU A 149 5. .066 -33. .387 -4. .026 1. .00 11. .38 A N
ATOM 1119 CA GLU A 149 4. .042 -32. .384 -3. .824 1. .00 11. .72 A c
ATOM 1120 CB GLU A 149 4. .614 -31. .224 -3. .046 1. .00 12. .01 A c
ATOM 1121 CG GLU A 149 4. .981 -31. .624 -1. .637 1. .00 12. .44 A c
ATOM 1122 CD GLU A 149 5. .857 -30. .602 -0. .954 1. .00 12. .98 A c
ATOM 1123 OEl GLU A 149 6. .421 -29. .712 -1. .679 1. .00 13. .15 A o
ATOM 1124 OE2 GLU A 149 5. .975 -30. .714 0. .305 1. .00 12. .81 A o
ATOM 1125 C GLU A 149 3. .503 -31. .865 -5. .139 1. .00 11. .83 A c
ATOM 1126 o GLU A 149 4. .282 -31. .557 -6. .060 1. .00 11. .79 A o
ATOM 1127 N TYR A 150 2. .178 -31. .724 -5. .199 1. .00 11. .76 A N
ATOM 1128 CA TYR A 150 1. .503 -31. .382 -6. .438 1. .00 11. .73 A c
ATOM 1129 CB TYR A 150 0. .047 -31. .854 -6. .381 1. .00 11. .48 A c
ATOM 1130 CG TYR A 150 -0. .495 -32. .275 -7. .722 1. .00 11. .34 A c
ATOM 1131 CDl TYR A 150 -0. .009 -33. .409 -8. .366 1. .00 11. .48 A c
ATOM 1132 CEl TYR A 150 -0. .488 -33. .787 -9. .606 1. .00 11. .42 A c
ATOM 1133 CZ TYR A 150 -1. .466 -33. .024 -10. .215 1. .00 11. .47 A c
ATOM 1134 OH TYR A 150 -1. .983 -33. .385 -11. .434 1. .00 11. .35 A o
ATOM 1135 CE2 TYR A 150 -1. .948 -31. .898 -9. .591 1. .00 11. .34 A c
ATOM 1136 CD 2 TYR A 150 -1. .465 -31. .540 -8. .353 1. .00 11. .15 A c
ATOM 1137 C TYR A 150 1. .594 -29. .893 -6. .778 1. .00 12. .17 A c
ATOM 1138 o TYR A 150 0. .579 -29. .194 -6. .852 1. .00 11. .75 A o
ATOM 1139 N TYR A 151 2. .820 -29. .409 -7. .010 1. .00 13. .06 A N
ATOM 1140 CA TYR A 151 3. .052 -27. .998 -7. .425 1. .00 13. .68 A c
ATOM 1141 CB TYR A 151 2. .853 -27. .019 -6. .258 1. .00 14. .30 A c
ATOM 1142 CG TYR A 151 2. .377 -25. .641 -6. .701 1. .00 15. .46 A c
ATOM 1143 CDl TYR A 151 3. .284 -24. .631 -7. .111 1. .00 16. .45 A c
ATOM 1144 CEl TYR A 151 2. .838 -23. .378 -7. .544 1. .00 16. .21 A c
ATOM 1145 CZ TYR A 151 1. .480 -23. .114 -7. .542 1. .00 16. .63 A c
ATOM 1146 OH TYR A 151 0. .955 -21. .884 -7. .943 1. .00 17. .27 A o
ATOM 1147 CE2 TYR A 151 0. .586 -24. .098 -7. .141 1. .00 16. .39 A c
ATOM 1148 CD 2 TYR A 151 1. .036 -25. .341 -6. .732 1. .00 15. .76 A c
ATOM 1149 C TYR A 151 4. .455 -27. .817 -7. .980 1. .00 13. .62 A c
ATOM 1150 o TYR A 151 5. .397 -28. .390 -7. .467 1. .00 14. .39 A o
ATOM 1151 N GLY A 152 4. .614 -27. .011 -9. .019 1. .00 13. .51 A N
ATOM 1152 CA GLY A 152 5. .939 -26. .701 -9. .531 1. .00 13. .34 A c
ATOM 1153 C GLY A 152 6. .653 -27. .917 -10. .097 1. .00 13. .83 A c
ATOM 1154 o GLY A 152 6. .032 -28. .807 -10. .695 1. .00 14. .49 A o
ATOM 1155 N GLU A 153 7. .966 -27. .961 -9. .916 1. .00 13. .72 A N
ATOM 1156 CA GLU A 153 8. .749 -29. .047 -10. .468 1. .00 13. .56 A c
ATOM 1157 CB GLU A 153 10. .238 -28. .725 -10. .362 1. .00 13. .75 A c
ATOM 1158 CG GLU A 153 10. .664 -27. .555 -11. .240 1. .00 13. .88 A c
ATOM 1159 CD GLU A 153 12. .180 -27. .399 -11. .424 1. .00 14. .09 A c
ATOM 1160 OEl GLU A 153 12. .942 -28. .380 -11. .352 1. .00 14. .77 A o
ATOM 1161 OE2 GLU A 153 12. .626 -26. .283 -11. .700 1. .00 13. .79 A o
ATOM 1162 C GLU A 153 8. .392 -30. .427 -9. .867 1. .00 13. .23 A c
ATOM 1163 o GLU A 153 8. .317 -31. .407 -10. .607 1. .00 13. .02 A o
ATOM 1164 N SER A 154 8. .152 -30. .502 -8. .556 1. .00 13. .06 A N
ATOM 1165 CA SER A 154 7. .720 -31. .766 -7. .919 1. .00 12. .61 A c
ATOM 1166 CB SER A 154 7. .509 -31. .629 -6. .409 1. .00 12. .60 A c
ATOM 1167 OG SER A 154 6. .935 -30. .397 -6. .002 1. .00 12. .59 A o
ATOM 1168 C SER A 154 6. .438 -32. .211 -8. .546 1. .00 12. .47 A c
ATOM 1169 o SER A 154 6. .205 -33. .388 -8. .804 1. .00 12. .67 A o
ATOM 1170 N GLY A 155 5. .586 -31. .245 -8. .817 1. .00 12. .56 A N
ATOM 1171 CA GLY A 155 4. .310 -31. .540 -9. .447 1. .00 12. .03 A c
ATOM 1172 C GLY A 155 4. .443 -32. .051 -10. .869 1. .00 11. .39 A c
ATOM 1173 o GLY A 155 3..646 -32..860 -11..295 1..00 11..89 A o
ATOM 1174 N ALA A 156 5. .413 -31. .568 -11. .633 1. .00 10. .56 A N
ATOM 1175 CA ALA A 156 5. .536 -32. .047 -13. .008 1. .00 9. .90 A C
ATOM 1176 CB ALA A 156 6. .481 -31. .175 -13. .804 1. .00 9. .92 A C
ATOM 1177 C ALA A 156 6. .015 -33. .501 -13. .004 1. .00 9. .25 A c
ATOM 1178 o ALA A 156 5. .502 -34. .330 -13. .728 1. .00 9. .03 A o
ATOM 1179 N LEU A 157 7. .020 -33. .773 -12. .184 1. .00 8. .76 A N
ATOM 1180 CA LEU A 157 7. .532 -35. .104 -11. .970 1. .00 8. .36 A c
ATOM 1181 CB LEU A 157 8. .540 -35. .070 -10. .837 1. .00 8. .37 A c
ATOM 1182 CG LEU A 157 10. .041 -35. .045 -11. .062 1. .00 8. .61 A c
ATOM 1183 CDl LEU A 157 10. .463 -34. .666 -12. .454 1. .00 8. .77 A c
ATOM 1184 CD 2 LEU A 157 10. .705 -34. .119 -10. .052 1. .00 8. .91 A c
ATOM 1185 C LEU A 157 6. .376 -36. .025 -11. .596 1. .00 8. .07 A c
ATOM 1186 o LEU A 157 6. .255 -37. .135 -12. .142 1. .00 7. .77 A o
ATOM 1187 N ASN A 158 5. .538 -35. .544 -10. .669 1. .00 7. .73 A N
ATOM 1188 CA ASN A 158 4. .376 -36. .292 -10. .195 1. .00 7. .65 A c
ATOM 1189 CB ASN A 158 3. .618 -35. .443 -9. .175 1. .00 7. .60 A c
ATOM 1190 CG ASN A 158 2. .454 -36. .174 -8. .544 1. .00 7. .45 A c
ATOM 1191 ODl ASN A 158 2. .219 -36. .081 -7. .338 1. .00 7. .24 A o
ATOM 1192 ND2 ASN A 158 1. .713 -36. .889 -9. .354 1. .00 7. .41 A N
ATOM 1193 C ASN A 158 3. .454 -36. .711 -11. .351 1. .00 7. .65 A c
ATOM 1194 o ASN A 158 3. .092 -37. .888 -11. .501 1. .00 7. .48 A o
ATOM 1195 N GLU A 159 3. .108 -35. .731 -12. .180 1. .00 7. .81 A N
ATOM 1196 CA GLU A 159 2. .317 -35. .962 -13. .381 1. .00 7. .91 A c
ATOM 1197 CB GLU A 159 1. .910 -34. .630 -14. .000 1. .00 7. .94 A c
ATOM 1198 CG GLU A 159 0. .601 -34. .083 -13. .429 1. .00 8. .02 A c
ATOM 1199 CD GLU A 159 -0. .576 -34. .968 -13. .795 1. .00 8. .26 A c
ATOM 1200 OEl GLU A 159 -0. .653 -35. .249 -15. .012 1. .00 8. .90 A o
ATOM 1201 OE2 GLU A 159 -1. .397 -35. .417 -12. .935 1. .00 8. .04 A o
ATOM 1202 C GLU A 159 3. .072 -36. .857 -14. .356 1. .00 8. .02 A c
ATOM 1203 o GLU A 159 2. .509 -37. .755 -14. .950 1. .00 8. .32 A o
ATOM 1204 N SER A 160 4. .373 -36. .676 -14. .460 1. .00 8. .05 A N
ATOM 1205 CA SER A 160 5. .141 -37. .443 -15. .423 1. .00 7. .94 A c
ATOM 1206 CB SER A 160 6. .597 -36. .950 -15. .477 1. .00 7. .76 A c
ATOM 1207 OG SER A 160 7. .318 -37. .607 -16. .500 1. .00 7. .64 A o
ATOM 1208 C SER A 160 5. .060 -38. .907 -15. .036 1. .00 8. .03 A c
ATOM 1209 o SER A 160 4. .736 -39. .785 -15. .860 1. .00 7. .90 A o
ATOM 1210 N ILE A 161 5. .343 -39. .165 -13. .767 1. .00 8. .08 A N
ATOM 1211 CA ILE A 161 5. .358 -40. .532 -13. .276 1. .00 8. .23 A c
ATOM 1212 CB ILE A 161 5. .615 -40. .592 -11. .763 1. .00 8. .23 A c
ATOM 1213 CGl ILE A 161 7. .021 -40. .033 -11. .446 1. .00 8. .35 A c
ATOM 1214 CDl ILE A 161 8. .170 -41. .019 -11. .674 1. .00 8. .40 A c
ATOM 1215 CG2 ILE A 161 5. .459 -42. .016 -11. .243 1. .00 8. .11 A c
ATOM 1216 C ILE A 161 4. .017 -41. .190 -13. .593 1. .00 8. .64 A c
ATOM 1217 o ILE A 161 3. .995 -42. .329 -14. .107 1. .00 8. .86 A o
ATOM 1218 N SER A 162 2. .903 -40. .468 -13. .327 1. .00 8. .55 A N
ATOM 1219 CA SER A 162 1. .563 -41. .009 -13. .583 1. .00 8. .24 A c
ATOM 1220 CB SER A 162 0. .470 -40. .063 -13. .041 1. .00 8. .36 A c
ATOM 1221 OG SER A 162 0. .268 -40. .222 -11. .610 1. .00 8. .36 A o
ATOM 1222 C SER A 162 1. .401 -41. .315 -15. .066 1. .00 7. .96 A c
ATOM 1223 o SER A 162 0. .870 -42. .360 -15. .452 1. .00 7. .78 A o
ATOM 1224 N ASP A 163 1. .900 -40. .410 -15. .891 1. .00 7. .89 A N
ATOM 1225 CA ASP A 163 1. .939 -40. .609 -17. .346 1. .00 8. .00 A c
ATOM 1226 CB ASP A 163 2. .451 -39. .323 -18. .029 1. .00 7. .81 A c
ATOM 1227 CG ASP A 163 1. .371 -38. .310 -18. .242 1. .00 7. .61 A c
ATOM 1228 ODl ASP A 163 0. .228 -38. .669 -17. .919 1. .00 7. .69 A o
ATOM 1229 OD2 ASP A 163 1. .637 -37. .194 -18. .750 1. .00 7. .24 A o
ATOM 1230 C ASP A 163 2. .842 -41. .791 -17. .764 1. .00 8. .39 A c
ATOM 1231 o ASP A 163 2. .464 -42. .654 -18. .573 1. .00 8. .14 A o
ATOM 1232 N ILE A 164 4. .058 -41. .823 -17. .223 1. .00 8. .75 A N
ATOM 1233 CA ILE A 164 4. .955 -42. .900 -17. .590 1. .00 9. .10 A c
ATOM 1234 CB ILE A 164 6. .308 -42. .744 -16. .902 1. .00 8. .62 A c
ATOM 1235 CGl ILE A 164 7. .058 -41. .631 -17. .541 1. .00 8. .29 A c
ATOM 1236 CDl ILE A 164 7. .945 -40. .950 -16. .552 1. .00 8. .37 A c
ATOM 1237 CG2 ILE A 164 7. .109 -44. .018 -17. .007 1. .00 8. .59 A c
ATOM 1238 C ILE A 164 4. .326 -44. .280 -17. .276 1. .00 9. .63 A c
ATOM 1239 o ILE A 164 4. .408 -45. .188 -18. .076 1. .00 9. .83 A o
ATOM 1240 N ILE A 165 3. .688 -44. .427 -16. .125 1. .00 10. .31 A N
ATOM 1241 CA ILE A 165 3. .113 -45. .730 -15. .759 1. .00 11. .09 A c
ATOM 1242 CB ILE A 165 3. .142 -45. .965 -14. .238 1. .00 11. .45 A c
ATOM 1243 CGl ILE A 165 4. .583 -46. .312 -13. .859 1. .00 11. .73 A c
ATOM 1244 CDl ILE A 165 4. .846 -46. .351 -12. .376 1. .00 12. .06 A c
ATOM 1245 CG2 ILE A 165 2. .257 -47. .137 -13. .843 1. .00 11. .71 A c
ATOM 1246 C ILE A 165 1. .743 -45. .953 -16. .396 1. .00 11. .24 A c
ATOM 1247 o ILE A 165 1. .519 -46. .993 -16. .983 1. .00 10. .71 A o
ATOM 1248 N GLY A 166 0. .866 -44. .956 -16. .352 1. .00 11. .84 A N
ATOM 1249 CA GLY A 166 -0. .347 -44. .989 -17. .161 1. .00 12. .20 A c
ATOM 1250 C GLY A 166 -0. .114 -45. .522 -18. .568 1. .00 12. .55 A c
ATOM 1251 o GLY A 166 -0. .856 -46. .371 -19. .055 1. .00 13. .27 A o
ATOM 1252 N ASN A 167 0..936 -45..042 -19..219 1..00 13..01 A N
ATOM 1253 CA ASN A 167 1. .211 -45. .411 -20. .617 1. .00 13. .46 A C
ATOM 1254 CB ASN A 167 2. .130 -44. .379 -21. .255 1. .00 13. .54 A C
ATOM 1255 CG ASN A 167 2. .598 -44. .799 -22. .620 1. .00 13. .80 A c
ATOM 1256 ODl ASN A 167 3. .650 -45. .428 -22. .768 1. .00 13. .76 A o
ATOM 1257 ND2 ASN A 167 1. .794 -44. .495 -23. .630 1. .00 13. .97 A N
ATOM 1258 C ASN A 167 1. .831 -46. .800 -20. .769 1. .00 13. .70 A c
ATOM 1259 o ASN A 167 1. .633 -47. .497 -21. .769 1. .00 13. .68 A o
ATOM 1260 N ALA A 168 2. .607 -47. .179 -19. .767 1. .00 14. .07 A N
ATOM 1261 CA ALA A 168 3. .260 -48. .453 -19. .765 1. .00 13. .94 A c
ATOM 1262 CB ALA A 168 4. .247 -48. .531 -18. .618 1. .00 13. .53 A c
ATOM 1263 C ALA A 168 2. .231 -49. .547 -19. .667 1. .00 14. .33 A c
ATOM 1264 o ALA A 168 2. .429 -50. .581 -20. .227 1. .00 13. .98 A o
ATOM 1265 N ILE A 169 1. .131 -49. .324 -18. .960 1. .00 15. .94 A N
ATOM 1266 CA ILE A 169 0. .218 -50. .428 -18. .655 1. .00 18. .10 A c
ATOM 1267 CB ILE A 169 -0. .969 -50. .037 -17. .743 1. .00 18. .79 A c
ATOM 1268 CGl ILE A 169 -0. .561 -50. .080 -16. .280 1. .00 19. .73 A c
ATOM 1269 CDl ILE A 169 -0. .048 -48. .784 -15. .730 1. .00 20. .46 A c
ATOM 1270 CG2 ILE A 169 -2. .130 -51. .016 -17. .942 1. .00 18. .64 A c
ATOM 1271 C ILE A 169 -0. .394 -50. .822 -19. .949 1. .00 19. .50 A c
ATOM 1272 o ILE A 169 -0. .420 -51. .982 -20. .301 1. .00 17. .56 A o
ATOM 1273 N ASP A 170 -0. .941 -49. .782 -20. .581 1. .00 22. .96 A N
ATOM 1274 CA ASP A 170 -1. .495 -49. .783 -21. .922 1. .00 25. .80 A c
ATOM 1275 CB ASP A 170 -1. .761 -48. .290 -22. .319 1. .00 28. .80 A c
ATOM 1276 CG ASP A 170 -3. .056 -48. .077 -23. .198 1. .00 31. .65 A c
ATOM 1277 ODl ASP A 170 -3. .727 -49. .094 -23. .585 1. .00 32. .68 A o
ATOM 1278 OD2 ASP A 170 -3. .385 -46. .874 -23. .485 1. .00 27. .68 A o
ATOM 1279 C ASP A 170 -0. .556 -50. .556 -22. .895 1. .00 25. .17 A c
ATOM 1280 o ASP A 170 -0. .916 -51. .613 -23. .330 1. .00 26. .97 A o
ATOM 1281 N GLY A 171 0. .654 -50. .077 -23. .186 1. .00 25. .32 A N
ATOM 1282 CA GLY A 171 1. .589 -50. .813 -24. .048 1. .00 25. .14 A c
ATOM 1283 C GLY A 171 1. .799 -50. .195 -25. .428 1. .00 26. .60 A c
ATOM 1284 o GLY A 171 2. .914 -50. .233 -25. .976 1. .00 26. .53 A o
ATOM 1285 N LYS A 172 0. .759 -49. .524 -25. .930 1. .00 26. .94 A N
ATOM 1286 CA LYS A 172 0. .444 -49. .463 -27. .366 1. .00 26. .88 A c
ATOM 1287 CB LYS A 172 -1. .051 -49. .132 -27. .537 1. .00 30. .72 A c
ATOM 1288 CG LYS A 172 -2. .071 -50. .219 -27. .134 1. .00 33. .65 A c
ATOM 1289 CD LYS A 172 -3. .392 -50. .025 -27. .922 1. .00 36. .81 A c
ATOM 1290 CE LYS A 172 -4. .669 -50. .070 -27. .073 1. .00 38. .06 A c
ATOM 1291 NZ LYS A 172 -5. .038 -48. .814 -26. .339 1. .00 36. .90 A N
ATOM 1292 C LYS A 172 1. .213 -48. .471 -28. .238 1. .00 23. .70 A c
ATOM 1293 o LYS A 172 1. .584 -48. .768 -29. .365 1. .00 23. .20 A o
ATOM 1294 N ASN A 173 1. .390 -47. .273 -27. .716 1. .00 20. .08 A N
ATOM 1295 CA ASN A 173 1. .898 -46. .146 -28. .467 1. .00 17. .00 A c
ATOM 1296 CB ASN A 173 0. .736 -45. .383 -29. .125 1. .00 16. .90 A c
ATOM 1297 CG ASN A 173 -0. .422 -45. .079 -28. .148 1. .00 16. .63 A c
ATOM 1298 ODl ASN A 173 -0. .260 -44. .495 -27. .064 1. .00 15. .50 A o
ATOM 1299 ND2 ASN A 173 -1. .602 -45. .470 -28. .552 1. .00 16. .78 A N
ATOM 1300 C ASN A 173 2. .538 -45. .275 -27. .429 1. .00 14. .76 A c
ATOM 1301 o ASN A 173 2. .573 -45. .681 -26. .284 1. .00 15. .23 A o
ATOM 1302 N TRP A 174 2. .986 -44. .078 -27. .784 1. .00 12. .57 A N
ATOM 1303 CA TRP A 174 3. .504 -43. .159 -26. .790 1. .00 11. .39 A c
ATOM 1304 CB TRP A 174 4. .895 -42. .700 -27. .180 1. .00 11. .51 A c
ATOM 1305 CG TRP A 174 5. .894 -43. .735 -27. .116 1. .00 11. .10 A c
ATOM 1306 CDl TRP A 174 6. .445 -44. .349 -28. .137 1. .00 10. .94 A c
ATOM 1307 NEl TRP A 174 7. .375 -45. .235 -27. .722 1. .00 11. .20 A N
ATOM 1308 CE2 TRP A 174 7. .431 -45. .189 -26. .362 1. .00 11. .59 A c
ATOM 1309 CD 2 TRP A 174 6. .499 -44. .247 -25. .953 1. .00 11. .43 A c
ATOM 1310 CE3 TRP A 174 6. .344 -44. .000 -24. .584 1. .00 11. .96 A c
ATOM 1311 CZ3 TRP A 174 7. .125 -44. .722 -23. .675 1. .00 11. .80 A c
ATOM 1312 CH2 TRP A 174 8. .045 -45. .657 -24. .122 1. .00 11. .84 A c
ATOM 1313 CZ2 TRP A 174 8. .216 -45. .910 -25. .461 1. .00 11. .89 A c
ATOM 1314 C TRP A 174 2. .619 -41. .936 -26. .558 1. .00 10. .44 A c
ATOM 1315 o TRP A 174 3. .119 -40. .869 -26. .219 1. .00 9. .94 A o
ATOM 1316 N LEU A 175 1. .309 -42. .121 -26. .673 1. .00 9. .73 A N
ATOM 1317 CA LEU A 175 0. .346 -41. .082 -26. .370 1. .00 9. .50 A c
ATOM 1318 CB LEU A 175 -0. .739 -41. .054 -27. .450 1. .00 9. .31 A c
ATOM 1319 CG LEU A 175 -0. .164 -41. .226 -28. .865 1. .00 9. .05 A c
ATOM 1320 CDl LEU A 175 -1. .260 -41. .361 -29. .880 1. .00 8. .82 A c
ATOM 1321 CD 2 LEU A 175 0. .776 -40. .096 -29. .223 1. .00 8. .97 A c
ATOM 1322 C LEU A 175 -0. .308 -41. .248 -24. .998 1. .00 9. .46 A c
ATOM 1323 o LEU A 175 -0. .256 -42. .298 -24. .395 1. .00 9. .36 A o
ATOM 1324 N ILE A 176 -0. .927 -40. .172 -24. .528 1. .00 9. .67 A N
ATOM 1325 CA ILE A 176 -1. .810 -40. .190 -23. .373 1. .00 9. .57 A c
ATOM 1326 CB ILE A 176 -1. .257 -39. .265 -22. .274 1. .00 9. .83 A c
ATOM 1327 CGl ILE A 176 0. .182 -39. .690 -21. .898 1. .00 10. .01 A c
ATOM 1328 CDl ILE A 176 0. .280 -41. .016 -21. .150 1. .00 9. .93 A c
ATOM 1329 CG2 ILE A 176 -2. .184 -39. .218 -21. .049 1. .00 9. .82 A c
ATOM 1330 C ILE A 176 -3. .206 -39. .704 -23. .778 1. .00 9. .56 A c
ATOM 1331 o ILE A 176 -3..349 -38..639 -24..428 1..00 8..84 A o
ATOM 1332 N GLY A 177 -4. .220 -40. .486 -23. .367 1. .00 9. .68 A N
ATOM 1333 CA GLY A 177 -5. .622 -40. .131 -23. .517 1. .00 9. .79 A C
ATOM 1334 C GLY A 177 -6. .120 -40. .170 -24. .946 1. .00 10. .29 A C
ATOM 1335 o GLY A 177 -7. .167 -39. .604 -25. .249 1. .00 10. .78 A o
ATOM 1336 N ASP A 178 -5. .381 -40. .826 -25. .840 1. .00 10. .68 A N
ATOM 1337 CA ASP A 178 -5. .808 -40. .998 -27. .226 1. .00 10. .63 A c
ATOM 1338 CB ASP A 178 -4. .848 -41. .873 -28. .063 1. .00 10. .79 A c
ATOM 1339 CG ASP A 178 -4. .414 -43. .165 -27. .352 1. .00 11. .25 A c
ATOM 1340 ODl ASP A 178 -4. .028 -43. .125 -26. .137 1. .00 11. .72 A o
ATOM 1341 OD2 ASP A 178 -4. .445 -44. .230 -28. .017 1. .00 11. .08 A o
ATOM 1342 C ASP A 178 -7. .221 -41. .536 -27. .336 1. .00 10. .59 A c
ATOM 1343 o ASP A 178 -7. .904 -41. .156 -28. .272 1. .00 11. .28 A o
ATOM 1344 N LEU A 179 -7. .671 -42. .364 -26. .395 1. .00 10. .20 A N
ATOM 1345 CA LEU A 179 -8. .985 -43. .023 -26. .512 1. .00 10. .39 A c
ATOM 1346 CB LEU A 179 -8. .959 -44. .429 -25. .884 1. .00 10. .21 A c
ATOM 1347 CG LEU A 179 -8. .140 -45. .483 -26. .620 1. .00 10. .17 A c
ATOM 1348 CDl LEU A 179 -8. .127 -46. .713 -25. .763 1. .00 10. .31 A c
ATOM 1349 CD2 LEU A 179 -8. .653 -45. .828 -28. .003 1. .00 9. .96 A c
ATOM 1350 C LEU A 179 -10. .171 -42. .272 -25. .891 1. .00 10. .69 A c
ATOM 1351 o LEU A 179 -11. .324 -42. .757 -25. .993 1. .00 10. .57 A o
ATOM 1352 N ILE A 180 -9. .884 -41. .142 -25. .240 1. .00 10. .58 A N
ATOM 1353 CA ILE A 180 -10. .901 -40. .329 -24. .611 1. .00 10. .92 A c
ATOM 1354 CB ILE A 180 -10. .662 -40. .171 -23. .101 1. .00 11. .08 A c
ATOM 1355 CGl ILE A 180 -9. .227 -39. .759 -22. .788 1. .00 10. .99 A c
ATOM 1356 CDl ILE A 180 -9. .107 -39. .174 -21. .404 1. .00 11. .00 A c
ATOM 1357 CG2 ILE A 180 -10. .988 -41. .455 -22. .355 1. .00 11. .54 A c
ATOM 1358 C ILE A 180 -11. .031 -38. .915 -25. .192 1. .00 11. .35 A c
ATOM 1359 o ILE A 180 -12. .085 -38. .286 -25. .012 1. .00 11. .56 A o
ATOM 1360 N TYR A 181 -9. .969 -38. .421 -25. .844 1. .00 11. .08 A N
ATOM 1361 CA TYR A 181 -9. .888 -37. .060 -26. .366 1. .00 11. .01 A c
ATOM 1362 CB TYR A 181 -8. .420 -36. .640 -26. .406 1. .00 10. .90 A c
ATOM 1363 CG TYR A 181 -8. .183 -35. .157 -26. .669 1. .00 10. .79 A c
ATOM 1364 CDl TYR A 181 -8. .717 -34. .181 -25. .830 1. .00 10. .58 A c
ATOM 1365 CEl TYR A 181 -8. .480 -32. .830 -26. .058 1. .00 10. .73 A c
ATOM 1366 CZ TYR A 181 -7. .665 -32. .423 -27. .122 1. .00 10. .52 A c
ATOM 1367 OH TYR A 181 -7. .417 -31. .084 -27. .349 1. .00 9. .91 A o
ATOM 1368 CE2 TYR A 181 -7. .122 -33. .375 -27. .956 1. .00 10. .67 A c
ATOM 1369 CD2 TYR A 181 -7. .377 -34. .734 -27. .723 1. .00 10. .92 A c
ATOM 1370 C TYR A 181 -10. .429 -36. .894 -27. .772 1. .00 11. .14 A c
ATOM 1371 o TYR A 181 -10. .050 -37. .616 -28. .648 1. .00 11. .55 A o
ATOM 1372 N THR A 182 -11. .277 -35. .901 -28. .001 1. .00 12. .04 A N
ATOM 1373 CA THR A 182 -11. .754 -35. .522 -29. .366 1. .00 12. .29 A c
ATOM 1374 CB THR A 182 -10. .647 -34. .772 -30. .147 1. .00 12. .04 A c
ATOM 1375 OGl THR A 182 -9. .549 -35. .675 -30. .435 1. .00 11. .78 A o
ATOM 1376 CG2 THR A 182 -10. .182 -33. .532 -29. .383 1. .00 11. .44 A c
ATOM 1377 C THR A 182 -12. .249 -36. .731 -30. .203 1. .00 12. .70 A c
ATOM 1378 o THR A 182 -11. .491 -37. .287 -31. .039 1. .00 12. .48 A o
ATOM 1379 N PRO A 183 -13. .497 -37. .159 -29. .955 1. .00 13. .03 A N
ATOM 1380 CA PRO A 183 -14. .066 -38. .320 -30. .627 1. .00 13. .57 A c
ATOM 1381 CB PRO A 183 -15. .451 -38. .487 -29. .993 1. .00 13. .44 A c
ATOM 1382 CG PRO A 183 -15. .611 -37. .419 -28. .985 1. .00 13. .35 A c
ATOM 1383 CD PRO A 183 -14. .320 -36. .699 -28. .831 1. .00 13. .41 A c
ATOM 1384 C PRO A 183 -14. .199 -38. .181 -32. .135 1. .00 13. .75 A c
ATOM 1385 o PRO A 183 -14. .230 -39. .180 -32. .839 1. .00 13. .12 A o
ATOM 1386 N ASN A 184 -14. .285 -36. .955 -32. .616 1. .00 14. .63 A N
ATOM 1387 CA ASN A 184 -14. .499 -36. .726 -34. .034 1. .00 15. .68 A c
ATOM 1388 CB ASN A 184 -15. .679 -35. .797 -34. .216 1. .00 16. .64 A c
ATOM 1389 CG ASN A 184 -16. .978 -36. .426 -33. .740 1. .00 17. .82 A c
ATOM 1390 ODl ASN A 184 -17. .165 -37. .653 -33. .767 1. .00 18. .50 A o
ATOM 1391 ND2 ASN A 184 -17. .878 -35. .586 -33. .293 1. .00 18. .75 A N
ATOM 1392 C ASN A 184 -13. .291 -36. .194 -34. .751 1. .00 15. .70 A c
ATOM 1393 o ASN A 184 -13. .363 -35. .865 -35. .931 1. .00 15. .92 A o
ATOM 1394 N THR A 185 -12. .182 -36. .102 -34. .027 1. .00 15. .51 A N
ATOM 1395 CA THR A 185 -10. .898 -35. .823 -34. .620 1. .00 14. .77 A c
ATOM 1396 CB THR A 185 -10. .251 -34. .603 -33. .976 1. .00 14. .28 A c
ATOM 1397 OGl THR A 185 -11. .137 -33. .476 -34. .101 1. .00 13. .52 A o
ATOM 1398 CG2 THR A 185 -8. .912 -34. .341 -34. .633 1. .00 13. .98 A c
ATOM 1399 C THR A 185 -10. .039 -37. .035 -34. .382 1. .00 14. .98 A c
ATOM 1400 o THR A 185 -9. .666 -37. .310 -33. .243 1. .00 16. .15 A o
ATOM 1401 N PRO A 186 -9. .769 -37. .814 -35. .435 1. .00 14. .99 A N
ATOM 1402 CA PRO A 186 -8. .988 -39. .026 -35. .190 1. .00 14. .73 A c
ATOM 1403 CB PRO A 186 -9. .308 -39. .914 -36. .399 1. .00 14. .75 A c
ATOM 1404 CG PRO A 186 -9. .666 -38. .966 -37. .480 1. .00 14. .83 A c
ATOM 1405 CD PRO A 186 -10. .245 -37. .732 -36. .828 1. .00 14. .83 A c
ATOM 1406 C PRO A 186 -7. .510 -38. .741 -35. .136 1. .00 14. .30 A c
ATOM 1407 o PRO A 186 -7. .056 -37. .670 -35. .509 1. .00 14. .74 A o
ATOM 1408 N GLY A 187 -6. .778 -39. .711 -34. .630 1. .00 14. .35 A N
ATOM 1409 CA GLY A 187 -5. .330 -39. .677 -34. .597 1. .00 14. .24 A c
ATOM 1410 C GLY A 187 -4..707 -38..787 -33..543 1..00 14..00 A C
ATOM 1411 o GLY A 187 -3. .502 -38. .880 -33. .301 1. .00 13. .60 A o
ATOM 1412 N ASP A 188 -5. .504 -37. .925 -32. .907 1. .00 13. .79 A N
ATOM 1413 CA ASP A 188 -4. .957 -37. .050 -31. .879 1. .00 13. .64 A C
ATOM 1414 CB ASP A 188 -5. .532 -35. .633 -32. .008 1. .00 13. .33 A C
ATOM 1415 CG ASP A 188 -6. .943 -35. .496 -31. .502 1. .00 13. .39 A c
ATOM 1416 ODl ASP A 188 -7. .707 -36. .462 -31. .383 1. .00 13. .27 A o
ATOM 1417 OD2 ASP A 188 -7. .318 -34. .350 -31. .215 1. .00 14. .35 A o
ATOM 1418 C ASP A 188 -5. .070 -37. .612 -30. .452 1. .00 13. .88 A c
ATOM 1419 o ASP A 188 -5. .619 -38. .712 -30. .208 1. .00 14. .39 A o
ATOM 1420 N ALA A 189 -4. .540 -36. .842 -29. .515 1. .00 13. .78 A N
ATOM 1421 CA ALA A 189 -4. .466 -37. .257 -28. .144 1. .00 13. .80 A c
ATOM 1422 CB ALA A 189 -3. .329 -38. .259 -27. .955 1. .00 13. .78 A c
ATOM 1423 C ALA A 189 -4. .288 -36. .053 -27. .242 1. .00 13. .69 A c
ATOM 1424 o ALA A 189 -4. .183 -34. .937 -27. .707 1. .00 13. .66 A o
ATOM 1425 N LEU A 190 -4. .260 -36. .310 -25. .941 1. .00 14. .07 A N
ATOM 1426 CA LEU A 190 -4. .173 -35. .276 -24. .926 1. .00 14. .36 A c
ATOM 1427 CB LEU A 190 -4. .778 -35. .797 -23. .621 1. .00 14. .90 A c
ATOM 1428 CG LEU A 190 -4. .925 -34. .762 -22. .530 1. .00 15. .37 A c
ATOM 1429 CDl LEU A 190 -5. .581 -33. .503 -23. .056 1. .00 15. .75 A c
ATOM 1430 CD 2 LEU A 190 -5. .757 -35. .349 -21. .418 1. .00 15. .87 A c
ATOM 1431 C LEU A 190 -2. .730 -34. .822 -24. .710 1. .00 13. .65 A c
ATOM 1432 o LEU A 190 -2. .470 -33. .616 -24. .670 1. .00 14. .14 A o
ATOM 1433 N ARG A 191 -1. .808 -35. .785 -24. .610 1. .00 12. .55 A N
ATOM 1434 CA ARG A 191 -0. .373 -35. .501 -24. .585 1. .00 11. .67 A c
ATOM 1435 CB ARG A 191 0. .172 -35. .511 -23. .158 1. .00 11. .66 A c
ATOM 1436 CG ARG A 191 -0. .511 -34. .557 -22. .197 1. .00 11. .40 A c
ATOM 1437 CD ARG A 191 0. .195 -34. .508 -20. .853 1. .00 11. .14 A c
ATOM 1438 NE ARG A 191 -0. .205 -35. .582 -19. .945 1. .00 10. .68 A N
ATOM 1439 CZ ARG A 191 -1. .333 -35. .589 -19. .264 1. .00 10. .70 A c
ATOM 1440 NHl ARG A 191 -2. .205 -34. .590 -19. .381 1. .00 11. .00 A N
ATOM 1441 NH2 ARG A 191 -1. .598 -36. .590 -18. .450 1. .00 10. .72 A N
ATOM 1442 C ARG A 191 0. .398 -36. .543 -25. .332 1. .00 11. .21 A C
ATOM 1443 o ARG A 191 -0. .009 -37. .712 -25. .424 1. .00 10. .54 A o
ATOM 1444 N SER A 192 1. .555 -36. .128 -25. .807 1. .00 11. .04 A N
ATOM 1445 CA SER A 192 2. .431 -37. .032 -26. .528 1. .00 11. .41 A C
ATOM 1446 CB SER A 192 2. .631 -36. .558 -27. .971 1. .00 11. .37 A c
ATOM 1447 OG SER A 192 3. .803 -37. .111 -28. .558 1. .00 11. .38 A o
ATOM 1448 C SER A 192 3. .765 -37. .098 -25. .819 1. .00 11. .56 A c
ATOM 1449 o SER A 192 4. .463 -36. .094 -25. .698 1. .00 11. .58 A o
ATOM 1450 N MET A 193 4. .127 -38. .289 -25. .384 1. .00 11. .67 A N
ATOM 1451 CA MET A 193 5. .411 -38. .483 -24. .767 1. .00 12. .16 A c
ATOM 1452 CB MET A 193 5. .413 -39. .767 -23. .944 1. .00 12. .44 A c
ATOM 1453 CG MET A 193 4. .355 -39. .828 -22. .870 1. .00 12. .51 A c
ATOM 1454 SD MET A 193 4. .455 -41. .399 -22. .016 1. .00 12. .70 A s
ATOM 1455 CE MET A 193 6. .110 -41. .322 -21. .326 1. .00 13. .02 A c
ATOM 1456 C MET A 193 6. .562 -38. .560 -25. .776 1. .00 12. .02 A c
ATOM 1457 o MET A 193 7. .719 -38. .425 -25. .398 1. .00 11. .80 A o
ATOM 1458 N GLU A 194 6. .292 -38. .847 -27. .033 1. .00 12. .27 A N
ATOM 1459 CA GLU A 194 7. .421 -38. .982 -27. .980 1. .00 12. .83 A c
ATOM 1460 CB GLU A 194 7. .081 -39. .968 -29. .077 1. .00 13. .09 A c
ATOM 1461 CG GLU A 194 5. .903 -39. .511 -29. .951 1. .00 13. .52 A c
ATOM 1462 CD GLU A 194 5. .281 -40. .631 -30. .743 1. .00 13. .63 A c
ATOM 1463 OEl GLU A 194 5. .799 -41. .773 -30. .651 1. .00 14. .89 A o
ATOM 1464 OE2 GLU A 194 4. .296 -40. .372 -31. .447 1. .00 12. .72 A o
ATOM 1465 C GLU A 194 7. .764 -37. .621 -28. .572 1. .00 13. .17 A c
ATOM 1466 o GLU A 194 8. .872 -37. .403 -28. .987 1. .00 13. .22 A o
ATOM 1467 N ASN A 195 6. .788 -36. .712 -28. .558 1. .00 13. .78 A N
ATOM 1468 CA ASN A 195 6. .905 -35. .373 -29. .097 1. .00 14. .09 A c
ATOM 1469 CB ASN A 195 6. .568 -35. .428 -30. .580 1. .00 13. .89 A c
ATOM 1470 CG ASN A 195 6. .721 -34. .074 -31. .267 1. .00 13. .72 A c
ATOM 1471 ODl ASN A 195 7. .627 -33. .311 -30. .972 1. .00 13. .41 A o
ATOM 1472 ND2 ASN A 195 5. .834 -33. .786 -32. .198 1. .00 13. .75 A N
ATOM 1473 C ASN A 195 5. .967 -34. .375 -28. .387 1. .00 14. .61 A c
ATOM 1474 o ASN A 195 4. .898 -34. .055 -28. .885 1. .00 15. .66 A o
ATOM 1475 N PRO A 196 6. .347 -33. .900 -27. .209 1. .00 14. .75 A N
ATOM 1476 CA PRO A 196 5. .418 -33. .102 -26. .381 1. .00 14. .82 A c
ATOM 1477 CB PRO A 196 6. .265 -32. .773 -25. .157 1. .00 14. .80 A c
ATOM 1478 CG PRO A 196 7. .180 -33. .963 -25. .022 1. .00 15. .30 A c
ATOM 1479 CD PRO A 196 7. .505 -34. .382 -26. .437 1. .00 15. .18 A c
ATOM 1480 C PRO A 196 4. .894 -31. .812 -27. .012 1. .00 14. .89 A c
ATOM 1481 o PRO A 196 3. .743 -31. .393 -26. .764 1. .00 14. .12 A o
ATOM 1482 N LYS A 197 5. .751 -31. .193 -27. .816 1. .00 15. .78 A N
ATOM 1483 CA LYS A 197 5. .454 -29. .918 -28. .464 1. .00 16. .20 A c
ATOM 1484 CB LYS A 197 6. .607 -29. .476 -29. .345 1. .00 17. .65 A c
ATOM 1485 CG LYS A 197 7. .392 -28. .274 -28. .883 1. .00 19. .35 A c
ATOM 1486 CD LYS A 197 8. .470 -28. .028 -29. .955 1. .00 21. .72 A c
ATOM 1487 CE LYS A 197 9. .427 -26. .872 -29. .652 1. .00 22. .98 A c
ATOM 1488 NZ LYS A 197 8. .975 -25. .622 -30. .336 1. .00 23. .87 A N
ATOM 1489 C LYS A 197 4..219 -30..061 -29..310 1..00 14..95 A C
ATOM 1490 o LYS A 197 3. .513 -29. .114 -29. .515 1. .00 13. .94 A o
ATOM 1491 N LEU A 198 3. .956 -31. .257 -29. .791 1. .00 14. .64 A N
ATOM 1492 CA LEU A 198 2. .770 -31. .476 -30. .581 1. .00 15. .36 A C
ATOM 1493 CB LEU A 198 2. .576 -32. .969 -30. .863 1. .00 15. .67 A C
ATOM 1494 CG LEU A 198 1. .296 -33. .521 -31. .533 1. .00 15. .57 A c
ATOM 1495 CDl LEU A 198 0. .973 -32. .894 -32. .886 1. .00 15. .47 A c
ATOM 1496 CD 2 LEU A 198 1. .415 -35. .038 -31. .654 1. .00 15. .06 A c
ATOM 1497 C LEU A 198 1. .554 -30. .888 -29. .906 1. .00 15. .80 A c
ATOM 1498 o LEU A 198 0. .812 -30. .175 -30. .537 1. .00 17. .11 A o
ATOM 1499 N TYR A 199 1. .347 -31. .155 -28. .628 1. .00 16. .25 A N
ATOM 1500 CA TYR A 199 0. .175 -30. .598 -27. .921 1. .00 16. .26 A c
ATOM 1501 CB TYR A 199 -0. .650 -31. .738 -27. .300 1. .00 15. .53 A c
ATOM 1502 CG TYR A 199 -1. .040 -32. .822 -28. .279 1. .00 14. .71 A c
ATOM 1503 CDl TYR A 199 -1. .966 -32. .579 -29. .279 1. .00 14. .13 A c
ATOM 1504 CEl TYR A 199 -2. .340 -33. .559 -30. .171 1. .00 13. .70 A c
ATOM 1505 CZ TYR A 199 -1. .790 -34. .803 -30. .078 1. .00 14. .03 A c
ATOM 1506 OH TYR A 199 -2. .164 -35. .782 -30. .956 1. .00 14. .59 A o
ATOM 1507 CE2 TYR A 199 -0. .875 -35. .098 -29. .085 1. .00 14. .38 A c
ATOM 1508 CD 2 TYR A 199 -0. .492 -34. .098 -28. .198 1. .00 14. .66 A c
ATOM 1509 C TYR A 199 0. .572 -29. .551 -26. .857 1. .00 17. .22 A c
ATOM 1510 o TYR A 199 0. .113 -29. .585 -25. .712 1. .00 17. .25 A o
ATOM 1511 N ASN A 200 1. .441 -28. .624 -27. .242 1. .00 18. .43 A N
ATOM 1512 CA ASN A 200 1. .827 -27. .479 -26. .386 1. .00 18. .86 A c
ATOM 1513 CB ASN A 200 0. .631 -26. .532 -26. .215 1. .00 21. .02 A c
ATOM 1514 CG ASN A 200 0. .375 -25. .721 -27. .468 1. .00 23. .20 A c
ATOM 1515 ODl ASN A 200 1. .312 -25. .396 -28. .219 1. .00 26. .27 A o
ATOM 1516 ND2 ASN A 200 -0. .876 -25. .382 -27. .704 1. .00 24. .08 A N
ATOM 1517 C ASN A 200 2. .439 -27. .802 -25. .035 1. .00 17. .25 A c
ATOM 1518 o ASN A 200 2. .142 -27. .171 -24. .036 1. .00 16. .12 A o
ATOM 1519 N GLN A 201 3. .287 -28. .816 -25. .018 1. .00 16. .59 A N
ATOM 1520 CA GLN A 201 4. .176 -29. .045 -23. .898 1. .00 15. .78 A c
ATOM 1521 CB GLN A 201 4. .079 -30. .469 -23. .387 1. .00 15. .50 A c
ATOM 1522 CG GLN A 201 2. .816 -30. .765 -22. .619 1. .00 15. .69 A c
ATOM 1523 CD GLN A 201 2. .783 -32. .192 -22. .089 1. .00 16. .07 A c
ATOM 1524 OEl GLN A 201 2. .975 -33. .164 -22. .829 1. .00 15. .13 A o
ATOM 1525 NE2 GLN A 201 2. .540 -32. .322 -20. .790 1. .00 16. .64 A N
ATOM 1526 C GLN A 201 5. .602 -28. .747 -24. .336 1. .00 15. .44 A c
ATOM 1527 o GLN A 201 6. .000 -29. .038 -25. .453 1. .00 14. .82 A o
ATOM 1528 N PRO A 202 6. .365 -28. .113 -23. .463 1. .00 16. .00 A N
ATOM 1529 CA PRO A 202 7. .760 -27. .900 -23. .754 1. .00 16. .63 A c
ATOM 1530 CB PRO A 202 8. .227 -27. .048 -22. .586 1. .00 16. .94 A c
ATOM 1531 CG PRO A 202 7. .226 -27. .316 -21. .507 1. .00 17. .12 A c
ATOM 1532 CD PRO A 202 5. .949 -27. .401 -22. .249 1. .00 16. .49 A c
ATOM 1533 C PRO A 202 8. .482 -29. .203 -23. .734 1. .00 16. .91 A c
ATOM 1534 o PRO A 202 8. .043 -30. .115 -23. .030 1. .00 17. .59 A o
ATOM 1535 N ASP A 203 9. .563 -29. .286 -24. .497 1. .00 16. .60 A N
ATOM 1536 CA ASP A 203 10. .369 -30. .469 -24. .532 1. .00 17. .19 A c
ATOM 1537 CB ASP A 203 10. .337 -31. .157 -25. .911 1. .00 17. .40 A c
ATOM 1538 CG ASP A 203 10. .885 -30. .299 -27. .056 1. .00 17. .15 A c
ATOM 1539 ODl ASP A 203 11. .307 -29. .124 -26. .880 1. .00 16. .43 A o
ATOM 1540 OD2 ASP A 203 10. .849 -30. .843 -28. .180 1. .00 16. .95 A o
ATOM 1541 C ASP A 203 11. .791 -30. .209 -24. .112 1. .00 18. .70 A c
ATOM 1542 o ASP A 203 12. .676 -31. .022 -24. .429 1. .00 19. .51 A o
ATOM 1543 N ARG A 204 12. .020 -29. .116 -23. .381 1. .00 19. .82 A N
ATOM 1544 CA ARG A 204 13. .245 -28. .985 -22. .593 1. .00 20. .95 A c
ATOM 1545 CB ARG A 204 14. .421 -28. .585 -23. .458 1. .00 23. .55 A c
ATOM 1546 CG ARG A 204 14. .337 -27. .186 -24. .020 1. .00 27. .12 A c
ATOM 1547 CD ARG A 204 15. .383 -27. .032 -25. .090 1. .00 30. .35 A c
ATOM 1548 NE ARG A 204 14. .974 -26. .129 -26. .152 1. .00 34. .09 A N
ATOM 1549 CZ ARG A 204 15. .738 -25. .158 -26. .639 1. .00 37. .57 A c
ATOM 1550 NHl ARG A 204 16. .955 -24. .947 -26. .119 1. .00 38. .53 A N
ATOM 1551 NH2 ARG A 204 15. .277 -24. .384 -27. .633 1. .00 37. .08 A N
ATOM 1552 C ARG A 204 13. .103 -27. .993 -21. .473 1. .00 19. .87 A C
ATOM 1553 o ARG A 204 12. .316 -27. .060 -21. .576 1. .00 18. .88 A o
ATOM 1554 N TYR A 205 13. .886 -28. .202 -20. .417 1. .00 19. .61 A N
ATOM 1555 CA TYR A 205 13. .838 -27. .375 -19. .190 1. .00 20. .53 A C
ATOM 1556 CB TYR A 205 15. .060 -27. .682 -18. .280 1. .00 20. .73 A c
ATOM 1557 CG TYR A 205 14. .926 -27. .129 -16. .882 1. .00 20. .80 A c
ATOM 1558 CDl TYR A 205 13. .810 -27. .430 -16. .109 1. .00 21. .37 A c
ATOM 1559 CEl TYR A 205 13. .660 -26. .932 -14. .832 1. .00 21. .21 A c
ATOM 1560 CZ TYR A 205 14. .641 -26. .148 -14. .306 1. .00 20. .82 A c
ATOM 1561 OH TYR A 205 14. .447 -25. .681 -13. .053 1. .00 20. .22 A o
ATOM 1562 CE2 TYR A 205 15. .776 -25. .857 -15. .025 1. .00 20. .57 A c
ATOM 1563 CD 2 TYR A 205 15. .908 -26. .336 -16. .317 1. .00 20. .84 A c
ATOM 1564 C TYR A 205 13. .749 -25. .859 -19. .440 1. .00 20. .17 A c
ATOM 1565 o TYR A 205 12. .904 -25. .167 -18. .875 1. .00 18. .72 A o
ATOM 1566 N GLN A 206 14. .603 -25. .377 -20. .335 1. .00 21. .34 A N
ATOM 1567 CA GLN A 206 14. .715 -23. .948 -20. .671 1. .00 22. .58 A c
ATOM 1568 CB GLN A 206 15..767 -23..764 -21..757 1..00 24..80 A C
ATOM 1569 CG GLN A 206 17. .129 -24. .352 -21. .385 1. .00 28. .21 A C
ATOM 1570 CD GLN A 206 17. .413 -25. .682 -22. .073 1. .00 31. .20 A c
ATOM 1571 OEl GLN A 206 16. .776 -26. .702 -21. .784 1. .00 33. .57 A o
ATOM 1572 NE2 GLN A 206 18. .366 -25. .673 -23. .013 1. .00 34. .48 A N
ATOM 1573 C GLN A 206 13. .413 -23. .257 -21. .115 1. .00 21. .39 A c
ATOM 1574 o GLN A 206 13. .335 -22. .012 -21. .080 1. .00 21. .09 A o
ATOM 1575 N ASP A 207 12. .419 -24. .061 -21. .530 1. .00 19. .47 A N
ATOM 1576 CA ASP A 207 11. .158 -23. .578 -22. .108 1. .00 17. .35 A c
ATOM 1577 CB ASP A 207 10. .898 -24. .207 -23. .492 1. .00 17. .00 A c
ATOM 1578 CG ASP A 207 11. .998 -23. .917 -24. .494 1. .00 16. .98 A c
ATOM 1579 ODl ASP A 207 12. .681 -22. .892 -24. .342 1. .00 17. .05 A o
ATOM 1580 OD2 ASP A 207 12. .192 -24. .713 -25. .433 1. .00 16. .83 A o
ATOM 1581 C ASP A 207 10. .007 -23. .911 -21. .198 1. .00 15. .93 A c
ATOM 1582 o ASP A 207 8. .858 -23. .867 -21. .605 1. .00 15. .49 A o
ATOM 1583 N ARG A 208 10. .299 -24. .246 -19. .960 1. .00 14. .96 A N
ATOM 1584 CA ARG A 208 9. .222 -24. .567 -19. .046 1. .00 14. .60 A c
ATOM 1585 CB ARG A 208 9. .746 -25. .100 -17. .708 1. .00 14. .67 A c
ATOM 1586 CG ARG A 208 10. .371 -24. .035 -16. .833 1. .00 14. .67 A c
ATOM 1587 CD ARG A 208 11. .284 -24. .671 -15. .819 1. .00 14. .86 A c
ATOM 1588 NE ARG A 208 12. .055 -23. .638 -15. .162 1. .00 15. .29 A N
ATOM 1589 CZ ARG A 208 13. .206 -23. .171 -15. .614 1. .00 16. .10 A c
ATOM 1590 NHl ARG A 208 13. .731 -23. .649 -16. .721 1. .00 17. .73 A N
ATOM 1591 NH2 ARG A 208 13. .845 -22. .226 -14. .964 1. .00 16. .00 A N
ATOM 1592 C ARG A 208 8. .373 -23. .358 -18. .777 1. .00 13. .74 A C
ATOM 1593 o ARG A 208 8. .860 -22. .278 -18. .641 1. .00 12. .69 A o
ATOM 1594 N TYR A 209 7. .081 -23. .595 -18. .688 1. .00 14. .32 A N
ATOM 1595 CA TYR A 209 6. .136 -22. .639 -18. .140 1. .00 14. .70 A C
ATOM 1596 CB TYR A 209 4. .711 -23. .201 -18. .179 1. .00 14. .05 A c
ATOM 1597 CG TYR A 209 3. .623 -22. .377 -17. .503 1. .00 13. .32 A c
ATOM 1598 CDl TYR A 209 3. .136 -21. .228 -18. .076 1. .00 13. .15 A c
ATOM 1599 CEl TYR A 209 2. .097 -20. .516 -17. .498 1. .00 12. .94 A c
ATOM 1600 CZ TYR A 209 1. .528 -20. .944 -16. .330 1. .00 13. .00 A c
ATOM 1601 OH TYR A 209 0. .493 -20. .212 -15. .726 1. .00 12. .90 A o
ATOM 1602 CE2 TYR A 209 2. .012 -22. .088 -15. .741 1. .00 12. .96 A c
ATOM 1603 CD 2 TYR A 209 3. .043 -22. .796 -16. .334 1. .00 12. .99 A c
ATOM 1604 C TYR A 209 6. .513 -22. .419 -16. .714 1. .00 15. .33 A c
ATOM 1605 o TYR A 209 6. .889 -23. .363 -16. .023 1. .00 15. .11 A o
ATOM 1606 N THR A 210 6. .359 -21. .175 -16. .286 1. .00 16. .15 A N
ATOM 1607 CA THR A 210 6. .796 -20. .737 -14. .986 1. .00 17. .20 A c
ATOM 1608 CB THR A 210 8. .162 -19. .996 -15. .135 1. .00 18. .44 A c
ATOM 1609 OGl THR A 210 8. .620 -19. .652 -13. .838 1. .00 22. .63 A o
ATOM 1610 CG2 THR A 210 8. .092 -18. .692 -15. .962 1. .00 18. .69 A c
ATOM 1611 C THR A 210 5. .720 -19. .937 -14. .186 1. .00 16. .04 A c
ATOM 1612 o THR A 210 5. .983 -19. .437 -13. .110 1. .00 15. .79 A o
ATOM 1613 N GLY A 211 4. .497 -19. .885 -14. .697 1. .00 16. .00 A N
ATOM 1614 CA GLY A 211 3. .389 -19. .131 -14. .079 1. .00 16. .15 A c
ATOM 1615 C GLY A 211 2. .576 -19. .933 -13. .066 1. .00 16. .36 A c
ATOM 1616 o GLY A 211 2. .959 -21. .048 -12. .712 1. .00 17. .38 A o
ATOM 1617 N PRO A 212 1. .458 -19. .375 -12. .575 1. .00 15. .90 A N
ATOM 1618 CA PRO A 212 0. .825 -19. .956 -11. .405 1. .00 15. .80 A c
ATOM 1619 CB PRO A 212 0. .200 -18. .756 -10. .716 1. .00 15. .94 A c
ATOM 1620 CG PRO A 212 -0. .123 -17. .809 -11. .817 1. .00 16. .11 A c
ATOM 1621 CD PRO A 212 0. .825 -18. .103 -12. .955 1. .00 16. .30 A c
ATOM 1622 C PRO A 212 -0. .258 -20. .921 -11. .730 1. .00 16. .41 A c
ATOM 1623 o PRO A 212 -0. .656 -21. .692 -10. .857 1. .00 16. .72 A o
ATOM 1624 N SER A 213 -0. .724 -20. .898 -12. .973 1. .00 16. .53 A N
ATOM 1625 CA SER A 213 -1. .837 -21. .716 -13. .358 1. .00 16. .75 A c
ATOM 1626 CB SER A 213 -2. .284 -21. .316 -14. .748 1. .00 17. .51 A c
ATOM 1627 OG SER A 213 -3. .661 -21. .579 -14. .853 1. .00 18. .94 A o
ATOM 1628 C SER A 213 -1. .481 -23. .209 -13. .345 1. .00 17. .13 A c
ATOM 1629 o SER A 213 -0. .285 -23. .588 -13. .469 1. .00 17. .29 A o
ATOM 1630 N ASP A 214 -2. .513 -24. .059 -13. .209 1. .00 16. .27 A N
ATOM 1631 CA ASP A 214 -2. .329 -25. .508 -13. .237 1. .00 15. .08 A c
ATOM 1632 CB ASP A 214 -1. .851 -25. .926 -14. .630 1. .00 15. .42 A c
ATOM 1633 CG ASP A 214 -1. .721 -27. .430 -14. .796 1. .00 15. .51 A c
ATOM 1634 ODl ASP A 214 -2. .543 -28. .180 -14. .216 1. .00 16. .01 A o
ATOM 1635 OD2 ASP A 214 -0. .798 -27. .862 -15. .528 1. .00 14. .86 A o
ATOM 1636 C ASP A 214 -1. .305 -25. .901 -12. .213 1. .00 14. .27 A c
ATOM 1637 o ASP A 214 -0. .375 -26. .606 -12. .522 1. .00 13. .66 A o
ATOM 1638 N ASN A 215 -1. .466 -25. .409 -10. .995 1. .00 14. .22 A N
ATOM 1639 CA ASN A 215 -0. .507 -25. .653 -9. .924 1. .00 14. .30 A c
ATOM 1640 CB ASN A 215 -0. .702 -27. .060 -9. .334 1. .00 13. .77 A c
ATOM 1641 CG ASN A 215 -1. .959 -27. .172 -8. .472 1. .00 13. .33 A c
ATOM 1642 ODl ASN A 215 -2. .241 -26. .309 -7. .648 1. .00 13. .58 A o
ATOM 1643 ND2 ASN A 215 -2. .705 -28. .225 -8. .658 1. .00 12. .58 A N
ATOM 1644 C ASN A 215 0. .944 -25. .479 -10. .367 1. .00 15. .43 A c
ATOM 1645 o ASN A 215 1. .768 -26. .360 -10. .129 1. .00 17. .15 A o
ATOM 1646 N GLY A 216 1. .267 -24. .372 -11. .033 1. .00 15. .63 A N
ATOM 1647 CA GLY A 216 2..641 -24..132 -11..479 1..00 15..35 A C
ATOM 1648 C GLY A 216 3. .070 -24. .980 -12. .666 1. .00 15. .58 A C
ATOM 1649 o GLY A 216 4. .219 -25. .467 -12. .737 1. .00 16. .25 A o
ATOM 1650 N GLY A 217 2. .158 -25. .181 -13. .611 1. .00 15. .34 A N
ATOM 1651 CA GLY A 217 2. .524 -25. .840 -14. .884 1. .00 14. .91 A c
ATOM 1652 C GLY A 217 2. .633 -27. .352 -14. .829 1. .00 14. .14 A c
ATOM 1653 o GLY A 217 3. .387 -27. .969 -15. .596 1. .00 14. .67 A o
ATOM 1654 N VAL A 218 1. .829 -27. .949 -13. .972 1. .00 12. .95 A N
ATOM 1655 CA VAL A 218 2. .024 -29. .338 -13. .605 1. .00 12. .93 A c
ATOM 1656 CB VAL A 218 1. .198 -29. .641 -12. .327 1. .00 12. .94 A c
ATOM 1657 CGl VAL A 218 0. .249 -30. .815 -12. .469 1. .00 12. .92 A c
ATOM 1658 CG2 VAL A 218 2. .142 -29. .767 -11. .133 1. .00 12. .90 A c
ATOM 1659 C VAL A 218 1. .825 -30. .284 -14. .785 1. .00 12. .86 A c
ATOM 1660 o VAL A 218 2. .681 -31. .110 -15. .074 1. .00 13. .09 A o
ATOM 1661 N HIS A 219 0. .733 -30. .092 -15. .512 1. .00 12. .63 A N
ATOM 1662 CA HIS A 219 0. .478 -30. .819 -16. .744 1. .00 12. .21 A c
ATOM 1663 CB HIS A 219 -1. .019 -30. .845 -17. .028 1. .00 12. .29 A c
ATOM 1664 CG HIS A 219 -1. .812 -31. .473 -15. .932 1. .00 12. .04 A c
ATOM 1665 NDl HIS A 219 -2. .339 -30. .747 -14. .895 1. .00 11. .93 A N
ATOM 1666 CEl HIS A 219 -2. .961 -31. .562 -14. .064 1. .00 12. .18 A c
ATOM 1667 NE2 HIS A 219 -2. .828 -32. .794 -14. .514 1. .00 12. .05 A N
ATOM 1668 CD 2 HIS A 219 -2. .113 -32. .765 -15. .682 1. .00 11. .89 A C
ATOM 1669 C HIS A 219 1. .167 -30. .213 -17. .943 1. .00 11. .95 A c
ATOM 1670 o HIS A 219 1. .170 -30. .826 -19. .008 1. .00 11. .86 A o
ATOM 1671 N ILE A 220 1. .725 -29. .015 -17. .805 1. .00 11. .44 A N
ATOM 1672 CA ILE A 220 2. .414 -28. .443 -18. .914 1. .00 11. .45 A c
ATOM 1673 CB ILE A 220 2. .384 -26. .927 -18. .838 1. .00 11. .68 A c
ATOM 1674 CGl ILE A 220 0. .951 -26. .446 -19. .053 1. .00 12. .04 A c
ATOM 1675 CDl ILE A 220 0. .737 -24. .988 -18. .653 1. .00 12. .23 A c
ATOM 1676 CG2 ILE A 220 3. .293 -26. .302 -19. .894 1. .00 11. .57 A c
ATOM 1677 C ILE A 220 3. .841 -28. .999 -18. .991 1. .00 11. .72 A c
ATOM 1678 o ILE A 220 4. .228 -29. .616 -20. .020 1. .00 11. .22 A o
ATOM 1679 N ASN A 221 4. .601 -28. .809 -17. .897 1. .00 11. .49 A N
ATOM 1680 CA ASN A 221 6. .051 -29. .113 -17. .882 1. .00 11. .39 A c
ATOM 1681 CB ASN A 221 6. .761 -28. .288 -16. .820 1. .00 11. .36 A c
ATOM 1682 CG ASN A 221 6. .457 -26. .809 -16. .934 1. .00 11. .22 A c
ATOM 1683 ODl ASN A 221 6. .580 -26. .185 -17. .993 1. .00 11. .34 A o
ATOM 1684 ND2 ASN A 221 6. .032 -26. .250 -15. .851 1. .00 11. .20 A N
ATOM 1685 C ASN A 221 6. .413 -30. .581 -17. .667 1. .00 11. .36 A c
ATOM 1686 o ASN A 221 7. .587 -30. .933 -17. .639 1. .00 11. .44 A o
ATOM 1687 N SER A 222 5. .403 -31. .442 -17. .547 1. .00 11. .25 A N
ATOM 1688 CA SER A 222 5. .638 -32. .877 -17. .417 1. .00 10. .81 A c
ATOM 1689 CB SER A 222 4. .345 -33. .617 -17. .026 1. .00 10. .68 A c
ATOM 1690 OG SER A 222 3. .340 -33. .460 -17. .996 1. .00 10. .76 A o
ATOM 1691 C SER A 222 6. .217 -33. .444 -18. .689 1. .00 10. .49 A c
ATOM 1692 o SER A 222 6. .888 -34. .485 -18. .652 1. .00 10. .48 A o
ATOM 1693 N GLY A 223 5. .946 -32. .771 -19. .810 1. .00 10. .19 A N
ATOM 1694 CA GLY A 223 6. .413 -33. .226 -21. .107 1. .00 10. .08 A c
ATOM 1695 C GLY A 223 7. .927 -33. .301 -21. .164 1. .00 10. .06 A c
ATOM 1696 o GLY A 223 8. .491 -34. .143 -21. .859 1. .00 9. .81 A o
ATOM 1697 N ILE A 224 8. .578 -32. .431 -20. .398 1. .00 10. .10 A N
ATOM 1698 CA ILE A 224 10. .020 -32. .426 -20. .317 1. .00 10. .23 A c
ATOM 1699 CB ILE A 224 10. .519 -31. .272 -19. .422 1. .00 10. .49 A c
ATOM 1700 CGl ILE A 224 10. .159 -29. .913 -20. .031 1. .00 10. .32 A c
ATOM 1701 CDl ILE A 224 9. .939 -28. .841 -18. .985 1. .00 10. .40 A c
ATOM 1702 CG2 ILE A 224 12. .037 -31. .376 -19. .189 1. .00 10. .68 A c
ATOM 1703 C ILE A 224 10. .505 -33. .749 -19. .756 1. .00 10. .23 A c
ATOM 1704 o ILE A 224 11. .364 -34. .386 -20. .336 1. .00 9. .86 A o
ATOM 1705 N ASN A 225 9. .949 -34. .164 -18. .625 1. .00 10. .63 A N
ATOM 1706 CA ASN A 225 10. .323 -35. .454 -18. .082 1. .00 11. .23 A c
ATOM 1707 CB ASN A 225 9. .905 -35. .631 -16. .640 1. .00 11. .81 A c
ATOM 1708 CG ASN A 225 10. .579 -36. .830 -15. .998 1. .00 12. .52 A c
ATOM 1709 ODl ASN A 225 9. .945 -37. .827 -15. .680 1. .00 13. .05 A o
ATOM 1710 ND2 ASN A 225 11. .883 -36. .753 -15. .847 1. .00 12. .97 A N
ATOM 1711 C ASN A 225 9. .780 -36. .617 -18. .879 1. .00 11. .45 A c
ATOM 1712 o ASN A 225 10. .456 -37. .629 -18. .972 1. .00 11. .51 A o
ATOM 1713 N ASN A 226 8. .575 -36. .500 -19. .457 1. .00 11. .45 A N
ATOM 1714 CA ASN A 226 8. .081 -37. .559 -20. .356 1. .00 11. .23 A c
ATOM 1715 CB ASN A 226 6. .650 -37. .267 -20. .854 1. .00 11. .25 A c
ATOM 1716 CG ASN A 226 5. .584 -37. .417 -19. .761 1. .00 11. .15 A c
ATOM 1717 ODl ASN A 226 5. .901 -37. .722 -18. .614 1. .00 10. .97 A o
ATOM 1718 ND2 ASN A 226 4. .313 -37. .165 -20. .112 1. .00 11. .00 A N
ATOM 1719 C ASN A 226 9. .039 -37. .761 -21. .539 1. .00 11. .16 A c
ATOM 1720 o ASN A 226 9. .376 -38. .871 -21. .901 1. .00 10. .70 A o
ATOM 1721 N LYS A 227 9. .501 -36. .669 -22. .125 1. .00 11. .75 A N
ATOM 1722 CA LYS A 227 10. .371 -36. .759 -23. .271 1. .00 12. .42 A c
ATOM 1723 CB LYS A 227 10. .731 -35. .370 -23. .764 1. .00 12. .84 A c
ATOM 1724 CG LYS A 227 11. .611 -35. .359 -24. .990 1. .00 13. .61 A c
ATOM 1725 CD LYS A 227 10. .945 -35. .898 -26. .266 1. .00 14. .22 A c
ATOM 1726 CE LYS A 227 12..014 -36..340 -27..269 1..00 15..09 A C
ATOM 1727 NZ LYS A 227 11. .580 -36. .298 -28. .698 1. .00 15. .81 A N
ATOM 1728 C LYS A 227 11. .612 -37. .562 -22. .904 1. .00 12. .89 A C
ATOM 1729 o LYS A 227 12. .015 -38. .460 -23. .641 1. .00 13. .47 A o
ATOM 1730 N ALA A 228 12. .193 -37. .269 -21. .740 1. .00 12. .98 A N
ATOM 1731 CA ALA A 228 13. .335 -38. .036 -21. .243 1. .00 12. .64 A C
ATOM 1732 CB ALA A 228 13. .813 -37. .442 -19. .926 1. .00 12. .73 A C
ATOM 1733 C ALA A 228 13. .068 -39. .558 -21. .096 1. .00 12. .18 A c
ATOM 1734 o ALA A 228 13. .905 -40. .380 -21. .471 1. .00 12. .38 A o
ATOM 1735 N PHE A 229 11. .914 -39. .929 -20. .545 1. .00 11. .74 A N
ATOM 1736 CA PHE A 229 11. .555 -41. .334 -20. .434 1. .00 11. .22 A c
ATOM 1737 CB PHE A 229 10. .240 -41. .554 -19. .676 1. .00 10. .83 A c
ATOM 1738 CG PHE A 229 9. .932 -42. .999 -19. .513 1. .00 10. .75 A c
ATOM 1739 CDl PHE A 229 10. .570 -43. .735 -18. .552 1. .00 10. .84 A c
ATOM 1740 CEl PHE A 229 10. .358 -45. .093 -18. .457 1. .00 11. .22 A c
ATOM 1741 CZ PHE A 229 9. .505 -45. .741 -19. .351 1. .00 10. .84 A c
ATOM 1742 CE2 PHE A 229 8. .890 -45. .023 -20. .333 1. .00 10. .64 A c
ATOM 1743 CD 2 PHE A 229 9. .104 -43. .659 -20. .409 1. .00 10. .89 A c
ATOM 1744 C PHE A 229 11. .470 -41. .957 -21. .827 1. .00 11. .34 A c
ATOM 1745 o PHE A 229 11. .985 -43. .054 -22. .072 1. .00 11. .16 A o
ATOM 1746 N TYR A 230 10. .831 -41. .248 -22. .750 1. .00 11. .53 A N
ATOM 1747 CA TYR A 230 10. .803 -41. .695 -24. .136 1. .00 11. .74 A c
ATOM 1748 CB TYR A 230 10. .119 -40. .669 -25. .062 1. .00 11. .82 A c
ATOM 1749 CG TYR A 230 10. .185 -41. .060 -26. .522 1. .00 11. .70 A c
ATOM 1750 CDl TYR A 230 9. .407 -42. .076 -27. .041 1. .00 11. .41 A c
ATOM 1751 CEl TYR A 230 9. .497 -42. .427 -28. .377 1. .00 11. .72 A c
ATOM 1752 CZ TYR A 230 10. .387 -41. .744 -29. .222 1. .00 12. .00 A c
ATOM 1753 OH TYR A 230 10. .553 -41. .983 -30. .564 1. .00 11. .37 A o
ATOM 1754 CE2 TYR A 230 11. .161 -40. .741 -28. .709 1. .00 12. .22 A c
ATOM 1755 CD 2 TYR A 230 11. .058 -40. .409 -27. .367 1. .00 12. .28 A c
ATOM 1756 C TYR A 230 12. .200 -42. .005 -24. .645 1. .00 11. .45 A c
ATOM 1757 o TYR A 230 12. .438 -43. .097 -25. .119 1. .00 11. .78 A o
ATOM 1758 N LEU A 231 13. .114 -41. .058 -24. .519 1. .00 11. .40 A N
ATOM 1759 CA LEU A 231 14. .473 -41. .254 -24. .997 1. .00 11. .79 A c
ATOM 1760 CB LEU A 231 15. .288 -39. .996 -24. .808 1. .00 11. .69 A c
ATOM 1761 CG LEU A 231 14. .814 -38. .855 -25. .698 1. .00 11. .76 A c
ATOM 1762 CDl LEU A 231 15. .341 -37. .549 -25. .148 1. .00 11. .92 A c
ATOM 1763 CD 2 LEU A 231 15. .246 -39. .049 -27. .144 1. .00 11. .76 A c
ATOM 1764 C LEU A 231 15. .190 -42. .435 -24. .338 1. .00 12. .58 A c
ATOM 1765 o LEU A 231 15. .881 -43. .196 -25. .035 1. .00 12. .49 A o
ATOM 1766 N ILE A 232 15. .003 -42. .611 -23. .021 1. .00 13. .10 A N
ATOM 1767 CA ILE A 232 15. .600 -43. .750 -22. .306 1. .00 13. .31 A c
ATOM 1768 CB ILE A 232 15. .493 -43. .616 -20. .781 1. .00 13. .13 A c
ATOM 1769 CGl ILE A 232 16. .478 -42. .569 -20. .316 1. .00 13. .85 A c
ATOM 1770 CDl ILE A 232 16. .013 -41. .724 -19. .150 1. .00 14. .38 A c
ATOM 1771 CG2 ILE A 232 15. .890 -44. .889 -20. .075 1. .00 12. .88 A c
ATOM 1772 C ILE A 232 15. .048 -45. .077 -22. .764 1. .00 14. .10 A c
ATOM 1773 o ILE A 232 15. .825 -46. .032 -22. .986 1. .00 14. .59 A o
ATOM 1774 N ALA A 233 13. .727 -45. .158 -22. .924 1. .00 15. .20 A N
ATOM 1775 CA ALA A 233 13. .080 -46. .436 -23. .335 1. .00 15. .74 A c
ATOM 1776 CB ALA A 233 11. .598 -46. .388 -23. .053 1. .00 15. .72 A c
ATOM 1777 C ALA A 233 13. .306 -46. .738 -24. .814 1. .00 16. .24 A c
ATOM 1778 o ALA A 233 13. .765 -47. .824 -25. .156 1. .00 16. .87 A o
ATOM 1779 N GLN A 234 13. .030 -45. .743 -25. .661 1. .00 15. .67 A N
ATOM 1780 CA GLN A 234 12. .883 -45. .933 -27. .091 1. .00 15. .40 A c
ATOM 1781 CB GLN A 234 11. .714 -45. .074 -27. .555 1. .00 14. .97 A c
ATOM 1782 CG GLN A 234 11. .303 -45. .270 -28. .993 1. .00 14. .65 A c
ATOM 1783 CD GLN A 234 10. .815 -46. .672 -29. .269 1. .00 14. .44 A c
ATOM 1784 OEl GLN A 234 9. .965 -47. .219 -28. .560 1. .00 14. .43 A o
ATOM 1785 NE2 GLN A 234 11. .323 -47. .247 -30. .327 1. .00 14. .09 A N
ATOM 1786 C GLN A 234 14. .139 -45. .538 -27. .894 1. .00 15. .79 A c
ATOM 1787 o GLN A 234 14. .349 -46. .002 -29. .017 1. .00 14. .62 A o
ATOM 1788 N GLY A 235 14. .970 -44. .664 -27. .344 1. .00 16. .03 A N
ATOM 1789 CA GLY A 235 16. .065 -44. .118 -28. .151 1. .00 16. .48 A c
ATOM 1790 C GLY A 235 15. .602 -43. .077 -29. .169 1. .00 16. .81 A c
ATOM 1791 o GLY A 235 14. .511 -43. .182 -29. .751 1. .00 17. .76 A o
ATOM 1792 N GLY A 236 16. .422 -42. .048 -29. .351 1. .00 16. .10 A N
ATOM 1793 CA GLY A 236 16. .220 -41. .069 -30. .403 1. .00 15. .98 A c
ATOM 1794 C GLY A 236 17. .318 -40. .016 -30. .319 1. .00 16. .20 A c
ATOM 1795 o GLY A 236 18. .156 -40. .076 -29. .432 1. .00 17. .05 A o
ATOM 1796 N THR A 237 17. .335 -39. .061 -31. .239 1. .00 15. .70 A N
ATOM 1797 CA THR A 237 18. .164 -37. .893 -31. .078 1. .00 15. .66 A c
ATOM 1798 CB THR A 237 19. .028 -37. .680 -32. .316 1. .00 15. .65 A c
ATOM 1799 OGl THR A 237 20. .044 -38. .688 -32. .371 1. .00 15. .12 A o
ATOM 1800 CG2 THR A 237 19. .671 -36. .339 -32. .258 1. .00 15. .82 A c
ATOM 1801 C THR A 237 17. .280 -36. .671 -30. .870 1. .00 16. .10 A c
ATOM 1802 o THR A 237 16. .260 -36. .549 -31. .531 1. .00 17. .31 A o
ATOM 1803 N HIS A 238 17. .707 -35. .747 -30. .000 1. .00 16. .14 A N
ATOM 1804 CA HIS A 238 16. .896 -34. .631 -29. .507 1. .00 15. .59 A c
ATOM 1805 CB HIS A 238 16..100 -35..136 -28..320 1..00 15..65 A C
ATOM 1806 CG HIS A 238 15. .015 -34. .220 -27. .870 1. .00 15. .62 A C
ATOM 1807 NDl HIS A 238 15. .038 -33. .597 -26. .642 1. .00 15. .28 A N
ATOM 1808 CEl HIS A 238 13. .957 -32. .857 -26. .511 1. .00 15. .61 A C
ATOM 1809 NE2 HIS A 238 13. .239 -32. .969 -27. .616 1. .00 15. .96 A N
ATOM 1810 CD 2 HIS A 238 13. .874 -33. .828 -28. .478 1. .00 15. .56 A C
ATOM 1811 C HIS A 238 17. .811 -33. .486 -29. .054 1. .00 16. .36 A C
ATOM 1812 o HIS A 238 18. .767 -33. .708 -28. .308 1. .00 16. .31 A o
ATOM 1813 N TYR A 239 17. .509 -32. .261 -29. .481 1. .00 17. .28 A N
ATOM 1814 CA TYR A 239 18. .437 -31. .129 -29. .358 1. .00 18. .38 A c
ATOM 1815 CB TYR A 239 18. .194 -30. .334 -28. .055 1. .00 18. .88 A c
ATOM 1816 CG TYR A 239 16. .844 -29. .703 -28. .089 1. .00 19. .54 A c
ATOM 1817 CDl TYR A 239 16. .565 -28. .661 -28. .966 1. .00 19. .99 A c
ATOM 1818 CEl TYR A 239 15. .286 -28. .100 -29. .034 1. .00 21. .13 A c
ATOM 1819 CZ TYR A 239 14. .263 -28. .596 -28. .214 1. .00 21. .56 A c
ATOM 1820 OH TYR A 239 12. .986 -28. .064 -28. .260 1. .00 23. .19 A o
ATOM 1821 CE2 TYR A 239 14. .530 -29. .623 -27. .329 1. .00 20. .93 A c
ATOM 1822 CD 2 TYR A 239 15. .809 -30. .183 -27. .281 1. .00 20. .58 A c
ATOM 1823 C TYR A 239 19. .906 -31. .552 -29. .542 1. .00 18. .22 A c
ATOM 1824 o TYR A 239 20. .776 -31. .289 -28. .713 1. .00 18. .56 A o
ATOM 1825 N GLY A 240 20. .155 -32. .254 -30. .633 1. .00 18. .16 A N
ATOM 1826 CA GLY A 240 21. .496 -32. .645 -30. .989 1. .00 17. .75 A c
ATOM 1827 C GLY A 240 22. .090 -33. .814 -30. .251 1. .00 17. .52 A c
ATOM 1828 o GLY A 240 23. .170 -34. .223 -30. .605 1. .00 19. .02 A o
ATOM 1829 N VAL A 241 21. .407 -34. .384 -29. .263 1. .00 17. .08 A N
ATOM 1830 CA VAL A 241 22. .001 -35. .435 -28. .424 1. .00 16. .66 A c
ATOM 1831 CB VAL A 241 21. .800 -35. .134 -26. .929 1. .00 16. .31 A c
ATOM 1832 CGl VAL A 241 22. .300 -36. .290 -26. .063 1. .00 15. .93 A c
ATOM 1833 CG2 VAL A 241 22. .477 -33. .828 -26. .550 1. .00 16. .07 A c
ATOM 1834 C VAL A 241 21. .381 -36. .786 -28. .715 1. .00 17. .12 A c
ATOM 1835 o VAL A 241 20. .177 -36. .895 -28. .798 1. .00 17. .62 A o
ATOM 1836 N THR A 242 22. .204 -37. .820 -28. .817 1. .00 17. .43 A N
ATOM 1837 CA THR A 242 21. .744 -39. .121 -29. .280 1. .00 18. .51 A c
ATOM 1838 CB THR A 242 22. .672 -39. .649 -30. .391 1. .00 18. .77 A c
ATOM 1839 OGl THR A 242 22. .716 -38. .675 -31. .456 1. .00 20. .65 A o
ATOM 1840 CG2 THR A 242 22. .198 -40. .996 -30. .941 1. .00 17. .75 A c
ATOM 1841 C THR A 242 21. .696 -40. .102 -28. .124 1. .00 19. .15 A c
ATOM 1842 o THR A 242 22. .645 -40. .197 -27. .349 1. .00 20. .63 A o
ATOM 1843 N VAL A 243 20. .597 -40. .841 -28. .008 1. .00 18. .62 A N
ATOM 1844 CA VAL A 243 20. .381 -41. .700 -26. .852 1. .00 17. .91 A c
ATOM 1845 CB VAL A 243 19. .219 -41. .203 -25. .937 1. .00 17. .53 A c
ATOM 1846 CGl VAL A 243 18. .882 -42. .211 -24. .866 1. .00 17. .59 A c
ATOM 1847 CG2 VAL A 243 19. .540 -39. .887 -25. .267 1. .00 17. .36 A c
ATOM 1848 C VAL A 243 20. .045 -43. .047 -27. .402 1. .00 17. .83 A c
ATOM 1849 o VAL A 243 19. .182 -43. .165 -28. .255 1. .00 17. .31 A o
ATOM 1850 N ASN A 244 20. .728 -44. .064 -26. .896 1. .00 18. .98 A N
ATOM 1851 CA ASN A 244 20. .444 -45. .429 -27. .283 1. .00 19. .14 A c
ATOM 1852 CB ASN A 244 21. .743 -46. .233 -27. .435 1. .00 20. .07 A c
ATOM 1853 CG ASN A 244 22. .687 -45. .637 -28. .492 1. .00 22. .13 A c
ATOM 1854 ODl ASN A 244 23. .898 -45. .673 -28. .328 1. .00 25. .76 A o
ATOM 1855 ND2 ASN A 244 22. .139 -45. .076 -29. .571 1. .00 22. .37 A N
ATOM 1856 C ASN A 244 19. .487 -46. .073 -26. .293 1. .00 17. .74 A c
ATOM 1857 o ASN A 244 19. .867 -46. .368 -25. .167 1. .00 17. .39 A o
ATOM 1858 N GLY A 245 18. .250 -46. .288 -26. .756 1. .00 16. .76 A N
ATOM 1859 CA GLY A 245 17. .168 -46. .961 -26. .003 1. .00 15. .81 A c
ATOM 1860 C GLY A 245 17. .533 -48. .262 -25. .293 1. .00 14. .82 A c
ATOM 1861 o GLY A 245 18. .329 -49. .031 -25. .768 1. .00 13. .85 A o
ATOM 1862 N ILE A 246 16. .931 -48. .493 -24. .137 1. .00 14. .54 A N
ATOM 1863 CA ILE A 246 17. .202 -49. .690 -23. .331 1. .00 14. .23 A c
ATOM 1864 CB ILE A 246 17. .692 -49. .293 -21. .907 1. .00 14. .22 A c
ATOM 1865 CGl ILE A 246 16. .529 -48. .766 -21. .060 1. .00 13. .97 A c
ATOM 1866 CDl ILE A 246 16. .857 -48. .508 -19. .623 1. .00 14. .08 A c
ATOM 1867 CG2 ILE A 246 18. .784 -48. .218 -22. .012 1. .00 14. .32 A c
ATOM 1868 C ILE A 246 15. .965 -50. .552 -23. .209 1. .00 13. .73 A c
ATOM 1869 o ILE A 246 15. .987 -51. .557 -22. .540 1. .00 12. .83 A o
ATOM 1870 N GLY A 247 14. .880 -50. .097 -23. .820 1. .00 14. .78 A N
ATOM 1871 CA GLY A 247 13. .606 -50. .812 -23. .849 1. .00 15. .96 A c
ATOM 1872 C GLY A 247 12. .624 -50. .351 -22. .790 1. .00 17. .03 A c
ATOM 1873 o GLY A 247 12. .999 -49. .794 -21. .732 1. .00 17. .49 A o
ATOM 1874 N ARG A 248 11. .349 -50. .581 -23. .066 1. .00 17. .34 A N
ATOM 1875 CA ARG A 248 10. .309 -50. .188 -22. .118 1. .00 17. .10 A c
ATOM 1876 CB ARG A 248 8. .940 -50. .518 -22. .669 1. .00 16. .58 A c
ATOM 1877 CG ARG A 248 8. .433 -49. .504 -23. .662 1. .00 16. .47 A c
ATOM 1878 CD ARG A 248 7. .050 -49. .883 -24. .118 1. .00 16. .25 A c
ATOM 1879 NE ARG A 248 6. .539 -48. .977 -25. .139 1. .00 17. .32 A N
ATOM 1880 CZ ARG A 248 5. .613 -48. .024 -24. .967 1. .00 18. .41 A c
ATOM 1881 NHl ARG A 248 5. .058 -47. .761 -23. .787 1. .00 18. .84 A N
ATOM 1882 NH2 ARG A 248 5. .232 -47. .308 -26. .009 1. .00 18. .99 A N
ATOM 1883 C ARG A 248 10. .493 -50. .875 -20. .763 1. .00 17. .84 A C
ATOM 1884 o ARG A 248 10..415 -50..214 -19..716 1..00 18..39 A o
ATOM 1885 N ASP A 249 10. .747 -52. .182 -20. .760 1. .00 17. .69 A N
ATOM 1886 CA ASP A 249 10. .706 -52. .918 -19. .487 1. .00 17. .91 A C
ATOM 1887 CB ASP A 249 10. .937 -54. .421 -19. .668 1. .00 19. .68 A C
ATOM 1888 CG ASP A 249 9. .848 -55. .096 -20. .488 1. .00 21. .62 A c
ATOM 1889 ODl ASP A 249 8. .623 -54. .884 -20. .223 1. .00 23. .50 A o
ATOM 1890 OD2 ASP A 249 10. .246 -55. .848 -21. .401 1. .00 22. .32 A o
ATOM 1891 C ASP A 249 11. .718 -52. .389 -18. .500 1. .00 15. .89 A c
ATOM 1892 o ASP A 249 11. .395 -52. .143 -17. .365 1. .00 15. .97 A o
ATOM 1893 N ALA A 250 12. .943 -52. .202 -18. .940 1. .00 14. .48 A N
ATOM 1894 CA ALA A 250 13. .986 -51. .761 -18. .044 1. .00 13. .79 A c
ATOM 1895 CB ALA A 250 15. .331 -51. .950 -18. .717 1. .00 13. .75 A c
ATOM 1896 C ALA A 250 13. .806 -50. .299 -17. .587 1. .00 13. .38 A c
ATOM 1897 o ALA A 250 14. .111 -49. .946 -16. .455 1. .00 12. .91 A o
ATOM 1898 N ALA A 251 13. .325 -49. .444 -18. .474 1. .00 13. .31 A N
ATOM 1899 CA ALA A 251 13. .146 -48. .054 -18. .117 1. .00 13. .55 A c
ATOM 1900 CB ALA A 251 12. .906 -47. .192 -19. .342 1. .00 13. .75 A c
ATOM 1901 C ALA A 251 12. .032 -47. .853 -17. .090 1. .00 13. .33 A c
ATOM 1902 o ALA A 251 12. .242 -47. .100 -16. .146 1. .00 13. .54 A o
ATOM 1903 N VAL A 252 10. .872 -48. .499 -17. .238 1. .00 13. .18 A N
ATOM 1904 CA VAL A 252 9. .833 -48. .337 -16. .191 1. .00 13. .49 A c
ATOM 1905 CB VAL A 252 8. .454 -49. .008 -16. .461 1. .00 13. .62 A c
ATOM 1906 CG2 VAL A 252 8. .450 -50. .435 -15. .961 1. .00 14. .26 A c
ATOM 1907 CGl VAL A 252 8. .094 -49. .017 -17. .928 1. .00 13. .79 A c
ATOM 1908 C VAL A 252 10. .377 -48. .832 -14. .850 1. .00 13. .05 A c
ATOM 1909 o VAL A 252 10. .070 -48. .244 -13. .836 1. .00 12. .86 A o
ATOM 1910 N GLN A 253 11. .193 -49. .886 -14. .855 1. .00 13. .17 A N
ATOM 1911 CA GLN A 253 11. .744 -50. .453 -13. .619 1. .00 13. .59 A c
ATOM 1912 CB GLN A 253 12. .576 -51. .689 -13. .924 1. .00 14. .23 A c
ATOM 1913 CG GLN A 253 12. .479 -52. .726 -12. .823 1. .00 15. .43 A c
ATOM 1914 CD GLN A 253 11. .152 -53. .484 -12. .862 1. .00 16. .19 A c
ATOM 1915 OEl GLN A 253 10. .488 -53. .660 -11. .849 1. .00 16. .30 A o
ATOM 1916 NE2 GLN A 253 10. .760 -53. .921 -14. .052 1. .00 16. .56 A N
ATOM 1917 C GLN A 253 12. .614 -49. .427 -12. .890 1. .00 13. .62 A c
ATOM 1918 o GLN A 253 12. .418 -49. .127 -11. .705 1. .00 13. .49 A o
ATOM 1919 N ILE A 254 13. .559 -48. .862 -13. .633 1. .00 13. .32 A N
ATOM 1920 CA ILE A 254 14. .372 -47. .776 -13. .145 1. .00 13. .03 A c
ATOM 1921 CB ILE A 254 15. .269 -47. .254 -14. .264 1. .00 13. .19 A c
ATOM 1922 CGl ILE A 254 16. .277 -48. .338 -14. .647 1. .00 13. .74 A c
ATOM 1923 CDl ILE A 254 17. .007 -48. .092 -15. .967 1. .00 13. .85 A c
ATOM 1924 CG2 ILE A 254 15. .985 -45. .984 -13. .832 1. .00 13. .13 A c
ATOM 1925 C ILE A 254 13. .521 -46. .622 -12. .589 1. .00 12. .90 A c
ATOM 1926 o ILE A 254 13. .843 -46. .043 -11. .541 1. .00 12. .83 A o
ATOM 1927 N PHE A 255 12. .453 -46. .249 -13. .273 1. .00 12. .49 A N
ATOM 1928 CA PHE A 255 11. .664 -45. .128 -12. .753 1. .00 12. .76 A c
ATOM 1929 CB PHE A 255 10. .822 -44. .475 -13. .840 1. .00 12. .83 A c
ATOM 1930 CG PHE A 255 11. .582 -43. .498 -14. .655 1. .00 12. .70 A c
ATOM 1931 CDl PHE A 255 12. .530 -43. .932 -15. .557 1. .00 12. .83 A c
ATOM 1932 CEl PHE A 255 13. .259 -43. .028 -16. .307 1. .00 12. .62 A c
ATOM 1933 CZ PHE A 255 13. .044 -41. .683 -16. .153 1. .00 12. .29 A c
ATOM 1934 CE2 PHE A 255 12. .105 -41. .249 -15. .251 1. .00 12. .48 A c
ATOM 1935 CD 2 PHE A 255 11. .384 -42. .153 -14. .498 1. .00 12. .59 A c
ATOM 1936 C PHE A 255 10. .813 -45. .495 -11. .534 1. .00 12. .72 A c
ATOM 1937 o PHE A 255 10. .656 -44. .670 -10. .623 1. .00 12. .55 A o
ATOM 1938 N TYR A 256 10. .308 -46. .730 -11. .494 1. .00 12. .65 A N
ATOM 1939 CA TYR A 256 9. .621 -47. .217 -10. .288 1. .00 12. .85 A c
ATOM 1940 CB TYR A 256 8. .944 -48. .575 -10. .520 1. .00 12. .32 A c
ATOM 1941 CG TYR A 256 8. .231 -49. .150 -9. .321 1. .00 12. .10 A c
ATOM 1942 CDl TYR A 256 6. .940 -48. .766 -8. .987 1. .00 11. .97 A c
ATOM 1943 CEl TYR A 256 6. .291 -49. .324 -7. .886 1. .00 12. .35 A c
ATOM 1944 CZ TYR A 256 6. .958 -50. .305 -7. .087 1. .00 12. .71 A c
ATOM 1945 OH TYR A 256 6. .407 -50. .893 -5. .963 1. .00 11. .74 A o
ATOM 1946 CE2 TYR A 256 8. .240 -50. .693 -7. .431 1. .00 12. .63 A c
ATOM 1947 CD 2 TYR A 256 8. .857 -50. .119 -8. .537 1. .00 12. .42 A c
ATOM 1948 C TYR A 256 10. .606 -47. .259 -9. .105 1. .00 13. .23 A c
ATOM 1949 o TYR A 256 10. .259 -46. .767 -8. .003 1. .00 13. .67 A o
ATOM 1950 N ASP A 257 11. .821 -47. .782 -9. .328 1. .00 12. .80 A N
ATOM 1951 CA ASP A 257 12. .798 -47. .841 -8. .248 1. .00 12. .91 A c
ATOM 1952 CB ASP A 257 14. .042 -48. .604 -8. .654 1. .00 13. .70 A c
ATOM 1953 CG ASP A 257 13. .783 -50. .108 -8. .772 1. .00 14. .87 A c
ATOM 1954 ODl ASP A 257 12. .705 -50. .623 -8. .313 1. .00 14. .92 A o
ATOM 1955 OD2 ASP A 257 14. .671 -50. .780 -9. .354 1. .00 16. .53 A o
ATOM 1956 C ASP A 257 13. .162 -46. .462 -7. .742 1. .00 12. .44 A c
ATOM 1957 o ASP A 257 13. .202 -46. .234 -6. .512 1. .00 11. .99 A o
ATOM 1958 N ALA A 258 13. .393 -45. .540 -8. .675 1. .00 11. .72 A N
ATOM 1959 CA ALA A 258 13. .632 -44. .133 -8. .324 1. .00 11. .33 A c
ATOM 1960 CB ALA A 258 13. .821 -43. .289 -9. .581 1. .00 11. .03 A c
ATOM 1961 C ALA A 258 12. .476 -43. .580 -7. .512 1. .00 11. .08 A c
ATOM 1962 o ALA A 258 12. .650 -42. .782 -6. .597 1. .00 10. .58 A o
ATOM 1963 N LEU A 259 11..274 -43..985 -7..885 1..00 11..33 A N
ATOM 1964 CA LEU A 259 10. .070 -43. .427 -7. .265 1. .00 11. .50 A C
ATOM 1965 CB LEU A 259 8. .813 -43. .839 -8. .048 1. .00 11. .12 A C
ATOM 1966 CG LEU A 259 7. .498 -43. .498 -7. .383 1. .00 11. .01 A c
ATOM 1967 CDl LEU A 259 7. .281 -41. .998 -7. .298 1. .00 11. .10 A c
ATOM 1968 CD 2 LEU A 259 6. .381 -44. .152 -8. .163 1. .00 11. .25 A c
ATOM 1969 C LEU A 259 9. .974 -43. .858 -5. .809 1. .00 11. .65 A c
ATOM 1970 o LEU A 259 9. .729 -43. .042 -4. .933 1. .00 11. .15 A o
ATOM 1971 N ILE A 260 10. .190 -45. .143 -5. .559 1. .00 12. .27 A N
ATOM 1972 CA ILE A 260 9. .993 -45. .655 -4. .222 1. .00 13. .14 A c
ATOM 1973 CB ILE A 260 9. .454 -47. .117 -4. .241 1. .00 13. .43 A c
ATOM 1974 CGl ILE A 260 10. .522 -48. .112 -4. .719 1. .00 13. .50 A c
ATOM 1975 CDl ILE A 260 10. .234 -49. .531 -4. .306 1. .00 13. .29 A c
ATOM 1976 CG2 ILE A 260 8. .188 -47. .221 -5. .092 1. .00 13. .46 A c
ATOM 1977 C ILE A 260 11. .215 -45. .571 -3. .302 1. .00 13. .39 A c
ATOM 1978 o ILE A 260 11. .093 -45. .924 -2. .160 1. .00 14. .38 A o
ATOM 1979 N ASN A 261 12. .376 -45. .141 -3. .776 1. .00 13. .69 A N
ATOM 1980 CA ASN A 261 13. .594 -45. .072 -2. .958 1. .00 13. .71 A c
ATOM 1981 CB ASN A 261 14. .671 -46. .031 -3. .498 1. .00 13. .86 A c
ATOM 1982 CG ASN A 261 14. .287 -47. .512 -3. .332 1. .00 14. .28 A c
ATOM 1983 ODl ASN A 261 13. .711 -47. .912 -2. .344 1. .00 14. .95 A o
ATOM 1984 ND2 ASN A 261 14. .606 -48. .317 -4. .304 1. .00 14. .25 A N
ATOM 1985 C ASN A 261 14. .149 -43. .646 -2. .898 1. .00 14. .22 A c
ATOM 1986 o ASN A 261 14. .355 -43. .085 -1. .825 1. .00 14. .32 A o
ATOM 1987 N TYR A 262 14. .379 -43. .034 -4. .044 1. .00 14. .90 A N
ATOM 1988 CA TYR A 262 15. .196 -41. .827 -4. .071 1. .00 15. .53 A c
ATOM 1989 CB TYR A 262 16. .323 -41. .998 -5. .092 1. .00 15. .60 A c
ATOM 1990 CG TYR A 262 17. .157 -43. .252 -4. .863 1. .00 15. .76 A c
ATOM 1991 CDl TYR A 262 17. .756 -43. .490 -3. .638 1. .00 15. .71 A c
ATOM 1992 CEl TYR A 262 18. .511 -44. .630 -3. .413 1. .00 15. .96 A c
ATOM 1993 CZ TYR A 262 18. .692 -45. .572 -4. .420 1. .00 15. .60 A c
ATOM 1994 OH TYR A 262 19. .453 -46. .702 -4. .174 1. .00 13. .73 A o
ATOM 1995 CE2 TYR A 262 18. .097 -45. .353 -5. .655 1. .00 16. .02 A c
ATOM 1996 CD 2 TYR A 262 17. .341 -44. .199 -5. .872 1. .00 15. .99 A c
ATOM 1997 C TYR A 262 14. .422 -40. .520 -4. .293 1. .00 15. .92 A c
ATOM 1998 o TYR A 262 14. .850 -39. .469 -3. .830 1. .00 17. .27 A o
ATOM 1999 N LEU A 263 13. .284 -40. .543 -4. .957 1. .00 15. .38 A N
ATOM 2000 CA LEU A 263 12. .508 -39. .307 -5. .019 1. .00 15. .76 A c
ATOM 2001 CB LEU A 263 11. .362 -39. .431 -6. .036 1. .00 16. .59 A c
ATOM 2002 CG LEU A 263 11. .562 -38. .897 -7. .463 1. .00 16. .71 A c
ATOM 2003 CDl LEU A 263 13. .023 -38. .786 -7. .862 1. .00 16. .41 A c
ATOM 2004 CD 2 LEU A 263 10. .766 -39. .742 -8. .454 1. .00 16. .56 A c
ATOM 2005 C LEU A 263 11. .949 -38. .939 -3. .637 1. .00 15. .00 A c
ATOM 2006 o LEU A 263 11. .773 -39. .803 -2. .785 1. .00 15. .82 A o
ATOM 2007 N THR A 264 11. .680 -37. .654 -3. .439 1. .00 14. .04 A N
ATOM 2008 CA THR A 264 11. .150 -37. .105 -2. .182 1. .00 13. .18 A c
ATOM 2009 CB THR A 264 12. .254 -36. .395 -1. .347 1. .00 12. .53 A c
ATOM 2010 OGl THR A 264 12. .519 -35. .080 -1. .876 1. .00 12. .08 A o
ATOM 2011 CG2 THR A 264 13. .522 -37. .213 -1. .294 1. .00 12. .33 A c
ATOM 2012 C THR A 264 10. .061 -36. .059 -2. .490 1. .00 13. .48 A c
ATOM 2013 o THR A 264 9. .862 -35. .671 -3. .655 1. .00 13. .25 A o
ATOM 2014 N PRO A 265 9. .396 -35. .535 -1. .446 1. .00 13. .46 A N
ATOM 2015 CA PRO A 265 8. .244 -34. .703 -1. .688 1. .00 13. .44 A c
ATOM 2016 CB PRO A 265 7. .713 -34. .453 -0. .278 1. .00 13. .36 A c
ATOM 2017 CG PRO A 265 8. .105 -35. .667 0. .469 1. .00 13. .47 A c
ATOM 2018 CD PRO A 265 9. .514 -35. .838 -0. .014 1. .00 13. .66 A c
ATOM 2019 C PRO A 265 8. .584 -33. .392 -2. .320 1. .00 13. .55 A c
ATOM 2020 o PRO A 265 7. .713 -32. .600 -2. .615 1. .00 14. .25 A o
ATOM 2021 N THR A 266 9. .862 -33. .187 -2. .529 1. .00 13. .50 A N
ATOM 2022 CA THR A 266 10. .439 -31. .881 -2. .743 1. .00 12. .66 A c
ATOM 2023 CB THR A 266 11. .222 -31. .577 -1. .437 1. .00 12. .59 A c
ATOM 2024 OGl THR A 266 10. .606 -30. .478 -0. .813 1. .00 12. .07 A o
ATOM 2025 CG2 THR A 266 12. .736 -31. .331 -1. .610 1. .00 12. .62 A c
ATOM 2026 C THR A 266 11. .320 -31. .926 -3. .951 1. .00 12. .14 A c
ATOM 2027 o THR A 266 11. .955 -30. .972 -4. .264 1. .00 12. .11 A o
ATOM 2028 N SER A 267 11. .378 -33. .074 -4. .611 1. .00 12. .40 A N
ATOM 2029 CA SER A 267 12. .317 -33. .305 -5. .672 1. .00 12. .42 A c
ATOM 2030 CB SER A 267 12. .291 -34. .755 -6. .099 1. .00 12. .13 A c
ATOM 2031 OG SER A 267 12. .643 -35. .580 -5. .035 1. .00 11. .99 A o
ATOM 2032 C SER A 267 11. .968 -32. .465 -6. .859 1. .00 13. .24 A c
ATOM 2033 o SER A 267 10. .812 -32. .409 -7. .303 1. .00 13. .97 A o
ATOM 2034 N ASN A 268 12. .978 -31. .795 -7. .366 1. .00 13. .85 A N
ATOM 2035 CA ASN A 268 12. .878 -31. .150 -8. .667 1. .00 14. .49 A c
ATOM 2036 CB ASN A 268 13. .528 -29. .763 -8. .601 1. .00 14. .22 A c
ATOM 2037 CG ASN A 268 15. .016 -29. .822 -8. .253 1. .00 13. .98 A c
ATOM 2038 ODl ASN A 268 15. .707 -30. .838 -8. .451 1. .00 13. .99 A o
ATOM 2039 ND2 ASN A 268 15. .511 -28. .726 -7. .730 1. .00 13. .52 A N
ATOM 2040 C ASN A 268 13. .532 -31. .987 -9. .787 1. .00 15. .25 A c
ATOM 2041 o ASN A 268 14. .066 -33. .113 -9. .552 1. .00 14. .36 A o
ATOM 2042 N PHE A 269 13..499 -31..408 -10..994 1..00 15..91 A N
ATOM 2043 CA PHE A 269 13. .978 -32. .076 -12. .198 1. .00 16. .68 A C
ATOM 2044 CB PHE A 269 13. .906 -31. .122 -13. .401 1. .00 16. .90 A C
ATOM 2045 CG PHE A 269 12. .562 -31. .075 -14. .062 1. .00 16. .51 A c
ATOM 2046 CD 2 PHE A 269 11. .620 -30. .146 -13. .683 1. .00 16. .34 A c
ATOM 2047 CE2 PHE A 269 10. .379 -30. .116 -14. .305 1. .00 16. .36 A c
ATOM 2048 CZ PHE A 269 10. .067 -31. .015 -15. .318 1. .00 15. .85 A c
ATOM 2049 CEl PHE A 269 10. .985 -31. .944 -15. .704 1. .00 15. .68 A c
ATOM 2050 CDl PHE A 269 12. .236 -31. .971 -15. .078 1. .00 16. .47 A c
ATOM 2051 C PHE A 269 15. .412 -32. .571 -12. .004 1. .00 16. .65 A c
ATOM 2052 o PHE A 269 15. .734 -33. .714 -12. .297 1. .00 16. .47 A o
ATOM 2053 N SER A 270 16. .261 -31. .703 -11. .487 1. .00 17. .12 A N
ATOM 2054 CA SER A 270 17. .660 -32. .075 -11. .211 1. .00 17. .53 A c
ATOM 2055 CB SER A 270 18. .420 -30. .901 -10. .589 1. .00 17. .92 A c
ATOM 2056 OG SER A 270 19. .771 -31. .074 -10. .914 1. .00 19. .56 A o
ATOM 2057 C SER A 270 17. .776 -33. .298 -10. .309 1. .00 16. .25 A c
ATOM 2058 o SER A 270 18. .521 -34. .249 -10. .592 1. .00 16. .12 A o
ATOM 2059 N ALA A 271 17. .014 -33. .274 -9. .226 1. .00 15. .54 A N
ATOM 2060 CA ALA A 271 16. .898 -34. .441 -8. .354 1. .00 14. .92 A c
ATOM 2061 CB ALA A 271 16. .098 -34. .060 -7. .101 1. .00 15. .08 A c
ATOM 2062 C ALA A 271 16. .276 -35. .679 -9. .083 1. .00 13. .85 A c
ATOM 2063 o ALA A 271 16. .669 -36. .848 -8. .852 1. .00 12. .80 A o
ATOM 2064 N MET A 272 15. .314 -35. .433 -9. .965 1. .00 13. .07 A N
ATOM 2065 CA MET A 272 14. .781 -36. .544 -10. .730 1. .00 13. .25 A c
ATOM 2066 CB MET A 272 13. .622 -36. .100 -11. .628 1. .00 13. .09 A c
ATOM 2067 CG MET A 272 13. .165 -37. .128 -12. .682 1. .00 12. .47 A c
ATOM 2068 SD MET A 272 12. .018 -38. .351 -12. .062 1. .00 11. .85 A s
ATOM 2069 CE MET A 272 12. .986 -39. .846 -11. .892 1. .00 11. .70 A c
ATOM 2070 C MET A 272 15. .882 -37. .220 -11. .555 1. .00 13. .54 A c
ATOM 2071 o MET A 272 15. .903 -38. .452 -11. .661 1. .00 13. .35 A o
ATOM 2072 N ARG A 273 16. .773 -36. .405 -12. .127 1. .00 13. .96 A N
ATOM 2073 CA ARG A 273 17. .927 -36. .880 -12. .896 1. .00 14. .72 A c
ATOM 2074 CB ARG A 273 18. .732 -35. .678 -13. .439 1. .00 16. .09 A c
ATOM 2075 CG ARG A 273 19. .897 -36. .062 -14. .351 1. .00 17. .57 A c
ATOM 2076 CD ARG A 273 20. .932 -34. .937 -14. .559 1. .00 19. .14 A c
ATOM 2077 NE ARG A 273 22. .199 -35. .555 -15. .019 1. .00 20. .49 A N
ATOM 2078 CZ ARG A 273 22. .627 -35. .627 -16. .282 1. .00 19. .97 A c
ATOM 2079 NHl ARG A 273 21. .946 -35. .082 -17. .277 1. .00 21. .14 A N
ATOM 2080 NH2 ARG A 273 23. .746 -36. .263 -16. .557 1. .00 19. .78 A N
ATOM 2081 C ARG A 273 18. .832 -37. .792 -12. .058 1. .00 14. .15 A C
ATOM 2082 o ARG A 273 19. .154 -38. .934 -12. .442 1. .00 13. .74 A o
ATOM 2083 N ALA A 274 19. .233 -37. .270 -10. .904 1. .00 13. .53 A N
ATOM 2084 CA ALA A 274 20. .050 -38. .025 -9. .967 1. .00 12. .90 A C
ATOM 2085 CB ALA A 274 20. .334 -37. .174 -8. .741 1. .00 12. .64 A c
ATOM 2086 C ALA A 274 19. .346 -39. .314 -9. .574 1. .00 12. .59 A c
ATOM 2087 o ALA A 274 19. .946 -40. .390 -9. .501 1. .00 12. .04 A o
ATOM 2088 N ALA A 275 18. .060 -39. .202 -9. .309 1. .00 12. .71 A N
ATOM 2089 CA ALA A 275 17. .357 -40. .339 -8. .776 1. .00 13. .34 A c
ATOM 2090 CB ALA A 275 15. .961 -39. .931 -8. .356 1. .00 13. .53 A c
ATOM 2091 C ALA A 275 17. .318 -41. .459 -9. .804 1. .00 13. .49 A c
ATOM 2092 o ALA A 275 17. .594 -42. .638 -9. .496 1. .00 13. .79 A o
ATOM 2093 N ALA A 276 16. .987 -41. .086 -11. .036 1. .00 13. .40 A N
ATOM 2094 CA ALA A 276 16. .968 -42. .041 -12. .114 1. .00 13. .48 A c
ATOM 2095 CB ALA A 276 16. .478 -41. .373 -13. .387 1. .00 13. .69 A c
ATOM 2096 C ALA A 276 18. .370 -42. .622 -12. .286 1. .00 13. .41 A c
ATOM 2097 o ALA A 276 18. .531 -43. .833 -12. .411 1. .00 12. .81 A o
ATOM 2098 N ILE A 277 19. .390 -41. .767 -12. .244 1. .00 13. .47 A N
ATOM 2099 CA ILE A 277 20. .744 -42. .282 -12. .313 1. .00 13. .96 A c
ATOM 2100 CB ILE A 277 21. .797 -41. .190 -12. .261 1. .00 14. .04 A c
ATOM 2101 CGl ILE A 277 21. .814 -40. .438 -13. .581 1. .00 14. .13 A c
ATOM 2102 CDl ILE A 277 22. .709 -39. .232 -13. .583 1. .00 14. .32 A c
ATOM 2103 CG2 ILE A 277 23. .163 -41. .829 -12. .023 1. .00 14. .29 A c
ATOM 2104 C ILE A 277 21. .066 -43. .276 -11. .210 1. .00 14. .15 A c
ATOM 2105 o ILE A 277 21. .596 -44. .354 -11. .478 1. .00 14. .38 A o
ATOM 2106 N GLN A 278 20. .762 -42. .921 -9. .973 1. .00 14. .64 A N
ATOM 2107 CA GLN A 278 21. .044 -43. .832 -8. .881 1. .00 15. .29 A c
ATOM 2108 CB GLN A 278 20. .665 -43. .220 -7. .546 1. .00 15. .95 A c
ATOM 2109 CG GLN A 278 21. .138 -44. .034 -6. .336 1. .00 16. .69 A c
ATOM 2110 CD GLN A 278 22. .656 -44. .231 -6. .267 1. .00 16. .71 A c
ATOM 2111 OEl GLN A 278 23. .418 -43. .326 -5. .935 1. .00 16. .42 A o
ATOM 2112 NE2 GLN A 278 23. .084 -45. .437 -6. .552 1. .00 17. .15 A N
ATOM 2113 C GLN A 278 20. .343 -45. .163 -9. .067 1. .00 15. .22 A c
ATOM 2114 o GLN A 278 20. .930 -46. .204 -8. .832 1. .00 15. .46 A o
ATOM 2115 N ALA A 279 19. .100 -45. .141 -9. .522 1. .00 15. .50 A N
ATOM 2116 CA ALA A 279 18. .344 -46. .381 -9. .668 1. .00 15. .59 A c
ATOM 2117 CB ALA A 279 16. .872 -46. .074 -9. .868 1. .00 15. .79 A c
ATOM 2118 C ALA A 279 18. .870 -47. .272 -10. .789 1. .00 15. .64 A c
ATOM 2119 o ALA A 279 18. .837 -48. .496 -10. .692 1. .00 16. .17 A o
ATOM 2120 N ALA A 280 19. .357 -46. .670 -11. .858 1. .00 15. .94 A N
ATOM 2121 CA ALA A 280 19..950 -47..456 -12..910 1..00 16..38 A C
ATOM 2122 CB ALA A 280 20. .116 -46. .649 -14. .174 1. .00 16. .73 A C
ATOM 2123 C ALA A 280 21. .286 -47. .972 -12. .446 1. .00 16. .78 A c
ATOM 2124 o ALA A 280 21. .616 -49. .113 -12. .734 1. .00 17. .18 A o
ATOM 2125 N THR A 281 22. .054 -47. .145 -11. .732 1. .00 17. .16 A N
ATOM 2126 CA THR A 281 23. .322 -47. .592 -11. .185 1. .00 17. .22 A c
ATOM 2127 CB THR A 281 23. .996 -46. .539 -10. .315 1. .00 17. .66 A c
ATOM 2128 OGl THR A 281 24. .434 -45. .442 -11. .137 1. .00 17. .89 A o
ATOM 2129 CG2 THR A 281 25. .202 -47. .154 -9. .572 1. .00 17. .44 A c
ATOM 2130 C THR A 281 23. .074 -48. .819 -10. .355 1. .00 17. .79 A c
ATOM 2131 o THR A 281 23. .709 -49. .845 -10. .578 1. .00 18. .78 A o
ATOM 2132 N ASP A 282 22. .119 -48. .745 -9. .432 1. .00 18. .24 A N
ATOM 2133 CA ASP A 282 21. .722 -49. .930 -8. .616 1. .00 18. .73 A c
ATOM 2134 CB ASP A 282 20. .399 -49. .683 -7. .892 1. .00 17. .78 A c
ATOM 2135 CG ASP A 282 20. .513 -48. .689 -6. .767 1. .00 17. .00 A c
ATOM 2136 ODl ASP A 282 21. .661 -48. .244 -6. .447 1. .00 15. .10 A o
ATOM 2137 OD2 ASP A 282 19. .413 -48. .384 -6. .218 1. .00 16. .44 A o
ATOM 2138 C ASP A 282 21. .538 -51. .236 -9. .375 1. .00 19. .72 A c
ATOM 2139 o ASP A 282 21. .845 -52. .281 -8. .873 1. .00 19. .64 A o
ATOM 2140 N LEU A 283 20. .992 -51. .163 -10. .575 1. .00 22. .83 A N
ATOM 2141 CA LEU A 283 20. .581 -52. .346 -11. .323 1. .00 23. .96 A c
ATOM 2142 CB LEU A 283 19. .265 -52. .043 -12. .036 1. .00 24. .88 A c
ATOM 2143 CG LEU A 283 18. .029 -51. .915 -11. .148 1. .00 25. .50 A c
ATOM 2144 CDl LEU A 283 16. .958 -51. .126 -11. .898 1. .00 26. .24 A c
ATOM 2145 CD 2 LEU A 283 17. .524 -53. .299 -10. .763 1. .00 25. .11 A c
ATOM 2146 C LEU A 283 21. .554 -52. .812 -12. .388 1. .00 23. .80 A c
ATOM 2147 o LEU A 283 21. .489 -53. .966 -12. .790 1. .00 23. .32 A o
ATOM 2148 N TYR A 284 22. .385 -51. .915 -12. .904 1. .00 24. .03 A N
ATOM 2149 CA TYR A 284 23. .184 -52. .237 -14. .085 1. .00 25. .72 A c
ATOM 2150 CB TYR A 284 22. .597 -51. .570 -15. .350 1. .00 25. .41 A c
ATOM 2151 CG TYR A 284 21. .211 -52. .073 -15. .711 1. .00 25. .02 A c
ATOM 2152 CDl TYR A 284 21. .037 -53. .340 -16. .265 1. .00 24. .40 A c
ATOM 2153 CEl TYR A 284 19. .766 -53. .811 -16. .579 1. .00 25. .54 A c
ATOM 2154 CZ TYR A 284 18. .630 -53. .007 -16. .344 1. .00 24. .69 A c
ATOM 2155 OH TYR A 284 17. .349 -53. .493 -16. .656 1. .00 23. .49 A o
ATOM 2156 CE2 TYR A 284 18. .801 -51. .748 -15. .782 1. .00 23. .41 A c
ATOM 2157 CD 2 TYR A 284 20. .071 -51. .292 -15. .469 1. .00 23. .48 A c
ATOM 2158 C TYR A 284 24. .632 -51. .848 -13. .937 1. .00 27. .83 A c
ATOM 2159 o TYR A 284 25. .428 -52. .120 -14. .841 1. .00 29. .91 A o
ATOM 2160 N GLY A 285 24. .982 -51. .213 -12. .822 1. .00 27. .88 A N
ATOM 2161 CA GLY A 285 26. .361 -50. .831 -12. .567 1. .00 29. .33 A c
ATOM 2162 C GLY A 285 26. .614 -49. .435 -13. .076 1. .00 32. .33 A c
ATOM 2163 o GLY A 285 26. .058 -49. .040 -14. .098 1. .00 36. .64 A o
ATOM 2164 N ALA A 286 27. .481 -48. .698 -12. .392 1. .00 32. .78 A N
ATOM 2165 CA ALA A 286 27. .576 -47. .250 -12. .579 1. .00 33. .56 A c
ATOM 2166 CB ALA A 286 28. .379 -46. .627 -11. .440 1. .00 34. .16 A c
ATOM 2167 C ALA A 286 28. .143 -46. .799 -13. .923 1. .00 33. .26 A c
ATOM 2168 o ALA A 286 28. .010 -45. .618 -14. .292 1. .00 34. .56 A o
ATOM 2169 N ASN A 287 28. .772 -47. .707 -14. .656 1. .00 31. .09 A N
ATOM 2170 CA ASN A 287 29. .308 -47. .330 -15. .949 1. .00 29. .96 A c
ATOM 2171 CB ASN A 287 30. .821 -47. .577 -15. .965 1. .00 30. .24 A c
ATOM 2172 CG ASN A 287 31. .522 -46. .889 -17. .130 1. .00 30. .47 A c
ATOM 2173 ODl ASN A 287 31. .112 -45. .823 -17. .601 1. .00 26. .91 A o
ATOM 2174 ND2 ASN A 287 32. .576 -47. .529 -17. .626 1. .00 31. .27 A N
ATOM 2175 C ASN A 287 28. .568 -48. .065 -17. .076 1. .00 27. .79 A c
ATOM 2176 o ASN A 287 29. .058 -48. .213 -18. .185 1. .00 26. .46 A o
ATOM 2177 N SER A 288 27. .350 -48. .482 -16. .802 1. .00 27. .08 A N
ATOM 2178 CA SER A 288 26. .584 -49. .237 -17. .781 1. .00 26. .73 A c
ATOM 2179 CB SER A 288 25. .406 -49. .971 -17. .108 1. .00 27. .43 A c
ATOM 2180 OG SER A 288 24. .598 -49. .085 -16. .318 1. .00 28. .18 A o
ATOM 2181 C SER A 288 26. .070 -48. .333 -18. .879 1. .00 24. .80 A c
ATOM 2182 o SER A 288 26. .043 -47. .106 -18. .746 1. .00 23. .67 A o
ATOM 2183 N SER A 289 25. .657 -48. .976 -19. .963 1. .00 24. .24 A N
ATOM 2184 CA SER A 289 24. .931 -48. .317 -21. .052 1. .00 24. .51 A c
ATOM 2185 CB SER A 289 24. .697 -49. .308 -22. .203 1. .00 23. .11 A c
ATOM 2186 OG SER A 289 24. .340 -50. .588 -21. .729 1. .00 21. .73 A o
ATOM 2187 C SER A 289 23. .576 -47. .698 -20. .591 1. .00 25. .23 A c
ATOM 2188 o SER A 289 23. .156 -46. .616 -21. .073 1. .00 27. .12 A o
ATOM 2189 N GLN A 290 22. .919 -48. .376 -19. .656 1. .00 23. .65 A N
ATOM 2190 CA GLN A 290 21. .640 -47. .929 -19. .149 1. .00 23. .31 A c
ATOM 2191 CB GLN A 290 21. .030 -48. .994 -18. .253 1. .00 22. .58 A c
ATOM 2192 CG GLN A 290 20. .519 -50. .209 -19. .023 1. .00 22. .68 A c
ATOM 2193 CD GLN A 290 21. .505 -51. .364 -19. .101 1. .00 22. .39 A c
ATOM 2194 OEl GLN A 290 22. .711 -51. .186 -19. .035 1. .00 23. .40 A o
ATOM 2195 NE2 GLN A 290 20. .980 -52. .561 -19. .222 1. .00 22. .20 A N
ATOM 2196 C GLN A 290 21. .855 -46. .649 -18. .386 1. .00 24. .05 A c
ATOM 2197 o GLN A 290 21. .177 -45. .636 -18. .626 1. .00 23. .70 A o
ATOM 2198 N VAL A 291 22. .836 -46. .672 -17. .493 1. .00 24. .02 A N
ATOM 2199 CA VAL A 291 23. .154 -45. .475 -16. .754 1. .00 23. .78 A c
ATOM 2200 CB VAL A 291 24..348 -45..668 -15..809 1..00 24..04 A C
ATOM 2201 CGl VAL A 291 24. .995 -44. .332 -15. .456 1. .00 23. .39 A C
ATOM 2202 CG2 VAL A 291 23. .882 -46. .376 -14. .555 1. .00 24. .62 A c
ATOM 2203 C VAL A 291 23. .475 -44. .407 -17. .748 1. .00 24. .05 A c
ATOM 2204 o VAL A 291 23. .070 -43. .242 -17. .593 1. .00 22. .27 A o
ATOM 2205 N ASN A 292 24. .215 -44. .790 -18. .781 1. .00 25. .34 A N
ATOM 2206 CA ASN A 292 24. .673 -43. .762 -19. .676 1. .00 26. .69 A c
ATOM 2207 CB ASN A 292 25. .884 -44. .205 -20. .478 1. .00 30. .49 A c
ATOM 2208 CG ASN A 292 26. .820 -43. .042 -20. .731 1. .00 35. .02 A c
ATOM 2209 ODl ASN A 292 27. .508 -42. .596 -19. .808 1. .00 39. .60 A o
ATOM 2210 ND2 ASN A 292 26. .793 -42. .487 -21. .952 1. .00 35. .12 A N
ATOM 2211 C ASN A 292 23. .553 -43. .174 -20. .551 1. .00 23. .23 A c
ATOM 2212 o ASN A 292 23. .547 -41. .978 -20. .829 1. .00 21. .51 A o
ATOM 2213 N ALA A 293 22. .594 -44. .013 -20. .932 1. .00 20. .89 A N
ATOM 2214 CA ALA A 293 21. .432 -43. .577 -21. .719 1. .00 19. .66 A c
ATOM 2215 CB ALA A 293 20. .559 -44. .780 -22. .043 1. .00 20. .04 A c
ATOM 2216 C ALA A 293 20. .614 -42. .573 -20. .957 1. .00 18. .76 A c
ATOM 2217 o ALA A 293 20. .105 -41. .606 -21. .499 1. .00 17. .05 A o
ATOM 2218 N VAL A 294 20. .461 -42. .866 -19. .669 1. .00 18. .81 A N
ATOM 2219 CA VAL A 294 19. .729 -42. .016 -18. .771 1. .00 17. .38 A c
ATOM 2220 CB VAL A 294 19. .646 -42. .671 -17. .382 1. .00 16. .37 A c
ATOM 2221 CGl VAL A 294 19. .185 -41. .672 -16. .324 1. .00 16. .38 A c
ATOM 2222 CG2 VAL A 294 18. .736 -43. .875 -17. .422 1. .00 15. .72 A c
ATOM 2223 C VAL A 294 20. .396 -40. .645 -18. .748 1. .00 17. .76 A c
ATOM 2224 o VAL A 294 19. .713 -39. .640 -18. .840 1. .00 17. .49 A o
ATOM 2225 N LYS A 295 21. .727 -40. .613 -18. .654 1. .00 18. .95 A N
ATOM 2226 CA LYS A 295 22. .461 -39. .349 -18. .560 1. .00 19. .76 A c
ATOM 2227 CB LYS A 295 23. .964 -39. .577 -18. .381 1. .00 21. .38 A c
ATOM 2228 CG LYS A 295 24. .399 -39. .923 -16. .961 1. .00 22. .34 A c
ATOM 2229 CD LYS A 295 25. .900 -40. .268 -16. .887 1. .00 23. .25 A c
ATOM 2230 CE LYS A 295 26. .277 -40. .738 -15. .476 1. .00 23. .34 A c
ATOM 2231 NZ LYS A 295 27. .731 -40. .846 -15. .162 1. .00 22. .84 A N
ATOM 2232 C LYS A 295 22. .239 -38. .480 -19. .774 1. .00 19. .36 A c
ATOM 2233 o LYS A 295 21. .916 -37. .284 -19. .655 1. .00 18. .79 A o
ATOM 2234 N LYS A 296 22. .394 -39. .073 -20. .944 1. .00 19. .79 A N
ATOM 2235 CA LYS A 296 22. .200 -38. .316 -22. .176 1. .00 21. .18 A c
ATOM 2236 CB LYS A 296 22. .618 -39. .143 -23. .379 1. .00 23. .67 A c
ATOM 2237 CG LYS A 296 24. .126 -39. .307 -23. .392 1. .00 27. .94 A c
ATOM 2238 CD LYS A 296 24. .657 -39. .899 -24. .691 1. .00 32. .89 A c
ATOM 2239 CE LYS A 296 26. .166 -39. .650 -24. .836 1. .00 37. .16 A c
ATOM 2240 NZ LYS A 296 26. .520 -38. .247 -25. .268 1. .00 38. .34 A N
ATOM 2241 C LYS A 296 20. .785 -37. .754 -22. .325 1. .00 19. .72 A c
ATOM 2242 o LYS A 296 20. .603 -36. .553 -22. .615 1. .00 18. .85 A o
ATOM 2243 N ALA A 297 19. .804 -38. .618 -22. .087 1. .00 18. .65 A N
ATOM 2244 CA ALA A 297 18. .395 -38. .236 -22. .059 1. .00 18. .30 A c
ATOM 2245 CB ALA A 297 17. .544 -39. .389 -21. .570 1. .00 19. .00 A c
ATOM 2246 C ALA A 297 18. .141 -37. .014 -21. .207 1. .00 18. .02 A c
ATOM 2247 o ALA A 297 17. .575 -36. .041 -21. .683 1. .00 18. .61 A o
ATOM 2248 N TYR A 298 18. .578 -37. .016 -19. .960 1. .00 17. .55 A N
ATOM 2249 CA TYR A 298 18. .361 -35. .808 -19. .165 1. .00 17. .98 A c
ATOM 2250 CB TYR A 298 18. .595 -36. .043 -17. .662 1. .00 17. .98 A c
ATOM 2251 CG TYR A 298 17. .361 -36. .698 -17. .049 1. .00 17. .27 A c
ATOM 2252 CDl TYR A 298 16. .272 -35. .926 -16. .677 1. .00 16. .76 A c
ATOM 2253 CEl TYR A 298 15. .140 -36. .498 -16. .150 1. .00 16. .52 A c
ATOM 2254 CZ TYR A 298 15. .057 -37. .866 -16. .011 1. .00 16. .59 A c
ATOM 2255 OH TYR A 298 13. .898 -38. .414 -15. .489 1. .00 15. .41 A o
ATOM 2256 CE2 TYR A 298 16. .135 -38. .665 -16. .381 1. .00 16. .79 A c
ATOM 2257 CD 2 TYR A 298 17. .268 -38. .079 -16. .910 1. .00 16. .48 A c
ATOM 2258 C TYR A 298 19. .123 -34. .601 -19. .686 1. .00 17. .99 A c
ATOM 2259 o TYR A 298 18. .623 -33. .470 -19. .572 1. .00 19. .07 A o
ATOM 2260 N THR A 299 20. .307 -34. .828 -20. .255 1. .00 17. .65 A N
ATOM 2261 CA THR A 299 21. .056 -33. .746 -20. .902 1. .00 17. .98 A c
ATOM 2262 CB THR A 299 22. .472 -34. .217 -21. .368 1. .00 17. .57 A c
ATOM 2263 OGl THR A 299 23. .235 -34. .706 -20. .250 1. .00 16. .90 A o
ATOM 2264 CG2 THR A 299 23. .217 -33. .076 -22. .047 1. .00 16. .53 A c
ATOM 2265 C THR A 299 20. .231 -33. .206 -22. .118 1. .00 18. .22 A c
ATOM 2266 o THR A 299 20. .019 -31. .985 -22. .289 1. .00 16. .64 A o
ATOM 2267 N ALA A 300 19. .744 -34. .132 -22. .938 1. .00 18. .02 A N
ATOM 2268 CA ALA A 300 18. .960 -33. .751 -24. .087 1. .00 18. .32 A c
ATOM 2269 CB ALA A 300 18. .408 -34. .982 -24. .786 1. .00 18. .60 A c
ATOM 2270 C ALA A 300 17. .840 -32. .798 -23. .701 1. .00 18. .60 A c
ATOM 2271 o ALA A 300 17. .659 -31. .798 -24. .366 1. .00 20. .19 A o
ATOM 2272 N VAL A 301 17. .101 -33. .074 -22. .630 1. .00 18. .61 A N
ATOM 2273 CA VAL A 301 15. .996 -32. .189 -22. .240 1. .00 18. .71 A c
ATOM 2274 CB VAL A 301 14. .856 -32. .940 -21. .538 1. .00 19. .41 A c
ATOM 2275 CGl VAL A 301 14. .404 -34. .146 -22. .338 1. .00 19. .54 A c
ATOM 2276 CG2 VAL A 301 15. .298 -33. .395 -20. .170 1. .00 20. .37 A c
ATOM 2277 C VAL A 301 16. .457 -31. .043 -21. .350 1. .00 18. .65 A c
ATOM 2278 o VAL A 301 15. .646 -30. .314 -20. .777 1. .00 18. .51 A o
ATOM 2279 N GLY A 302 17..758 -30..871 -21..231 1..00 19..01 A N
ATOM 2280 CA GLY A 302 18. .282 -29. .621 -20. .718 1. .00 19. .86 A C
ATOM 2281 C GLY A 302 18. .370 -29. .640 -19. .219 1. .00 21. .35 A C
ATOM 2282 o GLY A 302 18. .411 -28. .580 -18. .581 1. .00 20. .19 A o
ATOM 2283 N VAL A 303 18. .392 -30. .858 -18. .659 1. .00 23. .47 A N
ATOM 2284 CA VAL A 303 18. .503 -31. .054 -17. .208 1. .00 23. .96 A c
ATOM 2285 CB VAL A 303 17. .367 -31. .958 -16. .677 1. .00 23. .91 A c
ATOM 2286 CGl VAL A 303 17. .488 -32. .161 -15. .169 1. .00 24. .18 A c
ATOM 2287 CG2 VAL A 303 16. .027 -31. .330 -16. .985 1. .00 24. .04 A c
ATOM 2288 C VAL A 303 19. .868 -31. .647 -16. .845 1. .00 23. .68 A c
ATOM 2289 o VAL A 303 20. .199 -32. .752 -17. .266 1. .00 22. .79 A o
ATOM 2290 N ASN A 304 20. .630 -30. .924 -16. .033 1. .00 24. .44 A N
ATOM 2291 CA ASN A 304 21. .971 -31. .369 -15. .668 1. .00 27. .13 A c
ATOM 2292 CB ASN A 304 22. .976 -30. .333 -16. .137 1. .00 27. .63 A c
ATOM 2293 CG ASN A 304 22. .782 -29. .969 -17. .602 1. .00 28. .08 A c
ATOM 2294 ODl ASN A 304 22. .758 -30. .844 -18. .497 1. .00 26. .81 A o
ATOM 2295 ND2 ASN A 304 22. .632 -28. .666 -17. .855 1. .00 27. .74 A N
ATOM 2296 C ASN A 304 22. .203 -31. .666 -14. .188 1. .00 27. .90 A c
ATOM 2297 o ASN A 304 21. .646 -31. .075 -13. .248 1. .00 28. .54 A o
ATOM 2298 OXT ASN A 304 23. .015 -32. .544 -13. .941 1. .00 27. .35 A o
ATOM 2299 N ALA B 1 -27. .118 -11. .588 16. .141 1. .00 36. .52 B N
ATOM 2300 CA ALA B 1 -26. .133 -11. .218 17. .198 1. .00 37. .78 B c
ATOM 2301 CB ALA B 1 -25. .839 -12. .399 18. .109 1. .00 36. .98 B c
ATOM 2302 C ALA B 1 -24. .878 -10. .774 16. .492 1. .00 39. .27 B c
ATOM 2303 o ALA B 1 -24. .736 -11. .016 15. .302 1. .00 43. .37 B o
ATOM 2304 N THR B 2 -23. .958 -10. .156 17. .220 1. .00 39. .24 B N
ATOM 2305 CA THR B 2 -22. .776 -9. .556 16. .609 1. .00 38. .21 B c
ATOM 2306 CB THR B 2 -22. .792 -8. .015 16. .742 1. .00 38. .56 B c
ATOM 2307 OGl THR B 2 -23. .817 -7. .475 15. .901 1. .00 37. .57 B o
ATOM 2308 CG2 THR B 2 -21. .445 -7. .408 16. .322 1. .00 39. .78 B c
ATOM 2309 C THR B 2 -21. .477 -10. .140 17. .183 1. .00 37. .53 B c
ATOM 2310 o THR B 2 -21. .027 -9. .766 18. .266 1. .00 32. .77 B o
ATOM 2311 N GLY B 3 -20. .864 -11. .037 16. .413 1. .00 38. .90 B N
ATOM 2312 CA GLY B 3 -19. .625 -11. .693 16. .822 1. .00 39. .37 B c
ATOM 2313 C GLY B 3 -18. .385 -10. .922 16. .439 1. .00 37. .66 B c
ATOM 2314 o GLY B 3 -18. .379 -10. .180 15. .475 1. .00 38. .38 B o
ATOM 2315 N THR B 4 -17. .325 -11. .116 17. .193 1. .00 37. .26 B N
ATOM 2316 CA THR B 4 -16. .066 -10. .493 16. .873 1. .00 39. .03 B c
ATOM 2317 CB THR B 4 -15. .631 -9. .497 17. .978 1. .00 38. .57 B c
ATOM 2318 OGl THR B 4 -14. .242 -9. .154 17. .811 1. .00 38. .10 B o
ATOM 2319 CG2 THR B 4 -15. .829 -10. .089 19. .342 1. .00 36. .87 B c
ATOM 2320 C THR B 4 -14. .993 -11. .568 16. .642 1. .00 39. .28 B c
ATOM 2321 o THR B 4 -15. .018 -12. .622 17. .277 1. .00 37. .20 B o
ATOM 2322 N GLY B 5 -14. .064 -11. .284 15. .725 1. .00 38. .89 B N
ATOM 2323 CA GLY B 5 -12. .864 -12. .101 15. .541 1. .00 37. .29 B c
ATOM 2324 C GLY B 5 -11. .851 -11. .559 14. .531 1. .00 35. .59 B c
ATOM 2325 o GLY B 5 -12. .190 -10. .789 13. .611 1. .00 34. .39 B o
ATOM 2326 N LYS B 6 -10. .601 -11. .982 14. .704 1. .00 32. .33 B N
ATOM 2327 CA LYS B 6 -9. .501 -11. .572 13. .834 1. .00 30. .16 B c
ATOM 2328 CB LYS B 6 -8. .164 -11. .793 14. .523 1. .00 28. .67 B c
ATOM 2329 CG LYS B 6 -8. .056 -11. .021 15. .798 1. .00 29. .42 B c
ATOM 2330 CD LYS B 6 -6. .667 -11. .050 16. .395 1. .00 31. .17 B c
ATOM 2331 CE LYS B 6 -6. .396 -9. .726 17. .100 1. .00 31. .96 B c
ATOM 2332 NZ LYS B 6 -5. .427 -9. .958 18. .189 1. .00 33. .82 B N
ATOM 2333 C LYS B 6 -9. .528 -12. .360 12. .547 1. .00 28. .68 B c
ATOM 2334 o LYS B 6 -9. .889 -13. .529 12. .555 1. .00 29. .96 B o
ATOM 2335 N GLY B 7 -9. .141 -11. .718 11. .447 1. .00 26. .88 B N
ATOM 2336 CA GLY B 7 -9. .082 -12. .374 10. .150 1. .00 24. .95 B c
ATOM 2337 C GLY B 7 -7. .727 -13. .011 10. .017 1. .00 23. .60 B c
ATOM 2338 o GLY B 7 -6. .884 -12. .864 10. .883 1. .00 23. .09 B o
ATOM 2339 N VAL B 8 -7. .515 -13. .700 8. .912 1. .00 22. .56 B N
ATOM 2340 CA VAL B 8 -6. .255 -14. .375 8. .641 1. .00 22. .38 B c
ATOM 2341 CB VAL B 8 -6. .215 -14. .891 7. .197 1. .00 22. .59 B c
ATOM 2342 CGl VAL B 8 -4. .869 -15. .545 6. .892 1. .00 22. .83 B c
ATOM 2343 CG2 VAL B 8 -7. .357 -15. .870 6. .940 1. .00 22. .50 B c
ATOM 2344 C VAL B 8 -5. .041 -13. .479 8. .847 1. .00 22. .68 B c
ATOM 2345 o VAL B 8 -4. .003 -13. .935 9. .296 1. .00 21. .46 B o
ATOM 2346 N LEU B 9 -5. .173 -12. .201 8. .498 1. .00 24. .54 B N
ATOM 2347 CA LEU B 9 -4. .063 -11. .242 8. .600 1. .00 24. .12 B c
ATOM 2348 CB LEU B 9 -4. .135 -10. .261 7. .432 1. .00 23. .12 B c
ATOM 2349 CG LEU B 9 -3. .359 -10. .564 6. .154 1. .00 21. .95 B c
ATOM 2350 CDl LEU B 9 -3. .041 -12. .036 6. .027 1. .00 20. .77 B c
ATOM 2351 CD 2 LEU B 9 -4. .141 -9. .999 4. .961 1. .00 21. .42 B c
ATOM 2352 C LEU B 9 -4. .046 -10. .456 9. .890 1. .00 25. .26 B c
ATOM 2353 o LEU B 9 -3. .442 -9. .408 9. .933 1. .00 28. .39 B o
ATOM 2354 N GLY B 10 -4. .723 -10. .932 10. .930 1. .00 26. .73 B N
ATOM 2355 CA GLY B 10 -4. .586 -10. .358 12. .279 1. .00 26. .45 B c
ATOM 2356 C GLY B 10 -5. .481 -9. .174 12. .586 1. .00 26. .20 B c
ATOM 2357 o GLY B 10 -5. .297 -8. .504 13. .614 1. .00 24. .13 B o
ATOM 2358 N ASP B 11 -6..481 -8..966 11..727 1..00 26..26 B N
ATOM 2359 CA ASP B 11 -7. .342 -7. .781 11. .761 1. .00 26. .23 B C
ATOM 2360 CB ASP B 11 -7. .410 -7. .155 10. .356 1. .00 24. .59 B C
ATOM 2361 CG ASP B 11 -7. .968 -8. .109 9. .295 1. .00 24. .79 B c
ATOM 2362 ODl ASP B 11 -7. .465 -9. .238 9. .139 1. .00 25. .46 B o
ATOM 2363 OD2 ASP B 11 -8. .922 -7. .739 8. .596 1. .00 23. .52 B o
ATOM 2364 C ASP B 11 -8. .767 -8. .052 12. .313 1. .00 28. .01 B c
ATOM 2365 o ASP B 11 -9. .541 -8. .838 11. .737 1. .00 29. .86 B o
ATOM 2366 N THR B 12 -9. .127 -7. .357 13. .397 1. .00 28. .40 B N
ATOM 2367 CA THR B 12 -10. .417 -7. .555 14. .073 1. .00 27. .68 B c
ATOM 2368 CB THR B 12 -10. .402 -6. .914 15. .465 1. .00 25. .99 B c
ATOM 2369 OGl THR B 12 -9. .232 -7. .350 16. .173 1. .00 25. .66 B o
ATOM 2370 CG2 THR B 12 -11. .645 -7. .298 16. .258 1. .00 24. .54 B c
ATOM 2371 C THR B 12 -11. .633 -7. .041 13. .285 1. .00 29. .85 B c
ATOM 2372 o THR B 12 -11. .677 -5. .875 12. .875 1. .00 32. .91 B o
ATOM 2373 N LYS B 13 -12. .618 -7. .922 13. .090 1. .00 30. .70 B N
ATOM 2374 CA LYS B 13 -13. .867 -7. .580 12. .402 1. .00 31. .16 B c
ATOM 2375 CB LYS B 13 -14. .036 -8. .339 11. .087 1. .00 31. .49 B c
ATOM 2376 CG LYS B 13 -12. .756 -8. .854 10. .458 1. .00 32. .70 B c
ATOM 2377 CD LYS B 13 -13. .037 -9. .300 9. .041 1. .00 32. .47 B c
ATOM 2378 CE LYS B 13 -11. .763 -9. .658 8. .315 1. .00 32. .16 B c
ATOM 2379 NZ LYS B 13 -10. .786 -8. .555 8. .175 1. .00 31. .87 B N
ATOM 2380 C LYS B 13 -15. .052 -7. .967 13. .238 1. .00 33. .23 B c
ATOM 2381 o LYS B 13 -14. .940 -8. .784 14. .157 1. .00 39. .07 B o
ATOM 2382 N SER B 14 -16. .196 -7. .403 12. .866 1. .00 31. .47 B N
ATOM 2383 CA SER B 14 -17. .474 -7. .714 13. .446 1. .00 29. .93 B c
ATOM 2384 CB SER B 14 -18. .225 -6. .440 13. .792 1. .00 31. .68 B c
ATOM 2385 OG SER B 14 -17. .421 -5. .631 14. .618 1. .00 34. .18 B o
ATOM 2386 C SER B 14 -18. .244 -8. .385 12. .377 1. .00 28. .96 B c
ATOM 2387 o SER B 14 -17. .989 -8. .156 11. .196 1. .00 27. .52 B o
ATOM 2388 N PHE B 15 -19. .225 -9. .178 12. .773 1. .00 28. .58 B N
ATOM 2389 CA PHE B 15 -20. .097 -9. .822 11. .797 1. .00 28. .92 B c
ATOM 2390 CB PHE B 15 -19. .330 -10. .903 11. .010 1. .00 27. .95 B c
ATOM 2391 CG PHE B 15 -18. .345 -11. .675 11. .853 1. .00 26. .41 B c
ATOM 2392 CDl PHE B 15 -18. .751 -12. .766 12. .586 1. .00 24. .71 B c
ATOM 2393 CEl PHE B 15 -17. .861 -13. .459 13. .368 1. .00 24. .48 B c
ATOM 2394 CZ PHE B 15 -16. .548 -13. .067 13. .437 1. .00 25. .51 B c
ATOM 2395 CE2 PHE B 15 -16. .130 -11. .967 12. .722 1. .00 26. .27 B c
ATOM 2396 CD 2 PHE B 15 -17. .028 -11. .281 11. .934 1. .00 26. .09 B c
ATOM 2397 C PHE B 15 -21. .283 -10. .421 12. .515 1. .00 30. .15 B c
ATOM 2398 o PHE B 15 -21. .231 -10. .661 13. .735 1. .00 28. .64 B o
ATOM 2399 N THR B 16 -22. .350 -10. .643 11. .756 1. .00 32. .13 B N
ATOM 2400 CA THR B 16 -23. .564 -11. .231 12. .297 1. .00 35. .95 B c
ATOM 2401 CB THR B 16 -24. .775 -10. .980 11. .371 1. .00 35. .50 B c
ATOM 2402 OGl THR B 16 -25. .103 -9. .584 11. .373 1. .00 34. .31 B o
ATOM 2403 CG2 THR B 16 -26. .013 -11. .807 11. .799 1. .00 35. .19 B c
ATOM 2404 C THR B 16 -23. .380 -12. .745 12. .499 1. .00 40. .78 B c
ATOM 2405 o THR B 16 -23. .020 -13. .467 11. .556 1. .00 41. .40 B o
ATOM 2406 N THR B 17 -23. .627 -13. .198 13. .732 1. .00 42. .02 B N
ATOM 2407 CA THR B 17 -23. .766 -14. .616 14. .057 1. .00 43. .39 B c
ATOM 2408 CB THR B 17 -22. .819 -14. .986 15. .206 1. .00 42. .77 B c
ATOM 2409 OGl THR B 17 -23. .194 -14. .299 16. .410 1. .00 40. .33 B o
ATOM 2410 CG2 THR B 17 -21. .392 -14. .597 14. .826 1. .00 42. .32 B c
ATOM 2411 C THR B 17 -25. .237 -14. .905 14. .412 1. .00 47. .94 B c
ATOM 2412 o THR B 17 -26. .098 -14. .036 14. .216 1. .00 53. .17 B o
ATOM 2413 N THR B 18 -25. .536 -16. .119 14. .880 1. .00 48. .55 B N
ATOM 2414 CA THR B 18 -26. .883 -16. .470 15. .372 1. .00 47. .03 B c
ATOM 2415 CB THR B 18 -27. .715 -17. .260 14. .322 1. .00 46. .64 B c
ATOM 2416 OGl THR B 18 -27. .903 -16. .465 13. .143 1. .00 47. .35 B o
ATOM 2417 CG2 THR B 18 -29. .098 -17. .635 14. .867 1. .00 47. .20 B c
ATOM 2418 C THR B 18 -26. .781 -17. .247 16. .695 1. .00 49. .03 B c
ATOM 2419 o THR B 18 -25. .845 -18. .027 16. .910 1. .00 45. .35 B o
ATOM 2420 N GLN B 19 -27. .735 -16. .996 17. .592 1. .00 54. .36 B N
ATOM 2421 CA GLN B 19 -27. .790 -17. .676 18. .879 1. .00 54. .96 B c
ATOM 2422 CB GLN B 19 -28. .436 -16. .770 19. .934 1. .00 58. .37 B c
ATOM 2423 CG GLN B 19 -27. .996 -17. .086 21. .361 1. .00 62. .57 B c
ATOM 2424 CD GLN B 19 -28. .459 -16. .067 22. .402 1. .00 63. .05 B c
ATOM 2425 OEl GLN B 19 -27. .896 -14. .971 22. .517 1. .00 60. .83 B o
ATOM 2426 NE2 GLN B 19 -29. .472 -16. .437 23. .185 1. .00 62. .16 B N
ATOM 2427 C GLN B 19 -28. .597 -18. .953 18. .685 1. .00 53. .79 B c
ATOM 2428 o GLN B 19 -29. .711 -18. .899 18. .167 1. .00 53. .84 B o
ATOM 2429 N SER B 20 -28. .016 -20. .097 19. .046 1. .00 54. .80 B N
ATOM 2430 CA SER B 20 -28. .744 -21. .381 19. .062 1. .00 54. .29 B c
ATOM 2431 CB SER B 20 -28. .141 -22. .387 18. .081 1. .00 53. .79 B c
ATOM 2432 OG SER B 20 -29. .021 -23. .476 17. .888 1. .00 49. .78 B o
ATOM 2433 C SER B 20 -28. .687 -21. .918 20. .481 1. .00 53. .51 B c
ATOM 2434 o SER B 20 -27. .696 -22. .552 20. .883 1. .00 51. .94 B o
ATOM 2435 N GLY B 21 -29. .746 -21. .617 21. .235 1. .00 52. .98 B N
ATOM 2436 CA GLY B 21 -29. .787 -21. .842 22. .675 1. .00 53. .72 B c
ATOM 2437 C GLY B 21 -28..455 -21..571 23..358 1..00 53..77 B C
ATOM 2438 o GLY B 21 -28. .115 -20. .417 23. .666 1. .00 50. .85 B o
ATOM 2439 N SER B 22 -27. .690 -22. .641 23. .549 1. .00 53. .12 B N
ATOM 2440 CA SER B 22 -26. .521 -22. .621 24. .419 1. .00 59. .41 B C
ATOM 2441 CB SER B 22 -26. .174 -24. .057 24. .820 1. .00 59. .03 B C
ATOM 2442 OG SER B 22 -25. .106 -24. .053 25. .747 1. .00 61. .97 B o
ATOM 2443 C SER B 22 -25. .272 -21. .930 23. .824 1. .00 61. .98 B c
ATOM 2444 o SER B 22 -24. .452 -21. .348 24. .563 1. .00 61. .14 B o
ATOM 2445 N THR B 23 -25. .134 -21. .998 22. .501 1. .00 57. .12 B N
ATOM 2446 CA THR B 23 -23. .930 -21. .532 21. .828 1. .00 55. .19 B c
ATOM 2447 CB THR B 23 -23. .101 -22. .755 21. .366 1. .00 52. .30 B c
ATOM 2448 OGl THR B 23 -21. .696 -22. .470 21. .419 1. .00 49. .29 B o
ATOM 2449 CG2 THR B 23 -23. .522 -23. .221 19. .960 1. .00 51. .82 B c
ATOM 2450 C THR B 23 -24. .344 -20. .627 20. .655 1. .00 55. .21 B c
ATOM 2451 o THR B 23 -25. .542 -20. .492 20. .358 1. .00 54. .01 B o
ATOM 2452 N TYR B 24 -23. .365 -19. .996 20. .010 1. .00 52. .08 B N
ATOM 2453 CA TYR B 24 -23. .622 -19. .217 18. .798 1. .00 50. .27 B c
ATOM 2454 CB TYR B 24 -23. .019 -17. .812 18. .884 1. .00 52. .10 B c
ATOM 2455 CG TYR B 24 -23. .470 -16. .931 20. .029 1. .00 51. .06 B c
ATOM 2456 CDl TYR B 24 -24. .563 -16. .095 19. .888 1. .00 49. .59 B c
ATOM 2457 CEl TYR B 24 -24. .967 -15. .278 20. .923 1. .00 52. .70 B c
ATOM 2458 CZ TYR B 24 -24. .268 -15. .276 22. .121 1. .00 52. .07 B c
ATOM 2459 OH TYR B 24 -24. .689 -14. .454 23. .153 1. .00 52. .35 B o
ATOM 2460 CE2 TYR B 24 -23. .160 -16. .085 22. .277 1. .00 50. .76 B c
ATOM 2461 CD 2 TYR B 24 -22. .764 -16. .903 21. .235 1. .00 50. .70 B c
ATOM 2462 C TYR B 24 -22. .990 -19. .902 17. .600 1. .00 50. .42 B c
ATOM 2463 o TYR B 24 -21. .978 -20. .595 17. .725 1. .00 50. .73 B o
ATOM 2464 N GLN B 25 -23. .547 -19. .640 16. .425 1. .00 49. .79 B N
ATOM 2465 CA GLN B 25 -23. .089 -20. .271 15. .193 1. .00 51. .16 B c
ATOM 2466 CB GLN B 25 -24. .083 -21. .380 14. .804 1. .00 52. .14 B c
ATOM 2467 CG GLN B 25 -25. .550 -20. .946 14. .773 1. .00 51. .47 B c
ATOM 2468 CD GLN B 25 -26. .509 -22. .069 14. .400 1. .00 49. .02 B c
ATOM 2469 OEl GLN B 25 -26. .386 -23. .186 14. .879 1. .00 43. .29 B o
ATOM 2470 NE2 GLN B 25 -27. .483 -21. .759 13. .549 1. .00 49. .61 B N
ATOM 2471 C GLN B 25 -22. .919 -19. .219 14. .064 1. .00 52. .10 B c
ATOM 2472 o GLN B 25 -23. .666 -18. .240 14. .038 1. .00 54. .65 B o
ATOM 2473 N LEU B 26 -21. .940 -19. .406 13. .158 1. .00 49. .06 B N
ATOM 2474 CA LEU B 26 -21. .703 -18. .464 12. .035 1. .00 45. .19 B c
ATOM 2475 CB LEU B 26 -20. .376 -18. .751 11. .315 1. .00 46. .15 B c
ATOM 2476 CG LEU B 26 -19. .037 -18. .374 11. .951 1. .00 45. .52 B c
ATOM 2477 CDl LEU B 26 -17. .937 -18. .472 10. .912 1. .00 46. .14 B c
ATOM 2478 CD 2 LEU B 26 -19. .057 -16. .972 12. .511 1. .00 44. .30 B c
ATOM 2479 C LEU B 26 -22. .827 -18. .489 11. .006 1. .00 44. .22 B c
ATOM 2480 o LEU B 26 -22. .671 -19. .012 9. .903 1. .00 45. .46 B o
ATOM 2481 N LYS B 27 -23. .955 -17. .902 11. .377 1. .00 44. .24 B N
ATOM 2482 CA LYS B 27 -25. .140 -17. .854 10. .539 1. .00 44. .91 B c
ATOM 2483 CB LYS B 27 -26. .279 -18. .702 11. .154 1. .00 47. .98 B c
ATOM 2484 CG LYS B 27 -26. .908 -19. .739 10. .222 1. .00 50. .64 B c
ATOM 2485 CD LYS B 27 -28. .321 -20. .163 10. .639 1. .00 51. .72 B c
ATOM 2486 CE LYS B 27 -28. .667 -21. .578 10. .160 1. .00 50. .07 B c
ATOM 2487 NZ LYS B 27 -30. .130 -21. .767 9. .974 1. .00 48. .98 B N
ATOM 2488 C LYS B 27 -25. .533 -16. .389 10. .501 1. .00 43. .09 B c
ATOM 2489 o LYS B 27 -25. .380 -15. .676 11. .500 1. .00 42. .47 B o
ATOM 2490 N ASP B 28 -26. .028 -15. .939 9. .357 1. .00 40. .93 B N
ATOM 2491 CA ASP B 28 -26. .461 -14. .555 9. .190 1. .00 40. .17 B c
ATOM 2492 CB ASP B 28 -25. .400 -13. .747 8. .407 1. .00 40. .04 B c
ATOM 2493 CG ASP B 28 -25. .757 -12. .248 8. .223 1. .00 39. .03 B c
ATOM 2494 ODl ASP B 28 -26. .943 -11. .879 7. .999 1. .00 39. .21 B o
ATOM 2495 OD2 ASP B 28 -24. .807 -11. .438 8. .258 1. .00 34. .92 B o
ATOM 2496 C ASP B 28 -27. .793 -14. .620 8. .472 1. .00 39. .30 B c
ATOM 2497 o ASP B 28 -27. .863 -14. .812 7. .260 1. .00 37. .02 B o
ATOM 2498 N THR B 29 -28. .863 -14. .460 9. .234 1. .00 41. .34 B N
ATOM 2499 CA THR B 29 -30. .206 -14. .595 8. .673 1. .00 42. .38 B c
ATOM 2500 CB THR B 29 -31. .217 -15. .019 9. .771 1. .00 42. .14 B c
ATOM 2501 OGl THR B 29 -31. .801 -13. .865 10. .404 1. .00 41. .11 B o
ATOM 2502 CG2 THR B 29 -30. .511 -15. .907 10. .837 1. .00 41. .47 B c
ATOM 2503 C THR B 29 -30. .610 -13. .293 7. .942 1. .00 42. .90 B c
ATOM 2504 o THR B 29 -31. .536 -13. .303 7. .113 1. .00 41. .57 B o
ATOM 2505 N THR B 30 -29. .862 -12. .208 8. .209 1. .00 42. .18 B N
ATOM 2506 CA THR B 30 -30. .243 -10. .849 7. .803 1. .00 42. .26 B c
ATOM 2507 CB THR B 30 -29. .460 -9. .772 8. .569 1. .00 41. .59 B c
ATOM 2508 OGl THR B 30 -28. .125 -9. .732 8. .078 1. .00 44. .54 B o
ATOM 2509 CG2 THR B 30 -29. .427 -10. .041 10. .071 1. .00 41. .22 B c
ATOM 2510 C THR B 30 -30. .012 -10. .576 6. .324 1. .00 43. .07 B c
ATOM 2511 o THR B 30 -30. .569 -9. .628 5. .790 1. .00 43. .49 B o
ATOM 2512 N ARG B 31 -29. .170 -11. .381 5. .676 1. .00 43. .41 B N
ATOM 2513 CA ARG B 31 -28. .950 -11. .270 4. .234 1. .00 42. .73 B c
ATOM 2514 CB ARG B 31 -27. .457 -11. .104 3. .947 1. .00 41. .54 B c
ATOM 2515 CG ARG B 31 -26. .880 -9. .779 4. .412 1. .00 40. .12 B c
ATOM 2516 CD ARG B 31 -25..358 -9..694 4..271 1..00 40..81 B C
ATOM 2517 NE ARG B 31 -24. .850 -8. .404 4. .746 1. .00 39. .64 B N
ATOM 2518 CZ ARG B 31 -24. .620 -8. .104 6. .025 1. .00 37. .51 B C
ATOM 2519 NHl ARG B 31 -24. .818 -9. .001 6. .977 1. .00 40. .18 B N
ATOM 2520 NH2 ARG B 31 -24. .184 -6. .906 6. .361 1. .00 34. .41 B N
ATOM 2521 C ARG B 31 -29. .492 -12. .510 3. .521 1. .00 42. .99 B C
ATOM 2522 o ARG B 31 -29. .076 -13. .639 3. .813 1. .00 41. .18 B o
ATOM 2523 N GLY B 32 -30. .421 -12. .288 2. .595 1. .00 44. .05 B N
ATOM 2524 CA GLY B 32 -31. .026 -13. .364 1. .795 1. .00 47. .95 B C
ATOM 2525 C GLY B 32 -31. .677 -14. .463 2. .618 1. .00 49. .75 B C
ATOM 2526 o GLY B 32 -32. .181 -14. .216 3. .717 1. .00 52. .02 B o
ATOM 2527 N GLN B 33 -31. .633 -15. .689 2. .101 1. .00 49. .78 B N
ATOM 2528 CA GLN B 33 -32. .066 -16. .860 2. .865 1. .00 48. .09 B c
ATOM 2529 CB GLN B 33 -32. .511 -17. .987 1. .926 1. .00 49. .40 B c
ATOM 2530 CG GLN B 33 -33. .652 -17. .599 0. .979 1. .00 51. .77 B c
ATOM 2531 CD GLN B 33 -33. .573 -18. .279 -0. .391 1. .00 52. .73 B c
ATOM 2532 OEl GLN B 33 -33. .197 -19. .442 -0. .508 1. .00 50. .83 B o
ATOM 2533 NE2 GLN B 33 -33. .944 -17. .546 -1. .436 1. .00 56. .68 B N
ATOM 2534 C GLN B 33 -30. .966 -17. .360 3. .803 1. .00 45. .74 B c
ATOM 2535 o GLN B 33 -31. .055 -18. .473 4. .292 1. .00 48. .18 B o
ATOM 2536 N GLY B 34 -29. .933 -16. .551 4. .048 1. .00 44. .06 B N
ATOM 2537 CA GLY B 34 -28. .862 -16. .901 4. .998 1. .00 40. .43 B c
ATOM 2538 C GLY B 34 -27. .446 -16. .828 4. .428 1. .00 37. .82 B c
ATOM 2539 o GLY B 34 -27. .265 -16. .890 3. .210 1. .00 35. .60 B o
ATOM 2540 N ILE B 35 -26. .453 -16. .679 5. .320 1. .00 34. .43 B N
ATOM 2541 CA ILE B 35 -25. .030 -16. .796 4. .984 1. .00 33. .25 B c
ATOM 2542 CB ILE B 35 -24. .312 -15. .420 4. .930 1. .00 37. .23 B c
ATOM 2543 CGl ILE B 35 -24. .686 -14. .664 3. .653 1. .00 38. .63 B c
ATOM 2544 CDl ILE B 35 -24. .189 -13. .226 3. .623 1. .00 39. .64 B c
ATOM 2545 CG2 ILE B 35 -22. .779 -15. .561 4. .974 1. .00 37. .29 B c
ATOM 2546 C ILE B 35 -24. .372 -17. .650 6. .052 1. .00 31. .28 B c
ATOM 2547 o ILE B 35 -24. .379 -17. .291 7. .239 1. .00 29. .76 B o
ATOM 2548 N VAL B 36 -23. .779 -18. .768 5. .629 1. .00 30. .21 B N
ATOM 2549 CA VAL B 36 -23. .278 -19. .763 6. .577 1. .00 29. .18 B c
ATOM 2550 CB VAL B 36 -24. .183 -21. .024 6. .652 1. .00 29. .87 B c
ATOM 2551 CGl VAL B 36 -24. .401 -21. .390 8. .107 1. .00 31. .50 B c
ATOM 2552 CG2 VAL B 36 -25. .537 -20. .825 5. .979 1. .00 29. .38 B c
ATOM 2553 C VAL B 36 -21. .869 -20. .237 6. .267 1. .00 27. .11 B c
ATOM 2554 o VAL B 36 -21. .508 -20. .504 5. .123 1. .00 26. .29 B o
ATOM 2555 N THR B 37 -21. .101 -20. .409 7. .319 1. .00 26. .36 B N
ATOM 2556 CA THR B 37 -19. .716 -20. .767 7. .182 1. .00 27. .97 B c
ATOM 2557 CB THR B 37 -18. .851 -19. .545 7. .550 1. .00 29. .05 B c
ATOM 2558 OGl THR B 37 -19. .158 -18. .474 6. .637 1. .00 30. .25 B o
ATOM 2559 CG2 THR B 37 -17. .335 -19. .865 7. .538 1. .00 28. .48 B c
ATOM 2560 C THR B 37 -19. .367 -22. .015 8. .026 1. .00 28. .89 B c
ATOM 2561 o THR B 37 -19. .527 -22. .015 9. .258 1. .00 26. .39 B o
ATOM 2562 N TYR B 38 -18. .894 -23. .055 7. .321 1. .00 30. .58 B N
ATOM 2563 CA TYR B 38 -18. .515 -24. .352 7. .890 1. .00 33. .15 B c
ATOM 2564 CB TYR B 38 -19. .122 -25. .498 7. .067 1. .00 33. .68 B c
ATOM 2565 CG TYR B 38 -20. .602 -25. .408 6. .810 1. .00 34. .72 B c
ATOM 2566 CDl TYR B 38 -21. .101 -24. .645 5. .751 1. .00 33. .58 B c
ATOM 2567 CEl TYR B 38 -22. .459 -24. .560 5. .503 1. .00 33. .35 B c
ATOM 2568 CZ TYR B 38 -23. .338 -25. .250 6. .307 1. .00 33. .94 B c
ATOM 2569 OH TYR B 38 -24. .675 -25. .190 6. .053 1. .00 32. .94 B o
ATOM 2570 CE2 TYR B 38 -22. .875 -26. .007 7. .369 1. .00 36. .31 B c
ATOM 2571 CD 2 TYR B 38 -21. .509 -26. .091 7. .610 1. .00 36. .06 B c
ATOM 2572 C TYR B 38 -17. .006 -24. .557 7. .858 1. .00 33. .86 B c
ATOM 2573 o TYR B 38 -16. .284 -23. .768 7. .244 1. .00 35. .29 B o
ATOM 2574 N SER B 39 -16. .555 -25. .648 8. .483 1. .00 32. .45 B N
ATOM 2575 CA SER B 39 -15. .151 -26. .094 8. .447 1. .00 31. .81 B c
ATOM 2576 CB SER B 39 -14. .480 -25. .943 9. .826 1. .00 30. .22 B c
ATOM 2577 OG SER B 39 -13. .271 -26. .688 9. .939 1. .00 28. .69 B o
ATOM 2578 C SER B 39 -15. .130 -27. .560 8. .023 1. .00 32. .86 B c
ATOM 2579 o SER B 39 -15. .972 -28. .338 8. .481 1. .00 32. .92 B o
ATOM 2580 N ALA B 40 -14. .171 -27. .940 7. .169 1. .00 31. .62 B N
ATOM 2581 CA ALA B 40 -14. .112 -29. .305 6. .650 1. .00 30. .64 B c
ATOM 2582 CB ALA B 40 -13. .763 -29. .298 5. .174 1. .00 29. .75 B c
ATOM 2583 C ALA B 40 -13. .130 -30. .173 7. .436 1. .00 31. .48 B c
ATOM 2584 o ALA B 40 -12. .928 -31. .349 7. .097 1. .00 29. .96 B o
ATOM 2585 N GLY B 41 -12. .535 -29. .603 8. .487 1. .00 31. .27 B N
ATOM 2586 CA GLY B 41 -11. .567 -30. .329 9. .308 1. .00 32. .58 B c
ATOM 2587 C GLY B 41 -10. .464 -30. .911 8. .448 1. .00 34. .88 B c
ATOM 2588 o GLY B 41 -10. .005 -32. .016 8. .681 1. .00 41. .21 B o
ATOM 2589 N ASN B 42 -10. .055 -30. .164 7. .432 1. .00 35. .41 B N
ATOM 2590 CA ASN B 42 -8. .963 -30. .556 6. .542 1. .00 35. .57 B c
ATOM 2591 CB ASN B 42 -7. .626 -30. .565 7. .290 1. .00 35. .12 B c
ATOM 2592 CG ASN B 42 -7. .341 -29. .234 7. .988 1. .00 35. .46 B c
ATOM 2593 ODl ASN B 42 -6. .975 -29. .225 9. .143 1. .00 37. .01 B o
ATOM 2594 ND2 ASN B 42 -7. .508 -28. .109 7. .281 1. .00 35. .13 B N
ATOM 2595 C ASN B 42 -9..235 -31..851 5..820 1..00 35..04 B C
ATOM 2596 o ASN B 42 -8. .323 -32. .620 5. .567 1. .00 31. .81 B o
ATOM 2597 N ARG B 43 -10. .501 -32. .017 5. .426 1. .00 39. .05 B N
ATOM 2598 CA ARG B 43 -11. .015 -33. .222 4. .776 1. .00 43. .00 B C
ATOM 2599 CB ARG B 43 -11. .892 -33. .984 5. .775 1. .00 48. .73 B C
ATOM 2600 CG ARG B 43 -11. .097 -34. .876 6. .718 1. .00 53. .88 B c
ATOM 2601 CD ARG B 43 -10. .656 -36. .140 6. .001 1. .00 59. .88 B c
ATOM 2602 NE ARG B 43 -10. .497 -37. .266 6. .925 1. .00 71. .15 B N
ATOM 2603 CZ ARG B 43 -11. .497 -37. .925 7. .523 1. .00 72. .97 B c
ATOM 2604 NHl ARG B 43 -12. .772 -37. .577 7. .324 1. .00 70. .94 B N
ATOM 2605 NH2 ARG B 43 -11. .216 -38. .937 8. .346 1. .00 74. .66 B N
ATOM 2606 C ARG B 43 -11. .806 -32. .894 3. .521 1. .00 40. .05 B C
ATOM 2607 o ARG B 43 -11. .901 -31. .731 3. .132 1. .00 42. .57 B o
ATOM 2608 N SER B 44 -12. .381 -33. .915 2. .894 1. .00 38. .32 B N
ATOM 2609 CA SER B 44 -12. .999 -33. .759 1. .574 1. .00 39. .47 B C
ATOM 2610 CB SER B 44 -12. .712 -34. .982 0. .695 1. .00 40. .23 B c
ATOM 2611 OG SER B 44 -11. .445 -34. .869 0. .078 1. .00 42. .89 B o
ATOM 2612 C SER B 44 -14. .501 -33. .503 1. .554 1. .00 37. .25 B c
ATOM 2613 o SER B 44 -15. .006 -32. .835 0. .655 1. .00 36. .44 B o
ATOM 2614 N SER B 45 -15. .244 -34. .065 2. .486 1. .00 36. .28 B N
ATOM 2615 CA SER B 45 -16. .688 -34. .005 2. .324 1. .00 36. .90 B c
ATOM 2616 CB SER B 45 -17. .413 -35. .089 3. .144 1. .00 36. .36 B c
ATOM 2617 OG SER B 45 -17. .285 -34. .843 4. .525 1. .00 36. .97 B o
ATOM 2618 C SER B 45 -17. .190 -32. .595 2. .645 1. .00 36. .54 B c
ATOM 2619 o SER B 45 -16. .577 -31. .857 3. .420 1. .00 33. .48 B o
ATOM 2620 N LEU B 46 -18. .304 -32. .246 2. .012 1. .00 37. .13 B N
ATOM 2621 CA LEU B 46 -18. .929 -30. .944 2. .147 1. .00 39. .27 B c
ATOM 2622 CB LEU B 46 -18. .853 -30. .188 0. .811 1. .00 38. .08 B c
ATOM 2623 CG LEU B 46 -17. .468 -30. .074 0. .156 1. .00 36. .84 B c
ATOM 2624 CDl LEU B 46 -17. .606 -29. .703 -1. .326 1. .00 35. .76 B c
ATOM 2625 CD 2 LEU B 46 -16. .578 -29. .092 0. .925 1. .00 35. .95 B c
ATOM 2626 C LEU B 46 -20. .399 -31. .131 2. .546 1. .00 41. .41 B c
ATOM 2627 o LEU B 46 -20. .968 -32. .200 2. .316 1. .00 44. .36 B o
ATOM 2628 N PRO B 47 -21. .020 -30. .093 3. .130 1. .00 39. .28 B N
ATOM 2629 CA PRO B 47 -20. .411 -28. .820 3. .520 1. .00 37. .84 B c
ATOM 2630 CB PRO B 47 -21. .611 -28. .006 4. .011 1. .00 40. .67 B c
ATOM 2631 CG PRO B 47 -22. .644 -29. .037 4. .374 1. .00 40. .15 B c
ATOM 2632 CD PRO B 47 -22. .479 -30. .061 3. .306 1. .00 38. .74 B c
ATOM 2633 C PRO B 47 -19. .403 -28. .941 4. .649 1. .00 35. .08 B c
ATOM 2634 o PRO B 47 -18. .610 -28. .044 4. .831 1. .00 32. .64 B o
ATOM 2635 N GLY B 48 -19. .438 -30. .045 5. .390 1. .00 33. .92 B N
ATOM 2636 CA GLY B 48 -18. .651 -30. .180 6. .603 1. .00 32. .39 B c
ATOM 2637 C GLY B 48 -19. .466 -29. .671 7. .770 1. .00 33. .27 B c
ATOM 2638 o GLY B 48 -20. .677 -29. .476 7. .644 1. .00 33. .45 B o
ATOM 2639 N THR B 49 -18. .790 -29. .432 8. .892 1. .00 34. .94 B N
ATOM 2640 CA THR B 49 -19. .414 -28. .958 10. .130 1. .00 38. .98 B c
ATOM 2641 CB THR B 49 -18. .513 -29. .273 11. .339 1. .00 39. .73 B c
ATOM 2642 OGl THR B 49 -18. .099 -30. .641 11. .273 1. .00 40. .95 B o
ATOM 2643 CG2 THR B 49 -19. .242 -29. .015 12. .663 1. .00 39. .97 B c
ATOM 2644 C THR B 49 -19. .720 -27. .444 10. .184 1. .00 42. .89 B c
ATOM 2645 o THR B 49 -18. .880 -26. .602 9. .868 1. .00 40. .45 B o
ATOM 2646 N LEU B 50 -20. .933 -27. .114 10. .623 1. .00 48. .49 B N
ATOM 2647 CA LEU B 50 -21. .292 -25. .732 10. .920 1. .00 48. .73 B c
ATOM 2648 CB LEU B 50 -22. .795 -25. .610 11. .146 1. .00 49. .85 B c
ATOM 2649 CG LEU B 50 -23. .368 -24. .241 11. .494 1. .00 51. .48 B c
ATOM 2650 CDl LEU B 50 -22. .680 -23. .122 10. .722 1. .00 52. .59 B c
ATOM 2651 CD 2 LEU B 50 -24. .875 -24. .227 11. .229 1. .00 52. .22 B c
ATOM 2652 C LEU B 50 -20. .518 -25. .298 12. .157 1. .00 47. .59 B c
ATOM 2653 o LEU B 50 -20. .480 -26. .016 13. .158 1. .00 49. .60 B o
ATOM 2654 N LEU B 51 -19. .877 -24. .138 12. .057 1. .00 46. .71 B N
ATOM 2655 CA LEU B 51 -18. .968 -23. .635 13. .080 1. .00 43. .84 B c
ATOM 2656 CB LEU B 51 -17. .950 -22. .670 12. .451 1. .00 45. .70 B c
ATOM 2657 CG LEU B 51 -16. .529 -23. .222 12. .293 1. .00 46. .99 B c
ATOM 2658 CDl LEU B 51 -15. .996 -22. .783 10. .946 1. .00 47. .24 B c
ATOM 2659 CD 2 LEU B 51 -15. .613 -22. .792 13. .454 1. .00 46. .81 B c
ATOM 2660 C LEU B 51 -19. .690 -22. .965 14. .244 1. .00 41. .22 B c
ATOM 2661 o LEU B 51 -20. .753 -22. .352 14. .083 1. .00 37. .73 B o
ATOM 2662 N THR B 52 -19. .043 -23. .038 15. .403 1. .00 40. .19 B N
ATOM 2663 CA THR B 52 -19. .694 -22. .874 16. .699 1. .00 38. .68 B c
ATOM 2664 CB THR B 52 -20. .030 -24. .303 17. .224 1. .00 37. .51 B c
ATOM 2665 OGl THR B 52 -21. .182 -24. .776 16. .532 1. .00 34. .76 B o
ATOM 2666 CG2 THR B 52 -20. .290 -24. .379 18. .732 1. .00 37. .73 B c
ATOM 2667 C THR B 52 -18. .788 -22. .103 17. .672 1. .00 37. .74 B c
ATOM 2668 o THR B 52 -17. .577 -22. .245 17. .639 1. .00 39. .97 B o
ATOM 2669 N SER B 53 -19. .371 -21. .279 18. .529 1. .00 39. .22 B N
ATOM 2670 CA SER B 53 -18. .636 -20. .722 19. .673 1. .00 41. .33 B c
ATOM 2671 CB SER B 53 -17. .766 -19. .518 19. .263 1. .00 40. .16 B c
ATOM 2672 OG SER B 53 -17. .139 -18. .905 20. .382 1. .00 37. .49 B o
ATOM 2673 C SER B 53 -19. .643 -20. .307 20. .739 1. .00 45. .00 B c
ATOM 2674 o SER B 53 -20..589 -19..556 20..450 1..00 46..25 B o
ATOM 2675 N SER B 54 -19. .461 -20. .823 21. .955 1. .00 46. .91 B N
ATOM 2676 CA SER B 54 -20. .263 -20. .398 23. .104 1. .00 47. .89 B C
ATOM 2677 CB SER B 54 -20. .046 -21. .350 24. .292 1. .00 47. .12 B C
ATOM 2678 OG SER B 54 -18. .666 -21. .531 24. .586 1. .00 46. .27 B o
ATOM 2679 C SER B 54 -19. .953 -18. .928 23. .478 1. .00 48. .96 B c
ATOM 2680 o SER B 54 -20. .833 -18. .202 23. .926 1. .00 49. .21 B o
ATOM 2681 N SER B 55 -18. .718 -18. .493 23. .219 1. .00 47. .87 B N
ATOM 2682 CA SER B 55 -18. .222 -17. .161 23. .587 1. .00 44. .68 B c
ATOM 2683 CB SER B 55 -16. .685 -17. .209 23. .560 1. .00 44. .59 B c
ATOM 2684 OG SER B 55 -16. .106 -16. .112 24. .240 1. .00 44. .52 B o
ATOM 2685 C SER B 55 -18. .707 -15. .986 22. .695 1. .00 44. .27 B c
ATOM 2686 o SER B 55 -18. .553 -14. .809 23. .068 1. .00 44. .09 B o
ATOM 2687 N ASN B 56 -19. .279 -16. .300 21. .526 1. .00 42. .16 B N
ATOM 2688 CA ASN B 56 -19. .411 -15. .344 20. .385 1. .00 38. .46 B c
ATOM 2689 CB ASN B 56 -20. .558 -14. .340 20. .601 1. .00 35. .65 B c
ATOM 2690 CG ASN B 56 -21. .226 -13. .902 19. .290 1. .00 34. .01 B c
ATOM 2691 ODl ASN B 56 -21. .996 -12. .952 19. .283 1. .00 36. .17 B o
ATOM 2692 ND2 ASN B 56 -20. .947 -14. .590 18. .194 1. .00 30. .20 B N
ATOM 2693 C ASN B 56 -18. .101 -14. .601 19. .985 1. .00 38. .13 B c
ATOM 2694 o ASN B 56 -18. .137 -13. .659 19. .202 1. .00 35. .54 B o
ATOM 2695 N ILE B 57 -16. .967 -15. .032 20. .536 1. .00 38. .44 B N
ATOM 2696 CA ILE B 57 -15. .654 -14. .668 20. .039 1. .00 42. .11 B c
ATOM 2697 CB ILE B 57 -14. .683 -14. .350 21. .189 1. .00 42. .20 B c
ATOM 2698 CGl ILE B 57 -15. .350 -13. .491 22. .273 1. .00 44. .11 B c
ATOM 2699 CDl ILE B 57 -15. .809 -12. .115 21. .839 1. .00 44. .60 B c
ATOM 2700 CG2 ILE B 57 -13. .437 -13. .665 20. .654 1. .00 41. .76 B c
ATOM 2701 C ILE B 57 -15. .113 -15. .873 19. .234 1. .00 46. .06 B c
ATOM 2702 o ILE B 57 -15. .270 -17. .026 19. .669 1. .00 50. .20 B o
ATOM 2703 N TRP B 58 -14. .475 -15. .607 18. .085 1. .00 43. .11 B N
ATOM 2704 CA TRP B 58 -14. .066 -16. .648 17. .136 1. .00 40. .89 B c
ATOM 2705 CB TRP B 58 -14. .801 -16. .457 15. .834 1. .00 40. .59 B c
ATOM 2706 CG TRP B 58 -16. .245 -16. .402 16. .008 1. .00 40. .53 B c
ATOM 2707 CDl TRP B 58 -16. .962 -15. .345 16. .414 1. .00 40. .30 B c
ATOM 2708 NEl TRP B 58 -18. .288 -15. .660 16. .467 1. .00 40. .67 B N
ATOM 2709 CE2 TRP B 58 -18. .449 -16. .960 16. .090 1. .00 41. .82 B c
ATOM 2710 CD 2 TRP B 58 -17. .168 -17. .463 15. .793 1. .00 43. .03 B c
ATOM 2711 CE3 TRP B 58 -17. .038 -18. .798 15. .378 1. .00 44. .52 B c
ATOM 2712 CZ3 TRP B 58 -18. .194 -19. .573 15. .257 1. .00 46. .89 B c
ATOM 2713 CH2 TRP B 58 -19. .466 -19. .033 15. .563 1. .00 46. .00 B c
ATOM 2714 CZ2 TRP B 58 -19. .608 -17. .734 15. .987 1. .00 43. .73 B c
ATOM 2715 C TRP B 58 -12. .583 -16. .598 16. .838 1. .00 43. .33 B c
ATOM 2716 o TRP B 58 -12. .073 -15. .572 16. .390 1. .00 41. .28 B o
ATOM 2717 N ASN B 59 -11. .893 -17. .720 17. .041 1. .00 46. .24 B N
ATOM 2718 CA ASN B 59 -10. .441 -17. .752 16. .912 1. .00 45. .70 B c
ATOM 2719 CB ASN B 59 -9. .830 -18. .319 18. .178 1. .00 49. .90 B c
ATOM 2720 CG ASN B 59 -9. .910 -17. .334 19. .326 1. .00 57. .71 B c
ATOM 2721 ODl ASN B 59 -9. .071 -16. .430 19. .449 1. .00 61. .14 B o
ATOM 2722 ND2 ASN B 59 -10. .934 -17. .481 20. .165 1. .00 62. .09 B N
ATOM 2723 C ASN B 59 -9. .972 -18. .509 15. .696 1. .00 42. .04 B c
ATOM 2724 o ASN B 59 -8. .950 -19. .169 15. .726 1. .00 45. .30 B o
ATOM 2725 N ASP B 60 -10. .707 -18. .369 14. .609 1. .00 37. .51 B N
ATOM 2726 CA ASP B 60 -10. .363 -19. .023 13. .371 1. .00 36. .63 B c
ATOM 2727 CB ASP B 60 -11. .337 -20. .170 13. .119 1. .00 37. .97 B c
ATOM 2728 CG ASP B 60 -11. .017 -20. .941 11. .861 1. .00 36. .97 B c
ATOM 2729 ODl ASP B 60 -9. .899 -20. .784 11. .310 1. .00 35. .18 B o
ATOM 2730 OD2 ASP B 60 -11. .902 -21. .710 11. .429 1. .00 37. .14 B o
ATOM 2731 C ASP B 60 -10. .381 -18. .016 12. .211 1. .00 35. .22 B c
ATOM 2732 o ASP B 60 -11. .461 -17. .568 11. .745 1. .00 33. .57 B o
ATOM 2733 N GLY B 61 -9. .172 -17. .694 11. .746 1. .00 31. .50 B N
ATOM 2734 CA GLY B 61 -8. .947 -16. .600 10. .815 1. .00 29. .00 B c
ATOM 2735 C GLY B 61 -9. .628 -16. .829 9. .495 1. .00 28. .50 B c
ATOM 2736 o GLY B 61 -10. .389 -15. .978 9. .025 1. .00 29. .45 B o
ATOM 2737 N ALA B 62 -9. .380 -17. .980 8. .886 1. .00 27. .01 B N
ATOM 2738 CA ALA B 62 -9. .980 -18. .248 7. .581 1. .00 26. .15 B c
ATOM 2739 CB ALA B 62 -9. .484 -19. .558 7. .008 1. .00 27. .22 B c
ATOM 2740 C ALA B 62 -11. .494 -18. .232 7. .642 1. .00 25. .10 B c
ATOM 2741 o ALA B 62 -12. .121 -17. .707 6. .755 1. .00 25. .58 B o
ATOM 2742 N ALA B 63 -12. .090 -18. .777 8. .695 1. .00 25. .77 B N
ATOM 2743 CA ALA B 63 -13. .560 -18. .757 8. .810 1. .00 27. .21 B c
ATOM 2744 CB ALA B 63 -14. .029 -19. .602 9. .989 1. .00 27. .02 B c
ATOM 2745 C ALA B 63 -14. .118 -17. .325 8. .934 1. .00 27. .71 B c
ATOM 2746 o ALA B 63 -15. .165 -17. .007 8. .343 1. .00 27. .87 B o
ATOM 2747 N VAL B 64 -13. .417 -16. .488 9. .712 1. .00 26. .10 B N
ATOM 2748 CA VAL B 64 -13. .806 -15. .112 9. .932 1. .00 24. .19 B c
ATOM 2749 CB VAL B 64 -12. .831 -14. .437 10. .882 1. .00 24. .11 B c
ATOM 2750 CGl VAL B 64 -13. .003 -12. .926 10. .833 1. .00 24. .36 B c
ATOM 2751 CG2 VAL B 64 -13. .047 -14. .965 12. .292 1. .00 24. .69 B c
ATOM 2752 C VAL B 64 -13. .819 -14. .352 8. .619 1. .00 24. .48 B c
ATOM 2753 o VAL B 64 -14..837 -13..747 8..233 1..00 23..08 B o
ATOM 2754 N ASP B 65 -12. .687 -14. .386 7. .924 1. .00 24. .36 B N
ATOM 2755 CA ASP B 65 -12. .597 -13. .691 6. .657 1. .00 24. .27 B C
ATOM 2756 CB ASP B 65 -11. .194 -13. .785 6. .053 1. .00 24. .29 B C
ATOM 2757 CG ASP B 65 -10. .179 -12. .899 6. .778 1. .00 24. .48 B c
ATOM 2758 ODl ASP B 65 -10. .541 -11. .803 7. .209 1. .00 23. .48 B o
ATOM 2759 OD2 ASP B 65 -9. .004 -13. .284 6. .922 1. .00 25. .28 B o
ATOM 2760 C ASP B 65 -13. .650 -14. .266 5. .731 1. .00 24. .81 B c
ATOM 2761 o ASP B 65 -14. .431 -13. .507 5. .130 1. .00 24. .32 B o
ATOM 2762 N ALA B 66 -13. .720 -15. .597 5. .660 1. .00 24. .42 B N
ATOM 2763 CA ALA B 66 -14. .745 -16. .245 4. .827 1. .00 26. .00 B c
ATOM 2764 CB ALA B 66 -14. .748 -17. .751 5. .038 1. .00 26. .76 B c
ATOM 2765 C ALA B 66 -16. .143 -15. .693 5. .096 1. .00 25. .63 B c
ATOM 2766 o ALA B 66 -16. .880 -15. .319 4. .181 1. .00 22. .75 B o
ATOM 2767 N HIS B 67 -16. .480 -15. .650 6. .375 1. .00 27. .71 B N
ATOM 2768 CA HIS B 67 -17. .789 -15. .198 6. .817 1. .00 30. .45 B c
ATOM 2769 CB HIS B 67 -17. .945 -15. .490 8. .305 1. .00 32. .99 B c
ATOM 2770 CG HIS B 67 -19. .353 -15. .419 8. .779 1. .00 34. .84 B c
ATOM 2771 NDl HIS B 67 -20. .373 -16. .117 8. .170 1. .00 36. .52 B N
ATOM 2772 CEl HIS B 67 -21. .509 -15. .850 8. .785 1. .00 37. .20 B c
ATOM 2773 NE2 HIS B 67 -21. .257 -15. .016 9. .778 1. .00 36. .99 B N
ATOM 2774 CD 2 HIS B 67 -19. .916 -14. .729 9. .794 1. .00 34. .94 B C
ATOM 2775 C HIS B 67 -18. .026 -13. .710 6. .536 1. .00 29. .77 B c
ATOM 2776 o HIS B 67 -18. .971 -13. .350 5. .823 1. .00 28. .30 B o
ATOM 2777 N ALA B 68 -17. .159 -12. .853 7. .076 1. .00 29. .76 B N
ATOM 2778 CA ALA B 68 -17. .281 -11. .398 6. .850 1. .00 30. .76 B c
ATOM 2779 CB ALA B 68 -16. .138 -10. .632 7. .523 1. .00 30. .67 B c
ATOM 2780 C ALA B 68 -17. .320 -11. .067 5. .362 1. .00 29. .91 B c
ATOM 2781 o ALA B 68 -18. .336 -10. .605 4. .842 1. .00 29. .77 B o
ATOM 2782 N TYR B 69 -16. .217 -11. .347 4. .676 1. .00 27. .97 B N
ATOM 2783 CA TYR B 69 -16. .103 -10. .975 3. .281 1. .00 26. .15 B c
ATOM 2784 CB TYR B 69 -14. .755 -11. .400 2. .656 1. .00 25. .06 B c
ATOM 2785 CG TYR B 69 -13. .523 -10. .767 3. .264 1. .00 23. .20 B c
ATOM 2786 CDl TYR B 69 -13. .542 -9. .468 3. .784 1. .00 22. .72 B c
ATOM 2787 CEl TYR B 69 -12. .406 -8. .906 4. .356 1. .00 21. .86 B c
ATOM 2788 CZ TYR B 69 -11. .242 -9. .635 4. .396 1. .00 21. .61 B c
ATOM 2789 OH TYR B 69 -10. .096 -9. .115 4. .939 1. .00 20. .56 B o
ATOM 2790 CE2 TYR B 69 -11. .214 -10. .921 3. .894 1. .00 21. .81 B c
ATOM 2791 CD 2 TYR B 69 -12. .343 -11. .472 3. .329 1. .00 22. .03 B c
ATOM 2792 C TYR B 69 -17. .240 -11. .529 2. .460 1. .00 25. .31 B c
ATOM 2793 o TYR B 69 -17. .527 -11. .003 1. .400 1. .00 25. .46 B o
ATOM 2794 N THR B 70 -17. .899 -12. .582 2. .916 1. .00 27. .08 B N
ATOM 2795 CA THR B 70 -19. .056 -13. .065 2. .145 1. .00 28. .79 B c
ATOM 2796 CB THR B 70 -19. .421 -14. .549 2. .426 1. .00 29. .13 B c
ATOM 2797 OGl THR B 70 -18. .350 -15. .412 2. .011 1. .00 28. .17 B o
ATOM 2798 CG2 THR B 70 -20. .666 -14. .947 1. .640 1. .00 30. .19 B c
ATOM 2799 C THR B 70 -20. .236 -12. .077 2. .332 1. .00 28. .56 B c
ATOM 2800 o THR B 70 -20. .896 -11. .713 1. .345 1. .00 26. .58 B o
ATOM 2801 N ALA B 71 -20. .457 -11. .607 3. .569 1. .00 28. .13 B N
ATOM 2802 CA ALA B 71 -21. .405 -10. .506 3. .805 1. .00 27. .78 B c
ATOM 2803 CB ALA B 71 -21. .412 -10. .101 5. .261 1. .00 26. .69 B c
ATOM 2804 C ALA B 71 -21. .075 -9. .293 2. .922 1. .00 28. .42 B c
ATOM 2805 o ALA B 71 -21. .969 -8. .680 2. .317 1. .00 27. .67 B o
ATOM 2806 N LYS B 72 -19. .789 -8. .964 2. .840 1. .00 29. .66 B N
ATOM 2807 CA LYS B 72 -19. .346 -7. .772 2. .133 1. .00 31. .07 B c
ATOM 2808 CB LYS B 72 -17. .842 -7. .590 2. .277 1. .00 32. .79 B c
ATOM 2809 CG LYS B 72 -17. .258 -6. .408 1. .512 1. .00 35. .11 B c
ATOM 2810 CD LYS B 72 -15. .747 -6. .289 1. .716 1. .00 36. .65 B c
ATOM 2811 CE LYS B 72 -15. .242 -4. .933 1. .257 1. .00 38. .51 B c
ATOM 2812 NZ LYS B 72 -13. .761 -4. .866 1. .344 1. .00 40. .21 B N
ATOM 2813 C LYS B 72 -19. .717 -7. .872 0. .677 1. .00 32. .30 B c
ATOM 2814 o LYS B 72 -20. .162 -6. .889 0. .079 1. .00 35. .50 B o
ATOM 2815 N VAL B 73 -19. .546 -9. .066 0. .112 1. .00 32. .14 B N
ATOM 2816 CA VAL B 73 -19. .814 -9. .304 -1. .320 1. .00 30. .81 B c
ATOM 2817 CB VAL B 73 -19. .131 -10. .611 -1. .824 1. .00 29. .58 B c
ATOM 2818 CGl VAL B 73 -19. .415 -10. .861 -3. .297 1. .00 27. .79 B c
ATOM 2819 CG2 VAL B 73 -17. .620 -10. .558 -1. .574 1. .00 30. .18 B c
ATOM 2820 C VAL B 73 -21. .312 -9. .362 -1. .576 1. .00 30. .15 B c
ATOM 2821 o VAL B 73 -21. .756 -9. .011 -2. .646 1. .00 28. .69 B o
ATOM 2822 N TYR B 74 -22. .075 -9. .825 -0. .587 1. .00 32. .57 B N
ATOM 2823 CA TYR B 74 -23. .525 -9. .800 -0. .654 1. .00 34. .78 B c
ATOM 2824 CB TYR B 74 -24. .141 -10. .527 0. .543 1. .00 38. .44 B c
ATOM 2825 CG TYR B 74 -25. .653 -10. .515 0. .518 1. .00 42. .42 B c
ATOM 2826 CDl TYR B 74 -26. .367 -9. .478 1. .108 1. .00 45. .08 B c
ATOM 2827 CEl TYR B 74 -27. .747 -9. .452 1. .072 1. .00 46. .85 B c
ATOM 2828 CZ TYR B 74 -28. .423 -10. .461 0. .432 1. .00 46. .58 B c
ATOM 2829 OH TYR B 74 -29. .792 -10. .430 0. .400 1. .00 48. .77 B o
ATOM 2830 CE2 TYR B 74 -27. .740 -11. .498 -0. .165 1. .00 44. .52 B c
ATOM 2831 CD 2 TYR B 74 -26. .363 -11. .521 -0. .118 1. .00 42. .52 B c
ATOM 2832 C TYR B 74 -23..990 -8..348 -0..685 1..00 34..57 B C
ATOM 2833 o TYR B 74 -24. .756 -7. .962 -1. .585 1. .00 34. .24 B o
ATOM 2834 N ASP B 75 -23. .517 -7. .558 0. .289 1. .00 32. .83 B N
ATOM 2835 CA ASP B 75 -23. .765 -6. .110 0. .313 1. .00 32. .00 B C
ATOM 2836 CB ASP B 75 -22. .966 -5. .400 1. .423 1. .00 30. .80 B C
ATOM 2837 CG ASP B 75 -23. .468 -5. .736 2. .823 1. .00 29. .68 B c
ATOM 2838 ODl ASP B 75 -24. .558 -6. .343 2. .956 1. .00 26. .51 B o
ATOM 2839 OD2 ASP B 75 -22. .742 -5. .406 3. .791 1. .00 27. .80 B o
ATOM 2840 C ASP B 75 -23. .456 -5. .451 -1. .030 1. .00 32. .02 B c
ATOM 2841 o ASP B 75 -24. .321 -4. .795 -1. .602 1. .00 34. .17 B o
ATOM 2842 N TYR B 76 -22. .241 -5. .632 -1. .540 1. .00 31. .51 B N
ATOM 2843 CA TYR B 76 -21. .849 -5. .008 -2. .805 1. .00 30. .68 B c
ATOM 2844 CB TYR B 76 -20. .422 -5. .408 -3. .183 1. .00 31. .50 B c
ATOM 2845 CG TYR B 76 -19. .954 -4. .945 -4. .549 1. .00 32. .80 B c
ATOM 2846 CDl TYR B 76 -20. .312 -5. .644 -5. .677 1. .00 33. .28 B c
ATOM 2847 CEl TYR B 76 -19. .893 -5. .247 -6. .928 1. .00 33. .91 B c
ATOM 2848 CZ TYR B 76 -19. .094 -4. .147 -7. .077 1. .00 34. .08 B c
ATOM 2849 OH TYR B 76 -18. .735 -3. .832 -8. .366 1. .00 36. .34 B o
ATOM 2850 CE2 TYR B 76 -18. .696 -3. .416 -5. .974 1. .00 33. .35 B c
ATOM 2851 CD 2 TYR B 76 -19. .119 -3. .825 -4. .710 1. .00 34. .22 B c
ATOM 2852 C TYR B 76 -22. .847 -5. .352 -3. .904 1. .00 31. .30 B c
ATOM 2853 o TYR B 76 -23. .356 -4. .456 -4. .550 1. .00 33. .09 B o
ATOM 2854 N TYR B 77 -23. .154 -6. .633 -4. .100 1. .00 31. .67 B N
ATOM 2855 CA TYR B 77 -24. .106 -7. .030 -5. .143 1. .00 33. .09 B c
ATOM 2856 CB TYR B 77 -24. .288 -8. .571 -5. .236 1. .00 34. .51 B c
ATOM 2857 CG TYR B 77 -23. .373 -9. .296 -6. .237 1. .00 32. .63 B c
ATOM 2858 CDl TYR B 77 -22. .119 -9. .767 -5. .856 1. .00 32. .93 B c
ATOM 2859 CEl TYR B 77 -21. .279 -10. .412 -6. .756 1. .00 32. .14 B c
ATOM 2860 CZ TYR B 77 -21. .695 -10. .624 -8. .049 1. .00 32. .06 B c
ATOM 2861 OH TYR B 77 -20. .861 -11. .295 -8. .923 1. .00 32. .13 B o
ATOM 2862 CE2 TYR B 77 -22. .936 -10. .168 -8. .450 1. .00 31. .38 B c
ATOM 2863 CD 2 TYR B 77 -23. .766 -9. .512 -7. .544 1. .00 31. .01 B c
ATOM 2864 C TYR B 77 -25. .460 -6. .358 -4. .924 1. .00 33. .60 B c
ATOM 2865 o TYR B 77 -26. .025 -5. .791 -5. .864 1. .00 31. .95 B o
ATOM 2866 N LYS B 78 -25. .968 -6. .428 -3. .693 1. .00 35. .21 B N
ATOM 2867 CA LYS B 78 -27. .226 -5. .743 -3. .305 1. .00 38. .16 B c
ATOM 2868 CB LYS B 78 -27. .499 -5. .943 -1. .798 1. .00 41. .05 B c
ATOM 2869 CG LYS B 78 -28. .442 -4. .930 -1. .143 1. .00 44. .48 B c
ATOM 2870 CD LYS B 78 -29. .548 -5. .574 -0. .305 1. .00 46. .27 B c
ATOM 2871 CE LYS B 78 -30. .629 -6. .155 -1. .224 1. .00 49. .31 B c
ATOM 2872 NZ LYS B 78 -31. .826 -6. .666 -0. .496 1. .00 50. .68 B N
ATOM 2873 C LYS B 78 -27. .214 -4. .242 -3. .666 1. .00 38. .50 B c
ATOM 2874 o LYS B 78 -28. .116 -3. .739 -4. .348 1. .00 37. .83 B o
ATOM 2875 N ASN B 79 -26. .163 -3. .552 -3. .237 1. .00 36. .81 B N
ATOM 2876 CA ASN B 79 -26. .072 -2. .119 -3. .390 1. .00 35. .01 B c
ATOM 2877 CB ASN B 79 -25. .037 -1. .568 -2. .428 1. .00 34. .32 B c
ATOM 2878 CG ASN B 79 -25. .446 -1. .750 -0. .968 1. .00 34. .68 B c
ATOM 2879 ODl ASN B 79 -26. .640 -1. .847 -0. .631 1. .00 31. .67 B o
ATOM 2880 ND2 ASN B 79 -24. .451 -1. .805 -0. .090 1. .00 35. .09 B N
ATOM 2881 C ASN B 79 -25. .783 -1. .659 -4. .800 1. .00 36. .29 B c
ATOM 2882 o ASN B 79 -26. .446 -0. .757 -5. .290 1. .00 36. .69 B o
ATOM 2883 N LYS B 80 -24. .821 -2. .271 -5. .472 1. .00 39. .00 B N
ATOM 2884 CA LYS B 80 -24. .394 -1. .768 -6. .782 1. .00 41. .10 B c
ATOM 2885 CB LYS B 80 -22. .927 -2. .094 -7. .036 1. .00 45. .28 B c
ATOM 2886 CG LYS B 80 -21. .982 -1. .547 -5. .982 1. .00 51. .45 B c
ATOM 2887 CD LYS B 80 -21. .444 -0. .164 -6. .329 1. .00 56. .78 B c
ATOM 2888 CE LYS B 80 -20. .650 0. .395 -5. .153 1. .00 60. .79 B c
ATOM 2889 NZ LYS B 80 -21. .524 0. .661 -3. .966 1. .00 62. .58 B N
ATOM 2890 C LYS B 80 -25. .202 -2. .277 -7. .965 1. .00 41. .13 B c
ATOM 2891 o LYS B 80 -25. .033 -1. .754 -9. .072 1. .00 40. .54 B o
ATOM 2892 N PHE B 81 -26. .046 -3. .296 -7. .764 1. .00 40. .60 B N
ATOM 2893 CA PHE B 81 -26. .746 -3. .941 -8. .892 1. .00 40. .39 B c
ATOM 2894 CB PHE B 81 -26. .047 -5. .257 -9. .274 1. .00 42. .38 B c
ATOM 2895 CG PHE B 81 -24. .628 -5. .111 -9. .754 1. .00 43. .89 B c
ATOM 2896 CDl PHE B 81 -24. .300 -4. .227 -10. .770 1. .00 45. .90 B c
ATOM 2897 CEl PHE B 81 -22. .990 -4. .112 -11. .214 1. .00 47. .25 B c
ATOM 2898 CZ PHE B 81 -22. .000 -4. .911 -10. .664 1. .00 47. .90 B c
ATOM 2899 CE2 PHE B 81 -22. .319 -5. .821 -9. .672 1. .00 46. .56 B c
ATOM 2900 CD 2 PHE B 81 -23. .626 -5. .921 -9. .226 1. .00 45. .90 B c
ATOM 2901 C PHE B 81 -28. .217 -4. .290 -8. .659 1. .00 40. .16 B c
ATOM 2902 o PHE B 81 -28. .880 -4. .759 -9. .574 1. .00 39. .11 B o
ATOM 2903 N GLY B 82 -28. .720 -4. .127 -7. .443 1. .00 40. .78 B N
ATOM 2904 CA GLY B 82 -30. .054 -4. .617 -7. .106 1. .00 42. .16 B c
ATOM 2905 C GLY B 82 -30. .193 -6. .135 -7. .065 1. .00 44. .48 B c
ATOM 2906 o GLY B 82 -31. .308 -6. .662 -7. .002 1. .00 46. .91 B o
ATOM 2907 N ARG B 83 -29. .071 -6. .853 -7. .065 1. .00 44. .64 B N
ATOM 2908 CA ARG B 83 -29. .108 -8. .311 -7. .112 1. .00 42. .54 B c
ATOM 2909 CB ARG B 83 -27. .970 -8. .851 -7. .980 1. .00 43. .50 B c
ATOM 2910 CG ARG B 83 -27. .861 -10. .374 -7. .915 1. .00 44. .21 B c
ATOM 2911 CD ARG B 83 -26..887 -10..972 -8..920 1..00 42..64 B C
ATOM 2912 NE ARG B 83 -27. .330 -12. .309 -9. .284 1. .00 41. .71 B N
ATOM 2913 CZ ARG B 83 -28. .056 -12. .605 -10. .359 1. .00 41. .59 B C
ATOM 2914 NHl ARG B 83 -28. .397 -11. .672 -11. .239 1. .00 38. .71 B N
ATOM 2915 NH2 ARG B 83 -28. .427 -13. .862 -10. .570 1. .00 44. .02 B N
ATOM 2916 C ARG B 83 -29. .078 -8. .955 -5. .722 1. .00 39. .03 B C
ATOM 2917 o ARG B 83 -28. .308 -8. .560 -4. .851 1. .00 36. .63 B o
ATOM 2918 N ASN B 84 -29. .910 -9. .979 -5. .559 1. .00 37. .19 B N
ATOM 2919 CA ASN B 84 -30. .100 -10. .669 -4. .277 1. .00 35. .57 B C
ATOM 2920 CB ASN B 84 -31. .602 -10. .752 -3. .969 1. .00 32. .60 B C
ATOM 2921 CG ASN B 84 -31. .912 -11. .200 -2. .559 1. .00 30. .63 B c
ATOM 2922 ODl ASN B 84 -33. .073 -11. .419 -2. .241 1. .00 30. .00 B o
ATOM 2923 ND2 ASN B 84 -30. .903 -11. .321 -1. .709 1. .00 29. .72 B N
ATOM 2924 C ASN B 84 -29. .493 -12. .069 -4. .355 1. .00 35. .30 B c
ATOM 2925 o ASN B 84 -30. .018 -12. .925 -5. .050 1. .00 35. .02 B o
ATOM 2926 N SER B 85 -28. .379 -12. .275 -3. .648 1. .00 37. .34 B N
ATOM 2927 CA SER B 85 -27. .523 -13. .490 -3. .757 1. .00 37. .67 B c
ATOM 2928 CB SER B 85 -28. .072 -14. .642 -2. .910 1. .00 37. .87 B c
ATOM 2929 OG SER B 85 -27. .019 -15. .470 -2. .452 1. .00 36. .06 B o
ATOM 2930 C SER B 85 -27. .271 -13. .918 -5. .209 1. .00 36. .47 B c
ATOM 2931 o SER B 85 -27. .404 -13. .093 -6. .117 1. .00 38. .17 B o
ATOM 2932 N ILE B 86 -26. .911 -15. .177 -5. .445 1. .00 35. .78 B N
ATOM 2933 CA ILE B 86 -26. .422 -15. .556 -6. .788 1. .00 38. .90 B c
ATOM 2934 CB ILE B 86 -25. .482 -16. .789 -6. .767 1. .00 40. .34 B c
ATOM 2935 CGl ILE B 86 -26. .280 -18. .073 -6. .741 1. .00 43. .61 B c
ATOM 2936 CDl ILE B 86 -25. .397 -19. .286 -6. .631 1. .00 47. .20 B c
ATOM 2937 CG2 ILE B 86 -24. .540 -16. .770 -5. .564 1. .00 40. .32 B c
ATOM 2938 C ILE B 86 -27. .543 -15. .744 -7. .829 1. .00 38. .42 B c
ATOM 2939 o ILE B 86 -27. .374 -15. .397 -8. .994 1. .00 36. .18 B o
ATOM 2940 N ASP B 87 -28. .672 -16. .290 -7. .387 1. .00 41. .14 B N
ATOM 2941 CA ASP B 87 -29. .843 -16. .563 -8. .233 1. .00 41. .69 B c
ATOM 2942 CB ASP B 87 -30. .586 -17. .806 -7. .714 1. .00 41. .60 B c
ATOM 2943 CG ASP B 87 -31. .249 -17. .572 -6. .344 1. .00 41. .11 B c
ATOM 2944 ODl ASP B 87 -30. .790 -16. .683 -5. .603 1. .00 38. .26 B o
ATOM 2945 OD2 ASP B 87 -32. .205 -18. .286 -5. .983 1. .00 40. .33 B o
ATOM 2946 C ASP B 87 -30. .862 -15. .420 -8. .293 1. .00 43. .82 B c
ATOM 2947 o ASP B 87 -31. .952 -15. .624 -8. .833 1. .00 45. .59 B o
ATOM 2948 N GLY B 88 -30. .554 -14. .254 -7. .714 1. .00 42. .79 B N
ATOM 2949 CA GLY B 88 -31. .467 -13. .107 -7. .774 1. .00 42. .83 B c
ATOM 2950 C GLY B 88 -32. .580 -13. .102 -6. .734 1. .00 43. .95 B c
ATOM 2951 o GLY B 88 -33. .034 -12. .041 -6. .334 1. .00 41. .75 B o
ATOM 2952 N ASN B 89 -33. .061 -14. .284 -6. .346 1. .00 49. .48 B N
ATOM 2953 CA ASN B 89 -33. .806 -14. .473 -5. .085 1. .00 52. .34 B c
ATOM 2954 CB ASN B 89 -34. .804 -15. .628 -5. .189 1. .00 56. .66 B c
ATOM 2955 CG ASN B 89 -35. .843 -15. .406 -6. .287 1. .00 62. .28 B c
ATOM 2956 ODl ASN B 89 -35. .693 -14. .522 -7. .145 1. .00 63. .04 B o
ATOM 2957 ND2 ASN B 89 -36. .909 -16. .202 -6. .259 1. .00 63. .74 B N
ATOM 2958 C ASN B 89 -32. .735 -14. .793 -4. .086 1. .00 49. .08 B c
ATOM 2959 o ASN B 89 -31. .630 -15. .116 -4. .486 1. .00 57. .39 B o
ATOM 2960 N GLY B 90 -33. .003 -14. .724 -2. .798 1. .00 44. .73 B N
ATOM 2961 CA GLY B 90 -31. .880 -14. .648 -1. .838 1. .00 42. .09 B c
ATOM 2962 C GLY B 90 -31. .136 -15. .934 -1. .533 1. .00 40. .51 B c
ATOM 2963 o GLY B 90 -30. .983 -16. .274 -0. .367 1. .00 38. .47 B o
ATOM 2964 N PHE B 91 -30. .654 -16. .623 -2. .577 1. .00 40. .34 B N
ATOM 2965 CA PHE B 91 -30. .044 -17. .961 -2. .471 1. .00 41. .32 B c
ATOM 2966 CB PHE B 91 -29. .339 -18. .344 -3. .801 1. .00 45. .43 B c
ATOM 2967 CG PHE B 91 -28. .680 -19. .715 -3. .800 1. .00 49. .29 B c
ATOM 2968 CDl PHE B 91 -29. .447 -20. .880 -3. .899 1. .00 48. .89 B c
ATOM 2969 CEl PHE B 91 -28. .837 -22. .121 -3. .886 1. .00 50. .44 B c
ATOM 2970 CZ PHE B 91 -27. .450 -22. .219 -3. .792 1. .00 49. .76 B c
ATOM 2971 CE2 PHE B 91 -26. .679 -21. .081 -3. .708 1. .00 47. .44 B c
ATOM 2972 CD 2 PHE B 91 -27. .288 -19. .837 -3. .719 1. .00 49. .23 B c
ATOM 2973 C PHE B 91 -29. .071 -18. .048 -1. .308 1. .00 38. .84 B c
ATOM 2974 o PHE B 91 -28. .177 -17. .219 -1. .185 1. .00 41. .42 B o
ATOM 2975 N GLN B 92 -29. .259 -19. .038 -0. .440 1. .00 38. .23 B N
ATOM 2976 CA GLN B 92 -28. .398 -19. .195 0. .738 1. .00 37. .91 B c
ATOM 2977 CB GLN B 92 -28. .943 -20. .290 1. .660 1. .00 38. .21 B c
ATOM 2978 CG GLN B 92 -28. .030 -20. .632 2. .834 1. .00 41. .26 B c
ATOM 2979 CD GLN B 92 -28. .635 -21. .661 3. .787 1. .00 41. .52 B c
ATOM 2980 OEl GLN B 92 -29. .230 -22. .645 3. .356 1. .00 44. .14 B o
ATOM 2981 NE2 GLN B 92 -28. .453 -21. .451 5. .079 1. .00 40. .35 B N
ATOM 2982 C GLN B 92 -26. .930 -19. .456 0. .322 1. .00 36. .58 B c
ATOM 2983 o GLN B 92 -26. .652 -20. .169 -0. .649 1. .00 38. .61 B o
ATOM 2984 N LEU B 93 -26. .003 -18. .857 1. .055 1. .00 35. .02 B N
ATOM 2985 CA LEU B 93 -24. .599 -18. .840 0. .670 1. .00 35. .33 B c
ATOM 2986 CB LEU B 93 -24. .106 -17. .398 0. .619 1. .00 35. .64 B c
ATOM 2987 CG LEU B 93 -24. .765 -16. .482 -0. .435 1. .00 36. .84 B c
ATOM 2988 CDl LEU B 93 -24. .304 -15. .036 -0. .267 1. .00 36. .03 B c
ATOM 2989 CD 2 LEU B 93 -24. .506 -16. .983 -1. .859 1. .00 37. .70 B c
ATOM 2990 C LEU B 93 -23..745 -19..658 1..632 1..00 36..40 B C
ATOM 2991 o LEU B 93 -23. .507 -19. .249 2. .770 1. .00 36. .65 B o
ATOM 2992 N LYS B 94 -23. .292 -20. .820 1. .173 1. .00 37. .02 B N
ATOM 2993 CA LYS B 94 -22. .555 -21. .738 2. .041 1. .00 40. .31 B C
ATOM 2994 CB LYS B 94 -23. .009 -23. .211 1. .813 1. .00 43. .72 B C
ATOM 2995 CG LYS B 94 -24. .379 -23. .603 2. .386 1. .00 44. .25 B c
ATOM 2996 CD LYS B 94 -25. .058 -24. .748 1. .617 1. .00 46. .62 B c
ATOM 2997 CE LYS B 94 -26. .527 -24. .981 2. .021 1. .00 46. .67 B c
ATOM 2998 NZ LYS B 94 -26. .707 -25. .189 3. .493 1. .00 44. .46 B N
ATOM 2999 C LYS B 94 -21. .059 -21. .562 1. .748 1. .00 38. .21 B c
ATOM 3000 o LYS B 94 -20. .677 -21. .435 0. .599 1. .00 36. .56 B o
ATOM 3001 N SER B 95 -20. .226 -21. .552 2. .784 1. .00 35. .66 B N
ATOM 3002 CA SER B 95 -18. .801 -21. .364 2. .615 1. .00 35. .30 B c
ATOM 3003 CB SER B 95 -18. .393 -19. .953 3. .037 1. .00 37. .34 B c
ATOM 3004 OG SER B 95 -19. .004 -18. .966 2. .224 1. .00 40. .01 B o
ATOM 3005 C SER B 95 -18. .084 -22. .335 3. .508 1. .00 35. .67 B c
ATOM 3006 o SER B 95 -18. .331 -22. .355 4. .712 1. .00 35. .97 B o
ATOM 3007 N THR B 96 -17. .186 -23. .139 2. .952 1. .00 34. .75 B N
ATOM 3008 CA THR B 96 -16. .447 -24. .087 3. .788 1. .00 34. .33 B c
ATOM 3009 CB THR B 96 -16. .594 -25. .545 3. .289 1. .00 33. .88 B c
ATOM 3010 OGl THR B 96 -17. .978 -25. .859 3. .076 1. .00 34. .75 B o
ATOM 3011 CG2 THR B 96 -16. .021 -26. .523 4. .291 1. .00 33. .52 B c
ATOM 3012 C THR B 96 -14. .983 -23. .703 3. .791 1. .00 33. .72 B c
ATOM 3013 o THR B 96 -14. .398 -23. .508 2. .729 1. .00 33. .99 B o
ATOM 3014 N VAL B 97 -14. .397 -23. .586 4. .978 1. .00 33. .07 B N
ATOM 3015 CA VAL B 97 -12. .952 -23. .374 5. .093 1. .00 34. .16 B c
ATOM 3016 CB VAL B 97 -12. .592 -22. .282 6. .128 1. .00 34. .28 B c
ATOM 3017 CGl VAL B 97 -13. .159 -20. .957 5. .683 1. .00 35. .98 B c
ATOM 3018 CG2 VAL B 97 -13. .100 -22. .619 7. .515 1. .00 35. .36 B c
ATOM 3019 C VAL B 97 -12. .224 -24. .672 5. .432 1. .00 34. .05 B c
ATOM 3020 o VAL B 97 -12. .849 -25. .727 5. .565 1. .00 34. .39 B o
ATOM 3021 N HIS B 98 -10. .898 -24. .575 5. .543 1. .00 33. .56 B N
ATOM 3022 CA HIS B 98 -10. .042 -25. .695 5. .882 1. .00 32. .14 B c
ATOM 3023 CB HIS B 98 -10. .257 -26. .060 7. .328 1. .00 33. .55 B c
ATOM 3024 CG HIS B 98 -10. .063 -24. .924 8. .258 1. .00 34. .25 B c
ATOM 3025 NDl HIS B 98 -8. .841 -24. .315 8. .436 1. .00 35. .12 B N
ATOM 3026 CEl HIS B 98 -8. .961 -23. .356 9. .332 1. .00 36. .99 B c
ATOM 3027 NE2 HIS B 98 -10. .220 -23. .320 9. .733 1. .00 37. .68 B N
ATOM 3028 CD2 HIS B 98 -10. .927 -24. .299 9. .084 1. .00 34. .92 B C
ATOM 3029 C HIS B 98 -10. .337 -26. .911 5. .043 1. .00 31. .42 B c
ATOM 3030 o HIS B 98 -10. .422 -28. .024 5. .578 1. .00 30. .39 B o
ATOM 3031 N TYR B 99 -10. .524 -26. .701 3. .738 1. .00 29. .84 B N
ATOM 3032 CA TYR B 99 -10. .814 -27. .799 2. .820 1. .00 28. .03 B c
ATOM 3033 CB TYR B 99 -11. .373 -27. .284 1. .524 1. .00 27. .78 B c
ATOM 3034 CG TYR B 99 -11. .713 -28. .379 0. .558 1. .00 28. .82 B c
ATOM 3035 CDl TYR B 99 -12. .884 -29. .113 0. .710 1. .00 30. .01 B c
ATOM 3036 CEl TYR B 99 -13. .234 -30. .098 -0. .193 1. .00 29. .32 B c
ATOM 3037 CZ TYR B 99 -12. .406 -30. .367 -1. .259 1. .00 28. .91 B c
ATOM 3038 OH TYR B 99 -12. .778 -31. .345 -2. .132 1. .00 27. .23 B o
ATOM 3039 CE2 TYR B 99 -11. .227 -29. .664 -1. .436 1. .00 28. .87 B c
ATOM 3040 CD2 TYR B 99 -10. .888 -28. .671 -0. .526 1. .00 29. .25 B c
ATOM 3041 C TYR B 99 -9. .568 -28. .584 2. .503 1. .00 26. .15 B c
ATOM 3042 o TYR B 99 -8. .635 -28. .055 1. .878 1. .00 24. .18 B o
ATOM 3043 N SER B 100 -9. .576 -29. .839 2. .942 1. .00 24. .97 B N
ATOM 3044 CA SER B 100 -8. .515 -30. .805 2. .656 1. .00 25. .57 B c
ATOM 3045 CB SER B 100 -8. .519 -31. .186 1. .174 1. .00 23. .87 B c
ATOM 3046 OG SER B 100 -7. .308 -31. .791 0. .828 1. .00 22. .41 B o
ATOM 3047 C SER B 100 -7. .140 -30. .320 3. .143 1. .00 26. .93 B c
ATOM 3048 o SER B 100 -7. .067 -29. .280 3. .782 1. .00 28. .15 B o
ATOM 3049 N SER B 101 -6. .074 -31. .083 2. .875 1. .00 27. .99 B N
ATOM 3050 CA SER B 101 -4. .750 -30. .814 3. .463 1. .00 28. .45 B c
ATOM 3051 CB SER B 101 -4. .040 -32. .123 3. .845 1. .00 28. .72 B c
ATOM 3052 OG SER B 101 -2. .682 -32. .138 3. .419 1. .00 29. .51 B o
ATOM 3053 C SER B 101 -3. .884 -29. .984 2. .519 1. .00 29. .04 B c
ATOM 3054 o SER B 101 -3. .783 -30. .299 1. .331 1. .00 27. .72 B o
ATOM 3055 N ARG B 102 -3. .289 -28. .919 3. .069 1. .00 30. .50 B N
ATOM 3056 CA ARG B 102 -2. .401 -27. .999 2. .354 1. .00 30. .50 B c
ATOM 3057 CB ARG B 102 -0. .949 -28. .479 2. .461 1. .00 33. .61 B c
ATOM 3058 CG ARG B 102 -0. .281 -28. .133 3. .800 1. .00 37. .70 B c
ATOM 3059 CD ARG B 102 1. .209 -28. .482 3. .815 1. .00 40. .99 B c
ATOM 3060 NE ARG B 102 1. .410 -29. .932 3. .662 1. .00 45. .77 B N
ATOM 3061 CZ ARG B 102 2. .389 -30. .528 2. .961 1. .00 47. .99 B c
ATOM 3062 NHl ARG B 102 3. .304 -29. .804 2. .311 1. .00 50. .01 B N
ATOM 3063 NH2 ARG B 102 2. .460 -31. .870 2. .914 1. .00 44. .90 B N
ATOM 3064 C ARG B 102 -2. .840 -27. .800 0. .900 1. .00 28. .31 B C
ATOM 3065 o ARG B 102 -2. .069 -27. .986 -0. .020 1. .00 27. .45 B o
ATOM 3066 N TYR B 103 -4. .098 -27. .396 0. .740 1. .00 26. .02 B N
ATOM 3067 CA TYR B 103 -4. .787 -27. .284 -0. .548 1. .00 23. .64 B C
ATOM 3068 CB TYR B 103 -6. .247 -27. .678 -0. .330 1. .00 23. .86 B c
ATOM 3069 CG TYR B 103 -7..039 -27..730 -1..575 1..00 24..13 B C
ATOM 3070 CDl TYR B 103 -6. .841 -28. .754 -2. .479 1. .00 25. .33 B C
ATOM 3071 CEl TYR B 103 -7. .554 -28. .825 -3. .652 1. .00 25. .32 B C
ATOM 3072 CZ TYR B 103 -8. .476 -27. .862 -3. .928 1. .00 26. .06 B C
ATOM 3073 OH TYR B 103 -9. .167 -27. .961 -5. .104 1. .00 27. .97 B o
ATOM 3074 CE2 TYR B 103 -8. .707 -26. .819 -3. .041 1. .00 24. .94 B C
ATOM 3075 CD 2 TYR B 103 -7. .979 -26. .763 -1. .869 1. .00 24. .27 B C
ATOM 3076 C TYR B 103 -4. .718 -25. .851 -1. .153 1. .00 21. .60 B C
ATOM 3077 o TYR B 103 -5. .217 -24. .885 -0. .546 1. .00 19. .52 B o
ATOM 3078 N ASN B 104 -4. .110 -25. .743 -2. .349 1. .00 19. .76 B N
ATOM 3079 CA ASN B 104 -3. .842 -24. .452 -3. .015 1. .00 18. .78 B C
ATOM 3080 CB ASN B 104 -2. .521 -24. .503 -3. .810 1. .00 18. .63 B C
ATOM 3081 CG ASN B 104 -1. .267 -24. .521 -2. .930 1. .00 18. .22 B c
ATOM 3082 ODl ASN B 104 -1. .220 -23. .993 -1. .815 1. .00 18. .11 B o
ATOM 3083 ND2 ASN B 104 -0. .230 -25. .118 -3. .461 1. .00 17. .67 B N
ATOM 3084 C ASN B 104 -4. .969 -23. .980 -3. .962 1. .00 17. .89 B c
ATOM 3085 o ASN B 104 -4. .729 -23. .661 -5. .119 1. .00 16. .38 B o
ATOM 3086 N ASN B 105 -6. .195 -23. .906 -3. .463 1. .00 17. .58 B N
ATOM 3087 CA ASN B 105 -7. .247 -23. .368 -4. .261 1. .00 18. .17 B c
ATOM 3088 CB ASN B 105 -7. .549 -24. .310 -5. .395 1. .00 17. .95 B c
ATOM 3089 CG ASN B 105 -7. .575 -23. .611 -6. .739 1. .00 18. .43 B c
ATOM 3090 ODl ASN B 105 -7. .983 -22. .445 -6. .890 1. .00 18. .76 B o
ATOM 3091 ND2 ASN B 105 -7. .147 -24. .340 -7. .740 1. .00 19. .03 B N
ATOM 3092 C ASN B 105 -8. .558 -23. .035 -3. .544 1. .00 20. .12 B c
ATOM 3093 o ASN B 105 -8. .807 -23. .426 -2. .391 1. .00 22. .03 B o
ATOM 3094 N ALA B 106 -9. .386 -22. .274 -4. .247 1. .00 19. .79 B N
ATOM 3095 CA ALA B 106 -10. .718 -22. .010 -3. .819 1. .00 19. .99 B c
ATOM 3096 CB ALA B 106 -10. .897 -20. .520 -3. .551 1. .00 20. .22 B c
ATOM 3097 C ALA B 106 -11. .540 -22. .440 -4. .990 1. .00 20. .21 B c
ATOM 3098 o ALA B 106 -11. .021 -22. .459 -6. .098 1. .00 19. .79 B o
ATOM 3099 N PHE B 107 -12. .813 -22. .758 -4. .768 1. .00 21. .28 B N
ATOM 3100 CA PHE B 107 -13. .684 -23. .129 -5. .883 1. .00 22. .81 B c
ATOM 3101 CB PHE B 107 -13. .343 -24. .553 -6. .408 1. .00 24. .23 B c
ATOM 3102 CG PHE B 107 -13. .461 -25. .660 -5. .365 1. .00 25. .42 B c
ATOM 3103 CDl PHE B 107 -12. .387 -25. .980 -4. .532 1. .00 26. .00 B c
ATOM 3104 CEl PHE B 107 -12. .496 -26. .993 -3. .590 1. .00 26. .52 B c
ATOM 3105 CZ PHE B 107 -13. .686 -27. .714 -3. .479 1. .00 26. .55 B c
ATOM 3106 CE2 PHE B 107 -14. .754 -27. .427 -4. .310 1. .00 25. .62 B c
ATOM 3107 CD 2 PHE B 107 -14. .640 -26. .408 -5. .247 1. .00 25. .85 B c
ATOM 3108 C PHE B 107 -15. .174 -23. .011 -5. .576 1. .00 22. .11 B c
ATOM 3109 o PHE B 107 -15. .581 -22. .879 -4. .422 1. .00 21. .96 B o
ATOM 3110 N TRP B 108 -15. .962 -23. .035 -6. .644 1. .00 21. .93 B N
ATOM 3111 CA TRP B 108 -17. .418 -23. .093 -6. .576 1. .00 22. .59 B c
ATOM 3112 CB TRP B 108 -18. .045 -21. .893 -7. .330 1. .00 21. .95 B c
ATOM 3113 CG TRP B 108 -19. .427 -22. .087 -7. .888 1. .00 20. .54 B c
ATOM 3114 CDl TRP B 108 -19. .743 -22. .448 -9. .159 1. .00 20. .50 B c
ATOM 3115 NEl TRP B 108 -21. .102 -22. .522 -9. .318 1. .00 20. .10 B N
ATOM 3116 CE2 TRP B 108 -21. .701 -22. .176 -8. .143 1. .00 20. .03 B c
ATOM 3117 CD 2 TRP B 108 -20. .666 -21. .888 -7. .213 1. .00 20. .47 B c
ATOM 3118 CE3 TRP B 108 -21. .012 -21. .496 -5. .918 1. .00 20. .91 B c
ATOM 3119 CZ3 TRP B 108 -22. .392 -21. .423 -5. .591 1. .00 21. .48 B c
ATOM 3120 CH2 TRP B 108 -23. .393 -21. .729 -6. .552 1. .00 20. .23 B c
ATOM 3121 CZ2 TRP B 108 -23. .064 -22. .094 -7. .824 1. .00 19. .90 B c
ATOM 3122 C TRP B 108 -17. .813 -24. .400 -7. .210 1. .00 24. .22 B c
ATOM 3123 o TRP B 108 -17. .449 -24. .649 -8. .357 1. .00 24. .63 B o
ATOM 3124 N ASN B 109 -18. .555 -25. .233 -6. .479 1. .00 26. .95 B N
ATOM 3125 CA ASN B 109 -18. .965 -26. .547 -6. .990 1. .00 27. .50 B c
ATOM 3126 CB ASN B 109 -18. .725 -27. .619 -5. .921 1. .00 27. .76 B c
ATOM 3127 CG ASN B 109 -19. .755 -27. .595 -4. .793 1. .00 28. .70 B c
ATOM 3128 ODl ASN B 109 -20. .754 -26. .849 -4. .814 1. .00 27. .27 B o
ATOM 3129 ND2 ASN B 109 -19. .510 -28. .443 -3. .785 1. .00 29. .61 B N
ATOM 3130 C ASN B 109 -20. .405 -26. .611 -7. .505 1. .00 28. .31 B c
ATOM 3131 o ASN B 109 -21. .001 -27. .658 -7. .523 1. .00 28. .32 B o
ATOM 3132 N GLY B 110 -20. .971 -25. .490 -7. .919 1. .00 31. .03 B N
ATOM 3133 CA GLY B 110 -22. .345 -25. .465 -8. .439 1. .00 32. .29 B c
ATOM 3134 C GLY B 110 -23. .355 -25. .216 -7. .333 1. .00 33. .16 B c
ATOM 3135 o GLY B 110 -24. .504 -24. .822 -7. .595 1. .00 33. .81 B o
ATOM 3136 N VAL B 111 -22. .913 -25. .405 -6. .095 1. .00 33. .45 B N
ATOM 3137 CA VAL B 111 -23. .799 -25. .336 -4. .942 1. .00 35. .17 B c
ATOM 3138 CB VAL B 111 -24. .201 -26. .785 -4. .535 1. .00 34. .30 B c
ATOM 3139 CGl VAL B 111 -23. .952 -27. .096 -3. .048 1. .00 33. .42 B c
ATOM 3140 CG2 VAL B 111 -25. .649 -27. .041 -4. .959 1. .00 34. .43 B c
ATOM 3141 C VAL B 111 -23. .244 -24. .503 -3. .758 1. .00 36. .29 B c
ATOM 3142 o VAL B 111 -24. .018 -23. .960 -2. .969 1. .00 37. .98 B o
ATOM 3143 N GLN B 112 -21. .923 -24. .398 -3. .625 1. .00 35. .91 B N
ATOM 3144 CA GLN B 112 -21. .327 -23. .587 -2. .558 1. .00 35. .06 B c
ATOM 3145 CB GLN B 112 -21. .404 -24. .355 -1. .234 1. .00 35. .50 B c
ATOM 3146 CG GLN B 112 -20. .563 -25. .625 -1. .199 1. .00 34. .97 B c
ATOM 3147 CD GLN B 112 -20. .178 -26. .032 0. .207 1. .00 33. .92 B c
ATOM 3148 OEl GLN B 112 -20..655 -27..036 0..715 1..00 34..45 B o
ATOM 3149 NE2 GLN B 112 -19. .318 -25. .250 0. .843 1. .00 33. .47 B N
ATOM 3150 C GLN B 112 -19. .861 -23. .172 -2. .833 1. .00 33. .71 B C
ATOM 3151 o GLN B 112 -19. .261 -23. .555 -3. .847 1. .00 34. .36 B o
ATOM 3152 N MET B 113 -19. .295 -22. .404 -1. .907 1. .00 30. .68 B N
ATOM 3153 CA MET B 113 -17. .933 -21. .911 -2. .017 1. .00 28. .51 B C
ATOM 3154 CB MET B 113 -17. .849 -20. .424 -1. .641 1. .00 29. .34 B C
ATOM 3155 CG MET B 113 -18. .299 -19. .432 -2. .709 1. .00 29. .87 B c
ATOM 3156 SD MET B 113 -20. .078 -19. .409 -2. .981 1. .00 29. .78 B s
ATOM 3157 CE MET B 113 -20. .613 -18. .711 -1. .419 1. .00 30. .48 B c
ATOM 3158 C MET B 113 -17. .070 -22. .692 -1. .060 1. .00 27. .82 B c
ATOM 3159 o MET B 113 -17. .493 -23. .039 0. .062 1. .00 26. .31 B o
ATOM 3160 N VAL B 114 -15. .833 -22. .914 -1. .497 1. .00 27. .54 B N
ATOM 3161 CA VAL B 114 -14. .882 -23. .775 -0. .794 1. .00 26. .67 B c
ATOM 3162 CB VAL B 114 -14. .799 -25. .172 -1. .472 1. .00 27. .48 B c
ATOM 3163 CGl VAL B 114 -13. .869 -26. .096 -0. .697 1. .00 27. .84 B c
ATOM 3164 CG2 VAL B 114 -16. .183 -25. .792 -1. .594 1. .00 27. .90 B c
ATOM 3165 C VAL B 114 -13. .510 -23. .112 -0. .845 1. .00 23. .88 B c
ATOM 3166 o VAL B 114 -13. .093 -22. .652 -1. .913 1. .00 22. .42 B o
ATOM 3167 N TYR B 115 -12. .822 -23. .087 0. .291 1. .00 21. .58 B N
ATOM 3168 CA TYR B 115 -11. .557 -22. .383 0. .411 1. .00 21. .93 B c
ATOM 3169 CB TYR B 115 -11. .718 -21. .092 1. .229 1. .00 21. .40 B c
ATOM 3170 CG TYR B 115 -12. .731 -20. .164 0. .665 1. .00 21. .37 B c
ATOM 3171 CDl TYR B 115 -12. .421 -19. .308 -0. .358 1. .00 21. .96 B c
ATOM 3172 CEl TYR B 115 -13. .389 -18. .468 -0. .910 1. .00 22. .81 B c
ATOM 3173 CZ TYR B 115 -14. .677 -18. .480 -0. .422 1. .00 22. .74 B c
ATOM 3174 OH TYR B 115 -15. .665 -17. .644 -0. .940 1. .00 22. .96 B o
ATOM 3175 CE2 TYR B 115 -14. .992 -19. .339 0. .605 1. .00 22. .43 B c
ATOM 3176 CD 2 TYR B 115 -14. .028 -20. .175 1. .130 1. .00 22. .02 B c
ATOM 3177 C TYR B 115 -10. .500 -23. .244 1. .092 1. .00 22. .23 B c
ATOM 3178 o TYR B 115 -10. .611 -23. .520 2. .287 1. .00 21. .55 B o
ATOM 3179 N GLY B 116 -9. .458 -23. .609 0. .341 1. .00 21. .40 B N
ATOM 3180 CA GLY B 116 -8. .302 -24. .273 0. .901 1. .00 21. .51 B c
ATOM 3181 C GLY B 116 -7. .513 -23. .366 1. .821 1. .00 21. .86 B c
ATOM 3182 o GLY B 116 -7. .773 -22. .181 1. .900 1. .00 22. .60 B o
ATOM 3183 N ASP B 117 -6. .549 -23. .936 2. .523 1. .00 22. .59 B N
ATOM 3184 CA ASP B 117 -5. .689 -23. .176 3. .412 1. .00 23. .66 B c
ATOM 3185 CB ASP B 117 -5. .446 -23. .933 4. .723 1. .00 24. .06 B c
ATOM 3186 CG ASP B 117 -6. .583 -23. .800 5. .710 1. .00 24. .67 B c
ATOM 3187 ODl ASP B 117 -7. .346 -22. .803 5. .728 1. .00 25. .59 B o
ATOM 3188 OD2 ASP B 117 -6. .695 -24. .723 6. .502 1. .00 25. .80 B o
ATOM 3189 C ASP B 117 -4. .346 -22. .926 2. .766 1. .00 23. .69 B c
ATOM 3190 o ASP B 117 -3. .480 -22. .273 3. .347 1. .00 23. .57 B o
ATOM 3191 N GLY B 118 -4. .152 -23. .465 1. .575 1. .00 24. .06 B N
ATOM 3192 CA GLY B 118 -2. .868 -23. .321 0. .912 1. .00 24. .13 B c
ATOM 3193 C GLY B 118 -1. .737 -24. .045 1. .622 1. .00 22. .97 B c
ATOM 3194 o GLY B 118 -1. .779 -24. .292 2. .834 1. .00 22. .31 B o
ATOM 3195 N ASP B 119 -0. .709 -24. .364 0. .847 1. .00 22. .43 B N
ATOM 3196 CA ASP B 119 0. .478 -25. .039 1. .368 1. .00 21. .83 B c
ATOM 3197 CB ASP B 119 1. .323 -25. .608 0. .197 1. .00 20. .08 B c
ATOM 3198 CG ASP B 119 2. .036 -24. .543 -0. .596 1. .00 19. .22 B c
ATOM 3199 ODl ASP B 119 2. .324 -23. .446 -0. .078 1. .00 19. .73 B o
ATOM 3200 OD2 ASP B 119 2. .347 -24. .810 -1. .752 1. .00 17. .52 B o
ATOM 3201 C ASP B 119 1. .321 -24. .187 2. .353 1. .00 21. .78 B c
ATOM 3202 o ASP B 119 2. .321 -24. .651 2. .875 1. .00 21. .12 B o
ATOM 3203 N GLY B 120 0. .916 -22. .943 2. .587 1. .00 23. .30 B N
ATOM 3204 CA GLY B 120 1. .636 -22. .047 3. .486 1. .00 23. .87 B c
ATOM 3205 C GLY B 120 2. .932 -21. .462 2. .957 1. .00 24. .49 B c
ATOM 3206 o GLY B 120 3. .629 -20. .779 3. .676 1. .00 24. .47 B o
ATOM 3207 N VAL B 121 3. .284 -21. .718 1. .711 1. .00 26. .95 B N
ATOM 3208 CA VAL B 121 4. .523 -21. .143 1. .163 1. .00 29. .85 B c
ATOM 3209 CB VAL B 121 5. .613 -22. .221 0. .856 1. .00 29. .49 B c
ATOM 3210 CGl VAL B 121 6. .777 -21. .618 0. .072 1. .00 28. .64 B c
ATOM 3211 CG2 VAL B 121 6. .142 -22. .843 2. .140 1. .00 28. .93 B c
ATOM 3212 C VAL B 121 4. .211 -20. .346 -0. .094 1. .00 31. .76 B c
ATOM 3213 o VAL B 121 4. .770 -19. .262 -0. .314 1. .00 36. .09 B o
ATOM 3214 N THR B 122 3. .333 -20. .892 -0. .924 1. .00 30. .83 B N
ATOM 3215 CA THR B 122 2. .924 -20. .223 -2. .139 1. .00 29. .94 B c
ATOM 3216 CB THR B 122 2. .957 -21. .220 -3. .312 1. .00 32. .47 B c
ATOM 3217 OGl THR B 122 2. .621 -22. .519 -2. .826 1. .00 33. .51 B o
ATOM 3218 CG2 THR B 122 4. .399 -21. .336 -3. .879 1. .00 35. .40 B c
ATOM 3219 C THR B 122 1. .562 -19. .555 -1. .934 1. .00 26. .62 B c
ATOM 3220 o THR B 122 1. .221 -18. .626 -2. .642 1. .00 26. .32 B o
ATOM 3221 N PHE B 123 0. .790 -20. .010 -0. .955 1. .00 23. .60 B N
ATOM 3222 CA PHE B 123 -0. .483 -19. .367 -0. .627 1. .00 21. .85 B c
ATOM 3223 CB PHE B 123 -1. .700 -20. .064 -1. .261 1. .00 21. .42 B c
ATOM 3224 CG PHE B 123 -1. .758 -19. .968 -2. .752 1. .00 20. .41 B c
ATOM 3225 CD 2 PHE B 123 -2. .454 -18. .948 -3. .362 1. .00 20. .18 B c
ATOM 3226 CE2 PHE B 123 -2. .516 -18. .853 -4. .741 1. .00 20. .20 B c
ATOM 3227 cz PHE B 123 -1..865 -19..781 -5..527 1..00 20..04 B C
ATOM 3228 CEl PHE B 123 -1. .156 -20. .809 -4. .928 1. .00 20. .65 B C
ATOM 3229 CDl PHE B 123 -1. .120 -20. .906 -3. .544 1. .00 20. .63 B C
ATOM 3230 c PHE B 123 -0. .669 -19. .445 0. .854 1. .00 21. .39 B C
ATOM 3231 o PHE B 123 -0. .128 -20. .345 1. .499 1. .00 23. .40 B o
ATOM 3232 N ILE B 124 -1. .434 -18. .499 1. .383 1. .00 20. .17 B N
ATOM 3233 CA ILE B 124 -1. .961 -18. .572 2. .736 1. .00 18. .39 B C
ATOM 3234 CB ILE B 124 -1. .640 -17. .310 3. .541 1. .00 17. .54 B C
ATOM 3235 CGl ILE B 124 -2. .396 -16. .082 3. .033 1. .00 16. .90 B c
ATOM 3236 CDl ILE B 124 -2. .386 -14. .964 4. .038 1. .00 16. .17 B c
ATOM 3237 CG2 ILE B 124 -0. .147 -17. .048 3. .498 1. .00 17. .65 B c
ATOM 3238 C ILE B 124 -3. .444 -18. .826 2. .549 1. .00 18. .58 B c
ATOM 3239 o ILE B 124 -3. .891 -18. .998 1. .407 1. .00 18. .36 B o
ATOM 3240 N PRO B 125 -4. .203 -18. .918 3. .649 1. .00 18. .87 B N
ATOM 3241 CA PRO B 125 -5. .577 -19. .377 3. .443 1. .00 19. .02 B c
ATOM 3242 CB PRO B 125 -6. .169 -19. .403 4. .854 1. .00 19. .23 B c
ATOM 3243 CG PRO B 125 -4. .980 -19. .587 5. .754 1. .00 19. .46 B c
ATOM 3244 CD PRO B 125 -3. .825 -18. .905 5. .077 1. .00 19. .29 B c
ATOM 3245 C PRO B 125 -6. .356 -18. .467 2. .510 1. .00 19. .07 B c
ATOM 3246 o PRO B 125 -6. .278 -17. .247 2. .613 1. .00 18. .93 B o
ATOM 3247 N PHE B 126 -7. .105 -19. .080 1. .604 1. .00 18. .81 B N
ATOM 3248 CA PHE B 126 -7. .614 -18. .381 0. .437 1. .00 18. .56 B c
ATOM 3249 CB PHE B 126 -8. .131 -19. .385 -0. .604 1. .00 18. .49 B c
ATOM 3250 CG PHE B 126 -7. .064 -19. .911 -1. .508 1. .00 18. .66 B c
ATOM 3251 CDl PHE B 126 -6. .020 -20. .664 -1. .006 1. .00 19. .04 B c
ATOM 3252 CEl PHE B 126 -5. .020 -21. .148 -1. .831 1. .00 18. .97 B c
ATOM 3253 CZ PHE B 126 -5. .055 -20. .874 -3. .176 1. .00 19. .04 B c
ATOM 3254 CE2 PHE B 126 -6. .100 -20. .132 -3. .692 1. .00 18. .90 B c
ATOM 3255 CD 2 PHE B 126 -7. .098 -19. .653 -2. .860 1. .00 18. .72 B c
ATOM 3256 C PHE B 126 -8. .703 -17. .362 0. .755 1. .00 18. .62 B c
ATOM 3257 o PHE B 126 -9. .003 -16. .516 -0. .081 1. .00 19. .38 B o
ATOM 3258 N SER B 127 -9. .292 -17. .422 1. .945 1. .00 17. .97 B N
ATOM 3259 CA SER B 127 -10. .348 -16. .474 2. .291 1. .00 17. .25 B c
ATOM 3260 CB SER B 127 -11. .203 -17. .006 3. .427 1. .00 17. .21 B c
ATOM 3261 OG SER B 127 -10. .384 -17. .220 4. .554 1. .00 17. .32 B o
ATOM 3262 C SER B 127 -9. .808 -15. .133 2. .712 1. .00 16. .62 B c
ATOM 3263 o SER B 127 -10. .606 -14. .248 2. .963 1. .00 16. .39 B o
ATOM 3264 N ALA B 128 -8. .481 -14. .984 2. .782 1. .00 16. .07 B N
ATOM 3265 CA ALA B 128 -7. .847 -13. .752 3. .257 1. .00 15. .85 B c
ATOM 3266 CB ALA B 128 -6. .407 -14. .027 3. .600 1. .00 15. .64 B c
ATOM 3267 C ALA B 128 -7. .920 -12. .530 2. .315 1. .00 16. .85 B c
ATOM 3268 o ALA B 128 -7. .759 -11. .373 2. .775 1. .00 17. .34 B o
ATOM 3269 N ASP B 129 -8. .144 -12. .759 1. .019 1. .00 17. .61 B N
ATOM 3270 CA ASP B 129 -8. .243 -11. .666 0. .041 1. .00 17. .88 B c
ATOM 3271 CB ASP B 129 -7. .283 -11. .861 -1. .165 1. .00 18. .05 B c
ATOM 3272 CG ASP B 129 -7. .173 -10. .596 -2. .055 1. .00 19. .36 B c
ATOM 3273 ODl ASP B 129 -8. .206 -9. .927 -2. .291 1. .00 19. .57 B o
ATOM 3274 OD2 ASP B 129 -6. .063 -10. .247 -2. .541 1. .00 20. .33 B o
ATOM 3275 C ASP B 129 -9. .681 -11. .618 -0. .426 1. .00 17. .31 B c
ATOM 3276 o ASP B 129 -10. .152 -12. .569 -1. .029 1. .00 17. .85 B o
ATOM 3277 N PRO B 130 -10. .371 -10. .493 -0. .196 1. .00 17. .22 B N
ATOM 3278 CA PRO B 130 -11. .786 -10. .369 -0. .601 1. .00 17. .02 B c
ATOM 3279 CB PRO B 130 -12. .140 -8. .911 -0. .243 1. .00 16. .73 B c
ATOM 3280 CG PRO B 130 -11. .099 -8. .456 0. .723 1. .00 16. .71 B c
ATOM 3281 CD PRO B 130 -9. .855 -9. .235 0. .392 1. .00 17. .19 B c
ATOM 3282 C PRO B 130 -12. .074 -10. .631 -2. .085 1. .00 16. .62 B c
ATOM 3283 o PRO B 130 -13. .211 -10. .958 -2. .436 1. .00 15. .51 B o
ATOM 3284 N ASP B 131 -11. .072 -10. .485 -2. .948 1. .00 16. .98 B N
ATOM 3285 CA ASP B 131 -11. .310 -10. .688 -4. .384 1. .00 18. .29 B c
ATOM 3286 CB ASP B 131 -10. .235 -9. .999 -5. .283 1. .00 19. .03 B c
ATOM 3287 CG ASP B 131 -8. .835 -10. .602 -5. .142 1. .00 19. .39 B c
ATOM 3288 ODl ASP B 131 -8. .691 -11. .825 -5. .259 1. .00 19. .96 B o
ATOM 3289 OD2 ASP B 131 -7. .859 -9. .851 -4. .923 1. .00 20. .07 B o
ATOM 3290 C ASP B 131 -11. .495 -12. .177 -4. .702 1. .00 19. .01 B c
ATOM 3291 o ASP B 131 -12. .097 -12. .542 -5. .721 1. .00 17. .48 B o
ATOM 3292 N VAL B 132 -10. .995 -13. .028 -3. .804 1. .00 19. .89 B N
ATOM 3293 CA VAL B 132 -11. .221 -14. .456 -3. .922 1. .00 21. .16 B c
ATOM 3294 CB VAL B 132 -10. .333 -15. .232 -2. .948 1. .00 22. .10 B c
ATOM 3295 CGl VAL B 132 -10. .779 -16. .695 -2. .865 1. .00 22. .23 B c
ATOM 3296 CG2 VAL B 132 -8. .867 -15. .110 -3. .357 1. .00 22. .87 B c
ATOM 3297 C VAL B 132 -12. .683 -14. .825 -3. .651 1. .00 21. .46 B c
ATOM 3298 o VAL B 132 -13. .300 -15. .590 -4. .402 1. .00 20. .31 B o
ATOM 3299 N ILE B 133 -13. .220 -14. .282 -2. .562 1. .00 21. .93 B N
ATOM 3300 CA ILE B 133 -14. .609 -14. .519 -2. .215 1. .00 21. .56 B c
ATOM 3301 CB ILE B 133 -15. .025 -13. .773 -0. .956 1. .00 21. .14 B c
ATOM 3302 CGl ILE B 133 -14. .046 -14. .023 0. .199 1. .00 22. .31 B c
ATOM 3303 CDl ILE B 133 -13. .855 -15. .454 0. .620 1. .00 22. .87 B c
ATOM 3304 CG2 ILE B 133 -16. .455 -14. .105 -0. .599 1. .00 20. .64 B c
ATOM 3305 C ILE B 133 -15. .465 -13. .987 -3. .346 1. .00 22. .51 B c
ATOM 3306 o ILE B 133 -16..421 -14..642 -3..763 1..00 24..23 B o
ATOM 3307 N GLY B 134 -15. .108 -12. .798 -3. .844 1. .00 22. .08 B N
ATOM 3308 CA GLY B 134 -15. .828 -12. .177 -4. .929 1. .00 21. .41 B C
ATOM 3309 C GLY B 134 -15. .719 -13. .033 -6. .162 1. .00 22. .33 B C
ATOM 3310 o GLY B 134 -16. .690 -13. .223 -6. .891 1. .00 23. .18 B o
ATOM 3311 N HIS B 135 -14. .528 -13. .569 -6. .390 1. .00 23. .11 B N
ATOM 3312 CA HIS B 135 -14. .280 -14. .385 -7. .573 1. .00 23. .08 B c
ATOM 3313 CB HIS B 135 -12. .829 -14. .804 -7. .601 1. .00 21. .45 B c
ATOM 3314 CG HIS B 135 -12. .442 -15. .596 -8. .804 1. .00 20. .35 B c
ATOM 3315 NDl HIS B 135 -12. .056 -15. .007 -9. .982 1. .00 19. .67 B N
ATOM 3316 CEl HIS B 135 -11. .717 -15. .942 -10. .847 1. .00 19. .76 B c
ATOM 3317 NE2 HIS B 135 -11. .876 -17. .120 -10. .274 1. .00 19. .91 B N
ATOM 3318 CD 2 HIS B 135 -12. .317 -16. .930 -8. .991 1. .00 20. .18 B C
ATOM 3319 C HIS B 135 -15. .164 -15. .628 -7. .593 1. .00 25. .10 B c
ATOM 3320 o HIS B 135 -15. .726 -15. .994 -8. .651 1. .00 27. .12 B o
ATOM 3321 N GLU B 136 -15. .295 -16. .272 -6. .436 1. .00 25. .03 B N
ATOM 3322 CA GLU B 136 -16. .004 -17. .549 -6. .379 1. .00 25. .06 B c
ATOM 3323 CB GLU B 136 -15. .518 -18. .377 -5. .191 1. .00 24. .35 B c
ATOM 3324 CG GLU B 136 -14. .098 -18. .882 -5. .369 1. .00 24. .50 B c
ATOM 3325 CD GLU B 136 -13. .846 -19. .503 -6. .744 1. .00 25. .78 B c
ATOM 3326 OEl GLU B 136 -12. .713 -19. .404 -7. .229 1. .00 29. .10 B o
ATOM 3327 OE2 GLU B 136 -14. .753 -20. .096 -7. .371 1. .00 25. .51 B o
ATOM 3328 C GLU B 136 -17. .519 -17. .378 -6. .375 1. .00 25. .55 B c
ATOM 3329 o GLU B 136 -18. .227 -18. .100 -7. .086 1. .00 23. .74 B o
ATOM 3330 N LEU B 137 -17. .993 -16. .404 -5. .594 1. .00 26. .39 B N
ATOM 3331 CA LEU B 137 -19. .406 -16. .077 -5. .519 1. .00 26. .59 B c
ATOM 3332 CB LEU B 137 -19. .572 -14. .815 -4. .694 1. .00 27. .82 B c
ATOM 3333 CG LEU B 137 -20. .822 -14. .488 -3. .869 1. .00 29. .11 B c
ATOM 3334 CDl LEU B 137 -22. .031 -14. .318 -4. .757 1. .00 30. .30 B c
ATOM 3335 CD 2 LEU B 137 -21. .094 -15. .501 -2. .771 1. .00 30. .20 B c
ATOM 3336 C LEU B 137 -19. .893 -15. .841 -6. .930 1. .00 28. .03 B c
ATOM 3337 o LEU B 137 -20. .952 -16. .353 -7. .334 1. .00 29. .88 B o
ATOM 3338 N THR B 138 -19. .098 -15. .068 -7. .677 1. .00 28. .04 B N
ATOM 3339 CA THR B 138 -19. .400 -14. .703 -9. .054 1. .00 27. .52 B c
ATOM 3340 CB THR B 138 -18. .403 -13. .654 -9. .578 1. .00 27. .58 B c
ATOM 3341 OGl THR B 138 -18. .419 -12. .512 -8. .720 1. .00 25. .48 B o
ATOM 3342 CG2 THR B 138 -18. .744 -13. .228 -11. .013 1. .00 27. .35 B c
ATOM 3343 C THR B 138 -19. .371 -15. .928 -9. .967 1. .00 28. .01 B c
ATOM 3344 o THR B 138 -20. .163 -16. .016 -10. .896 1. .00 29. .23 B o
ATOM 3345 N HIS B 139 -18. .472 -16. .881 -9. .715 1. .00 28. .67 B N
ATOM 3346 CA HIS B 139 -18. .529 -18. .184 -10. .421 1. .00 27. .39 B c
ATOM 3347 CB HIS B 139 -17. .532 -19. .196 -9. .824 1. .00 26. .16 B c
ATOM 3348 CG HIS B 139 -16. .138 -19. .145 -10. .411 1. .00 25. .53 B c
ATOM 3349 NDl HIS B 139 -15. .900 -19. .058 -11. .764 1. .00 25. .15 B N
ATOM 3350 CEl HIS B 139 -14. .595 -19. .065 -11. .988 1. .00 24. .31 B c
ATOM 3351 NE2 HIS B 139 -13. .974 -19. .181 -10. .830 1. .00 24. .44 B N
ATOM 3352 CD 2 HIS B 139 -14. .915 -19. .249 -9. .829 1. .00 24. .67 B C
ATOM 3353 C HIS B 139 -19. .987 -18. .721 -10. .357 1. .00 28. .40 B c
ATOM 3354 o HIS B 139 -20. .511 -19. .275 -11. .337 1. .00 27. .07 B o
ATOM 3355 N GLY B 140 -20. .640 -18. .506 -9. .209 1. .00 29. .45 B N
ATOM 3356 CA GLY B 140 -22. .074 -18. .781 -9. .033 1. .00 30. .38 B c
ATOM 3357 C GLY B 140 -23. .047 -17. .934 -9. .872 1. .00 31. .74 B c
ATOM 3358 o GLY B 140 -23. .870 -18. .491 -10. .622 1. .00 32. .56 B o
ATOM 3359 N VAL B 141 -22. .982 -16. .605 -9. .742 1. .00 30. .73 B N
ATOM 3360 CA VAL B 141 -23. .765 -15. .712 -10. .609 1. .00 30. .84 B c
ATOM 3361 CB VAL B 141 -23. .302 -14. .229 -10. .488 1. .00 30. .98 B c
ATOM 3362 CGl VAL B 141 -24. .079 -13. .307 -11. .417 1. .00 30. .38 B c
ATOM 3363 CG2 VAL B 141 -23. .418 -13. .731 -9. .059 1. .00 33. .19 B c
ATOM 3364 C VAL B 141 -23. .653 -16. .184 -12. .087 1. .00 32. .64 B c
ATOM 3365 o VAL B 141 -24. .680 -16. .395 -12. .764 1. .00 34. .17 B o
ATOM 3366 N THR B 142 -22. .425 -16. .371 -12. .584 1. .00 30. .57 B N
ATOM 3367 CA THR B 142 -22. .238 -16. .711 -13. .978 1. .00 30. .33 B c
ATOM 3368 CB THR B 142 -20. .747 -16. .814 -14. .342 1. .00 28. .78 B c
ATOM 3369 OGl THR B 142 -20. .107 -15. .548 -14. .169 1. .00 28. .27 B o
ATOM 3370 CG2 THR B 142 -20. .562 -17. .241 -15. .778 1. .00 28. .27 B c
ATOM 3371 C THR B 142 -23. .018 -18. .012 -14. .321 1. .00 34. .44 B c
ATOM 3372 o THR B 142 -23. .756 -18. .043 -15. .311 1. .00 31. .77 B o
ATOM 3373 N GLU B 143 -22. .891 -19. .058 -13. .496 1. .00 39. .28 B N
ATOM 3374 CA GLU B 143 -23. .609 -20. .331 -13. .746 1. .00 44. .10 B c
ATOM 3375 CB GLU B 143 -23. .199 -21. .447 -12. .749 1. .00 46. .26 B c
ATOM 3376 CG GLU B 143 -23. .758 -22. .829 -13. .098 1. .00 46. .77 B c
ATOM 3377 CD GLU B 143 -23. .520 -23. .911 -12. .036 1. .00 50. .51 B c
ATOM 3378 OEl GLU B 143 -24. .476 -24. .652 -11. .712 1. .00 52. .85 B o
ATOM 3379 OE2 GLU B 143 -22. .388 -24. .056 -11. .531 1. .00 51. .61 B o
ATOM 3380 C GLU B 143 -25. .141 -20. .147 -13. .737 1. .00 43. .41 B c
ATOM 3381 o GLU B 143 -25. .837 -20. .722 -14. .579 1. .00 42. .45 B o
ATOM 3382 N HIS B 144 -25. .657 -19. .350 -12. .803 1. .00 41. .46 B N
ATOM 3383 CA HIS B 144 -27. .095 -19. .050 -12. .768 1. .00 42. .89 B c
ATOM 3384 CB HIS B 144 -27. .500 -18. .615 -11. .363 1. .00 43. .93 B c
ATOM 3385 CG HIS B 144 -27..711 -19.748 -10..415 1..00 48..17 B C
ATOM 3386 NDl HIS B 144 -26. .683 -20. 562 -9. .985 1. .00 53. .25 B N
ATOM 3387 CEl HIS B 144 -27. .156 -21. 457 -9. .134 1. .00 53. .12 B C
ATOM 3388 NE2 HIS B 144 -28. .453 -21. 245 -8. .991 1. .00 52. .99 B N
ATOM 3389 CD 2 HIS B 144 -28. .827 -20. 187 -9. .787 1. .00 49. .42 B C
ATOM 3390 C HIS B 144 -27. .596 -17. 985 -13. .790 1. .00 41. .27 B C
ATOM 3391 o HIS B 144 -28. .773 -17. 664 -13. .803 1. .00 41. .71 B o
ATOM 3392 N THR B 145 -26. .729 -17. 451 -14. .646 1. .00 39. .46 B N
ATOM 3393 CA THR B 145 -27. .124 -16. 412 -15. .614 1. .00 37. .58 B c
ATOM 3394 CB THR B 145 -26. .559 -15. 013 -15. .211 1. .00 39. .34 B c
ATOM 3395 OGl THR B 145 -25. .127 -15. 071 -15. .027 1. .00 36. .83 B o
ATOM 3396 CG2 THR B 145 -27. .213 -14. 517 -13. .918 1. .00 39. .08 B c
ATOM 3397 C THR B 145 -26. .685 -16. 769 -17. .042 1. .00 34. .70 B c
ATOM 3398 o THR B 145 -27. .380 -17. 459 -17. .750 1. .00 36. .43 B o
ATOM 3399 N ALA B 146 -25. .523 -16. 305 -17. .455 1. .00 33. .64 B N
ATOM 3400 CA ALA B 146 -25. .006 -16. 605 -18. .769 1. .00 33. .70 B c
ATOM 3401 CB ALA B 146 -23. .739 -15. 803 -19. .000 1. .00 33. .49 B c
ATOM 3402 C ALA B 146 -24. .709 -18. 100 -18. .948 1. .00 34. .85 B c
ATOM 3403 o ALA B 146 -24. .835 -18. 639 -20. .052 1. .00 36. .76 B o
ATOM 3404 N GLY B 147 -24. .277 -18. 752 -17. .873 1. .00 33. .97 B N
ATOM 3405 CA GLY B 147 -23. .841 -20. 144 -17. .930 1. .00 32. .43 B c
ATOM 3406 C GLY B 147 -22. .627 -20. 388 -18. .804 1. .00 31. .88 B c
ATOM 3407 o GLY B 147 -22. .585 -21. 373 -19. .541 1. .00 32. .47 B o
ATOM 3408 N LEU B 148 -21. .632 -19. 506 -18. .744 1. .00 32. .61 B N
ATOM 3409 CA LEU B 148 -20. .451 -19. 658 -19. .605 1. .00 33. .79 B c
ATOM 3410 CB LEU B 148 -19. .475 -18. 492 -19. .444 1. .00 35. .60 B c
ATOM 3411 CG LEU B 148 -19. .982 -17. 190 -20. .083 1. .00 38. .31 B c
ATOM 3412 CDl LEU B 148 -19. .402 -15. 964 -19. .399 1. .00 37. .11 B c
ATOM 3413 CD 2 LEU B 148 -19. .694 -17. 157 -21. .585 1. .00 40. .39 B c
ATOM 3414 C LEU B 148 -19. .783 -20. 967 -19. .246 1. .00 32. .00 B c
ATOM 3415 o LEU B 148 -19. .587 -21. 241 -18. .078 1. .00 29. .10 B o
ATOM 3416 N GLU B 149 -19. .474 -21. 789 -20. .246 1. .00 31. .33 B N
ATOM 3417 CA GLU B 149 -18. .940 -23. 146 -19. .978 1. .00 29. .16 B c
ATOM 3418 CB GLU B 149 -19. .192 -24. 108 -21. .161 1. .00 27. .96 B c
ATOM 3419 CG GLU B 149 -20. .666 -24. 425 -21. .298 1. .00 26. .85 B c
ATOM 3420 CD GLU B 149 -21. .026 -25. 095 -22. .589 1. .00 24. .90 B c
ATOM 3421 OEl GLU B 149 -22. .188 -25. 536 -22. .681 1. .00 23. .70 B o
ATOM 3422 OE2 GLU B 149 -20. .181 -25. 161 -23. .493 1. .00 23. .35 B o
ATOM 3423 C GLU B 149 -17. .471 -23. 082 -19. .639 1. .00 25. .48 B c
ATOM 3424 o GLU B 149 -16. .708 -22. 371 -20. .273 1. .00 24. .06 B o
ATOM 3425 N TYR B 150 -17. .091 -23. 848 -18. .640 1. .00 23. .26 B N
ATOM 3426 CA TYR B 150 -15. .795 -23. 690 -18. .059 1. .00 23. .09 B c
ATOM 3427 CB TYR B 150 -15. .847 -24. 115 -16. .606 1. .00 22. .13 B c
ATOM 3428 CG TYR B 150 -14. .796 -23. 476 -15. .770 1. .00 22. .41 B c
ATOM 3429 CDl TYR B 150 -14. .899 -22. 133 -15. .406 1. .00 22. .39 B c
ATOM 3430 CEl TYR B 150 -13. .920 -21. 529 -14. .620 1. .00 22. .34 B c
ATOM 3431 CZ TYR B 150 -12. .828 -22. 277 -14. .176 1. .00 22. .55 B c
ATOM 3432 OH TYR B 150 -11. .884 -21. 671 -13. .406 1. .00 21. .97 B o
ATOM 3433 CE2 TYR B 150 -12. .697 -23. 623 -14. .518 1. .00 22. .68 B c
ATOM 3434 CD 2 TYR B 150 -13. .676 -24. 213 -15. .319 1. .00 22. .78 B c
ATOM 3435 C TYR B 150 -14. .760 -24. 462 -18. .871 1. .00 23. .03 B c
ATOM 3436 o TYR B 150 -14. .194 -25. 466 -18. .425 1. .00 25. .23 B o
ATOM 3437 N TYR B 151 -14. .522 -23. 970 -20. .075 1. .00 21. .89 B N
ATOM 3438 CA TYR B 151 -13. .540 -24. 533 -20. .963 1. .00 22. .19 B c
ATOM 3439 CB TYR B 151 -14. .012 -25. 873 -21. .514 1. .00 22. .84 B c
ATOM 3440 CG TYR B 151 -12. .869 -26. 737 -21. .992 1. .00 24. .39 B c
ATOM 3441 CDl TYR B 151 -12. .365 -26. 643 -23. .293 1. .00 24. .16 B c
ATOM 3442 CEl TYR B 151 -11. .298 -27. 439 -23. .704 1. .00 23. .84 B c
ATOM 3443 CZ TYR B 151 -10. .738 -28. 326 -22. .820 1. .00 24. .46 B c
ATOM 3444 OH TYR B 151 -9. .695 -29. 143 -23. .159 1. .00 26. .46 B o
ATOM 3445 CE2 TYR B 151 -11. .214 -28. 432 -21. .538 1. .00 25. .25 B c
ATOM 3446 CD 2 TYR B 151 -12. .263 -27. 640 -21. .125 1. .00 25. .13 B c
ATOM 3447 C TYR B 151 -13. .325 -23. 580 -22. .124 1. .00 22. .44 B c
ATOM 3448 o TYR B 151 -14. .227 -22. 838 -22. .485 1. .00 22. .50 B o
ATOM 3449 N GLY B 152 -12. .139 -23. 613 -22. .717 1. .00 23. .25 B N
ATOM 3450 CA GLY B 152 -11. .812 -22. 762 -23. .866 1. .00 24. .07 B c
ATOM 3451 C GLY B 152 -12. .135 -21. 280 -23. .685 1. .00 24. .84 B c
ATOM 3452 o GLY B 152 -12. .043 -20. 733 -22. .564 1. .00 25. .07 B o
ATOM 3453 N GLU B 153 -12. .539 -20. 635 -24. .787 1. .00 25. .04 B N
ATOM 3454 CA GLU B 153 -12. .871 -19. 202 -24. .766 1. .00 24. .00 B c
ATOM 3455 CB GLU B 153 -13. .149 -18. 678 -26. .183 1. .00 23. .45 B c
ATOM 3456 CG GLU B 153 -11. .936 -18. 864 -27. .107 1. .00 23. .71 B c
ATOM 3457 CD GLU B 153 -11. .913 -17. 978 -28. .361 1. .00 24. .91 B c
ATOM 3458 OEl GLU B 153 -12. .587 -16. 903 -28. .423 1. .00 24. .29 B o
ATOM 3459 OE2 GLU B 153 -11. .174 -18. 362 -29. .304 1. .00 24. .99 B o
ATOM 3460 C GLU B 153 -14. .005 -18. 909 -23. .771 1. .00 23. .93 B c
ATOM 3461 o GLU B 153 -13. .861 -18. 016 -22. .931 1. .00 23. .19 B o
ATOM 3462 N SER B 154 -15. .085 -19. 689 -23. .812 1. .00 23. .68 B N
ATOM 3463 CA SER B 154 -16. .128 -19. 584 -22. .790 1. .00 24. .55 B c
ATOM 3464 CB SER B 154 -16..967 -20.848 -22..696 1..00 25..82 B C
ATOM 3465 OG SER B 154 -18. .170 -20. 690 -23. .396 1. .00 29. .35 B o
ATOM 3466 C SER B 154 -15. .567 -19. 381 -21. .419 1. .00 24. .67 B C
ATOM 3467 o SER B 154 -15. .952 -18. 454 -20. .715 1. .00 26. .62 B o
ATOM 3468 N GLY B 155 -14. .688 -20. 288 -21. .023 1. .00 24. .28 B N
ATOM 3469 CA GLY B 155 -14. .237 -20. 370 -19. .635 1. .00 24. .21 B C
ATOM 3470 C GLY B 155 -13. .255 -19. 268 -19. .266 1. .00 24. .50 B C
ATOM 3471 o GLY B 155 -13. .162 -18. 878 -18. .081 1. .00 24. .34 B o
ATOM 3472 N ALA B 156 -12. .518 -18. 776 -20. .272 1. .00 22. .74 B N
ATOM 3473 CA ALA B 156 -11. .638 -17. 640 -20. .087 1. .00 21. .34 B c
ATOM 3474 CB ALA B 156 -10. .756 -17. 444 -21. .302 1. .00 21. .61 B c
ATOM 3475 C ALA B 156 -12. .447 -16. 379 -19. .758 1. .00 20. .58 B c
ATOM 3476 o ALA B 156 -12. .066 -15. 588 -18. .881 1. .00 19. .77 B o
ATOM 3477 N LEU B 157 -13. .573 -16. 213 -20. .435 1. .00 20. .76 B N
ATOM 3478 CA LEU B 157 -14. .554 -15. 186 -20. .067 1. .00 21. .15 B c
ATOM 3479 CB LEU B 157 -15. .696 -15. 131 -21. .091 1. .00 22. .03 B c
ATOM 3480 CG LEU B 157 -15. .537 -14. 290 -22. .373 1. .00 23. .05 B c
ATOM 3481 CDl LEU B 157 -14. .127 -14. 275 -22. .957 1. .00 23. .70 B c
ATOM 3482 CD 2 LEU B 157 -16. .520 -14. 776 -23. .429 1. .00 23. .26 B c
ATOM 3483 C LEU B 157 -15. .124 -15. 451 -18. .670 1. .00 20. .38 B c
ATOM 3484 o LEU B 157 -15. .166 -14. 576 -17. .837 1. .00 20. .58 B o
ATOM 3485 N ASN B 158 -15. .558 -16. 669 -18. .414 1. .00 20. .57 B N
ATOM 3486 CA ASN B 158 -16. .143 -17. 009 -17. .122 1. .00 20. .45 B c
ATOM 3487 CB ASN B 158 -16. .434 -18. 523 -17. .105 1. .00 19. .60 B c
ATOM 3488 CG ASN B 158 -16. .948 -19. 017 -15. .773 1. .00 18. .40 B c
ATOM 3489 ODl ASN B 158 -17. .952 -19. 699 -15. .705 1. .00 17. .09 B o
ATOM 3490 ND2 ASN B 158 -16. .260 -18. 667 -14. .711 1. .00 18. .42 B N
ATOM 3491 C ASN B 158 -15. .205 -16. 580 -15. .964 1. .00 21. .47 B c
ATOM 3492 o ASN B 158 -15. .643 -15. 988 -14. .948 1. .00 21. .75 B o
ATOM 3493 N GLU B 159 -13. .923 -16. 919 -16. .124 1. .00 21. .70 B N
ATOM 3494 CA GLU B 159 -12. .856 -16. 482 -15. .213 1. .00 21. .57 B c
ATOM 3495 CB GLU B 159 -11. .542 -17. 158 -15. .612 1. .00 20. .39 B c
ATOM 3496 CG GLU B 159 -11. .355 -18. 493 -14. .966 1. .00 20. .39 B c
ATOM 3497 CD GLU B 159 -11. .302 -18. 353 -13. .467 1. .00 21. .79 B c
ATOM 3498 OEl GLU B 159 -10. .430 -17. 542 -13. .054 1. .00 25. .14 B o
ATOM 3499 OE2 GLU B 159 -12. .105 -18. 981 -12. .712 1. .00 20. .07 B o
ATOM 3500 C GLU B 159 -12. .692 -14. 940 -15. .195 1. .00 23. .60 B c
ATOM 3501 o GLU B 159 -12. .857 -14. 289 -14. .147 1. .00 22. .28 B o
ATOM 3502 N SER B 160 -12. .393 -14. 354 -16. .360 1. .00 25. .08 B N
ATOM 3503 CA SER B 160 -12. .228 -12. 906 -16. .432 1. .00 26. .35 B c
ATOM 3504 CB SER B 160 -12. .121 -12. 385 -17. .864 1. .00 26. .83 B c
ATOM 3505 OG SER B 160 -11. .919 -10. 970 -17. .841 1. .00 27. .65 B o
ATOM 3506 C SER B 160 -13. .362 -12. 181 -15. .740 1. .00 26. .39 B c
ATOM 3507 o SER B 160 -13. .108 -11. 202 -15. .049 1. .00 27. .56 B o
ATOM 3508 N ILE B 161 -14. .602 -12. 640 -15. .906 1. .00 25. .59 B N
ATOM 3509 CA ILE B 161 -15. .716 -11. 934 -15. .265 1. .00 25. .62 B c
ATOM 3510 CB ILE B 161 -17. .102 -12. 304 -15. .858 1. .00 25. .50 B c
ATOM 3511 CGl ILE B 161 -17. .410 -11. 343 -17. .010 1. .00 26. .10 B c
ATOM 3512 CDl ILE B 161 -18. .251 -11. 934 -18. .118 1. .00 26. .54 B c
ATOM 3513 CG2 ILE B 161 -18. .232 -12. 168 -14. .845 1. .00 25. .32 B c
ATOM 3514 C ILE B 161 -15. .633 -12. 060 -13. .752 1. .00 24. .63 B c
ATOM 3515 o ILE B 161 -15. .751 -11. 057 -13. .032 1. .00 25. .26 B o
ATOM 3516 N SER B 162 -15. .393 -13. 268 -13. .277 1. .00 22. .63 B N
ATOM 3517 CA SER B 162 -15. .191 -13. 452 -11. .859 1. .00 22. .29 B c
ATOM 3518 CB SER B 162 -14. .971 -14. 944 -11. .505 1. .00 22. .14 B c
ATOM 3519 OG SER B 162 -16. .160 -15. 704 -11. .695 1. .00 22. .68 B o
ATOM 3520 C SER B 162 -14. .026 -12. 561 -11. .365 1. .00 21. .42 B c
ATOM 3521 o SER B 162 -14. .094 -12. 053 -10. .261 1. .00 22. .43 B o
ATOM 3522 N ASP B 163 -12. .974 -12. 365 -12. .159 1. .00 20. .02 B N
ATOM 3523 CA ASP B 163 -11. .870 -11. 480 -11. .757 1. .00 20. .14 B c
ATOM 3524 CB ASP B 163 -10. .676 -11. 584 -12. .721 1. .00 19. .49 B c
ATOM 3525 CG ASP B 163 -9. .815 -12. 793 -12. .467 1. .00 18. .52 B c
ATOM 3526 ODl ASP B 163 -10. .121 -13. 559 -11. .555 1. .00 18. .96 B o
ATOM 3527 OD2 ASP B 163 -8. .819 -12. 979 -13. .170 1. .00 17. .18 B o
ATOM 3528 C ASP B 163 -12. .306 -10. Oil -11. .726 1. .00 21. .75 B c
ATOM 3529 o ASP B 163 -11. .987 -9. 257 -10. .797 1. .00 22. .65 B o
ATOM 3530 N ILE B 164 -13. .027 -9. 594 -12. .758 1. .00 22. .58 B N
ATOM 3531 CA ILE B 164 -13. .462 -8. 207 -12. .857 1. .00 22. .48 B c
ATOM 3532 CB ILE B 164 -14. .299 -7. 988 -14. .114 1. .00 22. .54 B c
ATOM 3533 CGl ILE B 164 -13. .386 -8. 005 -15. .345 1. .00 23. .45 B c
ATOM 3534 CDl ILE B 164 -14. .066 -8. 416 -16. .632 1. .00 23. .65 B c
ATOM 3535 CG2 ILE B 164 -15. .030 -6. 663 -14. .047 1. .00 21. .95 B c
ATOM 3536 C ILE B 164 -14. .258 -7. 827 -11. .634 1. .00 22. .72 B c
ATOM 3537 o ILE B 164 -14. .064 -6. 750 -11. .049 1. .00 23. .59 B o
ATOM 3538 N ILE B 165 -15. .145 -8. 718 -11. .229 1. .00 23. .05 B N
ATOM 3539 CA ILE B 165 -16. .010 -8. 405 -10. .127 1. .00 23. .88 B c
ATOM 3540 CB ILE B 165 -17. .296 -9. 240 -10. .153 1. .00 25. .46 B c
ATOM 3541 CGl ILE B 165 -18. .236 -8. 725 -11. .258 1. .00 25. .84 B c
ATOM 3542 CDl ILE B 165 -19. .692 -9. 093 -11. .047 1. .00 25. .86 B c
ATOM 3543 CG2 ILE B 165 -17..987 -9..179 -8..793 1..00 26..66 B C
ATOM 3544 C ILE B 165 -15. .281 -8. .569 -8. .814 1. .00 23. .03 B C
ATOM 3545 o ILE B 165 -15. .446 -7. .770 -7. .914 1. .00 23. .61 B o
ATOM 3546 N GLY B 166 -14. .475 -9. .601 -8. .693 1. .00 22. .77 B N
ATOM 3547 CA GLY B 166 -13. .811 -9. .838 -7. .437 1. .00 23. .61 B C
ATOM 3548 C GLY B 166 -12. .910 -8. .666 -7. .100 1. .00 24. .48 B C
ATOM 3549 o GLY B 166 -12. .834 -8. .213 -5. .949 1. .00 24. .77 B o
ATOM 3550 N ASN B 167 -12. .218 -8. .185 -8. .122 1. .00 24. .92 B N
ATOM 3551 CA ASN B 167 -11. .332 -7. .061 -7. .974 1. .00 25. .37 B c
ATOM 3552 CB ASN B 167 -10. .538 -6. .834 -9. .250 1. .00 25. .09 B c
ATOM 3553 CG ASN B 167 -9. .722 -5. .578 -9. .179 1. .00 24. .84 B c
ATOM 3554 ODl ASN B 167 -8. .663 -5. .557 -8. .554 1. .00 24. .32 B o
ATOM 3555 ND2 ASN B 167 -10. .223 -4. .509 -9. .792 1. .00 25. .27 B N
ATOM 3556 C ASN B 167 -12. .098 -5. .789 -7. .648 1. .00 25. .52 B c
ATOM 3557 o ASN B 167 -11. .629 -4. .960 -6. .876 1. .00 27. .09 B o
ATOM 3558 N ALA B 168 -13. .262 -5. .636 -8. .258 1. .00 25. .33 B N
ATOM 3559 CA ALA B 168 -14. .077 -4. .456 -8. .054 1. .00 26. .46 B c
ATOM 3560 CB ALA B 168 -15. .209 -4. .423 -9. .078 1. .00 26. .58 B c
ATOM 3561 C ALA B 168 -14. .627 -4. .372 -6. .633 1. .00 27. .05 B c
ATOM 3562 o ALA B 168 -14. .769 -3. .305 -6. .099 1. .00 25. .94 B o
ATOM 3563 N ILE B 169 -14. .948 -5. .496 -6. .021 1. .00 30. .59 B N
ATOM 3564 CA ILE B 169 -15. .426 -5. .488 -4. .640 1. .00 34. .83 B c
ATOM 3565 CB ILE B 169 -15. .783 -6. .925 -4. .196 1. .00 37. .29 B c
ATOM 3566 CGl ILE B 169 -17. .197 -7. .244 -4. .697 1. .00 40. .64 B c
ATOM 3567 CDl ILE B 169 -17. .388 -8. .660 -5. .177 1. .00 41. .49 B c
ATOM 3568 CG2 ILE B 169 -15. .710 -7. .094 -2. .681 1. .00 36. .37 B c
ATOM 3569 C ILE B 169 -14. .388 -4. .882 -3. .715 1. .00 36. .99 B c
ATOM 3570 o ILE B 169 -14. .662 -3. .984 -2. .918 1. .00 33. .86 B o
ATOM 3571 N ASP B 170 -13. .186 -5. .413 -3. .841 1. .00 43. .53 B N
ATOM 3572 CA ASP B 170 -12. .072 -5. .011 -3. .016 1. .00 48. .08 B c
ATOM 3573 CB ASP B 170 -10. .814 -5. .803 -3. .463 1. .00 51. .67 B c
ATOM 3574 CG ASP B 170 -9. .755 -5. .980 -2. .344 1. .00 52. .92 B c
ATOM 3575 ODl ASP B 170 -9. .729 -5. .192 -1. .351 1. .00 50. .54 B o
ATOM 3576 OD2 ASP B 170 -8. .931 -6. .919 -2. .499 1. .00 50. .26 B o
ATOM 3577 C ASP B 170 -11. .919 -3. .483 -3. .142 1. .00 44. .26 B c
ATOM 3578 o ASP B 170 -12. .078 -2. .785 -2. .164 1. .00 43. .51 B o
ATOM 3579 N GLY B 171 -11. .672 -2. .990 -4. .358 1. .00 43. .91 B N
ATOM 3580 CA GLY B 171 -11. .467 -1. .557 -4. .634 1. .00 44. .24 B c
ATOM 3581 C GLY B 171 -10. .003 -1. .160 -4. .820 1. .00 44. .95 B c
ATOM 3582 o GLY B 171 -9. .634 -0. .569 -5. .831 1. .00 43. .83 B o
ATOM 3583 N LYS B 172 -9. .194 -1. .498 -3. .815 1. .00 46. .20 B N
ATOM 3584 CA LYS B 172 -7. .749 -1. .197 -3. .709 1. .00 46. .62 B c
ATOM 3585 CB LYS B 172 -7. .096 -2. .285 -2. .836 1. .00 52. .15 B c
ATOM 3586 CG LYS B 172 -7. .272 -2. .161 -1. .319 1. .00 57. .60 B c
ATOM 3587 CD LYS B 172 -6. .481 -3. .256 -0. .557 1. .00 62. .15 B c
ATOM 3588 CE LYS B 172 -4. .946 -3. .091 -0. .575 1. .00 60. .28 B c
ATOM 3589 NZ LYS B 172 -4. .444 -1. .991 0. .304 1. .00 61. .46 B N
ATOM 3590 C LYS B 172 -6. .850 -1. .027 -4. .980 1. .00 42. .61 B c
ATOM 3591 o LYS B 172 -6. .188 -0. .001 -5. .125 1. .00 42. .17 B o
ATOM 3592 N ASN B 173 -6. .769 -2. .039 -5. .854 1. .00 36. .61 B N
ATOM 3593 CA ASN B 173 -5. .709 -2. .089 -6. .899 1. .00 30. .24 B c
ATOM 3594 CB ASN B 173 -4. .433 -2. .744 -6. .350 1. .00 28. .81 B c
ATOM 3595 CG ASN B 173 -4. .692 -4. .072 -5. .650 1. .00 29. .12 B c
ATOM 3596 ODl ASN B 173 -5. .413 -4. .949 -6. .145 1. .00 30. .32 B o
ATOM 3597 ND2 ASN B 173 -4. .092 -4. .228 -4. .481 1. .00 28. .75 B N
ATOM 3598 C ASN B 173 -6. .168 -2. .796 -8. .164 1. .00 26. .96 B c
ATOM 3599 o ASN B 173 -7. .342 -3. .036 -8. .324 1. .00 24. .81 B o
ATOM 3600 N TRP B 174 -5. .241 -3. .078 -9. .070 1. .00 25. .49 B N
ATOM 3601 CA TRP B 174 -5. .513 -3. .837 -10. .283 1. .00 25. .26 B c
ATOM 3602 CB TRP B 174 -4. .795 -3. .193 -11. .470 1. .00 25. .93 B c
ATOM 3603 CG TRP B 174 -5. .293 -1. .836 -11. .778 1. .00 26. .89 B c
ATOM 3604 CDl TRP B 174 -4. .593 -0. .665 -11. .679 1. .00 26. .32 B c
ATOM 3605 NEl TRP B 174 -5. .397 0. .382 -12. .017 1. .00 26. .11 B N
ATOM 3606 CE2 TRP B 174 -6. .637 -0. .087 -12. .361 1. .00 26. .19 B c
ATOM 3607 CD 2 TRP B 174 -6. .607 -1. .487 -12. .217 1. .00 26. .18 B c
ATOM 3608 CE3 TRP B 174 -7. .761 -2. .215 -12. .487 1. .00 26. .75 B c
ATOM 3609 CZ3 TRP B 174 -8. .904 -1. .520 -12. .907 1. .00 28. .43 B c
ATOM 3610 CH2 TRP B 174 -8. .895 -0. .122 -13. .051 1. .00 26. .84 B c
ATOM 3611 CZ2 TRP B 174 -7. .777 0. .606 -12. .787 1. .00 26. .52 B c
ATOM 3612 C TRP B 174 -5. .052 -5. .296 -10. .209 1. .00 24. .68 B c
ATOM 3613 o TRP B 174 -4. .843 -5. .937 -11. .257 1. .00 24. .26 B o
ATOM 3614 N LEU B 175 -4. .878 -5. .827 -9. .001 1. .00 22. .75 B N
ATOM 3615 CA LEU B 175 -4. .318 -7. .160 -8. .859 1. .00 21. .88 B c
ATOM 3616 CB LEU B 175 -3. .150 -7. .131 -7. .894 1. .00 20. .46 B c
ATOM 3617 CG LEU B 175 -2. .144 -5. .994 -8. .090 1. .00 19. .93 B c
ATOM 3618 CDl LEU B 175 -1. .194 -5. .955 -6. .916 1. .00 20. .20 B c
ATOM 3619 CD 2 LEU B 175 -1. .336 -6. .095 -9. .364 1. .00 19. .56 B c
ATOM 3620 C LEU B 175 -5. .389 -8. .154 -8. .417 1. .00 22. .98 B c
ATOM 3621 o LEU B 175 -6. .489 -7. .765 -8. .000 1. .00 23. .17 B o
ATOM 3622 N ILE B 176 -5..065 -9..439 -8..541 1..00 24..28 B N
ATOM 3623 CA ILE B 176 -5. .893 -10. .524 -7. .968 1. .00 24. .99 B C
ATOM 3624 CB ILE B 176 -6. .531 -11. .412 -9. .059 1. .00 26. .10 B C
ATOM 3625 CGl ILE B 176 -7. .357 -10. .570 -10. .055 1. .00 26. .43 B c
ATOM 3626 CDl ILE B 176 -8. .802 -10. .335 -9. .660 1. .00 26. .54 B c
ATOM 3627 CG2 ILE B 176 -7. .375 -12. .507 -8. .413 1. .00 26. .92 B c
ATOM 3628 C ILE B 176 -5. .044 -11. .412 -7. .040 1. .00 23. .20 B c
ATOM 3629 o ILE B 176 -3. .889 -11. .741 -7. .341 1. .00 21. .47 B o
ATOM 3630 N GLY B 177 -5. .620 -11. .773 -5. .902 1. .00 22. .18 B N
ATOM 3631 CA GLY B 177 -4. .925 -12. .603 -4. .925 1. .00 21. .76 B c
ATOM 3632 C GLY B 177 -3. .641 -11. .978 -4. .396 1. .00 20. .91 B c
ATOM 3633 o GLY B 177 -2. .768 -12. .680 -3. .908 1. .00 19. .00 B o
ATOM 3634 N ASP B 178 -3. .528 -10. .652 -4. .488 1. .00 21. .50 B N
ATOM 3635 CA ASP B 178 -2. .352 -9. .928 -3. .952 1. .00 20. .88 B c
ATOM 3636 CB ASP B 178 -2. .447 -8. .386 -4. .153 1. .00 20. .48 B c
ATOM 3637 CG ASP B 178 -3. .764 -7. .757 -3. .622 1. .00 20. .78 B c
ATOM 3638 ODl ASP B 178 -4. .882 -8. .233 -3. .951 1. .00 21. .09 B o
ATOM 3639 OD2 ASP B 178 -3. .680 -6. .747 -2. .891 1. .00 20. .74 B o
ATOM 3640 C ASP B 178 -2. .109 -10. .303 -2. .482 1. .00 20. .38 B c
ATOM 3641 o ASP B 178 -0. .951 -10. .556 -2. .090 1. .00 21. .24 B o
ATOM 3642 N LEU B 179 -3. .198 -10. .400 -1. .711 1. .00 18. .74 B N
ATOM 3643 CA LEU B 179 -3. .130 -10. .728 -0. .287 1. .00 18. .78 B c
ATOM 3644 CB LEU B 179 -4. .449 -10. .345 0. .395 1. .00 18. .48 B c
ATOM 3645 CG LEU B 179 -4. .697 -8. .834 0. .495 1. .00 18. .11 B c
ATOM 3646 CDl LEU B 179 -5. .946 -8. .555 1. .305 1. .00 17. .54 B c
ATOM 3647 CD 2 LEU B 179 -3. .488 -8. .118 1. .091 1. .00 17. .78 B c
ATOM 3648 C LEU B 179 -2. .776 -12. .178 0. .103 1. .00 18. .56 B c
ATOM 3649 o LEU B 179 -2. .211 -12. .399 1. .176 1. .00 20. .52 B o
ATOM 3650 N ILE B 180 -3. .101 -13. .155 -0. .735 1. .00 17. .63 B N
ATOM 3651 CA ILE B 180 -2. .873 -14. .586 -0. .399 1. .00 17. .04 B c
ATOM 3652 CB ILE B 180 -4. .068 -15. .475 -0. .767 1. .00 15. .77 B c
ATOM 3653 CGl ILE B 180 -4. .340 -15. .399 -2. .264 1. .00 15. .25 B c
ATOM 3654 CDl ILE B 180 -5. .519 -16. .216 -2. .719 1. .00 15. .28 B c
ATOM 3655 CG2 ILE B 180 -5. .267 -15. .102 0. .092 1. .00 15. .84 B c
ATOM 3656 C ILE B 180 -1. .628 -15. .229 -1. .033 1. .00 17. .27 B c
ATOM 3657 o ILE B 180 -1. .215 -16. .305 -0. .630 1. .00 16. .09 B o
ATOM 3658 N TYR B 181 -1. .032 -14. .546 -1. .996 1. .00 17. .64 B N
ATOM 3659 CA TYR B 181 -0. .004 -15. .128 -2. .796 1. .00 18. .26 B c
ATOM 3660 CB TYR B 181 -0. .095 -14. .544 -4. .179 1. .00 17. .80 B c
ATOM 3661 CG TYR B 181 0. .789 -15. .211 -5. .177 1. .00 17. .24 B c
ATOM 3662 CDl TYR B 181 0. .678 -16. .565 -5. .429 1. .00 16. .90 B c
ATOM 3663 CEl TYR B 181 1. .461 -17. .182 -6. .364 1. .00 16. .27 B c
ATOM 3664 CZ TYR B 181 2. .349 -16. .457 -7. .064 1. .00 16. .18 B c
ATOM 3665 OH TYR B 181 3. .129 -17. .077 -7. .986 1. .00 16. .18 B o
ATOM 3666 CE2 TYR B 181 2. .477 -15. .117 -6. .853 1. .00 16. .98 B c
ATOM 3667 CD 2 TYR B 181 1. .693 -14. .495 -5. .905 1. .00 16. .99 B c
ATOM 3668 C TYR B 181 1. .357 -14. .831 -2. .207 1. .00 20. .02 B c
ATOM 3669 o TYR B 181 1. .564 -13. .757 -1. .650 1. .00 20. .40 B o
ATOM 3670 N THR B 182 2. .255 -15. .812 -2. .327 1. .00 22. .26 B N
ATOM 3671 CA THR B 182 3. .651 -15. .730 -1. .896 1. .00 25. .08 B c
ATOM 3672 CB THR B 182 4. .512 -15. .160 -3. .027 1. .00 24. .99 B c
ATOM 3673 OGl THR B 182 3. .846 -14. .005 -3. .582 1. .00 24. .72 B o
ATOM 3674 CG2 THR B 182 4. .758 -16. .227 -4. .105 1. .00 24. .58 B c
ATOM 3675 C THR B 182 3. .832 -14. .850 -0. .671 1. .00 28. .60 B c
ATOM 3676 o THR B 182 4. .283 -13. .693 -0. .784 1. .00 30. .04 B o
ATOM 3677 N PRO B 183 3. .456 -15. .368 0. .504 1. .00 31. .17 B N
ATOM 3678 CA PRO B 183 3. .595 -14. .570 1. .747 1. .00 31. .48 B c
ATOM 3679 CB PRO B 183 3. .080 -15. .521 2. .843 1. .00 30. .90 B c
ATOM 3680 CG PRO B 183 3. .126 -16. .903 2. .223 1. .00 31. .55 B c
ATOM 3681 CD PRO B 183 2. .875 -16. .701 0. .756 1. .00 31. .17 B c
ATOM 3682 C PRO B 183 5. .033 -14. .084 2. .022 1. .00 29. .96 B c
ATOM 3683 o PRO B 183 5. .213 -13. .051 2. .626 1. .00 28. .64 B o
ATOM 3684 N ASN B 184 6. .034 -14. .795 1. .531 1. .00 31. .82 B N
ATOM 3685 CA ASN B 184 7. .418 -14. .330 1. .641 1. .00 34. .54 B c
ATOM 3686 CB ASN B 184 8. .349 -15. .531 1. .782 1. .00 37. .59 B c
ATOM 3687 CG ASN B 184 8. .493 -15. .958 3. .219 1. .00 40. .66 B c
ATOM 3688 ODl ASN B 184 7. .511 -16. .023 3. .964 1. .00 43. .19 B o
ATOM 3689 ND2 ASN B 184 9. .726 -16. .202 3. .637 1. .00 43. .92 B N
ATOM 3690 C ASN B 184 7. .932 -13. .407 0. .529 1. .00 33. .21 B c
ATOM 3691 o ASN B 184 9. .088 -13. .008 0. .557 1. .00 31. .64 B o
ATOM 3692 N THR B 185 7. .072 -13. .065 -0. .431 1. .00 32. .76 B N
ATOM 3693 CA THR B 185 7. .391 -12. .095 -1. .489 1. .00 29. .86 B c
ATOM 3694 CB THR B 185 7. .364 -12. .773 -2. .865 1. .00 28. .78 B c
ATOM 3695 OGl THR B 185 8. .096 -14. .008 -2. .838 1. .00 26. .37 B o
ATOM 3696 CG2 THR B 185 7. .922 -11. .871 -3. .926 1. .00 28. .45 B c
ATOM 3697 C THR B 185 6. .331 -10. .995 -1. .522 1. .00 30. .62 B c
ATOM 3698 o THR B 185 5. .205 -11. .248 -1. .957 1. .00 29. .21 B o
ATOM 3699 N PRO B 186 6. .666 -9. .783 -1. .033 1. .00 33. .29 B N
ATOM 3700 CA PRO B 186 5. .722 -8. .657 -1. .130 1. .00 32. .23 B c
ATOM 3701 CB PRO B 186 6..304 -7..611 -0..161 1..00 33..18 B C
ATOM 3702 CG PRO B 186 7. .766 -7. .921 -0. .084 1. .00 32. .85 B C
ATOM 3703 CD PRO B 186 7. .839 -9. .429 -0. .197 1. .00 34. .69 B C
ATOM 3704 C PRO B 186 5. .660 -8. .066 -2. .522 1. .00 30. .17 B C
ATOM 3705 o PRO B 186 6. .550 -8. .322 -3. .337 1. .00 28. .22 B o
ATOM 3706 N GLY B 187 4. .596 -7. .298 -2. .778 1. .00 28. .51 B N
ATOM 3707 CA GLY B 187 4. .409 -6. .578 -4. .045 1. .00 27. .51 B C
ATOM 3708 C GLY B 187 3. .834 -7. .367 -5. .220 1. .00 26. .61 B C
ATOM 3709 o GLY B 187 3. .282 -6. .772 -6. .151 1. .00 24. .33 B o
ATOM 3710 N ASP B 188 3. .956 -8. .702 -5. .198 1. .00 25. .58 B N
ATOM 3711 CA ASP B 188 3. .484 -9. .510 -6. .321 1. .00 23. .74 B c
ATOM 3712 CB ASP B 188 4. .340 -10. .765 -6. .539 1. .00 23. .72 B c
ATOM 3713 CG ASP B 188 4. .212 -11. .774 -5. .429 1. .00 24. .47 B c
ATOM 3714 ODl ASP B 188 3. .517 -11. .480 -4. .436 1. .00 26. .68 B o
ATOM 3715 OD2 ASP B 188 4. .805 -12. .876 -5. .549 1. .00 23. .28 B o
ATOM 3716 C ASP B 188 2. .006 -9. .823 -6. .175 1. .00 22. .61 B c
ATOM 3717 o ASP B 188 1. .335 -9. .343 -5. .259 1. .00 22. .22 B o
ATOM 3718 N ALA B 189 1. .502 -10. .584 -7. .135 1. .00 22. .07 B N
ATOM 3719 CA ALA B 189 0. .119 -10. .970 -7. .179 1. .00 21. .72 B c
ATOM 3720 CB ALA B 189 -0. .686 -9. .866 -7. .814 1. .00 21. .95 B c
ATOM 3721 C ALA B 189 -0. .063 -12. .285 -7. .949 1. .00 21. .99 B c
ATOM 3722 o ALA B 189 0. .894 -12. .860 -8. .477 1. .00 21. .72 B o
ATOM 3723 N LEU B 190 -1. .299 -12. .772 -7. .982 1. .00 22. .12 B N
ATOM 3724 CA LEU B 190 -1. .603 -14. .002 -8. .679 1. .00 22. .30 B c
ATOM 3725 CB LEU B 190 -2. .900 -14. .600 -8. .147 1. .00 21. .89 B c
ATOM 3726 CG LEU B 190 -3. .193 -16. .011 -8. .652 1. .00 21. .53 B c
ATOM 3727 CDl LEU B 190 -2. .019 -16. .923 -8. .379 1. .00 21. .51 B c
ATOM 3728 CD 2 LEU B 190 -4. .431 -16. .549 -7. .978 1. .00 22. .08 B c
ATOM 3729 C LEU B 190 -1. .723 -13. .721 -10. .171 1. .00 23. .63 B c
ATOM 3730 o LEU B 190 -1. .127 -14. .407 -11. .028 1. .00 23. .87 B o
ATOM 3731 N ARG B 191 -2. .521 -12. .709 -10. .474 1. .00 24. .40 B N
ATOM 3732 CA ARG B 191 -2. .519 -12. .133 -11. .801 1. .00 24. .81 B c
ATOM 3733 CB ARG B 191 -3. .435 -12. .925 -12. .755 1. .00 24. .95 B c
ATOM 3734 CG ARG B 191 -4. .751 -13. .372 -12. .166 1. .00 24. .69 B c
ATOM 3735 CD ARG B 191 -5. .454 -14. .478 -12. .961 1. .00 22. .98 B c
ATOM 3736 NE ARG B 191 -6. .713 -14. .712 -12. .268 1. .00 21. .71 B N
ATOM 3737 CZ ARG B 191 -6. .947 -15. .702 -11. .423 1. .00 22. .56 B c
ATOM 3738 NHl ARG B 191 -6. .055 -16. .663 -11. .206 1. .00 22. .99 B N
ATOM 3739 NH2 ARG B 191 -8. .121 -15. .770 -10. .827 1. .00 24. .08 B N
ATOM 3740 C ARG B 191 -2. .815 -10. .632 -11. .748 1. .00 23. .88 B C
ATOM 3741 o ARG B 191 -3. .248 -10. .103 -10. .707 1. .00 23. .94 B o
ATOM 3742 N SER B 192 -2. .488 -9. .956 -12. .850 1. .00 22. .79 B N
ATOM 3743 CA SER B 192 -2. .641 -8. .514 -12. .966 1. .00 22. .71 B C
ATOM 3744 CB SER B 192 -1. .283 -7. .836 -13. .169 1. .00 22. .27 B c
ATOM 3745 OG SER B 192 -1. .397 -6. .423 -12. .982 1. .00 21. .78 B o
ATOM 3746 C SER B 192 -3. .534 -8. .165 -14. .134 1. .00 22. .71 B c
ATOM 3747 o SER B 192 -3. .287 -8. .605 -15. .252 1. .00 22. .91 B o
ATOM 3748 N MET B 193 -4. .548 -7. .347 -13. .877 1. .00 23. .42 B N
ATOM 3749 CA MET B 193 -5. .441 -6. .863 -14. .932 1. .00 24. .44 B c
ATOM 3750 CB MET B 193 -6. .750 -6. .308 -14. .362 1. .00 24. .83 B c
ATOM 3751 CG MET B 193 -7. .378 -7. .179 -13. .277 1. .00 26. .13 B c
ATOM 3752 SD MET B 193 -9. .085 -6. .776 -12. .861 1. .00 28. .08 B s
ATOM 3753 CE MET B 193 -9. .889 -7. .597 -14. .223 1. .00 28. .27 B c
ATOM 3754 C MET B 193 -4. .739 -5. .779 -15. .723 1. .00 25. .15 B c
ATOM 3755 o MET B 193 -5. .018 -5. .604 -16. .894 1. .00 27. .54 B o
ATOM 3756 N GLU B 194 -3. .823 -5. .059 -15. .087 1. .00 25. .44 B N
ATOM 3757 CA GLU B 194 -3. .224 -3. .908 -15. .697 1. .00 25. .92 B c
ATOM 3758 CB GLU B 194 -2. .674 -2. .962 -14. .636 1. .00 27. .83 B c
ATOM 3759 CG GLU B 194 -1. .974 -1. .743 -15. .226 1. .00 30. .63 B c
ATOM 3760 CD GLU B 194 -0. .940 -1. .142 -14. .304 1. .00 32. .59 B c
ATOM 3761 OEl GLU B 194 -1. .326 -0. .320 -13. .455 1. .00 33. .88 B o
ATOM 3762 OE2 GLU B 194 0. .256 -1. .487 -14. .441 1. .00 34. .79 B o
ATOM 3763 C GLU B 194 -2. .129 -4. .387 -16. .641 1. .00 25. .90 B c
ATOM 3764 o GLU B 194 -2. .014 -3. .896 -17. .758 1. .00 26. .66 B o
ATOM 3765 N ASN B 195 -1. .333 -5. .351 -16. .206 1. .00 24. .42 B N
ATOM 3766 CA ASN B 195 -0. .279 -5. .876 -17. .042 1. .00 24. .87 B c
ATOM 3767 CB ASN B 195 1. .032 -5. .137 -16. .742 1. .00 26. .34 B c
ATOM 3768 CG ASN B 195 2. .250 -5. .738 -17. .467 1. .00 29. .35 B c
ATOM 3769 ODl ASN B 195 2. .153 -6. .336 -18. .562 1. .00 29. .51 B o
ATOM 3770 ND2 ASN B 195 3. .419 -5. .591 -16. .834 1. .00 31. .30 B N
ATOM 3771 C ASN B 195 -0. .196 -7. .413 -16. .888 1. .00 24. .24 B c
ATOM 3772 o ASN B 195 0. .600 -7. .933 -16. .101 1. .00 23. .20 B o
ATOM 3773 N PRO B 196 -1. .071 -8. .139 -17. .621 1. .00 24. .01 B N
ATOM 3774 CA PRO B 196 -1. .135 -9. .606 -17. .577 1. .00 23. .24 B c
ATOM 3775 CB PRO B 196 -2. .134 -9. .929 -18. .685 1. .00 23. .91 B c
ATOM 3776 CG PRO B 196 -3. .074 -8. .754 -18. .693 1. .00 23. .50 B c
ATOM 3777 CD PRO B 196 -2. .200 -7. .569 -18. .399 1. .00 23. .71 B c
ATOM 3778 C PRO B 196 0. .185 -10. .321 -17. .826 1. .00 22. .53 B c
ATOM 3779 o PRO B 196 0. .494 -11. .282 -17. .144 1. .00 21. .13 B o
ATOM 3780 N LYS B 197 0..974 -9..836 -18..774 1..00 23..69 B N
ATOM 3781 CA LYS B 197 2. .289 -10. .419 -19. .040 1. .00 24. .36 B C
ATOM 3782 CB LYS B 197 3. .051 -9. .624 -20. .106 1. .00 26. .48 B C
ATOM 3783 CG LYS B 197 2. .522 -9. .758 -21. .531 1. .00 28. .64 B c
ATOM 3784 CD LYS B 197 3. .512 -9. .183 -22. .540 1. .00 30. .82 B c
ATOM 3785 CE LYS B 197 4. .561 -10. .244 -22. .886 1. .00 33. .46 B c
ATOM 3786 NZ LYS B 197 5. .890 -9. .721 -23. .354 1. .00 34. .43 B N
ATOM 3787 C LYS B 197 3. .174 -10. .537 -17. .792 1. .00 23. .41 B c
ATOM 3788 o LYS B 197 4. .038 -11. .381 -17. .745 1. .00 23. .66 B o
ATOM 3789 N LEU B 198 2. .975 -9. .712 -16. .779 1. .00 22. .98 B N
ATOM 3790 CA LEU B 198 3. .839 -9. .773 -15. .594 1. .00 23. .36 B c
ATOM 3791 CB LEU B 198 3. .497 -8. .658 -14. .588 1. .00 24. .55 B c
ATOM 3792 CG LEU B 198 4. .462 -8. .316 -13. .434 1. .00 23. .95 B c
ATOM 3793 CDl LEU B 198 5. .905 -8. .032 -13. .877 1. .00 22. .89 B c
ATOM 3794 CD 2 LEU B 198 3. .851 -7. .126 -12. .692 1. .00 23. .13 B c
ATOM 3795 C LEU B 198 3. .763 -11. .120 -14. .903 1. .00 22. .24 B c
ATOM 3796 o LEU B 198 4. .739 -11. .550 -14. .277 1. .00 20. .67 B o
ATOM 3797 N TYR B 199 2. .609 -11. .773 -15. .013 1. .00 22. .06 B N
ATOM 3798 CA TYR B 199 2. .432 -13. .111 -14. .444 1. .00 22. .94 B c
ATOM 3799 CB TYR B 199 1. .500 -13. .048 -13. .207 1. .00 23. .41 B c
ATOM 3800 CG TYR B 199 1. .901 -11. .985 -12. .194 1. .00 23. .95 B c
ATOM 3801 CDl TYR B 199 3. .023 -12. .148 -11. .381 1. .00 24. .19 B c
ATOM 3802 CEl TYR B 199 3. .400 -11. .169 -10. .474 1. .00 24. .03 B c
ATOM 3803 CZ TYR B 199 2. .647 -10. .011 -10. .355 1. .00 24. .37 B c
ATOM 3804 OH TYR B 199 3. .002 -9. .038 -9. .442 1. .00 24. .91 B o
ATOM 3805 CE2 TYR B 199 1. .543 -9. .819 -11. .152 1. .00 24. .38 B c
ATOM 3806 CD 2 TYR B 199 1. .181 -10. .798 -12. .074 1. .00 24. .50 B c
ATOM 3807 C TYR B 199 1. .975 -14. .168 -15. .491 1. .00 22. .26 B c
ATOM 3808 o TYR B 199 1. .020 -14. .929 -15. .276 1. .00 21. .71 B o
ATOM 3809 N ASN B 200 2. .689 -14. .198 -16. .614 1. .00 21. .60 B N
ATOM 3810 CA ASN B 200 2. .589 -15. .264 -17. .620 1. .00 21. .13 B c
ATOM 3811 CB ASN B 200 3. .209 -16. .549 -17. .072 1. .00 22. .32 B c
ATOM 3812 CG ASN B 200 4. .606 -16. .323 -16. .485 1. .00 23. .87 B c
ATOM 3813 ODl ASN B 200 5. .610 -16. .490 -17. .183 1. .00 24. .05 B o
ATOM 3814 ND2 ASN B 200 4. .675 -15. .933 -15. .190 1. .00 24. .03 B N
ATOM 3815 C ASN B 200 1. .163 -15. .477 -18. .168 1. .00 19. .76 B c
ATOM 3816 o ASN B 200 0. .696 -16. .607 -18. .388 1. .00 17. .76 B o
ATOM 3817 N GLN B 201 0. .495 -14. .348 -18. .381 1. .00 18. .92 B N
ATOM 3818 CA GLN B 201 -0. .770 -14. .294 -19. .088 1. .00 19. .24 B c
ATOM 3819 CB GLN B 201 -1. .840 -13. .585 -18. .250 1. .00 17. .82 B c
ATOM 3820 CG GLN B 201 -2. .373 -14. .366 -17. .083 1. .00 16. .72 B c
ATOM 3821 CD GLN B 201 -3. .552 -13. .685 -16. .459 1. .00 16. .42 B c
ATOM 3822 OEl GLN B 201 -3. .450 -12. .553 -16. .004 1. .00 15. .89 B o
ATOM 3823 NE2 GLN B 201 -4. .687 -14. .371 -16. .429 1. .00 16. .72 B N
ATOM 3824 C GLN B 201 -0. .600 -13. .490 -20. .369 1. .00 20. .79 B c
ATOM 3825 o GLN B 201 -0. .009 -12. .417 -20. .355 1. .00 22. .47 B o
ATOM 3826 N PRO B 202 -1. .160 -13. .970 -21. .471 1. .00 21. .98 B N
ATOM 3827 CA PRO B 202 -1. .091 -13. .132 -22. .622 1. .00 22. .64 B c
ATOM 3828 CB PRO B 202 -1. .481 -14. .079 -23. .742 1. .00 22. .77 B c
ATOM 3829 CG PRO B 202 -2. .452 -15. .019 -23. .119 1. .00 22. .83 B c
ATOM 3830 CD PRO B 202 -2. .109 -15. .080 -21. .656 1. .00 22. .57 B c
ATOM 3831 C PRO B 202 -2. .085 -11. .965 -22. .505 1. .00 24. .85 B c
ATOM 3832 o PRO B 202 -3. .127 -12. .061 -21. .810 1. .00 23. .59 B o
ATOM 3833 N ASP B 203 -1. .737 -10. .880 -23. .202 1. .00 27. .61 B N
ATOM 3834 CA ASP B 203 -2. .492 -9. .640 -23. .199 1. .00 30. .45 B c
ATOM 3835 CB ASP B 203 -1. .610 -8. .492 -22. .682 1. .00 32. .67 B c
ATOM 3836 CG ASP B 203 -0. .356 -8. .294 -23. .502 1. .00 34. .23 B c
ATOM 3837 ODl ASP B 203 -0. .252 -8. .865 -24. .613 1. .00 36. .10 B o
ATOM 3838 OD2 ASP B 203 0. .534 -7. .576 -23. .017 1. .00 35. .07 B o
ATOM 3839 C ASP B 203 -3. .058 -9. .284 -24. .575 1. .00 32. .33 B c
ATOM 3840 o ASP B 203 -3. .488 -8. .154 -24. .772 1. .00 32. .63 B o
ATOM 3841 N ARG B 204 -3. .032 -10. .235 -25. .518 1. .00 34. .07 B N
ATOM 3842 CA ARG B 204 -3. .744 -10. .117 -26. .791 1. .00 34. .55 B c
ATOM 3843 CB ARG B 204 -2. .943 -9. .280 -27. .777 1. .00 36. .55 B c
ATOM 3844 CG ARG B 204 -1. .516 -9. .767 -27. .975 1. .00 39. .06 B c
ATOM 3845 CD ARG B 204 -0. .877 -9. .151 -29. .214 1. .00 42. .75 B c
ATOM 3846 NE ARG B 204 0. .412 -9. .771 -29. .545 1. .00 49. .37 B N
ATOM 3847 CZ ARG B 204 1. .388 -9. .199 -30. .267 1. .00 53. .04 B c
ATOM 3848 NHl ARG B 204 1. .253 -7. .971 -30. .769 1. .00 51. .45 B N
ATOM 3849 NH2 ARG B 204 2. .525 -9. .858 -30. .482 1. .00 53. .50 B N
ATOM 3850 C ARG B 204 -4. .071 -11. .495 -27. .408 1. .00 36. .34 B C
ATOM 3851 o ARG B 204 -3. .251 -12. .429 -27. .360 1. .00 36. .07 B o
ATOM 3852 N TYR B 205 -5. .271 -11. .592 -28. .001 1. .00 36. .40 B N
ATOM 3853 CA TYR B 205 -5. .844 -12. .829 -28. .581 1. .00 34. .16 B C
ATOM 3854 CB TYR B 205 -7. .022 -12. .465 -29. .497 1. .00 34. .62 B c
ATOM 3855 CG TYR B 205 -7. .925 -13. .612 -29. .902 1. .00 32. .64 B c
ATOM 3856 CDl TYR B 205 -8. .842 -14. .136 -29. .001 1. .00 32. .71 B c
ATOM 3857 CEl TYR B 205 -9. .685 -15. .166 -29. .348 1. .00 32. .40 B c
ATOM 3858 CZ TYR B 205 -9. .637 -15. .671 -30. .619 1. .00 32. .09 B c
ATOM 3859 OH TYR B 205 -10..483 -16.696 -30..926 1..00 29..46 B o
ATOM 3860 CE2 TYR B 205 -8. .743 -15. 161 -31. .546 1. .00 32. .02 B C
ATOM 3861 CD 2 TYR B 205 -7. .898 -14. 132 -31. .185 1. .00 31. .56 B C
ATOM 3862 C TYR B 205 -4. .872 -13. 655 -29. .394 1. .00 32. .77 B C
ATOM 3863 o TYR B 205 -4. .928 -14. 872 -29. .361 1. .00 31. .27 B o
ATOM 3864 N GLN B 206 -3. .996 -12. 993 -30. .136 1. .00 32. .81 B N
ATOM 3865 CA GLN B 206 -3. .030 -13. 715 -30. .972 1. .00 35. .21 B C
ATOM 3866 CB GLN B 206 -2. .272 -12. 841 -32. .044 1. .00 38. .64 B C
ATOM 3867 CG GLN B 206 -2. .106 -11. 308 -31. .866 1. .00 42. .08 B c
ATOM 3868 CD GLN B 206 -3. .425 -10. 488 -31. .920 1. .00 43. .10 B c
ATOM 3869 OEl GLN B 206 -3. .551 -9. 459 -31. .249 1. .00 44. .46 B o
ATOM 3870 NE2 GLN B 206 -4. .410 -10. 960 -32. .688 1. .00 42. .28 B N
ATOM 3871 C GLN B 206 -2. .071 -14. 536 -30. .129 1. .00 33. .13 B c
ATOM 3872 o GLN B 206 -1. .563 -15. 534 -30. .607 1. .00 35. .03 B o
ATOM 3873 N ASP B 207 -1. .855 -14. 166 -28. .870 1. .00 31. .41 B N
ATOM 3874 CA ASP B 207 -0. .906 -14. 913 -28. .018 1. .00 29. .64 B c
ATOM 3875 CB ASP B 207 -0. .053 -13. 937 -27. .197 1. .00 29. .62 B c
ATOM 3876 CG ASP B 207 0. .970 -13. 202 -28. .048 1. .00 30. .75 B c
ATOM 3877 ODl ASP B 207 1. .183 -13. 628 -29. .212 1. .00 30. .64 B o
ATOM 3878 OD2 ASP B 207 1. .553 -12. 200 -27. .561 1. .00 30. .25 B o
ATOM 3879 C ASP B 207 -1. .556 -15. 951 -27. .101 1. .00 27. .81 B c
ATOM 3880 o ASP B 207 -0. .896 -16. 513 -26. .227 1. .00 26. .27 B o
ATOM 3881 N ARG B 208 -2. .836 -16. 246 -27. .312 1. .00 26. .49 B N
ATOM 3882 CA ARG B 208 -3. .536 -17. 097 -26. .368 1. .00 24. .72 B c
ATOM 3883 CB ARG B 208 -5. .010 -17. 243 -26. .708 1. .00 24. .36 B c
ATOM 3884 CG ARG B 208 -5. .326 -17. 924 -28. .024 1. .00 24. .48 B c
ATOM 3885 CD ARG B 208 -6. .755 -17. 538 -28. .400 1. .00 25. .04 B c
ATOM 3886 NE ARG B 208 -7. .264 -18. 154 -29. .617 1. .00 24. .76 B N
ATOM 3887 CZ ARG B 208 -6. .783 -17. 933 -30. .837 1. .00 25. .11 B c
ATOM 3888 NHl ARG B 208 -5. .750 -17. 136 -31. .060 1. .00 25. .82 B N
ATOM 3889 NH2 ARG B 208 -7. .337 -18. 534 -31. .858 1. .00 26. .12 B N
ATOM 3890 C ARG B 208 -2. .920 -18. 451 -26. .283 1. .00 24. .48 B C
ATOM 3891 o ARG B 208 -2. .232 -18. 908 -27. .185 1. .00 25. .71 B o
ATOM 3892 N TYR B 209 -3. .188 -19. 103 -25. .167 1. .00 24. .84 B N
ATOM 3893 CA TYR B 209 -2. .840 -20. 510 -25. .000 1. .00 22. .96 B C
ATOM 3894 CB TYR B 209 -2. .724 -20. 842 -23. .521 1. .00 21. .57 B c
ATOM 3895 CG TYR B 209 -2. .520 -22. 291 -23. .180 1. .00 19. .77 B c
ATOM 3896 CDl TYR B 209 -1. .260 -22. 868 -23. .218 1. .00 18. .75 B c
ATOM 3897 CEl TYR B 209 -1. .091 -24. 213 -22. .858 1. .00 18. .78 B c
ATOM 3898 CZ TYR B 209 -2. .192 -24. 978 -22. .441 1. .00 18. .01 B c
ATOM 3899 OH TYR B 209 -2. .057 -26. 288 -22. .082 1. .00 17. .53 B o
ATOM 3900 CE2 TYR B 209 -3. .442 -24. 416 -22. .391 1. .00 18. .24 B c
ATOM 3901 CD 2 TYR B 209 -3. .603 -23. 077 -22. .740 1. .00 19. .13 B c
ATOM 3902 C TYR B 209 -3. .912 -21. 351 -25. .673 1. .00 22. .56 B c
ATOM 3903 o TYR B 209 -5. .106 -21. 048 -25. .608 1. .00 21. .55 B o
ATOM 3904 N THR B 210 -3. .438 -22. 421 -26. .304 1. .00 23. .19 B N
ATOM 3905 CA THR B 210 -4. .190 -23. 254 -27. .246 1. .00 21. .30 B c
ATOM 3906 CB THR B 210 -3. .509 -23. 070 -28. .627 1. .00 20. .51 B c
ATOM 3907 OGl THR B 210 -4. .283 -22. 128 -29. .351 1. .00 19. .96 B o
ATOM 3908 CG2 THR B 210 -3. .380 -24. 329 -29. .449 1. .00 21. .23 B c
ATOM 3909 C THR B 210 -4. .291 -24. 717 -26. .770 1. .00 20. .49 B c
ATOM 3910 o THR B 210 -4. .989 -25. 528 -27. .385 1. .00 22. .84 B o
ATOM 3911 N GLY B 211 -3. .622 -25. 037 -25. .662 1. .00 18. .65 B N
ATOM 3912 CA GLY B 211 -3. .502 -26. 404 -25. .164 1. .00 17. .86 B c
ATOM 3913 C GLY B 211 -4. .688 -26. 812 -24. .313 1. .00 17. .46 B c
ATOM 3914 o GLY B 211 -5. .628 -26. 022 -24. .134 1. .00 17. .51 B o
ATOM 3915 N PRO B 212 -4. .664 -28. 052 -23. .801 1. .00 16. .80 B N
ATOM 3916 CA PRO B 212 -5. .780 -28. 673 -23. .088 1. .00 17. .36 B c
ATOM 3917 CB PRO B 212 -5. .594 -30. 156 -23. .396 1. .00 16. .89 B c
ATOM 3918 CG PRO B 212 -4. .113 -30. 308 -23. .446 1. .00 17. .16 B c
ATOM 3919 CD PRO B 212 -3. .604 -29. 030 -24. .083 1. .00 17. .00 B c
ATOM 3920 C PRO B 212 -5. .769 -28. 494 -21. .573 1. .00 18. .49 B c
ATOM 3921 o PRO B 212 -6. .773 -28. 798 -20. .908 1. .00 19. .01 B o
ATOM 3922 N SER B 213 -4. .645 -28. 019 -21. .056 1. .00 18. .86 B N
ATOM 3923 CA SER B 213 -4. .391 -27. 910 -19. .645 1. .00 19. .95 B c
ATOM 3924 CB SER B 213 -2. .881 -27. 698 -19. .495 1. .00 22. .65 B c
ATOM 3925 OG SER B 213 -2. .471 -27. 825 -18. .161 1. .00 26. .25 B o
ATOM 3926 C SER B 213 -5. .168 -26. 724 -19. .078 1. .00 18. .23 B c
ATOM 3927 o SER B 213 -5. .345 -25. 770 -19. .779 1. .00 16. .91 B o
ATOM 3928 N ASP B 214 -5. .635 -26. 785 -17. .824 1. .00 18. .11 B N
ATOM 3929 CA ASP B 214 -6. .440 -25. 689 -17. .227 1. .00 17. .78 B c
ATOM 3930 CB ASP B 214 -5. .596 -24. 409 -17. .164 1. .00 17. .90 B c
ATOM 3931 CG ASP B 214 -6. .244 -23. 295 -16. .378 1. .00 17. .76 B c
ATOM 3932 ODl ASP B 214 -7. .112 -23. 546 -15. .494 1. .00 18. .10 B o
ATOM 3933 OD2 ASP B 214 -5. .857 -22. 141 -16. .651 1. .00 17. .17 B o
ATOM 3934 C ASP B 214 -7. .708 -25. 443 -18. .049 1. .00 18. .13 B c
ATOM 3935 o ASP B 214 -7. .986 -24. 311 -18. .477 1. .00 16. .78 B o
ATOM 3936 N ASN B 215 -8. .446 -26. 527 -18. .296 1. .00 18. .96 B N
ATOM 3937 CA ASN B 215 -9. .601 -26. 515 -19. .196 1. .00 19. .63 B c
ATOM 3938 CB ASN B 215 -10..848 -26.092 -18..422 1..00 20..32 B C
ATOM 3939 CG ASN B 215 -11. .257 -27. 138 -17. .405 1. .00 20. .81 B C
ATOM 3940 ODl ASN B 215 -11. .299 -28. 333 -17. .713 1. .00 21. .24 B o
ATOM 3941 ND2 ASN B 215 -11. .492 -26. 715 -16. .188 1. .00 21. .02 B N
ATOM 3942 C ASN B 215 -9. .354 -25. 645 -20. .420 1. .00 20. .01 B C
ATOM 3943 o ASN B 215 -10. .137 -24. 759 -20. .766 1. .00 20. .66 B o
ATOM 3944 N GLY B 216 -8. .219 -25. 896 -21. .058 1. .00 20. .01 B N
ATOM 3945 CA GLY B 216 -7. .796 -25. 146 -22. .226 1. .00 19. .24 B C
ATOM 3946 C GLY B 216 -7. .633 -23. 662 -21. .985 1. .00 18. .69 B C
ATOM 3947 o GLY B 216 -8. .297 -22. 859 -22. .638 1. .00 18. .64 B o
ATOM 3948 N GLY B 217 -6. .775 -23. 303 -21. .030 1. .00 18. .39 B N
ATOM 3949 CA GLY B 217 -6. .297 -21. 910 -20. .845 1. .00 18. .17 B c
ATOM 3950 C GLY B 217 -7. .079 -20. 998 -19. .908 1. .00 17. .90 B c
ATOM 3951 o GLY B 217 -6. .747 -19. 836 -19. .739 1. .00 18. .36 B o
ATOM 3952 N VAL B 218 -8. .082 -21. 542 -19. .248 1. .00 18. .00 B N
ATOM 3953 CA VAL B 218 -9. .075 -20. 757 -18. .535 1. .00 18. .49 B c
ATOM 3954 CB VAL B 218 -9. .978 -21. 757 -17. .786 1. .00 18. .67 B c
ATOM 3955 CGl VAL B 218 -10. .669 -21. 159 -16. .609 1. .00 19. .04 B c
ATOM 3956 CG2 VAL B 218 -11. .017 -22. 288 -18. .752 1. .00 19. .24 B c
ATOM 3957 C VAL B 218 -8. .520 -19. 593 -17. .660 1. .00 19. .13 B c
ATOM 3958 o VAL B 218 -9. .025 -18. 488 -17. .723 1. .00 18. .61 B o
ATOM 3959 N HIS B 219 -7. .480 -19. 833 -16. .865 1. .00 19. .66 B N
ATOM 3960 CA HIS B 219 -6. .885 -18. 786 -16. .037 1. .00 19. .59 B c
ATOM 3961 CB HIS B 219 -6. .449 -19. 301 -14. .641 1. .00 20. .15 B c
ATOM 3962 CG HIS B 219 -7. .529 -19. 983 -13. .848 1. .00 19. .47 B c
ATOM 3963 NDl HIS B 219 -7. .816 -21. 327 -13. .979 1. .00 19. .54 B N
ATOM 3964 CEl HIS B 219 -8. .807 -21. 643 -13. .163 1. .00 19. .59 B c
ATOM 3965 NE2 HIS B 219 -9. .158 -20. 559 -12. .494 1. .00 18. .98 B N
ATOM 3966 CD 2 HIS B 219 -8. .361 -19. 513 -12. .891 1. .00 19. .03 B C
ATOM 3967 C HIS B 219 -5. .658 -18. 243 -16. .725 1. .00 20. .25 B c
ATOM 3968 o HIS B 219 -5. .105 -17. 241 -16. .283 1. .00 20. .29 B o
ATOM 3969 N ILE B 220 -5. .171 -18. 915 -17. .766 1. .00 21. .20 B N
ATOM 3970 CA ILE B 220 -4. .097 -18. 309 -18. .566 1. .00 21. .97 B c
ATOM 3971 CB ILE B 220 -3. .375 -19. 323 -19. .457 1. .00 22. .68 B c
ATOM 3972 CGl ILE B 220 -2. .724 -20. 393 -18. .595 1. .00 23. .99 B c
ATOM 3973 CDl ILE B 220 -2. .178 -21. 553 -19. .404 1. .00 24. .68 B c
ATOM 3974 CG2 ILE B 220 -2. .293 -18. 655 -20. .293 1. .00 22. .37 B c
ATOM 3975 C ILE B 220 -4. .698 -17. 207 -19. .426 1. .00 22. .02 B c
ATOM 3976 o ILE B 220 -4. .261 -16. 068 -19. .344 1. .00 23. .21 B o
ATOM 3977 N ASN B 221 -5. .724 -17. 545 -20. .209 1. .00 20. .75 B N
ATOM 3978 CA ASN B 221 -6. .311 -16. 624 -21. .182 1. .00 20. .24 B c
ATOM 3979 CB ASN B 221 -6. .996 -17. 406 -22. .300 1. .00 18. .70 B c
ATOM 3980 CG ASN B 221 -6. .009 -18. 178 -23. .149 1. .00 17. .72 B c
ATOM 3981 ODl ASN B 221 -4. .883 -17. 752 -23. .379 1. .00 17. .36 B o
ATOM 3982 ND2 ASN B 221 -6. .425 -19. 321 -23. .609 1. .00 16. .99 B N
ATOM 3983 C ASN B 221 -7. .291 -15. 582 -20. .631 1. .00 21. .78 B c
ATOM 3984 o ASN B 221 -7. .719 -14. 705 -21. .386 1. .00 21. .93 B o
ATOM 3985 N SER B 222 -7. .651 -15. 633 -19. .346 1. .00 22. .00 B N
ATOM 3986 CA SER B 222 -8. .578 -14. 633 -18. .860 1. .00 22. .02 B c
ATOM 3987 CB SER B 222 -9. .109 -14. 959 -17. .466 1. .00 22. .44 B c
ATOM 3988 OG SER B 222 -8. .090 -15. 068 -16. .478 1. .00 23. .22 B o
ATOM 3989 C SER B 222 -7. .852 -13. 297 -18. .931 1. .00 23. .31 B c
ATOM 3990 o SER B 222 -8. .481 -12. 230 -19. .024 1. .00 22. .58 B o
ATOM 3991 N GLY B 223 -6. .516 -13. 371 -18. .945 1. .00 24. .52 B N
ATOM 3992 CA GLY B 223 -5. .651 -12. 186 -19. .052 1. .00 25. .84 B c
ATOM 3993 C GLY B 223 -6. .008 -11. 231 -20. .177 1. .00 26. .96 B c
ATOM 3994 o GLY B 223 -5. .884 -10. 001 -20. .034 1. .00 28. .19 B o
ATOM 3995 N ILE B 224 -6. .437 -11. 809 -21. .296 1. .00 26. .49 B N
ATOM 3996 CA ILE B 224 -6. .923 -11. 057 -22. .459 1. .00 25. .44 B c
ATOM 3997 CB ILE B 224 -7. .187 -12. Oil -23. .637 1. .00 24. .70 B c
ATOM 3998 CGl ILE B 224 -5. .849 -12. 487 -24. .198 1. .00 24. .83 B c
ATOM 3999 CDl ILE B 224 -5. .956 -13. 782 -24. .968 1. .00 25. .47 B c
ATOM 4000 CG2 ILE B 224 -8. .002 -11. 327 -24. .720 1. .00 24. .67 B c
ATOM 4001 C ILE B 224 -8. .172 -10. 209 -22. .179 1. .00 24. .64 B c
ATOM 4002 o ILE B 224 -8. .209 -9. 029 -22. .468 1. .00 25. .66 B o
ATOM 4003 N ASN B 225 -9. .212 -10. 798 -21. .637 1. .00 24. .78 B N
ATOM 4004 CA ASN B 225 -10. .377 -10. Oil -21. .335 1. .00 24. .71 B c
ATOM 4005 CB ASN B 225 -11. .549 -10. 903 -20. .978 1. .00 24. .55 B c
ATOM 4006 CG ASN B 225 -12. .869 -10. 188 -21. .126 1. .00 24. .56 B c
ATOM 4007 ODl ASN B 225 -13. .625 -9. 979 -20. .164 1. .00 23. .26 B o
ATOM 4008 ND2 ASN B 225 -13. .143 -9. 775 -22. .347 1. .00 25. .30 B N
ATOM 4009 C ASN B 225 -10. .097 -9. 051 -20. .188 1. .00 25. .63 B c
ATOM 4010 o ASN B 225 -10. .577 -7. 922 -20. .188 1. .00 25. .70 B o
ATOM 4011 N ASN B 226 -9. .321 -9. 494 -19. .204 1. .00 26. .62 B N
ATOM 4012 CA ASN B 226 -8. .969 -8. 608 -18. .104 1. .00 26. .81 B c
ATOM 4013 CB ASN B 226 -8. .135 -9. 330 -17. .035 1. .00 27. .03 B c
ATOM 4014 CG ASN B 226 -8. .963 -10. 256 -16. .156 1. .00 27. .23 B c
ATOM 4015 ODl ASN B 226 -10. .195 -10. 313 -16. .254 1. .00 26. .96 B o
ATOM 4016 ND2 ASN B 226 -8. .277 -11. 001 -15. .289 1. .00 27. .06 B N
ATOM 4017 C ASN B 226 -8..243 -7..340 -18..594 1..00 26..48 B C
ATOM 4018 o ASN B 226 -8. .512 -6. .254 -18. .096 1. .00 28. .43 B o
ATOM 4019 N LYS B 227 -7. .343 -7. .458 -19. .558 1. .00 24. .83 B N
ATOM 4020 CA LYS B 227 -6. .685 -6. .271 -20. .081 1. .00 25. .45 B C
ATOM 4021 CB LYS B 227 -5. .631 -6. .652 -21. .096 1. .00 25. .83 B C
ATOM 4022 CG LYS B 227 -4. .834 -5. .495 -21. .646 1. .00 25. .86 B c
ATOM 4023 CD LYS B 227 -3. .856 -4. .952 -20. .632 1. .00 27. .34 B c
ATOM 4024 CE LYS B 227 -3. .290 -3. .619 -21. .118 1. .00 28. .38 B c
ATOM 4025 NZ LYS B 227 -2. .147 -3. .154 -20. .291 1. .00 28. .32 B N
ATOM 4026 C LYS B 227 -7. .675 -5. .333 -20. .742 1. .00 26. .25 B c
ATOM 4027 o LYS B 227 -7. .581 -4. .130 -20. .580 1. .00 27. .67 B o
ATOM 4028 N ALA B 228 -8. .605 -5. .884 -21. .509 1. .00 26. .38 B N
ATOM 4029 CA ALA B 228 -9. .669 -5. .091 -22. .101 1. .00 26. .22 B c
ATOM 4030 CB ALA B 228 -10. .670 -5. .974 -22. .840 1. .00 26. .76 B c
ATOM 4031 C ALA B 228 -10. .387 -4. .320 -21. .027 1. .00 26. .05 B c
ATOM 4032 o ALA B 228 -10. .645 -3. .149 -21. .190 1. .00 28. .08 B o
ATOM 4033 N PHE B 229 -10. .725 -4. .969 -19. .926 1. .00 25. .85 B N
ATOM 4034 CA PHE B 229 -11. .412 -4. .266 -18. .853 1. .00 25. .93 B c
ATOM 4035 CB PHE B 229 -11. .755 -5. .203 -17. .712 1. .00 25. .94 B c
ATOM 4036 CG PHE B 229 -12. .518 -4. .533 -16. .642 1. .00 26. .06 B c
ATOM 4037 CDl PHE B 229 -13. .890 -4. .407 -16. .748 1. .00 26. .92 B c
ATOM 4038 CEl PHE B 229 -14. .620 -3. .758 -15. .766 1. .00 27. .95 B c
ATOM 4039 CZ PHE B 229 -13. .963 -3. .228 -14. .661 1. .00 27. .83 B c
ATOM 4040 CE2 PHE B 229 -12. .580 -3. .341 -14. .562 1. .00 27. .45 B c
ATOM 4041 CD 2 PHE B 229 -11. .868 -3. .985 -15. .551 1. .00 26. .96 B c
ATOM 4042 C PHE B 229 -10. .626 -3. .063 -18. .313 1. .00 25. .50 B c
ATOM 4043 o PHE B 229 -11. .162 -1. .968 -18. .214 1. .00 26. .44 B o
ATOM 4044 N TYR B 230 -9. .362 -3. .262 -17. .970 1. .00 25. .44 B N
ATOM 4045 CA TYR B 230 -8. .488 -2. .153 -17. .546 1. .00 26. .60 B c
ATOM 4046 CB TYR B 230 -7. .055 -2. .645 -17. .394 1. .00 26. .50 B c
ATOM 4047 CG TYR B 230 -6. .057 -1. .545 -17. .152 1. .00 26. .33 B c
ATOM 4048 CDl TYR B 230 -5. .980 -0. .908 -15. .912 1. .00 25. .76 B c
ATOM 4049 CEl TYR B 230 -5. .055 0. .087 -15. .667 1. .00 25. .25 B c
ATOM 4050 CZ TYR B 230 -4. .191 0. .458 -16. .664 1. .00 26. .43 B c
ATOM 4051 OH TYR B 230 -3. .275 1. .445 -16. .431 1. .00 27. .30 B o
ATOM 4052 CE2 TYR B 230 -4. .237 -0. .160 -17. .903 1. .00 27. .11 B c
ATOM 4053 CD 2 TYR B 230 -5. .181 -1. .149 -18. .146 1. .00 26. .74 B c
ATOM 4054 C TYR B 230 -8. .455 -0. .948 -18. .499 1. .00 26. .53 B c
ATOM 4055 o TYR B 230 -8. .456 0. .196 -18. .050 1. .00 26. .33 B o
ATOM 4056 N LEU B 231 -8. .386 -1. .221 -19. .798 1. .00 26. .27 B N
ATOM 4057 CA LEU B 231 -8. .373 -0. .180 -20. .809 1. .00 26. .57 B c
ATOM 4058 CB LEU B 231 -8. .041 -0. .775 -22. .171 1. .00 25. .37 B c
ATOM 4059 CG LEU B 231 -6. .568 -1. .208 -22. .262 1. .00 25. .50 B c
ATOM 4060 CDl LEU B 231 -6. .257 -2. .057 -23. .476 1. .00 25. .18 B c
ATOM 4061 CD 2 LEU B 231 -5. .657 0. .007 -22. .268 1. .00 26. .56 B c
ATOM 4062 C LEU B 231 -9. .705 0. .574 -20. .817 1. .00 28. .83 B c
ATOM 4063 o LEU B 231 -9. .743 1. .805 -20. .856 1. .00 30. .14 B o
ATOM 4064 N ILE B 232 -10. .799 -0. .156 -20. .705 1. .00 29. .54 B N
ATOM 4065 CA ILE B 232 -12. .115 0. .458 -20. .640 1. .00 29. .21 B c
ATOM 4066 CB ILE B 232 -13. .197 -0. .634 -20. .677 1. .00 28. .64 B c
ATOM 4067 CGl ILE B 232 -13. .234 -1. .247 -22. .084 1. .00 29. .59 B c
ATOM 4068 CDl ILE B 232 -14. .053 -2. .517 -22. .206 1. .00 29. .92 B c
ATOM 4069 CG2 ILE B 232 -14. .561 -0. .084 -20. .291 1. .00 28. .76 B c
ATOM 4070 C ILE B 232 -12. .269 1. .291 -19. .374 1. .00 30. .72 B c
ATOM 4071 o ILE B 232 -13. .009 2. .273 -19. .340 1. .00 33. .34 B o
ATOM 4072 N ALA B 233 -11. .595 0. .888 -18. .309 1. .00 31. .94 B N
ATOM 4073 CA ALA B 233 -11. .820 1. .522 -17. .007 1. .00 30. .90 B c
ATOM 4074 CB ALA B 233 -11. .604 0. .509 -15. .900 1. .00 31. .09 B c
ATOM 4075 C ALA B 233 -10. .896 2. .715 -16. .829 1. .00 29. .25 B c
ATOM 4076 o ALA B 233 -11. .338 3. .839 -16. .703 1. .00 26. .84 B o
ATOM 4077 N GLN B 234 -9. .601 2. .438 -16. .850 1. .00 28. .21 B N
ATOM 4078 CA GLN B 234 -8. .605 3. .442 -16. .643 1. .00 27. .52 B c
ATOM 4079 CB GLN B 234 -7. .332 2. .775 -16. .136 1. .00 27. .99 B c
ATOM 4080 CG GLN B 234 -6. .297 3. .757 -15. .629 1. .00 27. .70 B c
ATOM 4081 CD GLN B 234 -6. .901 4. .805 -14. .703 1. .00 27. .94 B c
ATOM 4082 OEl GLN B 234 -7. .897 4. .556 -13. .997 1. .00 27. .32 B o
ATOM 4083 NE2 GLN B 234 -6. .301 5. .988 -14. .702 1. .00 27. .80 B N
ATOM 4084 C GLN B 234 -8. .257 4. .222 -17. .892 1. .00 27. .94 B c
ATOM 4085 o GLN B 234 -7. .823 5. .377 -17. .791 1. .00 28. .34 B o
ATOM 4086 N GLY B 235 -8. .417 3. .590 -19. .059 1. .00 27. .37 B N
ATOM 4087 CA GLY B 235 -7. .817 4. .077 -20. .296 1. .00 25. .77 B c
ATOM 4088 C GLY B 235 -6. .345 3. .708 -20. .328 1. .00 25. .72 B c
ATOM 4089 o GLY B 235 -5. .740 3. .433 -19. .292 1. .00 25. .36 B o
ATOM 4090 N GLY B 236 -5. .769 3. .700 -21. .523 1. .00 25. .94 B N
ATOM 4091 CA GLY B 236 -4. .350 3. .423 -21. .698 1. .00 26. .60 B c
ATOM 4092 C GLY B 236 -4. .044 3. .322 -23. .177 1. .00 28. .63 B c
ATOM 4093 o GLY B 236 -4. .919 3. .572 -24. .017 1. .00 29. .26 B o
ATOM 4094 N THR B 237 -2. .801 2. .970 -23. .485 1. .00 29. .75 B N
ATOM 4095 CA THR B 237 -2. .327 2. .831 -24. .842 1. .00 31. .58 B c
ATOM 4096 CB THR B 237 -1..327 3..962 -25..206 1..00 33..98 B C
ATOM 4097 OGl THR B 237 -2. .063 5. .104 -25. .633 1. .00 37. .98 B o
ATOM 4098 CG2 THR B 237 -0. .360 3. .594 -26. .356 1. .00 34. .58 B C
ATOM 4099 C THR B 237 -1. .650 1. .496 -24. .899 1. .00 34. .03 B C
ATOM 4100 o THR B 237 -0. .632 1. .298 -24. .230 1. .00 34. .87 B o
ATOM 4101 N HIS B 238 -2. .184 0. .602 -25. .731 1. .00 36. .70 B N
ATOM 4102 CA HIS B 238 -1. .747 -0. .790 -25. .793 1. .00 37. .24 B C
ATOM 4103 CB HIS B 238 -2. .711 -1. .577 -24. .898 1. .00 42. .00 B C
ATOM 4104 CG HIS B 238 -2. .361 -3. .020 -24. .728 1. .00 43. .70 B c
ATOM 4105 NDl HIS B 238 -3. .268 -4. .030 -24. .968 1. .00 43. .48 B N
ATOM 4106 CEl HIS B 238 -2. .691 -5. .194 -24. .734 1. .00 46. .45 B c
ATOM 4107 NE2 HIS B 238 -1. .445 -4. .974 -24. .351 1. .00 47. .60 B N
ATOM 4108 CD2 HIS B 238 -1. .213 -3. .620 -24. .335 1. .00 45. .16 B C
ATOM 4109 C HIS B 238 -1. .769 -1. .323 -27. .239 1. .00 35. .71 B c
ATOM 4110 o HIS B 238 -2. .832 -1. .322 -27. .876 1. .00 31. .39 B o
ATOM 4111 N TYR B 239 -0. .616 -1. .798 -27. .743 1. .00 37. .49 B N
ATOM 4112 CA TYR B 239 -0. .431 -2. .163 -29. .201 1. .00 39. .68 B c
ATOM 4113 CB TYR B 239 -0. .973 -3. .577 -29. .559 1. .00 38. .30 B c
ATOM 4114 CG TYR B 239 -0. .280 -4. .661 -28. .775 1. .00 36. .05 B c
ATOM 4115 CDl TYR B 239 1. .087 -4. .867 -28. .915 1. .00 36. .03 B c
ATOM 4116 CEl TYR B 239 1. .755 -5. .830 -28. .174 1. .00 36. .29 B c
ATOM 4117 CZ TYR B 239 1. .042 -6. .605 -27. .259 1. .00 37. .19 B c
ATOM 4118 OH TYR B 239 1. .707 -7. .570 -26. .501 1. .00 34. .74 B o
ATOM 4119 CE2 TYR B 239 -0. .333 -6. .403 -27. .104 1. .00 36. .29 B c
ATOM 4120 CD2 TYR B 239 -0. .975 -5. .433 -27. .855 1. .00 35. .25 B c
ATOM 4121 C TYR B 239 -1. .026 -1. .116 -30. .152 1. .00 41. .11 B c
ATOM 4122 o TYR B 239 -2. .046 -1. .350 -30. .818 1. .00 40. .61 B o
ATOM 4123 N GLY B 240 -0. .401 0. .057 -30. .164 1. .00 42. .40 B N
ATOM 4124 CA GLY B 240 -0. .862 1. .165 -30. .985 1. .00 43. .82 B c
ATOM 4125 C GLY B 240 -2. .136 1. .887 -30. .549 1. .00 42. .06 B c
ATOM 4126 o GLY B 240 -2. .231 3. .116 -30. .685 1. .00 42. .31 B o
ATOM 4127 N VAL B 241 -3. .121 1. .152 -30. .047 1. .00 38. .05 B N
ATOM 4128 CA VAL B 241 -4. .450 1. .724 -29. .817 1. .00 37. .68 B c
ATOM 4129 CB VAL B 241 -5. .488 0. .599 -29. .856 1. .00 35. .77 B c
ATOM 4130 CGl VAL B 241 -6. .907 1. .130 -29. .740 1. .00 34. .09 B c
ATOM 4131 CG2 VAL B 241 -5. .277 -0. .194 -31. .139 1. .00 35. .98 B c
ATOM 4132 C VAL B 241 -4. .524 2. .586 -28. .519 1. .00 38. .81 B c
ATOM 4133 o VAL B 241 -3. .917 2. .253 -27. .499 1. .00 39. .08 B o
ATOM 4134 N THR B 242 -5. .204 3. .732 -28. .605 1. .00 38. .22 B N
ATOM 4135 CA THR B 242 -5. .407 4. .614 -27. .465 1. .00 38. .17 B c
ATOM 4136 CB THR B 242 -5. .044 6. .083 -27. .805 1. .00 37. .28 B c
ATOM 4137 OGl THR B 242 -3. .630 6. .233 -27. .717 1. .00 38. .40 B o
ATOM 4138 CG2 THR B 242 -5. .670 7. .096 -26. .838 1. .00 36. .94 B c
ATOM 4139 C THR B 242 -6. .865 4. .458 -27. .034 1. .00 39. .27 B c
ATOM 4140 o THR B 242 -7. .788 4. .557 -27. .851 1. .00 39. .33 B o
ATOM 4141 N VAL B 243 -7. .064 4. .176 -25. .752 1. .00 38. .72 B N
ATOM 4142 CA VAL B 243 -8. .396 4. .046 -25. .213 1. .00 38. .15 B c
ATOM 4143 CB VAL B 243 -8. .615 2. .696 -24. .551 1. .00 36. .94 B c
ATOM 4144 CGl VAL B 243 -10. .085 2. .522 -24. .211 1. .00 37. .69 B c
ATOM 4145 CG2 VAL B 243 -8. .171 1. .598 -25. .492 1. .00 39. .28 B c
ATOM 4146 C VAL B 243 -8. .566 5. .090 -24. .162 1. .00 39. .74 B c
ATOM 4147 o VAL B 243 -7. .658 5. .304 -23. .362 1. .00 40. .60 B o
ATOM 4148 N ASN B 244 -9. .727 5. .736 -24. .174 1. .00 40. .74 B N
ATOM 4149 CA ASN B 244 -10. .041 6. .753 -23. .201 1. .00 40. .96 B c
ATOM 4150 CB ASN B 244 -10. .781 7. .919 -23. .855 1. .00 43. .87 B c
ATOM 4151 CG ASN B 244 -9. .999 8. .560 -25. .011 1. .00 47. .13 B c
ATOM 4152 ODl ASN B 244 -8. .756 8. .572 -25. .061 1. .00 44. .34 B o
ATOM 4153 ND2 ASN B 244 -10. .748 9. .112 -25. .957 1. .00 51. .75 B N
ATOM 4154 C ASN B 244 -10. .921 6. .076 -22. .180 1. .00 38. .39 B c
ATOM 4155 o ASN B 244 -11. .998 5. .629 -22. .522 1. .00 40. .30 B o
ATOM 4156 N GLY B 245 -10. .462 5. .995 -20. .936 1. .00 34. .92 B N
ATOM 4157 CA GLY B 245 -11. .194 5. .303 -19. .883 1. .00 33. .21 B c
ATOM 4158 C GLY B 245 -12. .547 5. .921 -19. .615 1. .00 31. .52 B c
ATOM 4159 o GLY B 245 -12. .741 7. .104 -19. .850 1. .00 32. .30 B o
ATOM 4160 N ILE B 246 -13. .476 5. .110 -19. .122 1. .00 30. .79 B N
ATOM 4161 CA ILE B 246 -14. .800 5. .578 -18. .734 1. .00 31. .70 B c
ATOM 4162 CB ILE B 246 -15. .907 4. .792 -19. .467 1. .00 34. .63 B c
ATOM 4163 CGl ILE B 246 -15. .952 3. .312 -19. .041 1. .00 35. .25 B c
ATOM 4164 CDl ILE B 246 -17. .373 2. .797 -18. .876 1. .00 34. .91 B c
ATOM 4165 CG2 ILE B 246 -15. .708 4. .884 -20. .976 1. .00 35. .49 B c
ATOM 4166 C ILE B 246 -15. .056 5. .495 -17. .231 1. .00 31. .36 B c
ATOM 4167 o ILE B 246 -16. .153 5. .815 -16. .784 1. .00 29. .30 B o
ATOM 4168 N GLY B 247 -14. .038 5. .076 -16. .469 1. .00 33. .15 B N
ATOM 4169 CA GLY B 247 -14. .103 4. .926 -15. .007 1. .00 33. .39 B c
ATOM 4170 C GLY B 247 -14. .360 3. .484 -14. .662 1. .00 34. .14 B c
ATOM 4171 o GLY B 247 -14. .673 2. .715 -15. .550 1. .00 38. .81 B o
ATOM 4172 N ARG B 248 -14. .221 3. .094 -13. .398 1. .00 35. .49 B N
ATOM 4173 CA ARG B 248 -14. .521 1. .701 -13. .019 1. .00 34. .52 B c
ATOM 4174 CB ARG B 248 -13. .898 1. .291 -11. .678 1. .00 34. .54 B c
ATOM 4175 CG ARG B 248 -12..394 1..119 -11..670 1..00 33..03 B C
ATOM 4176 CD ARG B 248 -11. .942 0. .463 -10. .370 1. .00 31. .42 B C
ATOM 4177 NE ARG B 248 -10. .484 0. .407 -10. .297 1. .00 30. .41 B N
ATOM 4178 CZ ARG B 248 -9. .772 -0. .522 -9. .665 1. .00 30. .13 B C
ATOM 4179 NHl ARG B 248 -10. .351 -1. .520 -9. .018 1. .00 32. .14 B N
ATOM 4180 NH2 ARG B 248 -8. .455 -0. .457 -9. .676 1. .00 29. .38 B N
ATOM 4181 C ARG B 248 -16. .014 1. .528 -12. .922 1. .00 34. .18 B C
ATOM 4182 o ARG B 248 -16. .606 0. .839 -13. .724 1. .00 35. .53 B o
ATOM 4183 N ASP B 249 -16. .620 2. .168 -11. .935 1. .00 35. .34 B N
ATOM 4184 CA ASP B 249 -18. .020 1. .933 -11. .609 1. .00 37. .30 B C
ATOM 4185 CB ASP B 249 -18. .584 3. .108 -10. .808 1. .00 39. .37 B C
ATOM 4186 CG ASP B 249 -18. .039 3. .154 -9. .404 1. .00 40. .69 B c
ATOM 4187 ODl ASP B 249 -18. .225 2. .155 -8. .689 1. .00 41. .67 B o
ATOM 4188 OD2 ASP B 249 -17. .424 4. .177 -9. .012 1. .00 43. .16 B o
ATOM 4189 C ASP B 249 -18. .900 1. .649 -12. .835 1. .00 36. .02 B c
ATOM 4190 o ASP B 249 -19. .690 0. .703 -12. .830 1. .00 35. .49 B o
ATOM 4191 N ALA B 250 -18. .764 2. .454 -13. .876 1. .00 33. .52 B N
ATOM 4192 CA ALA B 250 -19. .556 2. .228 -15. .067 1. .00 34. .12 B c
ATOM 4193 CB ALA B 250 -19. .554 3. .465 -15. .932 1. .00 34. .74 B c
ATOM 4194 C ALA B 250 -19. .078 1. .005 -15. .872 1. .00 34. .00 B c
ATOM 4195 o ALA B 250 -19. .898 0. .291 -16. .453 1. .00 33. .32 B o
ATOM 4196 N ALA B 251 -17. .764 0. .775 -15. .914 1. .00 33. .23 B N
ATOM 4197 CA ALA B 251 -17. .192 -0. .376 -16. .634 1. .00 32. .65 B c
ATOM 4198 CB ALA B 251 -15. .680 -0. .332 -16. .595 1. .00 31. .92 B c
ATOM 4199 C ALA B 251 -17. .699 -1. .735 -16. .145 1. .00 33. .52 B c
ATOM 4200 o ALA B 251 -18. .037 -2. .579 -16. .969 1. .00 33. .05 B o
ATOM 4201 N VAL B 252 -17. .778 -1. .946 -14. .827 1. .00 34. .61 B N
ATOM 4202 CA VAL B 252 -18. .321 -3. .223 -14. .299 1. .00 37. .23 B c
ATOM 4203 CB VAL B 252 -18. .148 -3. .454 -12. .757 1. .00 38. .13 B c
ATOM 4204 CGl VAL B 252 -16. .734 -3. .132 -12. .298 1. .00 39. .21 B c
ATOM 4205 CG2 VAL B 252 -19. .148 -2. .657 -11. .925 1. .00 39. .85 B c
ATOM 4206 C VAL B 252 -19. .791 -3. .316 -14. .626 1. .00 38. .70 B c
ATOM 4207 o VAL B 252 -20. .309 -4. .393 -14. .881 1. .00 42. .70 B o
ATOM 4208 N GLN B 253 -20. .458 -2. .170 -14. .596 1. .00 39. .66 B N
ATOM 4209 CA GLN B 253 -21. .882 -2. .101 -14. .842 1. .00 38. .93 B c
ATOM 4210 CB GLN B 253 -22. .363 -0. .650 -14. .690 1. .00 39. .08 B c
ATOM 4211 CG GLN B 253 -23. .849 -0. .455 -14. .817 1. .00 38. .82 B c
ATOM 4212 CD GLN B 253 -24. .597 -1. .398 -13. .925 1. .00 40. .50 B c
ATOM 4213 OEl GLN B 253 -25. .255 -2. .330 -14. .399 1. .00 41. .81 B o
ATOM 4214 NE2 GLN B 253 -24. .472 -1. .195 -12. .621 1. .00 39. .98 B N
ATOM 4215 C GLN B 253 -22. .146 -2. .631 -16. .242 1. .00 38. .11 B c
ATOM 4216 o GLN B 253 -23. .110 -3. .345 -16. .462 1. .00 39. .28 B o
ATOM 4217 N ILE B 254 -21. .255 -2. .307 -17. .171 1. .00 37. .48 B N
ATOM 4218 CA ILE B 254 -21. .358 -2. .789 -18. .537 1. .00 37. .65 B c
ATOM 4219 CB ILE B 254 -20. .279 -2. .163 -19. .426 1. .00 37. .54 B c
ATOM 4220 CGl ILE B 254 -20. .665 -0. .718 -19. .712 1. .00 38. .79 B c
ATOM 4221 CDl ILE B 254 -19. .526 0. .104 -20. .271 1. .00 40. .86 B c
ATOM 4222 CG2 ILE B 254 -20. .068 -2. .972 -20. .714 1. .00 36. .04 B c
ATOM 4223 C ILE B 254 -21. .210 -4. .292 -18. .625 1. .00 38. .14 B c
ATOM 4224 o ILE B 254 -21. .986 -4. .948 -19. .323 1. .00 38. .29 B o
ATOM 4225 N PHE B 255 -20. .194 -4. .825 -17. .950 1. .00 37. .29 B N
ATOM 4226 CA PHE B 255 -19. .928 -6. .270 -17. .980 1. .00 35. .20 B c
ATOM 4227 CB PHE B 255 -18. .526 -6. .589 -17. .464 1. .00 34. .13 B c
ATOM 4228 CG PHE B 255 -17. .464 -6. .328 -18. .483 1. .00 33. .10 B c
ATOM 4229 CDl PHE B 255 -16. .910 -5. .080 -18. .618 1. .00 33. .11 B c
ATOM 4230 CEl PHE B 255 -15. .939 -4. .847 -19. .585 1. .00 34. .35 B c
ATOM 4231 CZ PHE B 255 -15. .532 -5. .870 -20. .437 1. .00 32. .78 B c
ATOM 4232 CE2 PHE B 255 -16. .107 -7. .110 -20. .329 1. .00 31. .36 B c
ATOM 4233 CD 2 PHE B 255 -17. .064 -7. .332 -19. .355 1. .00 32. .90 B c
ATOM 4234 C PHE B 255 -20. .993 -7. .089 -17. .266 1. .00 33. .97 B c
ATOM 4235 o PHE B 255 -21. .437 -8. .090 -17. .805 1. .00 33. .61 B o
ATOM 4236 N TYR B 256 -21. .439 -6. .656 -16. .091 1. .00 33. .92 B N
ATOM 4237 CA TYR B 256 -22. .584 -7. .298 -15. .444 1. .00 33. .80 B c
ATOM 4238 CB TYR B 256 -22. .962 -6. .573 -14. .186 1. .00 32. .62 B c
ATOM 4239 CG TYR B 256 -24. .124 -7. .165 -13. .423 1. .00 32. .49 B c
ATOM 4240 CDl TYR B 256 -25. .450 -6. .822 -13. .740 1. .00 31. .86 B c
ATOM 4241 CEl TYR B 256 -26. .517 -7. .342 -13. .024 1. .00 31. .32 B c
ATOM 4242 CZ TYR B 256 -26. .269 -8. .192 -11. .946 1. .00 32. .70 B c
ATOM 4243 OH TYR B 256 -27. .318 -8. .694 -11. .211 1. .00 32. .98 B o
ATOM 4244 CE2 TYR B 256 -24. .963 -8. .522 -11. .588 1. .00 32. .52 B c
ATOM 4245 CD 2 TYR B 256 -23. .903 -8. .012 -12. .328 1. .00 32. .27 B c
ATOM 4246 C TYR B 256 -23. .783 -7. .300 -16. .360 1. .00 36. .90 B c
ATOM 4247 o TYR B 256 -24. .413 -8. .325 -16. .534 1. .00 41. .30 B o
ATOM 4248 N ASP B 257 -24. .117 -6. .160 -16. .951 1. .00 39. .22 B N
ATOM 4249 CA ASP B 257 -25. .285 -6. .114 -17. .840 1. .00 40. .23 B c
ATOM 4250 CB ASP B 257 -25. .574 -4. .679 -18. .327 1. .00 42. .15 B c
ATOM 4251 CG ASP B 257 -26. .329 -3. .819 -17. .279 1. .00 43. .41 B c
ATOM 4252 ODl ASP B 257 -26. .693 -4. .314 -16. .188 1. .00 41. .38 B o
ATOM 4253 OD2 ASP B 257 -26. .567 -2. .623 -17. .563 1. .00 46. .53 B o
ATOM 4254 C ASP B 257 -25..131 -7.101 -19..013 1..00 38..49 B C
ATOM 4255 o ASP B 257 -26. .062 -7. 828 -19. .341 1. .00 37. .98 B o
ATOM 4256 N ALA B 258 -23. .949 -7. 150 -19. .616 1. .00 37. .63 B N
ATOM 4257 CA ALA B 258 -23. .694 -8. 082 -20. .718 1. .00 37. .54 B C
ATOM 4258 CB ALA B 258 -22. .317 -7. 832 -21. .331 1. .00 37. .74 B C
ATOM 4259 C ALA B 258 -23. .833 -9. 547 -20. .274 1. .00 36. .90 B c
ATOM 4260 o ALA B 258 -24. .351 -10. 371 -21. .013 1. .00 37. .34 B o
ATOM 4261 N LEU B 259 -23. .373 -9. 849 -19. .067 1. .00 35. .49 B N
ATOM 4262 CA LEU B 259 -23. .468 -11. 194 -18. .485 1. .00 36. .20 B c
ATOM 4263 CB LEU B 259 -22. .692 -11. 243 -17. .149 1. .00 35. .03 B c
ATOM 4264 CG LEU B 259 -22. .789 -12. 477 -16. .249 1. .00 33. .50 B c
ATOM 4265 CDl LEU B 259 -21. .969 -13. 599 -16. .855 1. .00 34. .00 B c
ATOM 4266 CD 2 LEU B 259 -22. .320 -12. 197 -14. .830 1. .00 32. .11 B c
ATOM 4267 C LEU B 259 -24. .910 -11. 618 -18. .227 1. .00 37. .29 B c
ATOM 4268 o LEU B 259 -25. .238 -12. 795 -18. .305 1. .00 37. .07 B o
ATOM 4269 N ILE B 260 -25. .760 -10. 662 -17. .889 1. .00 41. .20 B N
ATOM 4270 CA ILE B 260 -27. .138 -10. 968 -17. .499 1. .00 45. .53 B c
ATOM 4271 CB ILE B 260 -27. .679 -9. 922 -16. .468 1. .00 47. .96 B c
ATOM 4272 CGl ILE B 260 -27. .242 -10. 273 -15. .049 1. .00 49. .37 B c
ATOM 4273 CDl ILE B 260 -25. .754 -10. 302 -14. .809 1. .00 50. .87 B c
ATOM 4274 CG2 ILE B 260 -29. .203 -9. 896 -16. .425 1. .00 50. .61 B c
ATOM 4275 C ILE B 260 -28. .037 -11. 059 -18. .746 1. .00 41. .96 B c
ATOM 4276 o ILE B 260 -29. .047 -11. 766 -18. .741 1. .00 37. .45 B o
ATOM 4277 N ASN B 261 -27. .647 -10. 353 -19. .806 1. .00 41. .28 B N
ATOM 4278 CA ASN B 261 -28. .562 -10. 065 -20. .900 1. .00 42. .92 B c
ATOM 4279 CB ASN B 261 -28. .929 -8. 555 -20. .935 1. .00 41. .62 B c
ATOM 4280 CG ASN B 261 -29. .766 -8. 108 -19. .723 1. .00 42. .05 B c
ATOM 4281 ODl ASN B 261 -29. .472 -7. 101 -19. .087 1. .00 39. .28 B o
ATOM 4282 ND2 ASN B 261 -30. .817 -8. 854 -19. .410 1. .00 44. .78 B N
ATOM 4283 C ASN B 261 -28. .086 -10. 509 -22. .266 1. .00 42. .09 B c
ATOM 4284 o ASN B 261 -28. .894 -10. 541 -23. .181 1. .00 46. .04 B o
ATOM 4285 N TYR B 262 -26. .811 -10. 840 -22. .437 1. .00 40. .74 B N
ATOM 4286 CA TYR B 262 -26. .328 -11. 224 -23. .775 1. .00 43. .37 B c
ATOM 4287 CB TYR B 262 -25. .645 -10. 035 -24. .471 1. .00 45. .46 B c
ATOM 4288 CG TYR B 262 -26. .615 -8. 895 -24. .720 1. .00 50. .69 B c
ATOM 4289 CDl TYR B 262 -27. .687 -9. 048 -25. .610 1. .00 53. .20 B c
ATOM 4290 CEl TYR B 262 -28. .603 -8. 023 -25. .824 1. .00 51. .02 B c
ATOM 4291 CZ TYR B 262 -28. .459 -6. 829 -25. .145 1. .00 50. .83 B c
ATOM 4292 OH TYR B 262 -29. .355 -5. 817 -25. .374 1. .00 49. .75 B o
ATOM 4293 CE2 TYR B 262 -27. .406 -6. 644 -24. .259 1. .00 51. .59 B c
ATOM 4294 CD 2 TYR B 262 -26. .497 -7. 676 -24. .040 1. .00 52. .01 B c
ATOM 4295 C TYR B 262 -25. .448 -12. 478 -23. .816 1. .00 42. .34 B c
ATOM 4296 o TYR B 262 -25. .698 -13. 358 -24. .629 1. .00 40. .29 B o
ATOM 4297 N LEU B 263 -24. .442 -12. 568 -22. .943 1. .00 42. .79 B N
ATOM 4298 CA LEU B 263 -23. .480 -13. 686 -22. .966 1. .00 40. .87 B c
ATOM 4299 CB LEU B 263 -22. .404 -13. 522 -21. .890 1. .00 39. .39 B c
ATOM 4300 CG LEU B 263 -21. .392 -12. 379 -22. .072 1. .00 39. .16 B c
ATOM 4301 CDl LEU B 263 -20. .636 -12. 135 -20. .758 1. .00 38. .76 B c
ATOM 4302 CD 2 LEU B 263 -20. .439 -12. 620 -23. .251 1. .00 36. .77 B c
ATOM 4303 C LEU B 263 -24. .182 -15. 025 -22. .784 1. .00 41. .44 B c
ATOM 4304 o LEU B 263 -24. .950 -15. 224 -21. .830 1. .00 43. .17 B o
ATOM 4305 N THR B 264 -23. .920 -15. 937 -23. .710 1. .00 39. .41 B N
ATOM 4306 CA THR B 264 -24. .539 -17. 252 -23. .678 1. .00 39. .11 B c
ATOM 4307 CB THR B 264 -25. .110 -17. 637 -25. .071 1. .00 37. .81 B c
ATOM 4308 OGl THR B 264 -24. .209 -17. 240 -26. .114 1. .00 34. .47 B o
ATOM 4309 CG2 THR B 264 -26. .464 -16. 980 -25. .291 1. .00 37. .47 B c
ATOM 4310 C THR B 264 -23. .516 -18. 289 -23. .180 1. .00 39. .71 B c
ATOM 4311 o THR B 264 -22. .332 -17. 968 -22. .988 1. .00 39. .63 B o
ATOM 4312 N PRO B 265 -23. .967 -19. 534 -22. .956 1. .00 37. .47 B N
ATOM 4313 CA PRO B 265 -23. .020 -20. 582 -22. .606 1. .00 36. .51 B c
ATOM 4314 CB PRO B 265 -23. .914 -21. 815 -22. .485 1. .00 36. .96 B c
ATOM 4315 CG PRO B 265 -25. .212 -21. 258 -21. .998 1. .00 36. .90 B c
ATOM 4316 CD PRO B 265 -25. .362 -19. 978 -22. .764 1. .00 37. .02 B c
ATOM 4317 C PRO B 265 -21. .889 -20. 826 -23. .602 1. .00 34. .86 B c
ATOM 4318 o PRO B 265 -20. .886 -21. 386 -23. .218 1. .00 34. .81 B o
ATOM 4319 N THR B 266 -22. .029 -20. 371 -24. .836 1. .00 36. .32 B N
ATOM 4320 CA THR B 266 -21. .064 -20. 660 -25. .909 1. .00 38. .58 B c
ATOM 4321 CB THR B 266 -21. .832 -21. 113 -27. .172 1. .00 39. .51 B c
ATOM 4322 OGl THR B 266 -22. .792 -22. 103 -26. .783 1. .00 40. .49 B o
ATOM 4323 CG2 THR B 266 -20. .891 -21. 667 -28. .272 1. .00 39. .24 B c
ATOM 4324 C THR B 266 -20. .208 -19. 477 -26. .339 1. .00 37. .79 B c
ATOM 4325 o THR B 266 -19. .415 -19. 606 -27. .267 1. .00 40. .23 B o
ATOM 4326 N SER B 267 -20. .369 -18. 324 -25. .697 1. .00 36. .30 B N
ATOM 4327 CA SER B 267 -19. .731 -17. 102 -26. .183 1. .00 34. .28 B c
ATOM 4328 CB SER B 267 -20. .113 -15. 912 -25. .319 1. .00 35. .49 B c
ATOM 4329 OG SER B 267 -21. .451 -16. 033 -24. .828 1. .00 37. .99 B o
ATOM 4330 C SER B 267 -18. .230 -17. 251 -26. .190 1. .00 32. .77 B c
ATOM 4331 o SER B 267 -17. .641 -17. 643 -25. .208 1. .00 33. .92 B o
ATOM 4332 N ASN B 268 -17. .620 -16. 986 -27. .326 1. .00 32. .61 B N
ATOM 4333 CA ASN B 268 -16..182 -16..863 -27..415 1..00 33..06 B C
ATOM 4334 CB ASN B 268 -15. .729 -17. .371 -28. .773 1. .00 33. .54 B C
ATOM 4335 CG ASN B 268 -16. .267 -16. .536 -29. .895 1. .00 33. .79 B C
ATOM 4336 ODl ASN B 268 -17. .326 -15. .949 -29. .777 1. .00 35. .97 B o
ATOM 4337 ND2 ASN B 268 -15. .540 -16. .461 -30. .975 1. .00 34. .73 B N
ATOM 4338 C ASN B 268 -15. .787 -15. .390 -27. .231 1. .00 34. .80 B C
ATOM 4339 o ASN B 268 -16. .626 -14. .538 -26. .913 1. .00 34. .48 B o
ATOM 4340 N PHE B 269 -14. .514 -15. .079 -27. .443 1. .00 36. .91 B N
ATOM 4341 CA PHE B 269 -14. .026 -13. .738 -27. .157 1. .00 38. .91 B C
ATOM 4342 CB PHE B 269 -12. .507 -13. .628 -27. .385 1. .00 40. .79 B C
ATOM 4343 CG PHE B 269 -11. .681 -13. .874 -26. .141 1. .00 41. .78 B c
ATOM 4344 CDl PHE B 269 -11. .418 -12. .849 -25. .251 1. .00 41. .82 B c
ATOM 4345 CEl PHE B 269 -10. .654 -13. .078 -24. .112 1. .00 41. .04 B c
ATOM 4346 CZ PHE B 269 -10. .135 -14. .332 -23. .857 1. .00 38. .55 B c
ATOM 4347 CE2 PHE B 269 -10. .382 -15. .356 -24. .732 1. .00 38. .41 B c
ATOM 4348 CD 2 PHE B 269 -11. .155 -15. .130 -25. .867 1. .00 41. .11 B c
ATOM 4349 C PHE B 269 -14. .805 -12. .684 -27. .957 1. .00 38. .14 B c
ATOM 4350 o PHE B 269 -15. .419 -11. .804 -27. .371 1. .00 37. .56 B o
ATOM 4351 N SER B 270 -14. .842 -12. .803 -29. .281 1. .00 36. .64 B N
ATOM 4352 CA SER B 270 -15. .531 -11. .802 -30. .090 1. .00 34. .60 B c
ATOM 4353 CB SER B 270 -14. .897 -11. .695 -31. .499 1. .00 34. .71 B c
ATOM 4354 OG SER B 270 -15. .617 -12. .383 -32. .491 1. .00 34. .03 B o
ATOM 4355 C SER B 270 -17. .045 -12. .041 -30. .114 1. .00 32. .63 B c
ATOM 4356 o SER B 270 -17. .674 -11. .999 -31. .146 1. .00 36. .29 B o
ATOM 4357 N ALA B 271 -17. .604 -12. .349 -28. .960 1. .00 30. .68 B N
ATOM 4358 CA ALA B 271 -19. .038 -12. .294 -28. .730 1. .00 30. .92 B c
ATOM 4359 CB ALA B 271 -19. .613 -13. .701 -28. .600 1. .00 30. .65 B c
ATOM 4360 C ALA B 271 -19. .247 -11. .507 -27. .444 1. .00 30. .93 B c
ATOM 4361 o ALA B 271 -20. .307 -10. .917 -27. .213 1. .00 29. .36 B o
ATOM 4362 N MET B 272 -18. .229 -11. .586 -26. .584 1. .00 32. .20 B N
ATOM 4363 CA MET B 272 -18. .031 -10. .679 -25. .460 1. .00 32. .76 B c
ATOM 4364 CB MET B 272 -16. .756 -11. .071 -24. .673 1. .00 32. .48 B c
ATOM 4365 CG MET B 272 -16. .360 -10. .134 -23. .533 1. .00 31. .70 B c
ATOM 4366 SD MET B 272 -17. .286 -10. .362 -22. .001 1. .00 31. .29 B s
ATOM 4367 CE MET B 272 -18. .784 -9. .421 -22. .293 1. .00 30. .09 B c
ATOM 4368 C MET B 272 -17. .923 -9. .252 -25. .975 1. .00 32. .88 B c
ATOM 4369 o MET B 272 -18. .662 -8. .395 -25. .515 1. .00 32. .30 B o
ATOM 4370 N ARG B 273 -17. .011 -9. .021 -26. .933 1. .00 34. .73 B N
ATOM 4371 CA ARG B 273 -16. .906 -7. .739 -27. .658 1. .00 35. .03 B c
ATOM 4372 CB ARG B 273 -16. .032 -7. .842 -28. .925 1. .00 34. .92 B c
ATOM 4373 CG ARG B 273 -15. .783 -6. .483 -29. .582 1. .00 36. .57 B c
ATOM 4374 CD ARG B 273 -15. .352 -6. .494 -31. .046 1. .00 38. .56 B c
ATOM 4375 NE ARG B 273 -15. .489 -5. .154 -31. .660 1. .00 40. .10 B N
ATOM 4376 CZ ARG B 273 -14. .486 -4. .289 -31. .894 1. .00 40. .63 B c
ATOM 4377 NHl ARG B 273 -13. .218 -4. .572 -31. .590 1. .00 39. .02 B N
ATOM 4378 NH2 ARG B 273 -14. .752 -3. .107 -32. .442 1. .00 41. .17 B N
ATOM 4379 C ARG B 273 -18. .295 -7. .267 -28. .039 1. .00 34. .93 B C
ATOM 4380 o ARG B 273 -18. .770 -6. .252 -27. .549 1. .00 34. .29 B o
ATOM 4381 N ALA B 274 -18. .955 -8. .045 -28. .884 1. .00 37. .65 B N
ATOM 4382 CA ALA B 274 -20. .304 -7. .717 -29. .344 1. .00 37. .88 B C
ATOM 4383 CB ALA B 274 -20. .886 -8. .866 -30. .184 1. .00 38. .03 B c
ATOM 4384 C ALA B 274 -21. .217 -7. .383 -28. .170 1. .00 33. .95 B c
ATOM 4385 o ALA B 274 -21. .822 -6. .319 -28. .149 1. .00 32. .98 B o
ATOM 4386 N ALA B 275 -21. .296 -8. .285 -27. .200 1. .00 32. .07 B N
ATOM 4387 CA ALA B 275 -22. .201 -8. .106 -26. .070 1. .00 33. .08 B c
ATOM 4388 CB ALA B 275 -22. .345 -9. .407 -25. .299 1. .00 32. .37 B c
ATOM 4389 C ALA B 275 -21. .789 -6. .962 -25. .127 1. .00 34. .71 B c
ATOM 4390 o ALA B 275 -22. .640 -6. .437 -24. .384 1. .00 33. .51 B o
ATOM 4391 N ALA B 276 -20. .505 -6. .581 -25. .166 1. .00 34. .12 B N
ATOM 4392 CA ALA B 276 -19. .991 -5. .442 -24. .381 1. .00 34. .35 B c
ATOM 4393 CB ALA B 276 -18. .467 -5. .428 -24. .360 1. .00 34. .79 B c
ATOM 4394 C ALA B 276 -20. .486 -4. .140 -24. .970 1. .00 33. .42 B c
ATOM 4395 o ALA B 276 -20. .986 -3. .249 -24. .258 1. .00 30. .24 B o
ATOM 4396 N ILE B 277 -20. .313 -4. .046 -26. .284 1. .00 33. .82 B N
ATOM 4397 CA ILE B 277 -20. .893 -2. .967 -27. .069 1. .00 34. .25 B c
ATOM 4398 CB ILE B 277 -20. .669 -3. .167 -28. .584 1. .00 32. .40 B c
ATOM 4399 CGl ILE B 277 -19. .176 -2. .974 -28. .939 1. .00 30. .53 B c
ATOM 4400 CDl ILE B 277 -18. .811 -3. .402 -30. .343 1. .00 30. .29 B c
ATOM 4401 CG2 ILE B 277 -21. .570 -2. .220 -29. .370 1. .00 32. .72 B c
ATOM 4402 C ILE B 277 -22. .376 -2. .909 -26. .750 1. .00 35. .55 B c
ATOM 4403 o ILE B 277 -22. .852 -1. .988 -26. .123 1. .00 37. .39 B o
ATOM 4404 N GLN B 278 -23. .092 -3. .943 -27. .119 1. .00 38. .65 B N
ATOM 4405 CA GLN B 278 -24. .511 -3. .926 -26. .950 1. .00 39. .92 B c
ATOM 4406 CB GLN B 278 -25. .094 -5. .290 -27. .321 1. .00 39. .74 B c
ATOM 4407 CG GLN B 278 -26. .606 -5. .300 -27. .308 1. .00 39. .67 B c
ATOM 4408 CD GLN B 278 -27. .189 -4. .111 -28. .042 1. .00 38. .74 B c
ATOM 4409 OEl GLN B 278 -26. .710 -3. .731 -29. .109 1. .00 35. .78 B o
ATOM 4410 NE2 GLN B 278 -28. .208 -3. .499 -27. .453 1. .00 38. .39 B N
ATOM 4411 C GLN B 278 -24. .965 -3. .489 -25. .546 1. .00 42. .36 B c
ATOM 4412 o GLN B 278 -25..940 -2..757 -25..439 1..00 48..71 B o
ATOM 4413 N ALA B 279 -24. .285 -3. .905 -24. .478 1. .00 45. .05 B N
ATOM 4414 CA ALA B 279 -24. .730 -3. .520 -23. .108 1. .00 46. .98 B C
ATOM 4415 CB ALA B 279 -24. .072 -4. .393 -22. .055 1. .00 46. .66 B C
ATOM 4416 C ALA B 279 -24. .469 -2. .039 -22. .790 1. .00 48. .10 B c
ATOM 4417 o ALA B 279 -25. .275 -1. .393 -22. .123 1. .00 45. .73 B o
ATOM 4418 N ALA B 280 -23. .325 -1. .529 -23. .261 1. .00 50. .53 B N
ATOM 4419 CA ALA B 280 -22. .959 -0. .109 -23. .139 1. .00 49. .16 B c
ATOM 4420 CB ALA B 280 -21. .503 0. .098 -23. .531 1. .00 48. .26 B c
ATOM 4421 C ALA B 280 -23. .850 0. .770 -24. .006 1. .00 50. .26 B c
ATOM 4422 o ALA B 280 -24. .128 1. .910 -23. .647 1. .00 55. .46 B o
ATOM 4423 N THR B 281 -24. .272 0. .236 -25. .150 1. .00 46. .81 B N
ATOM 4424 CA THR B 281 -25. .211 0. .899 -26. .024 1. .00 45. .54 B c
ATOM 4425 CB THR B 281 -25. .317 0. .164 -27. .381 1. .00 47. .69 B c
ATOM 4426 OGl THR B 281 -24. .123 0. .397 -28. .143 1. .00 48. .16 B o
ATOM 4427 CG2 THR B 281 -26. .488 0. .648 -28. .210 1. .00 48. .37 B c
ATOM 4428 C THR B 281 -26. .557 1. .023 -25. .310 1. .00 47. .32 B c
ATOM 4429 o THR B 281 -27. .094 2. .131 -25. .213 1. .00 49. .73 B o
ATOM 4430 N ASP B 282 -27. .081 -0. .081 -24. .771 1. .00 47. .65 B N
ATOM 4431 CA ASP B 282 -28. .330 -0. .052 -23. .961 1. .00 49. .02 B c
ATOM 4432 CB ASP B 282 -28. .609 -1. .428 -23. .343 1. .00 49. .93 B c
ATOM 4433 CG ASP B 282 -29. .000 -2. .464 -24. .366 1. .00 51. .23 B c
ATOM 4434 ODl ASP B 282 -29. .308 -2. .090 -25. .518 1. .00 47. .87 B o
ATOM 4435 OD2 ASP B 282 -28. .995 -3. .662 -24. .005 1. .00 53. .69 B o
ATOM 4436 C ASP B 282 -28. .359 0. .976 -22. .811 1. .00 49. .83 B c
ATOM 4437 o ASP B 282 -29. .439 1. .378 -22. .350 1. .00 47. .84 B o
ATOM 4438 N LEU B 283 -27. .177 1. .363 -22. .329 1. .00 51. .88 B N
ATOM 4439 CA LEU B 283 -27. .052 2. .309 -21. .218 1. .00 52. .09 B c
ATOM 4440 CB LEU B 283 -26. .006 1. .820 -20. .213 1. .00 52. .89 B c
ATOM 4441 CG LEU B 283 -26. .431 0. .781 -19. .184 1. .00 52. .14 B c
ATOM 4442 CDl LEU B 283 -25. .348 0. .710 -18. .117 1. .00 51. .63 B c
ATOM 4443 CD 2 LEU B 283 -27. .796 1. .094 -18. .578 1. .00 50. .82 B c
ATOM 4444 C LEU B 283 -26. .675 3. .721 -21. .656 1. .00 49. .74 B c
ATOM 4445 o LEU B 283 -27. .352 4. .665 -21. .303 1. .00 50. .65 B o
ATOM 4446 N TYR B 284 -25. .586 3. .863 -22. .401 1. .00 48. .81 B N
ATOM 4447 CA TYR B 284 -25. .061 5. .189 -22. .727 1. .00 49. .44 B c
ATOM 4448 CB TYR B 284 -23. .556 5. .262 -22. .403 1. .00 50. .48 B c
ATOM 4449 CG TYR B 284 -23. .236 4. .737 -21. .026 1. .00 49. .15 B c
ATOM 4450 CDl TYR B 284 -23. .872 5. .254 -19. .903 1. .00 49. .52 B c
ATOM 4451 CEl TYR B 284 -23. .603 4. .762 -18. .632 1. .00 50. .75 B c
ATOM 4452 CZ TYR B 284 -22. .681 3. .732 -18. .471 1. .00 50. .38 B c
ATOM 4453 OH TYR B 284 -22. .404 3. .229 -17. .205 1. .00 47. .77 B o
ATOM 4454 CE2 TYR B 284 -22. .048 3. .197 -19. .584 1. .00 49. .51 B c
ATOM 4455 CD 2 TYR B 284 -22. .333 3. .695 -20. .848 1. .00 49. .51 B c
ATOM 4456 C TYR B 284 -25. .315 5. .610 -24. .171 1. .00 49. .25 B c
ATOM 4457 o TYR B 284 -24. .821 6. .647 -24. .590 1. .00 48. .69 B o
ATOM 4458 N GLY B 285 -26. .074 4. .821 -24. .930 1. .00 50. .48 B N
ATOM 4459 CA GLY B 285 -26. .504 5. .227 -26. .273 1. .00 49. .49 B c
ATOM 4460 C GLY B 285 -25. .475 4. .969 -27. .360 1. .00 48. .24 B c
ATOM 4461 o GLY B 285 -24. .297 5. .259 -27. .199 1. .00 44. .44 B o
ATOM 4462 N ALA B 286 -25. .958 4. .477 -28. .494 1. .00 49. .71 B N
ATOM 4463 CA ALA B 286 -25. .129 3. .842 -29. .533 1. .00 53. .31 B c
ATOM 4464 CB ALA B 286 -25. .958 3. .664 -30. .805 1. .00 54. .01 B c
ATOM 4465 C ALA B 286 -23. .777 4. .486 -29. .893 1. .00 53. .88 B c
ATOM 4466 o ALA B 286 -22. .839 3. .779 -30. .282 1. .00 51. .19 B o
ATOM 4467 N ASN B 287 -23. .673 5. .807 -29. .803 1. .00 54. .40 B N
ATOM 4468 CA ASN B 287 -22. .489 6. .464 -30. .315 1. .00 57. .64 B c
ATOM 4469 CB ASN B 287 -22. .872 7. .348 -31. .514 1. .00 60. .09 B c
ATOM 4470 CG ASN B 287 -22. .568 6. .674 -32. .851 1. .00 60. .57 B c
ATOM 4471 ODl ASN B 287 -21. .399 6. .491 -33. .202 1. .00 62. .04 B o
ATOM 4472 ND2 ASN B 287 -23. .610 6. .296 -33. .598 1. .00 57. .39 B N
ATOM 4473 C ASN B 287 -21. .741 7. .215 -29. .227 1. .00 58. .94 B c
ATOM 4474 o ASN B 287 -21. .301 8. .344 -29. .423 1. .00 58. .57 B o
ATOM 4475 N SER B 288 -21. .549 6. .542 -28. .093 1. .00 58. .78 B N
ATOM 4476 CA SER B 288 -21. .058 7. .184 -26. .870 1. .00 54. .62 B c
ATOM 4477 CB SER B 288 -21. .578 6. .456 -25. .636 1. .00 53. .53 B c
ATOM 4478 OG SER B 288 -22. .968 6. .277 -25. .713 1. .00 53. .88 B o
ATOM 4479 C SER B 288 -19. .554 7. .219 -26. .756 1. .00 52. .14 B c
ATOM 4480 o SER B 288 -18. .835 6. .460 -27. .428 1. .00 48. .93 B o
ATOM 4481 N SER B 289 -19. .101 8. .113 -25. .877 1. .00 49. .50 B N
ATOM 4482 CA SER B 289 -17. .748 8. .063 -25. .338 1. .00 48. .18 B c
ATOM 4483 CB SER B 289 -17. .658 8. .897 -24. .062 1. .00 46. .70 B c
ATOM 4484 OG SER B 289 -17. .504 10. .261 -24. .344 1. .00 47. .82 B o
ATOM 4485 C SER B 289 -17. .420 6. .629 -24. .973 1. .00 45. .61 B c
ATOM 4486 o SER B 289 -16. .363 6. .096 -25. .322 1. .00 42. .65 B o
ATOM 4487 N GLN B 290 -18. .371 6. .033 -24. .264 1. .00 44. .11 B N
ATOM 4488 CA GLN B 290 -18. .221 4. .722 -23. .655 1. .00 45. .53 B c
ATOM 4489 CB GLN B 290 -19. .422 4. .420 -22. .743 1. .00 46. .86 B c
ATOM 4490 CG GLN B 290 -19. .350 5. .126 -21. .390 1. .00 48. .38 B c
ATOM 4491 CD GLN B 290 -19..890 6..548 -21..405 1..00 46..61 B C
ATOM 4492 OEl GLN B 290 -20. .064 7. .138 -22. .465 1. .00 47. .54 B o
ATOM 4493 NE2 GLN B 290 -20. .156 7. .098 -20. .221 1. .00 44. .66 B N
ATOM 4494 C GLN B 290 -18. .081 3. .619 -24. .674 1. .00 43. .32 B C
ATOM 4495 o GLN B 290 -17. .141 2. .838 -24. .621 1. .00 41. .88 B o
ATOM 4496 N VAL B 291 -19. .029 3. .562 -25. .594 1. .00 41. .50 B N
ATOM 4497 CA VAL B 291 -19. .014 2. .555 -26. .622 1. .00 40. .16 B C
ATOM 4498 CB VAL B 291 -20. .266 2. .679 -27. .505 1. .00 39. .26 B C
ATOM 4499 CGl VAL B 291 -20. .219 1. .674 -28. .647 1. .00 39. .12 B c
ATOM 4500 CG2 VAL B 291 -21. .524 2. .494 -26. .651 1. .00 38. .82 B c
ATOM 4501 C VAL B 291 -17. .714 2. .639 -27. .432 1. .00 41. .56 B c
ATOM 4502 o VAL B 291 -17. .078 1. .624 -27. .664 1. .00 41. .96 B o
ATOM 4503 N ASN B 292 -17. .303 3. .847 -27. .821 1. .00 47. .66 B N
ATOM 4504 CA ASN B 292 -16. .051 4. .063 -28. .595 1. .00 49. .69 B c
ATOM 4505 CB ASN B 292 -15. .801 5. .576 -28. .850 1. .00 56. .17 B c
ATOM 4506 CG ASN B 292 -16. .608 6. .138 -30. .026 1. .00 59. .22 B c
ATOM 4507 ODl ASN B 292 -16. .441 5. .711 -31. .179 1. .00 58. .08 B o
ATOM 4508 ND2 ASN B 292 -17. .466 7. .126 -29. .741 1. .00 57. .45 B N
ATOM 4509 C ASN B 292 -14. .813 3. .473 -27. .908 1. .00 44. .46 B c
ATOM 4510 o ASN B 292 -13. .892 2. .961 -28. .567 1. .00 40. .14 B o
ATOM 4511 N ALA B 293 -14. .792 3. .576 -26. .581 1. .00 42. .31 B N
ATOM 4512 CA ALA B 293 -13. .730 2. .972 -25. .763 1. .00 41. .98 B c
ATOM 4513 CB ALA B 293 -13. .829 3. .451 -24. .321 1. .00 41. .43 B c
ATOM 4514 C ALA B 293 -13. .756 1. .433 -25. .810 1. .00 39. .16 B c
ATOM 4515 o ALA B 293 -12. .721 0. .815 -26. .082 1. .00 36. .57 B o
ATOM 4516 N VAL B 294 -14. .936 0. .852 -25. .539 1. .00 36. .84 B N
ATOM 4517 CA VAL B 294 -15. .177 -0. .595 -25. .610 1. .00 35. .25 B c
ATOM 4518 CB VAL B 294 -16. .659 -0. .950 -25. .468 1. .00 35. .72 B c
ATOM 4519 CGl VAL B 294 -16. .878 -2. .433 -25. .729 1. .00 37. .88 B c
ATOM 4520 CG2 VAL B 294 -17. .176 -0. .610 -24. .091 1. .00 36. .30 B c
ATOM 4521 C VAL B 294 -14. .748 -1. .144 -26. .945 1. .00 35. .55 B c
ATOM 4522 o VAL B 294 -13. .956 -2. .064 -26. .995 1. .00 33. .54 B o
ATOM 4523 N LYS B 295 -15. .286 -0. .587 -28. .025 1. .00 37. .14 B N
ATOM 4524 CA LYS B 295 -14. .869 -0. .983 -29. .360 1. .00 41. .15 B c
ATOM 4525 CB LYS B 295 -15. .422 -0. .035 -30. .422 1. .00 46. .63 B c
ATOM 4526 CG LYS B 295 -16. .913 -0. .162 -30. .660 1. .00 52. .98 B c
ATOM 4527 CD LYS B 295 -17. .355 0. .640 -31. .874 1. .00 58. .56 B c
ATOM 4528 CE LYS B 295 -18. .834 0. .407 -32. .159 1. .00 64. .17 B c
ATOM 4529 NZ LYS B 295 -19. .271 1. .113 -33. .395 1. .00 67. .47 B N
ATOM 4530 C LYS B 295 -13. .372 -0. .957 -29. .481 1. .00 39. .83 B c
ATOM 4531 o LYS B 295 -12. .768 -1. .874 -30. .035 1. .00 41. .50 B o
ATOM 4532 N LYS B 296 -12. .786 0. .118 -28. .972 1. .00 40. .95 B N
ATOM 4533 CA LYS B 296 -11. .379 0. .436 -29. .209 1. .00 42. .53 B c
ATOM 4534 CB LYS B 296 -11. .161 1. .962 -29. .047 1. .00 43. .71 B c
ATOM 4535 CG LYS B 296 -9. .937 2. .509 -29. .771 1. .00 47. .26 B c
ATOM 4536 CD LYS B 296 -10. .251 3. .670 -30. .724 1. .00 50. .59 B c
ATOM 4537 CE LYS B 296 -9. .147 3. .860 -31. .775 1. .00 51. .12 B c
ATOM 4538 NZ LYS B 296 -7. .865 4. .414 -31. .217 1. .00 50. .10 B N
ATOM 4539 C LYS B 296 -10. .477 -0. .407 -28. .291 1. .00 39. .86 B c
ATOM 4540 o LYS B 296 -9. .340 -0. .751 -28. .633 1. .00 39. .63 B o
ATOM 4541 N ALA B 297 -11. .013 -0. .758 -27. .131 1. .00 38. .67 B N
ATOM 4542 CA ALA B 297 -10. .337 -1. .648 -26. .193 1. .00 36. .50 B c
ATOM 4543 CB ALA B 297 -11. .132 -1. .753 -24. .896 1. .00 35. .52 B c
ATOM 4544 C ALA B 297 -10. .156 -3. .017 -26. .823 1. .00 35. .43 B c
ATOM 4545 o ALA B 297 -9. .033 -3. .437 -27. .087 1. .00 35. .98 B o
ATOM 4546 N TYR B 298 -11. .266 -3. .697 -27. .098 1. .00 33. .26 B N
ATOM 4547 CA TYR B 298 -11. .208 -5. .015 -27. .703 1. .00 30. .77 B c
ATOM 4548 CB TYR B 298 -12. .615 -5. .568 -27. .929 1. .00 29. .47 B c
ATOM 4549 CG TYR B 298 -13. .204 -6. .108 -26. .644 1. .00 28. .38 B c
ATOM 4550 CDl TYR B 298 -12. .809 -7. .349 -26. .131 1. .00 29. .24 B c
ATOM 4551 CEl TYR B 298 -13. .318 -7. .832 -24. .930 1. .00 28. .21 B c
ATOM 4552 CZ TYR B 298 -14. .234 -7. .070 -24. .228 1. .00 27. .78 B c
ATOM 4553 OH TYR B 298 -14. .763 -7. .485 -23. .031 1. .00 26. .67 B o
ATOM 4554 CE2 TYR B 298 -14. .638 -5. .854 -24. .728 1. .00 27. .85 B c
ATOM 4555 CD 2 TYR B 298 -14. .119 -5. .381 -25. .925 1. .00 27. .58 B c
ATOM 4556 C TYR B 298 -10. .332 -5. .057 -28. .972 1. .00 31. .41 B c
ATOM 4557 o TYR B 298 -9. .596 -6. .029 -29. .171 1. .00 33. .75 B o
ATOM 4558 N THR B 299 -10. .341 -4. .007 -29. .793 1. .00 30. .17 B N
ATOM 4559 CA THR B 299 -9. .452 -3. .990 -30. .981 1. .00 31. .63 B c
ATOM 4560 CB THR B 299 -9. .651 -2. .727 -31. .904 1. .00 30. .00 B c
ATOM 4561 OGl THR B 299 -11. .031 -2. .587 -32. .274 1. .00 29. .34 B o
ATOM 4562 CG2 THR B 299 -8. .825 -2. .848 -33. .164 1. .00 28. .55 B c
ATOM 4563 C THR B 299 -7. .963 -4. .124 -30. .561 1. .00 31. .90 B c
ATOM 4564 o THR B 299 -7. .142 -4. .745 -31. .262 1. .00 31. .07 B o
ATOM 4565 N ALA B 300 -7. .641 -3. .552 -29. .406 1. .00 32. .45 B N
ATOM 4566 CA ALA B 300 -6. .262 -3. .429 -28. .966 1. .00 33. .91 B c
ATOM 4567 CB ALA B 300 -6. .157 -2. .425 -27. .831 1. .00 35. .00 B c
ATOM 4568 C ALA B 300 -5. .718 -4. .754 -28. .521 1. .00 34. .05 B c
ATOM 4569 o ALA B 300 -4. .519 -5. .032 -28. .722 1. .00 33. .41 B o
ATOM 4570 N VAL B 301 -6..606 -5.551 -27..916 1..00 34..40 B N
ATOM 4571 CA VAL B 301 -6. .294 -6. 923 -27. .499 1. .00 35. .91 B C
ATOM 4572 CB VAL B 301 -7. .080 -7. 346 -26. .243 1. .00 35. .35 B C
ATOM 4573 CGl VAL B 301 -6. .679 -6. 467 -25. .065 1. .00 34. .72 B c
ATOM 4574 CG2 VAL B 301 -8. .587 -7. 313 -26. .485 1. .00 35. .39 B c
ATOM 4575 C VAL B 301 -6. .491 -7. 968 -28. .607 1. .00 37. .99 B c
ATOM 4576 o VAL B 301 -6. .283 -9. 152 -28. .384 1. .00 40. .13 B o
ATOM 4577 N GLY B 302 -6. .875 -7. 535 -29. .801 1. .00 39. .20 B N
ATOM 4578 CA GLY B 302 -6. .806 -8. 402 -30. .975 1. .00 38. .61 B c
ATOM 4579 C GLY B 302 -8. .120 -9. 085 -31. .268 1. .00 37. .68 B c
ATOM 4580 o GLY B 302 -8. .219 -9. 890 -32. .206 1. .00 36. .97 B o
ATOM 4581 N VAL B 303 -9. .123 -8. 764 -30. .457 1. .00 36. .46 B N
ATOM 4582 CA VAL B 303 -10. .463 -9. 269 -30. .646 1. .00 36. .09 B c
ATOM 4583 CB VAL B 303 -11. .186 -9. 418 -29. .310 1. .00 34. .30 B c
ATOM 4584 CGl VAL B 303 -12. .615 -9. 884 -29. .525 1. .00 34. .12 B c
ATOM 4585 CG2 VAL B 303 -10. .413 -10. 378 -28. .422 1. .00 34. .22 B c
ATOM 4586 C VAL B 303 -11. .210 -8. 285 -31. .529 1. .00 39. .41 B c
ATOM 4587 o VAL B 303 -11. .410 -7. 128 -31. .162 1. .00 39. .85 B o
ATOM 4588 N ASN B 304 -11. .623 -8. 767 -32. .695 1. .00 42. .29 B N
ATOM 4589 CA ASN B 304 -12. .178 -7. 934 -33. .741 1. .00 43. .11 B c
ATOM 4590 CB ASN B 304 -11. .400 -8. 162 -35. .039 1. .00 43. .44 B c
ATOM 4591 CG ASN B 304 -9. .894 -7. 915 -34. .868 1. .00 44. .48 B c
ATOM 4592 ODl ASN B 304 -9. .046 -8. 788 -35. .169 1. .00 39. .07 B o
ATOM 4593 ND2 ASN B 304 -9. .554 -6. 727 -34. .345 1. .00 44. .40 B N
ATOM 4594 C ASN B 304 -13. .644 -8. 265 -33. .895 1. .00 45. .91 B c
ATOM 4595 o ASN B 304 -14. .115 -9. 329 -33. .478 1. .00 47. .21 B o
ATOM 4596 OXT ASN B 304 -14. .398 -7. 442 -34. .401 1. .00 50. .28 B o
HETATM 4597 o HOH D 1 -14. .453 -29. 833 -15. .752 1. .00 11. .48 o
HETATM 4598 o HOH D 2 -3. .559 -28. 043 -4. .163 1. .00 10. .41 o
HETATM 4599 o HOH D 3 4. .756 -48. 667 -28. .368 1. .00 14. .01 o
HETATM 4600 o HOH D 4 18. .017 -46. 898 -29. .709 1. .00 17. .11 o
HETATM 4601 o HOH D 5 -18. .034 -41. 311 -16. .195 1. .00 16. .89 o
HETATM 4602 o HOH D 6 2. .102 -33. 576 -25. .415 1. .00 7. .28 o
HETATM 4603 o HOH D 7 4. .340 -35. 545 -22. .828 1. .00 6. .89 o
HETATM 4604 o HOH D 8 -1. .226 -54. 679 -7. .110 1. .00 10. .35 o
HETATM 4605 o HOH D 9 -12. .874 -50. 118 -9. .369 1. .00 13. .13 o
HETATM 4606 o HOH D 10 -1. .229 -11. 651 -14. .935 1. .00 8. .69 o
HETATM 4607 o HOH D 11 -26. .802 -9. 821 -2. .646 1. .00 34. .23 o
HETATM 4608 o HOH D 12 15. .279 -23. 352 -24. .790 1. .00 28. .05 o
HETATM 4609 o HOH D 14 -5. .337 -10. 672 -15. .773 1. .00 17. .85 o
HETATM 4610 o HOH D 15 1. .182 -34. 774 -17. .307 1. .00 14. .04 o
HETATM 4611 o HOH D 16 -10. .282 -45. 012 0. .457 1. .00 7. .05 o
HETATM 4612 o HOH D 17 -5. .067 -45. 950 -25. .877 1. .00 7. .74 o
HETATM 4613 o HOH D 18 -9. .466 -22. 365 4. .654 1. .00 9. .26 o
HETATM 4614 o HOH D 19 -14. .867 -34. 797 -31. .110 1. .00 12. .29 o
HETATM 4615 o HOH D 20 17. .658 -31. 345 -6. .147 1. .00 13. .22 o
HETATM 4616 o HOH D 21 -14. .706 -66. 680 -15. .999 1. .00 18. .23 o
HETATM 4617 o HOH D 24 22. .701 -44. 854 -24. .508 1. .00 13. .43 o
HETATM 4618 o HOH D 25 -1. .606 -44. 470 -24. .808 1. .00 4. .05 o
HETATM 4619 o HOH D 27 -14. .081 -49. 049 -23. .938 1. .00 5. .85 o
HETATM 4620 o HOH D 28 -1. .406 -15. 180 -13. .873 1. .00 20. .93 o
HETATM 4621 o HOH D 29 -18. .234 -61. 855 -23. .352 1. .00 15. .81 o
HETATM 4622 o HOH D 30 14. .980 -31. 161 -4. .673 1. .00 8. .84 o
HETATM 4623 o HOH D 31 25. .232 -37. 903 -28. .412 1. .00 7. .88 o
HETATM 4624 o HOH D 32 2. .306 -3. 607 -14. .150 1. .00 12. .43 o
HETATM 4625 o HOH D 33 8. .133 -32. 218 -28. .553 1. .00 21. .62 o
HETATM 4626 o HOH D 34 -9. .785 -46. 761 -10. .910 1. .00 11. .38 o
HETATM 4627 o HOH D 35 25. .957 -51. 974 -19. .833 1. .00 17. .72 o
HETATM 4628 o HOH D 36 -0. .537 -38. 406 2. .660 1. .00 12. .52 o
HETATM 4629 o HOH D 37 -6. .253 -26. 792 2. .618 1. .00 14. .95 o
HETATM 4630 o HOH D 38 -4. .277 -32. 186 -26. .909 1. .00 10. .72 o
HETATM 4631 o HOH D 40 -0. .230 -46. 981 -24. .263 1. .00 10. .61 o
HETATM 4632 o HOH D 41 9. .113 -53. 708 -16. .348 1. .00 8. .82 o
HETATM 4633 o HOH D 42 0. .527 -57. 811 -16. .009 1. .00 5. .69 o
HETATM 4634 o HOH D 43 7. .369 -49. 544 -27. .875 1. .00 11. .17 o
HETATM 4635 o HOH D 44 13. .059 -41. 050 -31. .554 1. .00 14. .34 o
HETATM 4636 o HOH D 45 -30. .779 -55. 305 -11. .958 1. .00 12. .66 o
HETATM 4637 o HOH D 46 -16. .179 -51. 696 -0. .530 1. .00 17. .86 o
HETATM 4638 o HOH D 47 6. .739 -26. 907 -6. .038 1. .00 8. .32 o
HETATM 4639 o HOH D 48 -1. .147 -27. 953 -5. .319 1. .00 11. .94 o
HETATM 4640 o HOH D 49 -27. .771 -63. 155 -6. .758 1. .00 25. .59 o
HETATM 4641 o HOH D 50 -22. .146 -51. 541 -20. .878 1. .00 23. .93 o
HETATM 4642 o HOH D 51 11. .498 -53. 494 -22. .966 1. .00 19. .18 o
HETATM 4643 o HOH D 52 -35. .618 -17. 756 3. .293 1. .00 30. .46 o
HETATM 4644 o HOH D 53 0. .936 -10. 997 -2. .654 1. .00 21. .53 o
HETATM 4645 o HOH D 55 -3. .931 -51. 435 -22. .740 1. .00 21. .73 o
HETATM 4646 o HOH D 56 -11. .411 -49. 131 -23. .961 1. .00 4. .13 o
HETATM 4647 o HOH D 57 10. .929 -42. 120 -2. .629 1. .00 8. .04 o
HETATM 4648 o HOH D 58 -5. .258 -24. 055 -13. .514 1. .00 7. .92 o
HETATM 4649 0 HOH D 59 -2..368 -2.482 -8..879 1..00 8..97 o
HETATM 4650 0 HOH D 60 22. .320 -35. 750 -12. .017 1. .00 10. .98 o
HETATM 4651 0 HOH D 61 -19. .413 -20. 255 -13. .553 1. .00 7. .71 o
HETATM 4652 0 HOH D 62 -0. .658 -31. 524 -23. .753 1. .00 8. .59 o
HETATM 4653 0 HOH D 63 14. .971 -39. 634 -33. .356 1. .00 12. .49 o
HETATM 4654 0 HOH D 64 -5. .191 -35. 793 -0. .990 1. .00 18. .79 o
HETATM 4655 0 HOH D 65 -7. .971 -52. 023 -23. .877 1. .00 7. .05 o
HETATM 4656 0 HOH D 66 -10. .996 -39. 555 -30. .895 1. .00 29. .45 o
HETATM 4657 0 HOH D 67 -5. .761 -28. 410 -26. .821 1. .00 10. .37 o
HETATM 4658 0 HOH D 69 -0. .623 -30. 084 -21. .186 1. .00 16. .74 o
HETATM 4659 0 HOH D 70 11. .237 -21. 250 -19. .622 1. .00 12. .84 o
HETATM 4660 0 HOH D 71 6. .423 -13. 673 -7. .327 1. .00 7. .62 o
HETATM 4661 0 HOH D 72 -12. .098 4. 570 -9. .813 1. .00 17. .86 o
HETATM 4662 0 HOH D 74 -19. .719 -36. 149 -15. .796 1. .00 6. .65 o
HETATM 4663 0 HOH D 75 -7. .298 -10. 821 6. .866 1. .00 16. .58 o
HETATM 4664 0 HOH D 76 24. .422 -49. 300 -6. .907 1. .00 13. .05 o
HETATM 4665 0 HOH D 79 2. .981 -11. 284 -0. .026 1. .00 18. .58 o
HETATM 4666 0 HOH D 80 -21. .114 -35. 355 -22. .146 1. .00 14. .58 o
HETATM 4667 0 HOH D 84 1. .731 -15. 045 -10. .266 1. .00 16. .73 o
HETATM 4668 0 HOH D 85 -14. .299 -20. 123 -30. .892 1. .00 18. .20 o
HETATM 4669 0 HOH D 86 14. .254 -53. 364 -21. .911 1. .00 8. .78 o
HETATM 4670 0 HOH D 87 1. .855 -39. 977 -9. .636 1. .00 9. .12 o
HETATM 4671 0 HOH D 88 0. .036 -27. 584 -22. .318 1. .00 19. .91 o
HETATM 4672 0 HOH D 89 -16. .641 8. 034 -21. .414 1. .00 28. .79 o
HETATM 4673 0 HOH D 91 6. .673 -19. 109 -18. .430 1. .00 14. .71 o
HETATM 4674 0 HOH D 92 15. .712 -28. 784 -11. .584 1. .00 17. .47 o
HETATM 4675 0 HOH D 93 -25. .882 -43. 603 -12. .917 1. .00 9. .36 o
HETATM 4676 0 HOH D 94 -13. .971 -58. 069 -2. .171 1. .00 16. .23 o
HETATM 4677 0 HOH D 96 10. .457 -26. 740 -26. .060 1. .00 11. .31 o
HETATM 4678 0 HOH D 97 -22. .816 -38. 364 -5. .993 1. .00 17. .13 o
HETATM 4679 0 HOH D 100 -9. .340 -47. 635 0. .235 1. .00 6. .76 o
HETATM 4680 0 HOH D 102 3. .056 -38. 032 -31. .275 1. .00 6. .12 o
HETATM 4681 0 HOH D 103 -25. .590 -42. 298 -15. .541 1. .00 17. .90 o
HETATM 4682 0 HOH D 104 10. .556 -51. 368 -25. .973 1. .00 9. .26 o
HETATM 4683 0 HOH D 106 -19. .882 -33. 352 4. .847 1. .00 30. .16 o
HETATM 4684 0 HOH D 107 -6. .248 -27. 219 -8. .518 1. .00 11. .81 o
HETATM 4685 0 HOH D 108 -31. .468 -21. 088 -1. .489 1. .00 12. .00 o
HETATM 4686 0 HOH D 111 21. .684 -30. 977 -26. .026 1. .00 23. .70 o
HETATM 4687 0 HOH D 112 -31. .951 -10. 039 3. .258 1. .00 21. .85 o
HETATM 4688 0 HOH D 113 -12. .420 -61. 104 -20. .866 1. .00 20. .71 o
HETATM 4689 0 HOH D 115 -9. .390 -46. 453 -3. .343 1. .00 11. .14 o
HETATM 4690 0 HOH D 116 -24. .310 -8. 827 -27. .982 1. .00 28. .62 o
HETATM 4691 0 HOH D 118 0. .928 0. 943 -27. .721 1. .00 20. .32 o
HETATM 4692 0 HOH D 119 -0. .811 -22. 368 -26. .821 1. .00 28. .05 o
HETATM 4693 0 HOH D 120 2. .928 -27. 375 -2. .252 1. .00 6. .28 o
HETATM 4694 0 HOH D 122 24. .797 -33. 048 -16. .191 1. .00 20. .61 o
HETATM 4695 0 HOH D 123 28. .116 -42. 682 -17. .519 1. .00 20. .23 o
HETATM 4696 0 HOH D 126 0. .728 -11. 568 -25. .035 1. .00 27. .72 o
HETATM 4697 0 HOH D 127 5. .110 -32. 881 1. .483 1. .00 8. .60 o
HETATM 4698 0 HOH D 128 -6. .910 -6. 512 -5. .883 1. .00 23. .17 o
HETATM 4699 0 HOH D 129 -14. .859 -32. 631 4. .922 1. .00 20. .12 o
HETATM 4700 0 HOH D 130 -9. .393 -20. 445 -22. .229 1. .00 11. .44 o
HETATM 4701 0 HOH D 131 5. .380 -45. 506 -20. .439 1. .00 18. .61 o
HETATM 4702 0 HOH D 132 -20. .298 -17. 857 4. .369 1. .00 24. .71 o
HETATM 4703 0 HOH D 133 -13. .074 -15. 017 -30. .254 1. .00 22. .69 o
HETATM 4704 0 HOH D 134 -22. .544 -64. 671 -13. .497 1. .00 18. .42 o
HETATM 4705 0 HOH D 135 -4. .355 -31. 730 -19. .579 1. .00 30. .49 o
HETATM 4706 0 HOH D 136 -4. .978 -28. 238 -15. .122 1. .00 22. .36 o
HETATM 4707 0 HOH D 137 -7. .834 -20. 152 9. .638 1. .00 18. .69 o
HETATM 4708 0 HOH D 138 -14. .293 -28. 356 -18. .330 1. .00 27. .34 o
HETATM 4709 0 HOH D 139 -22. .099 -32. 349 -8. .846 1. .00 29. .42 o
HETATM 4710 0 HOH D 140 8. .752 -28. 130 -6. .857 1. .00 8. .09 o
HETATM 4711 0 HOH D 141 15. .481 -31. 534 -31. .496 1. .00 7. .89 o
HETATM 4712 0 HOH D 142 -14. .386 -25. 883 -11. .379 1. .00 24. .39 o
HETATM 4713 0 HOH D 143 -2. .224 -28. 207 -27. .995 1. .00 21. .76 o
HETATM 4714 0 HOH D 144 -3. .038 2. 948 -18. .802 1. .00 17. .17 o
HETATM 4715 0 HOH D 145 -17. .234 -8. 824 -32. .860 1. .00 22. .34 o
HETATM 4716 0 HOH D 146 -21. .972 -36. 386 -17. .229 1. .00 15. .20 o
HETATM 4717 0 HOH D 147 21. .738 -50. 115 -22. .044 1. .00 41. .96 o
HETATM 4718 0 HOH D 148 -15. .129 -42. 497 -17. .235 1. .00 64. .58 o
HETATM 4719 0 HOH D 149 0. .499 -13. 659 1. .071 1. .00 20. .44 o
HETATM 4720 0 HOH D 150 26. .656 -39. 916 -12. .524 1. .00 28. .86 o
HETATM 4721 0 HOH D 151 -26. .068 -18. 778 22. .468 1. .00 63. .91 o
HETATM 4722 0 HOH D 152 17. .839 -37. 146 -6. .365 1. .00 17. .05 o
HETATM 4723 0 HOH D 153 -9. .872 -37. 859 3. .756 1. .00 29. .86 o
HETATM 4724 0 HOH D 154 -26. .704 -13. 656 -20. .767 1. .00 24. .94 o
HETATM 4725 0 HOH D 155 -16. .594 -46. 356 1. .735 1. .00 9. .02 o
HETATM 4726 0 HOH D 156 -3. .278 -28. 231 -11. .565 1. .00 15. .79 o
HETATM 4727 0 HOH D 157 -13. .773 -34. 807 7. .967 1. .00 26. .45 o
HETATM 4728 o HOH D 158 5..274 -27.734 -3..607 1..00 14..35 o
HETATM 4729 o HOH D 159 -10. .955 -62. 644 -9. .650 1. .00 22. .81 o
HETATM 4730 o HOH D 160 19. .801 -28. 085 -15. .802 1. .00 15. .92 o
HETATM 4731 o HOH D 161 14. .910 -35. 916 -3. .899 1. .00 14. .53 o
HETATM 4732 o HOH D 162 -7. .630 -39. 335 -29. .693 1. .00 19. .10 o
HETATM 4733 o HOH D 163 8. .909 -8. 381 -2. .714 1. .00 31. .11 o
HETATM 4734 o HOH D 164 -35. .136 -13. 839 -9. .366 1. .00 19. .26 o
HETATM 4735 o HOH D 165 -28. .655 -13. 870 18. .003 1. .00 25. .79 o
HETATM 4736 o HOH D 166 -4. .969 -28. 077 -6. .380 1. .00 15. .01 o
HETATM 4737 o HOH D 167 -12. .416 -58. 656 -21. .906 1. .00 38. .53 o
HETATM 4738 o HOH D 168 -1. .381 -22. 000 5. .296 1. .00 15. .16 o
HETATM 4739 o HOH D 169 -28. .073 -14. 871 -23. .335 1. .00 29. .90 o
HETATM 4740 o HOH D 170 -5. .698 -52. 447 -27. .051 1. .00 46. .81 o
HETATM 4741 o HOH D 171 25. .098 -40. 710 -27. .602 1. .00 31. .23 o
HETATM 4742 o HOH D 172 13. .253 -30. 057 -31. .043 1. .00 25. .08 o
HETATM 4743 CA CA C 1 -3. .996 -44. 763 -24. .393 1. .00 14. .92 CA
HETATM 4744 CA CA C 2 -9. .298 -38. 014 -30. .827 1. .00 19. .13 CA
HETATM 4745 CA CA C 3 -7. .033 -7. 984 -3. .851 1. .00 33. .23 CA
HETATM 4746 CA CA C 4 3. .009 -11. 945 -2. .235 1. .00 23. .81 CA
ATOM 4747 N VAL E 1 -6. .805 -32. 986 -18. .277 1. .00 18. .96 N
ATOM 4748 CA VAL E 1 -5. .543 -32. 961 -17. .454 1. .00 19. .68 c
ATOM 4749 CB VAL E 1 -5. .490 -31. 747 -16. .442 1. .00 19. .24 c
ATOM 4750 CGl VAL E 1 -5. .729 -30. 417 -17. .143 1. .00 19. .12 c
ATOM 4751 CG2 VAL E 1 -6. .448 -31. 893 -15. .256 1. .00 18. .78 c
ATOM 4752 C VAL E 1 -5. .209 -34. 318 -16. .766 1. .00 20. .53 c
ATOM 4753 o VAL E 1 -4. .162 -34. 931 -17. .045 1. .00 19. .81 o
ATOM 4754 N ARG E 2 -6. .036 -34. 659 -15. .814 1. .00 22. .30 N
ATOM 4755 CA ARG E 2 -5. .893 -35. 826 -14. .996 1. .00 22. .98 c
ATOM 4756 C ARG E 2 -5. .143 -35. 563 -13. .709 1. .00 23. .10 c
ATOM 4757 o ARG E 2 -3. .987 -35. 675 -13. .626 1. .00 21. .38 o
ATOM 4758 CB ARG E 2 -5. .370 -36. 923 -15. .862 1. .00 20. .00 c
ATOM 4759 CG ARG E 2 -6. .510 -37. 666 -16. .472 1. .00 20. .00 c
ATOM 4760 CD ARG E 2 -6. .236 -37. 842 -17. .914 1. .00 20. .00 c
ATOM 4761 NE ARG E 2 -5. .023 -38. 606 -18. .152 1. .00 20. .00 N
ATOM 4762 CZ ARG E 2 -4. .700 -39. 033 -19. .365 1. .00 20. .00 c
ATOM 4763 NHl ARG E 2 -5. .498 -38. 765 -20. .370 1. .00 20. .00 N
ATOM 4764 NH2 ARG E 2 -3. .590 -39. 683 -19. .606 1. .00 20. .00 N
ATOM 4765 N ALA E 3 -5. .874 -35. 228 -12. .682 1. .00 25. .76 N
ATOM 4766 CA ALA E 3 -5. .370 -34. 410 -11. .547 1. .00 29. .63 C
ATOM 4767 CB ALA E 3 -6. .254 -33. 159 -11. .469 1. .00 30. .22 c
ATOM 4768 C ALA E 3 -5. .257 -35. 094 -10. .105 1. .00 31. .58 c
ATOM 4769 o ALA E 3 -5. .874 -36. 130 -9. .844 1. .00 31. .51 o
ATOM 4770 N ALA E 4 -4. .491 -34. 497 -9. .169 1. .00 32. .55 N
ATOM 4771 CA ALA E 4 -4. .349 -35. 033 -7. .771 1. .00 30. .23 c
ATOM 4772 CB ALA E 4 -3. .660 -36. 382 -7. .798 1. .00 28. .96 c
ATOM 4773 C ALA E 4 -3. .600 -34. 141 -6. .772 1. .00 29. .50 c
ATOM 4774 o ALA E 4 -2. .820 -34. 655 -5. .948 1. .00 27. .58 o
ATOM 4775 N ARG F 1 -8. .429 -19. 552 -9. .416 1. .00 25. .91 N
ATOM 4776 CA ARG F 1 -9. .556 -20. 144 -8. .678 1. .00 28. .61 c
ATOM 4777 C ARG F 1 -10. .743 -20. 675 -9. .479 1. .00 29. .09 c
ATOM 4778 o ARG F 1 -11. .224 -20. 098 -10. .395 1. .00 27. .32 o
ATOM 4779 CB ARG F 1 -10. .034 -19. 244 -7. .562 1. .00 20. .00 c
ATOM 4780 CG ARG F 1 -9. .026 -18. 241 -7. .099 1. .00 20. .00 c
ATOM 4781 CD ARG F 1 -9. .684 -16. 875 -6. .961 1. .00 20. .00 c
ATOM 4782 NE ARG F 1 -8. .851 -15. 706 -6. .762 1. .00 20. .00 N
ATOM 4783 CZ ARG F 1 -7. .599 -15. 716 -6. .317 1. .00 20. .00 c
ATOM 4784 NHl ARG F 1 -6. .959 -16. 845 -6. .043 1. .00 20. .00 N
ATOM 4785 NH2 ARG F 1 -6. .952 -14. 572 -6. .163 1. .00 20. .00 N
ATOM 4786 N ALA F 2 -11. .202 -21. 816 -9. .078 1. .00 31. .68 N
ATOM 4787 CA ALA F 2 -11. .921 -22. 706 -9. .931 1. .00 35. .91 C
ATOM 4788 CB ALA F 2 -11. .159 -24. 023 -9. .929 1. .00 36. .85 c
ATOM 4789 C ALA F 2 -13. .430 -22. 961 -9. .726 1. .00 38. .32 c
ATOM 4790 o ALA F 2 -13. .892 -23. 333 -8. .669 1. .00 34. .79 o
ATOM 4791 N ALA F 3 -14. .167 -22. 664 -10. .769 1. .00 40. .70 N
ATOM 4792 CA ALA F 3 -15. .085 -23. 497 -11. .515 1. .00 40. .16 c
ATOM 4793 CB ALA F 3 -14. .939 -24. 977 -11. .187 1. .00 40. .29 c
ATOM 4794 C ALA F 3 -16. .524 -23. 097 -11. .612 1. .00 37. .96 c
ATOM 4795 o ALA F 3 -17. .129 -23. 397 -12. .612 1. .00 35. .80 o
END
EXAMPLE 3
Comparison of PehProl with Thermolysin structure
The structure of PehProl was compared to that of Thermolysin (B. thermoproteolyticus metalloprotease, pdb 1KEI.A) [Senda, M., Senda,T. and Kidokoro,S., Crystal Structure
Analyses Of Thermolysin In Complex With Its Inhibitors, Direct Submission]. The overall folding of PehProl is highly similar to Thermolysin and other known metalloproteases from Bacillus (B. cereus (pdb 1NPC.A) [Sidler,W., Niederer,E., Suter,F. and Zuber,H., The primary structure of Bacillus cereus neutral proteinase and comparison with thermolysin and Bacillus subtilis neutral Proteinase, Biol. Chem. Hoppe-Seyler 367 (7), 643-657 (1986)] and B.
stearothermophilus, and B. subtilis metalloproteases, consisting of two domains and a central connecting helix. A schematic of the overall topology of PehProl is presented and compared with Thermolysin in Figure 2. The main differences were found in regions where there were deletions in the PehProl sequence relative to that of other known metalloprotease structures. Two regions of deletion occur in PehProl, and as a consequence the main chain folding deviates from thermolysin after residue Trp58 of PehProl (see Figure 3), and after residue Asp 170 of PehProl (see Figure 4). Four residues in Thermolysin are replaced by Asn59 in PehProl and seven residues in Thermolysin are replaced by Glyl71-Lysl72 in PehProl, these deletions are indicated by arrows in Figure 2. The numbering of residues corresponds to the linear contiguous sequence of each mature enzyme, respectively.
Four calcium ions are bound in the Thermolysin structure: two at a double cation site (Cal,2), and one in each of the single cation sites (Ca3, Ca4). In contrast to Thermolysin, the PehProl structure has only two calcium binding sites, a single one near the double cation site (Cal-2) in Thermolysin and a second (Ca4) that seems to be conserved in the two molecules. One Thermolysin calcium site (Ca3) is completely absent in the PehProl structure. Since calcium dependence is considered to be a factor in some potential uses of these proteases, particularly as a detergent additive where builders are present specifically to reduce the hardness of water by chelating ions such as calcium and magnesium, these enzymes may prove to have reduced cation sensitivity and hence improved stability under conditions of low calcium availability.
The region around the Thermolysin double cation site (Cal,2) is shown in Figure 5. In this figure, the structure of Thermolysin is present as black lines, with the two calcium ions shown as crosses. The superimposed structure of PehProl is shown as a stick figure with its single calcium ion as a non-bonding sphere. It may be seen that the two sites are substantially
different. In Thermolysin, six residues along with solvent are present to stabilize the ion pair, including side chains of Aspl38, Glul77, Asp 185, Glul90, and the main chain carbonyls of residues Asnl83 and Glul87 (Thermolysin numbering). In PehProl (numbering relative to mature PehProl), the calcium in the same vicinity is stabilized by side chains of Aspl29, Aspl31, Aspl70 and Aspl78 along with the solvent. Only Aspl31 and Aspl78 in PehProl are homologous with side chains in Thermolysin Aspl38 and Glul90, respectively.
The second calcium binding site in PehProl is compared with the homologous site (Ca4) in Thermolysin in Figure 6. In this instance, there is a one to one correspondence of residues forming the calcium binding site in both Thermolysin and PehProl. In Thermolysin, the side chains of Thrl94 and Asp200 (Thermolysin numbering) along with the main chain carbonyls of residues Tyrl93, Thrl94 and Ilel97 form ligands to this calcium ion, while in PehProl it is the homologous residues Thrl82 and Asp 188 along with the carbonyl oxygen of residues Tyrl81, Thrl82 and Thrl85 (numbering relative to mature PehProl).
The structures of PehPro 1 and Thermolysin are compared in the vicinity of the Ca3 calcium site in Thermolysin in Figure 7. In Thermolysin the Ca3 calcium site is formed in a loop containing two aspartic acids residues Asp57 and Asp59, which along with the main chain carbonyl oxygen and solvent form ligands to the calcium ion, In contrast, in PehProl, the two (Asp) ligands are replaced with serine residues which, while in homologous conformations, will not stabilize binding of a calcium ion. In the electron density map there is no evidence of calcium binding under the conditions of crystallization.
EXAMPLE 4
Comparison of structures of PehProl and PpoPro2 metalloproteases
Recently, the structure of a metallopro tease from a member of the Paenibacillus genus, Paenibacillus polymyxa (PpoPro2), was reported (Ruf et al, Acta Cryst. D 69, 24-31 (2013)). The overall folding of PpoPro2 is highly homologous to Thermolysin and other known M4 metalloproteases. The PehProl and PpoPro2 structures consist of 304 residues that are aligned without insertions or deletions relative to each other. The PpoPro2 and PehProl structures therefore share a common pattern of deletions relative to that of other known metalloprotease structures. The overall folding of the PehProl and PpoPro2 is presented in Figure 8.
In contrast to PehProl, the structure of PpoPro2 was found to bind three calcium ions. The first two (Ca4 and a variant of Cal-2) described below are highly homologous between PehProl and PpoPro2 molecules, and the third is homologous to calcium site Ca3 site. The
common sites are compared in Figures 9 and 10. In both sites, all interactions seen in either PehProl or PpoPro2 are conserved in the other.
As mentioned above, the PpoPro2 has an additional calcium ion bound at Ca3 that is not seen in PehProl. Just as in the structure of Thermolysin (Figure 7), aspartic acid residues are found in PpoPro2 whereas in PehProl, we find Ser 53 and Ser55 instead of the aspartic acid residues (Figure 11).
EXAMPLE 5
Crystallization and structure determination of NprE
The metalloprotease NprE, obtained from Bacillus subtilis, is knownto perform in detergent formulations (as described in patent US 8,114,656 B2 Shaw et al and others). An NprE variant (S129I7F130L/M138L/V190I/D220P) was crystallized using the hanging drop method from a solution of protein stock at a concentration of 26.2 mg/mL in 40% Propylene Glycol + 50mM MES pH 5.4 + ImM Calcium chloride. Aliquots of 3 \L of the protein stock and 3 \L of the crystallization solution were mixed on a plastic coverslip and inverted and sealed on a chamber containing 23% Polyethylene Glycol 4000 + 0.20M Lithium chloride + 0.09M Bis Tris Propane pH 6.5 + 12% Isopropanol + 4 mM Zinc chloride + 12.5 mM Yttrium chloride in a Linbro 6 X 4 culture plate.
Crystals grew in the hexagonal space group P6(3)22 with unit cell dimensions; a=122.9
A, b=122.9 A, and c=l 19.1 A. Data were collected on native crystal to 2.5 A and the structure of NprE was determined by molecular replacement using a related protein (pdb ID 1ESP) as the phasing model. The statistics of data collection are presented in Table 5.1.
Table 5.1: Statistics of NprE Data collection
Wavelength 1.54 A
Space group P6322
Molecules in asymmetric unit 1
Unit cell dimensions a=122.9 A, b=122.9 A and
c=119.1 A
Resolution 30.0-2.49 A
Unique reflections 17969
Multiplicity 7.46 (7.36*)
Completeness 99.94% (99.9*)
Rmerge 0.067(0.25*)
Ι/σι 17.2(5.9*)
^Value in parenthesis is that of the outermost shell of data
The model was fitted in the resulting electron density using the program COOT [Emsley, P et al (2010) Acta Cryst. D66486-501]. After fitting and refitting adjustments, the coordinates were refined using the REFMAC program with standard defaults in the CCP4 software suite. The statistics of the current model are presented in Table 5.2.
The coordinates for structure of the NprE variant are provided below.
ATOM 1 N ALA A 1 -50. .837 -39. .587 -13. .317 1. .00 46. .97 A N
ATOM 2 CA ALA A 1 -51. .606 -39. .753 -14. .634 1. .00 45. .97 A C
ATOM 3 CB ALA A 1 -52. .426 -38. .479 -14. .961 1. .00 46. .00 A C
ATOM 4 C ALA A 1 -50. .598 -40. .107 -15. .764 1. .00 45. .46 A c
ATOM 5 o ALA A 1 -49. .808 -39. .271 -16. .244 1. .00 43. .56 A o
ATOM 6 N ALA A 2 -50. .582 -41. .387 -16. .118 1. .00 45. .03 A N
ATOM 7 CA ALA A 2 -49. .511 -41. .916 -16. .936 1. .00 44. .55 A c
ATOM 8 CB ALA A 2 -49. .635 -43. .447 -17. .040 1. .00 44. .73 A c
ATOM 9 C ALA A 2 -49. .578 -41. .279 -18. .307 1. .00 45. .19 A c
ATOM 10 o ALA A 2 -50. .549 -41. .460 -19. .038 1. .00 46. .01 A o
ATOM 11 N THR A 3 -48. .571 -40. .506 -18. .675 1. .00 45. .24 A N
ATOM 12 CA THR A 3 -48. .541 -40. .003 -20. .048 1. .00 44. .84 A c
ATOM 13 CB THR A 3 -49. .272 -38. .639 -20. .200 1. .00 44. .49 A c
ATOM 14 OGl THR A 3 -49..432 -38..341 -21..588 1..00 42..12 A o
ATOM 15 CG2 THR A 3 -48. .529 -37. .520 -19. .521 1. .00 41. .95 A C
ATOM 16 c THR A 3 -47. .144 -40. .023 -20. .726 1. .00 45. .42 A c
ATOM 17 o THR A 3 -46. .153 -40. .548 -20. .182 1. .00 46. .03 A o
ATOM 18 N THR A 4 -47. .105 -39. .436 -21. .913 1. .00 44. .79 A N
ATOM 19 CA THR A 4 -45. .981 -39. .502 -22. .803 1. .00 44. .31 A c
ATOM 20 CB THR A 4 -46. .352 -40. .377 -24. .023 1. .00 45. .17 A c
ATOM 21 OGl THR A 4 -45. .615 -41. .611 -23. .914 1. .00 45. .01 A o
ATOM 22 CG2 THR A 4 -46. .117 -39. .684 -25. .418 1. .00 46. .18 A c
ATOM 23 c THR A 4 -45. .505 -38. .090 -23. .095 1. .00 43. .59 A c
ATOM 24 o THR A 4 -46. .263 -37. .144 -22. .990 1. .00 43. .13 A o
ATOM 25 N GLY A 5 -44. .220 -37. .949 -23. .385 1. .00 42. .62 A N
ATOM 26 CA GLY A 5 -43. .593 -36. .642 -23. .465 1. .00 40. .86 A c
ATOM 27 c GLY A 5 -42. .380 -36. .751 -24. .358 1. .00 39. .27 A c
ATOM 28 o GLY A 5 -42. .184 -37. .762 -25. .008 1. .00 39. .11 A o
ATOM 29 N THR A 6 -41. .553 -35. .717 -24. .347 1. .00 38. .05 A N
ATOM 30 CA THR A 6 -40. .412 -35. .657 -25. .213 1. .00 37. .20 A c
ATOM 31 CB THR A 6 -40. .907 -35. .169 -26. .624 1. .00 37. .93 A c
ATOM 32 OGl THR A 6 -40. .731 -36. .218 -27. .585 1. .00 37. .23 A o
ATOM 33 CG2 THR A 6 -40. .272 -33. .892 -27. .082 1. .00 37. .05 A c
ATOM 34 c THR A 6 -39. .401 -34. .748 -24. .523 1. .00 36. .18 A c
ATOM 35 o THR A 6 -39. .794 -33. .933 -23. .690 1. .00 36. .69 A o
ATOM 36 N GLY A 7 -38. .109 -34. .926 -24. .791 1. .00 34. .95 A N
ATOM 37 CA GLY A 7 -37. .092 -34. .018 -24. .258 1. .00 33. .82 A c
ATOM 38 c GLY A 7 -35. .792 -34. .134 -25. .024 1. .00 33. .59 A c
ATOM 39 o GLY A 7 -35. .645 -35. .006 -25. .862 1. .00 34. .18 A o
ATOM 40 N THR A 8 -34. .849 -33. .253 -24. .732 1. .00 33. .90 A N
ATOM 41 CA THR A 8 -33. .598 -33. .129 -25. .464 1. .00 34. .22 A c
ATOM 42 CB THR A 8 -33. .226 -31. .608 -25. .718 1. .00 34. .37 A c
ATOM 43 OGl THR A 8 -34. .299 -30. .920 -26. .401 1. .00 36. .58 A o
ATOM 44 CG2 THR A 8 -31. .947 -31. .481 -26. .536 1. .00 33. .08 A c
ATOM 45 c THR A 8 -32. .453 -33. .790 -24. .669 1. .00 34. .72 A c
ATOM 46 o THR A 8 -32. .184 -33. .426 -23. .489 1. .00 34. .25 A o
ATOM 47 N THR A 9 -31. .753 -34. .728 -25. .323 1. .00 34. .59 A N
ATOM 48 CA THR A 9 -30. .639 -35. .395 -24. .677 1. .00 34. .66 A c
ATOM 49 CB THR A 9 -30. .238 -36. .722 -25. .329 1. .00 33. .98 A c
ATOM 50 OGl THR A 9 -29. .590 -36. .445 -26. .559 1. .00 37. .28 A o
ATOM 51 CG2 THR A 9 -31. .414 -37. .551 -25. .590 1. .00 33. .59 A c
ATOM 52 c THR A 9 -29. .431 -34. .488 -24. .559 1. .00 34. .50 A c
ATOM 53 o THR A 9 -29. .385 -33. .400 -25. .144 1. .00 33. .46 A o
ATOM 54 N LEU A 10 -28. .479 -34. .947 -23. .749 1. .00 34. .53 A N
ATOM 55 CA LEU A 10 -27. .257 -34. .224 -23. .481 1. .00 35. .27 A c
ATOM 56 CB LEU A 10 -26. .367 -35. .131 -22. .654 1. .00 34. .24 A c
ATOM 57 CG LEU A 10 -25. .892 -34. .808 -21. .256 1. .00 33. .07 A c
ATOM 58 CDl LEU A 10 -26. .322 -33. .431 -20. .727 1. .00 35. .04 A c
ATOM 59 CD 2 LEU A 10 -26. .213 -35. .900 -20. .296 1. .00 29. .81 A c
ATOM 60 c LEU A 10 -26. .539 -33. .859 -24. .786 1. .00 37. .02 A c
ATOM 61 o LEU A 10 -25. .854 -32. .837 -24. .839 1. .00 36. .69 A o
ATOM 62 N LYS A 11 -26. .672 -34. .715 -25. .801 1. .00 38. .07 A N
ATOM 63 CA LYS A 11 -26. .036 -34. .498 -27. .084 1. .00 41. .05 A c
ATOM 64 CB LYS A 11 -25. .488 -35. .850 -27. .666 1. .00 41. .74 A c
ATOM 65 CG LYS A 11 -24. .330 -36. .532 -26. .896 1. .00 41. .97 A c
ATOM 66 CD LYS A 11 -23. .014 -35. .884 -27. .186 1. .00 40. .92 A c
ATOM 67 CE LYS A 11 -21. .854 -36. .797 -26. .839 1. .00 44. .19 A c
ATOM 68 NZ LYS A 11 -21. .535 -36. .808 -25. .375 1. .00 43. .03 A N
ATOM 69 c LYS A 11 -26. .996 -33. .861 -28. .134 1. .00 42. .61 A c
ATOM 70 o LYS A 11 -26. .661 -33. .822 -29. .329 1. .00 43. .21 A o
ATOM 71 N GLY A 12 -28. .198 -33. .427 -27. .730 1. .00 43. .01 A N
ATOM 72 CA GLY A 12 -29. .046 -32. .651 -28. .623 1. .00 42. .11 A c
ATOM 73 C GLY A 12 -30. .002 -33. .454 -29. .460 1. .00 42. .80 A c
ATOM 74 o GLY A 12 -30. .566 -32. .919 -30. .409 1. .00 43. .22 A o
ATOM 75 N LYS A 13 -30. .208 -34. .725 -29. .127 1. .00 43. .45 A N
ATOM 76 CA LYS A 13 -31. .271 -35. .553 -29. .763 1. .00 44. .11 A c
ATOM 77 CB LYS A 13 -30. .888 -37. .042 -29. .814 1. .00 44. .72 A c
ATOM 78 CG LYS A 13 -29. .608 -37. .376 -30. .625 1. .00 50. .68 A c
ATOM 79 CD LYS A 13 -29. .503 -38. .928 -30. .912 1. .00 59. .09 A c
ATOM 80 CE LYS A 13 -28. .149 -39. .327 -31. .606 1. .00 62. .01 A c
ATOM 81 NZ LYS A 13 -28. .222 -40. .646 -32. .356 1. .00 60. .47 A N
ATOM 82 C LYS A 13 -32. .599 -35. .440 -29. .035 1. .00 43. .37 A c
ATOM 83 o LYS A 13 -32. .647 -35. .028 -27. .894 1. .00 43. .72 A o
ATOM 84 N THR A 14 -33. .676 -35. .837 -29. .697 1. .00 43. .02 A N
ATOM 85 CA THR A 14 -35. .013 -35. .820 -29. .126 1. .00 42. .26 A c
ATOM 86 CB THR A 14 -36. .049 -35. .120 -30. .099 1. .00 42. .99 A c
ATOM 87 OGl THR A 14 -35. .904 -33. .701 -29. .986 1. .00 40. .45 A o
ATOM 88 CG2 THR A 14 -37. .519 -35. .492 -29. .794 1. .00 41. .44 A c
ATOM 89 C THR A 14 -35. .441 -37. .241 -28. .799 1. .00 42. .01 A c
ATOM 90 o THR A 14 -35. .330 -38. .123 -29. .644 1. .00 42. .35 A o
ATOM 91 N VAL A 15 -35. .908 -37. .478 -27. .569 1. .00 40. .90 A N
ATOM 92 CA VAL A 15 -36. .346 -38. .846 -27. .192 1. .00 39. .44 A c
ATOM 93 CB VAL A 15 -35..297 -39..522 -26..261 1..00 39..86 A C
ATOM 94 CGl VAL A 15 -34. .013 -39. .848 -27. .046 1. .00 34. .51 A C
ATOM 95 CG2 VAL A 15 -34. .997 -38. .621 -24. .996 1. .00 37. .32 A c
ATOM 96 c VAL A 15 -37. .779 -38. .883 -26. .600 1. .00 39. .22 A c
ATOM 97 o VAL A 15 -38. .288 -37. .859 -26. .124 1. .00 38. .62 A o
ATOM 98 N SER A 16 -38. .443 -40. .034 -26. .653 1. .00 38. .75 A N
ATOM 99 CA SER A 16 -39. .693 -40. .193 -25. .874 1. .00 39. .39 A c
ATOM 100 CB SER A 16 -40. .511 -41. .380 -26. .338 1. .00 39. .15 A c
ATOM 101 OG SER A 16 -40. .729 -41. .230 -27. .691 1. .00 43. .31 A o
ATOM 102 c SER A 16 -39. .402 -40. .439 -24. .405 1. .00 39. .11 A c
ATOM 103 o SER A 16 -38. .488 -41. .214 -24. .085 1. .00 39. .19 A o
ATOM 104 N LEU A 17 -40. .218 -39. .838 -23. .532 1. .00 38. .27 A N
ATOM 105 CA LEU A 17 -40. .058 -39. .952 -22. .081 1. .00 37. .35 A c
ATOM 106 CB LEU A 17 -39. .700 -38. .582 -21. .507 1. .00 36. .35 A c
ATOM 107 CG LEU A 17 -38. .308 -38. .048 -21. .857 1. .00 33. .05 A c
ATOM 108 CDl LEU A 17 -38. .184 -36. .605 -21. .514 1. .00 25. .83 A c
ATOM 109 CD 2 LEU A 17 -37. .189 -38. .879 -21. .147 1. .00 31. .27 A c
ATOM 110 c LEU A 17 -41. .371 -40. .406 -21. .500 1. .00 37. .48 A c
ATOM 111 o LEU A 17 -42. .378 -39. .859 -21. .864 1. .00 38. .44 A o
ATOM 112 N ASN A 18 -41. .383 -41. .413 -20. .628 1. .00 37. .00 A N
ATOM 113 CA ASN A 18 -42. .589 -41. .755 -19. .891 1. .00 36. .02 A c
ATOM 114 CB ASN A 18 -42. .560 -43. .192 -19. .444 1. .00 35. .98 A c
ATOM 115 CG ASN A 18 -42. .465 -44. .148 -20. .596 1. .00 39. .27 A c
ATOM 116 ODl ASN A 18 -41. .623 -45. .048 -20. .623 1. .00 43. .56 A o
ATOM 117 ND2 ASN A 18 -43. .324 -43. .971 -21. .558 1. .00 40. .11 A N
ATOM 118 c ASN A 18 -42. .687 -40. .812 -18. .693 1. .00 35. .67 A c
ATOM 119 o ASN A 18 -41. .822 -40. .804 -17. .838 1. .00 34. .62 A o
ATOM 120 N ILE A 19 -43. .743 -40. .004 -18. .667 1. .00 35. .62 A N
ATOM 121 CA ILE A 19 -43. .935 -38. .949 -17. .666 1. .00 35. .75 A c
ATOM 122 CB ILE A 19 -43. .722 -37. .554 -18. .292 1. .00 35. .34 A c
ATOM 123 CGl ILE A 19 -44. .825 -37. .201 -19. .302 1. .00 33. .51 A c
ATOM 124 CDl ILE A 19 -44. .612 -35. .848 -19. .949 1. .00 34. .72 A c
ATOM 125 CG2 ILE A 19 -42. .332 -37. .528 -18. .917 1. .00 33. .23 A c
ATOM 126 c ILE A 19 -45. .291 -39. .046 -16. .909 1. .00 36. .80 A c
ATOM 127 o ILE A 19 -46. .081 -39. .965 -17. .145 1. .00 35. .92 A o
ATOM 128 N SER A 20 -45. .498 -38. .140 -15. .963 1. .00 38. .36 A N
ATOM 129 CA SER A 20 -46. .765 -38. .045 -15. .189 1. .00 40. .90 A c
ATOM 130 CB SER A 20 -46. .534 -38. .472 -13. .726 1. .00 40. .17 A c
ATOM 131 OG SER A 20 -47. .498 -37. .935 -12. .855 1. .00 39. .41 A o
ATOM 132 c SER A 20 -47. .313 -36. .615 -15. .209 1. .00 42. .05 A c
ATOM 133 o SER A 20 -46. .530 -35. .668 -14. .952 1. .00 42. .63 A o
ATOM 134 N SER A 21 -48. .586 -36. .438 -15. .529 1. .00 43. .64 A N
ATOM 135 CA SER A 21 -49. .219 -35. .132 -15. .353 1. .00 45. .31 A c
ATOM 136 CB SER A 21 -50. .357 -34. .872 -16. .336 1. .00 45. .18 A c
ATOM 137 OG SER A 21 -51. .138 -36. .000 -16. .559 1. .00 45. .91 A o
ATOM 138 c SER A 21 -49. .696 -35. .055 -13. .949 1. .00 45. .77 A c
ATOM 139 o SER A 21 -50. .535 -35. .811 -13. .556 1. .00 45. .47 A o
ATOM 140 N GLU A 22 -49. .113 -34. .148 -13. .193 1. .00 47. .74 A N
ATOM 141 CA GLU A 22 -49. .171 -34. .189 -11. .767 1. .00 49. .15 A c
ATOM 142 CB GLU A 22 -47. .892 -34. .769 -11. .260 1. .00 49. .13 A c
ATOM 143 CG GLU A 22 -48. .016 -36. .086 -10. .722 1. .00 46. .55 A c
ATOM 144 CD GLU A 22 -46. .717 -36. .646 -10. .354 1. .00 39. .46 A c
ATOM 145 OEl GLU A 22 -45. .983 -35. .997 -9. .639 1. .00 34. .91 A o
ATOM 146 OE2 GLU A 22 -46. .432 -37. .720 -10. .806 1. .00 32. .47 A o
ATOM 147 c GLU A 22 -49. .162 -32. .806 -11. .279 1. .00 51. .23 A c
ATOM 148 o GLU A 22 -48. .381 -32. .018 -11. .727 1. .00 52. .04 A o
ATOM 149 N SER A 23 -49. .996 -32. .494 -10. .320 1. .00 52. .77 A N
ATOM 150 CA SER A 23 -50. .001 -31. .133 -9. .903 1. .00 54. .10 A c
ATOM 151 CB SER A 23 -48. .649 -30. .810 -9. .340 1. .00 54. .93 A c
ATOM 152 OG SER A 23 -48. .179 -31. .939 -8. .645 1. .00 54. .76 A o
ATOM 153 C SER A 23 -50. .282 -30. .272 -11. .111 1. .00 54. .42 A c
ATOM 154 o SER A 23 -51. .075 -30. .606 -11. .970 1. .00 55. .29 A o
ATOM 155 N GLY A 24 -49. .653 -29. .143 -11. .212 1. .00 54. .60 A N
ATOM 156 CA GLY A 24 -50. .035 -28. .344 -12. .342 1. .00 54. .68 A c
ATOM 157 C GLY A 24 -49. .544 -28. .801 -13. .683 1. .00 54. .45 A c
ATOM 158 o GLY A 24 -50. .009 -28. .324 -14. .682 1. .00 54. .42 A o
ATOM 159 N LYS A 25 -48. .589 -29. .717 -13. .685 1. .00 53. .42 A N
ATOM 160 CA LYS A 25 -47. .626 -29. .848 -14. .742 1. .00 51. .96 A c
ATOM 161 CB LYS A 25 -46. .345 -29. .213 -14. .276 1. .00 51. .64 A c
ATOM 162 CG LYS A 25 -46. .385 -28. .938 -12. .870 1. .00 54. .15 A c
ATOM 163 CD LYS A 25 -45. .570 -29. .847 -12. .097 1. .00 57. .56 A c
ATOM 164 CE LYS A 25 -44. .768 -29. .072 -11. .100 1. .00 60. .94 A c
ATOM 165 NZ LYS A 25 -44. .500 -29. .845 -9. .858 1. .00 61. .61 A N
ATOM 166 C LYS A 25 -47. .270 -31. .238 -15. .143 1. .00 51. .03 A c
ATOM 167 o LYS A 25 -48. .023 -32. .164 -15. .011 1. .00 51. .65 A o
ATOM 168 N TYR A 26 -46. .058 -31. .349 -15. .644 1. .00 48. .55 A N
ATOM 169 CA TYR A 26 -45. .481 -32. .609 -15. .998 1. .00 45. .54 A c
ATOM 170 CB TYR A 26 -45. .266 -32. .653 -17. .468 1. .00 45. .44 A c
ATOM 171 CG TYR A 26 -46. .525 -32. .475 -18. .221 1. .00 47. .36 A c
ATOM 172 CDl TYR A 26 -47..208 -33..550 -18..707 1..00 47..06 A C
ATOM 173 CEl TYR A 26 -48. .330 -33. .377 -19. .398 1. .00 50. .44 A C
ATOM 174 CZ TYR A 26 -48. .788 -32. .124 -19. .615 1. .00 49. .90 A c
ATOM 175 OH TYR A 26 -49. .922 -31. .948 -20. .312 1. .00 52. .47 A o
ATOM 176 CE2 TYR A 26 -48. .138 -31. .061 -19. .143 1. .00 46. .84 A c
ATOM 177 CD 2 TYR A 26 -47. .028 -31. .228 -18. .457 1. .00 46. .94 A c
ATOM 178 C TYR A 26 -44. .191 -32. .834 -15. .297 1. .00 43. .35 A c
ATOM 179 o TYR A 26 -43. .380 -31. .955 -15. .155 1. .00 42. .38 A o
ATOM 180 N VAL A 27 -44. .026 -34. .045 -14. .834 1. .00 40. .47 A N
ATOM 181 CA VAL A 27 -42. .808 -34. .391 -14. .083 1. .00 38. .59 A c
ATOM 182 CB VAL A 27 -43. .103 -34. .570 -12. .556 1. .00 38. .99 A c
ATOM 183 CGl VAL A 27 -43. .789 -33. .357 -12. .001 1. .00 38. .60 A c
ATOM 184 CG2 VAL A 27 -43. .963 -35. .855 -12. .313 1. .00 37. .66 A c
ATOM 185 C VAL A 27 -42. .118 -35. .672 -14. .643 1. .00 36. .60 A c
ATOM 186 o VAL A 27 -42. .781 -36. .552 -15. .270 1. .00 34. .97 A o
ATOM 187 N LEU A 28 -40. .815 -35. .780 -14. .379 1. .00 33. .39 A N
ATOM 188 CA LEU A 28 -40. .087 -37. .030 -14. .686 1. .00 31. .31 A c
ATOM 189 CB LEU A 28 -38. .592 -36. .741 -14. .896 1. .00 30. .82 A c
ATOM 190 CG LEU A 28 -38. .370 -35. .763 -16. .069 1. .00 29. .25 A c
ATOM 191 CDl LEU A 28 -36. .887 -35. .614 -16. .436 1. .00 25. .75 A c
ATOM 192 CD 2 LEU A 28 -39. .188 -36. .282 -17. .297 1. .00 27. .62 A c
ATOM 193 C LEU A 28 -40. .356 -38. .195 -13. .692 1. .00 29. .91 A c
ATOM 194 o LEU A 28 -39. .512 -38. .572 -12. .864 1. .00 28. .72 A o
ATOM 195 N ARG A 29 -41. .548 -38. .759 -13. .821 1. .00 29. .17 A N
ATOM 196 CA ARG A 29 -41. .983 -39. .934 -13. .093 1. .00 29. .07 A c
ATOM 197 CB ARG A 29 -43. .031 -39. .566 -12. .002 1. .00 28. .30 A c
ATOM 198 CG ARG A 29 -43. .815 -40. .779 -11. .438 1. .00 29. .82 A c
ATOM 199 CD ARG A 29 -44. .958 -40. .532 -10. .414 1. .00 29. .04 A c
ATOM 200 NE ARG A 29 -44. .832 -39. .314 -9. .598 1. .00 28. .43 A N
ATOM 201 CZ ARG A 29 -44. .170 -39. .129 -8. .449 1. .00 27. .95 A c
ATOM 202 NHl ARG A 29 -43. .416 -40. .064 -7. .875 1. .00 28. .57 A N
ATOM 203 NH2 ARG A 29 -44. .232 -37. .925 -7. .885 1. .00 29. .61 A N
ATOM 204 C ARG A 29 -42. .556 -40. .961 -14. .088 1. .00 29. .23 A C
ATOM 205 o ARG A 29 -43. .510 -40. .685 -14. .745 1. .00 28. .41 A o
ATOM 206 N ASP A 30 -41. .990 -42. .170 -14. .153 1. .00 30. .20 A N
ATOM 207 CA ASP A 30 -42. .364 -43. .158 -15. .151 1. .00 30. .03 A C
ATOM 208 CB ASP A 30 -41. .100 -43. .849 -15. .701 1. .00 29. .34 A c
ATOM 209 CG ASP A 30 -41. .383 -44. .840 -16. .878 1. .00 30. .84 A c
ATOM 210 ODl ASP A 30 -42. .525 -45. .362 -17. .072 1. .00 29. .94 A o
ATOM 211 OD2 ASP A 30 -40. .425 -45. .107 -17. .621 1. .00 27. .79 A o
ATOM 212 C ASP A 30 -43. .360 -44. .123 -14. .524 1. .00 30. .55 A c
ATOM 213 o ASP A 30 -43. .089 -44. .784 -13. .525 1. .00 29. .55 A o
ATOM 214 N LEU A 31 -44. .531 -44. .182 -15. .129 1. .00 31. .84 A N
ATOM 215 CA LEU A 31 -45. .673 -44. .804 -14. .522 1. .00 33. .66 A c
ATOM 216 CB LEU A 31 -46. .741 -43. .758 -14. .269 1. .00 33. .92 A c
ATOM 217 CG LEU A 31 -47. .021 -43. .233 -12. .839 1. .00 37. .06 A c
ATOM 218 CDl LEU A 31 -45. .876 -43. .230 -11. .897 1. .00 35. .24 A c
ATOM 219 CD 2 LEU A 31 -47. .674 -41. .810 -12. .854 1. .00 38. .45 A c
ATOM 220 C LEU A 31 -46. .189 -45. .830 -15. .479 1. .00 35. .24 A c
ATOM 221 o LEU A 31 -47. .292 -46. .339 -15. .306 1. .00 36. .18 A o
ATOM 222 N SER A 32 -45. .347 -46. .150 -16. .474 1. .00 36. .86 A N
ATOM 223 CA SER A 32 -45. .652 -47. .055 -17. .588 1. .00 36. .85 A c
ATOM 224 CB SER A 32 -45. .024 -46. .556 -18. .925 1. .00 36. .60 A c
ATOM 225 OG SER A 32 -43. .606 -46. .774 -18. .972 1. .00 38. .59 A o
ATOM 226 C SER A 32 -45. .197 -48. .468 -17. .297 1. .00 37. .03 A c
ATOM 227 o SER A 32 -45. .544 -49. .365 -18. .061 1. .00 36. .94 A o
ATOM 228 N LYS A 33 -44. .434 -48. .691 -16. .225 1. .00 37. .38 A N
ATOM 229 CA LYS A 33 -43. .866 -50. .038 -16. .026 1. .00 38. .79 A c
ATOM 230 CB LYS A 33 -42. .573 -50. .035 -15. .186 1. .00 38. .26 A c
ATOM 231 CG LYS A 33 -41. .473 -49. .071 -15. .689 1. .00 34. .67 A c
ATOM 232 CD LYS A 33 -41. .118 -49. .392 -17. .134 1. .00 30. .21 A c
ATOM 233 CE LYS A 33 -39. .984 -48. .532 -17. .680 1. .00 29. .07 A c
ATOM 234 NZ LYS A 33 -39. .732 -48. .697 -19. .185 1. .00 23. .25 A N
ATOM 235 C LYS A 33 -44. .895 -51. .052 -15. .503 1. .00 41. .30 A c
ATOM 236 o LYS A 33 -45. .622 -50. .798 -14. .530 1. .00 40. .23 A o
ATOM 237 N PRO A 34 -44. .958 -52. .230 -16. .147 1. .00 44. .22 A N
ATOM 238 CA PRO A 34 -46. .201 -52. .950 -15. .790 1. .00 45. .38 A c
ATOM 239 CB PRO A 34 -46. .352 -54. .000 -16. .926 1. .00 47. .30 A c
ATOM 240 CG PRO A 34 -44. .809 -54. .186 -17. .497 1. .00 48. .14 A c
ATOM 241 CD PRO A 34 -43. .951 -53. .092 -16. .834 1. .00 44. .53 A c
ATOM 242 C PRO A 34 -46. .125 -53. .585 -14. .377 1. .00 44. .92 A c
ATOM 243 o PRO A 34 -47. .134 -54. .070 -13. .845 1. .00 45. .69 A o
ATOM 244 N THR A 35 -44. .963 -53. .546 -13. .741 1. .00 42. .51 A N
ATOM 245 CA THR A 35 -44. .926 -54. .019 -12. .364 1. .00 40. .40 A c
ATOM 246 CB THR A 35 -43. .499 -54. .464 -12. .004 1. .00 41. .17 A c
ATOM 247 OGl THR A 35 -42. .610 -53. .388 -12. .332 1. .00 40. .39 A o
ATOM 248 CG2 THR A 35 -43. .107 -55. .773 -12. .741 1. .00 39. .31 A c
ATOM 249 C THR A 35 -45. .346 -52. .956 -11. .315 1. .00 38. .28 A c
ATOM 250 o THR A 35 -45. .433 -53. .269 -10. .120 1. .00 36. .30 A o
ATOM 251 N GLY A 36 -45..536 -51..702 -11..755 1..00 36..35 A N
ATOM 252 CA GLY A 36 -45. .713 -50. .583 -10. .830 1. .00 32. .77 A C
ATOM 253 C GLY A 36 -44. .426 -49. .842 -10. .507 1. .00 31. .89 A C
ATOM 254 o GLY A 36 -44. .456 -48. .780 -9. .912 1. .00 31. .63 A o
ATOM 255 N THR A 37 -43. .266 -50. .351 -10. .924 1. .00 30. .83 A N
ATOM 256 CA THR A 37 -42. .003 -49. .747 -10. .482 1. .00 27. .70 A c
ATOM 257 CB THR A 37 -40. .819 -50. .642 -10. .820 1. .00 27. .55 A c
ATOM 258 OGl THR A 37 -40. .960 -51. .876 -10. .095 1. .00 28. .01 A o
ATOM 259 CG2 THR A 37 -39. .494 -49. .979 -10. .501 1. .00 23. .29 A c
ATOM 260 C THR A 37 -41. .851 -48. .380 -11. .106 1. .00 26. .95 A c
ATOM 261 o THR A 37 -41. .941 -48. .260 -12. .281 1. .00 26. .14 A o
ATOM 262 N GLN A 38 -41. .525 -47. .385 -10. .329 1. .00 26. .09 A N
ATOM 263 CA GLN A 38 -41. .319 -46. .059 -10. .826 1. .00 26. .76 A c
ATOM 264 CB GLN A 38 -41. .863 -45. .066 -9. .816 1. .00 27. .60 A c
ATOM 265 CG GLN A 38 -43. .300 -44. .836 -9. .957 1. .00 30. .56 A c
ATOM 266 CD GLN A 38 -43. .913 -44. .030 -8. .864 1. .00 34. .02 A c
ATOM 267 OEl GLN A 38 -43. .367 -43. .074 -8. .393 1. .00 35. .21 A o
ATOM 268 NE2 GLN A 38 -45. .077 -44. .404 -8. .485 1. .00 31. .60 A N
ATOM 269 C GLN A 38 -39. .881 -45. .752 -11. .122 1. .00 25. .09 A c
ATOM 270 o GLN A 38 -39. .025 -46. .182 -10. .432 1. .00 26. .13 A o
ATOM 271 N ILE A 39 -39. .629 -45. .004 -12. .176 1. .00 23. .80 A N
ATOM 272 CA ILE A 39 -38. .346 -44. .336 -12. .348 1. .00 24. .26 A c
ATOM 273 CB ILE A 39 -37. .699 -44. .596 -13. .772 1. .00 24. .68 A c
ATOM 274 CGl ILE A 39 -37. .395 -46. .080 -14. .014 1. .00 21. .84 A c
ATOM 275 CDl ILE A 39 -38. .507 -46. .858 -14. .474 1. .00 21. .10 A c
ATOM 276 CG2 ILE A 39 -36. .388 -43. .745 -13. .945 1. .00 24. .04 A c
ATOM 277 C ILE A 39 -38. .587 -42. .826 -12. .122 1. .00 24. .60 A c
ATOM 278 o ILE A 39 -39. .521 -42. .255 -12. .681 1. .00 25. .49 A o
ATOM 279 N ILE A 40 -37. .804 -42. .171 -11. .281 1. .00 24. .30 A N
ATOM 280 CA ILE A 40 -38. .138 -40. .820 -10. .904 1. .00 24. .67 A c
ATOM 281 CB ILE A 40 -38. .760 -40. .776 -9. .481 1. .00 25. .40 A c
ATOM 282 CGl ILE A 40 -39. .778 -41. .902 -9. .248 1. .00 26. .78 A c
ATOM 283 CDl ILE A 40 -40. .256 -41. .969 -7. .776 1. .00 28. .72 A c
ATOM 284 CG2 ILE A 40 -39. .456 -39. .440 -9. .198 1. .00 25. .40 A c
ATOM 285 C ILE A 40 -36. .831 -40. .033 -10. .917 1. .00 25. .31 A c
ATOM 286 o ILE A 40 -35. .881 -40. .469 -10. .303 1. .00 25. .86 A o
ATOM 287 N THR A 41 -36. .785 -38. .864 -11. .577 1. .00 25. .27 A N
ATOM 288 CA THR A 41 -35. .535 -38. .168 -11. .811 1. .00 24. .40 A c
ATOM 289 CB THR A 41 -35. .271 -38. .016 -13. .322 1. .00 23. .99 A c
ATOM 290 OGl THR A 41 -35. .523 -39. .264 -13. .986 1. .00 24. .89 A o
ATOM 291 CG2 THR A 41 -33. .870 -37. .563 -13. .592 1. .00 20. .66 A c
ATOM 292 C THR A 41 -35. .545 -36. .793 -11. .150 1. .00 26. .35 A c
ATOM 293 o THR A 41 -36. .499 -36. .004 -11. .319 1. .00 26. .67 A o
ATOM 294 N TYR A 42 -34. .488 -36. .490 -10. .401 1. .00 26. .81 A N
ATOM 295 CA TYR A 42 -34. .470 -35. .288 -9. .624 1. .00 28. .66 A c
ATOM 296 CB TYR A 42 -34. .363 -35. .615 -8. .121 1. .00 29. .19 A c
ATOM 297 CG TYR A 42 -35. .602 -36. .234 -7. .554 1. .00 28. .72 A c
ATOM 298 CDl TYR A 42 -35. .834 -37. .620 -7. .674 1. .00 29. .76 A c
ATOM 299 CEl TYR A 42 -36. .985 -38. .198 -7. .145 1. .00 30. .70 A c
ATOM 300 CZ TYR A 42 -37. .913 -37. .389 -6. .473 1. .00 32. .18 A c
ATOM 301 OH TYR A 42 -39. .044 -37. .951 -5. .962 1. .00 34. .06 A o
ATOM 302 CE2 TYR A 42 -37. .732 -36. .002 -6. .366 1. .00 29. .34 A c
ATOM 303 CD2 TYR A 42 -36. .556 -35. .441 -6. .883 1. .00 28. .41 A c
ATOM 304 C TYR A 42 -33. .275 -34. .456 -10. .028 1. .00 30. .08 A c
ATOM 305 o TYR A 42 -32. .293 -34. .980 -10. .550 1. .00 29. .14 A o
ATOM 306 N ASP A 43 -33. .356 -33. .160 -9. .738 1. .00 31. .69 A N
ATOM 307 CA ASP A 43 -32. .296 -32. .216 -10. .075 1. .00 33. .46 A c
ATOM 308 CB ASP A 43 -32. .867 -31. .090 -10. .989 1. .00 32. .64 A c
ATOM 309 CG ASP A 43 -31. .851 -29. .958 -11. .296 1. .00 32. .89 A c
ATOM 310 ODl ASP A 43 -30. .696 -29. .966 -10. .757 1. .00 30. .15 A o
ATOM 311 OD2 ASP A 43 -32. .236 -29. .054 -12. .087 1. .00 32. .73 A o
ATOM 312 C ASP A 43 -31. .740 -31. .685 -8. .754 1. .00 34. .58 A c
ATOM 313 o ASP A 43 -32. .470 -31. .124 -7. .943 1. .00 35. .27 A o
ATOM 314 N LEU A 44 -30. .453 -31. .866 -8. .521 1. .00 36. .27 A N
ATOM 315 CA LEU A 44 -29. .884 -31. .438 -7. .245 1. .00 37. .65 A c
ATOM 316 CB LEU A 44 -28. .720 -32. .371 -6. .881 1. .00 37. .26 A c
ATOM 317 CG LEU A 44 -28. .521 -33. .054 -5. .509 1. .00 39. .07 A c
ATOM 318 CDl LEU A 44 -29. .742 -33. .120 -4. .619 1. .00 36. .83 A c
ATOM 319 CD2 LEU A 44 -27. .831 -34. .449 -5. .635 1. .00 37. .50 A c
ATOM 320 C LEU A 44 -29. .472 -29. .939 -7. .294 1. .00 38. .87 A c
ATOM 321 o LEU A 44 -29. .162 -29. .343 -6. .279 1. .00 39. .39 A o
ATOM 322 N GLN A 45 -29. .471 -29. .328 -8. .482 1. .00 40. .24 A N
ATOM 323 CA GLN A 45 -28. .976 -27. .955 -8. .653 1. .00 40. .83 A c
ATOM 324 CB GLN A 45 -30. .003 -26. .930 -8. .127 1. .00 40. .93 A c
ATOM 325 CG GLN A 45 -31. .400 -27. .042 -8. .843 1. .00 43. .55 A c
ATOM 326 CD GLN A 45 -32. .557 -26. .463 -8. .026 1. .00 46. .24 A c
ATOM 327 OEl GLN A 45 -32. .440 -26. .239 -6. .825 1. .00 48. .19 A o
ATOM 328 NE2 GLN A 45 -33. .669 -26. .215 -8. .680 1. .00 44. .67 A N
ATOM 329 C GLN A 45 -27. .607 -27. .785 -8. .002 1. .00 41. .18 A c
ATOM 330 o GLN A 45 -27..368 -26..809 -7..304 1..00 42..73 A o
ATOM 331 N ASN A 46 -26. .710 -28. .738 -8. .202 1. .00 40. .77 A N
ATOM 332 CA ASN A 46 -25. .305 -28. .565 -7. .818 1. .00 41. .87 A C
ATOM 333 CB ASN A 46 -24. .676 -27. .325 -8. .485 1. .00 41. .62 A C
ATOM 334 CG ASN A 46 -24. .762 -27. .374 -10. .029 1. .00 42. .52 A c
ATOM 335 ODl ASN A 46 -25. .384 -26. .511 -10. .647 1. .00 42. .00 A o
ATOM 336 ND2 ASN A 46 -24. .173 -28. .426 -10. .642 1. .00 39. .75 A N
ATOM 337 C ASN A 46 -24. .977 -28. .607 -6. .340 1. .00 43. .16 A c
ATOM 338 o ASN A 46 -23. .805 -28. .419 -6. .002 1. .00 42. .88 A o
ATOM 339 N ARG A 47 -25. .992 -28. .859 -5. .485 1. .00 44. .54 A N
ATOM 340 CA ARG A 47 -25. .793 -29. .192 -4. .062 1. .00 46. .84 A c
ATOM 341 CB ARG A 47 -27. .013 -28. .809 -3. .177 1. .00 47. .30 A c
ATOM 342 CG ARG A 47 -28. .061 -27. .854 -3. .818 1. .00 52. .65 A c
ATOM 343 CD ARG A 47 -28. .528 -26. .620 -2. .951 1. .00 60. .12 A c
ATOM 344 NE ARG A 47 -27. .637 -25. .455 -3. .151 1. .00 65. .09 A N
ATOM 345 CZ ARG A 47 -27. .824 -24. .450 -4. .026 1. .00 67. .61 A c
ATOM 346 NHl ARG A 47 -28. .902 -24. .400 -4. .820 1. .00 67. .70 A N
ATOM 347 NH2 ARG A 47 -26. .908 -23. .483 -4. .120 1. .00 67. .50 A N
ATOM 348 C ARG A 47 -25. .431 -30. .704 -3. .904 1. .00 47. .66 A C
ATOM 349 o ARG A 47 -25. .563 -31. .500 -4. .854 1. .00 47. .75 A o
ATOM 350 N GLU A 48 -24. .958 -31. .100 -2. .723 1. .00 48. .47 A N
ATOM 351 CA GLU A 48 -24. .549 -32. .484 -2. .482 1. .00 49. .38 A C
ATOM 352 CB GLU A 48 -23. .016 -32. .618 -2. .288 1. .00 49. .89 A c
ATOM 353 CG GLU A 48 -22. .140 -31. .848 -3. .281 1. .00 53. .97 A c
ATOM 354 CD GLU A 48 -20. .699 -32. .390 -3. .369 1. .00 58. .12 A c
ATOM 355 OEl GLU A 48 -20. .138 -32. .504 -4. .487 1. .00 58. .48 A o
ATOM 356 OE2 GLU A 48 -20. .118 -32. .708 -2. .314 1. .00 60. .70 A o
ATOM 357 C GLU A 48 -25. .241 -33. .080 -1. .258 1. .00 49. .02 A c
ATOM 358 o GLU A 48 -24. .821 -34. .136 -0. .773 1. .00 48. .86 A o
ATOM 359 N TYR A 49 -26. .282 -32. .411 -0. .752 1. .00 48. .71 A N
ATOM 360 CA TYR A 49 -26. .949 -32. .832 0. .497 1. .00 48. .43 A c
ATOM 361 CB TYR A 49 -26. .434 -32. .015 1. .710 1. .00 49. .21 A c
ATOM 362 CG TYR A 49 -26. .684 -30. .530 1. .510 1. .00 53. .66 A c
ATOM 363 CDl TYR A 49 -25. .753 -29. .740 0. .794 1. .00 57. .40 A c
ATOM 364 CEl TYR A 49 -25. .994 -28. .371 0. .564 1. .00 61. .43 A c
ATOM 365 CZ TYR A 49 -27. .197 -27. .783 1. .046 1. .00 63. .54 A c
ATOM 366 OH TYR A 49 -27. .421 -26. .423 0. .803 1. .00 65. .65 A o
ATOM 367 CE2 TYR A 49 -28. .150 -28. .560 1. .742 1. .00 59. .44 A c
ATOM 368 CD 2 TYR A 49 -27. .883 -29. .918 1. .975 1. .00 56. .66 A c
ATOM 369 C TYR A 49 -28. .438 -32. .632 0. .350 1. .00 47. .07 A c
ATOM 370 o TYR A 49 -28. .896 -31. .946 -0. .594 1. .00 46. .06 A o
ATOM 371 N ASN A 50 -29. .192 -33. .194 1. .315 1. .00 46. .10 A N
ATOM 372 CA ASN A 50 -30. .657 -33. .095 1. .331 1. .00 43. .95 A c
ATOM 373 CB ASN A 50 -31. .101 -31. .597 1. .518 1. .00 44. .54 A c
ATOM 374 CG ASN A 50 -32. .582 -31. .439 1. .975 1. .00 46. .46 A c
ATOM 375 ODl ASN A 50 -33. .116 -32. .261 2. .725 1. .00 47. .44 A o
ATOM 376 ND2 ASN A 50 -33. .238 -30. .373 1. .511 1. .00 48. .73 A N
ATOM 377 C ASN A 50 -31. .196 -33. .744 0. .023 1. .00 41. .68 A c
ATOM 378 o ASN A 50 -32. .011 -33. .161 -0. .691 1. .00 40. .51 A o
ATOM 379 N LEU A 51 -30. .711 -34. .952 -0. .266 1. .00 39. .34 A N
ATOM 380 CA LEU A 51 -31. .135 -35. .742 -1. .434 1. .00 38. .05 A c
ATOM 381 CB LEU A 51 -30. .272 -37. .011 -1. .608 1. .00 36. .68 A c
ATOM 382 CG LEU A 51 -28. .736 -36. .853 -1. .766 1. .00 38. .02 A c
ATOM 383 CDl LEU A 51 -28. .040 -37. .730 -2. .821 1. .00 30. .41 A c
ATOM 384 CD 2 LEU A 51 -28. .301 -35. .401 -1. .953 1. .00 38. .51 A c
ATOM 385 C LEU A 51 -32. .609 -36. .125 -1. .302 1. .00 37. .04 A c
ATOM 386 o LEU A 51 -33. .115 -36. .208 -0. .183 1. .00 38. .60 A o
ATOM 387 N PRO A 52 -33. .296 -36. .391 -2. .426 1. .00 35. .16 A N
ATOM 388 CA PRO A 52 -32. .736 -36. .442 -3. .785 1. .00 35. .00 A c
ATOM 389 CB PRO A 52 -33. .631 -37. .467 -4. .472 1. .00 34. .76 A c
ATOM 390 CG PRO A 52 -34. .968 -37. .210 -3. .835 1. .00 35. .21 A c
ATOM 391 CD PRO A 52 -34. .680 -36. .861 -2. .384 1. .00 33. .35 A c
ATOM 392 C PRO A 52 -32. .741 -35. .098 -4. .564 1. .00 34. .93 A c
ATOM 393 o PRO A 52 -32. .065 -34. .989 -5. .602 1. .00 35. .60 A o
ATOM 394 N GLY A 53 -33. .486 -34. .105 -4. .068 1. .00 34. .24 A N
ATOM 395 CA GLY A 53 -33. .572 -32. .778 -4. .661 1. .00 33. .02 A c
ATOM 396 C GLY A 53 -34. .949 -32. .535 -5. .260 1. .00 32. .97 A c
ATOM 397 o GLY A 53 -35. .952 -33. .093 -4. .807 1. .00 33. .28 A o
ATOM 398 N THR A 54 -34. .967 -31. .739 -6. .320 1. .00 32. .27 A N
ATOM 399 CA THR A 54 -36. .160 -31. .260 -6. .945 1. .00 32. .37 A c
ATOM 400 CB THR A 54 -35. .947 -29. .811 -7. .437 1. .00 32. .98 A c
ATOM 401 OGl THR A 54 -35. .393 -29. .041 -6. .360 1. .00 34. .33 A o
ATOM 402 CG2 THR A 54 -37. .276 -29. .167 -8. .007 1. .00 31. .11 A c
ATOM 403 C THR A 54 -36. .605 -32. .137 -8. .106 1. .00 32. .94 A c
ATOM 404 o THR A 54 -35. .878 -32. .380 -9. .087 1. .00 31. .68 A o
ATOM 405 N LEU A 55 -37. .838 -32. .586 -7. .987 1. .00 33. .67 A N
ATOM 406 CA LEU A 55 -38. .430 -33. .378 -8. .995 1. .00 35. .36 A c
ATOM 407 CB LEU A 55 -39. .855 -33. .704 -8. .577 1. .00 34. .52 A c
ATOM 408 CG LEU A 55 -40. .594 -34. .680 -9. .486 1. .00 37. .35 A c
ATOM 409 CDl LEU A 55 -39..853 -36..006 -9..710 1..00 32..36 A C
ATOM 410 CD 2 LEU A 55 -41. .990 -34. .945 -8. .959 1. .00 38. .13 A C
ATOM 411 C LEU A 55 -38. .335 -32. .533 -10. .275 1. .00 36. .98 A c
ATOM 412 o LEU A 55 -38. .680 -31. .346 -10. .269 1. .00 37. .92 A o
ATOM 413 N VAL A 56 -37. .811 -33. .123 -11. .355 1. .00 37. .30 A N
ATOM 414 CA VAL A 56 -37. .657 -32. .406 -12. .591 1. .00 36. .64 A c
ATOM 415 CB VAL A 56 -36. .625 -33. .113 -13. .515 1. .00 36. .80 A c
ATOM 416 CGl VAL A 56 -36. .762 -32. .623 -14. .916 1. .00 34. .94 A c
ATOM 417 CG2 VAL A 56 -35. .191 -32. .844 -13. .013 1. .00 32. .55 A c
ATOM 418 C VAL A 56 -39. .034 -32. .199 -13. .231 1. .00 38. .20 A c
ATOM 419 o VAL A 56 -39. .807 -33. .136 -13. .400 1. .00 38. .95 A o
ATOM 420 N SER A 57 -39. .370 -30. .966 -13. .578 1. .00 40. .18 A N
ATOM 421 CA SER A 57 -40. .712 -30. .721 -14. .141 1. .00 42. .41 A c
ATOM 422 CB SER A 57 -41. .729 -30. .414 -13. .036 1. .00 41. .73 A c
ATOM 423 OG SER A 57 -41. .165 -29. .456 -12. .199 1. .00 42. .33 A o
ATOM 424 C SER A 57 -40. .771 -29. .642 -15. .221 1. .00 42. .87 A c
ATOM 425 o SER A 57 -39. .889 -28. .786 -15. .312 1. .00 42. .53 A o
ATOM 426 N SER A 58 -41. .805 -29. .725 -16. .046 1. .00 43. .46 A N
ATOM 427 CA SER A 58 -42. .064 -28. .689 -17. .021 1. .00 45. .24 A c
ATOM 428 CB SER A 58 -41. .435 -29. .040 -18. .379 1. .00 44. .87 A c
ATOM 429 OG SER A 58 -42. .368 -28. .988 -19. .446 1. .00 43. .17 A o
ATOM 430 C SER A 58 -43. .572 -28. .385 -17. .143 1. .00 46. .75 A c
ATOM 431 o SER A 58 -44. .444 -29. .258 -16. .870 1. .00 45. .93 A o
ATOM 432 N THR A 59 -43. .872 -27. .155 -17. .572 1. .00 47. .81 A N
ATOM 433 CA THR A 59 -45. .272 -26. .786 -17. .788 1. .00 48. .79 A c
ATOM 434 CB THR A 59 -45. .480 -25. .278 -17. .829 1. .00 49. .03 A c
ATOM 435 OGl THR A 59 -44. .902 -24. .807 -19. .041 1. .00 49. .03 A o
ATOM 436 CG2 THR A 59 -44. .827 -24. .562 -16. .589 1. .00 48. .04 A c
ATOM 437 C THR A 59 -45. .820 -27. .435 -19. .055 1. .00 48. .93 A c
ATOM 438 o THR A 59 -47. .025 -27. .449 -19. .250 1. .00 49. .98 A o
ATOM 439 N THR A 60 -44. .956 -28. .002 -19. .889 1. .00 48. .95 A N
ATOM 440 CA THR A 60 -45. .416 -28. .777 -21. .048 1. .00 49. .54 A c
ATOM 441 CB THR A 60 -44. .976 -28. .152 -22. .416 1. .00 50. .77 A c
ATOM 442 OGl THR A 60 -43. .537 -27. .921 -22. .449 1. .00 50. .15 A o
ATOM 443 CG2 THR A 60 -45. .795 -26. .834 -22. .706 1. .00 49. .54 A c
ATOM 444 C THR A 60 -44. .927 -30. .207 -21. .074 1. .00 49. .42 A c
ATOM 445 o THR A 60 -44. .079 -30. .621 -20. .300 1. .00 49. .57 A o
ATOM 446 N ASN A 61 -45. .521 -30. .947 -21. .987 1. .00 48. .77 A N
ATOM 447 CA ASN A 61 -45. .036 -32. .187 -22. .505 1. .00 47. .80 A c
ATOM 448 CB ASN A 61 -45. .682 -32. .345 -23. .885 1. .00 48. .54 A c
ATOM 449 CG ASN A 61 -46. .190 -33. .713 -24. .078 1. .00 52. .04 A c
ATOM 450 ODl ASN A 61 -46. .532 -34. .150 -25. .180 1. .00 52. .14 A o
ATOM 451 ND2 ASN A 61 -46. .237 -34. .448 -22. .960 1. .00 58. .59 A N
ATOM 452 C ASN A 61 -43. .527 -32. .339 -22. .754 1. .00 46. .83 A c
ATOM 453 o ASN A 61 -43. .056 -33. .455 -23. .094 1. .00 45. .82 A o
ATOM 454 N GLN A 62 -42. .780 -31. .234 -22. .648 1. .00 45. .02 A N
ATOM 455 CA GLN A 62 -41. .465 -31. .161 -23. .273 1. .00 43. .93 A c
ATOM 456 CB GLN A 62 -41. .479 -30. .234 -24. .529 1. .00 44. .43 A c
ATOM 457 CG GLN A 62 -42. .303 -30. .766 -25. .762 1. .00 49. .48 A c
ATOM 458 CD GLN A 62 -41. .858 -30. .185 -27. .192 1. .00 56. .15 A c
ATOM 459 OEl GLN A 62 -40. .951 -29. .336 -27. .299 1. .00 55. .55 A o
ATOM 460 NE2 GLN A 62 -42. .511 -30. .683 -28. .274 1. .00 54. .68 A N
ATOM 461 C GLN A 62 -40. .379 -30. .760 -22. .285 1. .00 42. .39 A c
ATOM 462 o GLN A 62 -40. .507 -29. .738 -21. .575 1. .00 41. .48 A o
ATOM 463 N PHE A 63 -39. .299 -31. .553 -22. .240 1. .00 40. .50 A N
ATOM 464 CA PHE A 63 -38. .183 -31. .224 -21. .338 1. .00 39. .06 A c
ATOM 465 CB PHE A 63 -37. .901 -32. .388 -20. .376 1. .00 38. .22 A c
ATOM 466 CG PHE A 63 -39. .057 -32. .701 -19. .488 1. .00 33. .68 A c
ATOM 467 CDl PHE A 63 -40. .184 -33. .360 -20. .008 1. .00 26. .93 A c
ATOM 468 CEl PHE A 63 -41. .301 -33. .621 -19. .216 1. .00 24. .98 A c
ATOM 469 CZ PHE A 63 -41. .285 -33. .253 -17. .871 1. .00 23. .12 A c
ATOM 470 CE2 PHE A 63 -40. .143 -32. .585 -17. .311 1. .00 26. .49 A c
ATOM 471 CD 2 PHE A 63 -39. .044 -32. .300 -18. .132 1. .00 30. .53 A c
ATOM 472 C PHE A 63 -36. .977 -30. .840 -22. .146 1. .00 39. .10 A c
ATOM 473 o PHE A 63 -36. .152 -31. .698 -22. .538 1. .00 38. .84 A o
ATOM 474 N THR A 64 -36. .891 -29. .544 -22. .428 1. .00 38. .79 A N
ATOM 475 CA THR A 64 -35. .953 -29. .061 -23. .422 1. .00 38. .65 A c
ATOM 476 CB THR A 64 -36. .671 -28. .406 -24. .642 1. .00 39. .24 A c
ATOM 477 OGl THR A 64 -37. .175 -27. .118 -24. .253 1. .00 36. .93 A o
ATOM 478 CG2 THR A 64 -37. .812 -29. .295 -25. .262 1. .00 35. .51 A c
ATOM 479 C THR A 64 -34. .986 -28. .050 -22. .862 1. .00 39. .61 A c
ATOM 480 o THR A 64 -34. .181 -27. .525 -23. .589 1. .00 41. .43 A o
ATOM 481 N THR A 65 -35. .033 -27. .741 -21. .586 1. .00 39. .94 A N
ATOM 482 CA THR A 65 -34. .115 -26. .719 -21. .101 1. .00 40. .84 A c
ATOM 483 CB THR A 65 -34. .622 -26. .076 -19. .777 1. .00 41. .39 A c
ATOM 484 OGl THR A 65 -34. .335 -26. .930 -18. .639 1. .00 45. .44 A o
ATOM 485 CG2 THR A 65 -36. .149 -25. .779 -19. .880 1. .00 39. .64 A c
ATOM 486 C THR A 65 -32. .716 -27. .304 -20. .962 1. .00 41. .43 A c
ATOM 487 o THR A 65 -32. .535 -28. .526 -20. .920 1. .00 42. .73 A o
ATOM 488 N SER A 66 -31..700 -26..465 -20..890 1..00 41..45 A N
ATOM 489 CA SER A 66 -30. .363 -27. .017 -20. .947 1. .00 41. .32 A C
ATOM 490 CB SER A 66 -29. .307 -25. .956 -21. .314 1. .00 41. .67 A C
ATOM 491 OG SER A 66 -28. .943 -25. .262 -20. .148 1. .00 42. .16 A o
ATOM 492 C SER A 66 -30. .011 -27. .800 -19. .658 1. .00 40. .64 A c
ATOM 493 o SER A 66 -29. .354 -28. .846 -19. .737 1. .00 41. .27 A o
ATOM 494 N SER A 67 -30. .456 -27. .327 -18. .495 1. .00 38. .90 A N
ATOM 495 CA SER A 67 -30. .160 -28. .045 -17. .230 1. .00 37. .15 A c
ATOM 496 CB SER A 67 -30. .297 -27. .124 -15. .998 1. .00 37. .36 A c
ATOM 497 OG SER A 67 -31. .667 -26. .844 -15. .786 1. .00 38. .44 A o
ATOM 498 C SER A 67 -30. .986 -29. .349 -17. .077 1. .00 35. .34 A c
ATOM 499 o SER A 67 -30. .624 -30. .228 -16. .287 1. .00 33. .43 A o
ATOM 500 N GLN A 68 -32. .039 -29. .457 -17. .882 1. .00 33. .79 A N
ATOM 501 CA GLN A 68 -32. .809 -30. .662 -18. .027 1. .00 34. .91 A c
ATOM 502 CB GLN A 68 -34. .204 -30. .295 -18. .571 1. .00 34. .66 A c
ATOM 503 CG GLN A 68 -35. .212 -29. .824 -17. .504 1. .00 38. .08 A c
ATOM 504 CD GLN A 68 -36. .542 -29. .280 -18. .091 1. .00 42. .37 A c
ATOM 505 OEl GLN A 68 -36. .660 -28. .995 -19. .300 1. .00 44. .88 A o
ATOM 506 NE2 GLN A 68 -37. .549 -29. .160 -17. .230 1. .00 40. .98 A N
ATOM 507 C GLN A 68 -32. .221 -31. .796 -18. .942 1. .00 35. .05 A c
ATOM 508 o GLN A 68 -32. .826 -32. .901 -19. .060 1. .00 34. .80 A o
ATOM 509 N ARG A 69 -31. .125 -31. .505 -19. .661 1. .00 34. .05 A N
ATOM 510 CA ARG A 69 -30. .582 -32. .456 -20. .596 1. .00 32. .71 A c
ATOM 511 CB ARG A 69 -29. .503 -31. .788 -21. .418 1. .00 33. .66 A c
ATOM 512 CG ARG A 69 -30. .046 -31. .047 -22. .706 1. .00 37. .81 A c
ATOM 513 CD ARG A 69 -28. .885 -30. .461 -23. .501 1. .00 43. .53 A c
ATOM 514 NE ARG A 69 -29. .328 -29. .621 -24. .606 1. .00 49. .85 A N
ATOM 515 CZ ARG A 69 -28. .711 -29. .520 -25. .780 1. .00 50. .78 A c
ATOM 516 NHl ARG A 69 -27. .614 -30. .221 -26. .045 1. .00 50. .71 A N
ATOM 517 NH2 ARG A 69 -29. .225 -28. .744 -26. .717 1. .00 52. .55 A N
ATOM 518 C ARG A 69 -30. .047 -33. .665 -19. .800 1. .00 31. .68 A C
ATOM 519 o ARG A 69 -30. .369 -34. .829 -20. .101 1. .00 31. .59 A o
ATOM 520 N ALA A 70 -29. .285 -33. .386 -18. .756 1. .00 28. .74 A N
ATOM 521 CA ALA A 70 -28. .724 -34. .423 -17. .974 1. .00 27. .59 A C
ATOM 522 CB ALA A 70 -27. .785 -33. .868 -16. .899 1. .00 26. .50 A c
ATOM 523 C ALA A 70 -29. .855 -35. .274 -17. .389 1. .00 27. .63 A c
ATOM 524 o ALA A 70 -29. .716 -36. .512 -17. .323 1. .00 28. .16 A o
ATOM 525 N ALA A 71 -30. .997 -34. .655 -17. .048 1. .00 26. .34 A N
ATOM 526 CA ALA A 71 -32. .130 -35. .431 -16. .500 1. .00 25. .13 A c
ATOM 527 CB ALA A 71 -33. .162 -34. .532 -15. .828 1. .00 26. .06 A c
ATOM 528 C ALA A 71 -32. .807 -36. .303 -17. .538 1. .00 24. .79 A c
ATOM 529 o ALA A 71 -33. .281 -37. .427 -17. .215 1. .00 25. .17 A o
ATOM 530 N VAL A 72 -32. .869 -35. .818 -18. .771 1. .00 23. .47 A N
ATOM 531 CA VAL A 72 -33. .480 -36. .593 -19. .829 1. .00 24. .72 A c
ATOM 532 CB VAL A 72 -33. .511 -35. .776 -21. .148 1. .00 26. .15 A c
ATOM 533 CGl VAL A 72 -34. .001 -36. .649 -22. .334 1. .00 25. .93 A c
ATOM 534 CG2 VAL A 72 -34. .336 -34. .478 -20. .993 1. .00 24. .20 A c
ATOM 535 C VAL A 72 -32. .662 -37. .892 -20. .057 1. .00 25. .57 A c
ATOM 536 o VAL A 72 -33. .232 -38. .995 -20. .138 1. .00 25. .05 A o
ATOM 537 N ASP A 73 -31. .322 -37. .780 -20. .115 1. .00 25. .59 A N
ATOM 538 CA ASP A 73 -30. .561 -38. .978 -20. .334 1. .00 25. .80 A c
ATOM 539 CB ASP A 73 -29. .082 -38. .733 -20. .575 1. .00 26. .54 A c
ATOM 540 CG ASP A 73 -28. .799 -38. .077 -21. .890 1. .00 25. .88 A c
ATOM 541 ODl ASP A 73 -29. .270 -36. .955 -22. .124 1. .00 29. .87 A o
ATOM 542 OD2 ASP A 73 -28. .011 -38. .626 -22. .658 1. .00 25. .27 A o
ATOM 543 C ASP A 73 -30. .811 -39. .944 -19. .153 1. .00 25. .39 A c
ATOM 544 o ASP A 73 -31. .104 -41. .169 -19. .401 1. .00 23. .26 A o
ATOM 545 N ALA A 74 -30. .776 -39. .386 -17. .923 1. .00 24. .46 A N
ATOM 546 CA ALA A 74 -30. .919 -40. .211 -16. .666 1. .00 24. .88 A c
ATOM 547 CB ALA A 74 -30. .708 -39. .411 -15. .371 1. .00 23. .92 A c
ATOM 548 C ALA A 74 -32. .261 -40. .865 -16. .648 1. .00 25. .23 A c
ATOM 549 o ALA A 74 -32. .355 -42. .051 -16. .430 1. .00 24. .99 A o
ATOM 550 N HIS A 75 -33. .305 -40. .100 -16. .967 1. .00 26. .40 A N
ATOM 551 CA HIS A 75 -34. .655 -40. .660 -16. .937 1. .00 26. .47 A c
ATOM 552 CB HIS A 75 -35. .729 -39. .551 -17. .047 1. .00 25. .93 A c
ATOM 553 CG HIS A 75 -37. .106 -40. .028 -16. .728 1. .00 26. .63 A c
ATOM 554 NDl HIS A 75 -37. .570 -40. .152 -15. .432 1. .00 24. .12 A N
ATOM 555 CEl HIS A 75 -38. .815 -40. .607 -15. .458 1. .00 26. .83 A c
ATOM 556 NE2 HIS A 75 -39. .178 -40. .775 -16. .720 1. .00 28. .65 A N
ATOM 557 CD 2 HIS A 75 -38. .119 -40. .438 -17. .535 1. .00 28. .72 A C
ATOM 558 C HIS A 75 -34. .817 -41. .735 -18. .031 1. .00 26. .15 A c
ATOM 559 o HIS A 75 -35. .248 -42. .830 -17. .754 1. .00 26. .75 A o
ATOM 560 N TYR A 76 -34. .435 -41. .418 -19. .262 1. .00 25. .17 A N
ATOM 561 CA TYR A 76 -34. .447 -42. .382 -20. .355 1. .00 24. .49 A c
ATOM 562 CB TYR A 76 -34. .010 -41. .649 -21. .618 1. .00 25. .96 A c
ATOM 563 CG TYR A 76 -34. .184 -42. .446 -22. .878 1. .00 28. .99 A c
ATOM 564 CDl TYR A 76 -35. .399 -42. .486 -23. .521 1. .00 30. .72 A c
ATOM 565 CEl TYR A 76 -35. .575 -43. .211 -24. .728 1. .00 32. .22 A c
ATOM 566 CZ TYR A 76 -34. .509 -43. .900 -25. .258 1. .00 35. .19 A c
ATOM 567 OH TYR A 76 -34..691 -44..631 -26..403 1..00 35..34 A o
ATOM 568 CE2 TYR A 76 -33. .273 -43. .884 -24. .614 1. .00 33. .11 A C
ATOM 569 CD 2 TYR A 76 -33. .110 -43. .170 -23. .432 1. .00 31. .42 A c
ATOM 570 C TYR A 76 -33. .562 -43. .611 -20. .148 1. .00 24. .10 A c
ATOM 571 o TYR A 76 -33. .976 -44. .755 -20. .350 1. .00 24. .86 A o
ATOM 572 N ASN A 77 -32. .325 -43. .420 -19. .724 1. .00 23. .91 A N
ATOM 573 CA ASN A 77 -31. .508 -44. .603 -19. .541 1. .00 22. .42 A c
ATOM 574 CB ASN A 77 -30. .023 -44. .258 -19. .441 1. .00 22. .43 A c
ATOM 575 CG ASN A 77 -29. .463 -43. .749 -20. .739 1. .00 17. .76 A c
ATOM 576 ODl ASN A 77 -29. .953 -44. .040 -21. .828 1. .00 22. .44 A o
ATOM 577 ND2 ASN A 77 -28. .526 -42. .890 -20. .620 1. .00 11. .56 A N
ATOM 578 C ASN A 77 -31. .943 -45. .543 -18. .424 1. .00 22. .81 A c
ATOM 579 o ASN A 77 -31. .979 -46. .757 -18. .642 1. .00 22. .77 A o
ATOM 580 N LEU A 78 -32. .249 -45. .009 -17. .242 1. .00 23. .23 A N
ATOM 581 CA LEU A 78 -32. .683 -45. .845 -16. .123 1. .00 24. .06 A c
ATOM 582 CB LEU A 78 -32. .929 -44. .983 -14. .929 1. .00 24. .24 A c
ATOM 583 CG LEU A 78 -31. .961 -44. .886 -13. .740 1. .00 27. .66 A c
ATOM 584 CDl LEU A 78 -30. .668 -45. .654 -13. .841 1. .00 22. .27 A c
ATOM 585 CD 2 LEU A 78 -31. .740 -43. .409 -13. .364 1. .00 29. .07 A c
ATOM 586 C LEU A 78 -33. .950 -46. .645 -16. .492 1. .00 24. .84 A c
ATOM 587 o LEU A 78 -34. .119 -47. .808 -16. .078 1. .00 24. .42 A o
ATOM 588 N GLY A 79 -34. .816 -46. .050 -17. .321 1. .00 25. .35 A N
ATOM 589 CA GLY A 79 -35. .968 -46. .791 -17. .824 1. .00 25. .79 A c
ATOM 590 C GLY A 79 -35. .489 -47. .947 -18. .686 1. .00 26. .54 A c
ATOM 591 o GLY A 79 -36. .045 -49. .046 -18. .604 1. .00 26. .41 A o
ATOM 592 N LYS A 80 -34. .488 -47. .698 -19. .550 1. .00 26. .38 A N
ATOM 593 CA LYS A 80 -33. .936 -48. .802 -20. .369 1. .00 27. .32 A c
ATOM 594 CB LYS A 80 -33. .011 -48. .302 -21. .504 1. .00 28. .49 A c
ATOM 595 CG LYS A 80 -33. .782 -47. .811 -22. .743 1. .00 33. .44 A c
ATOM 596 CD LYS A 80 -33. .098 -48. .294 -24. .045 1. .00 42. .67 A c
ATOM 597 CE LYS A 80 -32. .247 -47. .154 -24. .682 1. .00 48. .39 A c
ATOM 598 NZ LYS A 80 -32. .366 -47. .039 -26. .217 1. .00 49. .07 A N
ATOM 599 C LYS A 80 -33. .271 -49. .932 -19. .528 1. .00 25. .49 A c
ATOM 600 o LYS A 80 -33. .395 -51. .132 -19. .879 1. .00 25. .22 A o
ATOM 601 N VAL A 81 -32. .626 -49. .562 -18. .412 1. .00 23. .06 A N
ATOM 602 CA VAL A 81 -32. .000 -50. .552 -17. .577 1. .00 20. .88 A c
ATOM 603 CB VAL A 81 -30. .967 -49. .941 -16. .655 1. .00 21. .65 A c
ATOM 604 CGl VAL A 81 -30. .409 -51. .002 -15. .659 1. .00 19. .27 A c
ATOM 605 CG2 VAL A 81 -29. .825 -49. .304 -17. .481 1. .00 18. .92 A c
ATOM 606 C VAL A 81 -33. .028 -51. .393 -16. .828 1. .00 21. .39 A c
ATOM 607 o VAL A 81 -32. .859 -52. .610 -16. .699 1. .00 21. .09 A o
ATOM 608 N TYR A 82 -34. .113 -50. .760 -16. .375 1. .00 21. .90 A N
ATOM 609 CA TYR A 82 -35. .236 -51. .463 -15. .786 1. .00 21. .33 A c
ATOM 610 CB TYR A 82 -36. .373 -50. .475 -15. .331 1. .00 22. .04 A c
ATOM 611 CG TYR A 82 -37. .629 -51. .250 -14. .970 1. .00 18. .84 A c
ATOM 612 CDl TYR A 82 -38. .503 -51. .665 -15. .990 1. .00 19. .21 A c
ATOM 613 CEl TYR A 82 -39. .585 -52. .444 -15. .776 1. .00 18. .52 A c
ATOM 614 CZ TYR A 82 -39. .883 -52. .874 -14. .525 1. .00 21. .16 A c
ATOM 615 OH TYR A 82 -41. .020 -53. .656 -14. .432 1. .00 24. .42 A o
ATOM 616 CE2 TYR A 82 -39. .062 -52. .536 -13. .457 1. .00 20. .05 A c
ATOM 617 CD 2 TYR A 82 -37. .855 -51. .701 -13. .722 1. .00 16. .33 A c
ATOM 618 C TYR A 82 -35. .781 -52. .476 -16. .808 1. .00 22. .26 A c
ATOM 619 o TYR A 82 -36. .007 -53. .649 -16. .479 1. .00 22. .32 A o
ATOM 620 N ASP A 83 -36. .041 -52. .029 -18. .030 1. .00 22. .20 A N
ATOM 621 CA ASP A 83 -36. .498 -52. .971 -19. .075 1. .00 23. .53 A c
ATOM 622 CB ASP A 83 -36. .745 -52. .268 -20. .416 1. .00 23. .02 A c
ATOM 623 CG ASP A 83 -37. .831 -51. .196 -20. .317 1. .00 25. .23 A c
ATOM 624 ODl ASP A 83 -38. .713 -51. .279 -19. .401 1. .00 24. .63 A o
ATOM 625 OD2 ASP A 83 -37. .799 -50. .280 -21. .163 1. .00 28. .39 A o
ATOM 626 C ASP A 83 -35. .555 -54. .134 -19. .318 1. .00 23. .48 A c
ATOM 627 o ASP A 83 -35. .971 -55. .249 -19. .589 1. .00 23. .92 A o
ATOM 628 N TYR A 84 -34. .271 -53. .874 -19. .216 1. .00 24. .00 A N
ATOM 629 CA TYR A 84 -33. .326 -54. .902 -19. .519 1. .00 23. .71 A c
ATOM 630 CB TYR A 84 -31. .907 -54. .297 -19. .583 1. .00 24. .20 A c
ATOM 631 CG TYR A 84 -30. .858 -55. .363 -19. .629 1. .00 23. .19 A c
ATOM 632 CDl TYR A 84 -30. .519 -55. .931 -20. .823 1. .00 22. .87 A c
ATOM 633 CEl TYR A 84 -29. .551 -56. .947 -20. .875 1. .00 24. .91 A c
ATOM 634 CZ TYR A 84 -28. .992 -57. .421 -19. .717 1. .00 20. .31 A c
ATOM 635 OH TYR A 84 -28. .075 -58. .443 -19. .820 1. .00 22. .01 A o
ATOM 636 CE2 TYR A 84 -29. .342 -56. .869 -18. .521 1. .00 19. .40 A c
ATOM 637 CD 2 TYR A 84 -30. .252 -55. .840 -18. .465 1. .00 18. .29 A c
ATOM 638 C TYR A 84 -33. .437 -56. .034 -18. .501 1. .00 23. .26 A c
ATOM 639 o TYR A 84 -33. .541 -57. .178 -18. .881 1. .00 24. .20 A o
ATOM 640 N PHE A 85 -33. .418 -55. .715 -17. .218 1. .00 22. .52 A N
ATOM 641 CA PHE A 85 -33. .429 -56. .712 -16. .173 1. .00 22. .03 A c
ATOM 642 CB PHE A 85 -33. .030 -56. .067 -14. .835 1. .00 22. .20 A c
ATOM 643 CG PHE A 85 -31. .531 -55. .940 -14. .665 1. .00 20. .97 A c
ATOM 644 CDl PHE A 85 -30. .756 -57. .049 -14. .344 1. .00 18. .41 A c
ATOM 645 CEl PHE A 85 -29. .382 -56. .971 -14. .210 1. .00 17. .21 A c
ATOM 646 CZ PHE A 85 -28..735 -55..766 -14..418 1..00 20..03 A C
ATOM 647 CE2 PHE A 85 -29. .477 -54. .653 -14. .776 1. .00 21. .83 A C
ATOM 648 CD 2 PHE A 85 -30. .892 -54. .745 -14. .895 1. .00 23. .45 A c
ATOM 649 C PHE A 85 -34. .781 -57. .390 -16. .087 1. .00 23. .25 A c
ATOM 650 o PHE A 85 -34. .867 -58. .629 -15. .837 1. .00 21. .25 A o
ATOM 651 N TYR A 86 -35. .831 -56. .599 -16. .381 1. .00 23. .68 A N
ATOM 652 CA TYR A 86 -37. .186 -57. .146 -16. .398 1. .00 24. .50 A c
ATOM 653 CB TYR A 86 -38. .259 -56. .060 -16. .341 1. .00 25. .13 A c
ATOM 654 CG TYR A 86 -39. .648 -56. .640 -16. .311 1. .00 26. .50 A c
ATOM 655 CDl TYR A 86 -40. .122 -57. .303 -15. .169 1. .00 27. .15 A c
ATOM 656 CEl TYR A 86 -41. .398 -57. .867 -15. .148 1. .00 29. .74 A c
ATOM 657 CZ TYR A 86 -42. .220 -57. .763 -16. .274 1. .00 30. .75 A c
ATOM 658 OH TYR A 86 -43. .463 -58. .290 -16. .229 1. .00 33. .52 A o
ATOM 659 CE2 TYR A 86 -41. .800 -57. .146 -17. .414 1. .00 29. .62 A c
ATOM 660 CD 2 TYR A 86 -40. .477 -56. .574 -17. .429 1. .00 29. .65 A c
ATOM 661 C TYR A 86 -37. .438 -58. .080 -17. .562 1. .00 24. .44 A c
ATOM 662 o TYR A 86 -37. .906 -59. .199 -17. .381 1. .00 25. .04 A o
ATOM 663 N GLN A 87 -37. .088 -57. .657 -18. .754 1. .00 24. .92 A N
ATOM 664 CA GLN A 87 -37. .333 -58. .504 -19. .925 1. .00 26. .25 A c
ATOM 665 CB GLN A 87 -37. .232 -57. .687 -21. .197 1. .00 26. .93 A c
ATOM 666 CG GLN A 87 -38. .411 -56. .771 -21. .381 1. .00 31. .10 A c
ATOM 667 CD GLN A 87 -38. .085 -55. .660 -22. .348 1. .00 39. .99 A c
ATOM 668 OEl GLN A 87 -37. .081 -55. .726 -23. .071 1. .00 41. .78 A o
ATOM 669 NE2 GLN A 87 -38. .922 -54. .617 -22. .366 1. .00 42. .63 A N
ATOM 670 C GLN A 87 -36. .420 -59. .706 -20. .067 1. .00 26. .15 A c
ATOM 671 o GLN A 87 -36. .831 -60. .699 -20. .644 1. .00 24. .48 A o
ATOM 672 N LYS A 88 -35. .153 -59. .593 -19. .620 1. .00 25. .63 A N
ATOM 673 CA LYS A 88 -34. .252 -60. .725 -19. .772 1. .00 24. .20 A c
ATOM 674 CB LYS A 88 -32. .770 -60. .326 -19. .777 1. .00 24. .42 A c
ATOM 675 CG LYS A 88 -32. .352 -59. .286 -20. .748 1. .00 24. .40 A c
ATOM 676 CD LYS A 88 -32. .523 -59. .738 -22. .116 1. .00 26. .90 A c
ATOM 677 CE LYS A 88 -32. .183 -58. .598 -23. .050 1. .00 27. .59 A c
ATOM 678 NZ LYS A 88 -31. .931 -59. .174 -24. .395 1. .00 31. .00 A N
ATOM 679 C LYS A 88 -34. .457 -61. .711 -18. .670 1. .00 23. .70 A c
ATOM 680 o LYS A 88 -34. .342 -62. .871 -18. .919 1. .00 24. .35 A o
ATOM 681 N PHE A 89 -34. .692 -61. .267 -17. .440 1. .00 23. .60 A N
ATOM 682 CA PHE A 89 -34. .576 -62. .182 -16. .311 1. .00 23. .45 A c
ATOM 683 CB PHE A 89 -33. .397 -61. .806 -15. .422 1. .00 22. .33 A c
ATOM 684 CG PHE A 89 -32. .147 -61. .509 -16. .191 1. .00 23. .28 A c
ATOM 685 CDl PHE A 89 -31. .498 -62. .518 -16. .917 1. .00 19. .53 A c
ATOM 686 CEl PHE A 89 -30. .332 -62. .222 -17. .674 1. .00 21. .34 A c
ATOM 687 CZ PHE A 89 -29. .809 -60. .916 -17. .709 1. .00 20. .21 A c
ATOM 688 CE2 PHE A 89 -30. .462 -59. .892 -16. .997 1. .00 21. .28 A c
ATOM 689 CD 2 PHE A 89 -31. .634 -60. .190 -16. .251 1. .00 21. .81 A c
ATOM 690 C PHE A 89 -35. .845 -62. .205 -15. .497 1. .00 24. .67 A c
ATOM 691 o PHE A 89 -35. .910 -62. .900 -14. .489 1. .00 23. .59 A o
ATOM 692 N ASN A 90 -36. .848 -61. .422 -15. .927 1. .00 25. .75 A N
ATOM 693 CA ASN A 90 -38. .049 -61. .227 -15. .121 1. .00 26. .46 A c
ATOM 694 CB ASN A 90 -38. .887 -62. .559 -15. .076 1. .00 27. .00 A c
ATOM 695 CG ASN A 90 -40. .308 -62. .371 -14. .453 1. .00 30. .20 A c
ATOM 696 ODl ASN A 90 -41. .067 -61. .430 -14. .783 1. .00 32. .17 A o
ATOM 697 ND2 ASN A 90 -40. .664 -63. .284 -13. .556 1. .00 29. .30 A N
ATOM 698 C ASN A 90 -37. .691 -60. .676 -13. .725 1. .00 25. .55 A c
ATOM 699 o ASN A 90 -38. .285 -61. .086 -12. .707 1. .00 27. .83 A o
ATOM 700 N ARG A 91 -36. .740 -59. .751 -13. .662 1. .00 24. .18 A N
ATOM 701 CA ARG A 91 -36. .398 -59. .079 -12. .383 1. .00 24. .35 A c
ATOM 702 CB ARG A 91 -34. .894 -58. .713 -12. .244 1. .00 24. .28 A c
ATOM 703 CG ARG A 91 -34. .459 -58. .341 -10. .821 1. .00 20. .60 A c
ATOM 704 CD ARG A 91 -32. .985 -58. .061 -10. .691 1. .00 19. .78 A c
ATOM 705 NE ARG A 91 -32. .656 -57. .679 -9. .324 1. .00 16. .07 A N
ATOM 706 CZ ARG A 91 -32. .448 -58. .597 -8. .355 1. .00 20. .75 A c
ATOM 707 NHl ARG A 91 -32. .544 -59. .918 -8. .634 1. .00 14. .39 A N
ATOM 708 NH2 ARG A 91 -32. .194 -58. .219 -7. .091 1. .00 16. .44 A N
ATOM 709 C ARG A 91 -37. .210 -57. .826 -12. .208 1. .00 24. .66 A C
ATOM 710 o ARG A 91 -37. .210 -56. .943 -13. .073 1. .00 26. .57 A o
ATOM 711 N ASN A 92 -37. .924 -57. .722 -11. .102 1. .00 24. .72 A N
ATOM 712 CA ASN A 92 -38. .747 -56. .532 -10. .900 1. .00 24. .42 A C
ATOM 713 CB ASN A 92 -39. .951 -56. .942 -10. .084 1. .00 24. .43 A c
ATOM 714 CG ASN A 92 -40. .921 -55. .822 -9. .831 1. .00 27. .29 A c
ATOM 715 ODl ASN A 92 -40. .874 -54. .757 -10. .450 1. .00 30. .10 A o
ATOM 716 ND2 ASN A 92 -41. .866 -56. .084 -8. .913 1. .00 29. .96 A N
ATOM 717 C ASN A 92 -37. .915 -55. .455 -10. .201 1. .00 24. .37 A c
ATOM 718 o ASN A 92 -37. .937 -55. .333 -8. .965 1. .00 25. .59 A o
ATOM 719 N SER A 93 -37. .175 -54. .673 -10. .970 1. .00 22. .83 A N
ATOM 720 CA SER A 93 -36. .336 -53. .650 -10. .387 1. .00 22. .27 A c
ATOM 721 CB SER A 93 -37. .090 -52. .772 -9. .384 1. .00 21. .81 A c
ATOM 722 OG SER A 93 -36. .335 -51. .571 -9. .193 1. .00 20. .51 A o
ATOM 723 C SER A 93 -35. .081 -54. .191 -9. .730 1. .00 22. .08 A c
ATOM 724 o SER A 93 -34. .886 -55. .378 -9. .638 1. .00 23. .02 A o
ATOM 725 N TYR A 94 -34..213 -53..303 -9..254 1..00 23..13 A N
ATOM 726 CA TYR A 94 -32. .915 -53. .741 -8. .709 1. .00 22. .74 A C
ATOM 727 CB TYR A 94 -32. .040 -52. .547 -8. .387 1. .00 21. .69 A C
ATOM 728 CG TYR A 94 -32. .522 -51. .788 -7. .184 1. .00 21. .77 A c
ATOM 729 CDl TYR A 94 -31. .986 -52. .046 -5. .904 1. .00 25. .43 A c
ATOM 730 CEl TYR A 94 -32. .444 -51. .362 -4. .749 1. .00 21. .99 A c
ATOM 731 CZ TYR A 94 -33. .460 -50. .434 -4. .881 1. .00 24. .51 A c
ATOM 732 OH TYR A 94 -33. .935 -49. .748 -3. .758 1. .00 24. .58 A o
ATOM 733 CE2 TYR A 94 -34. .028 -50. .186 -6. .162 1. .00 23. .54 A c
ATOM 734 CD 2 TYR A 94 -33. .558 -50. .857 -7. .288 1. .00 18. .74 A c
ATOM 735 C TYR A 94 -33. .034 -54. .650 -7. .501 1. .00 23. .34 A c
ATOM 736 o TYR A 94 -32. .184 -55. .516 -7. .295 1. .00 25. .03 A o
ATOM 737 N ASP A 95 -34. .077 -54. .502 -6. .699 1. .00 24. .79 A N
ATOM 738 CA ASP A 95 -34. .229 -55. .405 -5. .504 1. .00 25. .96 A c
ATOM 739 CB ASP A 95 -34. .718 -54. .618 -4. .299 1. .00 25. .17 A c
ATOM 740 CG ASP A 95 -36. .080 -53. .926 -4. .563 1. .00 26. .88 A c
ATOM 741 ODl ASP A 95 -36. .708 -54. .173 -5. .621 1. .00 23. .59 A o
ATOM 742 OD2 ASP A 95 -36. .526 -53. .122 -3. .710 1. .00 30. .47 A o
ATOM 743 C ASP A 95 -35. .186 -56. .550 -5. .756 1. .00 26. .31 A c
ATOM 744 o ASP A 95 -35. .570 -57. .253 -4. .830 1. .00 28. .26 A o
ATOM 745 N ASN A 96 -35. .622 -56. .705 -6. .996 1. .00 26. .19 A N
ATOM 746 CA ASN A 96 -36. .600 -57. .726 -7. .345 1. .00 27. .04 A c
ATOM 747 CB ASN A 96 -35. .994 -59. .141 -7. .290 1. .00 25. .92 A c
ATOM 748 CG ASN A 96 -36. .783 -60. .126 -8. .133 1. .00 27. .06 A c
ATOM 749 ODl ASN A 96 -37. .509 -59. .722 -9. .059 1. .00 28. .41 A o
ATOM 750 ND2 ASN A 96 -36. .649 -61. .414 -7. .833 1. .00 23. .23 A N
ATOM 751 C ASN A 96 -37. .868 -57. .680 -6. .491 1. .00 27. .67 A c
ATOM 752 o ASN A 96 -38. .536 -58. .706 -6. .354 1. .00 27. .62 A o
ATOM 753 N LYS A 97 -38. .169 -56. .506 -5. .911 1. .00 28. .43 A N
ATOM 754 CA LYS A 97 -39. .373 -56. .260 -5. .095 1. .00 27. .97 A c
ATOM 755 CB LYS A 97 -39. .009 -56. .065 -3. .606 1. .00 28. .01 A c
ATOM 756 CG LYS A 97 -38. .492 -57. .348 -2. .937 1. .00 29. .56 A c
ATOM 757 CD LYS A 97 -38. .148 -57. .180 -1. .435 1. .00 31. .10 A c
ATOM 758 CE LYS A 97 -36. .711 -56. .724 -1. .178 1. .00 32. .30 A c
ATOM 759 NZ LYS A 97 -36. .314 -56. .990 0. .232 1. .00 35. .76 A N
ATOM 760 C LYS A 97 -40. .134 -55. .048 -5. .613 1. .00 28. .14 A c
ATOM 761 o LYS A 97 -41. .135 -54. .648 -5. .017 1. .00 28. .53 A o
ATOM 762 N GLY A 98 -39. .669 -54. .447 -6. .711 1. .00 27. .15 A N
ATOM 763 CA GLY A 98 -40. .370 -53. .299 -7. .301 1. .00 24. .49 A c
ATOM 764 C GLY A 98 -39. .850 -51. .961 -6. .793 1. .00 23. .46 A c
ATOM 765 o GLY A 98 -40. .445 -50. .935 -7. .082 1. .00 24. .40 A o
ATOM 766 N GLY A 99 -38. .776 -51. .947 -6. .013 1. .00 21. .47 A N
ATOM 767 CA GLY A 99 -38. .290 -50. .710 -5. .411 1. .00 20. .97 A c
ATOM 768 C GLY A 99 -38. .114 -49. .600 -6. .437 1. .00 23. .26 A c
ATOM 769 o GLY A 99 -37. .507 -49. .813 -7. .495 1. .00 22. .85 A o
ATOM 770 N LYS A 100 -38. .678 -48. .408 -6. .186 1. .00 24. .99 A N
ATOM 771 CA LYS A 100 -38. .545 -47. .281 -7. .141 1. .00 25. .11 A c
ATOM 772 CB LYS A 100 -39. .214 -46. .034 -6. .577 1. .00 25. .69 A c
ATOM 773 CG LYS A 100 -38. .639 -45. .629 -5. .203 1. .00 30. .14 A c
ATOM 774 CD LYS A 100 -39. .052 -44. .248 -4. .642 1. .00 32. .29 A c
ATOM 775 CE LYS A 100 -38. .162 -43. .991 -3. .336 1. .00 38. .39 A c
ATOM 776 NZ LYS A 100 -38. .707 -42. .859 -2. .443 1. .00 42. .60 A N
ATOM 777 C LYS A 100 -37. .036 -47. .043 -7. .447 1. .00 25. .30 A c
ATOM 778 o LYS A 100 -36. .150 -47. .345 -6. .610 1. .00 24. .91 A o
ATOM 779 N ILE A 101 -36. .761 -46. .564 -8. .663 1. .00 24. .85 A N
ATOM 780 CA ILE A 101 -35. .414 -46. .283 -9. .161 1. .00 23. .22 A c
ATOM 781 CB ILE A 101 -35. .255 -46. .923 -10. .522 1. .00 23. .11 A c
ATOM 782 CGl ILE A 101 -35. .219 -48. .449 -10. .364 1. .00 20. .36 A c
ATOM 783 CDl ILE A 101 -35. .453 -49. .172 -11. .638 1. .00 21. .07 A c
ATOM 784 CG2 ILE A 101 -33. .999 -46. .362 -11. .287 1. .00 23. .99 A c
ATOM 785 C ILE A 101 -35. .288 -44. .776 -9. .290 1. .00 24. .21 A c
ATOM 786 o ILE A 101 -35. .944 -44. .171 -10. .146 1. .00 26. .06 A o
ATOM 787 N VAL A 102 -34. .503 -44. .153 -8. .421 1. .00 23. .16 A N
ATOM 788 CA VAL A 102 -34. .478 -42. .727 -8. .287 1. .00 22. .20 A c
ATOM 789 CB VAL A 102 -34. .761 -42. .340 -6. .807 1. .00 23. .44 A c
ATOM 790 CGl VAL A 102 -34. .424 -40. .850 -6. .483 1. .00 19. .05 A c
ATOM 791 CG2 VAL A 102 -36. .180 -42. .671 -6. .460 1. .00 21. .14 A c
ATOM 792 C VAL A 102 -33. .084 -42. .267 -8. .677 1. .00 23. .93 A c
ATOM 793 o VAL A 102 -32. .091 -42. .941 -8. .325 1. .00 22. .72 A o
ATOM 794 N SER A 103 -32. .994 -41. .148 -9. .421 1. .00 24. .36 A N
ATOM 795 CA SER A 103 -31. .708 -40. .568 -9. .703 1. .00 25. .59 A c
ATOM 796 CB SER A 103 -31. .317 -40. .856 -11. .124 1. .00 25. .68 A c
ATOM 797 OG SER A 103 -31. .926 -39. .882 -11. .946 1. .00 28. .96 A o
ATOM 798 C SER A 103 -31. .654 -39. .047 -9. .411 1. .00 26. .51 A c
ATOM 799 o SER A 103 -32. .695 -38. .350 -9. .383 1. .00 26. .56 A o
ATOM 800 N SER A 104 -30. .442 -38. .556 -9. .140 1. .00 26. .44 A N
ATOM 801 CA SER A 104 -30. .225 -37. .140 -8. .958 1. .00 26. .76 A c
ATOM 802 CB SER A 104 -29. .852 -36. .784 -7. .518 1. .00 27. .23 A c
ATOM 803 OG SER A 104 -30. .856 -37. .188 -6. .574 1. .00 26. .06 A o
ATOM 804 C SER A 104 -29..123 -36..728 -9..918 1..00 27..68 A C
ATOM 805 o SER A 104 -27. .979 -37. .206 -9. .868 1. .00 27. .25 A o
ATOM 806 N VAL A 105 -29. .495 -35. .861 -10. .841 1. .00 28. .11 A N
ATOM 807 CA VAL A 105 -28. .530 -35. .248 -11. .711 1. .00 28. .88 A C
ATOM 808 CB VAL A 105 -29. .152 -35. .040 -13. .083 1. .00 29. .18 A C
ATOM 809 CGl VAL A 105 -29. .569 -36. .358 -13. .662 1. .00 27. .85 A c
ATOM 810 CG2 VAL A 105 -30. .338 -34. .066 -12. .990 1. .00 28. .33 A c
ATOM 811 C VAL A 105 -28. .034 -33. .904 -11. .141 1. .00 29. .60 A c
ATOM 812 o VAL A 105 -28. .611 -33. .353 -10. .151 1. .00 29. .63 A o
ATOM 813 N HIS A 106 -27. .005 -33. .356 -11. .782 1. .00 29. .73 A N
ATOM 814 CA HIS A 106 -26. .377 -32. .102 -11. .318 1. .00 30. .74 A c
ATOM 815 CB HIS A 106 -27. .287 -30. .869 -11. .536 1. .00 30. .34 A c
ATOM 816 CG HIS A 106 -27. .705 -30. .693 -12. .961 1. .00 27. .61 A c
ATOM 817 NDl HIS A 106 -26. .794 -30. .645 -13. .990 1. .00 25. .34 A N
ATOM 818 CEl HIS A 106 -27. .437 -30. .525 -15. .140 1. .00 28. .07 A c
ATOM 819 NE2 HIS A 106 -28. .732 -30. .482 -14. .893 1. .00 28. .43 A N
ATOM 820 CD 2 HIS A 106 -28. .922 -30. .593 -13. .532 1. .00 28. .46 A C
ATOM 821 C HIS A 106 -25. .971 -32. .252 -9. .860 1. .00 32. .36 A c
ATOM 822 o HIS A 106 -26. .131 -31. .330 -9. .040 1. .00 32. .69 A o
ATOM 823 N TYR A 107 -25. .461 -33. .433 -9. .528 1. .00 33. .47 A N
ATOM 824 CA TYR A 107 -24. .924 -33. .638 -8. .211 1. .00 35. .05 A c
ATOM 825 CB TYR A 107 -24. .727 -35. .116 -7. .926 1. .00 34. .59 A c
ATOM 826 CG TYR A 107 -24. .107 -35. .405 -6. .575 1. .00 35. .69 A c
ATOM 827 CDl TYR A 107 -24. .910 -35. .735 -5. .483 1. .00 35. .84 A c
ATOM 828 CEl TYR A 107 -24. .339 -36. .017 -4. .221 1. .00 36. .98 A c
ATOM 829 CZ TYR A 107 -22. .964 -35. .989 -4. .073 1. .00 37. .15 A c
ATOM 830 OH TYR A 107 -22. .457 -36. .265 -2. .851 1. .00 37. .25 A o
ATOM 831 CE2 TYR A 107 -22. .126 -35. .689 -5. .149 1. .00 36. .54 A c
ATOM 832 CD 2 TYR A 107 -22. .701 -35. .393 -6. .393 1. .00 35. .92 A c
ATOM 833 C TYR A 107 -23. .598 -32. .924 -8. .176 1. .00 36. .00 A c
ATOM 834 o TYR A 107 -22. .712 -33. .209 -9. .022 1. .00 35. .53 A o
ATOM 835 N GLY A 108 -23. .467 -32. .001 -7. .210 1. .00 37. .18 A N
ATOM 836 CA GLY A 108 -22. .178 -31. .379 -6. .893 1. .00 38. .18 A c
ATOM 837 C GLY A 108 -21. .753 -30. .343 -7. .914 1. .00 40. .33 A c
ATOM 838 o GLY A 108 -22. .577 -29. .768 -8. .643 1. .00 40. .64 A o
ATOM 839 N SER A 109 -20. .457 -30. .086 -7. .969 1. .00 42. .15 A N
ATOM 840 CA SER A 109 -19. .971 -29. .038 -8. .853 1. .00 44. .71 A c
ATOM 841 CB SER A 109 -19. .611 -27. .751 -8. .074 1. .00 45. .07 A c
ATOM 842 OG SER A 109 -19. .609 -26. .644 -8. .968 1. .00 45. .28 A o
ATOM 843 C SER A 109 -18. .768 -29. .559 -9. .638 1. .00 45. .55 A c
ATOM 844 o SER A 109 -17. .772 -30. .016 -9. .026 1. .00 45. .22 A o
ATOM 845 N ARG A 110 -18. .890 -29. .541 -10. .977 1. .00 45. .44 A N
ATOM 846 CA ARG A 110 -17. .854 -30. .119 -11. .821 1. .00 46. .27 A c
ATOM 847 CB ARG A 110 -16. .732 -29. .064 -11. .996 1. .00 47. .09 A c
ATOM 848 CG ARG A 110 -17. .316 -27. .667 -12. .469 1. .00 53. .17 A c
ATOM 849 CD ARG A 110 -16. .356 -26. .720 -13. .257 1. .00 61. .65 A c
ATOM 850 NE ARG A 110 -14. .954 -26. .807 -12. .807 1. .00 67. .59 A N
ATOM 851 CZ ARG A 110 -13. .906 -27. .184 -13. .564 1. .00 70. .42 A c
ATOM 852 NHl ARG A 110 -14. .028 -27. .510 -14. .865 1. .00 69. .00 A N
ATOM 853 NH2 ARG A 110 -12. .704 -27. .241 -13. .006 1. .00 71. .16 A N
ATOM 854 C ARG A 110 -17. .354 -31. .497 -11. .255 1. .00 44. .76 A C
ATOM 855 o ARG A 110 -16. .167 -31. .772 -11. .201 1. .00 44. .86 A o
ATOM 856 N TYR A 111 -18. .284 -32. .349 -10. .816 1. .00 43. .15 A N
ATOM 857 CA TYR A 111 -17. .967 -33. .613 -10. .113 1. .00 41. .46 A C
ATOM 858 CB TYR A 111 -19. .129 -33. .916 -9. .167 1. .00 41. .36 A c
ATOM 859 CG TYR A 111 -19. .025 -35. .147 -8. .321 1. .00 43. .63 A c
ATOM 860 CDl TYR A 111 -17. .981 -35. .319 -7. .403 1. .00 46. .38 A c
ATOM 861 CEl TYR A 111 -17. .907 -36. .482 -6. .593 1. .00 48. .54 A c
ATOM 862 CZ TYR A 111 -18. .895 -37. .465 -6. .693 1. .00 49. .57 A c
ATOM 863 OH TYR A 111 -18. .842 -38. .598 -5. .909 1. .00 50. .97 A o
ATOM 864 CE2 TYR A 111 -19. .946 -37. .312 -7. .594 1. .00 48. .80 A c
ATOM 865 CD 2 TYR A 111 -20. .004 -36. .152 -8. .405 1. .00 47. .79 A c
ATOM 866 C TYR A 111 -17. .735 -34. .788 -11. .088 1. .00 40. .02 A c
ATOM 867 o TYR A 111 -18. .580 -35. .098 -11. .906 1. .00 38. .85 A o
ATOM 868 N ASN A 112 -16. .571 -35. .429 -11. .013 1. .00 39. .72 A N
ATOM 869 CA ASN A 112 -16. .211 -36. .473 -11. .996 1. .00 38. .39 A c
ATOM 870 CB ASN A 112 -14. .688 -36. .460 -12. .320 1. .00 38. .11 A c
ATOM 871 CG ASN A 112 -14. .266 -35. .305 -13. .262 1. .00 37. .98 A c
ATOM 872 ODl ASN A 112 -14. .999 -34. .901 -14. .170 1. .00 38. .90 A o
ATOM 873 ND2 ASN A 112 -13. .071 -34. .782 -13. .039 1. .00 37. .99 A N
ATOM 874 C ASN A 112 -16. .660 -37. .890 -11. .576 1. .00 37. .82 A c
ATOM 875 o ASN A 112 -15. .835 -38. .808 -11. .493 1. .00 36. .91 A o
ATOM 876 N ASN A 113 -17. .957 -38. .074 -11. .336 1. .00 37. .02 A N
ATOM 877 CA ASN A 113 -18. .427 -39. .382 -10. .923 1. .00 37. .51 A c
ATOM 878 CB ASN A 113 -17. .979 -39. .699 -9. .489 1. .00 38. .57 A c
ATOM 879 CG ASN A 113 -17. .709 -41. .176 -9. .295 1. .00 43. .30 A c
ATOM 880 ODl ASN A 113 -16. .666 -41. .694 -9. .683 1. .00 44. .68 A o
ATOM 881 ND2 ASN A 113 -18. .682 -41. .875 -8. .730 1. .00 50. .44 A N
ATOM 882 C ASN A 113 -19. .941 -39. .639 -11. .059 1. .00 36. .09 A c
ATOM 883 o ASN A 113 -20..717 -38..706 -11..308 1..00 35..79 A o
ATOM 884 N ALA A 114 -20. .316 -40. .921 -10. .939 1. .00 33. .16 A N
ATOM 885 CA ALA A 114 -21. .697 -41. .374 -10. .936 1. .00 31. .35 A C
ATOM 886 CB ALA A 114 -22. .132 -41. .859 -12. .322 1. .00 30. .10 A C
ATOM 887 C ALA A 114 -21. .681 -42. .536 -9. .981 1. .00 30. .28 A c
ATOM 888 o ALA A 114 -20. .761 -43. .341 -9. .971 1. .00 29. .89 A o
ATOM 889 N ALA A 115 -22. .685 -42. .665 -9. .152 1. .00 28. .73 A N
ATOM 890 CA ALA A 115 -22. .587 -43. .775 -8. .219 1. .00 27. .85 A c
ATOM 891 CB ALA A 115 -21. .783 -43. .333 -6. .923 1. .00 26. .42 A c
ATOM 892 C ALA A 115 -23. .951 -44. .285 -7. .871 1. .00 27. .17 A c
ATOM 893 o ALA A 115 -24. .932 -43. .551 -7. .903 1. .00 26. .95 A o
ATOM 894 N TRP A 116 -24. .017 -45. .562 -7. .536 1. .00 27. .57 A N
ATOM 895 CA TRP A 116 -25. .151 -46. .046 -6. .778 1. .00 26. .56 A c
ATOM 896 CB TRP A 116 -25. .358 -47. .483 -7. .083 1. .00 25. .55 A c
ATOM 897 CG TRP A 116 -26. .399 -48. .130 -6. .276 1. .00 25. .34 A c
ATOM 898 CDl TRP A 116 -26. .198 -48. .955 -5. .212 1. .00 22. .58 A c
ATOM 899 NEl TRP A 116 -27. .417 -49. .374 -4. .711 1. .00 22. .11 A N
ATOM 900 CE2 TRP A 116 -28. .430 -48. .793 -5. .429 1. .00 20. .63 A c
ATOM 901 CD 2 TRP A 116 -27. .836 -48. .012 -6. .434 1. .00 22. .71 A c
ATOM 902 CE3 TRP A 116 -28. .674 -47. .274 -7. .297 1. .00 25. .00 A c
ATOM 903 CZ3 TRP A 116 -30. .096 -47. .399 -7. .160 1. .00 20. .26 A c
ATOM 904 CH2 TRP A 116 -30. .633 -48. .228 -6. .183 1. .00 20. .58 A c
ATOM 905 CZ2 TRP A 116 -29. .823 -48. .914 -5. .293 1. .00 20. .87 A c
ATOM 906 C TRP A 116 -24. .826 -45. .858 -5. .300 1. .00 28. .31 A c
ATOM 907 o TRP A 116 -23. .804 -46. .297 -4. .806 1. .00 25. .54 A o
ATOM 908 N ILE A 117 -25. .719 -45. .166 -4. .600 1. .00 31. .41 A N
ATOM 909 CA ILE A 117 -25. .501 -44. .758 -3. .224 1. .00 33. .35 A c
ATOM 910 CB ILE A 117 -25. .708 -43. .237 -3. .204 1. .00 34. .35 A c
ATOM 911 CGl ILE A 117 -24. .445 -42. .583 -2. .753 1. .00 35. .74 A c
ATOM 912 CDl ILE A 117 -23. .596 -42. .437 -3. .940 1. .00 36. .48 A c
ATOM 913 CG2 ILE A 117 -27. .052 -42. .729 -2. .567 1. .00 32. .98 A c
ATOM 914 C ILE A 117 -26. .427 -45. .554 -2. .264 1. .00 34. .89 A c
ATOM 915 o ILE A 117 -26. .928 -45. .013 -1. .236 1. .00 36. .20 A o
ATOM 916 N GLY A 118 -26. .682 -46. .830 -2. .606 1. .00 34. .05 A N
ATOM 917 CA GLY A 118 -27. .447 -47. .736 -1. .741 1. .00 32. .89 A c
ATOM 918 C GLY A 118 -28. .958 -47. .716 -2. .031 1. .00 33. .33 A c
ATOM 919 o GLY A 118 -29. .641 -48. .800 -2. .057 1. .00 33. .11 A o
ATOM 920 N ASP A 119 -29. .494 -46. .514 -2. .243 1. .00 30. .79 A N
ATOM 921 CA ASP A 119 -30. .881 -46. .411 -2. .581 1. .00 31. .30 A c
ATOM 922 CB ASP A 119 -31. .688 -45. .834 -1. .399 1. .00 33. .35 A c
ATOM 923 CG ASP A 119 -31. .091 -44. .540 -0. .838 1. .00 37. .71 A c
ATOM 924 ODl ASP A 119 -31. .838 -43. .790 -0. .087 1. .00 41. .58 A o
ATOM 925 OD2 ASP A 119 -29. .858 -44. .313 -1. .105 1. .00 38. .82 A o
ATOM 926 C ASP A 119 -31. .132 -45. .557 -3. .801 1. .00 29. .73 A c
ATOM 927 o ASP A 119 -32. .270 -45. .400 -4. .168 1. .00 29. .65 A o
ATOM 928 N GLN A 120 -30. .107 -44. .968 -4. .414 1. .00 28. .27 A N
ATOM 929 CA GLN A 120 -30. .358 -44. .121 -5. .565 1. .00 27. .33 A c
ATOM 930 CB GLN A 120 -30. .989 -42. .784 -5. .177 1. .00 26. .60 A c
ATOM 931 CG GLN A 120 -30. .031 -41. .829 -4. .485 1. .00 25. .55 A c
ATOM 932 CD GLN A 120 -30. .609 -40. .414 -4. .466 1. .00 27. .50 A c
ATOM 933 OEl GLN A 120 -31. .328 -39. .981 -3. .512 1. .00 26. .21 A o
ATOM 934 NE2 GLN A 120 -30. .340 -39. .689 -5. .532 1. .00 23. .92 A N
ATOM 935 C GLN A 120 -29. .117 -43. .901 -6. .390 1. .00 28. .01 A c
ATOM 936 o GLN A 120 -28. .015 -44. .342 -6. .021 1. .00 29. .44 A o
ATOM 937 N MET A 121 -29. .299 -43. .213 -7. .521 1. .00 27. .81 A N
ATOM 938 CA MET A 121 -28. .212 -42. .851 -8. .400 1. .00 26. .90 A c
ATOM 939 CB MET A 121 -28. .639 -43. .033 -9. .836 1. .00 26. .74 A c
ATOM 940 CG MET A 121 -28. .830 -44. .451 -10. .264 1. .00 28. .73 A c
ATOM 941 SD MET A 121 -27. .203 -45. .210 -10. .223 1. .00 33. .79 A s
ATOM 942 CE MET A 121 -26. .289 -44. .011 -11. .268 1. .00 35. .84 A c
ATOM 943 C MET A 121 -27. .925 -41. .400 -8. .183 1. .00 26. .76 A c
ATOM 944 o MET A 121 -28. .878 -40. .606 -8. .009 1. .00 27. .02 A o
ATOM 945 N ILE A 122 -26. .640 -41. .050 -8. .198 1. .00 25. .38 A N
ATOM 946 CA ILE A 122 -26. .227 -39. .676 -8. .347 1. .00 25. .64 A c
ATOM 947 CB ILE A 122 -25. .493 -39. .112 -7. .107 1. .00 25. .89 A c
ATOM 948 CGl ILE A 122 -24. .153 -39. .859 -6. .849 1. .00 26. .78 A c
ATOM 949 CDl ILE A 122 -23. .210 -39. .229 -5. .778 1. .00 28. .66 A c
ATOM 950 CG2 ILE A 122 -26. .401 -39. .291 -5. .890 1. .00 25. .18 A c
ATOM 951 C ILE A 122 -25. .352 -39. .591 -9. .585 1. .00 25. .99 A c
ATOM 952 o ILE A 122 -24. .582 -40. .512 -9. .892 1. .00 24. .65 A o
ATOM 953 N TYR A 123 -25. .477 -38. .468 -10. .292 1. .00 26. .83 A N
ATOM 954 CA TYR A 123 -24. .684 -38. .214 -11. .479 1. .00 27. .50 A c
ATOM 955 CB TYR A 123 -25. .620 -38. .158 -12. .642 1. .00 26. .01 A c
ATOM 956 CG TYR A 123 -26. .202 -39. .467 -12. .987 1. .00 28. .56 A c
ATOM 957 CDl TYR A 123 -25. .458 -40. .424 -13. .696 1. .00 26. .12 A c
ATOM 958 CEl TYR A 123 -26. .016 -41. .621 -14. .047 1. .00 27. .49 A c
ATOM 959 CZ TYR A 123 -27. .340 -41. .890 -13. .696 1. .00 29. .40 A c
ATOM 960 OH TYR A 123 -27. .940 -43. .075 -14. .048 1. .00 29. .36 A o
ATOM 961 CE2 TYR A 123 -28. .089 -40. .965 -12. .974 1. .00 29. .36 A c
ATOM 962 CD 2 TYR A 123 -27.. 525 -39. 761 -12 ..637 1..00 28..86 A C
ATOM 963 C TYR A 123 -24. .000 -36. 866 -11. .410 1. .00 27. .64 A C
ATOM 964 o TYR A 123 -24. .682 -35. 864 -11. .416 1. .00 27. .65 A o
ATOM 965 N GLY A 124 -22 . .675 -36. 814 -11. .397 1. .00 28. .67 A N
ATOM 966 CA GLY A 124 -21. .985 -35. 522 -11. .636 1. .00 29. .95 A c
ATOM 967 C GLY A 124 -22 . .156 -34. 939 -13 . .056 1. .00 32. .16 A c
ATOM 968 o GLY A 124 -22 . .633 -35. 631 -14. .029 1. .00 31. . 54 A o
ATOM 969 N ASP A 125 -21. .774 -33. 667 -13 . .197 1. .00 32. .99 A N
ATOM 970 CA ASP A 125 -21. .679 -33. 034 -14. . 514 1. .00 34. . 33 A c
ATOM 971 CB ASP A 125 -21. .971 -31. 562 -14. .386 1. .00 34. .40 A c
ATOM 972 CG ASP A 125 -23 . .380 -31. 287 -13 . .965 1. .00 37. .99 A c
ATOM 973 ODl ASP A 125 -24. .336 -31. 852 -14. . 549 1. .00 38. .07 A o
ATOM 974 OD2 ASP A 125 -23 . . 520 -30. 455 -13 . .045 1. .00 44. .23 A o
ATOM 975 C ASP A 125 -20. .288 -33. 194 -15 . .165 1. .00 34. .98 A c
ATOM 976 o ASP A 125 -20. .102 -32. 863 -16. .340 1. .00 34. . 73 A o
ATOM 977 N GLY A 126 -19. .312 -33. 685 -14. .397 1. .00 35. .47 A N
ATOM 978 CA GLY A 126 -17. .931 -33. 785 -14. .893 1. .00 36. .66 A c
ATOM 979 C GLY A 126 -17. .350 -32. 381 -15 . .012 1. .00 37. .88 A c
ATOM 980 o GLY A 126 -18. .083 -31. 394 -14. .794 1. .00 38. .63 A o
ATOM 981 N ASP A 127 -16. .060 -32. 284 -15 . .376 1. .00 37. .62 A N
ATOM 982 CA ASP A 127 -15 . .330 -31. 004 -15 . .363 1. .00 37. . 72 A c
ATOM 983 CB ASP A 127 -13 . .996 -31. 138 -14. .637 1. .00 37. .18 A c
ATOM 984 CG ASP A 127 -13 . .106 -32. 173 -15 . .272 1. .00 37. .42 A c
ATOM 985 ODl ASP A 127 -13 . .431 -32. 597 -16. .405 1. .00 36. .84 A o
ATOM 986 OD2 ASP A 127 -12 . .107 -32. 578 -14. .631 1. .00 35. . 38 A o
ATOM 987 C ASP A 127 -15 . .057 -30. 433 -16. .756 1. .00 37. . 76 A c
ATOM 988 o ASP A 127 -14. .229 -29. 510 -16. .877 1. .00 37. .23 A o
ATOM 989 N GLY A 128 -15 . .750 -30. 980 -17. .767 1. .00 37. .19 A N
ATOM 990 CA GLY A 128 -15 . .485 -30. 716 -19. .179 1. .00 37. .16 A c
ATOM 991 C GLY A 128 -14. .082 -31. 007 -19. .715 1. .00 38. .07 A c
ATOM 992 o GLY A 128 -13 . .859 -30. 746 -20. .890 1. .00 39. .17 A o
ATOM 993 N I LE A 129 -13 . .139 -31. 495 -18. .880 1. .00 37. . 52 A N
ATOM 994 CA I LE A 129 -11. .811 -31. 964 -19. .309 1. .00 36. .84 A c
ATOM 995 CB I LE A 129 -10. .651 -31. 606 -18. .310 1. .00 37. . 50 A c
ATOM 996 CGl I LE A 129 -10. .767 -30. 184 -17. .642 1. .00 38. . 34 A c
ATOM 997 CDl I LE A 129 -10. .877 -28. 983 -18. .606 1. .00 42. .13 A c
ATOM 998 CG2 I LE A 129 -9. .254 -31. 938 -18. .942 1. .00 33. .49 A c
ATOM 999 C I LE A 129 -11. .819 -33. 512 -19. .349 1. .00 37. . 57 A c
ATOM 1000 o I LE A 129 -11. . 514 -34. 142 -20. .378 1. .00 38. .01 A o
ATOM 1001 N LEU A 130 -12 . .150 -34. 132 -18. .216 1. .00 36. .97 A N
ATOM 1002 CA LEU A 130 -12 . .229 -35. 595 -18. .099 1. .00 36. . 57 A c
ATOM 1003 CB LEU A 130 -11. .936 -35. 959 -16. .669 1. .00 37. .18 A c
ATOM 1004 CG LEU A 130 -10. .659 -36. 632 -16. .212 1. .00 43. .85 A c
ATOM 1005 CDl LEU A 130 -10. .785 -38. 205 -16. . 580 1. .00 46. .49 A c
ATOM 1006 CD 2 LEU A 130 -9. .269 -35. 957 -16. .695 1. .00 47. .25 A c
ATOM 1007 C LEU A 130 -13 . . 599 -36. 199 -18. . 584 1. .00 35. .25 A c
ATOM 1008 o LEU A 130 -13 . .644 -37. 081 -19. .447 1. .00 33. . 76 A o
ATOM 1009 N PHE A 131 -14. .713 -35. 687 -18. .074 1. .00 34. .61 A N
ATOM 1010 CA PHE A 131 -16. .039 -36. 253 -18. .388 1. .00 34. .15 A c
ATOM 1011 CB PHE A 131 -16. .657 -36. 934 -17. .161 1. .00 34. .95 A c
ATOM 1012 CG PHE A 131 -15 . .891 -38. 104 -16. .672 1. .00 38. .14 A c
ATOM 1013 CDl PHE A 131 -15 . .883 -39. 308 -17. .404 1. .00 41. . 58 A c
ATOM 1014 CEl PHE A 131 -15 . .151 -40. 406 -16. .966 1. .00 44. . 73 A c
ATOM 1015 CZ PHE A 131 -14. .387 -40. 309 -15 . .767 1. .00 48. .86 A c
ATOM 1016 CE2 PHE A 131 -14. .398 -39. 106 -15 . .023 1. .00 47. .18 A c
ATOM 1017 CD 2 PHE A 131 -15 . .162 -38. Oil -15 . . 501 1. .00 41. . 75 A c
ATOM 1018 C PHE A 131 -17. .011 -35. 199 -18. .809 1. .00 32. .89 A c
ATOM 1019 o PHE A 131 -16. .964 -34. 096 -18. .280 1. .00 33. .01 A o
ATOM 1020 N SER A 132 -17. .907 -35. 526 -19. .737 1. .00 30. .84 A N
ATOM 1021 CA SER A 132 -19. .070 -34. 702 -19. .916 1. .00 29. .80 A c
ATOM 1022 CB SER A 132 -19. .624 -34. 804 -21. .323 1. .00 29. .21 A c
ATOM 1023 OG SER A 132 -19. .674 -36. 134 -21. .697 1. .00 30. .42 A o
ATOM 1024 C SER A 132 -20. .048 -35. 190 -18. .859 1. .00 29. . 53 A c
ATOM 1025 o SER A 132 -19. .685 -36. 006 -18. .036 1. .00 30. .08 A o
ATOM 1026 N PRO A 133 -21. .272 -34. 647 -18. .817 1. .00 29. . 36 A N
ATOM 1027 CA PRO A 133 -22 . .190 -35. 114 -17. .725 1. .00 27. . 74 A c
ATOM 1028 CB PRO A 133 -23 . .429 -34. 274 -17. .954 1. .00 27. .87 A c
ATOM 1029 CG PRO A 133 -22 . .824 -32. 907 -18. . 594 1. .00 28. .87 A c
ATOM 1030 CD PRO A 133 -21. .681 -33. 354 -19. .443 1. .00 28. . 76 A c
ATOM 1031 C PRO A 133 -22 . .473 -36. 640 -17. .708 1. .00 27. . 79 A c
ATOM 1032 o PRO A 133 -22 . .816 -37. 261 -18. .724 1. .00 28. .94 A o
ATOM 1033 N LEU A 134 -22 . .333 -37. 266 -16. . 551 1. .00 27. . 55 A N
ATOM 1034 CA LEU A 134 -22 . .239 -38. 723 -16. . 535 1. .00 26. . 30 A c
ATOM 1035 CB LEU A 134 -21. . 559 -39. 226 -15 . .287 1. .00 26. . 50 A c
ATOM 1036 CG LEU A 134 -20. .106 -38. 765 -15 . .416 1. .00 26. .04 A c
ATOM 1037 CDl LEU A 134 -19. .838 -37. 590 -14. .496 1. .00 24. .48 A c
ATOM 1038 CD 2 LEU A 134 -19. .191 -39. 925 -15 . .156 1. .00 25. . 59 A c
ATOM 1039 C LEU A 134 -23 . . 503 -39. 514 -16. .841 1. .00 26. . 32 A c
ATOM 1040 o LEU A 134 -23 . .407 -40. 717 -17. .164 1. .00 26. .47 A o
ATOM 1041 N SER A 135 -24..671 -38.862 -16..804 1..00 24..53 A N
ATOM 1042 CA SER A 135 -25. .889 -39. 545 -17. .217 1. .00 23. .28 A C
ATOM 1043 CB SER A 135 -27. .116 -38. 743 -16. .855 1. .00 23. .25 A C
ATOM 1044 OG SER A 135 -26. .917 -37. 361 -17. .117 1. .00 25. .21 A o
ATOM 1045 C SER A 135 -25. .899 -39. 891 -18. .701 1. .00 22. .93 A c
ATOM 1046 o SER A 135 -26. .695 -40. 741 -19. .145 1. .00 21. .32 A o
ATOM 1047 N GLY A 136 -24. .986 -39. 272 -19. .467 1. .00 23. .76 A N
ATOM 1048 CA GLY A 136 -25. .006 -39. 438 -20. .917 1. .00 24. .14 A c
ATOM 1049 C GLY A 136 -24. .621 -40. 823 -21. .457 1. .00 24. .78 A c
ATOM 1050 o GLY A 136 -24. .722 -41. 048 -22. .656 1. .00 26. .30 A o
ATOM 1051 N SER A 137 -24. .240 -41. 758 -20. .584 1. .00 24. .70 A N
ATOM 1052 CA SER A 137 -23. .777 -43. 079 -20. .985 1. .00 24. .83 A c
ATOM 1053 CB SER A 137 -22. .367 -43. 311 -20. .477 1. .00 24. .69 A c
ATOM 1054 OG SER A 137 -22. .103 -44. 685 -20. .366 1. .00 25. .08 A o
ATOM 1055 C SER A 137 -24. .685 -44. 169 -20. .437 1. .00 25. .13 A c
ATOM 1056 o SER A 137 -24. .759 -44. 368 -19. .222 1. .00 24. .93 A o
ATOM 1057 N LEU A 138 -25. .412 -44. 849 -21. .328 1. .00 24. .00 A N
ATOM 1058 CA LEU A 138 -26. .252 -45. 962 -20. .897 1. .00 22. .97 A c
ATOM 1059 CB LEU A 138 -27. .032 -46. 501 -22. .064 1. .00 21. .65 A c
ATOM 1060 CG LEU A 138 -27. .858 -47. 765 -21. .927 1. .00 22. .78 A c
ATOM 1061 CDl LEU A 138 -28. .727 -47. 666 -20. .674 1. .00 21. .27 A c
ATOM 1062 CD 2 LEU A 138 -28. .726 -47. 916 -23. .246 1. .00 18. .55 A c
ATOM 1063 C LEU A 138 -25. .439 -47. 092 -20. .237 1. .00 22. .85 A c
ATOM 1064 o LEU A 138 -25. .874 -47. 701 -19. .254 1. .00 23. .50 A o
ATOM 1065 N ASP A 139 -24. .260 -47. 382 -20. .755 1. .00 22. .10 A N
ATOM 1066 CA ASP A 139 -23. .512 -48. 490 -20. .171 1. .00 21. .45 A c
ATOM 1067 CB ASP A 139 -22. .459 -49. 121 -21. .135 1. .00 21. .46 A c
ATOM 1068 CG ASP A 139 -21. .378 -48. 184 -21. .548 1. .00 20. .87 A c
ATOM 1069 ODl ASP A 139 -20. .693 -47. 613 -20. .695 1. .00 19. .56 A o
ATOM 1070 OD2 ASP A 139 -21. .230 -48. 006 -22. .768 1. .00 26. .03 A o
ATOM 1071 C ASP A 139 -22. .996 -48. 153 -18. .787 1. .00 20. .85 A c
ATOM 1072 o ASP A 139 -22. .941 -49. 032 -17. .951 1. .00 20. .86 A o
ATOM 1073 N VAL A 140 -22. .708 -46. 881 -18. .518 1. .00 20. .51 A N
ATOM 1074 CA VAL A 140 -22. .297 -46. 459 -17. .184 1. .00 20. .92 A c
ATOM 1075 CB VAL A 140 -21. .593 -45. 074 -17. .222 1. .00 21. .74 A c
ATOM 1076 CGl VAL A 140 -21. .631 -44. 384 -15. .832 1. .00 21. .41 A c
ATOM 1077 CG2 VAL A 140 -20. .164 -45. 249 -17. .728 1. .00 21. .41 A c
ATOM 1078 C VAL A 140 -23. .476 -46. 498 -16. .156 1. .00 22. .07 A c
ATOM 1079 o VAL A 140 -23. .291 -46. 870 -14. .941 1. .00 21. .54 A o
ATOM 1080 N THR A 141 -24. .676 -46. 178 -16. .641 1. .00 20. .44 A N
ATOM 1081 CA THR A 141 -25. .833 -46. 224 -15. .813 1. .00 20. .85 A c
ATOM 1082 CB THR A 141 -26. .984 -45. 523 -16. .496 1. .00 21. .74 A c
ATOM 1083 OGl THR A 141 -26. .849 -44. 113 -16. .306 1. .00 23. .68 A o
ATOM 1084 CG2 THR A 141 -28. .304 -45. 978 -15. .950 1. .00 23. .15 A c
ATOM 1085 C THR A 141 -26. .163 -47. 695 -15. .559 1. .00 21. .53 A c
ATOM 1086 o THR A 141 -26. .583 -48. 086 -14. .444 1. .00 21. .87 A o
ATOM 1087 N ALA A 142 -25. .964 -48. 547 -16. .552 1. .00 20. .30 A N
ATOM 1088 CA ALA A 142 -26. .249 -49. 949 -16. .264 1. .00 20. .29 A c
ATOM 1089 CB ALA A 142 -26. .338 -50. 784 -17. .552 1. .00 18. .91 A c
ATOM 1090 C ALA A 142 -25. .177 -50. 503 -15. .260 1. .00 20. .38 A c
ATOM 1091 o ALA A 142 -25. .511 -51. 271 -14. .311 1. .00 19. .43 A o
ATOM 1092 N HIS A 143 -23. .912 -50. 094 -15. .455 1. .00 19. .82 A N
ATOM 1093 CA HIS A 143 -22. .832 -50. 454 -14. .479 1. .00 20. .46 A c
ATOM 1094 CB HIS A 143 -21. .554 -49. 725 -14. .830 1. .00 19. .52 A c
ATOM 1095 CG HIS A 143 -20. .477 -49. 854 -13. .814 1. .00 20. .81 A c
ATOM 1096 NDl HIS A 143 -19. .292 -50. 509 -14. .068 1. .00 20. .20 A N
ATOM 1097 CEl HIS A 143 -18. .521 -50. 442 -12. .994 1. .00 21. .05 A c
ATOM 1098 NE2 HIS A 143 -19. .171 -49. 786 -12. .044 1. .00 20. .22 A N
ATOM 1099 CD 2 HIS A 143 -20. .378 -49. 370 -12. .548 1. .00 23. .25 A C
ATOM 1100 C HIS A 143 -23. .266 -50. 149 -13. .024 1. .00 20. .74 A c
ATOM 1101 o HIS A 143 -23. .219 -50. 990 -12. .137 1. .00 20. .11 A o
ATOM 1102 N GLU A 144 -23. .722 -48. 929 -12. .824 1. .00 22. .35 A N
ATOM 1103 CA GLU A 144 -24. .156 -48. 452 -11. .507 1. .00 24. .02 A c
ATOM 1104 CB GLU A 144 -24. .237 -46. 884 -11. .486 1. .00 23. .44 A c
ATOM 1105 CG GLU A 144 -22. .935 -46. 184 -11. .827 1. .00 23. .80 A c
ATOM 1106 CD GLU A 144 -21. .806 -46. 396 -10. .835 1. .00 31. .05 A c
ATOM 1107 OEl GLU A 144 -20. .600 -46. 173 -11. .189 1. .00 37. .21 A o
ATOM 1108 OE2 GLU A 144 -22. .093 -46. 768 -9. .676 1. .00 33. .01 A o
ATOM 1109 C GLU A 144 -25. .452 -49. 143 -11. .015 1. .00 23. .04 A c
ATOM 1110 o GLU A 144 -25. .530 -49. 577 -9. .873 1. .00 24. .42 A o
ATOM 1111 N MET A 145 -26. .441 -49. 319 -11. .863 1. .00 22. .79 A N
ATOM 1112 CA MET A 145 -27. .614 -50. 030 -11. .390 1. .00 23. .27 A c
ATOM 1113 CB MET A 145 -28. .698 -50. 127 -12. .442 1. .00 23. .04 A c
ATOM 1114 CG MET A 145 -29. .845 -49. 154 -12. .293 1. .00 30. .13 A c
ATOM 1115 SD MET A 145 -30. .091 -48. 329 -10. .642 1. .00 38. .83 A s
ATOM 1116 CE MET A 145 -28. .992 -46. 995 -10. .984 1. .00 30. .09 A c
ATOM 1117 C MET A 145 -27. .255 -51. 425 -10. .899 1. .00 23. .43 A c
ATOM 1118 o MET A 145 -27. .820 -51. 930 -9. .890 1. .00 23. .83 A o
ATOM 1119 N THR A 146 -26. .308 -52. 042 -11. .602 1. .00 22. .59 A N
ATOM 1120 CA THR A 146 -25..933 -53.408 -11..333 1..00 22..67 A C
ATOM 1121 CB THR A 146 -25. .012 -53. 943 -12. .471 1. .00 23. .17 A C
ATOM 1122 OGl THR A 146 -25. .757 -53. 956 -13. .691 1. .00 21. .92 A o
ATOM 1123 CG2 THR A 146 -24. .520 -55. 370 -12. .182 1. .00 22. .76 A c
ATOM 1124 C THR A 146 -25. .310 -53. 564 -9. .938 1. .00 23. .21 A c
ATOM 1125 o THR A 146 -25. .425 -54. 655 -9. .340 1. .00 23. .05 A o
ATOM 1126 N HIS A 147 -24. .658 -52. 502 -9. .417 1. .00 22. .84 A N
ATOM 1127 CA HIS A 147 -24. .120 -52. 535 -8. .034 1. .00 23. .53 A c
ATOM 1128 CB HIS A 147 -23. .409 -51. 247 -7. .640 1. .00 23. .43 A c
ATOM 1129 CG HIS A 147 -22. .024 -51. 094 -8. .195 1. .00 25. .63 A c
ATOM 1130 NDl HIS A 147 -21. .056 -52. 081 -8. .097 1. .00 22. .45 A N
ATOM 1131 CEl HIS A 147 -19. .935 -51. 638 -8. .662 1. .00 23. .31 A c
ATOM 1132 NE2 HIS A 147 -20. .139 -50. 412 -9. .125 1. .00 22. .19 A N
ATOM 1133 CD 2 HIS A 147 -21. .432 -50. 042 -8. .838 1. .00 24. .54 A C
ATOM 1134 C HIS A 147 -25. .274 -52. 736 -7. .045 1. .00 23. .74 A c
ATOM 1135 o HIS A 147 -25. .099 -53. 368 -6. .037 1. .00 22. .83 A o
ATOM 1136 N GLY A 148 -26. .454 -52. 192 -7. .379 1. .00 24. .04 A N
ATOM 1137 CA GLY A 148 -27. .645 -52. 306 -6. .567 1. .00 23. .86 A c
ATOM 1138 C GLY A 148 -28. .157 -53. 715 -6. .634 1. .00 24. .32 A c
ATOM 1139 o GLY A 148 -28. .523 -54. 294 -5. .597 1. .00 26. .05 A o
ATOM 1140 N VAL A 149 -28. .141 -54. 301 -7. .825 1. .00 23. .92 A N
ATOM 1141 CA VAL A 149 -28. .526 -55. 705 -7. .988 1. .00 22. .96 A c
ATOM 1142 CB VAL A 149 -28. .493 -56. 127 -9. .460 1. .00 22. .83 A c
ATOM 1143 CGl VAL A 149 -28. .656 -57. 615 -9. .564 1. .00 18. .85 A c
ATOM 1144 CG2 VAL A 149 -29. .512 -55. 358 -10. .259 1. .00 20. .25 A c
ATOM 1145 C VAL A 149 -27. .569 -56. 616 -7. .200 1. .00 24. .15 A c
ATOM 1146 o VAL A 149 -27. .990 -57. 541 -6. .453 1. .00 25. .47 A o
ATOM 1147 N THR A 150 -26. .278 -56. 343 -7. .332 1. .00 23. .75 A N
ATOM 1148 CA THR A 150 -25. .284 -57. 085 -6. .559 1. .00 24. .24 A c
ATOM 1149 CB THR A 150 -23. .863 -56. 666 -6. .946 1. .00 23. .99 A c
ATOM 1150 OGl THR A 150 -23. .602 -57. 125 -8. .283 1. .00 22. .23 A o
ATOM 1151 CG2 THR A 150 -22. .845 -57. 248 -6. .005 1. .00 20. .09 A c
ATOM 1152 C THR A 150 -25. .514 -56. 948 -5. .041 1. .00 25. .81 A c
ATOM 1153 o THR A 150 -25. .448 -57. 939 -4. .305 1. .00 26. .18 A o
ATOM 1154 N GLN A 151 -25. .802 -55. 731 -4. .594 1. .00 26. .07 A N
ATOM 1155 CA GLN A 151 -25. .946 -55. 438 -3. .194 1. .00 27. .46 A c
ATOM 1156 CB GLN A 151 -26. .045 -53. 951 -3. .078 1. .00 28. .06 A c
ATOM 1157 CG GLN A 151 -26. .508 -53. 295 -1. .761 1. .00 34. .50 A c
ATOM 1158 CD GLN A 151 -26. .880 -51. 784 -2. .065 1. .00 38. .36 A c
ATOM 1159 OEl GLN A 151 -28. .045 -51. 379 -1. .940 1. .00 37. .38 A o
ATOM 1160 NE2 GLN A 151 -25. .886 -51. 007 -2. .557 1. .00 37. .31 A N
ATOM 1161 C GLN A 151 -27. .146 -56. 201 -2. .585 1. .00 27. .11 A c
ATOM 1162 o GLN A 151 -27. .025 -56. 777 -1. .499 1. .00 26. .88 A o
ATOM 1163 N GLU A 152 -28. .218 -56. 308 -3. .358 1. .00 25. .84 A N
ATOM 1164 CA GLU A 152 -29. .411 -57. 045 -2. .979 1. .00 26. .00 A c
ATOM 1165 CB GLU A 152 -30. .601 -56. 525 -3. .811 1. .00 24. .38 A c
ATOM 1166 CG GLU A 152 -30. .962 -55. 115 -3. .474 1. .00 28. .24 A c
ATOM 1167 CD GLU A 152 -31. .418 -55. 027 -2. .050 1. .00 30. .02 A c
ATOM 1168 OEl GLU A 152 -32. .452 -55. 626 -1. .757 1. .00 33. .64 A o
ATOM 1169 OE2 GLU A 152 -30. .694 -54. 464 -1. .202 1. .00 32. .95 A o
ATOM 1170 C GLU A 152 -29. .337 -58. 566 -3. .183 1. .00 25. .65 A c
ATOM 1171 o GLU A 152 -30. .318 -59. 303 -2. .924 1. .00 25. .43 A o
ATOM 1172 N THR A 153 -28. .193 -59. 026 -3. .670 1. .00 24. .78 A N
ATOM 1173 CA THR A 153 -28. .036 -60. 395 -4. .148 1. .00 23. .39 A c
ATOM 1174 CB THR A 153 -28. .026 -60. 258 -5. .660 1. .00 24. .08 A c
ATOM 1175 OGl THR A 153 -29. .320 -60. 620 -6. .229 1. .00 27. .23 A o
ATOM 1176 CG2 THR A 153 -27. .026 -60. 967 -6. .210 1. .00 21. .52 A c
ATOM 1177 C THR A 153 -26. .756 -60. 999 -3. .519 1. .00 23. .00 A c
ATOM 1178 o THR A 153 -26. .707 -61. 211 -2. .325 1. .00 22. .29 A o
ATOM 1179 N ALA A 154 -25. .685 -61. 182 -4. .301 1. .00 22. .49 A N
ATOM 1180 CA ALA A 154 -24. .415 -61. 685 -3. .835 1. .00 20. .07 A c
ATOM 1181 CB ALA A 154 -23. .506 -61. 833 -4. .985 1. .00 19. .57 A c
ATOM 1182 C ALA A 154 -23. .744 -60. 845 -2. .758 1. .00 20. .31 A c
ATOM 1183 o ALA A 154 -22. .986 -61. 382 -1. .911 1. .00 19. .99 A o
ATOM 1184 N ASN A 155 -23. .935 -59. 540 -2. .840 1. .00 19. .80 A N
ATOM 1185 CA ASN A 155 -23. .290 -58. 608 -1. .924 1. .00 20. .54 A c
ATOM 1186 CB ASN A 155 -23. .959 -58. 712 -0. .525 1. .00 20. .57 A c
ATOM 1187 CG ASN A 155 -23. .827 -57. 429 0. .321 1. .00 21. .69 A c
ATOM 1188 ODl ASN A 155 -24. .120 -57. 444 1. .545 1. .00 24. .14 A o
ATOM 1189 ND2 ASN A 155 -23. .340 -56. 352 -0. .283 1. .00 18. .66 A N
ATOM 1190 C ASN A 155 -21. .753 -58. 751 -1. .853 1. .00 20. .95 A c
ATOM 1191 o ASN A 155 -21. .134 -58. 840 -0. .755 1. .00 21. .27 A o
ATOM 1192 N LEU A 156 -21. .109 -58. 792 -3. .009 1. .00 21. .01 A N
ATOM 1193 CA LEU A 156 -19. .650 -58. 923 -3. .002 1. .00 20. .82 A c
ATOM 1194 CB LEU A 156 -19. .137 -58. 933 -4. .433 1. .00 20. .60 A c
ATOM 1195 CG LEU A 156 -19. .621 -60. 098 -5. .269 1. .00 19. .99 A c
ATOM 1196 CDl LEU A 156 -19. .739 -59. 645 -6. .739 1. .00 18. .05 A c
ATOM 1197 CD 2 LEU A 156 -18. .615 -61. 191 -5. .062 1. .00 15. .60 A c
ATOM 1198 C LEU A 156 -18. .998 -57. 809 -2. .193 1. .00 20. .75 A c
ATOM 1199 o LEU A 156 -19..303 -56. 638 -2 ..377 1..00 21..10 A o
ATOM 1200 N ASN A 157 -18. .135 -58. 188 -1. .268 1. .00 21. .00 A N
ATOM 1201 CA ASN A 157 -17. .314 -57. 263 -0. . 529 1. .00 21. .48 A C
ATOM 1202 CB ASN A 157 -16. .367 -58. 077 0. .293 1. .00 20. .96 A C
ATOM 1203 CG ASN A 157 -17. .026 -58. 748 1. .430 1. .00 19. .87 A c
ATOM 1204 ODl ASN A 157 -18. .154 -58. 388 1. .838 1. .00 24. .09 A o
ATOM 1205 ND2 ASN A 157 -16. .337 -59. 738 1. .977 1. .00 14. .00 A N
ATOM 1206 C ASN A 157 -16. .458 -56. 356 -1. .436 1. .00 24. . 39 A c
ATOM 1207 o ASN A 157 -15 . .973 -56. 793 -2 . .498 1. .00 24. .92 A o
ATOM 1208 N TYR A 158 -16. .273 -55. 110 -1. .031 1. .00 26. .83 A N
ATOM 1209 CA TYR A 158 -15 . . 597 -54. 138 -1. .874 1. .00 29. .99 A c
ATOM 1210 CB TYR A 158 -16. .133 -52. 730 -1. .625 1. .00 30. . 74 A c
ATOM 1211 CG TYR A 158 -16. .036 -51. 870 -2 . .854 1. .00 37. .88 A c
ATOM 1212 CDl TYR A 158 -16. .756 -52. 240 -4. .013 1. .00 44. .29 A c
ATOM 1213 CEl TYR A 158 -16. .708 -51. 472 -5 . .186 1. .00 46. .05 A c
ATOM 1214 CZ TYR A 158 -15 . .952 -50. 285 -5 . .215 1. .00 46. .84 A c
ATOM 1215 OH TYR A 158 -15 . .988 -49. 585 -6. .428 1. .00 48. . 74 A o
ATOM 1216 CE2 TYR A 158 -15 . .219 -49. 856 -4. .067 1. .00 41. .11 A c
ATOM 1217 CD 2 TYR A 158 -15 . .267 -50. 674 -2 . .884 1. .00 41. . 50 A c
ATOM 1218 C TYR A 158 -14. .104 -54. 136 -1. . 551 1. .00 29. .47 A c
ATOM 1219 o TYR A 158 -13 . .627 -53. 206 -0. .945 1. .00 30. .04 A o
ATOM 1220 N GLU A 159 -13 . .385 -55. 186 -1. .925 1. .00 28. .99 A N
ATOM 1221 CA GLU A 159 -11. .976 -55. 272 -1. .641 1. .00 28. .82 A c
ATOM 1222 CB GLU A 159 -11. .768 -55. 340 -0. .127 1. .00 29. .92 A c
ATOM 1223 CG GLU A 159 -12 . .306 -56. 655 0. .403 1. .00 37. . 72 A c
ATOM 1224 CD GLU A 159 -12 . .378 -56. 771 1. .908 1. .00 46. . 55 A c
ATOM 1225 OEl GLU A 159 -12 . .816 -57. 862 2 . .360 1. .00 50. .45 A o
ATOM 1226 OE2 GLU A 159 -11. .985 -55. 828 2 . .625 1. .00 48. .20 A o
ATOM 1227 C GLU A 159 -11. .430 -56. 526 -2 . .312 1. .00 26. .90 A c
ATOM 1228 o GLU A 159 -12 . .135 -57. 520 -2 . .455 1. .00 25. .63 A o
ATOM 1229 N ASN A 160 -10. .175 -56. 458 -2 . .749 1. .00 25. .86 A N
ATOM 1230 CA ASN A 160 -9. .476 -57. 603 -3 . .289 1. .00 24. . 72 A c
ATOM 1231 CB ASN A 160 -9. .059 -58. 529 -2 . .121 1. .00 25. .81 A c
ATOM 1232 CG ASN A 160 -8. .197 -57. 765 -1. .025 1. .00 27. . 32 A c
ATOM 1233 ODl ASN A 160 -7. .376 -56. 910 -1. .343 1. .00 31. . 59 A o
ATOM 1234 ND2 ASN A 160 -8. .415 -58. 075 0. .224 1. .00 26. . 78 A N
ATOM 1235 C ASN A 160 -10. .273 -58. 290 -4. .423 1. .00 24. .15 A c
ATOM 1236 o ASN A 160 -10. .980 -57. 617 -5 . .193 1. .00 24. .63 A o
ATOM 1237 N GLN A 161 -10. .171 -59. 597 -4. . 565 1. .00 23. .15 A N
ATOM 1238 CA GLN A 161 -10. .906 -60. 268 -5 . .611 1. .00 22. .89 A c
ATOM 1239 CB GLN A 161 -10. .611 -61. 755 -5 . .633 1. .00 23. .27 A c
ATOM 1240 CG GLN A 161 -9. .261 -62. 087 -6. .309 1. .00 25. .24 A c
ATOM 1241 CD GLN A 161 -8. .807 -63. 524 -6. .096 1. .00 24. .45 A c
ATOM 1242 OEl GLN A 161 -7. .827 -63. 747 -5 . .430 1. .00 28. .68 A o
ATOM 1243 NE2 GLN A 161 -9. . 507 -64. 484 -6. .661 1. .00 23. .13 A N
ATOM 1244 C GLN A 161 -12 . .409 -60. 032 -5 . . 552 1. .00 22. .22 A c
ATOM 1245 o GLN A 161 -12 . .998 -59. 792 -6. .604 1. .00 23. .02 A o
ATOM 1246 N PRO A 162 -13 . .039 -60. 085 -4. .344 1. .00 20. .98 A N
ATOM 1247 CA PRO A 162 -14. . 502 -59. 890 -4. .417 1. .00 19. . 36 A c
ATOM 1248 CB PRO A 162 -14. .975 -60. 120 -2 . .987 1. .00 18. .81 A c
ATOM 1249 CG PRO A 162 -13 . .912 -60. 912 -2 . .337 1. .00 18. .86 A c
ATOM 1250 CD PRO A 162 -12 . .606 -60. 623 -3 . .033 1. .00 19. . 79 A c
ATOM 1251 C PRO A 162 -14. .857 -58. 470 -4. .924 1. .00 19. .83 A c
ATOM 1252 o PRO A 162 -15 . .809 -58. 341 -5 . .670 1. .00 19. . 72 A o
ATOM 1253 N GLY A 163 -14. .068 -57. 436 -4. .605 1. .00 18. .23 A N
ATOM 1254 CA GLY A 163 -14. .331 -56. 114 -5 . .191 1. .00 17. .64 A c
ATOM 1255 C GLY A 163 -14. .089 -56. 028 -6. .705 1. .00 18. .03 A c
ATOM 1256 o GLY A 163 -14. .854 -55. 382 -7. .478 1. .00 17. .09 A o
ATOM 1257 N ALA A 164 -13 . .025 -56. 674 -7. .161 1. .00 16. .65 A N
ATOM 1258 CA ALA A 164 -12 . .727 -56. 654 -8. . 580 1. .00 16. . 33 A c
ATOM 1259 CB ALA A 164 -11. .406 -57. 419 -8. .845 1. .00 14. . 77 A c
ATOM 1260 C ALA A 164 -13 . .938 -57. 339 -9. .278 1. .00 17. . 55 A c
ATOM 1261 o ALA A 164 -14. .455 -56. 837 -10. .268 1. .00 18. .28 A o
ATOM 1262 N LEU A 165 -14. .420 -58. 448 -8. .707 1. .00 17. .14 A N
ATOM 1263 CA LEU A 165 -15 . .608 -59. 097 -9. .196 1. .00 17. .89 A c
ATOM 1264 CB LEU A 165 -15 . .877 -60. 287 -8. .315 1. .00 16. .99 A c
ATOM 1265 CG LEU A 165 -15 . .729 -61. 677 -8. .900 1. .00 19. .04 A c
ATOM 1266 CDl LEU A 165 -14. .973 -61. 795 -10. .252 1. .00 15. .06 A c
ATOM 1267 CD 2 LEU A 165 -15 . .198 -62. 613 -7. .856 1. .00 13. .97 A c
ATOM 1268 C LEU A 165 -16. .847 -58. 169 -9. .210 1. .00 18. . 52 A c
ATOM 1269 o LEU A 165 -17. .639 -58. 204 -10. .166 1. .00 19. .03 A o
ATOM 1270 N ASN A 166 -16. .998 -57. 340 -8. .177 1. .00 17. .89 A N
ATOM 1271 CA ASN A 166 -18. .166 -56. 480 -8. .021 1. .00 18. . 38 A c
ATOM 1272 CB ASN A 166 -18. .079 -55. 783 -6. .670 1. .00 18. .80 A c
ATOM 1273 CG ASN A 166 -19. .340 -54. 998 -6. .315 1. .00 22. . 37 A c
ATOM 1274 ODl ASN A 166 -19. .843 -55. 100 -5 . .194 1. .00 27. .99 A o
ATOM 1275 ND2 ASN A 166 -19. .845 -54. 238 -7. .231 1. .00 23. .69 A N
ATOM 1276 C ASN A 166 -18. .122 -55. 478 -9. .184 1. .00 18. .27 A c
ATOM 1277 o ASN A 166 -19. .090 -55. 312 -9. .911 1. .00 16. .89 A o
ATOM 1278 N GLU A 167 -16..956 -54. 845 -9..378 1..00 18.. 74 A N
ATOM 1279 CA GLU A 167 -16. .739 -53. 911 -10. . 509 1. .00 19. .05 A C
ATOM 1280 CB GLU A 167 -15 . .330 -53. 278 -10. .479 1. .00 19. .22 A C
ATOM 1281 CG GLU A 167 -15 . .166 -52. 277 -9. .341 1. .00 18. .04 A c
ATOM 1282 CD GLU A 167 -16. .188 -51. 122 -9. .491 1. .00 26. .42 A c
ATOM 1283 OEl GLU A 167 -16. .420 -50. 721 -10. .651 1. .00 23. .23 A o
ATOM 1284 OE2 GLU A 167 -16. .758 -50. 618 -8. .458 1. .00 31. .20 A o
ATOM 1285 C GLU A 167 -16. .989 -54. 607 -11. .845 1. .00 19. .13 A c
ATOM 1286 o GLU A 167 -17. .653 -54. 030 -12 . .724 1. .00 18. .28 A o
ATOM 1287 N SER A 168 -16. . 521 -55. 853 -11. .965 1. .00 18. .00 A N
ATOM 1288 CA SER A 168 -16. . 599 -56. 564 -13 . .230 1. .00 18. .98 A c
ATOM 1289 CB SER A 168 -15 . .698 -57. 800 -13 . .208 1. .00 19. .87 A c
ATOM 1290 OG SER A 168 -15 . .795 -58. 557 -14. .402 1. .00 21. . 32 A o
ATOM 1291 C SER A 168 -18. .005 -56. 948 -13 . .640 1. .00 19. .25 A c
ATOM 1292 o SER A 168 -18. .367 -56. 783 -14. .817 1. .00 20. .90 A o
ATOM 1293 N PHE A 169 -18. .794 -57. 485 -12 . .710 1. .00 18. .94 A N
ATOM 1294 CA PHE A 169 -20. .217 -57. 729 -12 . .980 1. .00 18. .08 A c
ATOM 1295 CB PHE A 169 -20. .900 -58. 365 -11. .790 1. .00 17. . 52 A c
ATOM 1296 CG PHE A 169 -20. .691 -59. 855 -11. .744 1. .00 18. . 33 A c
ATOM 1297 CDl PHE A 169 -21. . 599 -60. 729 -12 . .369 1. .00 20. .04 A c
ATOM 1298 CEl PHE A 169 -21. .384 -62. 140 -12 . .368 1. .00 18. .87 A c
ATOM 1299 CZ PHE A 169 -20. .211 -62. 664 -11. .775 1. .00 16. . 77 A c
ATOM 1300 CE2 PHE A 169 -19. .287 -61. 777 -11. .188 1. .00 15. .44 A c
ATOM 1301 CD 2 PHE A 169 -19. . 556 -60. 391 -11. .156 1. .00 15. . 38 A c
ATOM 1302 C PHE A 169 -20. .892 -56. 445 -13 . .414 1. .00 18. . 51 A c
ATOM 1303 o PHE A 169 -21. .651 -56. 464 -14. .360 1. .00 18. .82 A o
ATOM 1304 N SER A 170 -20. . 574 -55. 317 -12 . .778 1. .00 18. .28 A N
ATOM 1305 CA SER A 170 -21. .139 -54. 034 -13 . .214 1. .00 18. .86 A c
ATOM 1306 CB SER A 170 -20. .808 -52. 909 -12 . .207 1. .00 19. . 58 A c
ATOM 1307 OG SER A 170 -21. .680 -52. 939 -11. .063 1. .00 18. .44 A o
ATOM 1308 C SER A 170 -20. .703 -53. 636 -14. .648 1. .00 19. . 35 A c
ATOM 1309 o SER A 170 -21. . 548 -53. 179 -15 . .481 1. .00 19. .84 A o
ATOM 1310 N ASP A 171 -19. .419 -53. 836 -14. .973 1. .00 18. .01 A N
ATOM 1311 CA ASP A 171 -18. .950 -53. 628 -16. .357 1. .00 17. .49 A c
ATOM 1312 CB ASP A 171 -17. .426 -53. 709 -16. .481 1. .00 17. .01 A c
ATOM 1313 CG ASP A 171 -16. .753 -52. 437 -15 . .954 1. .00 19. .97 A c
ATOM 1314 ODl ASP A 171 -17. .486 -51. 457 -15 . .784 1. .00 23. . 37 A o
ATOM 1315 OD2 ASP A 171 -15 . . 541 -52. 393 -15 . .672 1. .00 21. .12 A o
ATOM 1316 C ASP A 171 -19. .625 -54. 597 -17. .318 1. .00 17. .10 A c
ATOM 1317 o ASP A 171 -19. .989 -54. 225 -18. .390 1. .00 16. .94 A o
ATOM 1318 N VAL A 172 -19. .821 -55. 841 -16. .929 1. .00 17. . 31 A N
ATOM 1319 CA VAL A 172 -20. .311 -56. 797 -17. .915 1. .00 17. .03 A c
ATOM 1320 CB VAL A 172 -20. .175 -58. 274 -17. .436 1. .00 17. .29 A c
ATOM 1321 CGl VAL A 172 -20. .952 -59. 218 -18. .390 1. .00 10. .63 A c
ATOM 1322 CG2 VAL A 172 -18. .727 -58. 633 -17. .292 1. .00 12. .24 A c
ATOM 1323 C VAL A 172 -21. .769 -56. 540 -18. .178 1. .00 17. .87 A c
ATOM 1324 o VAL A 172 -22 . .186 -56. 570 -19. .320 1. .00 20. .15 A o
ATOM 1325 N PHE A 173 -22 . . 566 -56. 286 -17. .139 1. .00 17. .61 A N
ATOM 1326 CA PHE A 173 -23 . .938 -55. 837 -17. .384 1. .00 16. . 74 A c
ATOM 1327 CB PHE A 173 -24. .788 -55. 923 -16. .129 1. .00 15. .90 A c
ATOM 1328 CG PHE A 173 -25 . .200 -57. 319 -15 . .836 1. .00 16. .63 A c
ATOM 1329 CDl PHE A 173 -26. .192 -57. 945 -16. .615 1. .00 15. .84 A c
ATOM 1330 CEl PHE A 173 -26. . 541 -59. 316 -16. .394 1. .00 15. . 38 A c
ATOM 1331 CZ PHE A 173 -25 . .920 -60. 041 -15 . .400 1. .00 12. . 78 A c
ATOM 1332 CE2 PHE A 173 -24. .915 -59. 420 -14. .624 1. .00 15. .12 A c
ATOM 1333 CD 2 PHE A 173 -24. . 547 -58. 063 -14. .864 1. .00 14. .07 A c
ATOM 1334 C PHE A 173 -23 . .980 -54. 476 -18. .083 1. .00 16. .64 A c
ATOM 1335 o PHE A 173 -24. .859 -54. 210 -18. .881 1. .00 16. .87 A o
ATOM 1336 N GLY A 174 -23 . .012 -53. 618 -17. .829 1. .00 16. .88 A N
ATOM 1337 CA GLY A 174 -22 . .910 -52. 412 -18. .676 1. .00 17. .01 A c
ATOM 1338 C GLY A 174 -22 . .824 -52. 773 -20. .129 1. .00 15. .87 A c
ATOM 1339 o GLY A 174 -23 . .639 -52. 364 -20. .946 1. .00 16. . 39 A o
ATOM 1340 N TYR A 175 -21. .850 -53. 597 -20. .440 1. .00 16. .21 A N
ATOM 1341 CA TYR A 175 -21. .672 -54. 101 -21. .818 1. .00 16. . 33 A c
ATOM 1342 CB TYR A 175 -20. . 505 -55. 135 -21. .929 1. .00 15. . 56 A c
ATOM 1343 CG TYR A 175 -20. .634 -55. 868 -23 . .242 1. .00 16. . 30 A c
ATOM 1344 CDl TYR A 175 -20. .244 -55. 242 -24. .446 1. .00 15. .97 A c
ATOM 1345 CEl TYR A 175 -20. .412 -55. 874 -25 . .660 1. .00 15. .05 A c
ATOM 1346 CZ TYR A 175 -20. .993 -57. 103 -25 . .692 1. .00 12. .27 A c
ATOM 1347 OH TYR A 175 -21. .122 -57. 668 -26. .889 1. .00 19. .05 A o
ATOM 1348 CE2 TYR A 175 -21. .447 -57. 760 -24. . 541 1. .00 15. .27 A c
ATOM 1349 CD 2 TYR A 175 -21. .266 -57. 140 -23 . .315 1. .00 16. . 32 A c
ATOM 1350 C TYR A 175 -22 . .940 -54. 727 -22 . .397 1. .00 16. .62 A c
ATOM 1351 o TYR A 175 -23 . .255 -54. 468 -23 . . 558 1. .00 17. .16 A o
ATOM 1352 N PHE A 176 -23 . .635 -55. 601 -21. .634 1. .00 16. . 39 A N
ATOM 1353 CA PHE A 176 -24. .897 -56. 208 -22 . .145 1. .00 16. .88 A c
ATOM 1354 CB PHE A 176 -25 . . 520 -57. 206 -21. .179 1. .00 15. .95 A c
ATOM 1355 CG PHE A 176 -24. .676 -58. 450 -20. .932 1. .00 17. . 51 A c
ATOM 1356 CDl PHE A 176 -23 . .993 -59. 092 -21. .990 1. .00 17. .21 A c
ATOM 1357 CEl PHE A 176 -23..200 -60.253 -21..776 1..00 14..72 A C
ATOM 1358 CZ PHE A 176 -23. .112 -60. 805 -20. .542 1. .00 13. .49 A C
ATOM 1359 CE2 PHE A 176 -23. .805 -60. 198 -19. .455 1. .00 16. .22 A c
ATOM 1360 CD 2 PHE A 176 -24. .583 -59. 005 -19. .657 1. .00 12. .99 A c
ATOM 1361 C PHE A 176 -25. .969 -55. 159 -22. .503 1. .00 18. .52 A c
ATOM 1362 o PHE A 176 -26. .918 -55. 487 -23. .240 1. .00 19. .58 A o
ATOM 1363 N ASN A 177 -25. .867 -53. 935 -21. .969 1. .00 18. .66 A N
ATOM 1364 CA ASN A 177 -26. .812 -52. 883 -22. .349 1. .00 20. .84 A c
ATOM 1365 CB ASN A 177 -27. .074 -51. 973 -21. .158 1. .00 21. .25 A c
ATOM 1366 CG ASN A 177 -28. .132 -52. 547 -20. .240 1. .00 23. .82 A c
ATOM 1367 ODl ASN A 177 -29. .337 -52. 292 -20. .447 1. .00 26. .73 A o
ATOM 1368 ND2 ASN A 177 -27. .713 -53. 430 -19. .304 1. .00 19. .14 A N
ATOM 1369 C ASN A 177 -26. .349 -52. 026 -23. .528 1. .00 22. .09 A c
ATOM 1370 o ASN A 177 -27. .098 -51. 180 -24. .026 1. .00 22. .65 A o
ATOM 1371 N ASP A 178 -25. .096 -52. 227 -23. .949 1. .00 22. .56 A N
ATOM 1372 CA ASP A 178 -24. .585 -51. 613 -25. .167 1. .00 22. .81 A c
ATOM 1373 CB ASP A 178 -23. .717 -50. 419 -24. .795 1. .00 22. .90 A c
ATOM 1374 CG ASP A 178 -23. .211 -49. 690 -26. .009 1. .00 24. .04 A c
ATOM 1375 ODl ASP A 178 -23. .707 -50. 024 -27. .136 1. .00 23. .24 A o
ATOM 1376 OD2 ASP A 178 -22. .320 -48. 827 -25. .821 1. .00 23. .69 A o
ATOM 1377 C ASP A 178 -23. .756 -52. 589 -25. .997 1. .00 22. .85 A c
ATOM 1378 o ASP A 178 -22. .551 -52. 517 -25. .957 1. .00 22. .00 A o
ATOM 1379 N THR A 179 -24. .373 -53. 519 -26. .733 1. .00 23. .82 A N
ATOM 1380 CA THR A 179 -23. .587 -54. 582 -27. .357 1. .00 23. .81 A c
ATOM 1381 CB THR A 179 -24. .382 -55. 843 -27. .549 1. .00 23. .60 A c
ATOM 1382 OGl THR A 179 -25. .444 -55. 583 -28. .454 1. .00 22. .97 A o
ATOM 1383 CG2 THR A 179 -24. .988 -56. 319 -26. .217 1. .00 23. .48 A c
ATOM 1384 C THR A 179 -22. .874 -54. 197 -28. .652 1. .00 25. .94 A c
ATOM 1385 o THR A 179 -22. .231 -55. 060 -29. .276 1. .00 28. .95 A o
ATOM 1386 N GLU A 180 -22. .905 -52. 916 -29. .011 1. .00 25. .67 A N
ATOM 1387 CA GLU A 180 -22. .389 -52. 446 -30. .283 1. .00 26. .89 A c
ATOM 1388 CB GLU A 180 -23. .122 -51. 171 -30. .761 1. .00 26. .98 A c
ATOM 1389 CG GLU A 180 -24. .670 -51. 330 -30. .837 1. .00 35. .87 A c
ATOM 1390 CD GLU A 180 -25. .179 -52. 083 -32. .100 1. .00 42. .93 A c
ATOM 1391 OEl GLU A 180 -25. .040 -51. 571 -33. .253 1. .00 44. .91 A o
ATOM 1392 OE2 GLU A 180 -25. .746 -53. 192 -31. .912 1. .00 46. .19 A o
ATOM 1393 C GLU A 180 -20. .879 -52. 186 -30. .191 1. .00 25. .23 A c
ATOM 1394 o GLU A 180 -20. .239 -52. 040 -31. .212 1. .00 23. .83 A o
ATOM 1395 N ASP A 181 -20. .348 -52. 112 -28. .967 1. .00 23. .52 A N
ATOM 1396 CA ASP A 181 -18. .938 -51. 832 -28. .760 1. .00 22. .58 A c
ATOM 1397 CB ASP A 181 -18. .655 -50. 340 -28. .850 1. .00 21. .01 A c
ATOM 1398 CG ASP A 181 -19. .321 -49. 522 -27. .710 1. .00 22. .57 A c
ATOM 1399 ODl ASP A 181 -18. .851 -49. 707 -26. .552 1. .00 18. .34 A o
ATOM 1400 OD2 ASP A 181 -20. .243 -48. 665 -27. .982 1. .00 16. .82 A o
ATOM 1401 C ASP A 181 -18. .475 -52. 504 -27. .448 1. .00 22. .44 A c
ATOM 1402 o ASP A 181 -19. .320 -52. 946 -26. .690 1. .00 23. .47 A o
ATOM 1403 N TRP A 182 -17. .171 -52. 683 -27. .223 1. .00 20. .84 A N
ATOM 1404 CA TRP A 182 -16. .721 -53. 385 -26. .028 1. .00 20. .90 A c
ATOM 1405 CB TRP A 182 -15. .592 -54. 408 -26. .332 1. .00 20. .47 A c
ATOM 1406 CG TRP A 182 -15. .970 -55. 461 -27. .334 1. .00 22. .13 A c
ATOM 1407 CDl TRP A 182 -15. .669 -55. 448 -28. .650 1. .00 22. .17 A c
ATOM 1408 NEl TRP A 182 -16. .166 -56. 554 -29. .262 1. .00 23. .53 A N
ATOM 1409 CE2 TRP A 182 -16. .785 -57. 337 -28. .332 1. .00 21. .98 A c
ATOM 1410 CD 2 TRP A 182 -16. .686 -56. 673 -27. .101 1. .00 20. .26 A c
ATOM 1411 CE3 TRP A 182 -17. .205 -57. 286 -25. .966 1. .00 23. .99 A c
ATOM 1412 CZ3 TRP A 182 -17. .855 -58. 507 -26. .101 1. .00 22. .34 A c
ATOM 1413 CH2 TRP A 182 -17. .953 -59. 143 -27. .362 1. .00 21. .91 A c
ATOM 1414 CZ2 TRP A 182 -17. .419 -58. 583 -28. .483 1. .00 20. .01 A c
ATOM 1415 C TRP A 182 -16. .261 -52. 469 -24. .900 1. .00 20. .55 A c
ATOM 1416 o TRP A 182 -15. .597 -52. 916 -23. .924 1. .00 20. .79 A o
ATOM 1417 N ASP A 183 -16. .572 -51. 197 -25. .029 1. .00 20. .24 A N
ATOM 1418 CA ASP A 183 -16. .041 -50. 196 -24. .082 1. .00 20. .11 A c
ATOM 1419 CB ASP A 183 -15. .603 -48. 958 -24. .837 1. .00 22. .04 A c
ATOM 1420 CG ASP A 183 -14. .519 -49. 243 -25. .853 1. .00 22. .53 A c
ATOM 1421 ODl ASP A 183 -13. .631 -50. 058 -25. .566 1. .00 22. .42 A o
ATOM 1422 OD2 ASP A 183 -14. .559 -48. 640 -26. .931 1. .00 28. .89 A o
ATOM 1423 C ASP A 183 -17. .103 -49. 771 -23. .098 1. .00 19. .38 A c
ATOM 1424 o ASP A 183 -18. .305 -49. 994 -23. .280 1. .00 18. .81 A o
ATOM 1425 N ILE A 184 -16. .634 -49. 198 -22. .016 1. .00 19. .19 A N
ATOM 1426 CA ILE A 184 -17. .472 -48. 656 -21. .008 1. .00 17. .88 A c
ATOM 1427 CB ILE A 184 -17. .207 -49. 273 -19. .633 1. .00 17. .96 A c
ATOM 1428 CGl ILE A 184 -17. .542 -50. 770 -19. .598 1. .00 15. .40 A c
ATOM 1429 CDl ILE A 184 -19. .003 -51. 161 -20. .100 1. .00 11. .93 A c
ATOM 1430 CG2 ILE A 184 -17. .982 -48. 453 -18. .531 1. .00 17. .15 A c
ATOM 1431 C ILE A 184 -17. .137 -47. 196 -20. .953 1. .00 19. .24 A c
ATOM 1432 o ILE A 184 -15. .951 -46. 792 -20. .858 1. .00 18. .87 A o
ATOM 1433 N GLY A 185 -18. .188 -46. 389 -21. .023 1. .00 21. .21 A N
ATOM 1434 CA GLY A 185 -18. .053 -44. 959 -20. .843 1. .00 21. .03 A c
ATOM 1435 C GLY A 185 -17. .689 -44. 215 -22. .100 1. .00 22. .01 A c
ATOM 1436 o GLY A 185 -17..408 -43.045 -21..967 1..00 24..52 A o
ATOM 1437 N GLU A 186 -17. .654 -44. 826 -23. .304 1. .00 22. .73 A N
ATOM 1438 CA GLU A 186 -17. .326 -44. 039 -24. .564 1. .00 23. .37 A C
ATOM 1439 CB GLU A 186 -17. .879 -44. 589 -25. .903 1. .00 22. .89 A C
ATOM 1440 CG GLU A 186 -18. .056 -45. 939 -26. .167 1. .00 25. .12 A c
ATOM 1441 CD GLU A 186 -19. .138 -46. 652 -25. .424 1. .00 22. .33 A c
ATOM 1442 OEl GLU A 186 -20. .284 -46. 845 -25. .960 1. .00 21. .68 A o
ATOM 1443 OE2 GLU A 186 -18. .737 -47. 213 -24. .397 1. .00 22. .18 A o
ATOM 1444 C GLU A 186 -18. .099 -42. 696 -24. .596 1. .00 22. .60 A c
ATOM 1445 o GLU A 186 -17. .618 -41. 754 -25. .165 1. .00 20. .62 A o
ATOM 1446 N ASP A 187 -19. .369 -42. 720 -24. .167 1. .00 22. .32 A N
ATOM 1447 CA ASP A 187 -20. .271 -41. 596 -24. .391 1. .00 23. .51 A c
ATOM 1448 CB ASP A 187 -21. .713 -42. 035 -24. .268 1. .00 23. .08 A c
ATOM 1449 CG ASP A 187 -22. .113 -42. 937 -25. .376 1. .00 25. .22 A c
ATOM 1450 ODl ASP A 187 -22. .001 -42. 509 -26. .563 1. .00 30. .20 A o
ATOM 1451 OD2 ASP A 187 -22. .524 -44. 071 -25. .076 1. .00 23. .02 A o
ATOM 1452 C ASP A 187 -20. .027 -40. 439 -23. .465 1. .00 23. .38 A c
ATOM 1453 o ASP A 187 -20. .566 -39. 384 -23. .691 1. .00 23. .91 A o
ATOM 1454 N ILE A 188 -19. .201 -40. 619 -22. .438 1. .00 23. .41 A N
ATOM 1455 CA ILE A 188 -18. .961 -39. 496 -21. .533 1. .00 23. .94 A c
ATOM 1456 CB ILE A 188 -19. .559 -39. 732 -20. .159 1. .00 23. .51 A c
ATOM 1457 CGl ILE A 188 -18. .854 -40. 951 -19. .557 1. .00 23. .55 A c
ATOM 1458 CDl ILE A 188 -19. .426 -41. 402 -18. .274 1. .00 32. .06 A c
ATOM 1459 CG2 ILE A 188 -21. .052 -39. 892 -20. .310 1. .00 22. .40 A c
ATOM 1460 C ILE A 188 -17. .497 -39. 168 -21. .316 1. .00 23. .80 A c
ATOM 1461 o ILE A 188 -17. .230 -38. 262 -20. .549 1. .00 23. .43 A o
ATOM 1462 N THR A 189 -16. .566 -39. 889 -21. .943 1. .00 24. .69 A N
ATOM 1463 CA THR A 189 -15. .119 -39. 571 -21. .732 1. .00 26. .63 A c
ATOM 1464 CB THR A 189 -14. .162 -40. 770 -21. .846 1. .00 26. .40 A c
ATOM 1465 OGl THR A 189 -14. .423 -41. 478 -23. .060 1. .00 27. .13 A o
ATOM 1466 CG2 THR A 189 -14. .341 -41. 690 -20. .690 1. .00 23. .01 A c
ATOM 1467 C THR A 189 -14. .682 -38. 528 -22. .714 1. .00 28. .64 A c
ATOM 1468 o THR A 189 -15. .058 -38. 577 -23. .901 1. .00 29. .97 A o
ATOM 1469 N ILE A 190 -13. .958 -37. 531 -22. .231 1. .00 30. .38 A N
ATOM 1470 CA ILE A 190 -13. .570 -36. 450 -23. .129 1. .00 32. .28 A c
ATOM 1471 CB ILE A 190 -13. .879 -35. 064 -22. .516 1. .00 34. .01 A c
ATOM 1472 CGl ILE A 190 -15. .423 -34. 848 -22. .441 1. .00 32. .91 A c
ATOM 1473 CDl ILE A 190 -15. .854 -33. 566 -21. .723 1. .00 31. .28 A c
ATOM 1474 CG2 ILE A 190 -13. .060 -33. 922 -23. .296 1. .00 32. .95 A c
ATOM 1475 C ILE A 190 -12. .094 -36. 542 -23. .563 1. .00 32. .73 A c
ATOM 1476 o ILE A 190 -11. .803 -36. 448 -24. .738 1. .00 32. .45 A o
ATOM 1477 N SER A 191 -11. .169 -36. 751 -22. .627 1. .00 33. .19 A N
ATOM 1478 CA SER A 191 -9. .775 -36. 805 -23. .025 1. .00 33. .49 A c
ATOM 1479 CB SER A 191 -8. .920 -36. 253 -21. .920 1. .00 33. .14 A c
ATOM 1480 OG SER A 191 -9. .041 -37. 100 -20. .809 1. .00 36. .97 A o
ATOM 1481 C SER A 191 -9. .306 -38. 202 -23. .382 1. .00 34. .18 A c
ATOM 1482 o SER A 191 -8. .091 -38. 453 -23. .467 1. .00 35. .06 A o
ATOM 1483 N GLN A 192 -10. .228 -39. 146 -23. .573 1. .00 33. .35 A N
ATOM 1484 CA GLN A 192 -9. .783 -40. 462 -23. .989 1. .00 32. .23 A c
ATOM 1485 CB GLN A 192 -9. .101 -41. 218 -22. .838 1. .00 33. .39 A c
ATOM 1486 CG GLN A 192 -9. .988 -41. 561 -21. .702 1. .00 38. .13 A c
ATOM 1487 CD GLN A 192 -9. .247 -42. 255 -20. .544 1. .00 43. .66 A c
ATOM 1488 OEl GLN A 192 -8. .231 -41. 748 -20. .087 1. .00 47. .31 A o
ATOM 1489 NE2 GLN A 192 -9. .778 -43. 396 -20. .052 1. .00 41. .63 A N
ATOM 1490 C GLN A 192 -10. .937 -41. 186 -24. .580 1. .00 30. .01 A c
ATOM 1491 o GLN A 192 -12. .071 -40. 805 -24. .353 1. .00 30. .89 A o
ATOM 1492 N PRO A 193 -10. .678 -42. 212 -25. .372 1. .00 27. .78 A N
ATOM 1493 CA PRO A 193 -11. .870 -42. 698 -26. .109 1. .00 26. .45 A c
ATOM 1494 CB PRO A 193 -11. .270 -43. 631 -27. .207 1. .00 26. .27 A c
ATOM 1495 CG PRO A 193 -9. .795 -43. 281 -27. .236 1. .00 27. .16 A c
ATOM 1496 CD PRO A 193 -9. .408 -42. 778 -25. .858 1. .00 26. .09 A c
ATOM 1497 C PRO A 193 -12. .923 -43. 471 -25. .273 1. .00 25. .90 A c
ATOM 1498 o PRO A 193 -14. .023 -43. 682 -25. .773 1. .00 27. .07 A o
ATOM 1499 N ALA A 194 -12. .574 -43. 950 -24. .072 1. .00 24. .70 A N
ATOM 1500 CA ALA A 194 -13. .440 -44. 762 -23. .204 1. .00 23. .36 A c
ATOM 1501 CB ALA A 194 -13. .575 -46. 154 -23. .742 1. .00 22. .19 A c
ATOM 1502 C ALA A 194 -12. .818 -44. 815 -21. .812 1. .00 24. .00 A c
ATOM 1503 o ALA A 194 -11. .698 -44. 385 -21. .593 1. .00 24. .86 A o
ATOM 1504 N LEU A 195 -13. .539 -45. 349 -20. .857 1. .00 23. .81 A N
ATOM 1505 CA LEU A 195 -13. .018 -45. 520 -19. .534 1. .00 24. .41 A c
ATOM 1506 CB LEU A 195 -14. .229 -45. 511 -18. .651 1. .00 25. .95 A c
ATOM 1507 CG LEU A 195 -14. .275 -44. 996 -17. .236 1. .00 30. .68 A c
ATOM 1508 CDl LEU A 195 -13. .317 -43. 838 -17. .055 1. .00 33. .65 A c
ATOM 1509 CD 2 LEU A 195 -15. .726 -44. 586 -16. .969 1. .00 30. .18 A c
ATOM 1510 C LEU A 195 -12. .270 -46. 863 -19. .403 1. .00 24. .08 A c
ATOM 1511 o LEU A 195 -11. .192 -46. 935 -18. .804 1. .00 23. .41 A o
ATOM 1512 N ARG A 196 -12. .841 -47. 922 -20. .014 1. .00 23. .67 A N
ATOM 1513 CA ARG A 196 -12. .370 -49. 296 -19. .891 1. .00 22. .76 A c
ATOM 1514 CB ARG A 196 -12. .961 -49. 963 -18. .629 1. .00 23. .02 A c
ATOM 1515 CG ARG A 196 -12..367 -49..426 -17..342 1..00 21..73 A C
ATOM 1516 CD ARG A 196 -12. .813 -50. .233 -16. .158 1. .00 23. .25 A C
ATOM 1517 NE ARG A 196 -14. .264 -50. .087 -15. .937 1. .00 24. .59 A N
ATOM 1518 CZ ARG A 196 -14. .837 -49. .069 -15. .282 1. .00 20. .86 A C
ATOM 1519 NHl ARG A 196 -14. .092 -48. .100 -14. .791 1. .00 17. .04 A N
ATOM 1520 NH2 ARG A 196 -16. .159 -49. .037 -15. .109 1. .00 21. .02 A N
ATOM 1521 C ARG A 196 -12. .807 -50. .069 -21. .114 1. .00 22. .52 A C
ATOM 1522 o ARG A 196 -13. .819 -49. .727 -21. .723 1. .00 21. .99 A o
ATOM 1523 N SER A 197 -12. .018 -51. .090 -21. .485 1. .00 22. .05 A N
ATOM 1524 CA SER A 197 -12. .362 -51. .996 -22. .573 1. .00 21. .00 A C
ATOM 1525 CB SER A 197 -11. .229 -52. .025 -23. .613 1. .00 20. .95 A C
ATOM 1526 OG SER A 197 -11. .566 -52. .922 -24. .687 1. .00 18. .92 A o
ATOM 1527 C SER A 197 -12. .544 -53. .422 -22. .020 1. .00 21. .27 A c
ATOM 1528 o SER A 197 -11. .708 -53. .882 -21. .198 1. .00 21. .38 A o
ATOM 1529 N LEU A 198 -13. .585 -54. .117 -22. .484 1. .00 19. .82 A N
ATOM 1530 CA LEU A 198 -13. .686 -55. .557 -22. .248 1. .00 19. .79 A c
ATOM 1531 CB LEU A 198 -15. .145 -56. .034 -22. .319 1. .00 19. .75 A c
ATOM 1532 CG LEU A 198 -15. .904 -56. .087 -20. .985 1. .00 21. .07 A c
ATOM 1533 CDl LEU A 198 -16. .178 -54. .692 -20. .481 1. .00 21. .88 A c
ATOM 1534 CD 2 LEU A 198 -17. .157 -56. .815 -21. .298 1. .00 21. .91 A c
ATOM 1535 C LEU A 198 -12. .806 -56. .434 -23. .166 1. .00 19. .74 A c
ATOM 1536 o LEU A 198 -12. .344 -57. .508 -22. .740 1. .00 19. .53 A o
ATOM 1537 N SER A 199 -12. .609 -56. .013 -24. .424 1. .00 19. .06 A N
ATOM 1538 CA SER A 199 -11. .884 -56. .819 -25. .395 1. .00 19. .27 A c
ATOM 1539 CB SER A 199 -12. .216 -56. .441 -26. .825 1. .00 18. .43 A c
ATOM 1540 OG SER A 199 -11. .972 -55. .055 -27. .037 1. .00 20. .70 A o
ATOM 1541 C SER A 199 -10. .433 -56. .637 -25. .153 1. .00 19. .83 A c
ATOM 1542 o SER A 199 -9. .659 -57. .529 -25. .360 1. .00 20. .84 A o
ATOM 1543 N ASN A 200 -10. .032 -55. .478 -24. .689 1. .00 21. .41 A N
ATOM 1544 CA ASN A 200 -8. .634 -55. .334 -24. .362 1. .00 21. .87 A c
ATOM 1545 CB ASN A 200 -7. .791 -54. .832 -25. .537 1. .00 21. .65 A c
ATOM 1546 CG ASN A 200 -6. .249 -54. .889 -25. .231 1. .00 27. .06 A c
ATOM 1547 ODl ASN A 200 -5. .475 -54. .393 -26. .049 1. .00 30. .41 A o
ATOM 1548 ND2 ASN A 200 -5. .809 -55. .501 -24. .039 1. .00 24. .34 A N
ATOM 1549 C ASN A 200 -8. .422 -54. .438 -23. .181 1. .00 21. .54 A c
ATOM 1550 o ASN A 200 -8. .158 -53. .226 -23. .359 1. .00 22. .88 A o
ATOM 1551 N PRO A 201 -8. .456 -55. .035 -21. .969 1. .00 20. .76 A N
ATOM 1552 CA PRO A 201 -8. .386 -54. .221 -20. .767 1. .00 19. .97 A c
ATOM 1553 CB PRO A 201 -8. .583 -55. .233 -19. .649 1. .00 20. .04 A c
ATOM 1554 CG PRO A 201 -9. .418 -56. .297 -20. .256 1. .00 17. .27 A c
ATOM 1555 CD PRO A 201 -8. .940 -56. .400 -21. .672 1. .00 20. .21 A c
ATOM 1556 C PRO A 201 -7. .119 -53. .460 -20. .605 1. .00 20. .08 A c
ATOM 1557 o PRO A 201 -7. .154 -52. .398 -19. .957 1. .00 20. .34 A o
ATOM 1558 N THR A 202 -6. .013 -53. .952 -21. .165 1. .00 20. .30 A N
ATOM 1559 CA THR A 202 -4. .687 -53. .266 -20. .959 1. .00 20. .87 A c
ATOM 1560 CB THR A 202 -3. .423 -54. .140 -21. .428 1. .00 21. .44 A c
ATOM 1561 OGl THR A 202 -3. .517 -54. .431 -22. .817 1. .00 20. .58 A o
ATOM 1562 CG2 THR A 202 -3. .344 -55. .458 -20. .668 1. .00 20. .68 A c
ATOM 1563 C THR A 202 -4. .593 -51. .904 -21. .646 1. .00 21. .36 A c
ATOM 1564 o THR A 202 -3. .792 -51. .104 -21. .320 1. .00 22. .47 A o
ATOM 1565 N LYS A 203 -5. .450 -51. .641 -22. .592 1. .00 22. .15 A N
ATOM 1566 CA LYS A 203 -5. .507 -50. .383 -23. .264 1. .00 23. .44 A c
ATOM 1567 CB LYS A 203 -6. .710 -50. .552 -24. .145 1. .00 23. .94 A c
ATOM 1568 CG LYS A 203 -6. .858 -49. .774 -25. .356 1. .00 27. .38 A c
ATOM 1569 CD LYS A 203 -8. .155 -50. .373 -25. .996 1. .00 33. .35 A c
ATOM 1570 CE LYS A 203 -8. .589 -49. .721 -27. .299 1. .00 34. .69 A c
ATOM 1571 NZ LYS A 203 -9. .750 -50. .462 -27. .851 1. .00 28. .98 A N
ATOM 1572 C LYS A 203 -5. .760 -49. .217 -22. .295 1. .00 24. .00 A c
ATOM 1573 o LYS A 203 -5. .411 -48. .078 -22. .598 1. .00 24. .08 A o
ATOM 1574 N TYR A 204 -6. .439 -49. .493 -21. .165 1. .00 23. .80 A N
ATOM 1575 CA TYR A 204 -6. .757 -48. .477 -20. .131 1. .00 22. .53 A c
ATOM 1576 CB TYR A 204 -8. .279 -48. .163 -19. .987 1. .00 21. .98 A c
ATOM 1577 CG TYR A 204 -8. .883 -47. .674 -21. .292 1. .00 21. .51 A c
ATOM 1578 CDl TYR A 204 -8. .557 -46. .403 -21. .813 1. .00 22. .54 A c
ATOM 1579 CEl TYR A 204 -9. .011 -45. .973 -23. .036 1. .00 20. .99 A c
ATOM 1580 CZ TYR A 204 -9. .841 -46. .786 -23. .781 1. .00 26. .90 A c
ATOM 1581 OH TYR A 204 -10. .293 -46. .348 -25. .000 1. .00 29. .43 A o
ATOM 1582 CE2 TYR A 204 -10. .178 -48. .064 -23. .333 1. .00 25. .65 A c
ATOM 1583 CD 2 TYR A 204 -9. .663 -48. .503 -22. .069 1. .00 24. .69 A c
ATOM 1584 C TYR A 204 -6. .159 -48. .892 -18. .820 1. .00 22. .27 A c
ATOM 1585 o TYR A 204 -6. .671 -48. .521 -17. .794 1. .00 21. .04 A o
ATOM 1586 N GLY A 205 -5. .058 -49. .650 -18. .870 1. .00 22. .10 A N
ATOM 1587 CA GLY A 205 -4. .262 -49. .918 -17. .675 1. .00 22. .18 A c
ATOM 1588 C GLY A 205 -4. .809 -50. .989 -16. .730 1. .00 22. .79 A c
ATOM 1589 o GLY A 205 -4. .430 -50. .991 -15. .582 1. .00 23. .60 A o
ATOM 1590 N GLN A 206 -5. .648 -51. .923 -17. .219 1. .00 21. .26 A N
ATOM 1591 CA GLN A 206 -6. .107 -53. .065 -16. .447 1. .00 19. .18 A c
ATOM 1592 CB GLN A 206 -7. .630 -53. .235 -16. .524 1. .00 18. .15 A c
ATOM 1593 CG GLN A 206 -8. .377 -52. .048 -16. .028 1. .00 17. .17 A c
ATOM 1594 CD GLN A 206 -9..904 -52. 209 -16..063 1..00 21.. 79 A C
ATOM 1595 OEl GLN A 206 -10. . 523 -52. 330 -17. .135 1. .00 18. .29 A o
ATOM 1596 NE2 GLN A 206 -10. . 525 -52. 152 -14. .883 1. .00 20. .04 A N
ATOM 1597 C GLN A 206 -5 . .450 -54. 321 -16. .974 1. .00 19. . 36 A C
ATOM 1598 o GLN A 206 -5 . .357 -54. 518 -18. .186 1. .00 19. .20 A o
ATOM 1599 N PRO A 207 -5 . .012 -55. 210 -16. .056 1. .00 19. .13 A N
ATOM 1600 CA PRO A 207 -4. .493 -56. 519 -16. .465 1. .00 17. . 37 A C
ATOM 1601 CB PRO A 207 -4. .123 -57. 151 -15 . .119 1. .00 17. . 34 A C
ATOM 1602 CG PRO A 207 -4. .994 -56. 447 -14. .112 1. .00 16. .68 A c
ATOM 1603 CD PRO A 207 -5 . .103 -55. 070 -14. . 581 1. .00 17. .24 A c
ATOM 1604 C PRO A 207 -5 . .609 -57. 340 -17. .104 1. .00 19. .09 A c
ATOM 1605 o PRO A 207 -6. .823 -57. 179 -16. .786 1. .00 18. .40 A o
ATOM 1606 N ASP A 208 -5 . .242 -58. 267 -17. .982 1. .00 19. . 79 A N
ATOM 1607 CA ASP A 208 -6. .287 -59. 043 -18. .617 1. .00 19. . 30 A c
ATOM 1608 CB ASP A 208 -6. .405 -58. 653 -20. .118 1. .00 20. .08 A c
ATOM 1609 CG ASP A 208 -5 . .187 -59. 120 -20. .946 1. .00 21. .13 A c
ATOM 1610 ODl ASP A 208 -4. .286 -59. 708 -20. .379 1. .00 20. .02 A o
ATOM 1611 OD2 ASP A 208 -5 . .120 -58. 915 -22 . .167 1. .00 29. .06 A o
ATOM 1612 C ASP A 208 -5 . .899 -60. 513 -18. .392 1. .00 19. . 37 A c
ATOM 1613 o ASP A 208 -6. .395 -61. 433 -19. .078 1. .00 19. .60 A o
ATOM 1614 N ASN A 209 -4. .972 -60. 727 -17. .455 1. .00 18. . 32 A N
ATOM 1615 CA ASN A 209 -4. .466 -62. 070 -17. .169 1. .00 17. . 32 A c
ATOM 1616 CB ASN A 209 -3 . .246 -62. 433 -18. .071 1. .00 15. .81 A c
ATOM 1617 CG ASN A 209 -2 . .821 -63. 952 -17. .937 1. .00 18. . 79 A c
ATOM 1618 ODl ASN A 209 -2 . .149 -64. 383 -16. .941 1. .00 17. .96 A o
ATOM 1619 ND2 ASN A 209 -3 . .226 -64. 760 -18. .938 1. .00 16. .61 A N
ATOM 1620 C ASN A 209 -4. .108 -62. 160 -15 . .700 1. .00 16. .81 A c
ATOM 1621 o ASN A 209 -3 . . 563 -61. 188 -15 . .078 1. .00 18. .22 A o
ATOM 1622 N PHE A 210 -4. .332 -63. 314 -15 . .130 1. .00 15. .27 A N
ATOM 1623 CA PHE A 210 -4. .271 -63. 352 -13 . .695 1. .00 16. . 31 A c
ATOM 1624 CB PHE A 210 -5 . .023 -64. 587 -13 . .159 1. .00 15. .05 A c
ATOM 1625 CG PHE A 210 -5 . .035 -64. 702 -11. .635 1. .00 18. .41 A c
ATOM 1626 CDl PHE A 210 -5 . .798 -63. 830 -10. .847 1. .00 17. . 35 A c
ATOM 1627 CEl PHE A 210 -5 . .823 -63. 930 -9. .476 1. .00 14. .09 A c
ATOM 1628 CZ PHE A 210 -5 . .139 -64. 956 -8. .821 1. .00 18. .23 A c
ATOM 1629 CE2 PHE A 210 -4. .398 -65. 857 -9. . 542 1. .00 22. .42 A c
ATOM 1630 CD 2 PHE A 210 -4. .331 -65. 726 -10. .982 1. .00 22. .85 A c
ATOM 1631 C PHE A 210 -2 . .805 -63. 235 -13 . .180 1. .00 16. .82 A c
ATOM 1632 o PHE A 210 -2 . . 584 -62. 770 -12 . .078 1. .00 18. .49 A o
ATOM 1633 N LYS A 211 -1. .820 -63. 679 -13 . .963 1. .00 16. . 71 A N
ATOM 1634 CA LYS A 211 -0. .456 -63. 522 -13 . . 587 1. .00 16. .11 A c
ATOM 1635 CB LYS A 211 0. . 520 -64. 063 -14. .628 1. .00 15. .62 A c
ATOM 1636 CG LYS A 211 0. .349 -65. 592 -14. .816 1. .00 18. .60 A c
ATOM 1637 CD LYS A 211 1. .446 -66. 227 -15 . . 594 1. .00 18. . 76 A c
ATOM 1638 CE LYS A 211 1. .391 -65. 839 -17. .100 1. .00 22. .01 A c
ATOM 1639 NZ LYS A 211 0. .075 -66. 030 -17. .786 1. .00 23. .18 A N
ATOM 1640 C LYS A 211 -0. .191 -62. 056 -13 . .365 1. .00 16. . 71 A c
ATOM 1641 o LYS A 211 0. .733 -61. 781 -12 . .666 1. .00 18. . 56 A o
ATOM 1642 N ASN A 212 -0. .989 -61. 139 -13 . .917 1. .00 16. .09 A N
ATOM 1643 CA ASN A 212 -0. .705 -59. 723 -13 . .783 1. .00 17. .44 A c
ATOM 1644 CB ASN A 212 -0. .759 -59. 008 -15 . .168 1. .00 15. .91 A c
ATOM 1645 CG ASN A 212 0. .176 -59. 639 -16. .156 1. .00 18. .08 A c
ATOM 1646 ODl ASN A 212 1. .287 -60. 089 -15 . .768 1. .00 20. . 31 A o
ATOM 1647 ND2 ASN A 212 -0. .239 -59. 719 -17. .437 1. .00 13. .44 A N
ATOM 1648 C ASN A 212 -1. .638 -58. 995 -12 . .839 1. .00 18. . 72 A c
ATOM 1649 o ASN A 212 -1. .699 -57. 779 -12 . .907 1. .00 20. . 55 A o
ATOM 1650 N TYR A 213 -2 . .417 -59. 718 -12 . .041 1. .00 20. .14 A N
ATOM 1651 CA TYR A 213 -3 . .203 -59. 181 -10. .941 1. .00 22. .18 A c
ATOM 1652 CB TYR A 213 -3 . .678 -60. 382 -10. .076 1. .00 21. . 74 A c
ATOM 1653 CG TYR A 213 -4. . 569 -60. 001 -8. .895 1. .00 22. .28 A c
ATOM 1654 CDl TYR A 213 -5 . .960 -60. 034 -9. .009 1. .00 21. . 52 A c
ATOM 1655 CEl TYR A 213 -6. .771 -59. 682 -7. .945 1. .00 25. .23 A c
ATOM 1656 CZ TYR A 213 -6. .199 -59. 285 -6. .716 1. .00 24. . 59 A c
ATOM 1657 OH TYR A 213 -7. .033 -58. 937 -5 . .676 1. .00 25. . 57 A o
ATOM 1658 CE2 TYR A 213 -4. .841 -59. 229 -6. . 572 1. .00 20. .07 A c
ATOM 1659 CD 2 TYR A 213 -4. .020 -59. 585 -7. .679 1. .00 23. .48 A c
ATOM 1660 C TYR A 213 -2 . .325 -58. 231 -10. .096 1. .00 23. .86 A c
ATOM 1661 o TYR A 213 -1. .247 -58. 629 -9. .696 1. .00 24. .04 A o
ATOM 1662 N LYS A 214 -2 . .769 -56. 999 -9. .862 1. .00 26. . 34 A N
ATOM 1663 CA LYS A 214 -1. .988 -55. 999 -9. .139 1. .00 29. .23 A c
ATOM 1664 CB LYS A 214 -2 . .379 -54. 571 -9. . 560 1. .00 28. .88 A c
ATOM 1665 CG LYS A 214 -1. .891 -54. 173 -10. .948 1. .00 34. . 77 A c
ATOM 1666 CD LYS A 214 -0. .472 -54. 771 -11. .307 1. .00 42. . 59 A c
ATOM 1667 CE LYS A 214 0. .018 -54. 429 -12 . .759 1. .00 46. . 77 A c
ATOM 1668 NZ LYS A 214 -0. . 563 -55. 320 -13 . .814 1. .00 44. . 75 A N
ATOM 1669 C LYS A 214 -2 . .153 -56. 159 -7. .638 1. .00 30. . 36 A c
ATOM 1670 o LYS A 214 -3 . .239 -55. 937 -7. .112 1. .00 29. . 56 A o
ATOM 1671 N ASN A 215 -1. .087 -56. 456 -6. .949 1. .00 32. . 59 A N
ATOM 1672 CA ASN A 215 -1. .146 -56. 618 -5 . . 534 1. .00 35. .97 A c
ATOM 1673 CB ASN A 215 -0..024 -57..504 -5..121 1..00 37..03 A C
ATOM 1674 CG ASN A 215 -0. .447 -58. .524 -4. .182 1. .00 45. .30 A C
ATOM 1675 ODl ASN A 215 -1. .581 -58. .963 -4. .202 1. .00 55. .68 A o
ATOM 1676 ND2 ASN A 215 0. .460 -58. .920 -3. .309 1. .00 48. .95 A N
ATOM 1677 C ASN A 215 -1. .097 -55. .333 -4. .736 1. .00 35. .60 A c
ATOM 1678 o ASN A 215 -0. .160 -55. .071 -4. .071 1. .00 37. .05 A o
ATOM 1679 N LEU A 216 -2. .142 -54. .545 -4. .803 1. .00 35. .58 A N
ATOM 1680 CA LEU A 216 -2. .245 -53. .342 -4. .006 1. .00 34. .88 A c
ATOM 1681 CB LEU A 216 -3. .192 -52. .367 -4. .683 1. .00 33. .33 A c
ATOM 1682 CG LEU A 216 -2. .645 -51. .966 -6. .042 1. .00 33. .49 A c
ATOM 1683 CDl LEU A 216 -1. .328 -51. .060 -5. .941 1. .00 30. .51 A c
ATOM 1684 CD 2 LEU A 216 -3. .737 -51. .333 -6. .956 1. .00 30. .71 A c
ATOM 1685 C LEU A 216 -2. .672 -53. .627 -2. .544 1. .00 35. .63 A c
ATOM 1686 o LEU A 216 -3. .253 -54. .695 -2. .238 1. .00 34. .93 A o
ATOM 1687 N PRO A 217 -2. .313 -52. .703 -1. .617 1. .00 36. .04 A N
ATOM 1688 CA PRO A 217 -2. .773 -52. .946 -0. .251 1. .00 34. .97 A c
ATOM 1689 CB PRO A 217 -1. .826 -52. .085 0. .598 1. .00 34. .61 A c
ATOM 1690 CG PRO A 217 -1. .400 -50. .968 -0. .374 1. .00 36. .58 A c
ATOM 1691 CD PRO A 217 -1. .221 -51. .699 -1. .661 1. .00 36. .55 A c
ATOM 1692 C PRO A 217 -4. .268 -52. .572 -0. .092 1. .00 34. .04 A c
ATOM 1693 o PRO A 217 -4. .858 -51. .753 -0. .843 1. .00 33. .03 A o
ATOM 1694 N ASN A 218 -4. .876 -53. .226 0. .879 1. .00 32. .61 A N
ATOM 1695 CA ASN A 218 -6. .270 -53. .043 1. .126 1. .00 31. .31 A c
ATOM 1696 CB ASN A 218 -6. .832 -54. .318 1. .763 1. .00 29. .93 A c
ATOM 1697 CG ASN A 218 -8. .318 -54. .301 1. .829 1. .00 27. .40 A c
ATOM 1698 ODl ASN A 218 -8. .947 -53. .358 1. .320 1. .00 26. .18 A o
ATOM 1699 ND2 ASN A 218 -8. .911 -55. .309 2. .494 1. .00 19. .83 A N
ATOM 1700 C ASN A 218 -6. .520 -51. .815 1. .987 1. .00 31. .62 A c
ATOM 1701 o ASN A 218 -6. .790 -51. .939 3. .153 1. .00 31. .01 A o
ATOM 1702 N THR A 219 -6. .450 -50. .630 1. .382 1. .00 32. .99 A N
ATOM 1703 CA THR A 219 -6. .485 -49. .327 2. .093 1. .00 33. .63 A c
ATOM 1704 CB THR A 219 -5. .053 -48. .809 2. .427 1. .00 34. .29 A c
ATOM 1705 OGl THR A 219 -4. .364 -48. .497 1. .191 1. .00 36. .98 A o
ATOM 1706 CG2 THR A 219 -4. .243 -49. .832 3. .250 1. .00 33. .05 A c
ATOM 1707 C THR A 219 -7. .013 -48. .315 1. .104 1. .00 33. .34 A c
ATOM 1708 o THR A 219 -6. .959 -48. .567 -0. .089 1. .00 33. .10 A o
ATOM 1709 N PRO A 220 -7. .484 -47. .146 1. .562 1. .00 33. .55 A N
ATOM 1710 CA PRO A 220 -7. .957 -46. .213 0. .490 1. .00 34. .11 A c
ATOM 1711 CB PRO A 220 -8. .394 -44. .943 1. .263 1. .00 33. .67 A c
ATOM 1712 CG PRO A 220 -8. .401 -45. .295 2. .659 1. .00 32. .53 A c
ATOM 1713 CD PRO A 220 -7. .794 -46. .666 2. .911 1. .00 32. .53 A c
ATOM 1714 C PRO A 220 -6. .879 -45. .880 -0. .591 1. .00 34. .21 A c
ATOM 1715 o PRO A 220 -7. .205 -45. .756 -1. .779 1. .00 34. .70 A o
ATOM 1716 N ALA A 221 -5. .621 -45. .743 -0. .178 1. .00 33. .57 A N
ATOM 1717 CA ALA A 221 -4. .528 -45. .392 -1. .112 1. .00 33. .92 A c
ATOM 1718 CB ALA A 221 -3. .157 -45. .124 -0. .344 1. .00 33. .52 A c
ATOM 1719 C ALA A 221 -4. .353 -46. .519 -2. .148 1. .00 33. .79 A c
ATOM 1720 o ALA A 221 -4. .193 -46. .233 -3. .326 1. .00 35. .18 A o
ATOM 1721 N GLY A 222 -4. .375 -47. .779 -1. .694 1. .00 32. .11 A N
ATOM 1722 CA GLY A 222 -4. .400 -48. .959 -2. .550 1. .00 30. .09 A c
ATOM 1723 C GLY A 222 -5. .687 -49. .271 -3. .346 1. .00 29. .61 A c
ATOM 1724 o GLY A 222 -5. .760 -50. .308 -4. .010 1. .00 28. .33 A o
ATOM 1725 N ASP A 223 -6. .692 -48. .385 -3. .349 1. .00 28. .45 A N
ATOM 1726 CA ASP A 223 -7. .980 -48. .764 -4. .003 1. .00 28. .35 A c
ATOM 1727 CB ASP A 223 -7. .787 -48. .802 -5. .520 1. .00 27. .61 A c
ATOM 1728 CG ASP A 223 -9. .098 -48. .814 -6. .281 1. .00 30. .68 A c
ATOM 1729 ODl ASP A 223 -9. .101 -49. .277 -7. .448 1. .00 32. .09 A o
ATOM 1730 OD2 ASP A 223 -10. .127 -48. .359 -5. .724 1. .00 36. .19 A o
ATOM 1731 C ASP A 223 -8. .530 -50. .124 -3. .459 1. .00 27. .02 A c
ATOM 1732 o ASP A 223 -8. .979 -51. .018 -4. .195 1. .00 25. .89 A o
ATOM 1733 N TYR A 224 -8. .429 -50. .276 -2. .148 1. .00 26. .54 A N
ATOM 1734 CA TYR A 224 -8. .894 -51. .485 -1. .451 1. .00 26. .72 A c
ATOM 1735 CB TYR A 224 -10. .425 -51. .446 -1. .256 1. .00 25. .59 A c
ATOM 1736 CG TYR A 224 -10. .803 -50. .163 -0. .604 1. .00 25. .61 A c
ATOM 1737 CDl TYR A 224 -10. .450 -49. .932 0. .719 1. .00 26. .00 A c
ATOM 1738 CEl TYR A 224 -10. .759 -48. .717 1. .364 1. .00 26. .61 A c
ATOM 1739 CZ TYR A 224 -11. .426 -47. .718 0. .670 1. .00 28. .65 A c
ATOM 1740 OH TYR A 224 -11. .695 -46. .564 1. .364 1. .00 31. .55 A o
ATOM 1741 CE2 TYR A 224 -11. .778 -47. .884 -0. .680 1. .00 24. .77 A c
ATOM 1742 CD 2 TYR A 224 -11. .448 -49. .132 -1. .315 1. .00 26. .18 A c
ATOM 1743 C TYR A 224 -8. .455 -52. .742 -2. .151 1. .00 26. .55 A c
ATOM 1744 o TYR A 224 -9. .255 -53. .616 -2. .386 1. .00 27. .97 A o
ATOM 1745 N GLY A 225 -7. .174 -52. .825 -2. .484 1. .00 26. .70 A N
ATOM 1746 CA GLY A 225 -6. .604 -54. .038 -3. .046 1. .00 24. .99 A c
ATOM 1747 C GLY A 225 -6. .686 -54. .032 -4. .576 1. .00 24. .95 A c
ATOM 1748 o GLY A 225 -6. .602 -55. .087 -5. .173 1. .00 25. .97 A o
ATOM 1749 N GLY A 226 -6. .881 -52. .879 -5. .206 1. .00 22. .96 A N
ATOM 1750 CA GLY A 226 -6. .876 -52. .794 -6. .658 1. .00 23. .27 A c
ATOM 1751 C GLY A 226 -8. .208 -53. .065 -7. .380 1. .00 23. .87 A c
ATOM 1752 o GLY A 226 -8..258 -53.513 -8..540 1..00 24..79 A o
ATOM 1753 N VAL A 227 -9. .290 -52. 745 -6. .710 1. .00 23. .04 A N
ATOM 1754 CA VAL A 227 -10. .625 -53. 162 -7. .073 1. .00 22. .69 A C
ATOM 1755 CB VAL A 227 -11. .553 -52. 701 -5. .895 1. .00 23. .09 A C
ATOM 1756 CGl VAL A 227 -12. .761 -52. 005 -6. .310 1. .00 20. .90 A c
ATOM 1757 CG2 VAL A 227 -11. .769 -53. 815 -4. .873 1. .00 22. .17 A c
ATOM 1758 C VAL A 227 -11. .033 -52. 668 -8. .467 1. .00 23. .44 A c
ATOM 1759 o VAL A 227 -11. .670 -53. 398 -9. .206 1. .00 23. .58 A o
ATOM 1760 N HIS A 228 -10. .608 -51. 461 -8. .843 1. .00 23. .13 A N
ATOM 1761 CA HIS A 228 -10. .921 -50. 876 -10. .133 1. .00 23. .87 A c
ATOM 1762 CB HIS A 228 -10. .907 -49. 340 -10. .010 1. .00 24. .16 A c
ATOM 1763 CG HIS A 228 -12. .028 -48. 829 -9. .173 1. .00 29. .12 A c
ATOM 1764 NDl HIS A 228 -11. .909 -48. 651 -7. .803 1. .00 27. .92 A N
ATOM 1765 CEl HIS A 228 -13. .076 -48. 251 -7. .325 1. .00 29. .37 A c
ATOM 1766 NE2 HIS A 228 -13. .939 -48. 169 -8. .327 1. .00 29. .73 A N
ATOM 1767 CD 2 HIS A 228 -13. .315 -48. 522 -9. .498 1. .00 26. .55 A C
ATOM 1768 C HIS A 228 -9. .905 -51. 230 -11. .202 1. .00 23. .76 A c
ATOM 1769 o HIS A 228 -10. .149 -50. 923 -12. .372 1. .00 23. .21 A o
ATOM 1770 N THR A 229 -8. .734 -51. 751 -10. .819 1. .00 22. .54 A N
ATOM 1771 CA THR A 229 -7. .830 -52. 122 -11. .846 1. .00 23. .69 A c
ATOM 1772 CB THR A 229 -6. .389 -51. 542 -11. .723 1. .00 25. .20 A c
ATOM 1773 OGl THR A 229 -5. .400 -52. 578 -11. .619 1. .00 28. .21 A o
ATOM 1774 CG2 THR A 229 -6. .279 -50. 571 -10. .632 1. .00 24. .20 A c
ATOM 1775 C THR A 229 -7. .947 -53. 613 -12. .134 1. .00 23. .03 A c
ATOM 1776 o THR A 229 -8. .152 -53. 971 -13. .277 1. .00 22. .94 A o
ATOM 1777 N ASN A 230 -7. .940 -54. 455 -11. .100 1. .00 22. .15 A N
ATOM 1778 CA ASN A 230 -8. .058 -55. 904 -11. .271 1. .00 21. .10 A c
ATOM 1779 CB ASN A 230 -7. .726 -56. 621 -9. .992 1. .00 19. .61 A c
ATOM 1780 CG ASN A 230 -6. .306 -56. 361 -9. .574 1. .00 22. .93 A c
ATOM 1781 ODl ASN A 230 -5. .397 -56. 225 -10. .416 1. .00 25. .85 A o
ATOM 1782 ND2 ASN A 230 -6. .084 -56. 287 -8. .289 1. .00 24. .86 A N
ATOM 1783 C ASN A 230 -9. .353 -56. 449 -11. .870 1. .00 20. .93 A c
ATOM 1784 o ASN A 230 -9. .417 -57. 628 -12. .232 1. .00 21. .10 A o
ATOM 1785 N SER A 231 -10. .353 -55. 601 -12. .040 1. .00 19. .41 A N
ATOM 1786 CA SER A 231 -11. .594 -56. 083 -12. .603 1. .00 19. .21 A c
ATOM 1787 CB SER A 231 -12. .638 -54. 982 -12. .525 1. .00 19. .11 A c
ATOM 1788 OG SER A 231 -12. .088 -53. 760 -13. .008 1. .00 20. .47 A o
ATOM 1789 C SER A 231 -11. .362 -56. 457 -14. .053 1. .00 19. .87 A c
ATOM 1790 o SER A 231 -12. .201 -57. 153 -14. .688 1. .00 22. .04 A o
ATOM 1791 N GLY A 232 -10. .239 -56. 000 -14. .607 1. .00 18. .34 A N
ATOM 1792 CA GLY A 232 -9. .908 -56. 335 -15. .989 1. .00 17. .71 A c
ATOM 1793 C GLY A 232 -9. .746 -57. 827 -16. .229 1. .00 17. .62 A c
ATOM 1794 o GLY A 232 -9. .950 -58. 302 -17. .370 1. .00 18. .95 A o
ATOM 1795 N ILE A 233 -9. .433 -58. 587 -15. .169 1. .00 16. .84 A N
ATOM 1796 CA ILE A 233 -9. .226 -60. 005 -15. .346 1. .00 15. .89 A c
ATOM 1797 CB ILE A 233 -8. .370 -60. 622 -14. .217 1. .00 16. .51 A c
ATOM 1798 CGl ILE A 233 -6. .945 -60. 055 -14. .326 1. .00 16. .48 A c
ATOM 1799 CDl ILE A 233 -6. .233 -59. 984 -12. .977 1. .00 17. .92 A c
ATOM 1800 CG2 ILE A 233 -8. .355 -62. 182 -14. .255 1. .00 12. .46 A c
ATOM 1801 C ILE A 233 -10. .523 -60. 704 -15. .579 1. .00 16. .17 A c
ATOM 1802 o ILE A 233 -10. .652 -61. 379 -16. .578 1. .00 16. .06 A o
ATOM 1803 N PRO A 234 -11. .503 -60. 554 -14. .674 1. .00 16. .91 A N
ATOM 1804 CA PRO A 234 -12. .803 -61. 186 -14. .959 1. .00 16. .88 A c
ATOM 1805 CB PRO A 234 -13. .588 -61. 028 -13. .663 1. .00 17. .47 A c
ATOM 1806 CG PRO A 234 -12. .874 -59. 914 -12. .897 1. .00 17. .44 A c
ATOM 1807 CD PRO A 234 -11. .413 -60. 111 -13. .282 1. .00 16. .92 A c
ATOM 1808 C PRO A 234 -13. .540 -60. 494 -16. .103 1. .00 17. .34 A c
ATOM 1809 o PRO A 234 -14. .370 -61. 164 -16. .763 1. .00 17. .89 A o
ATOM 1810 N ASN A 235 -13. .213 -59. 230 -16. .421 1. .00 16. .49 A N
ATOM 1811 CA ASN A 235 -13. .880 -58. 615 -17. .615 1. .00 16. .69 A c
ATOM 1812 CB ASN A 235 -13. .571 -57. 150 -17. .771 1. .00 16. .50 A c
ATOM 1813 CG ASN A 235 -14. .452 -56. 279 -16. .873 1. .00 17. .42 A c
ATOM 1814 ODl ASN A 235 -15. .346 -56. 800 -16. .177 1. .00 16. .73 A o
ATOM 1815 ND2 ASN A 235 -14. .217 -54. 948 -16. .890 1. .00 14. .95 A N
ATOM 1816 C ASN A 235 -13. .467 -59. 334 -18. .849 1. .00 17. .37 A c
ATOM 1817 o ASN A 235 -14. .303 -59. 692 -19. .699 1. .00 17. .84 A o
ATOM 1818 N LYS A 236 -12. .159 -59. 618 -18. .927 1. .00 17. .83 A N
ATOM 1819 CA LYS A 236 -11. .641 -60. 409 -20. .021 1. .00 16. .30 A c
ATOM 1820 CB LYS A 236 -10. .143 -60. 479 -19. .933 1. .00 16. .14 A c
ATOM 1821 CG LYS A 236 -9. .520 -61. 075 -21. .131 1. .00 13. .45 A c
ATOM 1822 CD LYS A 236 -9. .677 -60. 098 -22. .339 1. .00 19. .20 A c
ATOM 1823 CE LYS A 236 -8. .565 -60. 313 -23. .457 1. .00 24. .27 A c
ATOM 1824 NZ LYS A 236 -9. .006 -61. 451 -24. .142 1. .00 25. .04 A N
ATOM 1825 C LYS A 236 -12. .232 -61. 820 -20. .059 1. .00 17. .07 A c
ATOM 1826 o LYS A 236 -12. .539 -62. 351 -21. .166 1. .00 16. .49 A o
ATOM 1827 N ALA A 237 -12. .404 -62. 457 -18. .887 1. .00 16. .60 A N
ATOM 1828 CA ALA A 237 -12. .982 -63. 842 -18. .917 1. .00 15. .77 A c
ATOM 1829 CB ALA A 237 -12. .995 -64. 516 -17. .535 1. .00 13. .36 A c
ATOM 1830 C ALA A 237 -14. .408 -63. 738 -19. .500 1. .00 15. .82 A c
ATOM 1831 o ALA A 237 -14..820 -64.585 -20..294 1..00 15..89 A o
ATOM 1832 N ALA A 238 -15. .122 -62. 664 -19. .148 1. .00 14. .96 A N
ATOM 1833 CA ALA A 238 -16. .455 -62. 493 -19. .616 1. .00 14. .72 A C
ATOM 1834 CB ALA A 238 -17. .103 -61. 346 -18. .843 1. .00 15. .43 A C
ATOM 1835 C ALA A 238 -16. .482 -62. 242 -21. .142 1. .00 14. .97 A c
ATOM 1836 o ALA A 238 -17. .297 -62. 807 -21. .866 1. .00 15. .12 A o
ATOM 1837 N TYR A 239 -15. .574 -61. 427 -21. .633 1. .00 15. .89 A N
ATOM 1838 CA TYR A 239 -15. .480 -61. 143 -23. .068 1. .00 17. .95 A c
ATOM 1839 CB TYR A 239 -14. .410 -60. 061 -23. .352 1. .00 18. .82 A c
ATOM 1840 CG TYR A 239 -13. .741 -60. 115 -24. .716 1. .00 19. .94 A c
ATOM 1841 CDl TYR A 239 -14. .213 -59. 292 -25. .773 1. .00 21. .70 A c
ATOM 1842 CEl TYR A 239 -13. .606 -59. 300 -27. .001 1. .00 19. .11 A c
ATOM 1843 CZ TYR A 239 -12. .507 -60. 154 -27. .212 1. .00 19. .40 A c
ATOM 1844 OH TYR A 239 -11. .959 -60. 182 -28. .450 1. .00 20. .23 A o
ATOM 1845 CE2 TYR A 239 -12. .015 -60. 996 -26. .200 1. .00 16. .51 A c
ATOM 1846 CD 2 TYR A 239 -12. .640 -60. 970 -24. .960 1. .00 17. .39 A c
ATOM 1847 C TYR A 239 -15. .126 -62. 428 -23. .754 1. .00 19. .06 A c
ATOM 1848 o TYR A 239 -15. .687 -62. 740 -24. .802 1. .00 21. .37 A o
ATOM 1849 N ASN A 240 -14. .229 -63. 216 -23. .175 1. .00 18. .84 A N
ATOM 1850 CA ASN A 240 -13. .906 -64. 501 -23. .817 1. .00 17. .95 A c
ATOM 1851 CB ASN A 240 -12. .789 -65. 267 -23. .125 1. .00 17. .02 A c
ATOM 1852 CG ASN A 240 -11. .459 -64. 609 -23. .259 1. .00 16. .24 A c
ATOM 1853 ODl ASN A 240 -11. .195 -63. 810 -24. .179 1. .00 18. .47 A o
ATOM 1854 ND2 ASN A 240 -10. .575 -64. 965 -22. .360 1. .00 13. .19 A N
ATOM 1855 C ASN A 240 -15. .126 -65. 358 -23. .841 1. .00 17. .29 A c
ATOM 1856 o ASN A 240 -15. .321 -66. 126 -24. .820 1. .00 17. .61 A o
ATOM 1857 N THR A 241 -15. .960 -65. 253 -22. .803 1. .00 16. .40 A N
ATOM 1858 CA THR A 241 -17. .108 -66. 151 -22. .843 1. .00 16. .12 A c
ATOM 1859 CB THR A 241 -17. .653 -66. 698 -21. .463 1. .00 16. .69 A c
ATOM 1860 OGl THR A 241 -19. .095 -66. 600 -21. .334 1. .00 18. .84 A o
ATOM 1861 CG2 THR A 241 -16. .875 -66. 395 -20. .334 1. .00 5. .55 A c
ATOM 1862 C THR A 241 -18. .214 -65. 732 -23. .801 1. .00 16. .89 A c
ATOM 1863 o THR A 241 -18. .763 -66. 561 -24. .531 1. .00 17. .17 A o
ATOM 1864 N ILE A 242 -18. .475 -64. 435 -23. .829 1. .00 16. .90 A N
ATOM 1865 CA ILE A 242 -19. .404 -63. 861 -24. .758 1. .00 16. .79 A c
ATOM 1866 CB ILE A 242 -19. .520 -62. 366 -24. .521 1. .00 17. .11 A c
ATOM 1867 CGl ILE A 242 -20. .083 -62. 103 -23. .129 1. .00 13. .60 A c
ATOM 1868 CDl ILE A 242 -19. .869 -60. 607 -22. .655 1. .00 17. .41 A c
ATOM 1869 CG2 ILE A 242 -20. .358 -61. 731 -25. .622 1. .00 13. .89 A c
ATOM 1870 C ILE A 242 -19. .070 -64. 125 -26. .232 1. .00 17. .41 A c
ATOM 1871 o ILE A 242 -19. .983 -64. 398 -27. .051 1. .00 17. .82 A o
ATOM 1872 N THR A 243 -17. .793 -64. 041 -26. .583 1. .00 17. .72 A N
ATOM 1873 CA THR A 243 -17. .392 -64. 274 -27. .982 1. .00 18. .06 A c
ATOM 1874 CB THR A 243 -15. .931 -63. 774 -28. .295 1. .00 17. .72 A c
ATOM 1875 OGl THR A 243 -15. .019 -64. 485 -27. .481 1. .00 17. .90 A o
ATOM 1876 CG2 THR A 243 -15. .758 -62. 235 -27. .989 1. .00 14. .22 A c
ATOM 1877 C THR A 243 -17. .501 -65. 747 -28. .366 1. .00 20. .21 A c
ATOM 1878 o THR A 243 -17. .439 -66. 072 -29. .545 1. .00 20. .40 A o
ATOM 1879 N LYS A 244 -17. .602 -66. 650 -27. .377 1. .00 21. .24 A N
ATOM 1880 CA LYS A 244 -17. .624 -68. 092 -27. .650 1. .00 21. .87 A c
ATOM 1881 CB LYS A 244 -16. .972 -68. 936 -26. .509 1. .00 21. .68 A c
ATOM 1882 CG LYS A 244 -15. .628 -69. 561 -26. .846 1. .00 27. .48 A c
ATOM 1883 CD LYS A 244 -14. .538 -69. 622 -25. .605 1. .00 35. .73 A c
ATOM 1884 CE LYS A 244 -13. .219 -70. 459 -25. .990 1. .00 38. .68 A c
ATOM 1885 NZ LYS A 244 -13. .444 -72. 043 -26. .349 1. .00 33. .65 A N
ATOM 1886 C LYS A 244 -19. .073 -68. 462 -27. .796 1. .00 21. .76 A c
ATOM 1887 o LYS A 244 -19. .422 -69. 182 -28. .721 1. .00 21. .38 A o
ATOM 1888 N ILE A 245 -19. .918 -67. 949 -26. .884 1. .00 21. .31 A N
ATOM 1889 CA ILE A 245 -21. .286 -68. 479 -26. .727 1. .00 20. .42 A c
ATOM 1890 CB ILE A 245 -21. .520 -69. 132 -25. .334 1. .00 20. .57 A c
ATOM 1891 CGl ILE A 245 -21. .640 -68. 087 -24. .227 1. .00 18. .94 A c
ATOM 1892 CDl ILE A 245 -22. .106 -68. 673 -22. .920 1. .00 17. .00 A c
ATOM 1893 CG2 ILE A 245 -20. .419 -70. 121 -24. .984 1. .00 20. .88 A c
ATOM 1894 C ILE A 245 -22. .407 -67. 471 -27. .044 1. .00 20. .62 A c
ATOM 1895 o ILE A 245 -23. .554 -67. 877 -27. .233 1. .00 21. .25 A o
ATOM 1896 N GLY A 246 -22. .076 -66. 182 -27. .160 1. .00 19. .44 A N
ATOM 1897 CA GLY A 246 -23. .054 -65. 205 -27. .613 1. .00 20. .30 A c
ATOM 1898 C GLY A 246 -23. .672 -64. 532 -26. .400 1. .00 20. .27 A c
ATOM 1899 o GLY A 246 -23. .565 -65. 092 -25. .298 1. .00 19. .99 A o
ATOM 1900 N VAL A 247 -24. .275 -63. 348 -26. .583 1. .00 19. .71 A N
ATOM 1901 CA VAL A 247 -24. .808 -62. 615 -25. .468 1. .00 20. .66 A c
ATOM 1902 CB VAL A 247 -24. .838 -61. 037 -25. .578 1. .00 21. .06 A c
ATOM 1903 CGl VAL A 247 -24. .159 -60. 493 -26. .787 1. .00 20. .58 A c
ATOM 1904 CG2 VAL A 247 -26. .206 -60. 431 -25. .285 1. .00 21. .14 A c
ATOM 1905 C VAL A 247 -26. .030 -63. 180 -24. .828 1. .00 21. .73 A c
ATOM 1906 o VAL A 247 -26. .071 -63. 239 -23. .616 1. .00 23. .82 A o
ATOM 1907 N ASN A 248 -26. .975 -63. 695 -25. .594 1. .00 21. .97 A N
ATOM 1908 CA ASN A 248 -28. .169 -64. 283 -25. .003 1. .00 23. .02 A c
ATOM 1909 CB ASN A 248 -29. .082 -64. 962 -26. .087 1. .00 23. .95 A c
ATOM 1910 CG ASN A 248 -29..794 -63.932 -27..012 1..00 29..57 A C
ATOM 1911 ODl ASN A 248 -30. .030 -64. 209 -28. .217 1. .00 42. .08 A o
ATOM 1912 ND2 ASN A 248 -30. .108 -62. 755 -26. .485 1. .00 30. .06 A N
ATOM 1913 C ASN A 248 -27. .822 -65. 295 -23. .931 1. .00 21. .63 A C
ATOM 1914 o ASN A 248 -28. .454 -65. 298 -22. .887 1. .00 22. .73 A o
ATOM 1915 N LYS A 249 -26. .903 -66. 221 -24. .226 1. .00 19. .62 A N
ATOM 1916 CA LYS A 249 -26. .557 -67. 246 -23. .272 1. .00 18. .79 A C
ATOM 1917 CB LYS A 249 -25. .866 -68. 406 -23. .961 1. .00 18. .46 A C
ATOM 1918 CG LYS A 249 -26. .757 -69. 173 -24. .902 1. .00 19. .59 A c
ATOM 1919 CD LYS A 249 -26. .019 -70. 451 -25. .276 1. .00 23. .34 A c
ATOM 1920 CE LYS A 249 -26. .834 -71. 447 -26. .132 1. .00 23. .02 A c
ATOM 1921 NZ LYS A 249 -25. .958 -72. 544 -26. .700 1. .00 24. .35 A N
ATOM 1922 C LYS A 249 -25. .692 -66. 650 -22. .150 1. .00 18. .27 A c
ATOM 1923 o LYS A 249 -25. .931 -66. 895 -20. .964 1. .00 18. .67 A o
ATOM 1924 N ALA A 250 -24. .728 -65. 812 -22. .511 1. .00 18. .25 A N
ATOM 1925 CA ALA A 250 -23. .781 -65. 288 -21. .533 1. .00 18. .63 A c
ATOM 1926 CB ALA A 250 -22. .612 -64. 563 -22. .178 1. .00 16. .62 A c
ATOM 1927 C ALA A 250 -24. .490 -64. 403 -20. .508 1. .00 19. .22 A c
ATOM 1928 o ALA A 250 -24. .128 -64. 419 -19. .319 1. .00 19. .71 A o
ATOM 1929 N GLU A 251 -25. .513 -63. 667 -20. .930 1. .00 19. .16 A N
ATOM 1930 CA GLU A 251 -26. .133 -62. 772 -19. .962 1. .00 18. .90 A c
ATOM 1931 CB GLU A 251 -26. .864 -61. 637 -20. .610 1. .00 17. .73 A c
ATOM 1932 CG GLU A 251 -28. .130 -62. 056 -21. .261 1. .00 19. .93 A c
ATOM 1933 CD GLU A 251 -28. .718 -60. 975 -22. .197 1. .00 20. .89 A c
ATOM 1934 OEl GLU A 251 -28. .226 -59. 813 -22. .204 1. .00 16. .53 A o
ATOM 1935 OE2 GLU A 251 -29. .671 -61. 319 -22. .925 1. .00 22. .41 A o
ATOM 1936 C GLU A 251 -27. .018 -63. 599 -18. .987 1. .00 19. .67 A c
ATOM 1937 o GLU A 251 -27. .126 -63. 256 -17. .811 1. .00 18. .68 A o
ATOM 1938 N GLN A 252 -27. .591 -64. 720 -19. .450 1. .00 18. .71 A N
ATOM 1939 CA GLN A 252 -28. .298 -65. 580 -18. .502 1. .00 17. .84 A c
ATOM 1940 CB GLN A 252 -29. .096 -66. 642 -19. .250 1. .00 17. .39 A c
ATOM 1941 CG GLN A 252 -30. .141 -66. 048 -20. .183 1. .00 17. .73 A c
ATOM 1942 CD GLN A 252 -31. .265 -65. 373 -19. .427 1. .00 23. .25 A c
ATOM 1943 OEl GLN A 252 -31. .531 -65. 695 -18. .253 1. .00 24. .70 A o
ATOM 1944 NE2 GLN A 252 -31. .902 -64. 382 -20. .068 1. .00 21. .47 A N
ATOM 1945 C GLN A 252 -27. .316 -66. 222 -17. .496 1. .00 18. .12 A c
ATOM 1946 o GLN A 252 -27. .576 -66. 284 -16. .292 1. .00 18. .70 A o
ATOM 1947 N ILE A 253 -26. .167 -66. 661 -17. .983 1. .00 17. .81 A N
ATOM 1948 CA ILE A 253 -25. .181 -67. 356 -17. .153 1. .00 16. .02 A c
ATOM 1949 CB ILE A 253 -24. .079 -67. 899 -18. .093 1. .00 15. .55 A c
ATOM 1950 CGl ILE A 253 -24. .629 -69. 145 -18. .832 1. .00 15. .24 A c
ATOM 1951 CDl ILE A 253 -23. .758 -69. 590 -20. .013 1. .00 15. .45 A c
ATOM 1952 CG2 ILE A 253 -22. .759 -68. 151 -17. .353 1. .00 11. .68 A c
ATOM 1953 C ILE A 253 -24. .659 -66. 419 -16. .024 1. .00 16. .62 A c
ATOM 1954 o ILE A 253 -24. .695 -66. 802 -14. .828 1. .00 15. .86 A o
ATOM 1955 N TYR A 254 -24. .283 -65. 187 -16. .423 1. .00 16. .13 A N
ATOM 1956 CA TYR A 254 -23. .859 -64. 098 -15. .561 1. .00 16. .69 A c
ATOM 1957 CB TYR A 254 -23. .426 -62. 842 -16. .387 1. .00 15. .61 A c
ATOM 1958 CG TYR A 254 -21. .977 -62. 980 -16. .659 1. .00 16. .81 A c
ATOM 1959 CDl TYR A 254 -21. .025 -62. 441 -15. .767 1. .00 15. .95 A c
ATOM 1960 CEl TYR A 254 -19. .660 -62. 726 -15. .920 1. .00 16. .12 A c
ATOM 1961 CZ TYR A 254 -19. .265 -63. 540 -16. .983 1. .00 16. .40 A c
ATOM 1962 OH TYR A 254 -17. .933 -63. 797 -17. .199 1. .00 15. .02 A o
ATOM 1963 CE2 TYR A 254 -20. .194 -64. 080 -17. .871 1. .00 15. .41 A c
ATOM 1964 CD 2 TYR A 254 -21. .529 -63. 828 -17. .700 1. .00 13. .73 A c
ATOM 1965 C TYR A 254 -24. .888 -63. 742 -14. .479 1. .00 18. .24 A c
ATOM 1966 o TYR A 254 -24. .514 -63. 497 -13. .318 1. .00 18. .18 A o
ATOM 1967 N TYR A 255 -26. .160 -63. 727 -14. .863 1. .00 18. .34 A N
ATOM 1968 CA TYR A 255 -27. .226 -63. 290 -13. .994 1. .00 18. .95 A c
ATOM 1969 CB TYR A 255 -28. .510 -62. 998 -14. .805 1. .00 17. .25 A c
ATOM 1970 CG TYR A 255 -29. .636 -62. 557 -13. .921 1. .00 16. .18 A c
ATOM 1971 CDl TYR A 255 -29. .658 -61. 279 -13. .396 1. .00 14. .41 A c
ATOM 1972 CEl TYR A 255 -30. .653 -60. 865 -12. .553 1. .00 17. .82 A c
ATOM 1973 CZ TYR A 255 -31. .640 -61. 758 -12. .173 1. .00 19. .38 A c
ATOM 1974 OH TYR A 255 -32. .618 -61. 323 -11. .341 1. .00 20. .14 A o
ATOM 1975 CE2 TYR A 255 -31. .642 -63. 055 -12. .644 1. .00 18. .82 A c
ATOM 1976 CD 2 TYR A 255 -30. .620 -63. 447 -13. .526 1. .00 17. .58 A c
ATOM 1977 C TYR A 255 -27. .441 -64. 415 -12. .940 1. .00 20. .84 A c
ATOM 1978 o TYR A 255 -27. .610 -64. 166 -11. .724 1. .00 20. .60 A o
ATOM 1979 N ARG A 256 -27. .438 -65. 652 -13. .423 1. .00 21. .16 A N
ATOM 1980 CA ARG A 256 -27. .617 -66. 775 -12. .554 1. .00 21. .24 A c
ATOM 1981 CB ARG A 256 -27. .617 -68. 057 -13. .402 1. .00 20. .10 A c
ATOM 1982 CG ARG A 256 -27. .889 -69. 310 -12. .614 1. .00 20. .46 A c
ATOM 1983 CD ARG A 256 -28. .636 -70. 402 -13. .386 1. .00 22. .52 A c
ATOM 1984 NE ARG A 256 -29. .042 -71. 451 -12. .449 1. .00 25. .65 A N
ATOM 1985 CZ ARG A 256 -30. .190 -71. 448 -11. .756 1. .00 24. .08 A c
ATOM 1986 NHl ARG A 256 -31. .107 -70. 479 -11. .918 1. .00 18. .40 A N
ATOM 1987 NH2 ARG A 256 -30. .395 -72. 414 -10. .890 1. .00 18. .20 A N
ATOM 1988 C ARG A 256 -26. .455 -66. 748 -11. .539 1. .00 21. .58 A C
ATOM 1989 o ARG A 256 -26..664 -66.813 -10..345 1..00 23..44 A o
ATOM 1990 N ALA A 257 -25. .226 -66. 616 -12. .003 1. .00 21. .29 A N
ATOM 1991 CA ALA A 257 -24. .070 -66. 707 -11. .091 1. .00 20. .37 A C
ATOM 1992 CB ALA A 257 -22. .807 -66. 514 -11. .846 1. .00 18. .20 A C
ATOM 1993 C ALA A 257 -24. .154 -65. 660 -9. .994 1. .00 20. .56 A c
ATOM 1994 o ALA A 257 -23. .861 -65. 947 -8. .809 1. .00 20. .92 A o
ATOM 1995 N LEU A 258 -24. .536 -64. 448 -10. .406 1. .00 20. .17 A N
ATOM 1996 CA LEU A 258 -24. .565 -63. 313 -9. .543 1. .00 20. .36 A c
ATOM 1997 CB LEU A 258 -24. .787 -62. 029 -10. .315 1. .00 19. .99 A c
ATOM 1998 CG LEU A 258 -24. .858 -60. 759 -9. .436 1. .00 20. .59 A c
ATOM 1999 CDl LEU A 258 -23. .600 -60. 617 -8. .588 1. .00 16. .80 A c
ATOM 2000 CD 2 LEU A 258 -25. .098 -59. 441 -10. .256 1. .00 18. .81 A c
ATOM 2001 C LEU A 258 -25. .643 -63. 493 -8. .471 1. .00 21. .49 A c
ATOM 2002 o LEU A 258 -25. .359 -63. 253 -7. .290 1. .00 20. .13 A o
ATOM 2003 N THR A 259 -26. .814 -64. 018 -8. .861 1. .00 21. .25 A N
ATOM 2004 CA THR A 259 -27. .954 -63. 957 -8. .010 1. .00 22. .14 A c
ATOM 2005 CB THR A 259 -29. .256 -63. 572 -8. .813 1. .00 22. .89 A c
ATOM 2006 OGl THR A 259 -29. .521 -64. 589 -9. .777 1. .00 21. .97 A o
ATOM 2007 CG2 THR A 259 -29. .109 -62. 251 -9. .512 1. .00 21. .29 A c
ATOM 2008 C THR A 259 -28. .188 -65. 287 -7. .337 1. .00 23. .10 A c
ATOM 2009 o THR A 259 -29. .019 -65. 396 -6. .446 1. .00 22. .98 A o
ATOM 2010 N VAL A 260 -27. .497 -66. 334 -7. .749 1. .00 23. .70 A N
ATOM 2011 CA VAL A 260 -27. .751 -67. 645 -7. .104 1. .00 22. .78 A c
ATOM 2012 CB VAL A 260 -28. .299 -68. 684 -8. .114 1. .00 22. .81 A c
ATOM 2013 CGl VAL A 260 -28. .313 -70. 064 -7. .524 1. .00 21. .92 A c
ATOM 2014 CG2 VAL A 260 -29. .712 -68. 253 -8. .612 1. .00 22. .11 A c
ATOM 2015 C VAL A 260 -26. .561 -68. 217 -6. .345 1. .00 22. .91 A c
ATOM 2016 o VAL A 260 -26. .741 -68. 754 -5. .252 1. .00 23. .99 A o
ATOM 2017 N TYR A 261 -25. .366 -68. 069 -6. .897 1. .00 21. .81 A N
ATOM 2018 CA TYR A 261 -24. .181 -68. 768 -6. .417 1. .00 21. .43 A c
ATOM 2019 CB TYR A 261 -23. .470 -69. 511 -7. .565 1. .00 20. .42 A c
ATOM 2020 CG TYR A 261 -24. .256 -70. 683 -8. .061 1. .00 19. .92 A c
ATOM 2021 CDl TYR A 261 -24. .485 -71. 807 -7. .226 1. .00 20. .08 A c
ATOM 2022 CEl TYR A 261 -25. .248 -72. 907 -7. .649 1. .00 19. .11 A c
ATOM 2023 CZ TYR A 261 -25. .785 -72. 870 -8. .926 1. .00 23. .20 A c
ATOM 2024 OH TYR A 261 -26. .510 -73. 952 -9. .382 1. .00 21. .60 A o
ATOM 2025 CE2 TYR A 261 -25. .539 -71. 750 -9. .788 1. .00 18. .76 A c
ATOM 2026 CD 2 TYR A 261 -24. .775 -70. 695 -9. .342 1. .00 17. .58 A c
ATOM 2027 C TYR A 261 -23. .165 -67. 922 -5. .704 1. .00 21. .41 A c
ATOM 2028 o TYR A 261 -22. .458 -68. 423 -4. .888 1. .00 23. .70 A o
ATOM 2029 N LEU A 262 -23. .052 -66. 646 -6. .011 1. .00 21. .84 A N
ATOM 2030 CA LEU A 262 -21. .933 -65. 876 -5. .498 1. .00 20. .81 A c
ATOM 2031 CB LEU A 262 -21. .499 -64. 783 -6. .525 1. .00 20. .64 A c
ATOM 2032 CG LEU A 262 -20. .712 -65. 319 -7. .777 1. .00 17. .72 A c
ATOM 2033 CDl LEU A 262 -20. .347 -64. 218 -8. .742 1. .00 15. .44 A c
ATOM 2034 CD 2 LEU A 262 -19. .485 -66. 126 -7. .488 1. .00 13. .13 A c
ATOM 2035 C LEU A 262 -22. .211 -65. 361 -4. .075 1. .00 21. .67 A c
ATOM 2036 o LEU A 262 -23. .357 -65. 179 -3. .681 1. .00 21. .61 A o
ATOM 2037 N THR A 263 -21. .153 -65. 179 -3. .288 1. .00 22. .08 A N
ATOM 2038 CA THR A 263 -21. .296 -64. 852 -1. .855 1. .00 22. .85 A c
ATOM 2039 CB THR A 263 -20. .821 -66. Oil -0. .975 1. .00 22. .90 A c
ATOM 2040 OGl THR A 263 -19. .435 -66. 202 -1. .246 1. .00 24. .49 A o
ATOM 2041 CG2 THR A 263 -21. .591 -67. 324 -1. .303 1. .00 20. .75 A c
ATOM 2042 C THR A 263 -20. .430 -63. 596 -1. .581 1. .00 23. .07 A c
ATOM 2043 o THR A 263 -19. .704 -63. 163 -2. .461 1. .00 23. .16 A o
ATOM 2044 N PRO A 264 -20. .524 -62. 984 -0. .381 1. .00 22. .93 A N
ATOM 2045 CA PRO A 264 -19. .713 -61. 734 -0. .268 1. .00 21. .80 A c
ATOM 2046 CB PRO A 264 -20. .013 -61. 259 1. .168 1. .00 20. .85 A c
ATOM 2047 CG PRO A 264 -21. .494 -61. 677 1. .307 1. .00 20. .96 A c
ATOM 2048 CD PRO A 264 -21. .548 -63. 073 0. .686 1. .00 21. .37 A c
ATOM 2049 C PRO A 264 -18. .219 -61. 927 -0. .449 1. .00 21. .95 A c
ATOM 2050 o PRO A 264 -17. .527 -60. 980 -0. .854 1. .00 21. .74 A o
ATOM 2051 N SER A 265 -17. .689 -63. 107 -0. .155 1. .00 21. .51 A N
ATOM 2052 CA SER A 265 -16. .245 -63. 202 -0. .203 1. .00 22. .77 A c
ATOM 2053 CB SER A 265 -15. .708 -63. 723 1. .131 1. .00 23. .22 A c
ATOM 2054 OG SER A 265 -16. .294 -64. 984 1. .338 1. .00 27. .76 A o
ATOM 2055 C SER A 265 -15. .714 -64. 054 -1. .385 1. .00 22. .08 A c
ATOM 2056 o SER A 265 -14. .572 -64. 565 -1. .337 1. .00 21. .37 A o
ATOM 2057 N SER A 266 -16. .554 -64. 203 -2. .402 1. .00 21. .31 A N
ATOM 2058 CA SER A 266 -16. .239 -64. 941 -3. .615 1. .00 21. .74 A c
ATOM 2059 CB SER A 266 -17. .390 -64. 849 -4. .624 1. .00 20. .96 A c
ATOM 2060 OG SER A 266 -18. .465 -65. 654 -4. .203 1. .00 23. .84 A o
ATOM 2061 C SER A 266 -14. .949 -64. 428 -4. .260 1. .00 21. .37 A c
ATOM 2062 o SER A 266 -14. .822 -63. 246 -4. .543 1. .00 21. .41 A o
ATOM 2063 N THR A 267 -13. .993 -65. 334 -4. .447 1. .00 19. .86 A N
ATOM 2064 CA THR A 267 -12. .823 -65. 083 -5. .229 1. .00 18. .51 A c
ATOM 2065 CB THR A 267 -11. .802 -66. 126 -4. .784 1. .00 19. .66 A c
ATOM 2066 OGl THR A 267 -12. .308 -67. 447 -5. .103 1. .00 19. .50 A o
ATOM 2067 CG2 THR A 267 -11. .539 -66. 029 -3. .234 1. .00 17. .09 A c
ATOM 2068 C THR A 267 -13..116 -65.295 -6..759 1..00 19..26 A C
ATOM 2069 o THR A 267 -14. .219 -65. 810 -7. .179 1. .00 18. .49 A o
ATOM 2070 N PHE A 268 -12. .140 -64. 915 -7. .597 1. .00 18. .40 A N
ATOM 2071 CA PHE A 268 -12. .115 -65. 257 -9. .035 1. .00 17. .62 A C
ATOM 2072 CB PHE A 268 -10. .766 -64. 858 -9. .626 1. .00 17. .69 A C
ATOM 2073 CG PHE A 268 -10. .559 -63. 372 -9. .729 1. .00 15. .59 A c
ATOM 2074 CDl PHE A 268 -11. .476 -62. 467 -9. .151 1. .00 15. .00 A c
ATOM 2075 CEl PHE A 268 -11. .320 -61. 031 -9. .284 1. .00 14. .29 A c
ATOM 2076 CZ PHE A 268 -10. .192 -60. 528 -9. .924 1. .00 10. .88 A c
ATOM 2077 CE2 PHE A 268 -9. .224 -61. 438 -10. .418 1. .00 16. .00 A c
ATOM 2078 CD 2 PHE A 268 -9. .422 -62. 870 -10. .339 1. .00 12. .08 A c
ATOM 2079 C PHE A 268 -12. .310 -66. 753 -9. .254 1. .00 18. .07 A c
ATOM 2080 o PHE A 268 -13. .080 -67. 204 -10. .110 1. .00 18. .45 A o
ATOM 2081 N LYS A 269 -11. .604 -67. 547 -8. .493 1. .00 18. .34 A N
ATOM 2082 CA LYS A 269 -11. .833 -68. 966 -8. .606 1. .00 20. .19 A c
ATOM 2083 CB LYS A 269 -10. .924 -69. 711 -7. .635 1. .00 20. .91 A c
ATOM 2084 CG LYS A 269 -10. .228 -70. 808 -8. .311 1. .00 24. .31 A c
ATOM 2085 CD LYS A 269 -8. .941 -70. 383 -8. .907 1. .00 23. .96 A c
ATOM 2086 CE LYS A 269 -8. .774 -71. 095 -10. .196 1. .00 24. .14 A c
ATOM 2087 NZ LYS A 269 -7. .867 -72. 214 -10. .403 1. .00 20. .27 A N
ATOM 2088 C LYS A 269 -13. .302 -69. 340 -8. .328 1. .00 20. .16 A c
ATOM 2089 o LYS A 269 -13. .864 -70. 209 -9. .017 1. .00 19. .03 A o
ATOM 2090 N ASP A 270 -13. .942 -68. 678 -7. .342 1. .00 20. .01 A N
ATOM 2091 CA ASP A 270 -15. .339 -69. 019 -7. .061 1. .00 19. .27 A c
ATOM 2092 CB ASP A 270 -15. .851 -68. 360 -5. .764 1. .00 18. .81 A c
ATOM 2093 CG ASP A 270 -15. .108 -68. 810 -4. .541 1. .00 21. .89 A c
ATOM 2094 ODl ASP A 270 -14. .949 -70. 010 -4. .345 1. .00 23. .08 A o
ATOM 2095 OD2 ASP A 270 -14. .667 -67. 973 -3. .738 1. .00 25. .68 A o
ATOM 2096 C ASP A 270 -16. .226 -68. 573 -8. .236 1. .00 18. .97 A c
ATOM 2097 o ASP A 270 -17. .210 -69. 268 -8. .563 1. .00 20. .23 A o
ATOM 2098 N ALA A 271 -15. .938 -67. 397 -8. .818 1. .00 17. .67 A N
ATOM 2099 CA ALA A 271 -16. .789 -66. 827 -9. .864 1. .00 17. .60 A c
ATOM 2100 CB ALA A 271 -16. .341 -65. 408 -10. .223 1. .00 17. .75 A c
ATOM 2101 C ALA A 271 -16. .719 -67. 744 -11. .122 1. .00 18. .15 A c
ATOM 2102 o ALA A 271 -17. .742 -68. 120 -11. .703 1. .00 15. .72 A o
ATOM 2103 N LYS A 272 -15. .491 -68. 135 -11. .474 1. .00 17. .71 A N
ATOM 2104 CA LYS A 272 -15. .259 -69. 255 -12. .392 1. .00 18. .86 A c
ATOM 2105 CB LYS A 272 -13. .796 -69. 746 -12. .312 1. .00 18. .42 A c
ATOM 2106 CG LYS A 272 -13. .494 -70. 766 -13. .309 1. .00 17. .22 A c
ATOM 2107 CD LYS A 272 -12. .161 -71. 342 -13. .061 1. .00 15. .91 A c
ATOM 2108 CE LYS A 272 -11. .739 -72. 203 -14. .227 1. .00 14. .80 A c
ATOM 2109 NZ LYS A 272 -10. .791 -73. 326 -13. .827 1. .00 15. .95 A N
ATOM 2110 C LYS A 272 -16. .188 -70. 425 -12. .144 1. .00 18. .82 A c
ATOM 2111 o LYS A 272 -16. .921 -70. 829 -13. .044 1. .00 20. .76 A o
ATOM 2112 N ALA A 273 -16. .160 -70. 970 -10. .941 1. .00 18. .23 A N
ATOM 2113 CA ALA A 273 -16. .998 -72. 154 -10. .623 1. .00 19. .13 A c
ATOM 2114 CB ALA A 273 -16. .647 -72. 807 -9. .192 1. .00 16. .62 A c
ATOM 2115 C ALA A 273 -18. .471 -71. 778 -10. .703 1. .00 19. .05 A c
ATOM 2116 o ALA A 273 -19. .307 -72. 577 -11. .169 1. .00 20. .74 A o
ATOM 2117 N ALA A 274 -18. .813 -70. 577 -10. .278 1. .00 17. .40 A N
ATOM 2118 CA ALA A 274 -20. .247 -70. 246 -10. .346 1. .00 17. .80 A c
ATOM 2119 CB ALA A 274 -20. .571 -69. 077 -9. .474 1. .00 15. .47 A c
ATOM 2120 C ALA A 274 -20. .745 -70. 018 -11. .791 1. .00 17. .78 A c
ATOM 2121 o ALA A 274 -21. .911 -70. 319 -12. .089 1. .00 19. .25 A o
ATOM 2122 N LEU A 275 -19. .896 -69. 473 -12. .671 1. .00 16. .84 A N
ATOM 2123 CA LEU A 275 -20. .292 -69. 266 -14. .053 1. .00 17. .21 A c
ATOM 2124 CB LEU A 275 -19. .396 -68. 234 -14. .730 1. .00 16. .62 A c
ATOM 2125 CG LEU A 275 -19. .504 -66. 851 -14. .062 1. .00 16. .84 A c
ATOM 2126 CDl LEU A 275 -18. .140 -66. 091 -14. .152 1. .00 8. .70 A c
ATOM 2127 CD 2 LEU A 275 -20. .648 -66. 083 -14. .679 1. .00 14. .58 A c
ATOM 2128 C LEU A 275 -20. .316 -70. 642 -14. .817 1. .00 17. .79 A c
ATOM 2129 o LEU A 275 -21. .207 -70. 909 -15. .632 1. .00 16. .56 A o
ATOM 2130 N ILE A 276 -19. .383 -71. 542 -14. .501 1. .00 17. .59 A N
ATOM 2131 CA ILE A 276 -19. .467 -72. 859 -15. .076 1. .00 17. .24 A c
ATOM 2132 CB ILE A 276 -18. .225 -73. 656 -14. .721 1. .00 17. .48 A c
ATOM 2133 CGl ILE A 276 -17. .017 -73. 094 -15. .440 1. .00 13. .52 A c
ATOM 2134 CDl ILE A 276 -15. .754 -73. 748 -14. .901 1. .00 3. .30 A c
ATOM 2135 CG2 ILE A 276 -18. .402 -75. 137 -15. .034 1. .00 17. .60 A c
ATOM 2136 C ILE A 276 -20. .749 -73. 565 -14. .630 1. .00 18. .56 A c
ATOM 2137 o ILE A 276 -21. .492 -74. 148 -15. .449 1. .00 19. .97 A o
ATOM 2138 N GLN A 277 -21. .057 -73. 506 -13. .341 1. .00 18. .86 A N
ATOM 2139 CA GLN A 277 -22. .182 -74. 275 -12. .870 1. .00 18. .92 A c
ATOM 2140 CB GLN A 277 -22. .273 -74. 263 -11. .334 1. .00 19. .61 A c
ATOM 2141 CG GLN A 277 -23. .503 -74. 991 -10. .746 1. .00 21. .40 A c
ATOM 2142 CD GLN A 277 -23. .470 -76. 498 -11. .075 1. .00 23. .90 A c
ATOM 2143 OEl GLN A 277 -22. .447 -77. 138 -10. .868 1. .00 25. .80 A o
ATOM 2144 NE2 GLN A 277 -24. .577 -77. 045 -11. .614 1. .00 18. .38 A N
ATOM 2145 C GLN A 277 -23. .427 -73. 656 -13. .481 1. .00 19. .42 A c
ATOM 2146 o GLN A 277 -24. .344 -74. 397 -13. .839 1. .00 21. .09 A o
ATOM 2147 N SER A 278 -23..488 -72.323 -13..581 1..00 18..34 A N
ATOM 2148 CA SER A 278 -24. .692 -71. 660 -14. .126 1. .00 18. .25 A C
ATOM 2149 CB SER A 278 -24. .629 -70. 154 -13. .977 1. .00 17. .87 A C
ATOM 2150 OG SER A 278 -24. .503 -69. 758 -12. .604 1. .00 16. .50 A o
ATOM 2151 C SER A 278 -24. .939 -72. 068 -15. .578 1. .00 19. .54 A c
ATOM 2152 o SER A 278 -26. .084 -72. 350 -15. .980 1. .00 20. .47 A o
ATOM 2153 N ALA A 279 -23. .860 -72. 206 -16. .337 1. .00 19. .79 A N
ATOM 2154 CA ALA A 279 -23. .960 -72. 760 -17. .666 1. .00 21. .00 A c
ATOM 2155 CB ALA A 279 -22. .615 -72. 646 -18. .398 1. .00 20. .07 A c
ATOM 2156 C ALA A 279 -24. .516 -74. 211 -17. .734 1. .00 21. .50 A c
ATOM 2157 o ALA A 279 -25. .345 -74. 508 -18. .588 1. .00 21. .44 A o
ATOM 2158 N ARG A 280 -24. .019 -75. 117 -16. .894 1. .00 22. .65 A N
ATOM 2159 CA ARG A 280 -24. .598 -76. 453 -16. .826 1. .00 23. .31 A c
ATOM 2160 CB ARG A 280 -23. .966 -77. 278 -15. .740 1. .00 23. .89 A c
ATOM 2161 CG ARG A 280 -22. .545 -77. 418 -15. .885 1. .00 26. .68 A c
ATOM 2162 CD ARG A 280 -22. .073 -78. 462 -14. .928 1. .00 35. .43 A c
ATOM 2163 NE ARG A 280 -21. .148 -79. 273 -15. .687 1. .00 44. .20 A N
ATOM 2164 CZ ARG A 280 -19. .848 -79. 206 -15. .520 1. .00 46. .31 A c
ATOM 2165 NHl ARG A 280 -19. .351 -78. 425 -14. .558 1. .00 44. .34 A N
ATOM 2166 NH2 ARG A 280 -19. .073 -79. 932 -16. .307 1. .00 50. .17 A N
ATOM 2167 C ARG A 280 -26. .050 -76. 405 -16. .479 1. .00 23. .26 A C
ATOM 2168 o ARG A 280 -26. .803 -77. 133 -17. .062 1. .00 23. .68 A o
ATOM 2169 N ASP A 281 -26. .446 -75. 567 -15. .519 1. .00 23. .26 A N
ATOM 2170 CA ASP A 281 -27. .850 -75. 536 -15. .101 1. .00 23. .49 A C
ATOM 2171 CB ASP A 281 -28. .145 -74. 472 -14. .012 1. .00 24. .21 A c
ATOM 2172 CG ASP A 281 -27. .444 -74. 729 -12. .668 1. .00 26. .18 A c
ATOM 2173 ODl ASP A 281 -26. .972 -75. 873 -12. .401 1. .00 24. .91 A o
ATOM 2174 OD2 ASP A 281 -27. .406 -73. 738 -11. .864 1. .00 26. .85 A o
ATOM 2175 C ASP A 281 -28. .701 -75. 177 -16. .315 1. .00 22. .86 A c
ATOM 2176 o ASP A 281 -29. .726 -75. 776 -16. .535 1. .00 21. .44 A o
ATOM 2177 N LEU A 282 -28. .284 -74. 155 -17. .063 1. .00 22. .26 A N
ATOM 2178 CA LEU A 282 -29. .152 -73. 538 -18. .067 1. .00 22. .50 A c
ATOM 2179 CB LEU A 282 -28. .882 -72. 041 -18. .151 1. .00 21. .78 A c
ATOM 2180 CG LEU A 282 -29. .252 -71. 174 -16. .961 1. .00 22. .74 A c
ATOM 2181 CDl LEU A 282 -28. .603 -69. 829 -17. .165 1. .00 19. .04 A c
ATOM 2182 CD 2 LEU A 282 -30. .773 -71. 069 -16. .821 1. .00 20. .56 A c
ATOM 2183 C LEU A 282 -29. .018 -74. 180 -19. .462 1. .00 22. .63 A c
ATOM 2184 o LEU A 282 -30. .002 -74. 340 -20. .151 1. .00 21. .89 A o
ATOM 2185 N TYR A 283 -27. .809 -74. 605 -19. .842 1. .00 22. .88 A N
ATOM 2186 CA TYR A 283 -27. .545 -75. 030 -21. .212 1. .00 22. .90 A c
ATOM 2187 CB TYR A 283 -26. .845 -73. 929 -22. .020 1. .00 21. .85 A c
ATOM 2188 CG TYR A 283 -27. .559 -72. 574 -21. .968 1. .00 21. .84 A c
ATOM 2189 CDl TYR A 283 -28. .816 -72. 417 -22. .547 1. .00 18. .80 A c
ATOM 2190 CEl TYR A 283 -29. .461 -71. 200 -22. .491 1. .00 20. .76 A c
ATOM 2191 CZ TYR A 283 -28. .874 -70. 092 -21. .858 1. .00 20. .12 A c
ATOM 2192 OH TYR A 283 -29. .586 -68. 908 -21. .854 1. .00 20. .69 A o
ATOM 2193 CE2 TYR A 283 -27. .652 -70. 195 -21. .253 1. .00 15. .68 A c
ATOM 2194 CD 2 TYR A 283 -26. .983 -71. 454 -21. .307 1. .00 17. .76 A c
ATOM 2195 C TYR A 283 -26. .777 -76. 314 -21. .367 1. .00 23. .64 A c
ATOM 2196 o TYR A 283 -26. .744 -76. 821 -22. .465 1. .00 23. .90 A o
ATOM 2197 N GLY A 284 -26. .149 -76. 846 -20. .308 1. .00 24. .18 A N
ATOM 2198 CA GLY A 284 -25. .490 -78. 146 -20. .441 1. .00 23. .74 A c
ATOM 2199 C GLY A 284 -23. .995 -78. 012 -20. .547 1. .00 25. .56 A c
ATOM 2200 o GLY A 284 -23. .429 -76. 878 -20. .400 1. .00 26. .07 A o
ATOM 2201 N SER A 285 -23. .367 -79. 169 -20. .765 1. .00 25. .64 A N
ATOM 2202 CA SER A 285 -21. .924 -79. 403 -20. .789 1. .00 26. .97 A c
ATOM 2203 CB SER A 285 -21. .644 -80. 813 -21. .289 1. .00 27. .65 A c
ATOM 2204 OG SER A 285 -21. .679 -81. 599 -20. .147 1. .00 30. .68 A o
ATOM 2205 C SER A 285 -21. .060 -78. 586 -21. .678 1. .00 26. .93 A c
ATOM 2206 o SER A 285 -19. .949 -78. 197 -21. .282 1. .00 27. .19 A o
ATOM 2207 N GLN A 286 -21. .517 -78. 384 -22. .892 1. .00 26. .76 A N
ATOM 2208 CA GLN A 286 -20. .648 -77. 835 -23. .874 1. .00 28. .08 A c
ATOM 2209 CB GLN A 286 -21. .265 -78. 047 -25. .242 1. .00 30. .00 A c
ATOM 2210 CG GLN A 286 -20. .317 -78. 539 -26. .290 1. .00 39. .99 A c
ATOM 2211 CD GLN A 286 -21. .093 -79. 305 -27. .400 1. .00 52. .85 A c
ATOM 2212 OEl GLN A 286 -22. .302 -79. 063 -27. .620 1. .00 56. .21 A o
ATOM 2213 NE2 GLN A 286 -20. .401 -80. 226 -28. .097 1. .00 54. .74 A N
ATOM 2214 C GLN A 286 -20. .490 -76. 349 -23. .594 1. .00 26. .64 A c
ATOM 2215 o GLN A 286 -19. .363 -75. 804 -23. .701 1. .00 26. .48 A o
ATOM 2216 N ASP A 287 -21. .589 -75. 686 -23. .203 1. .00 24. .40 A N
ATOM 2217 CA ASP A 287 -21. .488 -74. 240 -22. .904 1. .00 22. .97 A c
ATOM 2218 CB ASP A 287 -22. .865 -73. 495 -22. .906 1. .00 21. .60 A c
ATOM 2219 CG ASP A 287 -23. .535 -73. 501 -24. .311 1. .00 24. .04 A c
ATOM 2220 ODl ASP A 287 -24. .782 -73. 687 -24. .383 1. .00 27. .03 A o
ATOM 2221 OD2 ASP A 287 -22. .824 -73. 346 -25. .351 1. .00 23. .58 A o
ATOM 2222 C ASP A 287 -20. .686 -74. 062 -21. .631 1. .00 21. .52 A c
ATOM 2223 o ASP A 287 -19. .872 -73. 146 -21. .556 1. .00 20. .96 A o
ATOM 2224 N ALA A 288 -20. .869 -74. 979 -20. .663 1. .00 21. .28 A N
ATOM 2225 CA ALA A 288 -19. .968 -75. 095 -19. .491 1. .00 20. .85 A c
ATOM 2226 CB ALA A 288 -20..373 -76.242 -18..555 1..00 20..98 A C
ATOM 2227 C ALA A 288 -18. .502 -75. 224 -19. .849 1. .00 20. .23 A C
ATOM 2228 o ALA A 288 -17. .687 -74. 457 -19. .337 1. .00 23. .40 A o
ATOM 2229 N ALA A 289 -18. .134 -76. 136 -20. .728 1. .00 18. .74 A N
ATOM 2230 CA ALA A 289 -16. .734 -76. 188 -21. .224 1. .00 18. .20 A c
ATOM 2231 CB ALA A 289 -16. .517 -77. 355 -22. .253 1. .00 15. .30 A c
ATOM 2232 C ALA A 289 -16. .224 -74. 821 -21. .797 1. .00 18. .09 A c
ATOM 2233 o ALA A 289 -15. .079 -74. 402 -21. .525 1. .00 19. .17 A o
ATOM 2234 N SER A 290 -17. .035 -74. 145 -22. .592 1. .00 17. .27 A N
ATOM 2235 CA SER A 290 -16. .602 -72. 866 -23. .165 1. .00 18. .01 A c
ATOM 2236 CB SER A 290 -17. .574 -72. 332 -24. .200 1. .00 17. .59 A c
ATOM 2237 OG SER A 290 -17. .978 -73. 398 -25. .030 1. .00 17. .68 A o
ATOM 2238 C SER A 290 -16. .430 -71. 814 -22. .096 1. .00 17. .84 A c
ATOM 2239 o SER A 290 -15. .458 -71. 040 -22. .161 1. .00 18. .11 A o
ATOM 2240 N VAL A 291 -17. .347 -71. 766 -21. .119 1. .00 17. .53 A N
ATOM 2241 CA VAL A 291 -17. .137 -70. 846 -19. .979 1. .00 16. .01 A c
ATOM 2242 CB VAL A 291 -18. .259 -70. 906 -18. .946 1. .00 16. .40 A c
ATOM 2243 CGl VAL A 291 -17. .867 -70. 159 -17. .668 1. .00 12. .35 A c
ATOM 2244 CG2 VAL A 291 -19. .547 -70. 364 -19. .535 1. .00 14. .61 A c
ATOM 2245 C VAL A 291 -15. .790 -71. 192 -19. .360 1. .00 16. .98 A c
ATOM 2246 o VAL A 291 -14. .935 -70. 295 -19. .156 1. .00 17. .93 A o
ATOM 2247 N GLU A 292 -15. .554 -72. 485 -19. .084 1. .00 17. .26 A N
ATOM 2248 CA GLU A 292 -14. .285 -72. 893 -18. .404 1. .00 17. .43 A c
ATOM 2249 CB GLU A 292 -14. .296 -74. 410 -18. .184 1. .00 16. .88 A c
ATOM 2250 CG GLU A 292 -13. .056 -74. 909 -17. .514 1. .00 18. .64 A c
ATOM 2251 CD GLU A 292 -13. .160 -76. 349 -17. .130 1. .00 21. .95 A c
ATOM 2252 OEl GLU A 292 -13. .129 -77. 179 -18. .042 1. .00 22. .49 A o
ATOM 2253 OE2 GLU A 292 -13. .281 -76. 658 -15. .926 1. .00 21. .17 A o
ATOM 2254 C GLU A 292 -13. .009 -72. 459 -19. .221 1. .00 17. .74 A c
ATOM 2255 o GLU A 292 -12. .023 -71. 872 -18. .666 1. .00 19. .53 A o
ATOM 2256 N ALA A 293 -13. .031 -72. 732 -20. .521 1. .00 15. .97 A N
ATOM 2257 CA ALA A 293 -11. .959 -72. 339 -21. .435 1. .00 16. .10 A c
ATOM 2258 CB ALA A 293 -12. .266 -72. 836 -22. .889 1. .00 13. .76 A c
ATOM 2259 C ALA A 293 -11. .743 -70. 814 -21. .410 1. .00 17. .14 A c
ATOM 2260 o ALA A 293 -10. .569 -70. 319 -21. .455 1. .00 17. .89 A o
ATOM 2261 N ALA A 294 -12. .849 -70. 063 -21. .330 1. .00 16. .60 A N
ATOM 2262 CA ALA A 294 -12. .746 -68. 599 -21. .268 1. .00 17. .10 A c
ATOM 2263 CB ALA A 294 -14. .098 -67. 948 -21. .258 1. .00 16. .35 A c
ATOM 2264 C ALA A 294 -11. .953 -68. 177 -20. .039 1. .00 17. .40 A c
ATOM 2265 o ALA A 294 -11. .212 -67. 221 -20. .121 1. .00 17. .93 A o
ATOM 2266 N TRP A 295 -12. .058 -68. 906 -18. .916 1. .00 17. .09 A N
ATOM 2267 CA TRP A 295 -11. .301 -68. 546 -17. .702 1. .00 16. .03 A c
ATOM 2268 CB TRP A 295 -12. .029 -69. 018 -16. .423 1. .00 16. .23 A c
ATOM 2269 CG TRP A 295 -13. .219 -68. 152 -16. .073 1. .00 13. .59 A c
ATOM 2270 CDl TRP A 295 -14. .511 -68. 249 -16. .584 1. .00 12. .53 A c
ATOM 2271 NEl TRP A 295 -15. .301 -67. 226 -16. .047 1. .00 16. .35 A N
ATOM 2272 CE2 TRP A 295 -14. .543 -66. 484 -15. .161 1. .00 14. .53 A c
ATOM 2273 CD 2 TRP A 295 -13. .226 -67. 016 -15. .169 1. .00 12. .86 A c
ATOM 2274 CE3 TRP A 295 -12. .249 -66. 411 -14. .357 1. .00 12. .83 A c
ATOM 2275 CZ3 TRP A 295 -12. .591 -65. 298 -13. .575 1. .00 11. .80 A c
ATOM 2276 CH2 TRP A 295 -13. .910 -64. 782 -13. .569 1. .00 12. .57 A c
ATOM 2277 CZ2 TRP A 295 -14. .894 -65. 343 -14. .376 1. .00 15. .73 A c
ATOM 2278 C TRP A 295 -9. .895 -69. 097 -17. .803 1. .00 17. .18 A c
ATOM 2279 o TRP A 295 -8. .914 -68. 446 -17. .386 1. .00 18. .22 A o
ATOM 2280 N ASN A 296 -9. .749 -70. 269 -18. .417 1. .00 16. .56 A N
ATOM 2281 CA ASN A 296 -8. .391 -70. 769 -18. .692 1. .00 15. .21 A c
ATOM 2282 CB ASN A 296 -8. .457 -72. 131 -19. .424 1. .00 14. .65 A c
ATOM 2283 CG ASN A 296 -9. .033 -73. 285 -18. .512 1. .00 16. .77 A c
ATOM 2284 ODl ASN A 296 -9. .175 -73. 141 -17. .276 1. .00 20. .24 A o
ATOM 2285 ND2 ASN A 296 -9. .387 -74. 380 -19. .120 1. .00 14. .16 A N
ATOM 2286 C ASN A 296 -7. .521 -69. 729 -19. .432 1. .00 16. .44 A c
ATOM 2287 o ASN A 296 -6. .303 -69. 529 -19. .113 1. .00 16. .54 A o
ATOM 2288 N ALA A 297 -8. .126 -69. 035 -20. .406 1. .00 16. .57 A N
ATOM 2289 CA ALA A 297 -7. .355 -68. 195 -21. .309 1. .00 16. .69 A c
ATOM 2290 CB ALA A 297 -8. .181 -67. 747 -22. .564 1. .00 15. .79 A c
ATOM 2291 C ALA A 297 -6. .858 -66. 990 -20. .556 1. .00 17. .86 A c
ATOM 2292 o ALA A 297 -5. .951 -66. 356 -21. .041 1. .00 19. .04 A o
ATOM 2293 N VAL A 298 -7. .426 -66. 663 -19. .388 1. .00 18. .30 A N
ATOM 2294 CA VAL A 298 -6. .891 -65. 550 -18. .595 1. .00 19. .09 A c
ATOM 2295 CB VAL A 298 -7. .981 -64. 544 -18. .074 1. .00 19. .27 A c
ATOM 2296 CGl VAL A 298 -8. .904 -64. 123 -19. .182 1. .00 18. .35 A c
ATOM 2297 CG2 VAL A 298 -8. .752 -65. 155 -16. .892 1. .00 17. .14 A c
ATOM 2298 C VAL A 298 -6. .069 -66. 035 -17. .372 1. .00 20. .71 A c
ATOM 2299 o VAL A 298 -5. .776 -65. 201 -16. .456 1. .00 21. .47 A o
ATOM 2300 N GLY A 299 -5. .710 -67. 337 -17. .362 1. .00 18. .91 A N
ATOM 2301 CA GLY A 299 -4. .856 -67. 900 -16. .345 1. .00 18. .24 A c
ATOM 2302 C GLY A 299 -5. .536 -68. 500 -15. .113 1. .00 19. .14 A c
ATOM 2303 o GLY A 299 -4. .903 -68. 602 -14. .071 1. .00 19. .70 A o
ATOM 2304 N LEU A 300 -6. .801 -68. 912 -15. .215 1. .00 19. .37 A N
ATOM 2305 CA LEU A 300 -7..579 -69.370 -14..049 1..00 19..59 A C
ATOM 2306 CB LEU A 300 -8. .594 -68. 309 -13. .572 1. .00 18. .80 A C
ATOM 2307 CG LEU A 300 -8. .010 -67. 213 -12. .664 1. .00 20. .17 A c
ATOM 2308 CDl LEU A 300 -8. .820 -65. 889 -12. .682 1. .00 14. .68 A c
ATOM 2309 CD 2 LEU A 300 -7. .730 -67. 747 -11. .152 1. .00 15. .80 A c
ATOM 2310 c LEU A 300 -8. .321 -70. 657 -14. .342 1. .00 20. .21 A c
ATOM 2311 o LEU A 300 -8. .607 -70. 984 -15. .546 1. .00 19. .40 A o
ATOM 2312 OXT LEU A 300 -8. .659 -71. 329 -13. .331 1. .00 19. .54 A o
ATOM 2313 ZN ZN A 325 -18. .474 -49. 581 -10. .110 1. .00 26. .57 A ZN
ATOM 2314 CA CA A 326 -20. .141 -49. 094 -24. .614 1. .00 21. .37 A CA
ATOM 2315 CA CA A 327 -21. .620 -47. 425 -27. .379 1. .00 13. .56 A CA
ATOM 2316 08 BTB A 401 -25. .754 -64. 686 -4. .944 1. .00 33. .84 o
ATOM 2317 C8 BTB A 401 -27. .177 -64. 941 -4. .724 1. .00 49. .20 C
ATOM 2318 C7 BTB A 401 -27. .961 -64. 219 -3. .595 1. .00 48. .31 C
ATOM 2319 N BTB A 401 -28. .068 -65. 122 -2. .424 1. .00 50. .93 N
ATOM 2320 C5 BTB A 401 -29. .458 -65. 487 -2. .106 1. .00 53. .08 C
ATOM 2321 C6 BTB A 401 -30. .027 -64. 461 -1. .056 1. .00 54. .37 C
ATOM 2322 06 BTB A 401 -29. .100 -63. 396 -0. .674 1. .00 51. .50 o
ATOM 2323 C2 BTB A 401 -26. .911 -65. 600 -1. .545 1. .00 50. .97 c
ATOM 2324 C4 BTB A 401 -25. .924 -64. 439 -1. .315 1. .00 49. .99 c
ATOM 2325 04 BTB A 401 -25. .290 -64. 470 -0. .033 1. .00 50. .81 o
ATOM 2326 C3 BTB A 401 -26. .124 -66. 761 -2. .205 1. .00 49. .77 c
ATOM 2327 03 BTB A 401 -25. .471 -67. 594 -1. .239 1. .00 49. .48 o
ATOM 2328 Cl BTB A 401 -27. .471 -66. 012 -0. .165 1. .00 51. .74 c
ATOM 2329 01 BTB A 401 -28. .588 -66. 951 -0. .241 1. .00 51. .00 o
ATOM 2330 o HOH C 2 -2. .711 -67. 592 -19. .132 1. .00 29. .87 o
ATOM 2331 o HOH C 3 -16. .211 -62. 592 -15. .497 1. .00 13. .75 o
ATOM 2332 o HOH c 5 -13. .080 -72. 566 -9. .617 1. .00 25. .61 o
ATOM 2333 o HOH c 6 -12. .806 -53. 340 -28. .915 1. .00 18. .86 o
ATOM 2334 o HOH c 7 -2. .312 -58. 186 -18. .387 1. .00 21. .39 o
ATOM 2335 o HOH c 8 -17. .631 -66. 593 -17. .691 1. .00 14. .22 o
ATOM 2336 o HOH c 9 -35. .936 -48. 250 -3. .867 1. .00 19. .09 o
ATOM 2337 o HOH c 10 -20. .260 -73. 864 -26. .521 1. .00 21. .53 o
ATOM 2338 o HOH c 11 -7. .569 -64. 056 -22. .670 1. .00 16. .33 o
ATOM 2339 o HOH c 12 -41. .422 -26. 102 -22. .458 1. .00 36. .88 o
ATOM 2340 o HOH c 13 -2. .583 -67. 718 -13. .855 1. .00 19. .81 o
ATOM 2341 o HOH c 14 -42. .378 -48. 644 -20. .422 1. .00 24. .29 o
ATOM 2342 o HOH c 15 -40. .574 -61. 262 -18. .180 1. .00 38. .06 o
ATOM 2343 o HOH c 16 -30. .259 -66. 532 -15. .709 1. .00 21. .74 o
ATOM 2344 o HOH c 17 -28. .285 -38. 912 -27. .320 1. .00 17. .16 o
ATOM 2345 o HOH c 18 -32. .187 -62. 257 -7. .228 1. .00 16. .83 o
ATOM 2346 o HOH c 19 -25. .078 -44. 158 -23. .968 1. .00 14. .65 o
ATOM 2347 o HOH c 20 -23. .895 -46. 936 -23. .545 1. .00 16. .14 o
ATOM 2348 o HOH c 21 -41. .667 -48. 219 -7. .746 1. .00 34. .18 o
ATOM 2349 o HOH c 22 -40. .068 -48. 275 -3. .726 1. .00 19. .95 o
ATOM 2350 o HOH c 23 -35. .010 -62. 824 -11. .601 1. .00 26. .66 o
ATOM 2351 o HOH c 24 -13. .021 -76. 519 -21. .028 1. .00 30. .07 o
ATOM 2352 o HOH c 25 -19. .087 -36. 433 -24. .374 1. .00 34. .42 o
ATOM 2353 o HOH c 26 -24. .793 -80. 040 -12. .678 1. .00 29. .84 o
ATOM 2354 o HOH c 27 -30. .660 -63. 583 -22. .716 1. .00 19. .99 o
ATOM 2355 o HOH c 28 -24. .403 -76. 833 -24. .011 1. .00 25. .02 o
ATOM 2356 o HOH c 29 -1. .256 -55. 688 -17. .362 1. .00 25. .31 o
ATOM 2357 o HOH c 30 -31. .120 -63. 745 -5. .118 1. .00 25. .53 o
ATOM 2358 o HOH c 31 -32. .816 -71. 675 -9. .104 1. .00 42. .94 o
ATOM 2359 o HOH c 32 -25. .511 -47. 418 -25. .772 1. .00 30. .04 o
ATOM 2360 o HOH c 33 2. .080 -61. 199 -7. .018 1. .00 32. .19 o
ATOM 2361 o HOH c 34 -10. .798 -60. 304 0. .807 1. .00 34. .30 o
ATOM 2362 o HOH c 35 -13. .969 -52. 276 -13. .493 1. .00 22. .29 o
ATOM 2363 o HOH c 36 -26. .801 -37. 860 -24. .720 1. .00 24. .12 o
ATOM 2364 o HOH c 37 -20. .776 -45. 215 -22. .957 1. .00 21. .88 o
ATOM 2365 o HOH c 38 1. .055 -57. 909 -10. .764 1. .00 16. .66 o
ATOM 2366 o HOH c 39 -32. .697 -59. 896 -4. .934 1. .00 23. .95 o
ATOM 2367 o HOH c 40 -33. .179 -53. 385 -12. .401 1. .00 27. .60 o
ATOM 2368 o HOH c 41 -7. .976 -52. 645 -29. .054 1. .00 32. .74 o
ATOM 2369 o HOH c 42 -24. .307 -79. 767 -24. .391 1. .00 35. .33 o
ATOM 2370 o HOH c 43 -38. .839 -42. 447 -20. .245 1. .00 21. .37 o
ATOM 2371 o HOH c 44 -52. .198 -32. 387 -13. .024 1. .00 34. .97 o
ATOM 2372 o HOH c 45 -33. .718 -45. 777 -6. .287 1. .00 21. .53 o
ATOM 2373 o HOH c 46 -5. .504 -62. 986 -21. .066 1. .00 33. .17 o
ATOM 2374 o HOH c 47 -18. .734 -64. 795 2. .288 1. .00 34. .55 o
ATOM 2375 o HOH c 48 -24. .367 -38. 933 -24. .187 1. .00 26. .39 o
ATOM 2376 o HOH c 49 -43. .788 -47. 175 -13. .701 1. .00 27. .38 o
ATOM 2377 o HOH c 50 -26. .131 -66. 593 -26. .975 1. .00 31. .01 o
ATOM 2378 o HOH c 51 -22. .554 -53. 372 -4. .818 1. .00 25. .37 o
ATOM 2379 o HOH c 52 -38. .611 -43. 353 -22. .739 1. .00 28. .58 o
ATOM 2380 o HOH c 53 1. .781 -56. 450 -8. .391 1. .00 20. .44 o
ATOM 2381 o HOH c 54 -9. .763 -51. 219 -19. .497 1. .00 21. .78 o
ATOM 2382 o HOH c 55 -35. .947 -54. 526 -13. .693 1. .00 29. .02 o
ATOM 2383 o HOH c 56 -34. .353 -65. 294 -14. .056 1. .00 32. .29 o
ATOM 2384 o HOH C 57 0..430 -61..703 -8..963 1..00 31..79 o
ATOM 2385 o HOH C 58 -46. .066 -43. .418 -20. .148 1. .00 39. .75 o
ATOM 2386 o HOH C 59 -9. .719 -55. .069 -28. .478 1. .00 22. .91 o
ATOM 2387 o HOH C 60 -11. .594 -47. .814 -26. .606 1. .00 28. .37 o
ATOM 2388 o HOH C 61 -27. .425 -59. .413 -0. .115 1. .00 30. .47 o
ATOM 2389 o HOH C 62 -25. .237 -34. .589 -13. .754 1. .00 25. .20 o
ATOM 2390 o HOH C 63 -24. .889 -76. .446 -26. .846 1. .00 39. .30 o
ATOM 2391 o HOH C 64 -28. .189 -67. .960 -28. .520 1. .00 9. .69 o
ATOM 2392 o HOH C 65 2. .279 -57. .488 -13. .341 1. .00 22. .09 o
ATOM 2393 o HOH C 66 -9. .170 -66. .952 -6. .893 1. .00 17. .86 o
ATOM 2394 o HOH C 67 -18. .314 -47. .411 -9. .661 1. .00 20. .32 o
ATOM 2395 o HOH C 68 -31. .399 -68. .090 -23. .976 1. .00 28. .09 o
ATOM 2396 o HOH C 69 -12. .106 -51. .680 -27. .036 1. .00 14. .12 o
ATOM 2397 o HOH C 70 -17. .481 -60. .702 -14. .176 1. .00 25. .54 o
ATOM 2398 o HOH C 71 -1. .207 -68. .518 -16. .338 1. .00 21. .45 o
ATOM 2399 o HOH C 72 -40. .653 -60. .453 -10. .248 1. .00 45. .50 o
ATOM 2400 o HOH C 73 -17. .827 -46. .310 -13. .499 1. .00 31. .29 o
ATOM 2401 o HOH C 74 -23. .273 -80. .385 -17. .437 1. .00 38. .60 o
ATOM 2402 o HOH C 75 -11. .710 -54. .235 -18. .487 1. .00 12. .63 o
ATOM 2403 o HOH C 76 -37. .268 -63. .184 -10. .316 1. .00 34. .47 o
ATOM 2404 o HOH C 77 -40. .855 -53. .336 -19. .367 1. .00 40. .20 o
ATOM 2405 o HOH C 78 -15. .231 -52. .071 -29. .251 1. .00 14. .34 o
ATOM 2406 o HOH C 79 -18. .374 -75. .243 -10. .951 1. .00 32. .51 o
ATOM 2407 o HOH C 80 -8. .556 -71. .510 -23. .158 1. .00 27. .00 o
ATOM 2408 o HOH c 81 -39. .663 -31. .157 -5. .844 1. .00 41. .74 o
ATOM 2409 o HOH c 82 -27. .219 -53. .428 -26. .557 1. .00 32. .84 o
ATOM 2410 o HOH c 83 -14. .922 -49. .381 -29. .521 1. .00 26. .74 o
ATOM 2411 o HOH c 84 -9. .883 -70. .265 -25. .549 1. .00 31. .60 o
ATOM 2412 o HOH c 85 -6. .047 -71. .565 -22. .212 1. .00 27. .12 o
ATOM 2413 o HOH c 86 -4. .894 -73. .457 -20. .619 1. .00 24. .66 o
ATOM 2414 o HOH c 87 -9. .284 -61. .962 -2. .485 1. .00 18. .79 o
ATOM 2415 o HOH c 88 -22. .712 -48. .116 -28. .995 1. .00 23. .45 o
ATOM 2416 o HOH c 89 -20. .620 -51. .414 -24. .485 1. .00 19. .66 o
ATOM 2417 o HOH c 90 -23. .556 -62. .487 -29. .443 1. .00 22. .98 o
ATOM 2418 o HOH c 91 -20. .711 -46. .214 -28. .623 1. .00 18. .98 o
ATOM 2419 o HOH c 92 -8. .725 -56. .266 -6. .821 1. .00 31. .39 o
ATOM 2420 o HOH c 93 -22. .021 -55. .134 -9. .353 1. .00 26. .24 o
ATOM 2421 o HOH c 94 -23. .737 -28. .744 -1. .310 1. .00 41. .74 o
ATOM 2422 o HOH c 95 -6. .811 -49. .921 -8. .253 1. .00 35. .42 o
ATOM 2423 o HOH c 96 -25. .425 -53. .168 -35. .560 1. .00 24. .85 o
ATOM 2424 o HOH c 97 -31. .444 -62. .742 -2. .659 1. .00 35. .46 o
ATOM 2425 o HOH c 98 -6. .736 -58. .471 -24. .600 1. .00 38. .37 o
ATOM 2426 o HOH c 99 -28. .262 -30. .941 -18. .263 1. .00 25. .36 o
ATOM 2427 o HOH c 100 -25. .294 -36. .174 -16. .058 1. .00 28. .89 o
ATOM 2428 o HOH c 101 -34. .158 -41. .383 -12. .513 1. .00 36. .88 o
ATOM 2429 o HOH c 102 -20. .678 -59. .982 -28. .773 1. .00 32. .58 o
ATOM 2430 o HOH c 103 -23. .104 -45. .976 -26. .531 1. .00 19. .37 o
ATOM 2431 o HOH c 104 -14. .860 -50. .263 -12. .303 1. .00 37. .60 o
ATOM 2432 o HOH c 105 -21. .078 -29. .119 -12. .350 1. .00 40. .95 o
ATOM 2433 o HOH c 106 -38. .049 -43. .845 -18. .170 1. .00 28. .92 o
ATOM 2434 o HOH c 107 -20. .238 -77. .224 -12. .325 1. .00 29. .15 o
ATOM 2435 o HOH c 108 -1. .438 -48. .204 1. .601 1. .00 28. .53 o
ATOM 2436 o HOH c 109 -5. .758 -57. .592 -3. .844 1. .00 37. .72 o
ATOM 2438 o HOH c 111 -36. .779 -29. .048 -13. .433 1. .00 33. .74 o
ATOM 2439 o HOH c 112 -31. .245 -68. .295 -13. .382 1. .00 27. .31 o
ATOM 2440 o HOH c 113 -4. .425 -45. .328 2. .720 1. .00 36. .16 o
ATOM 2441 o HOH c 114 -13. .705 -60. .485 1. .229 1. .00 34. .26 o
ATOM 2442 o HOH c 115 -21. .165 -32. .036 -10. .846 1. .00 44. .52 o
ATOM 2444 o HOH c 117 -38. .547 -52. .247 -2. .195 1. .00 23. .00 o
END
EXAMPLE 6
Comparison of NprE variant structure with Thermolysin
A structure based sequence alignment of NprE variant with other metalloproteases is shown in Figure 12. Mature protein sequences of metalloproteases Thermolysin (Bacillus thermoproteolyticus, protein 1), PbaProl (Paenibacillus barcinonensis, protein 1), PhuProl (Paenibacillus hunanensis, protein 1), PhuPro2 (Paenibacillus hunanensis, protein 2), PehProl
((Paenibacillus ehimensis, protein 1, Pehl.A crystal structure) , PpoProl (Paenibacillus polymyxa, protein 1), PspPro3 (Paenibacillus sp., protein 3), and PspPro2 (Paenibacillus sp., protein 2), and BbrProl (Brevibacillus brevis, protein 1) were aligned with sequences of known Paenibacillus metalloproteases from P. polymyxa (PpoPro2, YP_003872179.1), P. peoriae (PpeProl, ZP_10241029.1), P. terrae (PteProl, F5LRG4) and known neutral protease homologs 1NPC.A (Bacillus cereus metalloprotease) and 1 KEI.A (Thermolysin, Bacillus
thermoproteolyticus) . This alignment shows that the NprE variant shares a common deletion with PehProl and PpoPro2 relative to Thermolysin (pdb entry 1KEI).
In the sequence of native NprE and NprE variant (shown), this five residue deletion occurs after residue Asp 178 (NprE numbering). Seven residues in Thermolysin are replaced by Thrl79- Glul80 of NprE. In addition, NprE variant manifests three other deletions, a 3-residues deletion after Serl91, a 10-residues deletion after Thr243 and a 2-residues deletion after Gly284, and three insertions of two residues after Lys33, one residue after Tyr49 and four residues after Pro217 (NprE numbering) not common with PehProl and PpoPro2. Nevertheless, the overall topology between NprE variant and Thermolysin is highly conserved as shown in Figure 16, and also conserved in PehProl and PpoPro2 (not shown).
EXAMPLE 7
Differences in Calcium Binding sites between various metalloproteases
In the electron density from the crystal of the NprE variant, there is density for two calcium ions, corresponding to Cal,2 (the double calcium in Thermolysin described above). There is no electron density for calcium ions at sites Ca3 or Ca4 that are seen in Thermolysin. Note that the Ca4 site is conserved in both PehProl and PpoPro2, and the Ca3 site is also seen in the PpoPro2 structure as noted previously.
In the vicinity of the Thermolysin double calcium site (Cal,2) the structure of the NprE variant retains a similar binding pattern as shown in Figure 13. Despite having similar deletions as seen in PehProl and PpoPro2, the constellation of ligands is with one exception maintained by the presence of Aspl81 which along with Glul86 (NprE numbering) forms ligands to both calcium ions. The single exception is that the carbonyl O of residue 183 in Thermolysin is absent owing to the deletion that is present in the NprE and common to PehProl and PpoPro2 structures. The carboxylates of Asp 185 and Glul90 in Thermolysin form ligands to both calcium ions in Thermolysin and this pattern is retained in NprE with Aspl81 and Glul86.
Referring back to Figure 9, the difference in calcium binding seen between Thermolysin, NprE variant, PpoPro2 and PehProl can be attributed to the specific sequence differences as
well as the presence of the five residue deletion. In Thermolysin, the Cal-2 site is created by six ligands, while in NprE five of these ligands are retained, the last being removed due to the five residue deletion. Specifically, Aspl81 in NprE and Asp 185 in Thermolysin are replaced by Asnl73 in PehProl and PpoPro2, Glu 186 in NprE and Glul90 in Thermolysin are replaced by Asnl78 in PehProl and PpoPro2 (PehProl or PpoPro2 numbering, mature sequence). This deletion in PehProl and PpoPro2 removes three potential ligands. In addition, there is the removal of a main chain carbonyl (Asnl83 in Thermolysin) and the presence of a new ligand (Asp 129) in PehProl and PpoPro2 results in an altered calcium binding site in the PehProl and PpoPro2 enzyme structures, instead of the previously observed double site Cal-2. In PehProl and PpoPro2, Asp 129 replaces Gly and Ser found in Thermolysin and the NprE variant respectively. This site in PehProl and PpoPro2 has effectively been re-sculpted to form a single Ca binding site arising from the reduction of six to four calcium ligands.
It is interesting that with the replacement of Asp57 and Asp59 (thermolysin numbering) in PehProl the DxD motif present in the majority of the M4 metallopro tease is now replaced by SSS/N at the "Ca3" site andPehProl does not have calcium binding at this site (Figure 7 and Figure 11). While the main chain conformation is conserved at the DxD site, aspartic acids at these positions are replaced with serine residues in PehProl. In the structure of the NprE variant (Figure 14), although the main chain conformation is again conserved, the aspartic acid residues observed in Thermolysin are now replaced by Ser and Thr residues, and calcium binding is absent.
From multiple sequence alignment shown in Figure 12, it is apparent that based on the presence of the DxD motif (the Ca3 site in Thermolysin and the third calcium site in PpoPro2), there seem to be different subsets of metallopro teases. Metalloproteases that have the DxD motif are exemplified by Thermolysin, the Bacillus cereus neutral protease and PpoPro2, while those that do not have the DxD motif have members such as PehProl and NprE. We see that several of proteases that contain the double delete lack the DxD motif (Figure 15- blowup of Figure 12).
Thermolysin, PpoPro2 and PehProl all share one common Ca binding site, the Ca4 site in Thermolysin (See Figures 6 and 10). In the NprE variant, this site is absent owing to a deletion of three residues following Serl91 in the NprE variant relative to Thermolysin, PehProl and PpoPro2. A comparison of the structure of Thermolysin and the NprE variant are shown in Figure 17.
EXAMPLE 8
Strategy to eliminate calcium dependence in metalloproteases
The fundamental teaching derived from attempts to remove calcium from proteases such as subtilisin and Thermolysin is that removal of calcium is detrimental to stability folding and function of these enzymes. However, to use these proteases in detergents, one desires that the proteases function in a low calcium environment. Presence of calcium in high concentration is considered undesirable as it affects the hardness of water. Detergent manufacturers add chelating agent to remove dissolved calcium. Not wishing to be bound by theory, it is proposed that calcium dependence may be a primary contributor to the instability of metalloproteases, such as Thermolysin, in detergent solutions. Thus, a metalloprotease that requires less calcium for folding and stability would likely be more stable in detergent formulations.
One approach would be to begin with an enzyme that naturally had fewer calcium ions bound such as those manifesting the pattern of double delete metalloproteases or one lacking DxD motif.
In one embodiment, the strategy for removing the Thermolysin Ca4 calcium would follow the homology seen for NprE, namely, to replace residues at sites equivalent to residues 193-200 (YTPGISGD (SEQ ID NO: 17)) in Thermolysin with the sequence TISQP (SEQ ID NO: 18) present in NprE resulting in a three residue deletion.
The strategy for removing the site corresponding to Ca3 in Thermolysin would be to replace residues at sites equivalent to residues 55-66 (WADADNQFFASY (SEQ ID NO: 19)) in Thermolysin with either a sequence replacing the DxD motif (i.e. WASSSNQFFASY (SEQ ID NO:20)) or replacing the DxD motif in Thermolysin along with the PehProl type deletion (i.e. LTSSSNIWN (SEQ ID NO:21)).
The strategy for removing the double calcium site in Thermolysin (Cal,2) could be staged, first to replace the double site with a single site as found in PehProl and PpoPro2.
Replacing the residues in Thermolysin at sites equivalent to residues 177-185 (EFYANKNPD (SEQ ID NO:22)) with DGKN (SEQ ID NO:23) in PehProl (resulting in a five residue deletion) along with the substitutions of the residue equivalent to Thermolysin position 136 (G) with Asp and Thermolysin position 190 (E) to Asp would result in the loss of one calcium.
To replace the remaining calcium ion, one additional step would be to replace the residue equivalent to Thermolysin position 136 with Lys or Arg so as to stabilize the negative charge present at the position equivalent to position 190 now an Asp. An additional step may be
required to replace the residues equivalent to Thermolysin residues 177 (now Asp from above) to Asn or Ser and Thermolysin 138 (Asp) to Ser.
PROTEIN SEQUENCES FOR SEQUENCE LISTING:
PehProl (Paenibacillus ehimensis, protein 1 )
ATGTGKGVLGDTKSFTTTQSGSTYQLKDTTRGQGIVTYSAGNRSSLPGTLLTSSSNIWN
DGAAVDAHAYTAKVYDYYKNKFGRNSIDGNGFQLKSTVHYSSRYNNAFWNGVQMV
YGDGDGVTFIPFSADPDVIGHELTHGVTEHTAGLEYYGESGALNESISDIIGNAIDGKNW
LIGDLIYTPNTPGDALRSMENPKLYNQPDRYQDRYTGPSDNGGVHINSGINNKAFYLIA
QGGTHYGVTVNGIGRDAAVQIFYDALINYLTPTSNFSAMRAAAIQAATDLYGANSSQV
NAVKKAYTAVGVN (SEQ ID NO: l)
PbaProl (Paenibacillus barcinonensis, protein 1)
ATGTGTGVHGDTKTLTTTQSGSTYQLKDTTRGKGIQTYTANNRSSLPGSLSTSSNNVWT
DRAAVDAHAYAAATYDFYKNKFNRNGIDGNGLLIRSTVHYGSNYKNAFWNGAQIVYG
DGDGIEFGPFSGDLDVVGHELTHGVIEYTANLEYRNEPGALNEAFADIMGNTIESKNWL
LGDGIYTPNIPGDALRSLSDPTLYNQPDKYSDRYTGSQDNGGVHINSGIINKAYYLAAQ
GGTHNGVTVSGIGRDKAVRIFYSTLVNYLTPTSKFAAAKTATIQAAKDLYGANSAEAT
AFTKAYQAVGL (SEQ ID NO:2)
PhuProl (Paenibacillus hunanensis, protein 1 )
ATGTGKGVLGDTKSFTVGTSGSSYVMTDSTRGKGIQTYTASNRTSLPGSTVTSSSSTFN
DPASVDAHAYAQKVYDFYKSNFNRNSIDGNGLAIRSTTHYSTRYNNAFWNGSQMVYG
DGDGSQFIAFSGDLDVVGHELTHGVTEYTANLEYYGQSGALNESISDIFGNTIEGKNWM
VGDAIYTPGVSGDALRYMDDPTKGGQPARMADYNNTSADNGGVHTNSGIPNKAYYLL
AQGGTFGGVNVTGIGRSQAIQIVYRALTYYLTSTSNFSNYRSAMVQASTDLYGANSTQT
TAVKNSLSAVGIN (SEQ ID NO:3)
PpoPro2 (Paenibacillus polymyxa, protein 2)
ATGTGKGVLGDTKSFTTTASGSSYQLKDTTRGNGIVTYTASNRQSIPGTLLTDADNVWNDPAGV DAHAYAAKTYDYYKSKFGRDSVDGRGLQLRSTVHYGSRYNNAFWNGSQMTYGDGDGSTFIAF SGDPDVVGHELTHGVTEYTSNLEYYGESGALNEAFSDVIGNDIQRKNWLVGDDIYTPNIAGDAL RSMSNPTLYDQPDHYSNLYKGSSDNGGVHTNSGIINKAYYLLAQGGTFHGVAVNGIGRDAAVQ IYYSAFTNYLTSSSDFSNARAAVIQAAKDLYGANSAEATAAAKSFDAVGVN (SEQ ID NO:4)
PpoProl (Paenibacillus polymyxa, protein 1 )
ATGTGKGVLGDSKSFTTTASGSSYQLKDTTRGNGIVTYTASNRQSIPGTILTDADNVWN
DPAGVDAHAYAAKTYDYYKAKFGRNSIDGRGLQLRSTVHYGSRYNNAFWNGSQMTY
GDGDGSTFIAFSGDPDVVGHELTHGVTEYTSNLEYYGESGALNEAFSDVIGNDIQRKNW
LVGDDIYTPNIAGDALRSMSNPTLYDQPDHYSNLYRGSSDNGGVHTNSGIINKAYYLLA
QGGNFHGVTVNGIGRDAAVQIYYSAFTNYLTSSSDFSNARAAVIQAAKDLYGANSAEA
TAAAKSFDAVGVN (SEQ ID NO:5)
PamProl (Paenibacillus amylolyticus, protein 1 )
ATGTGTGVLGDTKTLTTTQSGSTFQLKDTTRGNGIQTYTANNGSSLPGSLLTDSDNVWT
DRAGVDAHAHAAATYDFYKNKFNRNGINGNGLLIRSTVHYGSNYNNAFWNGAQIVFG
DGDGTMFRSLSGDLDVVGHELTHGVIEYTANLEYRNEPGALNEAFADIFGNTIQSKNW
LLGDDIYTPNTPGDALRSLSNPTLYGQPDKYSDRYTGSQDNGGVHINSGIINKAYFLAA
QGGTHNGVTVTGIGRDKAIQIFYSTLVNYLTPTSKFAAAKTATIQAAKDLYGATSAEAT
AITKAYQAVGL (SEQ ID NO:6)
PhuPro2 (Paenibacillus hunanensis, protein 2)
ATGSGTGVLGDNKTFQTTLSGSTYQLKDTTRGNGIYTYTASNRTTIPGTLLTDADNVWT
DGAAVDAHTYAGKVYDFYKTKFGRNSLDGNGLLIRSSVHYSSRYNNAFWNGTQIVFG
DGDGSTFIPLSGDLDVVGHELSHGVIEYTSNLQYLNESGALNESYADVLGNSIQAKNWL
IGDDVYTPGISGDALRSMSNPTLYGQPDNYANRYTGSSDNGGVHTNSGITNKAFYLLA
QGGTQNGVTVAGIGRDAAVNIFYNTVAYYLTSTSNFAAAKNASIQAAKDLYGTGSSYV
TSVTNAFRAVGL (SEQ ID NO:7)
PspPro2 (Paenibacillus sp., protein 2)
ATGTGRGVDGKTKSFTTTASGNRYQLKDTTRSNGIVTYTAGNRQTTPGTILTDTDNVW
EDPAAVDAHAYAIKTYDYYKNKFGRDSIDGRGMQIRSTVHYGKKYNNAFWNGSQMT
YGDGDGSTFTFFSGDPDVVGHELTHGVTEFTSNLEYYGESGALNEAFSDIIGNDIDGTS
WLLGDGIYTPNIPGDALRSLSDPTRFGQPDHYSNFYPDPNNDDEGGVHTNSGIINKAYY
LLAQGGTSHGVTVTGIGREAAVFIYYNAFTNYLTSTSNFSNARAAVIQAAKDFYGADSL
AVTSAIQSFDAVGIK (SEQ ID NO: 8)
PspPro3 (Paenibacillus sp., protein 3)
ATGTGKGVLGDTKTFNTTASGSSYQLRDTTRGNGIVTYTASNRQSIPGTILTDADNVWN DPAGVDAHAYAAKTYDYYKEKFNRNSIDGRGLQLRSTVHYGNRYNNAFWNGSQMTY GDGDGTTFIAFSGDPDVVGHELTHGVTEYTSNLEYYGESGALNEAFSDIIGNDIQRKNW LVGDDIYTPRIAGDALRSMSNPTLYDQPDHYSNLYRGSSDNGGVHTNSGIINKAYYLLA QGGTFHGVTVNGIGRDAAVQIYYSAFTNYLTSSSDFSNARDAVVQAAKDLYGASSAQA TAAAKSFDAVGVN (SEQ ID NO:9)
PpeProl (Paenibacillus peoriae, protein 1 )
ATGTGRGVDGVTKSFTTTASGNGYQLKDTTRSNGIVTYTANNRQTTPGTIMTDADNVWNDPAA VDAHAYAIKTYDYYKNKFGRDSIDGRGMQIRSTVHYGKKYVNAFWNGSQMTYGDGDGSTFTF FSGDPDVVGHELTHGVTEFTSNLEYYGESGALNEAFSDIIGNDIDGANWLLGDGIYTPGIPGDAL RSLSDPTRFGQPDHYSNFYPDPNNDDEGGVHTNSGIINKAYYLLAQGGTSHGVKVTGIGREAAV FIYYNAFTNYLTSTSNFSNARAAVIQAAKDFYGADSLAVTSAIKSFDAVGIK (SEQ ID NO: 10)
PteProl (Paenibacillus terrae, protein 1 )
ATGTGVGVLGDTKTFTTTQSGTQYVMQDTTRGGGIVTYSAGNTQSLPGTLMRDTDNV
WTDPAAVDAHAYAAVVYDYFKNNFNRDSLDGRGMAIKSTVHYGSRYNNAFWNGTQI
AYGDGDGTTFRAFSGDLDVIGHELTHGITEKTAGLIYQGESGALNESISDVFGNTIQGKN
WLIGDDIYTPSIPGDALRSMENPTLFNQPDHYSNIYRGSDDNGGVHTNSGIPNKAFYLLA
QGGTHRGVSVTGIGRGDAAKIVYKALTYYLTSTSNFAAMRQAAISSATDLFGANSAQV
NSVKAAYAAVGI (SEQ ID NO: 11)
BbrProl (Brevibacillus brevis, protein 1 )
VTATGKGVLGDTKQFETTKQGSTYMLKDTTRGKGIETYTANNRTSLPGTLMTDSDNY
WTDGAAVDAHAHAQKTYDYFRNVHNRNSYDGNGAVIRSTVHYSTRYNNAFWNGSQ
MVYGDGDGTTFLPLSGGLDVVAHELTHAVTERTAGLVYQNESGALNESMSDIFGAMV
DNDDWLMGEDIYTPGRSGDALRSLQDPAAYGDPDHYSKRYTGSQDNGGVHTNSGINN
KAAYLLAEGGTHYGVRVNGIGRTDTAKIYYHALTHYLTPYSNFSAMRRAAVLSATDLF
GANSRQVQAVNAAYDAVGVK (SEQ ID NO: 12)
1KEI.A (H niii:s thermoproteolyticus, thermi ysin)
ITGTSTVGVGRGVLGDQKNINTTYSTYYYLQDNTRGNGIFTYDAKYRTTLPGSLWADA
DNQFFASYDAPAVDAHYYAGVTYDYYKNVHNRLSYDGNNAAIRSSVHYSQGYNNAF
WNGSQMVYGDGDGQTFIPLSGGIDVVAHELTHAVTDYTAGLIYQNESGAINEAISDIFG
TLVEFYANKNPDWEIGEDVYTPGISGDSLRSMSDPAKYGDPDHYSKRYTGTQDNGGVH
INSGIINKAAYLISQGGTHYGVSVVGIGRDKLGKIFYRALTQYLTPTSNFSQLRAAAVQS
ATDLYGSTSQEVASVKQAFDAVGVK (SEQ ID NO: 13)
1NPC.A (Bacillus cereus)
VTGTNKVGTGKGVLGDTKSLNTTLSGSSYYLQDNTRGATIFTYDAKNRSTLPGTLWAD
ADNVFNAAYDAAAVDAHYYAGKTYDYYKATFNRNSINDAGAPLKSTVHYGSNYNNA
FWNGSQMVYGDGDGVTFTSLSGGIDVIGHELTHAVTENSSNLIYQNESGALNEAISDIFG
TLVEFYDNRNPDWEIGEDIYTPGKAGDALRSMSDPTKYGDPDHYSKRYTGSSDNGGVH
TNSGIINKQAYLLANGGTHYGVTVTGIGKDKLGAIYYRANTQYFTQSTTFSQARAGAV
QAAADLYGANSAEVAAVKQSFSAVGVN (SEQ ID NO: 14)
NprE_var (Bacillus subtilis)
AATTGTGTTLKGKTVSLNISSESGKYVLRDLSKPTGTQIITYDLQNREYNLPGTLVSSTT
NQFTTSSQRAAVDAHYNLGKVYDYFYQKFNRNSYDNKGGKIVSSVHYGSRYNNAAWI
GDQMIYGDGDGILFSPLSGSLDVTAHEMTHGVTQETANLNYENQPGALNESFSDVFGY
FNDTEDWDIGEDITISQPALRSLSNPTKYGQPDNFKNYKNLPNTPAGDYGGVHTNSGIP
NKAAYNTITKIGVNKAEQIYYRALTVYLTPSSTFKDAKAALIQSARDLYGSQDAASVEA
AWNAVGL (SEQ ID NO: 15)
NprE (Bacillus subtilis)
AATTGTGTTLKGKTVSLNISSESGKYVLRDLSKPTGTQIITYDLQNREYNLPGTLVSSTT
NQFTTSSQRAAVDAHYNLGKVYDYFYQKFNRNSYDNKGGKIVSSVHYGSRYNNAAWI
GDQMIYGDGDGSFFSPLSGSMDVTAHEMTHGVTQETANLNYENQPGALNESFSDVFGY
FNDTEDWDIGEDITVSQPALRSLSNPTKYGQPDNFKNYKNLPNTDAGDYGGVHTNSGIP
NKAAYNTITKIGVNKAEQIYYRALTVYLTPSSTFKDAKAALIQSARDLYGSQDAASVEA
AWNAVGL (SEQ ID NO: 16)
Claims
A metalloprotease polypeptide comprising a calcium binding region.
The polypeptide of claim 1, wherein the polypeptide comprises a modification in at least one amino acid residue in one of the calcium binding regions, Cal-2, Ca3 and Ca4, (including residues 55-66, 136, 138, 177-190, and 193-200) of the polypeptide, wherein the amino acid positions of the polypeptide are numbered by correspondence with the amino acid sequence of Bacillus thermoproteolyticus metalloprotease set forth in SEQ ID NO: 13.
The polypeptide of claim 2, wherein the polypeptide comprises a modification in at least one amino acid residue in a calcium binding region 1-2 of residues 177-190, 136 and 138 of the polypeptide.
The polypeptide of any of the above claims, wherein the polypeptide comprises an amino acid at position 184 selected from the group consisting of lysine, threonine, alanine, glutamic acid and aspartic acid.
The polypeptide of any of the above claims, wherein the amino acid at position 185 is an amino acid other than aspartic acid.
The polypeptide of claim 5, wherein the amino acid at position 185 is a non-negatively charged residue.
The polypeptide of any of claims 5 or 6, wherein the amino acid at position 185 is a neutrally charged residue.
The polypeptide of any of claims 5-7, wherein the amino acid at position 185 is an asparagine or serine.
The polypeptide of any of the above claims, wherein the amino acid at position 187 is a non-negatively charged residue.
The polypeptide of claim 9, wherein the amino acid at position 187 is a neutrally charged residue.
The polypeptide of any of claims 9 or 10, wherein the amino acid at position 187 is a leucine or methionine.
The polypeptide of any of claims 1-8, wherein the amino acid at position 187 is an aspartic acid.
The polypeptide of any of the above claims, wherein the amino acid at position 188 is a leucine, valine or methionine.
14. The polypeptide of any of the above claims, wherein the amino acid at position 190 is a residue other than glutamic acid.
15. The polypeptide of claim 14, wherein the amino acid at position 190 is aspartic acid.
16. The polypeptide of any of the above claims, wherein the polypeptide comprises a
deletion at amino acid residue positions 179-183.
17. The polypeptide of any of the above claims, wherein the amino acid at position 177 is a neutrally charged residue or aspartic acid.
18. The polypeptide of any of the above claims, wherein the amino acid at position 177 is glutamine or aspartic acid.
19. The polypeptide of any of the above claims, wherein the amino acid at position 178 is a residue selected from the group consisting of glycine, serine, arginine, alanine, asparagine, and threonine.
20. The polypeptide of any of the above claims, wherein the amino acid at position 136 is an aspartic acid or serine.
21. The polypeptide of any of the above claims, comprising a modification in at least one amino acid residue in a calcium binding region 3 of residues 55-66, wherein the amino acid positions of the polypeptide are numbered by correspondence with the amino acid sequence of Bacillus thermoproteolyticus metalloprotease set forth in SEQ ID NO: 13.
22. The polypeptide of any of the above claims, wherein the amino acid at position 55 is a residue selected from the group consisting of leucine, serine, valine, and methionine.
23. The polypeptide of any of the above claims, wherein the amino acid at position 56 is a residue selected from the group consisting of serine, arginine and threonine.
24. The polypeptide of any of the above claims, wherein the amino acid at position 57 is a serine.
25. The polypeptide of any of the above claims, wherein the amino acid at position 58 is a serine or threonine.
26. The polypeptide of any of the above claims, wherein the amino acid at position 59 is a residue selected from the group consisting of serine, threonine, and asparagine.
27. The polypeptide of any of the above claims, wherein the amino acid at position 60 is a serine.
28. The polypeptide of any of the above claims, wherein the amino acid at position 61 is a residue selected from the group consisting of isoleucine, valine, and threonine.
29. The polypeptide of any of the above claims, wherein the amino acid at position 62 is a residue selected from the group consisting of tryptophan and phenylalanine.
30. The polypeptide of any of the above claims, wherein the amino acid at position 63 is a residue selected from the group consisting of asparagine, glutamic acid, and threonine.
31. The polypeptide of any of the above claims, wherein the polypeptide comprises a
deletion at amino acid residue positions 64-66.
32. The polypeptide of any of the above claims, comprising a modification in at least one amino acid residue in a calcium binding region 4 of residues 193-200, wherein the amino acid positions of the polypeptide are numbered by correspondence with the amino acid sequence of Bacillus thermoproteolyticus metalloprotease set forth in SEQ ID NO: 13.
33. The polypeptide of any of the above claims, wherein the amino acid at position 193 is a threonine.
34. The polypeptide of any of the above claims, wherein the amino acid at position 194 is an isoleucine.
35. The polypeptide of any of the above claims, wherein the amino acid at position 195 is a serine.
36. The polypeptide of any of the above claims, wherein the polypeptide comprises a
deletion at amino acid residue positions 196-198.
37. The polypeptide of any of the above claims, wherein the amino acid at position 199 is a glutamine.
38. The polypeptide of any of the above claims, wherein the amino acid at position 200 is a proline.
39. The polypeptide of any of the above claims, wherein the calcium binding region 1-2 binds fewer than two calcium ions.
40. The polypeptide of any of the above claims, wherein the calcium binding region 3 binds fewer than one calcium ion.
41. The polypeptide of any of the above claims, wherein the calcium binding region 4 binds fewer than one calcium ion.
42. The polypeptide of any of the previous claims, wherein the polypeptide is a variant of a parent polypeptide.
43. The polypeptide of claim 42, wherein the variant comprises a modification in a calcium binding region of the parent polypeptide.
44. The polypepide of claim 43, wherein the modification is to any of the amino acids listed in claims 4-38.
45. The polypeptide of any of the previous claims, wherein the parent polypeptide is an M4 metalloprotease.
46. The polypeptide of any of the previous claims, wherein the polypeptide has at least 60% sequence identity to the parent polypeptide.
47. The polypeptide of any of the previous claims, wherein the polypeptide has at least 60% sequence identity to any one of SEQ ID NOs: 1-15.
48. The polypeptide of any of the previous claims, wherein the polypeptide has at least 60% sequence identity to SEQ ID NOs: 13.
49. The polypeptide of any of the previous claims, wherein the polypeptide has
metalloprotease activity.
50. A composition comprising any of the polypeptides of claims 1-49.
51. The composition of claim 50, wherein said composition is a cleaning composition.
52. The composition of claim 51 , wherein said composition is a detergent composition.
53. The composition of claim 52, wherein said detergent composition is selected from the group consisting of a laundry detergent, a fabric softening detergent, a dishwashing detergent, and a hard-surface cleaning detergent.
54. The composition of any of claims 50 to 53, wherein said composition further comprises a
surfactant.
55. The composition of claim 54, wherein said surfactant is selected from the group consisting of an anionic surfactant, a cationic surfactant, a zwitterionic surfactant, a ampholytic surfactant, a semi-polar non-ionic surfactant, and a combination thereof.
56. The composition of claim 55, wherein said surfactant is an ionic surfactant.
57. The composition of claim 55, wherein said surfactant is a non-ionic surfactant.
58. The composition of any of claims 50-57, wherein said composition further comprises at least one stabilizer.
59. The composition of any of claims 50-58, wherein said composition comprises from about 0.001 to about 10 weight % of said polypeptide.
60. The composition of any of claims 50-59, further comprising at least one bleaching agent.
61. The composition of any of claims 50-60, wherein said cleaning composition is phosphate -free.
62. The composition of any of claims 50-60, wherein said cleaning composition contains phosphate.
63. The composition of any of claims 50-62, further comprising at least one adjunct ingredient.
64. The composition of any of claims 50-63, wherein said composition is a granular, powder, solid, bar, liquid, tablet, gel, unit dose or paste composition.
65. The composition of any of claims 50-64, further comprising one or more additional enzymes or enzyme derivatives selected from the group consisting of acyl transferases, alpha-amylases, beta- amylases, alpha-galactosidases, arabinosidases, aryl esterases, beta-galactosidases,
carrageenases, catalases, cellobiohydrolases, cellulases, chondroitinases, cutinases, endo-beta-1, 4-glucanases, endo-beta-mannanases, esterases, exo-mannanases, galactanases, glucoamylases, hemicellulases, hyaluronidases, keratinases, laccases, lactases, ligninases, lipases, lipoxygenases,
mannanases, oxidases, pectate lyases, pectin acetyl esterases, pectinases, pentosanases, peroxidases, phenoloxidases, phosphatases, phospholipases, phytases, polygalacturonases, proteases, pullulanases, reductases, rhamnogalacturonases, beta-glucanases, tannases, transglutaminases, xylan acetyl-esterases, xylanases, xyloglucanases, and xylosidases, additional metallopotease enzymes and combinations thereof.
66. The composition of any of claims 50-65, wherein said composition is formulated at a pH of from about 5.0 to about 12.0.
67. A method of cleaning, comprising contacting a surface or an item with a composition comprising the variant of any one of claims 1-49.
68. A method of cleaning comprising contacting a surface or an item with the composition of any one of claims 50-66.
69. The method of claim 67 or 68, further comprising rinsing said surface or item after contacting said surface or item, respectively, with said composition.
70. The method of any one of claims 67-69, wherein said item is dishware.
71. The method of any one of claims 67-70, wherein said item is fabric.
72. The method of any one of claims 67-71, further comprising the step of rinsing said surface or item after contacting said surface or item with said composition.
73. The method of claim 72, further comprising the step of drying said surface or item after said rinsing of said surface or item.
74. A method of cleaning a surface or item, comprising: providing the composition of any of claims 50-66 and a surface or item in need of cleaning; and contacting said composition with said surface or item in need of cleaning under conditions suitable for the cleansing of said surface of said surface or item, to produce a cleansed surface or item.
75. The method of claim 74, further comprising the step of rinsing said cleansed surface or item to produce a rinsed surface or item.
76. The method of any of claims 74 or 75, further comprising the step of drying said rinsed surface or item.
77. A method for producing the variant of any of claims 1-49 comprising:
a. stably transforming a host cell with an expression vector comprising a polynucleotide encoding the variant of any of claims 1-49;
b. cultivating said transformed host cell under conditions suitable for said host cell to
produce said protease; and
c. recovering said protease.
78. The method of claim 77, wherein said host cell is a filamentous fungus or bacterial cell.
79. The method of any of claims 77 or 78, wherein said host cell is selected from Bacillus spp., Streptomyces spp. , Escherichia spp., Aspergillus spp. , Trichoderma spp., Pseudomonas spp., Corynebacterium spp., Saccharomyces spp., or Pichia spp.
80. A textile processing composition comprising the variant of any one of claims 1-49.
81. An animal feed composition comprising the variant of any one of claims 1-49.
82. A leather processing composition comprising the variant of any one of claims 1-49.
83. A feather processing composition comprising the variant or recombinant polypeptide of any one of claims 1-49.
84. A lens cleaning composition comprising the variant of any one of claims 1-49.
85. A tissue debridement composition comprising the variant of any one of claims 1-49.
86. A tissue cell culture additive composition comprising the variant of any one of claims 1-49.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/893,440 US20160108387A1 (en) | 2013-05-29 | 2014-05-29 | Novel metalloproteases |
EP14737359.1A EP3004342B1 (en) | 2013-05-29 | 2014-05-29 | Novel metalloproteases |
CN201480042744.8A CN105452456A (en) | 2013-05-29 | 2014-05-29 | Novel metalloproteases |
JP2016516828A JP6367930B2 (en) | 2013-05-29 | 2014-05-29 | Novel metalloprotease |
US15/725,627 US20180073006A1 (en) | 2013-05-29 | 2017-10-05 | Novel metalloproteases |
US16/717,216 US20200115693A1 (en) | 2013-05-29 | 2019-12-17 | Novel metalloproteases |
US18/487,157 US20240229001A1 (en) | 2013-05-29 | 2023-10-16 | Novel metalloproteases |
Applications Claiming Priority (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013076415 | 2013-05-29 | ||
CNPCT/CN2013/076419 | 2013-05-29 | ||
CNPCT/CN2013/076415 | 2013-05-29 | ||
CNPCT/CN2013/076398 | 2013-05-29 | ||
CN2013076390 | 2013-05-29 | ||
CNPCT/CN2013/076384 | 2013-05-29 | ||
CN2013076406 | 2013-05-29 | ||
CN2013076387 | 2013-05-29 | ||
CN2013076414 | 2013-05-29 | ||
CN2013076369 | 2013-05-29 | ||
CNPCT/CN2013/076369 | 2013-05-29 | ||
CNPCT/CN2013/076383 | 2013-05-29 | ||
CN2013076383 | 2013-05-29 | ||
CNPCT/CN2013/076386 | 2013-05-29 | ||
CN2013076386 | 2013-05-29 | ||
CNPCT/CN2013/076414 | 2013-05-29 | ||
CN2013076401 | 2013-05-29 | ||
CNPCT/CN2013/076387 | 2013-05-29 | ||
CN2013076419 | 2013-05-29 | ||
CNPCT/CN2013/076401 | 2013-05-29 | ||
CN2013076398 | 2013-05-29 | ||
CNPCT/CN2013/076390 | 2013-05-29 | ||
CN2013076384 | 2013-05-29 | ||
CNPCT/CN2013/076406 | 2013-05-29 | ||
US201361874813P | 2013-09-06 | 2013-09-06 | |
US61/874,813 | 2013-09-06 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/893,440 A-371-Of-International US20160108387A1 (en) | 2013-05-29 | 2014-05-29 | Novel metalloproteases |
US15/725,627 Continuation US20180073006A1 (en) | 2013-05-29 | 2017-10-05 | Novel metalloproteases |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014194117A2 true WO2014194117A2 (en) | 2014-12-04 |
WO2014194117A3 WO2014194117A3 (en) | 2015-01-22 |
Family
ID=51168342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2014/040063 WO2014194117A2 (en) | 2013-05-29 | 2014-05-29 | Novel metalloproteases |
Country Status (4)
Country | Link |
---|---|
US (4) | US20160108387A1 (en) |
EP (1) | EP3004342B1 (en) |
JP (2) | JP6367930B2 (en) |
WO (1) | WO2014194117A2 (en) |
Cited By (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016069552A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016069569A2 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016069544A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016069557A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases of bacillus species |
WO2016069548A2 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016205755A1 (en) | 2015-06-17 | 2016-12-22 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
WO2017079756A1 (en) | 2015-11-05 | 2017-05-11 | Danisco Us Inc | Paenibacillus and bacillus spp. mannanases |
WO2017079751A1 (en) | 2015-11-05 | 2017-05-11 | Danisco Us Inc | Paenibacillus sp. mannanases |
WO2017106676A1 (en) | 2015-12-18 | 2017-06-22 | Danisco Us Inc | Polypeptides with endoglucanase activity and uses thereof |
WO2017192300A1 (en) | 2016-05-05 | 2017-11-09 | Danisco Us Inc | Protease variants and uses thereof |
WO2017192692A1 (en) | 2016-05-03 | 2017-11-09 | Danisco Us Inc | Protease variants and uses thereof |
WO2017210295A1 (en) | 2016-05-31 | 2017-12-07 | Danisco Us Inc. | Protease variants and uses thereof |
WO2017219011A1 (en) | 2016-06-17 | 2017-12-21 | Danisco Us Inc | Protease variants and uses thereof |
EP3275989A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275987A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275986A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275988A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275985A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2018085524A2 (en) | 2016-11-07 | 2018-05-11 | Danisco Us Inc | Laundry detergent composition |
EP3330348A1 (en) | 2016-12-02 | 2018-06-06 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2018102479A1 (en) | 2016-12-02 | 2018-06-07 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP3339423A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2018118917A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Protease variants and uses thereof |
WO2018118950A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
WO2018169750A1 (en) | 2017-03-15 | 2018-09-20 | Danisco Us Inc | Trypsin-like serine proteases and uses thereof |
WO2018184004A1 (en) | 2017-03-31 | 2018-10-04 | Danisco Us Inc | Alpha-amylase combinatorial variants |
CN109355222A (en) * | 2018-11-06 | 2019-02-19 | 上海交通大学 | There is the bacillus of antagonism to rice leaf spot bacteria and separate and apply |
WO2019036721A2 (en) | 2017-08-18 | 2019-02-21 | Danisco Us Inc | Alpha-amylase variants |
WO2019108599A1 (en) | 2017-11-29 | 2019-06-06 | Danisco Us Inc | Subtilisin variants having improved stability |
EP3502246A1 (en) | 2017-12-19 | 2019-06-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3502244A1 (en) | 2017-12-19 | 2019-06-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3502245A1 (en) | 2017-12-19 | 2019-06-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3502227A1 (en) | 2017-12-19 | 2019-06-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019168650A1 (en) | 2018-02-28 | 2019-09-06 | The Procter & Gamble Company | Methods of cleaning |
WO2019168649A1 (en) | 2018-02-28 | 2019-09-06 | The Procter & Gamble Company | Cleaning compositions |
WO2019245838A1 (en) | 2018-06-19 | 2019-12-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019245705A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
WO2019245839A1 (en) | 2018-06-19 | 2019-12-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019245704A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
WO2020028443A1 (en) | 2018-07-31 | 2020-02-06 | Danisco Us Inc | Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid |
WO2020068486A1 (en) | 2018-09-27 | 2020-04-02 | Danisco Us Inc | Compositions for medical instrument cleaning |
WO2020077331A2 (en) | 2018-10-12 | 2020-04-16 | Danisco Us Inc | Alpha-amylases with mutations that improve stability in the presence of chelants |
WO2020112599A1 (en) | 2018-11-28 | 2020-06-04 | Danisco Us Inc | Subtilisin variants having improved stability |
US10696958B2 (en) | 2013-05-29 | 2020-06-30 | Danisco Us Inc | Metalloproteases |
WO2020186052A1 (en) | 2019-03-14 | 2020-09-17 | The Procter & Gamble Company | Method for treating cotton |
WO2020186028A1 (en) | 2019-03-14 | 2020-09-17 | The Procter & Gamble Company | Cleaning compositions comprising enzymes |
WO2020186030A1 (en) | 2019-03-14 | 2020-09-17 | The Procter & Gamble Company | Cleaning compositions comprising enzymes |
EP3741283A1 (en) | 2019-05-22 | 2020-11-25 | The Procter & Gamble Company | Automatic dishwashing method |
WO2020242858A1 (en) | 2019-05-24 | 2020-12-03 | Danisco Us Inc | Subtilisin variants and methods of use |
WO2020243738A1 (en) | 2019-05-24 | 2020-12-03 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2020247582A1 (en) | 2019-06-06 | 2020-12-10 | Danisco Us Inc | Methods and compositions for cleaning |
WO2021081547A2 (en) | 2019-10-24 | 2021-04-29 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising a protease |
WO2021080948A2 (en) | 2019-10-24 | 2021-04-29 | Danisco Us Inc | Variant maltopentaose/maltohexaose-forming alpha-amylases |
WO2021081548A1 (en) | 2019-10-24 | 2021-04-29 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising an amylase |
EP3835396A1 (en) | 2019-12-09 | 2021-06-16 | The Procter & Gamble Company | A detergent composition comprising a polymer |
EP3862412A1 (en) | 2020-02-04 | 2021-08-11 | The Procter & Gamble Company | Detergent composition |
EP3872174A1 (en) | 2015-05-13 | 2021-09-01 | Danisco US Inc. | Aprl-clade protease variants and uses thereof |
WO2021247801A1 (en) | 2020-06-05 | 2021-12-09 | The Procter & Gamble Company | Detergent compositions containing a branched surfactant |
EP3950912A1 (en) | 2020-08-04 | 2022-02-09 | The Procter & Gamble Company | Automatic dishwashing method |
EP3949824A1 (en) | 2020-08-04 | 2022-02-09 | The Procter & Gamble Company | Automatic dishwashing method |
EP3950913A1 (en) | 2020-08-04 | 2022-02-09 | The Procter & Gamble Company | Automatic dishwashing method and pack |
EP3950911A1 (en) | 2020-08-04 | 2022-02-09 | The Procter & Gamble Company | Automatic dishwashing method |
WO2022047149A1 (en) | 2020-08-27 | 2022-03-03 | Danisco Us Inc | Enzymes and enzyme compositions for cleaning |
WO2022043745A1 (en) | 2020-08-28 | 2022-03-03 | Kerry Luxembourg S.a.r.l. | Feed composition supplemented with a protease combination comprising neutral metalloprotease and serine alkaline protease at a given ratio |
WO2022094163A1 (en) | 2020-10-29 | 2022-05-05 | The Procter & Gamble Company | Cleaning composition comprising alginate lyase enzymes |
EP4001387A1 (en) | 2020-11-17 | 2022-05-25 | The Procter & Gamble Company | Automatic dishwashing composition commprising amphiphilic graft polymer |
EP4001390A1 (en) | 2020-11-17 | 2022-05-25 | The Procter & Gamble Company | Automatic dishwashing method with alkaline rinse |
EP4001388A1 (en) | 2020-11-17 | 2022-05-25 | The Procter & Gamble Company | Automatic dishwashing method with amphiphilic graft polymer in the rinse |
EP4006131A1 (en) | 2020-11-30 | 2022-06-01 | The Procter & Gamble Company | Method of laundering fabric |
WO2022136389A1 (en) | 2020-12-23 | 2022-06-30 | Basf Se | Amphiphilic alkoxylated polyamines and their uses |
WO2022165107A1 (en) | 2021-01-29 | 2022-08-04 | Danisco Us Inc | Compositions for cleaning and methods related thereto |
EP4060010A2 (en) | 2021-03-15 | 2022-09-21 | The Procter & Gamble Company | Cleaning compositions containing polypeptide variants |
EP4086330A1 (en) | 2021-05-06 | 2022-11-09 | The Procter & Gamble Company | Surface treatment |
WO2022235720A1 (en) | 2021-05-05 | 2022-11-10 | The Procter & Gamble Company | Methods for making cleaning compositions and detecting soils |
EP4108767A1 (en) | 2021-06-22 | 2022-12-28 | The Procter & Gamble Company | Cleaning or treatment compositions containing nuclease enzymes |
WO2023278297A1 (en) | 2021-06-30 | 2023-01-05 | Danisco Us Inc | Variant lipases and uses thereof |
EP4123007A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Fabric treatment using bacterial spores |
EP4123006A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Composition comprising spores and pro-perfume materials |
WO2023034486A2 (en) | 2021-09-03 | 2023-03-09 | Danisco Us Inc. | Laundry compositions for cleaning |
WO2023064749A1 (en) | 2021-10-14 | 2023-04-20 | The Procter & Gamble Company | A fabric and home care product comprising cationic soil release polymer and lipase enzyme |
EP4194537A1 (en) | 2021-12-08 | 2023-06-14 | The Procter & Gamble Company | Laundry treatment cartridge |
EP4194536A1 (en) | 2021-12-08 | 2023-06-14 | The Procter & Gamble Company | Laundry treatment cartridge |
WO2023114794A1 (en) | 2021-12-16 | 2023-06-22 | The Procter & Gamble Company | Fabric and home care composition comprising a protease |
WO2023114792A1 (en) | 2021-12-16 | 2023-06-22 | The Procter & Gamble Company | Home care composition comprising an amylase |
WO2023114988A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Variant maltopentaose/maltohexaose-forming alpha-amylases |
WO2023114939A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114932A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114795A1 (en) | 2021-12-16 | 2023-06-22 | The Procter & Gamble Company | Automatic dishwashing composition comprising a protease |
WO2023114936A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114793A1 (en) | 2021-12-16 | 2023-06-22 | The Procter & Gamble Company | Home care composition |
WO2023168234A1 (en) | 2022-03-01 | 2023-09-07 | Danisco Us Inc. | Enzymes and enzyme compositions for cleaning |
EP4273210A1 (en) | 2022-05-04 | 2023-11-08 | The Procter & Gamble Company | Detergent compositions containing enzymes |
EP4273209A1 (en) | 2022-05-04 | 2023-11-08 | The Procter & Gamble Company | Machine-cleaning compositions containing enzymes |
EP4279571A1 (en) | 2022-05-19 | 2023-11-22 | The Procter & Gamble Company | Laundry composition comprising spores |
WO2023250301A1 (en) | 2022-06-21 | 2023-12-28 | Danisco Us Inc. | Methods and compositions for cleaning comprising a polypeptide having thermolysin activity |
CN117487724A (en) * | 2023-12-29 | 2024-02-02 | 东北林业大学 | Bacillus proteolyticus CWJ-2-GJ and application thereof |
EP4321604A1 (en) | 2022-08-08 | 2024-02-14 | The Procter & Gamble Company | A fabric and home care composition comprising surfactant and a polyester |
WO2024050339A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Mannanase variants and methods of use |
WO2024050343A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Subtilisin variants and methods related thereto |
WO2024050346A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Detergent compositions and methods related thereto |
WO2024094803A1 (en) | 2022-11-04 | 2024-05-10 | The Procter & Gamble Company | Fabric and home care composition |
WO2024094802A1 (en) | 2022-11-04 | 2024-05-10 | The Procter & Gamble Company | Fabric and home care composition |
WO2024094800A1 (en) | 2022-11-04 | 2024-05-10 | The Procter & Gamble Company | Fabric and home care composition |
WO2024102698A1 (en) | 2022-11-09 | 2024-05-16 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024119298A1 (en) | 2022-12-05 | 2024-06-13 | The Procter & Gamble Company | Fabric and home care composition comprising a polyalkylenecarbonate compound |
EP4386074A1 (en) | 2022-12-16 | 2024-06-19 | The Procter & Gamble Company | Fabric and home care composition |
WO2024129520A1 (en) | 2022-12-12 | 2024-06-20 | The Procter & Gamble Company | Fabric and home care composition |
EP4389864A1 (en) | 2022-12-20 | 2024-06-26 | Basf Se | Cutinases |
EP4388967A1 (en) | 2022-12-19 | 2024-06-26 | The Procter & Gamble Company | Dishwashing method |
EP4410941A1 (en) | 2023-02-01 | 2024-08-07 | The Procter & Gamble Company | Detergent compositions containing enzymes |
WO2024163584A1 (en) | 2023-02-01 | 2024-08-08 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024186819A1 (en) | 2023-03-06 | 2024-09-12 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024191711A1 (en) | 2023-03-16 | 2024-09-19 | Nutrition & Biosciences USA 4, Inc. | Brevibacillus fermentate extracts for cleaning and malodor control and use thereof |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111615559B (en) | 2018-01-16 | 2024-01-16 | 花王株式会社 | Keratin dirt cleaning agent and method for evaluating Keratin dirt decomposing ability |
AU2020272127B2 (en) | 2019-04-12 | 2022-12-08 | Ecolab Usa Inc. | Antimicrobial multi-purpose cleaner and methods of making and using the same |
WO2021085563A1 (en) * | 2019-10-30 | 2021-05-06 | 花王株式会社 | Leather improving agent |
Citations (163)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1296839A (en) | 1969-05-29 | 1972-11-22 | ||
GB1372034A (en) | 1970-12-31 | 1974-10-30 | Unilever Ltd | Detergent compositions |
US4246612A (en) | 1979-02-28 | 1981-01-20 | Barr & Stroud Limited | Optical raster scanning system |
US4302544A (en) | 1979-10-15 | 1981-11-24 | University Of Rochester | Asporogenous mutant of B. subtilis for use as host component of HV1 system |
US4430243A (en) | 1981-08-08 | 1984-02-07 | The Procter & Gamble Company | Bleach catalyst compositions and use thereof in laundry bleaching and detergent compositions |
US4435307A (en) | 1980-04-30 | 1984-03-06 | Novo Industri A/S | Detergent cellulase |
US4450235A (en) | 1982-04-21 | 1984-05-22 | Cpc International Inc. | Asporogenic mutant of bacillus subtilis useful as a host in a host-vector system |
EP0134048A1 (en) | 1983-07-06 | 1985-03-13 | Gist-Brocades N.V. | Molecular cloning and expression in industrial microorganism species |
EP0214761A2 (en) | 1985-08-07 | 1987-03-18 | Novo Nordisk A/S | An enzymatic detergent additive, a detergent, and a washing method |
EP0218272A1 (en) | 1985-08-09 | 1987-04-15 | Gist-Brocades N.V. | Novel lipolytic enzymes and their use in detergent compositions |
EP0238023A2 (en) | 1986-03-17 | 1987-09-23 | Novo Nordisk A/S | Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
EP0258068A2 (en) | 1986-08-29 | 1988-03-02 | Novo Nordisk A/S | Enzymatic detergent additive |
US4760025A (en) | 1984-05-29 | 1988-07-26 | Genencor, Inc. | Modified enzymes and methods for making same |
WO1988009367A1 (en) | 1987-05-29 | 1988-12-01 | Genencor, Inc. | Cutinase cleaning composition |
EP0305216A1 (en) | 1987-08-28 | 1989-03-01 | Novo Nordisk A/S | Recombinant Humicola lipase and process for the production of recombinant humicola lipases |
US4810410A (en) | 1986-12-13 | 1989-03-07 | Interox Chemicals Limited | Bleach activation |
JPS6474992A (en) | 1987-09-16 | 1989-03-20 | Fuji Oil Co Ltd | Dna sequence, plasmid and production of lipase |
WO1989006270A1 (en) | 1988-01-07 | 1989-07-13 | Novo-Nordisk A/S | Enzymatic detergent |
EP0331376A2 (en) | 1988-02-28 | 1989-09-06 | Amano Pharmaceutical Co., Ltd. | Recombinant DNA, bacterium of the genus pseudomonas containing it, and process for preparing lipase by using it |
WO1990009446A1 (en) | 1989-02-17 | 1990-08-23 | Plant Genetic Systems N.V. | Cutinase |
US4977252A (en) | 1988-03-11 | 1990-12-11 | National Starch And Chemical Investment Holding Corporation | Modified starch emulsifier characterized by shelf stability |
WO1991000353A2 (en) | 1989-06-29 | 1991-01-10 | Gist-Brocades N.V. | MUTANT MICROBIAL α-AMYLASES WITH INCREASED THERMAL, ACID AND/OR ALKALINE STABILITY |
WO1991016422A1 (en) | 1990-04-14 | 1991-10-31 | Kali-Chemie Aktiengesellschaft | Alkaline bacillus lipases, coding dna sequences therefor and bacilli which produce these lipases |
EP0495257A1 (en) | 1991-01-16 | 1992-07-22 | The Procter & Gamble Company | Compact detergent compositions with high activity cellulase |
WO1992021760A1 (en) | 1991-05-29 | 1992-12-10 | Cognis, Inc. | Mutant proteolytic enzymes from bacillus |
US5227084A (en) | 1991-04-17 | 1993-07-13 | Lever Brothers Company, Division Of Conopco, Inc. | Concentrated detergent powder compositions |
US5264366A (en) | 1984-05-29 | 1993-11-23 | Genencor, Inc. | Protease deficient bacillus |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
WO1994012621A1 (en) | 1992-12-01 | 1994-06-09 | Novo Nordisk | Enhancement of enzyme reactions |
WO1994018314A1 (en) | 1993-02-11 | 1994-08-18 | Genencor International, Inc. | Oxidatively stable alpha-amylase |
US5354559A (en) | 1990-05-29 | 1994-10-11 | Grain Processing Corporation | Encapsulation with starch hydrolyzate acid esters |
WO1994026859A1 (en) | 1993-05-08 | 1994-11-24 | Henkel Kommanditgesellschaft Auf Aktien | Silver-corrosion protection agent (i) |
WO1994026860A1 (en) | 1993-05-08 | 1994-11-24 | Henkel Kommanditgesellschaft Auf Aktien | Silver-corrosion protection agent (ii) |
WO1995001426A1 (en) | 1993-06-29 | 1995-01-12 | Novo Nordisk A/S | Enhancement of laccase reactions |
WO1995010603A1 (en) | 1993-10-08 | 1995-04-20 | Novo Nordisk A/S | Amylase variants |
WO1995023221A1 (en) | 1994-02-24 | 1995-08-31 | Cognis, Inc. | Improved enzymes and detergents containing them |
WO1995026397A1 (en) | 1994-03-29 | 1995-10-05 | Novo Nordisk A/S | Alkaline bacillus amylase |
WO1995035382A2 (en) | 1994-06-17 | 1995-12-28 | Genecor International Inc. | NOVEL AMYLOLYTIC ENZYMES DERIVED FROM THE B. LICHENIFORMIS α-AMYLASE, HAVING IMPROVED CHARACTERISTICS |
US5486303A (en) | 1993-08-27 | 1996-01-23 | The Procter & Gamble Company | Process for making high density detergent agglomerates using an anhydrous powder additive |
US5489392A (en) | 1994-09-20 | 1996-02-06 | The Procter & Gamble Company | Process for making a high density detergent composition in a single mixer/densifier with selected recycle streams for improved agglomerate properties |
WO1996005295A2 (en) | 1994-08-11 | 1996-02-22 | Genencor International, Inc. | An improved cleaning composition |
US5516448A (en) | 1994-09-20 | 1996-05-14 | The Procter & Gamble Company | Process for making a high density detergent composition which includes selected recycle streams for improved agglomerate |
WO1996023873A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | Amylase variants |
WO1996023874A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | A method of designing alpha-amylase mutants with predetermined properties |
WO1996030481A1 (en) | 1995-03-24 | 1996-10-03 | Genencor International, Inc. | An improved laundry detergent composition comprising amylase |
US5565422A (en) | 1995-06-23 | 1996-10-15 | The Procter & Gamble Company | Process for preparing a free-flowing particulate detergent composition having improved solubility |
US5569645A (en) | 1995-04-24 | 1996-10-29 | The Procter & Gamble Company | Low dosage detergent composition containing optimum proportions of agglomerates and spray dried granules for improved flow properties |
US5574005A (en) | 1995-03-07 | 1996-11-12 | The Procter & Gamble Company | Process for producing detergent agglomerates from high active surfactant pastes having non-linear viscoelastic properties |
US5576282A (en) | 1995-09-11 | 1996-11-19 | The Procter & Gamble Company | Color-safe bleach boosters, compositions and laundry methods employing same |
US5595967A (en) | 1995-02-03 | 1997-01-21 | The Procter & Gamble Company | Detergent compositions comprising multiperacid-forming bleach activators |
US5597936A (en) | 1995-06-16 | 1997-01-28 | The Procter & Gamble Company | Method for manufacturing cobalt catalysts |
WO1997010342A1 (en) | 1995-09-13 | 1997-03-20 | Genencor International, Inc. | Alkaliphilic and thermophilic microorganisms and enzymes obtained therefrom |
WO1997011151A1 (en) | 1995-09-18 | 1997-03-27 | The Procter & Gamble Company | Delivery systems |
US5646101A (en) | 1993-01-18 | 1997-07-08 | The Procter & Gamble Company | Machine dishwashing detergents containing an oxygen bleach and an anti-tarnishing mixture of a paraffin oil and sequestrant |
WO1997041213A1 (en) | 1996-04-30 | 1997-11-06 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
US5686014A (en) | 1994-04-07 | 1997-11-11 | The Procter & Gamble Company | Bleach compositions comprising manganese-containing bleach catalysts |
WO1997043424A1 (en) | 1996-05-14 | 1997-11-20 | Genencor International, Inc. | MODIFIED α-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
US5691297A (en) | 1994-09-20 | 1997-11-25 | The Procter & Gamble Company | Process for making a high density detergent composition by controlling agglomeration within a dispersion index |
US5695679A (en) | 1994-07-07 | 1997-12-09 | The Procter & Gamble Company | Detergent compositions containing an organic silver coating agent to minimize silver training in ADW washing methods |
US5698504A (en) | 1993-07-01 | 1997-12-16 | The Procter & Gamble Company | Machine dishwashing composition containing oxygen bleach and paraffin oil and benzotriazole compound silver tarnishing inhibitors |
US5700676A (en) | 1984-05-29 | 1997-12-23 | Genencor International Inc. | Modified subtilisins having amino acid alterations |
US5705464A (en) | 1995-06-16 | 1998-01-06 | The Procter & Gamble Company | Automatic dishwashing compositions comprising cobalt catalysts |
US5710115A (en) | 1994-12-09 | 1998-01-20 | The Procter & Gamble Company | Automatic dishwashing composition containing particles of diacyl peroxides |
WO1998026078A1 (en) | 1996-12-09 | 1998-06-18 | Genencor International, Inc. | H mutant alpha-amylase enzymes |
US5801039A (en) | 1994-02-24 | 1998-09-01 | Cognis Gesellschaft Fuer Bio Und Umwelttechnologie Mbh | Enzymes for detergents |
US5855625A (en) | 1995-01-17 | 1999-01-05 | Henkel Kommanditgesellschaft Auf Aktien | Detergent compositions |
WO1999002702A1 (en) | 1997-07-11 | 1999-01-21 | Genencor International, Inc. | MUTANT α-AMYLASE HAVING INTRODUCED THEREIN A DISULFIDE BOND |
WO1999006521A1 (en) | 1997-08-02 | 1999-02-11 | The Procter & Gamble Company | Detergent tablet |
US5874276A (en) | 1993-12-17 | 1999-02-23 | Genencor International, Inc. | Cellulase enzymes and systems for their expressions |
WO1999009183A1 (en) | 1997-08-19 | 1999-02-25 | Genencor International, Inc. | MUTANT α-AMYLASE COMPRISING MODIFICATION AT RESIDUES CORRESPONDING TO A210, H405 AND/OR T412 IN $i(BACILLUS LICHENIFORMIS) |
US5879584A (en) | 1994-09-10 | 1999-03-09 | The Procter & Gamble Company | Process for manufacturing aqueous compositions comprising peracids |
WO1999019467A1 (en) | 1997-10-13 | 1999-04-22 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
WO1999023211A1 (en) | 1997-10-30 | 1999-05-14 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
EP0922499A2 (en) | 1993-12-15 | 1999-06-16 | Ing. Erich Pfeiffer GmbH | Fluid dispenser |
WO1999029876A2 (en) | 1997-12-09 | 1999-06-17 | Genencor International, Inc. | Mutant bacillus licheniformis alpha-amylase |
WO1999034011A2 (en) | 1997-12-24 | 1999-07-08 | Genencor International, Inc. | Method of assaying for a preferred enzyme and/or detergent |
US5935826A (en) | 1997-10-31 | 1999-08-10 | National Starch And Chemical Investment Holding Corporation | Glucoamylase converted starch derivatives and their use as emulsifying and encapsulating agents |
WO1999042567A1 (en) | 1998-02-18 | 1999-08-26 | Novo Nordisk A/S | Alkaline bacillus amylase |
WO1999043793A1 (en) | 1998-02-27 | 1999-09-02 | Novo Nordisk A/S | Amylolytic enzyme variants |
WO1999043794A1 (en) | 1998-02-27 | 1999-09-02 | Novo Nordisk A/S | Maltogenic alpha-amylase variants |
WO1999046399A1 (en) | 1998-03-09 | 1999-09-16 | Novo Nordisk A/S | Enzymatic preparation of glucose syrup from starch |
US5955340A (en) | 1984-05-29 | 1999-09-21 | Genencor International, Inc. | Modified subtilisins having amino acid alterations |
WO2000029560A1 (en) | 1998-11-16 | 2000-05-25 | Novozymes A/S | α-AMYLASE VARIANTS |
WO2000032601A2 (en) | 1998-11-30 | 2000-06-08 | The Procter & Gamble Company | Process for preparing cross-bridged tetraaza macrocycles |
US6077316A (en) | 1995-07-19 | 2000-06-20 | Novo Nordisk A/S | Treatment of fabrics |
WO2000060059A2 (en) | 1999-03-30 | 2000-10-12 | NovozymesA/S | Alpha-amylase variants |
WO2000060058A2 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2000060060A2 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2001014532A2 (en) | 1999-08-20 | 2001-03-01 | Novozymes A/S | Alkaline bacillus amylase |
US6225464B1 (en) | 1997-03-07 | 2001-05-01 | The Procter & Gamble Company | Methods of making cross-bridged macropolycycles |
WO2001034784A1 (en) | 1999-11-10 | 2001-05-17 | Novozymes A/S | Fungamyl-like alpha-amylase variants |
WO2001064852A1 (en) | 2000-03-03 | 2001-09-07 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2001066712A2 (en) | 2000-03-08 | 2001-09-13 | Novozymes A/S | Variants with altered properties |
US6306812B1 (en) | 1997-03-07 | 2001-10-23 | Procter & Gamble Company, The | Bleach compositions containing metal bleach catalyst, and bleach activators and/or organic percarboxylic acids |
US6312936B1 (en) | 1997-10-23 | 2001-11-06 | Genencor International, Inc. | Multiply-substituted protease variants |
WO2001088107A2 (en) | 2000-05-12 | 2001-11-22 | Novozymes A/S | Alpha-amylase variants with altered 1,6-activity |
US6326348B1 (en) | 1996-04-16 | 2001-12-04 | The Procter & Gamble Co. | Detergent compositions containing selected mid-chain branched surfactants |
WO2001096537A2 (en) | 2000-06-14 | 2001-12-20 | Novozymes A/S | Pre-oxidized alpha-amylase |
WO2002010355A2 (en) | 2000-08-01 | 2002-02-07 | Novozymes A/S | Alpha-amylase mutants with altered stability |
WO2002031124A2 (en) | 2000-10-13 | 2002-04-18 | Novozymes A/S | Alpha-amylase variant with altered properties |
US6376450B1 (en) | 1998-10-23 | 2002-04-23 | Chanchal Kumar Ghosh | Cleaning compositions containing multiply-substituted protease variants |
US6440991B1 (en) | 2000-10-02 | 2002-08-27 | Wyeth | Ethers of 7-desmethlrapamycin |
WO2002092797A2 (en) | 2001-05-15 | 2002-11-21 | Novozymes A/S | Alpha-amylase variant with altered properties |
US6566114B1 (en) | 1998-06-10 | 2003-05-20 | Novozymes, A/S | Mannanases |
US6602842B2 (en) | 1994-06-17 | 2003-08-05 | Genencor International, Inc. | Cleaning compositions containing plant cell wall degrading enzymes and their use in cleaning methods |
US6605458B1 (en) | 1997-11-21 | 2003-08-12 | Novozymes A/S | Protease variants and compositions |
WO2004113551A1 (en) | 2003-06-25 | 2004-12-29 | Novozymes A/S | Process for the hydrolysis of starch |
WO2005001064A2 (en) | 2003-06-25 | 2005-01-06 | Novozymes A/S | Polypeptides having alpha-amylase activity and polypeptides encoding same |
WO2005003311A2 (en) | 2003-06-25 | 2005-01-13 | Novozymes A/S | Enzymes for starch processing |
WO2005018336A1 (en) | 2003-08-22 | 2005-03-03 | Novozymes A/S | Process for preparing a dough comprising a starch-degrading glucogenic exo-amylase of family 13 |
WO2005019443A2 (en) | 2003-08-22 | 2005-03-03 | Novozymes A/S | Fungal alpha-amylase variants |
WO2005054475A1 (en) | 2003-12-03 | 2005-06-16 | Meiji Seika Kaisha, Ltd. | Endoglucanase stce and cellulase preparation containing the same |
WO2005056782A2 (en) | 2003-12-03 | 2005-06-23 | Genencor International, Inc. | Perhydrolase |
WO2005056787A1 (en) | 2003-12-08 | 2005-06-23 | Meiji Seika Kaisha, Ltd. | Surfactant-tolerant cellulase and method of converting the same |
WO2005066338A1 (en) | 2004-01-08 | 2005-07-21 | Novozymes A/S | Amylase |
US20050202535A1 (en) | 2003-11-06 | 2005-09-15 | Katherine Collier | Bacterial expression of protease inhibitors and variants thereof |
WO2006012899A1 (en) | 2004-08-02 | 2006-02-09 | Novozymes A/S | Maltogenic alpha-amylase variants |
WO2006012902A2 (en) | 2004-08-02 | 2006-02-09 | Novozymes A/S | Creation of diversity in polypeptides |
WO2006031554A2 (en) | 2004-09-10 | 2006-03-23 | Novozymes North America, Inc. | Methods for preventing, removing, reducing, or disrupting biofilm |
WO2006063594A1 (en) | 2004-12-15 | 2006-06-22 | Novozymes A/S | Alkaline bacillus amylase |
WO2006066594A2 (en) | 2004-12-23 | 2006-06-29 | Novozymes A/S | Alpha-amylase variants |
WO2006066596A2 (en) | 2004-12-22 | 2006-06-29 | Novozymes A/S | Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence |
WO2006136161A2 (en) | 2005-06-24 | 2006-12-28 | Novozymes A/S | Amylases for pharmaceutical use |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
WO2007145964A2 (en) | 2006-06-05 | 2007-12-21 | The Procter & Gamble Company | Enzyme stabilizer |
WO2008000825A1 (en) | 2006-06-30 | 2008-01-03 | Novozymes A/S | Bacterial alpha-amylase variants |
US20080090747A1 (en) | 2006-07-18 | 2008-04-17 | Pieter Augustinus | Protease variants active over a broad temperature range |
WO2008088493A2 (en) | 2006-12-21 | 2008-07-24 | Danisco Us, Inc., Genencor Division | Compositions and uses for an alpha-amylase polypeptide of bacillus species 195 |
WO2008092919A1 (en) | 2007-02-01 | 2008-08-07 | Novozymes A/S | Alpha-amylase and its use |
WO2008101894A1 (en) | 2007-02-19 | 2008-08-28 | Novozymes A/S | Polypeptides with starch debranching activity |
US7449318B2 (en) | 2003-04-30 | 2008-11-11 | Danisco A/S, Genencor Division | Bacillus mHKcel cellulase |
WO2009061381A2 (en) | 2007-11-05 | 2009-05-14 | Danisco Us Inc., Genencor Division | Alpha-amylase variants with altered properties |
WO2009100102A2 (en) | 2008-02-04 | 2009-08-13 | Danisco Us Inc., Genencor Division | Ts23 alpha-amylase variants with altered properties |
EP2100949A1 (en) | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2009140504A1 (en) | 2008-05-16 | 2009-11-19 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2009149200A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Compositions and methods comprising variant microbial proteases |
WO2009149419A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Variant alpha-amylases from bacillus subtilis and methods of use, thereof |
WO2010056640A2 (en) | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
WO2010056653A2 (en) | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Proteases comprising one or more combinable mutations |
WO2010059413A2 (en) | 2008-11-20 | 2010-05-27 | Novozymes, Inc. | Polypeptides having amylolytic enhancing activity and polynucleotides encoding same |
WO2010065455A2 (en) | 2008-12-01 | 2010-06-10 | Danisco Us Inc. | Enzymes with lipase activity |
WO2010088447A1 (en) | 2009-01-30 | 2010-08-05 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2010091221A1 (en) | 2009-02-06 | 2010-08-12 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2010104675A1 (en) | 2009-03-10 | 2010-09-16 | Danisco Us Inc. | Bacillus megaterium strain dsm90-related alpha-amylases, and methods of use, thereof |
WO2010107560A2 (en) | 2009-03-18 | 2010-09-23 | Danisco Us Inc. | Fungal cutinase from magnaporthe grisea |
WO2010115021A2 (en) | 2009-04-01 | 2010-10-07 | Danisco Us Inc. | Compositions and methods comprising alpha-amylase variants with altered properties |
WO2010117511A1 (en) | 2009-04-08 | 2010-10-14 | Danisco Us Inc. | Halomonas strain wdg195-related alpha-amylases, and methods of use, thereof |
WO2011072099A2 (en) | 2009-12-09 | 2011-06-16 | Danisco Us Inc. | Compositions and methods comprising protease variants |
WO2011078949A1 (en) | 2009-12-21 | 2011-06-30 | Danisco Us Inc. | Surfactants that improve the cleaning of lipid-based stains treated with lipases |
WO2011076897A1 (en) | 2009-12-22 | 2011-06-30 | Novozymes A/S | Use of amylase variants at low temperature |
WO2011076123A1 (en) | 2009-12-22 | 2011-06-30 | Novozymes A/S | Compositions comprising boosting polypeptide and starch degrading enzyme and uses thereof |
WO2011080352A1 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Alpha-amylases |
WO2011084599A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing bacillus subtilis lipase and methods of use thereof |
WO2011084412A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing thermobifida fusca lipase and methods of use thereof |
WO2011084417A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing geobacillus stearothermophilus lipase and methods of use thereof |
WO2011098531A1 (en) | 2010-02-10 | 2011-08-18 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
WO2011140364A1 (en) | 2010-05-06 | 2011-11-10 | Danisco Us Inc. | Compositions and methods comprising subtilisin variants |
WO2011150157A2 (en) | 2010-05-28 | 2011-12-01 | Danisco Us Inc. | Detergent compositions containing streptomyces griseus lipase and methods of use thereof |
WO2012137147A1 (en) | 2011-04-08 | 2012-10-11 | Danisco Us, Inc. | Compositions |
WO2012151534A1 (en) | 2011-05-05 | 2012-11-08 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
WO2013033318A1 (en) | 2011-08-31 | 2013-03-07 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
WO2013063460A2 (en) | 2011-10-28 | 2013-05-02 | Danisco Us Inc. | Variant maltohexaose-forming alpha-amylase variants |
WO2013096653A1 (en) | 2011-12-22 | 2013-06-27 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5496710A (en) * | 1992-06-08 | 1996-03-05 | Sagami Chemical Research Center | Protease |
JPH06181761A (en) * | 1992-06-08 | 1994-07-05 | Tosoh Corp | New protease |
EP0867512A1 (en) * | 1997-03-27 | 1998-09-30 | Rijksuniversiteit te Groningen | Improved metallo-endopeptidases from Bacillus stearothermophilus |
MX2009011566A (en) * | 2007-04-30 | 2009-11-10 | Danisco Us Inc Genencor Div | Use of protein hydrolysates to stabilize metalloprotease detergent formulations. |
EP2229439A1 (en) * | 2007-10-31 | 2010-09-22 | Danisco US Inc. | Use and production of neutral metallproteases in a serine protease-free background |
CN101842481B (en) * | 2007-10-31 | 2016-05-11 | 丹尼斯科美国公司 | Purposes and the production of the neutral metal protease to citrate-stable |
EP2205732A2 (en) * | 2007-11-01 | 2010-07-14 | Danisco US Inc. | Production of thermolysin and variants thereof and use in liquid detergents |
WO2014194034A2 (en) * | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
WO2015094714A1 (en) * | 2013-12-19 | 2015-06-25 | Danisco Us Inc. | Proteases in grain processing |
-
2014
- 2014-05-29 JP JP2016516828A patent/JP6367930B2/en active Active
- 2014-05-29 EP EP14737359.1A patent/EP3004342B1/en active Active
- 2014-05-29 WO PCT/US2014/040063 patent/WO2014194117A2/en active Application Filing
- 2014-05-29 US US14/893,440 patent/US20160108387A1/en not_active Abandoned
-
2017
- 2017-10-05 US US15/725,627 patent/US20180073006A1/en not_active Abandoned
-
2018
- 2018-07-05 JP JP2018128210A patent/JP6612398B2/en active Active
-
2019
- 2019-12-17 US US16/717,216 patent/US20200115693A1/en not_active Abandoned
-
2023
- 2023-10-16 US US18/487,157 patent/US20240229001A1/en active Pending
Patent Citations (177)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1296839A (en) | 1969-05-29 | 1972-11-22 | ||
GB1372034A (en) | 1970-12-31 | 1974-10-30 | Unilever Ltd | Detergent compositions |
US4246612A (en) | 1979-02-28 | 1981-01-20 | Barr & Stroud Limited | Optical raster scanning system |
US4302544A (en) | 1979-10-15 | 1981-11-24 | University Of Rochester | Asporogenous mutant of B. subtilis for use as host component of HV1 system |
US4435307A (en) | 1980-04-30 | 1984-03-06 | Novo Industri A/S | Detergent cellulase |
US4430243A (en) | 1981-08-08 | 1984-02-07 | The Procter & Gamble Company | Bleach catalyst compositions and use thereof in laundry bleaching and detergent compositions |
US4450235A (en) | 1982-04-21 | 1984-05-22 | Cpc International Inc. | Asporogenic mutant of bacillus subtilis useful as a host in a host-vector system |
EP0134048A1 (en) | 1983-07-06 | 1985-03-13 | Gist-Brocades N.V. | Molecular cloning and expression in industrial microorganism species |
US4760025A (en) | 1984-05-29 | 1988-07-26 | Genencor, Inc. | Modified enzymes and methods for making same |
US5264366A (en) | 1984-05-29 | 1993-11-23 | Genencor, Inc. | Protease deficient bacillus |
USRE34606E (en) | 1984-05-29 | 1994-05-10 | Genencor, Inc. | Modified enzymes and methods for making same |
US5955340A (en) | 1984-05-29 | 1999-09-21 | Genencor International, Inc. | Modified subtilisins having amino acid alterations |
US5700676A (en) | 1984-05-29 | 1997-12-23 | Genencor International Inc. | Modified subtilisins having amino acid alterations |
EP0214761A2 (en) | 1985-08-07 | 1987-03-18 | Novo Nordisk A/S | An enzymatic detergent additive, a detergent, and a washing method |
EP0218272A1 (en) | 1985-08-09 | 1987-04-15 | Gist-Brocades N.V. | Novel lipolytic enzymes and their use in detergent compositions |
EP0238023A2 (en) | 1986-03-17 | 1987-09-23 | Novo Nordisk A/S | Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
EP0258068A2 (en) | 1986-08-29 | 1988-03-02 | Novo Nordisk A/S | Enzymatic detergent additive |
US4810410A (en) | 1986-12-13 | 1989-03-07 | Interox Chemicals Limited | Bleach activation |
WO1988009367A1 (en) | 1987-05-29 | 1988-12-01 | Genencor, Inc. | Cutinase cleaning composition |
EP0305216A1 (en) | 1987-08-28 | 1989-03-01 | Novo Nordisk A/S | Recombinant Humicola lipase and process for the production of recombinant humicola lipases |
JPS6474992A (en) | 1987-09-16 | 1989-03-20 | Fuji Oil Co Ltd | Dna sequence, plasmid and production of lipase |
WO1989006270A1 (en) | 1988-01-07 | 1989-07-13 | Novo-Nordisk A/S | Enzymatic detergent |
EP0331376A2 (en) | 1988-02-28 | 1989-09-06 | Amano Pharmaceutical Co., Ltd. | Recombinant DNA, bacterium of the genus pseudomonas containing it, and process for preparing lipase by using it |
US4977252A (en) | 1988-03-11 | 1990-12-11 | National Starch And Chemical Investment Holding Corporation | Modified starch emulsifier characterized by shelf stability |
WO1990009446A1 (en) | 1989-02-17 | 1990-08-23 | Plant Genetic Systems N.V. | Cutinase |
WO1991000353A2 (en) | 1989-06-29 | 1991-01-10 | Gist-Brocades N.V. | MUTANT MICROBIAL α-AMYLASES WITH INCREASED THERMAL, ACID AND/OR ALKALINE STABILITY |
WO1991016422A1 (en) | 1990-04-14 | 1991-10-31 | Kali-Chemie Aktiengesellschaft | Alkaline bacillus lipases, coding dna sequences therefor and bacilli which produce these lipases |
US5354559A (en) | 1990-05-29 | 1994-10-11 | Grain Processing Corporation | Encapsulation with starch hydrolyzate acid esters |
EP0495257A1 (en) | 1991-01-16 | 1992-07-22 | The Procter & Gamble Company | Compact detergent compositions with high activity cellulase |
US5227084A (en) | 1991-04-17 | 1993-07-13 | Lever Brothers Company, Division Of Conopco, Inc. | Concentrated detergent powder compositions |
WO1992021760A1 (en) | 1991-05-29 | 1992-12-10 | Cognis, Inc. | Mutant proteolytic enzymes from bacillus |
US5500364A (en) | 1991-05-29 | 1996-03-19 | Cognis, Inc. | Bacillus lentus alkaline protease varints with enhanced stability |
US5340735A (en) | 1991-05-29 | 1994-08-23 | Cognis, Inc. | Bacillus lentus alkaline protease variants with increased stability |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
WO1994012621A1 (en) | 1992-12-01 | 1994-06-09 | Novo Nordisk | Enhancement of enzyme reactions |
US5646101A (en) | 1993-01-18 | 1997-07-08 | The Procter & Gamble Company | Machine dishwashing detergents containing an oxygen bleach and an anti-tarnishing mixture of a paraffin oil and sequestrant |
WO1994018314A1 (en) | 1993-02-11 | 1994-08-18 | Genencor International, Inc. | Oxidatively stable alpha-amylase |
WO1994026859A1 (en) | 1993-05-08 | 1994-11-24 | Henkel Kommanditgesellschaft Auf Aktien | Silver-corrosion protection agent (i) |
WO1994026860A1 (en) | 1993-05-08 | 1994-11-24 | Henkel Kommanditgesellschaft Auf Aktien | Silver-corrosion protection agent (ii) |
WO1995001426A1 (en) | 1993-06-29 | 1995-01-12 | Novo Nordisk A/S | Enhancement of laccase reactions |
US5698504A (en) | 1993-07-01 | 1997-12-16 | The Procter & Gamble Company | Machine dishwashing composition containing oxygen bleach and paraffin oil and benzotriazole compound silver tarnishing inhibitors |
US5486303A (en) | 1993-08-27 | 1996-01-23 | The Procter & Gamble Company | Process for making high density detergent agglomerates using an anhydrous powder additive |
WO1995010603A1 (en) | 1993-10-08 | 1995-04-20 | Novo Nordisk A/S | Amylase variants |
EP0922499A2 (en) | 1993-12-15 | 1999-06-16 | Ing. Erich Pfeiffer GmbH | Fluid dispenser |
US5874276A (en) | 1993-12-17 | 1999-02-23 | Genencor International, Inc. | Cellulase enzymes and systems for their expressions |
US5801039A (en) | 1994-02-24 | 1998-09-01 | Cognis Gesellschaft Fuer Bio Und Umwelttechnologie Mbh | Enzymes for detergents |
WO1995023221A1 (en) | 1994-02-24 | 1995-08-31 | Cognis, Inc. | Improved enzymes and detergents containing them |
WO1995026397A1 (en) | 1994-03-29 | 1995-10-05 | Novo Nordisk A/S | Alkaline bacillus amylase |
US5686014A (en) | 1994-04-07 | 1997-11-11 | The Procter & Gamble Company | Bleach compositions comprising manganese-containing bleach catalysts |
US6602842B2 (en) | 1994-06-17 | 2003-08-05 | Genencor International, Inc. | Cleaning compositions containing plant cell wall degrading enzymes and their use in cleaning methods |
WO1995035382A2 (en) | 1994-06-17 | 1995-12-28 | Genecor International Inc. | NOVEL AMYLOLYTIC ENZYMES DERIVED FROM THE B. LICHENIFORMIS α-AMYLASE, HAVING IMPROVED CHARACTERISTICS |
US5695679A (en) | 1994-07-07 | 1997-12-09 | The Procter & Gamble Company | Detergent compositions containing an organic silver coating agent to minimize silver training in ADW washing methods |
WO1996005295A2 (en) | 1994-08-11 | 1996-02-22 | Genencor International, Inc. | An improved cleaning composition |
US5879584A (en) | 1994-09-10 | 1999-03-09 | The Procter & Gamble Company | Process for manufacturing aqueous compositions comprising peracids |
US5489392A (en) | 1994-09-20 | 1996-02-06 | The Procter & Gamble Company | Process for making a high density detergent composition in a single mixer/densifier with selected recycle streams for improved agglomerate properties |
US5516448A (en) | 1994-09-20 | 1996-05-14 | The Procter & Gamble Company | Process for making a high density detergent composition which includes selected recycle streams for improved agglomerate |
US5691297A (en) | 1994-09-20 | 1997-11-25 | The Procter & Gamble Company | Process for making a high density detergent composition by controlling agglomeration within a dispersion index |
US5710115A (en) | 1994-12-09 | 1998-01-20 | The Procter & Gamble Company | Automatic dishwashing composition containing particles of diacyl peroxides |
US5855625A (en) | 1995-01-17 | 1999-01-05 | Henkel Kommanditgesellschaft Auf Aktien | Detergent compositions |
WO1996023873A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | Amylase variants |
US5595967A (en) | 1995-02-03 | 1997-01-21 | The Procter & Gamble Company | Detergent compositions comprising multiperacid-forming bleach activators |
WO1996023874A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | A method of designing alpha-amylase mutants with predetermined properties |
US5574005A (en) | 1995-03-07 | 1996-11-12 | The Procter & Gamble Company | Process for producing detergent agglomerates from high active surfactant pastes having non-linear viscoelastic properties |
WO1996030481A1 (en) | 1995-03-24 | 1996-10-03 | Genencor International, Inc. | An improved laundry detergent composition comprising amylase |
US5569645A (en) | 1995-04-24 | 1996-10-29 | The Procter & Gamble Company | Low dosage detergent composition containing optimum proportions of agglomerates and spray dried granules for improved flow properties |
US5705464A (en) | 1995-06-16 | 1998-01-06 | The Procter & Gamble Company | Automatic dishwashing compositions comprising cobalt catalysts |
US5597936A (en) | 1995-06-16 | 1997-01-28 | The Procter & Gamble Company | Method for manufacturing cobalt catalysts |
US5565422A (en) | 1995-06-23 | 1996-10-15 | The Procter & Gamble Company | Process for preparing a free-flowing particulate detergent composition having improved solubility |
US6077316A (en) | 1995-07-19 | 2000-06-20 | Novo Nordisk A/S | Treatment of fabrics |
US5576282A (en) | 1995-09-11 | 1996-11-19 | The Procter & Gamble Company | Color-safe bleach boosters, compositions and laundry methods employing same |
WO1997010342A1 (en) | 1995-09-13 | 1997-03-20 | Genencor International, Inc. | Alkaliphilic and thermophilic microorganisms and enzymes obtained therefrom |
WO1997011151A1 (en) | 1995-09-18 | 1997-03-27 | The Procter & Gamble Company | Delivery systems |
US6326348B1 (en) | 1996-04-16 | 2001-12-04 | The Procter & Gamble Co. | Detergent compositions containing selected mid-chain branched surfactants |
WO1997041213A1 (en) | 1996-04-30 | 1997-11-06 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
WO1997043424A1 (en) | 1996-05-14 | 1997-11-20 | Genencor International, Inc. | MODIFIED α-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
WO1998026078A1 (en) | 1996-12-09 | 1998-06-18 | Genencor International, Inc. | H mutant alpha-amylase enzymes |
US6306812B1 (en) | 1997-03-07 | 2001-10-23 | Procter & Gamble Company, The | Bleach compositions containing metal bleach catalyst, and bleach activators and/or organic percarboxylic acids |
US6225464B1 (en) | 1997-03-07 | 2001-05-01 | The Procter & Gamble Company | Methods of making cross-bridged macropolycycles |
WO1999002702A1 (en) | 1997-07-11 | 1999-01-21 | Genencor International, Inc. | MUTANT α-AMYLASE HAVING INTRODUCED THEREIN A DISULFIDE BOND |
WO1999006521A1 (en) | 1997-08-02 | 1999-02-11 | The Procter & Gamble Company | Detergent tablet |
WO1999009183A1 (en) | 1997-08-19 | 1999-02-25 | Genencor International, Inc. | MUTANT α-AMYLASE COMPRISING MODIFICATION AT RESIDUES CORRESPONDING TO A210, H405 AND/OR T412 IN $i(BACILLUS LICHENIFORMIS) |
WO1999019467A1 (en) | 1997-10-13 | 1999-04-22 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
US6312936B1 (en) | 1997-10-23 | 2001-11-06 | Genencor International, Inc. | Multiply-substituted protease variants |
US6482628B1 (en) | 1997-10-23 | 2002-11-19 | Genencor International, Inc. | Multiply-substituted protease variants |
WO1999023211A1 (en) | 1997-10-30 | 1999-05-14 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
US5935826A (en) | 1997-10-31 | 1999-08-10 | National Starch And Chemical Investment Holding Corporation | Glucoamylase converted starch derivatives and their use as emulsifying and encapsulating agents |
US6605458B1 (en) | 1997-11-21 | 2003-08-12 | Novozymes A/S | Protease variants and compositions |
WO1999029876A2 (en) | 1997-12-09 | 1999-06-17 | Genencor International, Inc. | Mutant bacillus licheniformis alpha-amylase |
WO1999034011A2 (en) | 1997-12-24 | 1999-07-08 | Genencor International, Inc. | Method of assaying for a preferred enzyme and/or detergent |
WO1999042567A1 (en) | 1998-02-18 | 1999-08-26 | Novo Nordisk A/S | Alkaline bacillus amylase |
WO1999043793A1 (en) | 1998-02-27 | 1999-09-02 | Novo Nordisk A/S | Amylolytic enzyme variants |
WO1999043794A1 (en) | 1998-02-27 | 1999-09-02 | Novo Nordisk A/S | Maltogenic alpha-amylase variants |
WO1999046399A1 (en) | 1998-03-09 | 1999-09-16 | Novo Nordisk A/S | Enzymatic preparation of glucose syrup from starch |
US6566114B1 (en) | 1998-06-10 | 2003-05-20 | Novozymes, A/S | Mannanases |
US6376450B1 (en) | 1998-10-23 | 2002-04-23 | Chanchal Kumar Ghosh | Cleaning compositions containing multiply-substituted protease variants |
WO2000029560A1 (en) | 1998-11-16 | 2000-05-25 | Novozymes A/S | α-AMYLASE VARIANTS |
WO2000032601A2 (en) | 1998-11-30 | 2000-06-08 | The Procter & Gamble Company | Process for preparing cross-bridged tetraaza macrocycles |
WO2000060059A2 (en) | 1999-03-30 | 2000-10-12 | NovozymesA/S | Alpha-amylase variants |
WO2000060058A2 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2000060060A2 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2001014532A2 (en) | 1999-08-20 | 2001-03-01 | Novozymes A/S | Alkaline bacillus amylase |
WO2001034784A1 (en) | 1999-11-10 | 2001-05-17 | Novozymes A/S | Fungamyl-like alpha-amylase variants |
WO2001064852A1 (en) | 2000-03-03 | 2001-09-07 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2001066712A2 (en) | 2000-03-08 | 2001-09-13 | Novozymes A/S | Variants with altered properties |
US6610642B2 (en) | 2000-04-20 | 2003-08-26 | The Procter And Gamble Company | Cleaning compositions containing multiply-substituted protease variants |
WO2001088107A2 (en) | 2000-05-12 | 2001-11-22 | Novozymes A/S | Alpha-amylase variants with altered 1,6-activity |
WO2001096537A2 (en) | 2000-06-14 | 2001-12-20 | Novozymes A/S | Pre-oxidized alpha-amylase |
WO2002010355A2 (en) | 2000-08-01 | 2002-02-07 | Novozymes A/S | Alpha-amylase mutants with altered stability |
US6440991B1 (en) | 2000-10-02 | 2002-08-27 | Wyeth | Ethers of 7-desmethlrapamycin |
WO2002031124A2 (en) | 2000-10-13 | 2002-04-18 | Novozymes A/S | Alpha-amylase variant with altered properties |
WO2002092797A2 (en) | 2001-05-15 | 2002-11-21 | Novozymes A/S | Alpha-amylase variant with altered properties |
US7833773B2 (en) | 2003-04-30 | 2010-11-16 | Danisco Us Inc. | Bacillus mHKcel cellulase |
US7449318B2 (en) | 2003-04-30 | 2008-11-11 | Danisco A/S, Genencor Division | Bacillus mHKcel cellulase |
WO2005001064A2 (en) | 2003-06-25 | 2005-01-06 | Novozymes A/S | Polypeptides having alpha-amylase activity and polypeptides encoding same |
WO2005003311A2 (en) | 2003-06-25 | 2005-01-13 | Novozymes A/S | Enzymes for starch processing |
WO2004113551A1 (en) | 2003-06-25 | 2004-12-29 | Novozymes A/S | Process for the hydrolysis of starch |
WO2005018336A1 (en) | 2003-08-22 | 2005-03-03 | Novozymes A/S | Process for preparing a dough comprising a starch-degrading glucogenic exo-amylase of family 13 |
WO2005019443A2 (en) | 2003-08-22 | 2005-03-03 | Novozymes A/S | Fungal alpha-amylase variants |
US20050202535A1 (en) | 2003-11-06 | 2005-09-15 | Katherine Collier | Bacterial expression of protease inhibitors and variants thereof |
WO2005054475A1 (en) | 2003-12-03 | 2005-06-16 | Meiji Seika Kaisha, Ltd. | Endoglucanase stce and cellulase preparation containing the same |
WO2005056782A2 (en) | 2003-12-03 | 2005-06-23 | Genencor International, Inc. | Perhydrolase |
WO2005056787A1 (en) | 2003-12-08 | 2005-06-23 | Meiji Seika Kaisha, Ltd. | Surfactant-tolerant cellulase and method of converting the same |
WO2005066338A1 (en) | 2004-01-08 | 2005-07-21 | Novozymes A/S | Amylase |
WO2006012899A1 (en) | 2004-08-02 | 2006-02-09 | Novozymes A/S | Maltogenic alpha-amylase variants |
WO2006012902A2 (en) | 2004-08-02 | 2006-02-09 | Novozymes A/S | Creation of diversity in polypeptides |
WO2006031554A2 (en) | 2004-09-10 | 2006-03-23 | Novozymes North America, Inc. | Methods for preventing, removing, reducing, or disrupting biofilm |
WO2006063594A1 (en) | 2004-12-15 | 2006-06-22 | Novozymes A/S | Alkaline bacillus amylase |
WO2006066596A2 (en) | 2004-12-22 | 2006-06-29 | Novozymes A/S | Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence |
WO2006066594A2 (en) | 2004-12-23 | 2006-06-29 | Novozymes A/S | Alpha-amylase variants |
WO2006136161A2 (en) | 2005-06-24 | 2006-12-28 | Novozymes A/S | Amylases for pharmaceutical use |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
US8114656B2 (en) | 2005-10-12 | 2012-02-14 | Danisco Us Inc. | Thermostable neutral metalloproteases |
WO2007145964A2 (en) | 2006-06-05 | 2007-12-21 | The Procter & Gamble Company | Enzyme stabilizer |
WO2008000825A1 (en) | 2006-06-30 | 2008-01-03 | Novozymes A/S | Bacterial alpha-amylase variants |
US20080090747A1 (en) | 2006-07-18 | 2008-04-17 | Pieter Augustinus | Protease variants active over a broad temperature range |
WO2008088493A2 (en) | 2006-12-21 | 2008-07-24 | Danisco Us, Inc., Genencor Division | Compositions and uses for an alpha-amylase polypeptide of bacillus species 195 |
WO2008092919A1 (en) | 2007-02-01 | 2008-08-07 | Novozymes A/S | Alpha-amylase and its use |
WO2008101894A1 (en) | 2007-02-19 | 2008-08-28 | Novozymes A/S | Polypeptides with starch debranching activity |
WO2009061381A2 (en) | 2007-11-05 | 2009-05-14 | Danisco Us Inc., Genencor Division | Alpha-amylase variants with altered properties |
WO2009100102A2 (en) | 2008-02-04 | 2009-08-13 | Danisco Us Inc., Genencor Division | Ts23 alpha-amylase variants with altered properties |
EP2100949A1 (en) | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2009140504A1 (en) | 2008-05-16 | 2009-11-19 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2009149200A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Compositions and methods comprising variant microbial proteases |
WO2009149145A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc., Genencor Division | Compositions and methods comprising variant microbial proteases |
WO2009149144A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Compositions and methods comprising variant microbial proteases |
WO2009149419A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Variant alpha-amylases from bacillus subtilis and methods of use, thereof |
WO2010056640A2 (en) | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
WO2010056653A2 (en) | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Proteases comprising one or more combinable mutations |
WO2010059413A2 (en) | 2008-11-20 | 2010-05-27 | Novozymes, Inc. | Polypeptides having amylolytic enhancing activity and polynucleotides encoding same |
WO2010065455A2 (en) | 2008-12-01 | 2010-06-10 | Danisco Us Inc. | Enzymes with lipase activity |
WO2010088447A1 (en) | 2009-01-30 | 2010-08-05 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2010091221A1 (en) | 2009-02-06 | 2010-08-12 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2010104675A1 (en) | 2009-03-10 | 2010-09-16 | Danisco Us Inc. | Bacillus megaterium strain dsm90-related alpha-amylases, and methods of use, thereof |
WO2010107560A2 (en) | 2009-03-18 | 2010-09-23 | Danisco Us Inc. | Fungal cutinase from magnaporthe grisea |
WO2010115021A2 (en) | 2009-04-01 | 2010-10-07 | Danisco Us Inc. | Compositions and methods comprising alpha-amylase variants with altered properties |
WO2010117511A1 (en) | 2009-04-08 | 2010-10-14 | Danisco Us Inc. | Halomonas strain wdg195-related alpha-amylases, and methods of use, thereof |
WO2011072099A2 (en) | 2009-12-09 | 2011-06-16 | Danisco Us Inc. | Compositions and methods comprising protease variants |
WO2011084417A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing geobacillus stearothermophilus lipase and methods of use thereof |
WO2011084599A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing bacillus subtilis lipase and methods of use thereof |
WO2011078949A1 (en) | 2009-12-21 | 2011-06-30 | Danisco Us Inc. | Surfactants that improve the cleaning of lipid-based stains treated with lipases |
WO2011084412A1 (en) | 2009-12-21 | 2011-07-14 | Danisco Us Inc. | Detergent compositions containing thermobifida fusca lipase and methods of use thereof |
WO2011087836A2 (en) | 2009-12-22 | 2011-07-21 | Novozymes A/S | Pullulanase variants and uses thereof |
WO2011076897A1 (en) | 2009-12-22 | 2011-06-30 | Novozymes A/S | Use of amylase variants at low temperature |
WO2011076123A1 (en) | 2009-12-22 | 2011-06-30 | Novozymes A/S | Compositions comprising boosting polypeptide and starch degrading enzyme and uses thereof |
WO2011080354A1 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Alpha-amylases |
WO2011082429A1 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Alpha-amylases |
WO2011082425A2 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2011080353A1 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Stabilization of alpha-amylases towards calcium depletion and acidic ph |
WO2011080352A1 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Alpha-amylases |
WO2011098531A1 (en) | 2010-02-10 | 2011-08-18 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
WO2011140364A1 (en) | 2010-05-06 | 2011-11-10 | Danisco Us Inc. | Compositions and methods comprising subtilisin variants |
WO2011150157A2 (en) | 2010-05-28 | 2011-12-01 | Danisco Us Inc. | Detergent compositions containing streptomyces griseus lipase and methods of use thereof |
WO2012137147A1 (en) | 2011-04-08 | 2012-10-11 | Danisco Us, Inc. | Compositions |
WO2012151534A1 (en) | 2011-05-05 | 2012-11-08 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
WO2013033318A1 (en) | 2011-08-31 | 2013-03-07 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
WO2013063460A2 (en) | 2011-10-28 | 2013-05-02 | Danisco Us Inc. | Variant maltohexaose-forming alpha-amylase variants |
WO2013096653A1 (en) | 2011-12-22 | 2013-06-27 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
Non-Patent Citations (77)
Title |
---|
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410 |
ALTSCHUL, SF ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402 |
ARIGONI ET AL., MOL. MICROBIOL., vol. 31, 1999, pages 1407 - 1415 |
BEAUCAGE ET AL., TETRAHEDRON LETTERS, vol. 22, 1981, pages 1859 - 69 |
BITTKER ET AL., NRR, vol. 20, 2001, pages 1024 - 9 |
CALDWEL ET AL., J. BACTERIOL., vol. 183, 2001, pages 7329 - 7340 |
CHANG ET AL., MOL. GEN. GENET., vol. 168, 1979, pages 11 - 115 |
CHRISTIANSON ET AL., ANAL. BIOCHEM., vol. 223, 1994, pages 119 - 129 |
CONTENTE ET AL., PLASMID, vol. 2, 1979, pages 555 - 571 |
DAHLQUIST, F.W.; LONG, J.W.; BIGBEE, W.L.: "Role of Calcium in the Thermal Stability of Thermolysin", BIOCHEMISTRY, vol. 15, 1976, pages 1103 |
DARTOIS ET AL., BIOCHEM. BIOPHYS. ACTA, vol. 1131, 1993, pages 253 - 260 |
DEL MAR ET AL., ANAL. BIOCHEM., vol. 99, 1979, pages 316 - 320 |
DEVEREUX ET AL., NUCL. ACID RES., vol. 12, 1984, pages 387 - 395 |
EIJSINK ET AL., PROT. SCI., vol. 20, 2011, pages 1346 |
EIJSINK; MATTHEWS; VRIEND, PROT SCI, vol. 20, 2011, pages 1346 - 1355 |
EMSLEY ET AL., ACTA CRYSTALLOGR D BIOL CRYSTALLOGR., vol. 66, 2010, pages 486 |
EMSLEY, P ET AL., ACTA CRYST., vol. D66, 2010, pages 486 - 501 |
FAHNESTOCK; FISCHER, J. BACTERIOL., vol. 165, 1986, pages 796 - 804 |
FENG; DOOLITTLE, J. MOL. EVOL., vol. 35, 1987, pages 351 - 360 |
FERRARI ET AL.: "Bacillus", 1989, PLENUM PUBLISHING CORP., article "Genetics", pages: 57 - 72 |
FISHER ET AL., ARCH. MICROBIOL., vol. 139, 1981, pages 213 - 217 |
HAIMA ET AL., MOL. GEN. GENET., vol. 223, 1990, pages 185 - 191 |
HARWOOD AND CUTTING: "Molecular Biological Methods for Bacillus", 1990, JOHN WILEY & SONS, pages: 92 |
HASS ET AL., GENE, vol. 109, 1991, pages 117 - 113 |
HIGGINS; SHARP, CABIOS, vol. 5, 1989, pages 151 - 153 |
HOCH ET AL., GENETICS, vol. 73, 1973, pages 215 - 228 |
HOCH ET AL., J. BACTERIOL., vol. 93, 1967, pages 1925 - 1937 |
HOLUBOVA, FOLIA MICROBIOL., vol. 30, 1985, pages 97 |
HSIA ET AL., ANAL BIOCHEM., vol. 242, 1999, pages 221 - 227 |
ITAKURA ET AL., ANN. REV. BIOCHEM., vol. 53, 1984, pages 323 |
ITAKURA ET AL., SCIENCE, vol. 198, 1984, pages 1056 |
KALISZ: "Advances in Biochemical Engineering/Biotechnology", 1988, article "Microbial Proteinases" |
KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 5787 |
KR ET AL., DNA CELL BIOL., vol. 12, 1993, pages 441 - 53 |
KUGIMIYA ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 56, 1992, pages 716 - 719 |
LUTZ ET AL., SCRACHY, vol. 98, 2001, pages 11248 - 53 |
MADDOX ET AL., J. EXP. MED., vol. 158, 1983, pages 1211 |
MANN ET AL., CURRENT MICROBIOL., vol. 13, 1986, pages 131 - 135 |
MATTHES ET AL., EMBO J., vol. 3, 1984, pages 801 - 805 |
MATTHEWS, B.W.; WEAVER, L.H.; KESTER, W.R.: "The Conformation of Thermolysin", J.BIOL.CHEM., vol. 249, 1974, pages 8030 |
MCDONALD, J. GEN. MICROBIOL., vol. 130, 1984, pages 203 |
MSADEK ET AL., J. BACTERIOL., vol. 172, 1990, pages 824 - 834 |
NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 |
OLMOS ET AL., MOL. GEN. GENET., vol. 253, 1997, pages 562 - 567 |
OSTERMEIER ET AL., ITCHY, vol. 7, 1999, pages 2139 - 44 |
PALMEROS ET AL., GENE, vol. 247, 2000, pages 255 - 264 |
PALVA ET AL., GENE, vol. 19, 1982, pages 81 - 87 |
PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444 |
PEREGO ET AL., MOL. MICROBIOL., vol. 5, 1991, pages 173 - 185 |
PEREGO ET AL.: "Bacillus subtilis and Other Gram-Positive Bacteria: Biochemistry, Physiology and Molecular Genetics", 1993, AMERICAN SOCIETY FOR MICROBIOLOGY, article "Integrational Vectors for Genetic Manipulations in Bacillus subtilis", pages: 615 - 624 |
PORATH, PROTEIN EXPR. PURIF., vol. 3, 1992, pages 263 - 281 |
RAWLINGS ET AL., NUCLEIC ACID RES., vol. 38, 2010, pages D227 |
RAWLINGS ET AL., NUCLEIC ACIDS RES, vol. 40, 2012, pages D343 - D350 |
RUF ET AL., ACTA CRYST. D, vol. 69, 2013, pages 24 - 31 |
RUF ET AL., ACTA CRYST., vol. D69, 2013, pages 4 - 1 |
SAUNDER ET AL., J. BACTERIOL., vol. 157, 1984, pages 718 - 726 |
SCHAFFER, AA ET AL., NUCLEIC ACIDS RES., vol. 29, 2001, pages 2994 - 3005 |
SCHIMADA ET AL., J. BIOCHEM., vol. 106, 1989, pages 383 - 388 |
SENDA, M.; SENDA,T.; KIDOKORO,S.: "Crystal Structure Analyses Of Thermolysin In Complex With Its Inhibitors", DIRECT SUBMISSION |
SIDLER,W.; NIEDERER,E.; SUTER,F.; ZUBER,H.: "The primary structure of Bacillus cereus neutral proteinase and comparison with thermolysin and Bacillus subtilis neutral Proteinase", BIOL. CHEM. HOPPE-SEYLER, vol. 367, 1986, pages 643 - 657 |
SIEBER ET AL., SHIPREC, vol. 19, 2001, pages 456 - 60 |
SMITH ET AL., APPL. ENV. MICROBIOL., vol. 51, 1986, pages 634 |
SMITH; WATERMAN, ADV. APPL. MATH, vol. 2, 1981, pages 482 |
STAHL ET AL., J. BACTERIOL., vol. 158, 1984, pages 411 - 418 |
STARK ET AL., EUR. J. BIOCHEM., vol. 207, 1992, pages 207 |
STONER ET AL., BIOTECHNOL PROG., vol. 21, no. 6, 2005, pages 1716 - 23 |
THOMPSON ET AL., NUCLEIC ACIDS RES., vol. 22, 1994, pages 4673 - 4680 |
VELTMAN ET AL., BIOCHEM., vol. 37, 1998, pages 5312 |
VELTMAN ET AL., FEBS, vol. 405, 1997, pages 241 |
VOROBJEVA ET AL., FEMS MICROBIOL. LETT., vol. 7, 1980, pages 261 - 263 |
WANG ET AL., GENE, vol. 69, 1988, pages 39 - 47 |
WARD: "Microbial Enzymes and Biotechnology, Applied Science, London", 1983, article "Proteinases", pages: 251 - 317 |
WEINRAUCH ET AL., J. BACTERIOL., vol. 154, 1983, pages 1077 - 1087 |
WEINRAUCH ET AL., J. BACTERIOL., vol. 169, 1987, pages 1205 - 1211 |
WELLS ET AL., NUCLEIC ACIDS RES., vol. 11, 1983, pages 7911 - 7925 |
WU; CHEN, APPL. BIOL. BIOTECHNOL., vol. 92, 2011, pages 253 |
YAMAGUCHI ET AL., GENE, vol. 103, 1991, pages 61 - 67 |
Cited By (158)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10696958B2 (en) | 2013-05-29 | 2020-06-30 | Danisco Us Inc | Metalloproteases |
WO2016069552A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016069569A2 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016069544A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016069557A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases of bacillus species |
WO2016069548A2 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
EP3550017A1 (en) | 2014-10-27 | 2019-10-09 | Danisco US Inc. | Serine proteases |
EP4403631A2 (en) | 2014-10-27 | 2024-07-24 | Danisco US Inc. | Serine proteases |
EP3872174A1 (en) | 2015-05-13 | 2021-09-01 | Danisco US Inc. | Aprl-clade protease variants and uses thereof |
EP4219704A2 (en) | 2015-05-13 | 2023-08-02 | Danisco US Inc | Aprl-clade protease variants and uses thereof |
WO2016205755A1 (en) | 2015-06-17 | 2016-12-22 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
EP4234693A2 (en) | 2015-06-17 | 2023-08-30 | Danisco US Inc | Bacillus gibsonii-clade serine proteases |
EP4141113A1 (en) | 2015-11-05 | 2023-03-01 | Danisco US Inc | Paenibacillus sp. mannanases |
WO2017079751A1 (en) | 2015-11-05 | 2017-05-11 | Danisco Us Inc | Paenibacillus sp. mannanases |
WO2017079756A1 (en) | 2015-11-05 | 2017-05-11 | Danisco Us Inc | Paenibacillus and bacillus spp. mannanases |
WO2017106676A1 (en) | 2015-12-18 | 2017-06-22 | Danisco Us Inc | Polypeptides with endoglucanase activity and uses thereof |
WO2017192692A1 (en) | 2016-05-03 | 2017-11-09 | Danisco Us Inc | Protease variants and uses thereof |
WO2017192300A1 (en) | 2016-05-05 | 2017-11-09 | Danisco Us Inc | Protease variants and uses thereof |
EP3845642A1 (en) | 2016-05-05 | 2021-07-07 | Danisco US Inc. | Protease variants and uses thereof |
WO2017210295A1 (en) | 2016-05-31 | 2017-12-07 | Danisco Us Inc. | Protease variants and uses thereof |
WO2017219011A1 (en) | 2016-06-17 | 2017-12-21 | Danisco Us Inc | Protease variants and uses thereof |
EP4151726A1 (en) | 2016-06-17 | 2023-03-22 | Danisco US Inc | Protease variants and uses thereof |
EP3275987A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275985A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275988A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275986A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275989A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2018085524A2 (en) | 2016-11-07 | 2018-05-11 | Danisco Us Inc | Laundry detergent composition |
WO2018102479A1 (en) | 2016-12-02 | 2018-06-07 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2018102478A1 (en) | 2016-12-02 | 2018-06-07 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP3330348A1 (en) | 2016-12-02 | 2018-06-06 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP4001389A1 (en) | 2016-12-02 | 2022-05-25 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2018112123A1 (en) | 2016-12-15 | 2018-06-21 | Danisco Us Inc. | Polypeptides with endoglucanase activity and uses thereof |
WO2018118950A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
WO2018118917A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Protease variants and uses thereof |
EP4424805A2 (en) | 2016-12-21 | 2024-09-04 | Danisco Us Inc | Bacillus gibsonii-clade serine proteases |
EP4212622A2 (en) | 2016-12-21 | 2023-07-19 | Danisco US Inc. | Bacillus gibsonii-clade serine proteases |
EP3339423A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2018169750A1 (en) | 2017-03-15 | 2018-09-20 | Danisco Us Inc | Trypsin-like serine proteases and uses thereof |
WO2018184004A1 (en) | 2017-03-31 | 2018-10-04 | Danisco Us Inc | Alpha-amylase combinatorial variants |
WO2019036721A2 (en) | 2017-08-18 | 2019-02-21 | Danisco Us Inc | Alpha-amylase variants |
WO2019108599A1 (en) | 2017-11-29 | 2019-06-06 | Danisco Us Inc | Subtilisin variants having improved stability |
WO2019125986A1 (en) | 2017-12-19 | 2019-06-27 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3502246A1 (en) | 2017-12-19 | 2019-06-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3502244A1 (en) | 2017-12-19 | 2019-06-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019125984A1 (en) | 2017-12-19 | 2019-06-27 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3502245A1 (en) | 2017-12-19 | 2019-06-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019125990A1 (en) | 2017-12-19 | 2019-06-27 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019125985A1 (en) | 2017-12-19 | 2019-06-27 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3502227A1 (en) | 2017-12-19 | 2019-06-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019168649A1 (en) | 2018-02-28 | 2019-09-06 | The Procter & Gamble Company | Cleaning compositions |
WO2019168650A1 (en) | 2018-02-28 | 2019-09-06 | The Procter & Gamble Company | Methods of cleaning |
WO2019245838A1 (en) | 2018-06-19 | 2019-12-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019245705A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
WO2019245839A1 (en) | 2018-06-19 | 2019-12-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019245704A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
WO2020028443A1 (en) | 2018-07-31 | 2020-02-06 | Danisco Us Inc | Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid |
WO2020068486A1 (en) | 2018-09-27 | 2020-04-02 | Danisco Us Inc | Compositions for medical instrument cleaning |
WO2020077331A2 (en) | 2018-10-12 | 2020-04-16 | Danisco Us Inc | Alpha-amylases with mutations that improve stability in the presence of chelants |
CN109355222A (en) * | 2018-11-06 | 2019-02-19 | 上海交通大学 | There is the bacillus of antagonism to rice leaf spot bacteria and separate and apply |
WO2020112599A1 (en) | 2018-11-28 | 2020-06-04 | Danisco Us Inc | Subtilisin variants having improved stability |
WO2020186030A1 (en) | 2019-03-14 | 2020-09-17 | The Procter & Gamble Company | Cleaning compositions comprising enzymes |
WO2020186028A1 (en) | 2019-03-14 | 2020-09-17 | The Procter & Gamble Company | Cleaning compositions comprising enzymes |
WO2020186052A1 (en) | 2019-03-14 | 2020-09-17 | The Procter & Gamble Company | Method for treating cotton |
WO2020237253A1 (en) | 2019-05-22 | 2020-11-26 | The Procter & Gamble Company | Automatic dishwashing method |
EP3741283A1 (en) | 2019-05-22 | 2020-11-25 | The Procter & Gamble Company | Automatic dishwashing method |
WO2020243738A1 (en) | 2019-05-24 | 2020-12-03 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2020242858A1 (en) | 2019-05-24 | 2020-12-03 | Danisco Us Inc | Subtilisin variants and methods of use |
WO2020247582A1 (en) | 2019-06-06 | 2020-12-10 | Danisco Us Inc | Methods and compositions for cleaning |
WO2021081547A2 (en) | 2019-10-24 | 2021-04-29 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising a protease |
WO2021081548A1 (en) | 2019-10-24 | 2021-04-29 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising an amylase |
WO2021080948A2 (en) | 2019-10-24 | 2021-04-29 | Danisco Us Inc | Variant maltopentaose/maltohexaose-forming alpha-amylases |
WO2021118814A1 (en) | 2019-12-09 | 2021-06-17 | The Procter & Gamble Company | A detergent composition comprising a polymer |
EP3835396A1 (en) | 2019-12-09 | 2021-06-16 | The Procter & Gamble Company | A detergent composition comprising a polymer |
WO2021158429A1 (en) | 2020-02-04 | 2021-08-12 | The Procter & Gamble Company | Detergent composition |
EP3862412A1 (en) | 2020-02-04 | 2021-08-11 | The Procter & Gamble Company | Detergent composition |
WO2021247801A1 (en) | 2020-06-05 | 2021-12-09 | The Procter & Gamble Company | Detergent compositions containing a branched surfactant |
EP3950912A1 (en) | 2020-08-04 | 2022-02-09 | The Procter & Gamble Company | Automatic dishwashing method |
WO2022031310A1 (en) | 2020-08-04 | 2022-02-10 | The Procter & Gamble Company | Automatic dishwashing method |
WO2022031312A1 (en) | 2020-08-04 | 2022-02-10 | The Procter & Gamble Company | Automatic dishwashing method and pack |
WO2022031309A1 (en) | 2020-08-04 | 2022-02-10 | The Procter & Gamble Company | Automatic dishwashing method |
WO2022031311A1 (en) | 2020-08-04 | 2022-02-10 | The Procter & Gamble Company | Automatic dishwashing method |
EP3950911A1 (en) | 2020-08-04 | 2022-02-09 | The Procter & Gamble Company | Automatic dishwashing method |
EP3950913A1 (en) | 2020-08-04 | 2022-02-09 | The Procter & Gamble Company | Automatic dishwashing method and pack |
EP3949824A1 (en) | 2020-08-04 | 2022-02-09 | The Procter & Gamble Company | Automatic dishwashing method |
WO2022047149A1 (en) | 2020-08-27 | 2022-03-03 | Danisco Us Inc | Enzymes and enzyme compositions for cleaning |
WO2022043745A1 (en) | 2020-08-28 | 2022-03-03 | Kerry Luxembourg S.a.r.l. | Feed composition supplemented with a protease combination comprising neutral metalloprotease and serine alkaline protease at a given ratio |
WO2022094589A1 (en) | 2020-10-29 | 2022-05-05 | The Procter & Gamble Company | Cleaning compositions containing alginase enzymes |
WO2022094590A1 (en) | 2020-10-29 | 2022-05-05 | The Procter & Gamble Company | Cleaning compositions containing alginate lyase enzymes |
WO2022094164A1 (en) | 2020-10-29 | 2022-05-05 | The Procter & Gamble Company | Cleaning composition comprising alginate lyase enzymes |
WO2022094588A1 (en) | 2020-10-29 | 2022-05-05 | The Procter & Gamble Company | Cleaning compositions containing alginate lyase enzymes |
WO2022094163A1 (en) | 2020-10-29 | 2022-05-05 | The Procter & Gamble Company | Cleaning composition comprising alginate lyase enzymes |
EP4001387A1 (en) | 2020-11-17 | 2022-05-25 | The Procter & Gamble Company | Automatic dishwashing composition commprising amphiphilic graft polymer |
EP4001390A1 (en) | 2020-11-17 | 2022-05-25 | The Procter & Gamble Company | Automatic dishwashing method with alkaline rinse |
WO2022108611A1 (en) | 2020-11-17 | 2022-05-27 | The Procter & Gamble Company | Automatic dishwashing method with alkaline rinse |
WO2022108766A1 (en) | 2020-11-17 | 2022-05-27 | The Procter & Gamble Company | Automatic dishwashing composition comprising amphiphilic graft polymer |
WO2022108765A1 (en) | 2020-11-17 | 2022-05-27 | The Procter & Gamble Company | Automatic dishwashing method with amphiphilic graft polymer in the rinse |
EP4001388A1 (en) | 2020-11-17 | 2022-05-25 | The Procter & Gamble Company | Automatic dishwashing method with amphiphilic graft polymer in the rinse |
EP4006131A1 (en) | 2020-11-30 | 2022-06-01 | The Procter & Gamble Company | Method of laundering fabric |
WO2022136389A1 (en) | 2020-12-23 | 2022-06-30 | Basf Se | Amphiphilic alkoxylated polyamines and their uses |
WO2022165107A1 (en) | 2021-01-29 | 2022-08-04 | Danisco Us Inc | Compositions for cleaning and methods related thereto |
EP4060010A2 (en) | 2021-03-15 | 2022-09-21 | The Procter & Gamble Company | Cleaning compositions containing polypeptide variants |
WO2022197512A1 (en) | 2021-03-15 | 2022-09-22 | The Procter & Gamble Company | Cleaning compositions containing polypeptide variants |
EP4095223A1 (en) | 2021-05-05 | 2022-11-30 | The Procter & Gamble Company | Methods for making cleaning compositions and for detecting soils |
WO2022235720A1 (en) | 2021-05-05 | 2022-11-10 | The Procter & Gamble Company | Methods for making cleaning compositions and detecting soils |
WO2022236297A1 (en) | 2021-05-06 | 2022-11-10 | The Procter & Gamble Company | Surface treatment |
EP4086330A1 (en) | 2021-05-06 | 2022-11-09 | The Procter & Gamble Company | Surface treatment |
EP4108767A1 (en) | 2021-06-22 | 2022-12-28 | The Procter & Gamble Company | Cleaning or treatment compositions containing nuclease enzymes |
WO2022272255A1 (en) | 2021-06-22 | 2022-12-29 | The Procter & Gamble Company | Cleaning or treatment compositions containing nuclease enzymes |
WO2023278297A1 (en) | 2021-06-30 | 2023-01-05 | Danisco Us Inc | Variant lipases and uses thereof |
WO2023004215A1 (en) | 2021-07-19 | 2023-01-26 | The Procter & Gamble Company | Composition comprising spores and pro-perfume materials |
WO2023003633A1 (en) | 2021-07-19 | 2023-01-26 | The Procter & Gamble Company | Fabric treatment using bacterial spores |
EP4123006A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Composition comprising spores and pro-perfume materials |
EP4123007A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Fabric treatment using bacterial spores |
WO2023034486A2 (en) | 2021-09-03 | 2023-03-09 | Danisco Us Inc. | Laundry compositions for cleaning |
WO2023064749A1 (en) | 2021-10-14 | 2023-04-20 | The Procter & Gamble Company | A fabric and home care product comprising cationic soil release polymer and lipase enzyme |
EP4194537A1 (en) | 2021-12-08 | 2023-06-14 | The Procter & Gamble Company | Laundry treatment cartridge |
EP4194536A1 (en) | 2021-12-08 | 2023-06-14 | The Procter & Gamble Company | Laundry treatment cartridge |
WO2023107804A1 (en) | 2021-12-08 | 2023-06-15 | The Procter & Gamble Company | Laundry treatment cartridge |
WO2023107803A1 (en) | 2021-12-08 | 2023-06-15 | The Procter & Gamble Company | Laundry treatment cartridge |
WO2023114795A1 (en) | 2021-12-16 | 2023-06-22 | The Procter & Gamble Company | Automatic dishwashing composition comprising a protease |
WO2023114932A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114936A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114939A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114988A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Variant maltopentaose/maltohexaose-forming alpha-amylases |
WO2023114793A1 (en) | 2021-12-16 | 2023-06-22 | The Procter & Gamble Company | Home care composition |
WO2023114792A1 (en) | 2021-12-16 | 2023-06-22 | The Procter & Gamble Company | Home care composition comprising an amylase |
WO2023114794A1 (en) | 2021-12-16 | 2023-06-22 | The Procter & Gamble Company | Fabric and home care composition comprising a protease |
WO2023168234A1 (en) | 2022-03-01 | 2023-09-07 | Danisco Us Inc. | Enzymes and enzyme compositions for cleaning |
WO2023215679A1 (en) | 2022-05-04 | 2023-11-09 | The Procter & Gamble Company | Detergent compositions containing enzymes |
WO2023215680A1 (en) | 2022-05-04 | 2023-11-09 | The Procter & Gamble Company | Machine-cleaning compositions containing enzymes |
EP4273209A1 (en) | 2022-05-04 | 2023-11-08 | The Procter & Gamble Company | Machine-cleaning compositions containing enzymes |
EP4273210A1 (en) | 2022-05-04 | 2023-11-08 | The Procter & Gamble Company | Detergent compositions containing enzymes |
EP4279571A1 (en) | 2022-05-19 | 2023-11-22 | The Procter & Gamble Company | Laundry composition comprising spores |
WO2023224754A1 (en) | 2022-05-19 | 2023-11-23 | The Procter & Gamble Company | Laundry composition comprising spores |
WO2023250301A1 (en) | 2022-06-21 | 2023-12-28 | Danisco Us Inc. | Methods and compositions for cleaning comprising a polypeptide having thermolysin activity |
EP4321604A1 (en) | 2022-08-08 | 2024-02-14 | The Procter & Gamble Company | A fabric and home care composition comprising surfactant and a polyester |
WO2024036126A1 (en) | 2022-08-08 | 2024-02-15 | The Procter & Gamble Company | A fabric and home care composition comprising surfactant and a polyester |
WO2024050346A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Detergent compositions and methods related thereto |
WO2024050343A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Subtilisin variants and methods related thereto |
WO2024050339A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Mannanase variants and methods of use |
WO2024094800A1 (en) | 2022-11-04 | 2024-05-10 | The Procter & Gamble Company | Fabric and home care composition |
WO2024094803A1 (en) | 2022-11-04 | 2024-05-10 | The Procter & Gamble Company | Fabric and home care composition |
WO2024094802A1 (en) | 2022-11-04 | 2024-05-10 | The Procter & Gamble Company | Fabric and home care composition |
WO2024102698A1 (en) | 2022-11-09 | 2024-05-16 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024119298A1 (en) | 2022-12-05 | 2024-06-13 | The Procter & Gamble Company | Fabric and home care composition comprising a polyalkylenecarbonate compound |
WO2024129520A1 (en) | 2022-12-12 | 2024-06-20 | The Procter & Gamble Company | Fabric and home care composition |
EP4386074A1 (en) | 2022-12-16 | 2024-06-19 | The Procter & Gamble Company | Fabric and home care composition |
EP4388967A1 (en) | 2022-12-19 | 2024-06-26 | The Procter & Gamble Company | Dishwashing method |
WO2024132625A1 (en) | 2022-12-20 | 2024-06-27 | Basf Se | Cutinases |
EP4389864A1 (en) | 2022-12-20 | 2024-06-26 | Basf Se | Cutinases |
EP4410941A1 (en) | 2023-02-01 | 2024-08-07 | The Procter & Gamble Company | Detergent compositions containing enzymes |
WO2024163695A1 (en) | 2023-02-01 | 2024-08-08 | The Procter & Gamble Company | Detergent compositions containing enzymes |
WO2024163584A1 (en) | 2023-02-01 | 2024-08-08 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024186819A1 (en) | 2023-03-06 | 2024-09-12 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024191711A1 (en) | 2023-03-16 | 2024-09-19 | Nutrition & Biosciences USA 4, Inc. | Brevibacillus fermentate extracts for cleaning and malodor control and use thereof |
CN117487724B (en) * | 2023-12-29 | 2024-03-22 | 东北林业大学 | Bacillus proteolyticus CWJ-2-GJ and application thereof |
CN117487724A (en) * | 2023-12-29 | 2024-02-02 | 东北林业大学 | Bacillus proteolyticus CWJ-2-GJ and application thereof |
Also Published As
Publication number | Publication date |
---|---|
EP3004342A2 (en) | 2016-04-13 |
JP6367930B2 (en) | 2018-08-01 |
US20160108387A1 (en) | 2016-04-21 |
US20200115693A1 (en) | 2020-04-16 |
JP6612398B2 (en) | 2019-11-27 |
WO2014194117A3 (en) | 2015-01-22 |
JP2016527876A (en) | 2016-09-15 |
US20180073006A1 (en) | 2018-03-15 |
EP3004342B1 (en) | 2023-01-11 |
JP2018186821A (en) | 2018-11-29 |
US20240229001A1 (en) | 2024-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3004342A2 (en) | Novel metalloproteases | |
US10450553B2 (en) | Polypeptides having protease activity and polynucleotides encoding same | |
EP1713919A2 (en) | Protease variants | |
US10144922B2 (en) | Subtilase variants and compositions comprising the same | |
AU701759B2 (en) | Crystal structure and mutants of interleukin-1beta converting enzyme | |
CN104781400A (en) | Compositions and methods comprising thermolysin protease variants | |
EP1590454A2 (en) | Subtilases | |
EP1002061A1 (en) | FAMILY 6 ENDO-1,4-$g(b)-GLUCANASE VARIANTS AND CLEANING COMPOSIT IONS CONTAINING THEM | |
WO2015189371A1 (en) | Alpha-amylase variants and polynucleotides encoding same | |
WO2015038792A1 (en) | Compositions and methods comprising lg12-clade protease variants | |
US20070015240A1 (en) | Subtilases | |
CN105452456A (en) | Novel metalloproteases | |
AU2007204226B2 (en) | ACE N-domain crystal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201480042744.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14737359 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014737359 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2016516828 Country of ref document: JP Kind code of ref document: A |